Anilide derivative, production and use thereof

ABSTRACT

This invention is to provide a compound of the formula: ##STR1## wherein R 1  is an optionally substituted 5- to 6-membered ring: C is a divalent group of the formula: ##STR2## wherein the ring A is an optionally substituted 5- to 6-membered aromatic ring, X is an optionally substituted C, N or O atom, and the ring B is an optionally substituted 5- to 7-membered ring; Z is a chemical bond or a divalent group; R 2  is (1) an optionally substituted amino group in which a nitrogen atom may form a quaternary ammonium, etc., or a salt thereof, which is useful for antagonizing MCP-1 receptor.

TECHNICAL FIELD

The present invention relates to an anilide derivative or a salt thereofhaving antagonistic activity on MCP-1 (monocyte chemoattractantprotein-1) receptor, production method and use thereof.

BACKGROUND ART

MCP-1 is known to be a monocyte chemotactic factor relating toinflammatory diseases, and belongs to CC chemokine sub-family. MCP-1 isfound to express not only from monocyte but also from cardiac musclecell, blood vessel endothelial cell, fibroblast, chondrocyte, smoothmuscle cell, mesangial cell, aveolar cell, T lymphocyte, macrophage,etc. in various pathosis (specifically, angiostenosis, arteriosclerosis,rheumatic arthritis, diabetic microangiopathy, granulomatousinflammation (tuberculosis, sarcoidosis, etc.), solid cancer, diastoliccardiomyopathy (chronic heart failure, etc.), glomerulonephritis, etc.),and MCP-1 deeply relate to crisis and progression these pathosis.Therefore, MCP-1 receptor antagonists are used as a medicament for thetreatment and prophylaxis of these pathosis.

So far, there have been only a little reports on low molecule compoundshaving antagonistic activity on MCP-1 receptor. For example, it isdisclosed that aryloxy-propanolamine derivatives being active asβ-blocker show weak inhibitory activity on MCP-1 binding to its receptorin JP-A-25756/1995 and that phenylethanolamine derivatives havingsympathetic activity and sympatholytic activity show weak inhibitoryactivity on MCP-1 binding to its receptor in JP-A-25757/1995.

On the other hand, phosphonic acid derivatives having osteogenesisactivity is disclosed in JP-A-73476/1996 but there is no description onMCP-1 receptor antagonistic activity.

The present invention is to provide a new anilide derivative or a saltthereof having antagonistic activity on MCP-1 receptor and therapeuticand prophylactic effect on cardiac infarction, myocarditis,cardiomyopathy, chronic heart failure, restenosis after angioplasty,disorder after reperfusion in lung and heart, inflammatory diseases(e.g. arteriosclerosis, arteriosclerosis after heart transplantation,(chronic) rheumatic arthritis, nephritis, etc.), rejection after organtransplantation, fibroid lung, renal insufficiency, diabetic diseases(e.g. diabetes, diabetic nephropathy, diabetic complication, diabeticretinopathy, diabetic retinitis, diabetic microangiopathy, etc.), tumor(e.g. bladder cancer, breast carcinoma, cervical carcinoma, chroniclymphocytic leukemia, chronic myelocytic leukemia, colon carcinoma,multiple myeloma, malignant myeloma, prostatic cancer, lung cancer,stomach cancer, Hodgkin's disease, etc.) infectious diseases (e.g.tuberculosis, invasive staphylococcia, etc.), etc.; production methodand use thereof.

DISCLOSURE OF INVENTION

The present inventors diligently made extensive studies on compoundshaving MCP-1 receptor antagonistic activity and, as a result, they foundthat an anilide derivative of the following formula (I) or a saltthereof [hereinafter, referred to as Compound (I)] unexpectedlypossesses potent MCP-1 receptor antagonistic activity and clinicallydesirable pharmaceutical effect. Based on the finding, the presentinvention was accomplished.

More specifically, the present invention relates to

(1) a compound of the formula: ##STR3## wherein R¹ is an optionallysubstituted 5- to 6-membered ring, W is a divalent group of the formula:##STR4## wherein the ring A is an optionally substituted 5- to6-membered aromatic ring, X is an optionally substituted carbon atom, anoptionally substituted nitrogen atom, sulfur atom or oxygen atom, thering B is an optionally substituted 5- to 7-membered ring, Z is achemical bond or a divalent group, R² is (1) an optionally substitutedamino group in which a nitrogen atom may form a quaternary ammonium, (2)an optionally substituted nitrogen-containing heterocyclic ring groupwhich may contain a sulfur atom or an oxygen atom as ring constitutingatoms and wherein a nitrogen atom may form a quaternary ammonium, (3) agroup binding through a sulfur atom or (4) a group of the formula:##STR5## wherein k is 0 or 1, and when k is 0, a phosphorus atom mayform a phosphonium; and R⁵ and R⁶ are independently an optionallysubstituted hydrocarbon group or an optionally substituted amino group,and R⁵ and R⁶ may bind to each other to form a cyclic group togetherwith the adjacent phosphorus atom, or a salt thereof;

(2) a compound of the above (1), wherein R¹ is benzene, furan,thiophene, pyridine, cyclopentane, cyclohexane, pyrrolidine, piperidine,piperazine, morpholine, thiomorpholine or tetrahydropyran, each of whichmay be substituted;

(3) a compound of the above (1), wherein R¹ is an optionally substitutedbenzene;

(4) a compound of the above (1), wherein the ring A is furan, thiophene,pyrrole, pyridine or benzene, each of which may be substituted;

(5) a compound of the above (1), wherein the ring A is an optionallysubstituted benzene;

(6) a compound of the above (1), wherein W is a group of the formula:##STR6## wherein each symbol is as defined in the above (1); (7) acompound of the above (1), wherein W is a group of the formula: ##STR7##wherein each symbol is as defined in the above (1); (8) a compound ofthe above (7), wherein the ring B is a 5- to 7-membered ring group ofthe formula: ##STR8## wherein Y is --Y'--(CH₂)_(m) -- (Y'is --S--,--O--, --NH-- or --CH₂ --, and m is an integer of 0-2), --CH═CH-- or--N═CH--), which may have a substituent at any possible position;

(9) a compound of the above (8), wherein Y is --Y'--(CH₂)₂ -- (Y' is--S--, --O--, --NH-- or --CH₂ --);

(10) a compound of the above (8), wherein Y is --(CH₂)₂ --, --(CH₂)₃ --or --O--(CH₂)₂ --;

(11) a compound of the above (10), wherein the ring A is an optionallysubstituted benzene;

(12) a compound of the above (1), wherein Z is an optionally substitutedC₁₋₃ alkylene;

(13) a compound of the above (1), wherein Z is a divalent group of theformula: --Z'--(CH₂)_(n) -- (Z' is --CH(OH)--, --C(O)-- or --CH₂ --, andn is an integer of 0-2) in which an optional methylene group may besubstituted;

(14) a compound of the above (1), wherein Z is methylene;

(15) a compound of the above (1), wherein Z is substituted at paraposition of the benzene ring;

(16) a compound of the above (1), wherein R² is (1) an optionallysubstituted amino group in which a nitrogen atom may form a quaternaryammonium, (2) an optionally substituted nitrogen-containing heterocyclicring group which may contain a sulfur atom or an oxygen atom as ringconstituting atoms and wherein a nitrogen atom may form a quaternaryammonium, or (3) a group of the formula: ##STR9## wherein R⁵ and R⁶ areindependently an optionally substituted hydrocarbon group, and R⁵ and R⁶may bind to each other to form a cyclic group together with the adjacentphosphorus atom;

(17) a compound of the formula: ##STR10## wherein X⁻ is an anion; (18) acompound of the above (17), wherein X is a halogen atom;

(19) a compound selected from the class consisting of

N-methyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]-piperidiniumiodide,

N-methyl-N-[4-[[[7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl]carbonyl]amino]benzyl]piperidiniumiodide,

N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxmide,

N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-7-(4-morpholinophenyl)-2,3-dihydro-1-benzoxepine-4-carboxmide,

7-(4-ethoxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxmide,

N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]-N-(tetrahydropyran-4-yl)ammoniumiodide and

N-methyl-N-[4-[[[7-(4-methylphenyl)-3,4-dihydro-naphthalen-2-yl]carbonyl]amino]benzyl]piperidiniumiodide,

or a salt thereof;

(20) a method for producing a compound of the formula: ##STR11## whereineach symbol is as defined above (1) or a salt thereof, which comprisessubjecting a compound of the formula:

    R.sup.1 --W--COOH                                          (II)

wherein each symbol is as defined above (1), a salt or a reactivederivative thereof to condensation reaction with a compound of theformula: ##STR12## wherein Z is as defined above (1) and R² ' is (1) anoptionally substituted amino group in which a nitrogen atom may form aquaternary ammonium, (2) an optionally substituted nitrogen-containingheterocyclic ring group which may contain a sulfur atom or an oxygenatom as ring constituting atoms and wherein a nitrogen atom may form aquaternary ammonium, (3) a group binding through a sulfur atom or (4) agroup of the formula: ##STR13## wherein k is 0 or 1, and when k is 0, aphosphorus atom may form a phosphonium; and R⁵ and R⁶ are independentlyan optionally substituted hydrocarbon group or an optionally substitutedamino group, and R⁵ and R⁶ may bind to each other to form a cyclic grouptogether with the adjacent phosphorus atom, the above groups (1)-(4)being optionally protected, or a salt thereof, and, if desired,subjecting the obtained product to deprotection, oxidation, reductionand/or ammoniumation;

(21) 3-(4-methylphenyl)-8,9-dihydro-7H-benzocycloheptene-6-carboxylicacid or a salt thereof;

(22) a pharmaceutical composition comprising a compound of the above (1)or a salt thereof;

(23) a composition of the above (22), which is for antagonizing MCP-1receptor;

(24) a composition of the above (22), which is for the treatment orprophylaxis of cardiac infarction or myocarditis;

(25) a pharmaceutical composition for antagonizing MCP-1 receptor (or apharmaceutical composition for inhibiting binding of MCP-1 (a ligand) toMCP-1 receptor or a pharmaceutical composition for antagonizing bindingof MCP-1 to its receptor), which comprises a compound of the formula:##STR14## wherein R¹ is an optionally substituted 5- to 6-membered ring,W is a divalent group of the formula: ##STR15## wherein the ring A is anoptionally substituted 5- to 6-membered aromatic ring, X is anoptionally substituted carbon atom, an optionally substituted nitrogenatom, sulfur atom or oxygen atom, the ring B is an optionallysubstituted 5- to 7-membered ring, Z is a chemical bond or a divalentgroup, R² is (1) an optionally substituted amino group in which anitrogen atom may form a quaternary ammonium, (2) an optionallysubstituted nitrogen-containing heterocyclic ring group which maycontain a sulfur atom or an oxygen atom as ring constituting atoms andwherein a nitrogen atom may form a quaternary ammonium, (3) a groupbinding through a sulfur atom or (4) a group of the formula: ##STR16##wherein k is 0 or 1, and when k is 0, a phosphorus atom may form aphosphonium; and R⁵ ' and R⁶ ' are independently an optionallysubstituted hydrocarbon group, an optionally substituted hydroxy groupor an optionally substituted amino group, and R⁵ ' and R⁶ ' may bind toeach other to form a cyclic group together with the adjacent phosphorusatom, or a salt thereof;

(26) a method for antagonizing MCP-1 receptor which comprisesadministering to a mammal in need thereof an effective amount of acompound of the formula: ##STR17## wherein R¹ is an optionallysubstituted 5- to 6-membered ring; W is a divalent group of the formula:##STR18## wherein the ring A is an optionally substituted 5- to6-membered aromatic ring, X is an optionally substituted carbon atom, anoptionally substituted nitrogen atom, sulfur atom or oxygen atom, andthe ring B is an optionally substituted 5- to 7-membered ring; Z is achemical bond or a divalent group; R² is (1) an optionally substitutedamino group in which a nitrogen atom may form a quaternary ammonium, (2)an optionally substituted nitrogen-containing heterocyclic ring groupwhich may contain a sulfur atom or an oxygen atom as ring constitutingatoms and wherein a nitrogen atom may form a quaternary ammonium, (3) agroup binding through a sulfur atom or (4) a group of the formula:##STR19## wherein k is 0 or 1, and when k is 0, a phosphorus atom mayform a phosphonium; and R⁵ ' and R6' are independently an optionallysubstituted hydrocarbon group, an optionally substituted hydroxy groupor an optionally substituted amino group, and R⁵ ' and R⁶ ' may bind toeach other to form a cyclic group together with the adjacent phosphorusatom, or a salt thereof;

(27) a method for antagonizing MCP-1 receptor which comprisesadministering to a mammal in need thereof an effective amount of acompound of the above (1) or a salt thereof;

(28) use of a compound of the formula: ##STR20## wherein R is anoptionally substituted 5- to 6-membered ring; W is a divalent group ofthe formula: ##STR21## wherein the ring A is an optionally substituted5- to 6-membered aromatic ring, X is an optionally substituted carbonatom, an optionally substituted nitrogen atom, sulfur atom or oxygenatom, and the ring B is an optionally substituted 5- to 7-membered ring;Z is a chemical bond or a divalent group; R² is (1) an optionallysubstituted amino group in which a nitrogen atom may form a quaternaryammonium, (2) an optionally substituted nitrogen-containing heterocyclicring group which may contain a sulfur atom or an oxygen atom as ringconstituting atoms and wherein a nitrogen atom may form a quaternaryammonium, (3) a group binding through a sulfur atom or (4) a group ofthe formula: ##STR22## wherein k is 0 or 1, and when k is 0, aphosphorus atom may form a phosphonium; and R⁵ ' and R⁶ ' areindependently an optionally substituted hydrocarbon group, an optionallysubstituted hydroxy group or an optionally substituted amino group, andR⁵ ' and R⁶ ' may bind to each other to form a cyclic group togetherwith the adjacent phosphorus atom, or a salt thereof, for themanufacture of a medicament for antagonizing MCP-1 receptor;

(29) use of a compound of the above (1) or a salt thereof for themanufacture of a medicament for antagonizing MCP-1 receptor; etc.

In the above formula (I), examples of the "5- to 6-membered ring" of the"optionally substituted 5- to 6-membered ring" represented by R¹ includea 6-membered aromatic hydrocarbon such as benzene, etc.; a 5- to6-membered aliphatic hydrocarbon such as cyclopentane, cyclohexane,cyclopentene, cyclohexene, cyclopentanediene, cyclohexanediene, etc.; 5-to 6-membered aromatic heterocyclic ring containing 1 to 4 hetero-atomsconsisting of 1 to 2 kinds of hetero-atoms selected from oxygen atom,sulfur atom and nitrogen atom such as furan, thiophene, pyrrole,imidazole, pyrazole, thiazole, oxazole, isothiazole, isoxazole,tetrazole, pyridine, pyrazine, pyrimidine, pyridazine, triazole, etc.;5- to 6-membered non-aromatic heterocyclic ring containing 1 to 4hetero-atoms consisting of 1 to 2 kinds of hetero-atoms selected fromoxygen atom, sulfur atom and nitrogen atom such as tetrahydrofuran,tetrahydrothiophene, dithiolane, oxathiolane, pyrrolidine, pyrroline,imidazolidine, imidazoline, pyrazolidine, pyrazoline, piperidine,piperazine, oxazine, oxadiazine, thiazine, thiadiazine, morpholine,thiomorpholine, pyran, tetrahydropyran, tetrahydrothiopyran, etc.; etc.Among others, benzene, furan, thiophene, pyridine, cyclopentane,cyclohexane, pyrrolidine, piperidine, piperazine, morpholine,thiomorpholine, tetrahydropyran (preferably, 6-membered ring), etc. arepreferable, and in particular, benzene is preferable.

Example of the "substituents" which the "5- to 6-membered ring" in the"optionally substituted 5- to 6-membered ring" represented by R¹ mayhave include halogen atom, nitro, cyano, an optionally substitutedalkyl, an optionally substituted cycloalkyl, an optionally substitutedhydroxy group, an optionally substituted thiol group wherein a sulfuratom may be optionally oxidized to form a sulfinyl group or a sulfonylgroup, an optionally substituted amino group, an optionally substitutedacyl, an optionally esterified carboxyl group, an optionally substitutedaromatic group, etc.

Examples of the halogen as the substituents for R¹ include fluorine,chlorine, bromine, iodine, etc. Among others, fluorine and chlorine arepreferable.

Examples of the alkyl in the optionally substituted alkyl as thesubstituents for R¹ include a straight or branched C₁₋₁₀ alkyl such asmethyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl,tert-butyl, pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl,decyl, etc., and preferably lower (C₁₋₆) alkyl.

Examples of the substituents in the optionally substituted alkyl includehalogen (e.g. fluorine, chlorine, bromine, iodine, etc.), nitro, cyano,hydroxy group, thiol group, amino group, carboxyl group, an optionallyhalogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy,trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.),C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl, ethanesulfonyl, etc.), etc.,and the number of the substituents are preferably 1 to 3.

Examples of the cycloalkyl in the optionally substituted cycloalkyl asthe substituents for R¹ include C₃₋₇ cycloalkyl, etc. such ascyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, etc.

Examples of the substituents in the optionally substituted cycloalkylinclude halogen (e.g. fluorine, chlorine, bromine, iodine, etc.), nitro,cyano, hydroxy group, thiol group, amino group, carboxyl group, anoptionally halogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl, ethyl,etc.), an optionally halogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy,trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g. acetyl,propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

Examples of the substituents in the optionally substituted hydroxy groupas the substituents for R¹ include

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl, 3-hexenyl, etc., preferably lower (C₂₋₆)alkenyl,etc.);

(4) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.):

(5) an optionally substituted aralkyl (e.g. phenyl-C₁₋₄ alkyl (e.g.benzyl, phenethyl, etc.), etc.);

(6) an optionally substituted acyl (e.g. C₂₋₄ alkanoyl (e.g. acetyl,propionyl, butyryl, isobutyryl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc.);

(7) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.); etc.

Examples of the substituents which the above-mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted alkenyl, (4) optionally substituted cycloalkenyl, (5)optionally substituted aralkyl, (6) optionally substituted acyl and (7)optionally substituted aryl may have include halogen (e.g. fluorine,chlorine, bromine, iodine, etc.), nitro, cyano, hydroxy group, thiolgroup, amino group, carboxyl group, an optionally halogenated C₁₋₄ alkyl(e.g. trifluoromethyl, methyl, ethyl, etc.), an optionally halogenatedC₁₋₄ alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy,etc.), C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl(e.g. methanesulfonyl, ethanesulfonyl, etc.), etc., and the number ofthe substituents are preferably 1 to 3.

Examples of the substituents in the optionally substituted thiol groupas the substituents for R¹ are similar to the above-describedsubstituents in the optionally substituted hydroxy group as thesubstituents for R¹, and among others,

(1) an optionally substituted alkyl (e.g. C₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted aralkyl (e.g. phenyl-C₁₋₄ alkyl (e.g.benzyl, phenethyl, etc.), etc.);

(4) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.); etc.are preferable.

Examples of the substituents which the above-mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted aralkyl and (4) optionally substituted aryl may have includehalogen (e.g. fluorine, chlorine, bromine, iodine, etc.), nitro, cyano,hydroxy group, thiol group, amino group, carboxyl group, an optionallyhalogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl, ethyl, etc.), anoptionally halogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy,trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g. acetyl,propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

Examples of the substituents in the optionally substituted amino groupas the substituents for R¹ are similar to the above-describedsubstituents in the optionally substituted hydroxy group as thesubstituents for R¹, and examples of the optionally substituted aminogroup as the substituents for R¹ include an amino group which may haveone to two substituents selected from the above-described substituentsin the optionally substituted hydroxy group as the substituents for R¹,etc. Among others, as the substituents in the optionally substitutedamino group as the substituents for R¹,

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl, 3-hexenyl, etc., preferably lower (C₂₋₆) alkenyl,etc.);

(4) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.);

(5) an optionally substituted acyl (e.g. C₂₋₄ alkanoyl (e.g. acetyl,propionyl, butyryl, isobutyryl, etc.), C₁₋₄ alkylsulf onyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc.);

(6) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.); etc.are preferable.

Examples of the substituents, which each of the above-described (1)optionally substituted alkyl, (2) optionally substituted cycloalkyl, (3)optionally substituted alkenyl, (4) optionally substituted cycloalkenyl,(5) optionally substituted acyl and (6) optionally substituted aryl mayhave, include halogen (e.g. fluorine, chlorine, bromine, iodine, etc.),nitro, cyano, hydroxy group, thiol group, amino group, carboxyl group,an optionally halogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl,ethyl, etc.), an optionally halogenated C₁₋₄ alkoxy (e.g. methoxy,ethoxy, trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g.acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

The substituents in the optionally substituted amino group as thesubstituents for R¹ may bind to each other to form a cyclic amino group(e.g. 5- to 6-membered cyclic amino, etc. such as tetrahydropyrrole,piperazine, piperidine, morpholine, thiomorpholine, pyrrole, imidazole,etc.). Said cyclic amino group may have a substituent, and examples ofthe substituents include halogen (e.g. fluorine, chlorine, bromine,iodine, etc.), nitro, cyano, hydroxy group, thiol group, amino group,carboxyl group, an optionally halogenated C₁₋₄ alkyl (e.g.trifluoromethyl, methyl, ethyl, etc.), an optionally halogenated C₁₋₄alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy, etc.),C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc., and the number of thesubstituents are preferably 1 to 3.

Examples of the optionally substituted acyl as the substituents for R¹include a carbonyl group or a sulfonyl group binding to

(1) hydrogen;

(2) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(3) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(4) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl,3-hexenyl, etc., preferably lower (C₂₋₆) alkenyl,etc.);

(5) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.);

(6) an optionally substituted 5- to 6-membered monocyclic aromatic group(e.g. phenyl, pyridyl, etc.); etc.

Examples of the acyl include acetyl, propionyl, butyryl, isobutyryl,valeryl, isovaleryl, pivaloyl, hexanoyl, heptanoyl, octanoyl,cyclobutanecarbonyl, cyclopentanecarbonyl, cyclohexanecarbonyl,cycloheptanecarbonyl, crotonyl, 2-cyclohexenecarbonyl, benzoyl,nicotinoyl, methanesulfonyl, ethanesulfonyl, etc.

Examples of the substituents, which the above-mentioned (2) optionallysubstituted alkyl, (3) optionally substituted cycloalkyl, (4) optionallysubstituted alkenyl, (5) optionally substituted cycloalkenyl and (6)optionally substituted 5- to 6-membered monocyclic aromatic group mayhave, include halogen (e.g. fluorine, chlorine, bromine, iodine, etc.),nitro, cyano, hydroxy group, thiol group, amino group, carboxyl group,an optionally halogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl,ethyl, etc.), an optionally halogenated C₁₋₄ alkoxy (e.g. methoxy,ethoxy, trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g.acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

Examples of the optionally esterified carboxyl group as the substituentsfor R¹ include a carbonyloxy group binding to

(1) hydrogen;

(2) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(3) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(4) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl, 3-hexenyl, etc., preferably lower (C₂₋₆) alkenyl,etc.);

(5) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.);

(6) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.); etc.,and preferably carboxyl, lower (C₁₋₆) alkoxycarbonyl, aryloxycarbonyl(e.g. methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, phenoxycarbonyl,naphthoxycarbonyl, etc.), etc.

Examples of the substituents, which the above-mentioned (2) optionallysubstituted alkyl, (3) optionally substituted cycloalkyl, (4) optionallysubstituted alkenyl, (5) optionally substituted cycloalkenyl and (6)optionally substituted aryl may have, include halogen (e.g. fluorine,chlorine, bromine, iodine, etc.), nitro, cyano, hydroxy group, thiolgroup, amino group, carboxyl group, an optionally halogenated C₁₋₄ alkyl(e.g. trifluoromethyl, methyl, ethyl, etc.), an optionally halogenatedC₁₋₄ alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy,etc.), C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl(e.g. methanesulfonyl, ethanesulfonyl, etc.), etc., and the number ofthe substituents are preferably 1 to 3.

Examples of the aromatic group in the optionally substituted aromaticgroup as the substituents for R¹ include 5- to 6-membered homocyclic orheterocyclic ring aromatic ring, etc. suchasphenyl, pyridyl, furyl,thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl,isothiazolyl, isoxazolyl, tetrazolyl, pyrazinyl, pyrimidinyl,pyridazinyl, triazolyl, etc.

Examples of the substituents for these aromatic group include halogen(e.g. fluorine, chlorine, bromine, iodine, etc.), nitro, cyano,hydroxygroup, thiol group, amino group, carboxyl group, an optionallyhalogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl, ethyl, etc.), anoptionally halogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy,trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g. acetyl,propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

The number of the above-mentioned substituents for R¹ is 1-4 (preferably1-2) and they may be same or different and present at any possibleposition on the ring represented by R¹. When two or more substituentsare present on the 5- to 6-membered ring in the "an optionallysubstituted 5- to 6-membered ring" represented by R¹, two substituentsamong them may bind to each other to form a lower (C₁₋₆) alkylene (e.g.trimethylene, tetramethylene, etc.), a lower (C₁₋₆) alkyleneoxy (e.g.--CH₂ --O--CH₂ --, --O--CH₂ --CH₂ --, etc.), a lower (C₁₋₆)alkylenedioxy (e.g. --O--CH₂ --O--, --O--CH₂ --CH₂ --O--, etc.), a lower(C₂₋₆) alkenylene (e.g. --CH₂ --CH═CH--, --CH₂ --CH₂ --CH═CH--, --CH₂--CH═CH--CH₂ --, etc.), a lower (C₄₋₆) alkadienylene (e.g.--CH═CH--CH═CH--, etc.), etc.

Preferred examples of the "substituents", which the "5- to 6-memberedring" in the "an optionally substituted 5- to 6-membered ring"represented by R¹ may have, include an optionally halogenated lower(C₁₋₄) alkyl (e.g. methyl, ethyl, t-butyl, trifluoromethyl, etc.), anoptionally halogenated lower (C₁₋₄) alkoxy (e.g. methoxy, ethoxy,t-butoxy, trifluoromethoxy, etc.), halogen (e.g. fluorine, chlorine,etc.), nitro, cyano, an amino group optionally substituted with 1-2lower (C₁₋₄) alkyl groups (e.g. amino, methylamino, dimethylamino,etc.), 5- to 6-membered cyclic amino (e.g. 1-pyrrolidinyl,1-piperazinyl, 1-piperidinyl, 4-morpholino, 4-thiomorpholin,1-imidazolyl, 4-tetrahydropyranyl, etc.), etc., and when R¹ is abenzene, the "substituent" is preferably present at para position.

In the above formula (I), examples of the "5- to 6-membered aromaticring" in the "optionally substituted 5- to 6-membered aromatic ring"represented by A include 6-membered aromatic hydrocarbon such asbenzene, etc.; 5- to 6-membered aromatic heterocyclic ring containing 1to 3 hetero-atoms consisting of 1 to 2 kinds of hetero-atoms selectedfrom oxygen atom, sulfur atom and nitrogen atom such as furan,thiophene, pyrrole, imidazole, pyrazole, thiazole, oxazole, isothiazole,isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, triazole, etc.;etc. Among others, benzene, furan, thiophene, pyridine (preferably,6-membered ring) etc. are preferable, and in particular benzene ispreferable.

Examples of the "substituents", which the "5- to 6-membered aromaticring" in the "optionally substituted 5- to 6-membered aromatic ring"represented by A may have, are similar to the "substituents" which the"5- to 6-membered ring" in the "optionally substituted 5- to 6-memberedring" represented by R¹ may have. The number of said substituents forthe ring A is 1-4 (preferably 1-2), and they may be same or differentand present at any possible position (e.g. the position of the group Xand the other positions) on the ring represented by A.

In the above formula (I), a group of the formula: ##STR23## binds toadjacent groups in the following manner: ##STR24##

In the above formula (I), examples of the "5- to 7-membered ring" in the"optionally substituted 5- to 7-membered ring" represented by B includea 5- to 7-membered ring group of the formula: ##STR25## which may have asubstituent at any possible position, etc.

In the above formula, the divalent group represented by Y may be anydivalent group as far as the ring B forms an optionally substituted 5-to 7-membered ring, and preferred examples of the divalent groupsinclude

(1) --(CH₂)_(a1) --O--(CH₂)_(a2) -- (a₁ and a₂ are same or different and0, 1 or 2, provided that the sum of a₁ and a₂ is 2 or less),--O--(CH═CH)--, --(CH═CH)--O--;

(2) --(CH₂)_(b1) --S--(CH₂)_(b2) -- (b₁ and b₂ are same or different and0, 1 or 2, provided that the sum of b₁ and b₂ is 2 or less),--S--(CH═CH)--, --(CH═CH)--S--;

(3) --(CH₂)_(d1) -- (d₁ is 1, 2 or 3), --CH₂ --(CH═CH)--, --(CH═CH)--CH₂ --, --CH═CH--;

(4) --(CH₂)_(e1) --NH--(CH₂)_(e2) -- (e₁ and e₂ are same or differentand 0, 1 or 2, provided that the sum of e₁ and e₂ is 2 or less),--NH--(CH═CH)--, --(CH═CH)--NH--, --(CH₂)_(e6) --(N═CH)--(CH₂)_(e7) --,--(CH₂)_(e7) --(CH═N)--(CH₂)_(e6) -- (one of e₆ and e₇ is 0, and theother is 1), --(CH₂)_(e8) --(N═N) --(CH₂)_(e9) --(one of e₈ and e₉ is 0,and the other is 1); etc. More preferred examples of the divalent groupsinclude --O--, --O--CH₂ --, --O--CH₂ --CH₂ --, --O--CH═CH--, --S--,--S--CH₂ --, --S--CH₂ --CH₂ --, --S--CH═CH--, --CH₂ --, --(CH₂)₂ --,--(CH₂)₃ --, --CH═CH--, --CH═CH--CH₂ --, --CH₂ --CH═CH--, --NH--,--N═CH--, --CH═N--, --N═N-- (in which each of the above formulasrepresent that it binds to the ring A through its left chemical bond),etc.

The divalent group may have a substituent. Examples of the substituentinclude those for the "5- to 6-membered ring" in the "optionallysubstituted 5- to 6-membered ring" represented by R¹ and an oxo group,etc. Among others, a lower (C₁₋₃) alkyl (e.g. methyl, ethyl, propyl,etc.), a phenyl group, an oxo group, a hydroxy group, etc. arepreferable. In addition, the divalent group may be --O--C(0)--(in whicheach of the above formulas represent that it binds to the ring A throughits left chemical bond), etc. The number of the substituents arepreferably 1 to 4 (preferably, 1-2), and they may be same or differentand bind to the divalent group at any possible position.

As the divalent group represented by Y, a group of the formula:--Y'--(CH₂)_(m) --(Y' is --S--, --O--, --NH-- or --CH₂ --, and m is aninteger of 0-2), --CH═CH--, --N═CH--, --(CH₂)_(m) --Y'-- (Y' is --S--,--O--, --NH--or --CH₂ --, and m is an integer of 0-2), --CH═N-- (inwhich each of the above formulas represent that it binds to the ring Athrough its left chemical bond), etc. is preferable. Among others, agroup of the formula: --Y'--(CH₂)_(m) -- (Y' is --S--, --O--, --NH-- or--CH₂ --, and m is an integer of 0-2), --CH═CH--, --N═CH-- (in whicheach of the above formulas represent that it binds to the ring A throughits left chemical bond), etc. is preferable. In particular, Y ispreferably a group of the formula: --Y'--(CH₂)₂ -- (Y' is --S----O--,--NH-- or --CH₂ -- (preferably --S--, --O-- or --CH₂ --, more preferably--O-- or --CH₂ --)) in which the formula binds to the ring A through itsleft chemical bond, etc.; and the ring B is preferably a 7-memberedring. As the divalent group represented by Y, a group of the formula:--(CH₂)₂ --, --(CH₂)₃ -- or --O--(CH₂)₂ -- is preferable.

Examples of the "substituents", which the "5- to 7-membered ring" in the"optionally substituted 5- to 7-membered ring" represented by B mayhave, include those for the "5- to 6-membered ring" in the "optionallysubstituted 5- to 6-membered ring" represented by R¹ and an oxo group,etc. The number of the substituents are preferably 1 to 4 (preferably,1-2), and they may be same or different and bind to the divalent groupat any possible position.

In a group of the formula: ##STR26## represented by W, a carbon atom atthe position a is preferably unsubstituted.

In the above formula (I), examples of the divalent group represented byZ include an optionally substituted divalent group whose straight chainis constituted by 1 to 4 carbon atoms (e.g. C₁₋₄ alkylene, C₂₋₄alkenylene, etc., preferably C₁₋₃ alkylene, more preferably methylene),etc. The group Z may be bound to any possible position of the benzenering, and preferably to para position of the benzene ring.

The divalent group represented by Z may be any divalent group whosestraight chain is constituted by 1 to 4 atoms and exemplified by analkylene chain of the formula: --(CH₂)_(k1) -- (k₁ is an integer of1-4), an alkenylene chain of the formula: --(CH₂)_(k2)--(CH═CH)--(CH₂)_(k3) -- (k₂ and k₃ are same or different and 0, 1 or 2,provided that the sum of k₂ and k₃ is 2 or less), etc.

Examples of the substituent for the divalent group represented by Zinclude any one which is capable of binding to the straight chain of thedivalent group, and preferably C₁₋₆ lower alkyl (e.g. methyl, ethyl,propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl,isopentyl, neopentyl, hexyl, etc.), lower (C₃₋₇) cycloalkyl (e.g.cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, etc.), anoptionally esterified phosphono group, an optionally esterified carboxylgroup, hydroxy group, oxo, etc., and more preferably C₁₋₆ lower alkyl(preferably C₁₋₃ alkyl), hydroxy group, oxo, etc.

Examples of the optionally esterified phosphono group include a group ofthe formula: P(O) (OR⁷) (OR⁸) wherein R⁷ and R⁸ are independentlyhydrogen, a C₁₋₆ alkyl group or a C₃₋₇ cycloalkyl group, and R⁷ and R⁸may bind to each other to form a 5- to 7-membered ring.

In the above formula, examples of the C₁₋₆ alkyl group represented by R⁷and R⁸ include methyl, ethyl, propyl, isopropyl, butyl, isobutyl,sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, etc., andexamples of the C₃₋₇ cycloalkyl include cyclopropyl, cyclobutyl,cyclopentyl, cyclohexyl, cycloheptyl, etc. Among other, a straight C₁₋₆lower alkyl is preferable and C₁₋₃ lower alkyl is more preferable. Thegroups R⁷ and R⁸ may be same or different, and preferably the groups R⁷and R⁸ are same. When R⁷ and R⁸ may bind to each other to form a 5- to7-membered ring, the groups R ⁷ and R⁸ bind to each other to represent astraight C₂₋₄ alkylene chain of the formula: --(CH₂)₂ --, --(CH₂)₃ --,--(CH₂)₄ --, etc. Said chain may have a substituent, and examples of thesubstituent include hydroxy group, halogen, etc.

Examples of the optionally esterified carboxyl group include a carboxylgroup and an ester group formed by binding a carboxyl group to a C₁₋₆alkyl group or a C₃₋₇ cycloalkyl group (e.g. methoxycarbonyl,ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl,isobutoxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl,pentyloxycarbonyl, hexyloxycarbonyl, etc.).

As the divalent group represented by Z, an optionally substituted C₁₋₃alkylene is preferable, and C₁₋₃ alkylene which may be substituted byC₁₋₃ alkyl, hydroxy group or oxo is more preferable.

Among others, as the divalent group represented by Z, a group of theformula: --Z'--(CH₂)_(n) -- or --(CH₂)_(n) --Z'-- (Z' is --CH(OH)--,--C(O)-- or --CH₂ --, and n is an integer of 0-2) in which each of theabove formulas represent that it binds to the benzene ring through itsleft chemical bond and each of the methylene groups may be substitutedby 1-2 same or different substituents is preferable, a group of theformula: --Z'--(CH₂)_(n) -- (Z' is --CH(OH)--, --C(O)-- or --CH₂ --, andn is an integer of 0-2 (preferably, n is 0)) in which the formula bindsto the benzene ring through its left chemical bond and each of themethylene groups may be substituted by 1-2 same or differentsubstituents is more preferable, and methylene is particularlypreferable.

In the above-mentioned formula (I), examples of the "amino group" in the"optionally substituted amino group in which a nitrogen atom may form aquaternary ammonium" represented by R² include an amino group which mayhave 1-2 substituents, an amino group having 3 substituents wherein thenitrogen atom forms a quaternary ammonium, etc. When the number of thesubstituents on the nitrogen atom is 2 or more, these substituents maybe same or different. When the total number of the substituents andhydrogen atoms on the nitrogen atom is 3, the "amino group" representedby R² may be any type of an amino group represented by the formula: --N⁺R₃, --N⁺ R₂ R' or --N⁺ RR'R" (R, R' and R" are independently a hydrogenatom or a substituent). Examples of the counter anion of the amino groupwherein the nitrogen atom forms a quaternary ammonium include an anionof a halogen atom (e.g. Cl⁻⁻, Br⁻⁻, I⁻⁻, etc.), etc., and also an anionderived from an inorganic acid such as hydrochloric acid, hydrobromicacid, nitric acid, sulfuric acid, phosphoric acid, etc.; an anionderived from an organic acid such as formic acid, acetic acid,trifluoroacetic acid, fumaric acid, oxalic acid, tartaric acid, maleicacid, citric acid, succinic acid, malic acid, methanesulfonic acid,benzenesulfonic acid, p-toluenesulfonic acid, etc.; an anion derivedfrom an acidic amino acid such as aspartic acid, glutamic acid, etc.;etc. Among others, Cl⁻⁻, Br⁻⁻, I⁻⁻, etc. are preferable.

Examples of the substituents for said amino group include

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₈ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,cyclooctyl, etc.), provided that

(2-1) said cycloalkyl may contain one hetero-atom selected from a sulfuratom, an oxygen atom and a nitrogen atom to form oxirane, thiorane,aziridine, tetrahydrofuran, tetrahydrothiophene, pyrrolidine,tetrahydropyran, tetrahydrothiopyran, tetrahydrothiopyran 1-oxide,piperidine, etc. (preferably, 6-membered ring such as tetrahydropyran,tetrahydrothiopyran, piperidine, etc.) and these groups preferably bindto the amino group at their 3- or 4-position (preferably, 4-position),that

(2-2) said cycloalkyl may be fused with a benzene ring to form indane,tetrahydronaphthalene, etc. (preferably, indane, etc.), and that

(2-3) said cycloalkyl may have a bridging comprising a straight chainconstituted by 1-2 carbon atoms to form a bridged hydrocarbon residuesuch as bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl, bicyclo[3.2.1]octyl,bicyclo[3.2.2]nonyl, etc., preferably, a cyclohexyl group, etc. having abridging comprising a straight chain constituted by 1-2 carbon atoms,and more preferably bicyclo[2.2.1]heptyl, etc.;

(3) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl,3-hexenyl, etc., preferably lower (C₂₋₆)alkenyl,etc.);

(4) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.);

(5) an optionally substituted aralkyl (e.g. phenyl-C₁₋₄ alkyl (e.g.benzyl, phenethyl, etc.), etc.);

(6) an optionally substituted acyl (e.g. C₂₋₄ alkanoyl (e.g. acetyl,propionyl, butyryl, isobutyryl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc.);

(7) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.);

(8) an optionally substituted heterocyclic ring group (e.g. 5- to6-membered aromatic heterocyclic ring containing 1 to 4 hetero-atomsconsisting of 1 to 2 kinds of hetero-atoms selected from oxygen atom,sulfur atom and nitrogen atom such as furan, thiophene, pyrrole,imidazole, pyrazole, thiazole, oxazole, isothiazole, isoxazole,tetrazole, pyridine, pyrazine, pyrimidine, pyridazine, triazole, etc.;5- to 6-membered non-aromatic heterocyclic ring containing 1 to 4hetero-atoms consisting of 1 to 2 kinds of hetero-atoms selected fromoxygen atom, sulfur atom and nitrogen atom such as tetrahydrofuran,tetrahydrothiophene, dithiolane, oxathiolane, pyrrolidine, pyrroline,imidazolidine, imidazoline, pyrazolidine, pyrazoline, piperidine,piperazine, oxazine, oxadiazine, thiazine, thiadiazine, morpholine,thiomorpholine, pyran, tetrahydropyran, etc.; etc.; preferably 5- to6-membered non-aromatic heterocyclic ring, etc.; more preferably 5- to6-membered non-aromatic heterocyclic ring containing one hetero-atom,etc. such as tetrahydrofuran, piperidine, tetrahydropyran,tetrahydrothiopyran, etc.); etc.

Examples of the substituents, which the above-mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted alkenyl, (4) optionally substituted cycloalkenyl, (5)optionally substituted aralkyl, (6) optionally substituted acyl, (7)optionally substituted aryl and (8) optionally substituted heterocyclicring group may have, include halogen (e.g. fluorine, chlorine, bromine,iodine, etc.), an optionally halogenated lower (C₁₋₄) alkyl, anoptionally halogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy,trifluoromethoxy, trifluoroethoxy, etc.), C₁₋₄ alkylenedioxy (e.g.--O--CH₂ --O--, --O--CH₂ --CH₂ --O--, etc.), C₂₋₄ alkanoyl (e.g. acetyl,propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), phenyl-lower (C₁₋₄) alkyl, C₃₋₇ cycloalkyl,cyano, nitro, hydroxy group, thiol group, amino group, carboxyl group,lower (C₁₋₄) alkoxy-carbonyl (preferably, halogen, an optionallyhalogenated lower (C₁₋₄) alkyl, an optionally halogenated lower (C₁₋₄)alkoxy, phenyl-lower (C₁₋₄) alkyl, C₃₋₇ cycloalkyl, cyano, hydroxygroup, etc.), etc., and the number of the substituents are preferably 1to 3.

In the above formula (I), preferred examples of the "optionallysubstituted amino group in which a nitrogen atom may form a quaternaryammonium" represented by R² include an amino group which may have 1-3substituents selected from

(1) a straight or branched lower (C₁₋₆) alkyl which may have 1 to 3substituents selected from halogen, cyano, hydroxy group or C₃₋₇cycloalkyl;

(2) a C₅₋₈ cycloalkyl which may have 1 to 3 substituents selected fromhalogen, an optionally halogenated lower (C₁₋₄) alkyl or phenyl-lower(C₁₋₄) alkyl, which may contain one hetero-atom selected from a sulfuratom, an oxygen atom and a nitrogen atom, which may be fused with abenzene ring, and which may have a bridging comprising a straight chainconstituted by 1-2 carbon atoms (e.g. cyclopentyl, cyclohexyl,cycloheptyl, cyclooctyl, tetrahydropyranyl, tetrahydrothiapyranyl,piperidinyl, indanyl, tetrahydronaphthalenyl, bicyclo[2.2.1]heptyl,etc., each of which may be substituted);

(3) a phenyl-lower (C₁₋₄) alkyl which may have 1 to 3 substituentsselected from halogen, an optionally halogenated lower (C₁₋₄) alkyl oran optionally halogenated lower (C₁₋₄) alkoxy;

(4) a phenyl which may have 1 to 3 substituents selected from halogen,an optionally halogenated lower (C₁₋₄) alkyl or an optionallyhalogenated lower (C₁₋₄) alkoxy; and

(5) a 5- to 6-membered aromatic heterocyclic ring (e.g. furan,thiophene, pyrrole, pyridine, etc.) which may have 1 to 3 substituentsselected from halogen, an optionally halogenated lower (C₁₋₄) alkyl, anoptionally halogenated lower (C₁₋₄) alkoxy, an optionally halogenatedlower (C₁₋₄) alkoxy-lower (C₁₋₄) alkoxy, phenyl-lower (C₁₋₄) alkyl,cyano or hydroxy group.

In the above formula (I), examples of the "nitrogen-containingheterocyclic ring" in the "optionally substituted nitrogen-containingheterocyclic ring group which may contain a sulfur atom or an oxygenatom as ring constituting atoms and wherein a nitrogen atom may form aquaternary ammonium" include a 5- to 6-membered aromatic heterocyclicring which may contain 1 to 3 hetero-atoms consisting of 1 to 2 kinds ofhetero-atoms selected from an oxygen atom, a sulfur atom and a nitrogenatom other than one nitrogen atom such as pyrrole, imidazole, pyrazole,thiazole, oxazole, isothiazole, isoxazole, tetrazole, pyridine,pyrazine, pyrimidine, pyridazine, triazole, etc.; 5-8 memberednon-aromatic heterocyclic ring which may contain 1 to 3 hetero-atomsconsisting of 1 to 2 kinds of hetero-atoms selected from an oxygen atom,a sulfur atom and a nitrogen atom other than one nitrogen atom such aspyrrolidine, pyrroline, imidazolidine, imidazoline, pyrazolidine,pyrazoline, piperidine, piperazine, oxazine, oxadiazine, thiazine,thiadiazine, morpholine, thiomorpholine, azacycloheptane, azacyclooctane(azocane), etc.; etc. These nitrogen-containing heterocyclic rings mayhave a bridging comprising a straight chain constituted by 1-2 carbonatoms to form a bridged nitrogen-containing heterocyclic ringazabicyclo[2.2.1]heptane, azabicyclo[2.2.2]octane (quinuclidine), etc.(preferably, piperidine having a bridging comprising a straight chainconstituted by 1-2 carbon atoms, etc.).

Among the above-exemplified nitrogen-containing heterocyclic rings,pyridine, imidazole, pyrrolidine, piperidine, piperazine, morpholine,thiomorpholine, azabicyclo[2.2.2]octane (preferably, a 6-membered ring)are preferable.

The nitrogen atom of said "nitrogen-containing heterocyclic ring" mayform a quaternary ammonium or may be oxidized. When the nitrogen atom ofsaid "nitrogen-containing heterocyclic ring" forms a quaternaryammonium, examples of the counter anion of the "nitrogen-containingheterocyclic ring wherein the nitrogen atom forms a quaternary ammonium"include an anion of a halogen atom (e.g. Cl⁻⁻, Br⁻⁻, I⁻⁻, etc.), etc.,and also an anion derived from an inorganic acid such as hydrochloricacid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid,etc.; an anion derived from an organic acid such as formic acid, aceticacid, trifluoroacetic acid, fumaric acid, oxalic acid, tartaric acid,maleic acid, citric acid, succinic acid, malic acid, methanesulfonicacid, benzenesulfonic acid, p-toluenesulfonic acid, etc.; an anionderived from an acidic amino acid such as aspartic acid, glutamic acid,etc.; etc. Among others, Cl⁻⁻, Br⁻⁻, I⁻⁻, etc. are preferable.

Said "nitrogen-containing heterocyclic ring" may bind to the divalentgroup represented by Z through either a carbon atom or a nitrogen atom,and may be 2-pyridyl, 3-pyridyl, 2-piperidinyl, etc. which binds to thedivalent group represented by Z through a carbon atoms. Preferably, the"nitrogen-containing heterocyclic ring" binds to the divalent grouprepresented by Z through a nitrogen atom, as exemplified by thefollowing formulas: ##STR27##

Examples of the substituents, which said "nitrogen containingheterocyclic ring" may have, include halogen (e.g. fluorine, chlorine,bromine, iodine, etc.), an optionally substituted lower (C₁₋₄) alkyl, anoptionally substituted lower (C₁₋₄) alkoxy, an optionally substitutedphenyl, an optionally substituted mono- or di-phenyl-lower (C₁₋₄) alkyl,an optionally substituted C₃₋₇ cycloalkyl, cyano, nitro, hydroxy group,thiol group, amino group, carboxyl group, lower (C₁₋₄) alkoxy-carbonyl,lower (C₂₋₄) alkanoyl, lower (C₁₋₄) alkylsulf onyl, an optionallysubstituted heterocyclic ring group (e. g. 5- to 6-membered aromaticheterocyclic ring containing 1 to 4 hetero-atoms consisting of 1 to 2kinds of hetero-atoms selected from an oxygen atom, a sulfur atom and anitrogen atom such as furan, thiophene, pyrrole, imidazole, pyrazole,thiazole, oxazole, isothiazole, isoxazole, tetrazole, pyridine,pyrazine, pyrimidine, pyridazine, triazole, etc.; 5- to 6-memberednon-aromatic heterocyclic ring containing 1 to 4 hetero-atoms consistingof 1 to 2 kinds of hetero-atoms selected from an oxygen atom, a sulfuratom and a nitrogen atom such as tetrahydrofuran, tetrahydrothiophene,dithiolane, oxathiolane, pyrrolidine, pyrroline, imidazolidine,imidazoline, pyrazolidine, pyrazoline, piperidine, piperazine, oxazine,oxadiazine, thiazine, thiadiazine, morpholine, thiomorpholine, pyran,tetrahydropyran, tetrahydrothiopyran, etc.; etc.), etc., and the numberof the substituents is preferably 1-3.

Examples of the substituent, which the "optionally substituted lower(C₁₋₄,) alkyl", the "optionally substituted lower (C₁₋₄) alkoxy", the"optionally substituted phenyl", the "optionally substituted mono- ordi-phenyl-lower (C₁₋₄) alkyl", the "optionally substituted C₃₋₇cycloalkyl" and the "optionally substituted heterocyclic ring group" asa substituent for said "nitrogen-containing heterocyclic ring" may have,include halogen (e.g. fluorine, chlorine, bromine, iodine, etc.), anoptionally halogenated lower (C₁₋₄) alkyl, an optionally halogenatedC₁₋₄ alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy,etc.), C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl(e.g. methanesulfonyl, ethanesulfonyl, etc.), C₁₋₃ alkylenedioxy (e.g.methylenedioxy, ethylenedioxy, etc.), cyano, nitro, hydroxy group, thiolgroup, amino group, carboxyl group, lower (C₁₋₄) alkoxy-carbonyl, etc.,and the number of the substituents are preferably 1 to 3.

In the above formula (I), preferred example of the substituents for the"nitrogen-containing heterocyclic ring" in the "optionally substitutednitrogen-containing heterocyclic ring group which may contain a sulfuratom or an oxygen atom as ring constituting atoms and wherein a nitrogenatom may form a quaternary ammonium" include (1) halogen, (2) cyano, (3)hydroxy group, (4) carboxyl group, (5) lower (C₁₋₄) alkoxy-carbonyl, (6)lower (C₁₋₄) alkyl which may be substituted with halogen, hydroxy groupor lower (C₁₋₄) alkoxy, (7) lower (C₁₋₄,) alkoxy which may besubstituted with halogen, hydroxy group or lower (C₁₋₄) alkoxy, (8)phenyl which may be substituted with halogen, lower (C₁₋₄) alkyl,hydroxy group, lower (C₁₋₄) alkoxy or C₁₋₃ alkylenedioxy, (9) mono- ordi-phenyl-lower (C₁₋₄) alkyl whose benzene ring may be substituted withhalogen, lower (C₁₋₄) alkyl, hydroxy group, lower (C₁₋₄) alkoxy or C₁₋₃alkylenedioxy, (10) 5- to 6-membered aromatic heterocyclic ring such asfuran, thiophene, pyrrole, pyridine, etc., etc.

In the above formula (I), examples of the "group binding through asulfur atom" represented by R² include a group of the formula:--S(O)_(m) --R^(s) wherein m is an integer of 0-2, and R^(s) is asubstituent.

In the above formula, preferred examples of the "substituent"represented by R^(s) include

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted aralkyl (e.g. phenyl-C₁₋₄ alkyl (e.g.benzyl, phenethyl, etc.), etc.);

(4) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.) etc.

Examples of the substituent, which the above-mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted aralkyl and (4) an optionally substituted aryl may have,include halogen (e.g. fluorine, chlorine, bromine, iodine, etc.), nitro,cyano, hydroxy group, thiol group, amino group, carboxyl group, anoptionally halogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl, ethyl,etc.), an optionally halogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy,trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g. acetyl,propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

In the above formula (I), examples of the "hydrocarbon group" in the"optionally substituted hydrocarbon group" represented by R⁵ and R⁶ ofthe "group of the formula: ##STR28## wherein k is 0 or 1, and when k is0, a phosphorus atom may form a phosphonium; and R⁵ and R⁶ areindependently an optionally substituted hydrocarbon group or anoptionally substituted amino group, and R⁵ and R⁶ may bind to each otherto form a cyclic group together with the adjacent phosphorus atom"represented by R² include

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl,3-hexenyl, etc., preferably lower (C₂₋₆) alkenyl,etc.);

(4) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.);

(5) an optionally substituted alkynyl (e.g. C₂₋₁₀ alkynyl such asethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-pentynyl, 3-hexynyl, etc.,preferably lower (C₂₋₆) alkynyl, etc.);

(6) an optionally substituted aralkyl (e.g. phenyl-C₁₋₄ alkyl (e.g.benzyl, phenethyl, etc.), etc.);

(7) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.); etc.

Examples of the substituents, which the above-mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted alkenyl, (4) optionally substituted cycloalkenyl, (5)optionally substituted alkynyl, (6) optionally substituted aralkyl and(7) optionally substituted aryl may have, include halogen (e.g.fluorine, chlorine, bromine, iodine, etc.), nitro, cyano, hydroxy group,thiol group, amino group, carboxyl group, an optionally halogenated C₁₋₄alkyl (e.g. trifluoromethyl, methyl, ethyl, etc.), an optionallyhalogenated C₁₋₄ alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy,trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.),C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl, ethanesulfonyl, etc.), etc.,and the number of the substituents are preferably 1 to 3.

Examples of the optionally substituted amino group represented by R⁵ andR⁶ include an amino group which may have 1-2 substituents selected from

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl,3-hexenyl, etc., preferably lower (C₂₋₆)alkenyl,etc.);

(4) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl suchas 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc., etc.);

(5) an optionally substituted acyl (e.g. C₂₋₄ alkanoyl (e.g. acetyl,propionyl, butyryl, isobutyryl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc.);

(6) an amino group which may have 1-2 optionally substituted aryl groups(e.g. phenyl, naphthyl, etc.); etc.

Examples of the substituent, which the above mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted alkenyl, (4) optionally substituted cycloalkenyl, (5)optionally substituted acyl and (6) optionally substituted aryl mayhave, include halogen (e.g. fluorine, chlorine, bromine, iodine, etc.),nitro, cyano, hydroxy group, thiol group, amino group, carboxyl group,an optionally halogenated C₁₋₄ alkyl (e.g. trifluoromethyl, methyl,ethyl, etc.), an optionally halogenated C₁₋₄ alkoxy (e.g. methoxy,ethoxy, trifluoromethoxy, trifluoroethoxy, etc.), C₂₋₄ alkanoyl (e.g.acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g. methanesulfonyl,ethanesulfonyl, etc.), etc., and the number of the substituents arepreferably 1 to 3.

In the above formula, the groups R⁵ and R⁶ may bind to each other toform a cyclic group (preferably, 5- to 7-membered ring) together withthe adjacent phosphorus atom. Said cyclic group may have a substituent.Examples of the substituent include halogen (e.g. fluorine, chlorine,bromine, iodine, etc.), nitro, cyano, hydroxy group, thiol group, aminogroup, carboxyl group, an optionally halogenated C₁₋₄ alkyl (e.g.trifluoromethyl, methyl, ethyl, etc.), an optionally halogenated C₁₋₄alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy, etc.),C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc., and the number of thesubstituents are preferably 1 to 3.

In the above formula (I), examples of the counter anion, when thephosphorus atom forms a phosphonium, include an anion of a halogen atom(e.g. Cl⁻⁻, Br⁻⁻, I⁻⁻, etc.), etc., and also an anion derived from aninorganic acid such as hydrochloric acid, hydrobromic acid, nitric acid,sulfuric acid, phosphoric acid, etc.; an anion derived from an organicacid such as formic acid, acetic acid, trifluoroacetic acid, fumaricacid, oxalic acid, tartaric acid, maleic acid, citric acid, succinicacid, malic acid, methanesulfonic acid, benzenesulfonic acid,p-toluenesulfonic acid, etc.; an anion derived from an acidic amino acidsuch as aspartic acid, glutamic acid, etc.; etc. Among others, Cl⁻⁻,Br⁻⁻, I⁻⁻, etc. are preferable.

As the group R², (1) an optionally substituted amino group in which anitrogen atom may form a quaternary ammonium, (2) an optionallysubstituted nitrogen-containing heterocyclic ring group which maycontain a sulfur atom or an oxygen atom as ring constituting atoms andwherein a nitrogen atom may form a quaternary ammonium, (3) a group ofthe formula: ##STR29## wherein R⁵ and R⁶ are independently an optionallysubstituted hydrocarbon group, and R⁵ and R⁶ may bind to each other toform a cyclic group together with the adjacent phosphorus atom, etc. arepreferable.

In the above formula (I'), examples of the "optionally substitutedhydrocarbon group" and the "optionally substituted amino group"represented by R⁵ ' and R⁶ ' in the "group of the formula: ##STR30##wherein k is 0 or 1, and when k is 0, a phosphorus atom may form aphosphonium; and R⁵ ' and R⁶ ' are independently an optionallysubstituted hydrocarbon group, an optionally substituted hydroxy groupor an optionally substituted amino group, and R⁵ ' and R⁶ ' may bind toeach other to form a cyclic group together with the adjacent phosphorusatom" represented by R² include those exemplified as the "optionallysubstituted hydrocarbon group" and the "optionally substituted aminogroup" represented by R⁵ and R⁶, respectively.

In the above formula (I'), examples of the "optionally substitutedhydroxy group" represented by R⁵ ' and R⁶ ' include a hydroxy groupwhich may-have

(1) an optionally substituted alkyl (e.g. C₁₋₁₀ alkyl such as methyl,ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl,pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.,preferably lower (C₁₋₆) alkyl, etc.);

(2) an optionally substituted cycloalkyl (e.g. C₃₋₇ cycloalkyl, etc.such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl,etc.);

(3) an optionally substituted alkenyl (e.g. C₂₋₁₀ alkenyl such as allyl,crotyl, 2-pentenyl,3-hexenyl, etc., preferably lower (C₂₋₆)alkenyl,etc.);

(4) an optionally substituted cycloalkenyl (e.g. C₃₋₇ cycloalkenyl, etc.such as 2-cyclopentenyl, 2-cyclohexenyl, 2-cyclopentenylmethyl,2-cyclohexenylmethyl, etc.);

(5) an optionally substituted aralkyl (e.g. phenyl-C₁₋₄ alkyl (e.g.benzyl, phenethyl, etc.), etc.);

(6) an optionally substituted acyl (e.g. C₂₋₄ alkanoyl (e.g. acetyl,propionyl, butyryl, isobutyryl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc.);

(7) an optionally substituted aryl (e.g. phenyl, naphthyl, etc.); etc.

Examples of the substituents, which the above-mentioned (1) optionallysubstituted alkyl, (2) optionally substituted cycloalkyl, (3) optionallysubstituted alkenyl, (4) optionally substituted cycloalkenyl, (5)optionally substituted aralkyl, (6) optionally substituted acyl and (7)optionally substituted aryl may have, include halogen (e.g. fluorine,chlorine, bromine, iodine, etc.), nitro, cyano, hydroxy group, thiolgroup, amino group, carboxyl group, an optionally halogenated C₁₋₄ alkyl(e.g. trifluoromethyl, methyl, ethyl, etc.), an optionally halogenatedC₁₋₄ alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy,etc.), C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl(e.g. methanesulfonyl, ethanesulfonyl, etc.), etc., and the number ofthe substituents are preferably 1 to 3.

In the above formula, the groups R⁵ ' and R⁶ ' may bind to each other toform a cyclic group (preferably, 5- to 7-membered ring) together withthe adjacent phosphorus atom. Said cyclic group may have a substituent.Examples of the substituent include halogen (e.g. fluorine, chlorine,bromine, iodine, etc.), nitro, cyano, hydroxy group, thiol group, aminogroup, carboxyl group, an optionally halogenated C₁₋₄ alkyl (e.g.trifluoromethyl, methyl, ethyl, etc.), an optionally halogenated C₁₋₄alkoxy (e.g. methoxy, ethoxy, trifluoromethoxy, trifluoroethoxy, etc.),C₂₋₄ alkanoyl (e.g. acetyl, propionyl, etc.), C₁₋₄ alkylsulfonyl (e.g.methanesulfonyl, ethanesulfonyl, etc.), etc., and the number of thesubstituents are preferably 1 to 3.

In the above formula (I'), examples of the counter anion, when thephosphorus atom forms a phosphonium, include an anion of a halogen atom(e.g. Cl⁻⁻, Br⁻⁻, I⁻⁻, etc.), etc., and also an anion derived from aninorganic acid such as hydrochloric acid, hydrobromic acid, nitric acid,sulfuric acid, phosphoric acid, etc.; an anion derived from an organicacid such as formic acid, acetic acid, trifluoroacetic acid, fumaricacid, oxalic acid, tartaric acid, maleic acid, citric acid, succinicacid, malic acid, methanesulfonic acid, benzenesulfonic acid,p-toluenesulfonic acid, etc.; an anion derived from an acidic amino acidsuch as aspartic acid, glutamic acid, etc.; etc. Among others, Cl⁻⁻,Br⁻⁻, I⁻⁻, etc. are preferable.

As the group R², (1) an optionally substituted amino group in which anitrogen atom may form a quaternary ammonium is preferable, and a groupof the formula:

--N⁺ RR'R" wherein R, R' and R" are independently an optionallysubstituted aliphatic hydrocarbon group or an optionally substitutedalicyclic heterocyclic ring group is more preferable.

Among the Compound (I), a compound of the formula: ##STR31## wherein R¹is an optionally substituted benzene or an optionally substitutedthiophene; Y" is --CH₂ --, --S-- or --O--; and R, R' and R" areindependently an optionally substituted aliphatic hydrocarbon group oran optionally substituted alicyclic heterocyclic ring group ispreferable.

Examples of the "optionally substituted aliphatic hydrocarbon group" andthe "optionally substituted alicyclic heterocyclic ring group"represented by R, R' or R" include those exemplified by the substituentsfor the "optionally substituted amino" represented by R². Among them, asthe group R or R', an optionally substituted acyclic hydrocarbon groupis preferable, an optionally substituted C₁₋₆ alkyl group is morepreferable, and methyl is most preferable; and as the group R", anoptionally substituted alicyclic hydrocarbon group (more preferably, anoptionally substituted C₃₋₈ cycloalkyl group; further more preferably,an optionally substituted cyclohexyl) or an optionally substitutedalicyclic heterocyclic ring group (more preferably, an optionallysubstituted saturated alicyclic heterocyclic ring group (preferably6-membered ring group); further more preferably, an optionallysubstituted tetrahydropyranyl, an optionally substitutedtetrahydrothiopyranyl or an optionally substituted piperidyl; mostpreferably, an optionally substituted tetrahydropyranyl) is preferable.

Among the Compound (I), a compound of the formula: ##STR32## wherein X⁻⁻is an anion is preferable.

Examples of the anion include that of a halogen atom; that derived froman inorganic acid such as hydrochloric acid, hydrobromic acid, nitricacid, sulfuric acid, phosphoric acid, etc.; that derived from an organicacid such as formic acid, acetic acid, trifluoroacetic acid, fumaricacid, oxalic acid, tartaric acid, maleic acid, citric acid, succinicacid, malic acid, methanesulfonic acid, benzenesulfonic acid,p-toluenesulfonic acid, etc.; that derived from an acidic amino acidsuch as aspartic acid, glutamic acid, etc.; etc. Among others, an anionof a halogen atom is preferable.

Among the Compound (I), the following compounds and their salts arepreferable:

N-methyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]-piperidiniumiodide;

N-methyl-N-[4-[[[7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-y]carbonyl]amino]benzyl]piperidiniumiodide;

N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxmide;

N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-7-(4-morpholinophenyl)-2,3-dihydro-1-benzoxepine-4-carboxmide;

7-(4-ethoxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxmide;

N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]-N-(tetrahydropyran-4-yl)ammoniumiodide;

N,N-dimethyl-N-[4-[[[7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl]carbonyl]amino]benzyl]-N-(4-oxocyclohexyl)ammoniumchloride;

N,N-dimethyl-N-[4-[[[7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepin-4-yl]carbonyl]amino]benzyl]-N-(tetrahydropyran-4-yl)ammoniumchloride;

N-methyl-N-[4-[[[7-(4-methylphenyl)-3,4-dihydro-naphthalen-2-yl]carbonyl]amino]benzyl]piperidiniumiodide; etc.

Examples of the salts of the compound represented by the formula (I)[including the formula (I')] include a pharmaceutically acceptable saltsuch as a salt with inorganic base, a salt with organic base, a saltwith inorganic acid, a salt with organic acid, a salt with basic oracidic amino acid, etc. Examples of the salt with the inorganic baseinclude a salt with alkali metal (e.g. sodium, potassium, etc.),alkaline earth metal (e.g. calcium, magnesium, etc.), aluminum,ammonium, etc. Examples of the salt with the organic base include a saltwith trimethylamine, triethylamine, pyridine, picoline, ethanolamine,diethanolamine, triethanolamine, dicyclohexylamine,N,N'-dibenzylethylenediamine, etc. Examples of the salt with theinorganic acid include a salt with hydrochloric acid, hydrobromic acid,nitric acid, sulfuric acid, phosphoric acid, etc. Examples of the saltwith the organic acid include a salt with formic acid, acetic acid,trifluoroacetic acid, fumaric acid, oxalic acid, tartaric acid, maleicacid, citric acid, succinic acid, malic acid, methanesulfonic acid,benzenesulfonic acid, p-toluenesulfonic acid, etc. Examples of the saltwith the basic amino acid include a salt with arginine, lysine,ornithine, etc. Examples of the salt with the acidic amino acid includea salt with aspartic acid, glutamic acid, etc.

The compound of the formula (I) [including the formula (I')] of thepresent invention may be hydrated or solvated. When the compound of theformula (I) [including the formula (I')] of the present invention existsas configuration isomer, diastereomer, conformer, etc., it is possibleto isolate individual isomers with per se known separation andpurification method, if desired. When the compound of the formula (I)[including the formula (I')] of the present invention is racemate, itcan be separated into (S)-compound and (R)-compound with usual opticalresolution and individual optical isomers and a mixture thereof areincluded in the scope of the present invention.

The present compound of the formula (I) or a salt thereof (hereinafter,"Compound (I)" include the compound of the formula (I) and its salt; andalso a compound of the formula (I') and its salt) alone or as anadmixture with a pharmaceutically acceptable carrier (e.g. solidformulations such as tablets, capsules, granules, powders, etc.; liquidformulations such as syrups, injections, etc.) may be orally ornon-orally administered.

Examples of non-oral formulations include injections, drops,suppositories, pessaryies, etc.

Examples of the carriers include various organic or inorganic carrierswhich are generally used in this field. For example, an excipient, alubricant, a binder, an disintegrating agent, etc. are used in the solidformulations, and a solvent, a solubilizer, a suspending agent, aisotonizing agent, a buffer, a soothing agent, etc. are used in theliquid formulations. In addition, if desired, an appropriate additivesuch as a preservative, an antioxidant, a colorant, a sweetener, etc.may be used in the above formulations.

Examples of the excipient include lactose, sucrose, D-mannitol, starch,crystalline cellulose, light silic acid anhydride, etc. Examples of thelubricant include magnesium stearate, calcium stearate, talc, colloidalsilica, etc. Examples of the binder include crystalline cellulose,sucrose, D-mannitol, dextrin, hydroxypropyl cellulose,hydroxypropylmethyl cellulose, polyvinylpyrrolidone, etc. Examples ofthe disintegrating agent include starch, carboxymethyl cellulose,carboxymethyl cellulose calcium, croscarmellose sodium, sodiumcarboxymethyl starch, etc. Examples of the solvent include water forinjection, alcohol, propyleneglycol, macrogol, sesame oil, corn oil,etc. Examples of the solubilizer include polyethyleneglycol,propyleneglycol, D-mannitol, benzyl benzoate, ethanol, trisaminomethane,cholesterol, triethanolamine, sodium carbonate, sodium citrate, etc.Examples of the suspending agent include surfactants such as stearyltriethanolamine, sodium laurylsulfate, laurylaminopropionic acid,lecithin, benzalkonium chloride, benzetonium chloride, glycerinmonostearate, etc.; hydrophilic polymers such as polyvinylalcohol,polyvinylpyrrolidone, sodium carboxymethyl cellulose, methyl cellulose,hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropylcellulose, etc.; etc. Examples of the isotonizing agent include sodiumchloride, glycerin, D-mannitol, etc. Examples of the buffer include abuffer solution of phosphate, acetate, carbonate, citrate, etc. Examplesof the soothing agent include benzylalcohol, etc. Examples of thepreservative include paraoxybenzoic acid esters, chlorobutanol,benzylalcohol, phenethylalcohol, dehydroacetic acid, sorbic acid, etc.Examples of the antioxidant include sulfites, ascorbic acid, etc.

The present invention is further to provide a production method of acompound of the formula (I) or a salt thereof.

The compound of the formula (I) or a salt thereof can be produced inaccordance with per se known methods, for example, the methods describedbelow, the methods described in JP-A-73476/1996, or analogous methodsthereto.

A salt of the compound of the formulas (I), (II), (III), (IV), (V),(I-1), (I-2) and (I-3) may be similar to that of the compound theformula (I).

In the following reaction steps, when the starting compounds have, assubstituents, an amino group, a carboxyl group and/or hydroxy group,these groups may be protected by ordinary protective groups such asthose generally employed in peptide chemistry, etc. After the reaction,if necessary, the protective groups may be removed to obtain the desiredcompound.

Examples of the amino-protective group include an optionally substitutedC₁₋₆ alkylcarbonyl (e.g. formyl, methylcarbonyl, ethylcarbonyl, etc.),phenylcarbonyl, C₁₋₆ alkyloxycarbonyl (e.g. methoxycarbonyl,ethoxycarbonyl, t-butoxycarbonyl, etc.), aryloxycarbonyl (e.g.phenoxycarbonyl, etc.), C₇₋₁₀ aralkyloxycarbonyl (e.g.benzyloxycarbonyl, etc.), trityl, phthaloyl, etc. These protectivegroups may be substituted by 1 to 3 substituents such as halogen atom(e.g. fluorine, chlorine, bromine, iodine, etc.), C₁₋₆ alkylcarbonyl(e.g. acetyl, propionyl, butyryl, etc.), nitro group, etc.

Examples of the carboxyl-protective group include an optionallysubstituted C₁₋₆ alkyl (e.g. methyl, ethyl, propyl, isopropyl, butyl,tert-butyl, etc.), phenyl, trityl, silyl, etc. These protective groupsmay be substituted by 1 to 3 substituents such as halogen atom (e.g.fluorine, chlorine, bromine, iodine, etc.), C₁₋₆ alkylcarbonyl (e.g.formyl, acetyl, propionyl, butyryl, etc.), nitro group, etc.

Examples of the hydroxy-protective group include an optionallysubstituted C₁₋₆ alkyl (e.g. methyl, ethyl, propyl, isopropyl, butyl,tert-butyl, etc.), phenyl, C₇₋₁₀ aralkyl (e.g. benzyl, etc.), C₁₋₆alkylcarbonyl (e.g. formyl, acetyl, propionyl, etc.), phenyloxycarbonyl,C₇₋₁₀ aralkyloxycarbonyl (e.g. benzyloxycarbonyl, etc.), pyranyl,furanyl, silyl, etc. These protective groups may be substituted by 1 to4 substituents such as halogen atom (e.g. fluorine, chlorine, bromine,iodine, etc.), C₁₋₆ alkyl, phenyl, C₇₋₁₀ aralkyl ,nitro group, etc.

These protective group may be introduced or removed by per se knownmethods (e.g. a method described in Protective Groups in OrganicChemistry (J. F. W. McOmie et al.; Plenum Press Inc.) or the methodsanalogous thereto. For example, employable method for removing theprotective groups is a method using an acid, a base, reduction,ultraviolet ray, hydrazine, phenylhydrazine, sodiumN-methyldithiocarbamate, tetrabutylammonium fluoride, palladium acetate,etc. ##STR33## herein each symbol is as defined above.

This production method is carried out by reacting the compound [II] withthe aniline derivative [III] to obtain the anilide Compound [I-1].

The condensation reaction of the compounds [II] and [III] is carried outby usual methods for peptide synthesis. Said methods for peptidesynthesis are employed according to optional known methods, for example,methods described in "Peptide Synthesis" written by M. Bodansky and M.A. Ondetti, Interscience, New York, 1966; "The Proteins", volume 2,written by F. M. Finn and K. Hofmann, H. Nenrath and R. L. Hill edition,Academic Press Inc., New York, 1976; "peputido-gosei no kiso to jikken(Basis and Experiment of Peptide Synthesis)" written by Nobuo Izumiya etal., Maruzen K. K.,1985; etc., as well as azide method, chloride method,acid anhydride method, mixed acid anhydride method, DCC method, activeester method, method using Woodward reagent K, carbonyldiimidazolemethod, oxidation-reduction method, DCC/HONB method, etc. and inaddition WSC method, method using diethyl cyanophosphate (DEPC), etc.

The condensation reaction can be carried out in a solvent. Examples ofthe solvents to be employed in the reaction include anhydrous or hydrousN,N-dimethylformamide (DMF), dimethylsulfoxide, pyridine, chloroform,dichloromethane, tetrahydrofuran, dioxane, acetonitrile, or a suitablemixture of these solvents. The reaction temperature is generally about-20° C. to about 50° C., preferably about -10° C. to about 30° C. andthe reaction time is generally about 1 to about 100 hours, preferablyabout 2 to about 40 hours.

The thus obtained anilide derivative [I-1] can be isolated and purifiedby known separation and purification methods such as concentration,concentration under reduced pressure, extraction, crystallization,recrystallization, solvent convert, chromatography, etc. ##STR34## 1When the group R² " in Compound [I-2] is, for example, a tertiary amineresidue, Compound [I-1] wherein the group R² ' is an quaternary ammoniumcan be produced by reacting Compound [I-2] with halogenated alkyl orhalogenated aralkyl. Examples of a halogen atom include chlorine,bromine, iodine, etc. and usually about 1 to 5 moles of the halogenatedalkyl (e.g. halogenated lower (C₁₋₆) alkyl, etc.) or halogenated aralkyl(e.g. halogenated lower (C₁₋₄) alkyl-phenyl, etc.) is used per mole ofCompound [I-2]. The reaction is carried out in an inert solvent such astoluene, benzene, xylene, dichloromethane, chloroform,1,2-dichloroethane, dimethylformamide, dimethylacetamide, etc., or asuitable mixture of these solvents. The reaction temperature isgenerally about 10° C. to about 160° C., preferably about 20° C. toabout 120° C. and the reaction time is generally about 1 hour to about100 hours, preferably about 2 hours to about 40 hours. This reaction ispreferably carried out under inert gas (e.g. nitrogen, argon, etc.)atmosphere.

2 When the group R² " in Compound [I-2] is, for example, a secondaryamine residue, Compound [I-1] wherein the group R² " is a tertiary aminocan be produced by reacting Compound [I-2] with halogenated alkyl orhalogenated aralkyl. Examples of a halogen atom include chlorine,bromine iodine, etc. and usually about 1 to 2 moles of the halogenatedalkyl or halogenated aralkyl is used per mole of Compound [I-2]. Ifnecessary, the reaction smoothly proceeds by addition of about once tothrice moles of a base such as triethylamine, diisopropylethylamine,pyridine, lithium hydride, sodium hydride, sodium methoxide, sodiumethoxide, sodium carbonate, potassium carbonate, sodium hydrogencarbonate and further sodium iodide, potassium iodide, etc.

This tertiary amination reaction is carried out in an inert solvent suchas methanol, ethanol, propanol, isopropanol, n-butanol, tetrahydrofuran,diethylether, dimethoxyethane, 1,4-dioxane, toluene, benzene, xylene,dichloromethane, chloroform, 1,2-dichloroethane, dimethylformamide(DMF), dimethylsulfoxide (DMSO), pyridine, etc., or a suitable mixtureof these solvents. The reaction temperature is generally about 0° C. to180° C., and the reaction time is generally about 1 hour to about 40hours. This reaction is preferably carried out under inert gas (e.g.nitrogen, argon, etc.) atmosphere.

3 When the group R² " in Compound [I-2] is, for example, a secondaryamine residue, Compound [I-1] wherein the group R² ' is a tertiary aminocan be produced by reacting Compound [I-2] with aldehyde compound in thepresence of a reductive amination reagent such as triacetoxysodium boronhydride, cyanosodium boron hydride, sodium boron hydride, etc.

The conditions of this reductive amination reaction varies depending onthe reagent to be used. For example, when triacetoxysodium boron hydrideis used ,reaction is carried out in an inert solvent such asdichloromethane, chloroform, 1,2-dichloroethane, tetrahydrofuran,diethylether, dioxane, acetonitrile, dimethylformamide (DMF), etc., or asuitable mixture of these solvents. In this case, about 1 to 2 moles ofthe reagent is used per mole of Compound [I-2]. The reaction temperatureis generally about 0° C. to about 80° C., and the reaction time isgenerally about 1 hour to about 40 hours. This reaction is preferablycarried out under inert gas (e.g. nitrogen, argon, etc.) atmosphere.

4 When the group R² " in Compound [I-2] is, for example, a sulfideresidue or a tertiary amine residue, Compound [I-1] wherein the group R²' is a sulfinyl group, a sulfonyl group or an amine oxide group can beproduced by reacting Compound [I-2] with an oxidizing agent such asm-chloroperbenzoic acid, perbenzoic acid, p-nitroperbenzoic acid,magnesium monoperoxyphthalate, peracetic acid, hydrogen peroxide, sodiumperiodate, potassium periodate, etc. The conditions of this oxidationreaction varies depending on the oxidizing agent to be used. Forexample, when m-chloroperbenzoic acid is used, reaction is carried outin an inert solvent such as dichloromethane, chloroform,1,2-dichloroethane, diethylether, tetrahydrofuran, acetone, ethylacetate, etc., or a suitable mixture of these solvents. Usually, about1-3 moles of oxidizing agent is used per mole of Compound [I-2]. Thereaction temperature is generally about -25° C. to about 80° C.(preferably -25° C. to 25° C.), and the reaction time is generally about1 hour to about 40 hours. ##STR35## wherein V in the Compound [IV] is ahalogen atom (chlorine, bromine, iodine, etc.), or a sulfonyloxy group(methanesulfonyloxy group, trifluoromethanesulfonyloxy group,benzenesulfonyloxy group, toluenesulfonyloxy group, etc.), and the othersymbols are as defined above.

1 Compound [I-1] wherein the group R² ' is a quaternary ammonium can beproduced by reacting Compound [IV] and a tertiary amine. The reaction iscarried out in an inert solvent such as toluene, benzene, xylene,dichloromethane, chloroform, 1,2-dichloroethane, dimethylformamide(DMF), dimethylacetamide, etc., or a suitable mixture of these solvents.Usually, about 1-3 moles of the tertiary amine is used per mole ofCompound [IV]. The reaction temperature is generally about 10° C. toabout 120° C., and the reaction time is generally about 1 hour to about40 hours. This reaction is preferably carried out under inert gas (e.g.nitrogen, argon, etc.) atmosphere.

2 Compound [I-1] wherein the group R² ' is a quaternary phosphonium canbe produced by reacting Compound [IV] and a tertiary phosphine. Thereaction is carried out in an inert solvent such as toluene, benzene,xylene, dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile,dimethylformamide (DMF), or a suitable mixture of these solvents.Usually, about 1-2 moles of the tertiary phosphine is used per mole ofCompound [IV]. The reaction temperature is generally about 20° C. toabout 150° C., and the reaction time is generally about 1 hour to about50 hours. This reaction is preferably carried out under inert gas (e.g.nitrogen, argon, etc.) atmosphere.

3 Compound [I-1] wherein the group R² ' is a secondary or tertiary aminogroup or a thio group can be produced by reacting Compound [IV] andprimary or secondary amine compound or thiol compound. Usually, about 1°C. to 3 moles of the primary or secondary amine compound or the thiolcompound is used per mole of Compound [IV]. If necessary, the reactionsmoothly proceeds by addition of about once to thrice moles of a basesuch as triethylamine, diisopropylethylamine, pyridine, lithium hydride,sodium hydride, sodium methoxide, sodium ethoxide, sodium carbonate,potassium carbonate, sodium hydrogen carbonate and further sodiumiodide, potassium iodide, etc. This substitution reaction is carried outin an inert solvent such as methanol, ethanol, propanol, isopropanol,n-butanol, tetrahydrofuran, diethylether, dimethoxyethane, 1,4-dioxane,toluene, benzene, xylene, dichloromethane, chloroform,1,2-dichloroethane, dimethylformamide (DMF),dimethylsulfoxide (DMSO),pyridine, etc., or a suitable mixture of these solvents. The reactiontemperature is generally about -10° C. to about 180° C., and thereaction time is generally about 1 hour to about 40 hours. The reactionis carried out preferably under inert gas (e.g. nitrogen, argon, etc.)atmosphere. ##STR36## wherein V' is a halogen atom (bromine, iodine,etc.) or a sulfonyloxy group (trifluoromethanesulfonyloxy group, etc.),and the other symbols are as defined above.

Compound [I-3] wherein the group R¹ ' is a 5- to 6-membered aromaticring group can be produced by subjecting Compound [V] to, for example,Suzuki reaction [cross condensation reaction of aryl borate with e.g.aryl halide or aryloxy trifluoromethanesulfonate in the presence ofpalladium catalyst; A. Suzuki et al., Synth. Commun. 1981, 11, 513].Usually, about 1-1.5 times moles of aryl borate is used per mole ofCompound [V].

Compound [II] used as a starting material can be produced by a knownmethod (e.g. method described in JP-A-73476/1996, etc.) or the methodsanalogous thereto. For example, Compound [II] can be produced by amethod described in the following Reaction Scheme I, a method describedin the following Reference Examples or the methods analogous thereto.##STR37## wherein R⁹ is a C₁₋₄ alkyl group, Y" is a divalent group,which does not contain a unsaturated bond and by which the ring B formsa 5- to 7-membered ring, and the other symbols are as defined above.

In this reaction, the compound of the formula [VI] is heated with apolyphosphoric acid, or Compound [VI] is converted to acid chloride withthionyl chloride, oxalyl chloride, phosphorous oxychloride, phosphorouspentachloride, etc., followed by subjecting the resulting acid chlorideto usual Friedel-Crafts reaction and cyclizing the same to produceCompound [VII]. Compound [VII] is reacted with carbonate ester in thepresence of a base to produce ketoester [VIII]. Compound [VIII] issubjected to reduction with catalytic hydrogenation or sodium boronhydride, etc. to produce Compound [IX]. Compound [IX] is subjected todehydration and ester hydrolysis by per se known method to produceunsaturated carboxylic acid [II-1].

Compound [III] can be produced by a known method (e.g. method describedin JP-A-73476/1996, etc.) or the methods analogous thereto. For example,Compound [III] can be produced by a method described in the followingReaction Scheme II, a method described in the following ReferenceExamples or the methods analogous thereto. ##STR38##

The reduction of Compound [X] can be carried out per se known methods,for example, reduction with metal, reduction with metal hydride,reduction with metal hydride complex compound, reduction with diboraneor substituted borane, catalytic hydrogenation, etc. That is, thisreaction is carried out by treating Compound [X] with reduction agent.Examples of the reduction agent include metal such as reduced iron, zincpowder, etc.; alkali metal boron hydride (e.g. sodium boron hydride,lithium boron hydride, etc.); metal hydride complex compound such asaluminum lithium hydride, etc.; metal hydride such as sodium hydrideetc.; organic tin compound (triphenyltin hydride, etc.), metal complexcompound and metal salt such as nickel compound, zinc compound etc.;catalytic reduction agent using hydrogen and transit metal catalyst suchas palladium, plutinum, rhodium, etc.; diborane; etc. Among others, asthe reduction agent, catalytic reduction agent using hydrogen andtransit metal catalyst such as palladium, plutinum, rhodium, etc.;reduced iron, etc. are preferable. The reaction is carried out in asolvent which does not affect the reaction. Examples of the solventinclude benzene, toluene, xylene, chloroform, carbon tetrachloride,dichloromethane, 1,2-dichloroethane, 1,1,2,2-tetrachloroethane,diethylether, tetrahydrofuran, dioxane, methanol, ethanol, propanol,isopropanol, 2-methoxyethanol, N,N-dimethylformamide, acetic acid, or asuitable mixture of these solvents, etc. The solvent is appropriatelyselected depending on kind of the reduction agent. The reactiontemperature is generally about -20° C. to about 150° C., preferablyabout 0° C. to about 100° C., and the reaction time is generally about 1to about 24 hours.

The resulting Compound [III] can be separated and purified with knowseparation and purification methods such as concentration, concentrationunder reduced pressure, extraction, crystallization, was recrystallizedwith, solvent conversion, chromatography, etc.

The compound of the formula (I) or a salt thereof of the presentinvention has potent antagonistic activity on MCP-1 receptor andtherefore can be used for the treatment or prophylaxis of variousinflammatory diseases, cardiac infarction, myocarditis, etc. in humanand animals (e.g. mouse, rat, cat, dog, rabbit, bovine, swine, etc.).The compound of the formula (I) or a salt thereof of the presentinvention is low toxic and safely used as MCP-1 receptor antagonist(e.g. a medicament for the treatment or prophylaxis of cardiacinfarction, myocarditis, etc.).

The dose per day of the compound of the formula (I) or a salt thereofvaries depending on the condition and body weight of a patient,administration route, etc. Typical daily dose per adult patient (bodyweight: 50 Kg) for oral administration is about 5-100 mg, preferablyabout 10-600 mg, and in particular about 15-150 mg, as active ingredient[the compound of the formula (I) or a salt thereof] and the compound ofthe formula (I) or a salt thereof is administered once or 2-3 times parday.

BEST MODE FOR CARRYING OUT THE INVENTION

The present invention is hereinafter described in more detail by meansof the following Test Example, Reference Example and Working Example,which are mere examples of the present invention and are not construedas limitative to the present invention.

TEST EXAMPLE 1

Determination of Inhibitory Activity on MCP-1 Receptor

According to a method described in Working Example 1 ofJP-A-238688/1997, human MCP-1 receptor gene was prepared. Said gene wasinserted to plasmid pMCR, which was introduced into CHO cell. Theresultant transformant [CHO(MCR); FERM BP-5446; IFO 50461] was used forthe following experiment.

On 96 well culture plate (Packard Instrument Company), 7×10⁴ cell/wellof CHO cells expressing human MCP-1 receptor were inoculated, and thecells were cultivated at 37° C. overnight. The medium was removed bymeans of suction. To the residue were added a buffer solution (D-MEMcontaining 0.5% BSA and 20 mM HEPES; pH7.4), Test Compound (1 μM) and¹²⁵ I-human recombinant MCP-1 (Amersham; final concentration: 100 pM),and the mixture was allowed to react at room temperature for 40 minutes.The buffer solution was removed by means of suction and washed twicewith PBS. To the residue was added MICROSCINT-20 (Packard InstrumentCompany), radioactivity of ¹²⁵ I (cpm) was determined with Topcount(Packard).

The count number (cpm) (non-specific binding) of ¹²⁵ I which binds toCHO cells (mock) having a vector was taken from the count number (cpm)of ¹²⁵ I which binds to CHO cells expressing human MCP-1 receptor toobtain the amended count number, which was converted into 100%, andinhibition rate of Test Compound (whose number is referred to in thefollowing Examples) against MCP-1 binding to its receptor wascalculated. The results are shown in Table 1.

                  TABLE 1                                                         ______________________________________                                        Compound Number                                                                              Inhibition Rate (%)                                            ______________________________________                                         16            89                                                                72 77                                                                         94 92                                                                         97 96                                                                        128 80                                                                        151 80                                                                        178 64                                                                        220 98                                                                      ______________________________________                                    

TEST EXAMPLE 2

Chemotaxis Inhibition Assay

To a lower chamber of 96 well chemotaxis chamber (Neuro Probe, AB96) wasadded a solution of 20 nM MCP-1 (chemotaxis inducer) in buffer (D-MEMcontaining 0.5% BSA and 20 mM HEPES; pH7. 4), and the chamber wascovered by a filter coated with bovine fibronectin. To its upper chamberwere added CHO cells expressing human MCP-1 receptor (2×10⁵ cell/well)and Test Compound (1 μM), followed by incubation at 37° C. in 5% CO₂ for4 hours. The cells migrated under the filter was stained with DiffQuick, and absorbance at 600 nm of wave length (O.D at 600 nm) wasdetermined by microplate reader. The absorbance in the absence of MCP-1in the lower chamber was taken from the absorbance in the presence ofMCP-1 in the lower chamber to obtain the amended absorbance (ΔO.D,chemotaxis induced by MCP-1), which was converted into 100%, andchemotaxis inhibition rate of Test Compound was calculated.

The results are shown in Table 2.

2 A drug containing about 10-300 mg of the compound of the formula (I')or a salt thereof and a drug containing about 300-1200 mg of saquinavirto one adult patient (body weight: 50 Kg) are administered. Each of thedrugs may be administered to the one and the same subject simultaneouslyor with time intervals of 12 hours or less.

BEST MODE FOR CARRYING OUT THE INVENTION

The present invention is hereinafter described in more detail by meansof the following Test Example, Reference Example and Working Example,which are mere examples of the present invention and are not construedas limitative to the present invention.

The following gene manipulation is carried out in accordance withmethods described in textbook (Maniatis et al., Molecular Cloning, ColdSpring Harbor Laboratory, 1989) or protocol attached to reagents.

TEST EXAMPLE

(1) Cloning of Human CCR5 Chemokine Receptor

Cloning of CCR5 gene was carried out by PCR (polymerase chain reaction)from human spleen cDNA. With using 0.5 ng of spleen cDNA (Toyobo,QUICK-Clone cDNA) as template, PCR was performed in DNA Thermal Cycler480 (Perkin-Elmer) (reaction conditions: 30 cycles of 95° C. for 1minute, 60° C. for 1 minute, and 75° C. for 5 minutes) by adding primerset, 5'-CAGGATCCGATG GATTATCAAGTGTCAAGTCCAA-3' (25 pmol) and5'-TCTAGATCACAAGCC CACAGATATTTCCTGCTCC-3' (25 pmol), which were designedreferring to nucleotide sequence of CCR5 gene reported by Samson et al.(Biochemistry, 35(11), 3362-3367 (1996)) and by using TaKaRa EX Taq(Takara Shuzo). The resultant PCR product was subjected to agarose gelelectrophoresis to collect about 1.0 kb DNA fragment, which wassubjected to Original TA Cloning Kit (Funakoshi) to carry out cloning ofCCR5 gene.

(2) Preparation of Plasmid for Expression of Human CCR5

The plasmid obtained in the above (1) was digested with restrictionenzymes XbaI (Takara Shuzo) and BamHI (Takara Shuzo) and subjected toagarose gel electrophoresis to collect about 1.0 kb DNA fragment. TheDNA fragment was mixed with plasmid pcDNA3.1 (Funakoshi) for expressionin animal cells, said plasmid being digested with XbaI and BamHI, andthey were ligated with DNA Ligation Kit Ver.2 (Takara Shuzo). Theresulting plasmid was subjected to transformation of competent cell ofE. coli JM109 (Takara Shuzo) to obtain plasmid pCKR5.

(3) Introduction of Dlasmid for Expression of Human CCR5 into CHO-K1Cell and Expression of said Plasmid in CHO-K1 Cell

CHO-K1 cells were grown in 750 ml of tissue culture flask (BectonDickinson) using Ham's F12 medium (Nihon Pharmaceutical) containing 10%fetal calf serum (Life Tech Oriental) and took off with 0.5 g/Ltrypsin-0.2 g/L EDTA (Life Tech Oriental). The cells were washed withPBS (Life Tech Oriental), centrifuged (1000 rpm, 5 minutes), andsuspended in PBS. With using Gene Pulser (Bio-Rad Laboratories), DNA wasintroduced into the cells under the conditions shown below. That is, tothe cuvette of 0.4 cm gap were added 8×10⁶ cells and 10 μg of plasmidpCKR5 for expression of human CCR5, and electroporation was carried outunder 0.25 kV of voltage and 960 μF of capacitance. The cells weretransferred into Ham's F12 medium (Nihon Pharmaceutical) containing 10%fetal calf serum, and cultivated for 24 hours. The cells were again tookoff and centrifuged, and suspended in Ham's F12 medium (NihonPharmaceutical) containing 10% fetal calf serum and 500 μg/ml ofgeneticin (Life Tech Oriental). The suspension was diluted to give 10⁴cells/ml of the suspension, which was inoculated on 96 well plate(Becton Dickinson) to give geneticin resistant cells. The resultinggeneticin resistant cells were cultivated in 96 well plate (BectonDickinson), and cells expressing CCR5 were selected from the geneticinresistant cells. That is, in assay buffer (Ham's F12 medium containing0.5% BSA and 20 mM HEPES (Wako Pure Chemical, pH7.2) to which was added200 pM of [¹²⁵ I]-RANTES (Amersham) as ligand, binding reaction wascarried out at room temperature for 40 minutes, and the buffer waswashed with cooled PBS. To the buffer was added 50 μl/well of 1M NaOH,and the mixture was stirred. Radioactivity was determined with γ-counterto select CHO/CCR5 cells which specifically bind to the ligand.

(4) Evaluation of Test Compounds based on CCR5 Antagonistic Activity

The CHO/CCR5 were inoculated on 96 well microplate (5×10⁴ cells/well)and cultivated for 24 hours. The medium was removed by means of suction,and to each well was added assay buffer containing Test Compound (1 μM)and then 100 pM of [¹²⁵ I]-RANTES (Amersham) as ligand. Binding assaywas carried out at room temperature for 30 minutes, and assay buffer wasremoved by means of suction. Each well was washed twice with cooled PBS,and 200 μl of Microscint-20 (Packard Instrument, Inc.) was added to eachwell. Radio-activity was determined with Top-Count Micro ScintillationCounter (Packard Instrument, Inc.).

According to the method described above, inhibition rate of TestCompound (whose number is referred to in the following Examples) to CCR5binding.

The results are shown in Table 1.

                  TABLE 1                                                         ______________________________________                                        Compound Number                                                                              Inhibition Rate (%)                                            ______________________________________                                         16            88                                                                92 100                                                                        96 93                                                                         97 94                                                                        100 100                                                                       128 87                                                                        180 99                                                                        209 80                                                                        248 99                                                                        249 96                                                                        250 96                                                                        Ref Ex 51 73                                                                ______________________________________                                    

(5) Inhibitory Effect on HIV-1 Infection to MAGI-CCR5 Cell

The plasmid where β-galactosidase gene was ligated downstream of HIV-1LTR was introduced into CD4 positive HeLa cell, to which human CCR5 wasfurther introduced to obtain transformant MAGI-CCR5. By using saidtransformant MAGI-CCR5, degree of HIV-1 infection was calculated fromβ-galactosidase activity (blue color due to decomposition of5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside). Specifically,MAGI-CCR5 cells were suspended in DMEM medium containing 10% serum toprepare 5×10⁴ cells/ml suspension. To each well of 96 well plate wasinoculated 200 μl of the suspension, and the cells were cultivated at37° C. overnight. The medium was removed by means of suction, and to theresidue was added 100 μl of the above medium containing 1.6 μM of TestCompound 96 or 0.064 μM of Test Compound 248 and 100 μl of the abovemedium containing 300PFU of HIV-1 BA-L cells. The cells were cultivatedat 37° C. for 2 days. The medium was removed by means of suction. To theresidue was added 200 μl of cell fixative (PBS containing 1%formaldehyde and 0.2% glutaraldehyde), and the mixture was allowed tostand at room temperature for 5 minutes and washed twice with PBS. Tothe mixture was added 100 μl of staining solution (PBS containing 4 μMpotassium ferrocyanide, 4 μM potassium ferricyanade, 2 μM MgCl₂ and 0.4mg/ml X-gal), and the mixture was allowed to stand at 37° C. for 50minutes and washed twice with PBS. The number of blue cells was countedby microscope and defined as the number of cells infected with HIV-1.According to this method, inhibition rate on HIV-1 infection wasdetermined and found that Compounds 96 and 248 respectively show 92% and100% inhibition on HIV-1 infection.

(6) Inhibitory Effect on HIV-1 Infection to Human PBMC

From normal person human peripheral blood mononuclear cells (PBMC) wereseparated, and the cells were stimulated with 10 μg/ml of PHA(Phytohemaglutinin) and 20U/ml of interleukin-2 (IL-2) for 3 days. Thecells were suspended in RPMI-1640 medium containing 20% serum to prepare1×10⁶ /ml suspension. To the suspension were infected HIV-1 BA-L cells(20 ng as an amount of p24 antigen), and viruses were absorbed at 37° C.for 2 hours. The cells were washed and suspended in RPMI-1640 mediumcontaining 20% serum and IL-2 20U/ml to prepare 1×10⁵ /ml suspension. Tothe PBMC suspension was added the same amount of a solution whichcontains 2.0 μM of Test Compound 96 or 0.32 μM of Test Compound 248, andthe cells were cultivated at 37° C. for 7 days in carbon dioxide gasincubator. The amount of p24 antigen in supernatant of the cultivatedmedium was determined by enzyme-linked immunosorbent assay (ELISA) anddefined as degree of HIV-1 infection. According to this method,inhibition rate on HIV-1 infection was determined and found thatCompounds 96 and 248 respectively show 96% and 74% inhibition on HIV-1infection.

The pharmaceutical composition for antagonizing CCR5 (e.g. a medicamentfor the treatment or prophylaxis of infectious disease of HIV, amedicament for the treatment or prophylaxis of AIDS, etc.) comprisingthe compound of the formula (I') or a salt thereof of the presentinvention, as an active ingredient, can be prepared, for example, by thefollowing prescriptions:

1. Capsule

    ______________________________________                                        (1) Compound obtained in Working Example 128                                                           40 mg                                                  (2) lactose 70 mg                                                             (3) fine crystalline cellulose  9 mg                                          (4) magnesium stearate  1 mg                                                  1 capsule 120 mg                                                            ______________________________________                                    

(1), (2), (3) and 1/2 of (4) are mixed and then granulated.

To the granules is added the remainder of (4), and the whole is filledinto a gelatin capsule.

2. Tablet

    ______________________________________                                        (1) Compound obtained in Working Example 128                                                             40 mg                                                (2) lactose 58 mg                                                             (3) corn starch 18 mg                                                         (4) fine crystalline cellulose 3.5 mg                                         (5) magnesium stearate 0.5 mg                                                 1 tablet 120 mg                                                             ______________________________________                                    

(1), (2), (3), 2/3 of (4) and 1/2 of (5) are mixed and then granulated.To the granules are added the remainders of (4) and (5), followed bysubjecting the mixture to compression molding.

3. Injection

A mixture of Compound obtained in Working Example 248 (500 mg), mannitol(1000 mg) and polysorbate 80 (100 mg) is dissolved in distilled water(10 ml), and to the solution is added distilled water to make the wholevolume 20 ml. The solution is filtered under sterile conditions. Each 2ml of the solution is filled into a vial for injection under sterileconditions.

WORKING EXAMPLE REFERENCE EXAMPLE 1

In THF (50 ml) was dissolved 4-nitrobenzylchloride (5.00 g), andpiperidine (6.20 g) was added to the mixture. The reaction mixture wasstirred at room temperature for 20 hours. To the mixture was added water(500 ml), and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/hexane=1/2) to give 1-(4-nitrobenzyl)piperidine (6.41 g) as paleyellow oil. ¹ H NMR (200 MHz, CDCl₃) δ: 1.38-1.70 (6H, m), 2.30-2.45(4H, m), 3.55 (2H, s), 7.51 (2H, d, J=8.8 Hz), 8.17 (2H, d, J=8.8 Hz).

REFERENCE EXAMPLE 2

In ethanol(50 ml) was dissolved 1-(4-nitrobenzyl)-hydrochloric acid tothe aqueous layer and extracted with ethyl acetate. The organic layerwas washed with saturated sodium chloride solution, dried with anhydroussodium sulfate and concentrated under reduced pressure. The residue wasrecrystallized from ethanol-water to give7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (7.47 g) as browncrystals.

mp 204-208° C.; ¹ H NMR (200 MHz, CDCl₃) δ: 2.61-2.73 (2H, m), 2.88-3.00(2H, m), 7.23-7.60 (8H, m), 7.74 (1H, s).

REFERENCE EXAMPLE 10

In THF (250 ml) was dissolved 4-nitrobenzylbromide (25.0 g), and to themixture was added morpholine (25.2 ml) at 0° C. The reaction mixture wasstirred for 15 hours at room temperature. To the mixture was added water(500 ml), and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate) to give 4-(4-nitrobenzyl)morpholine (25.5 g) as pale yellowcrystals. A portion of the crystals was recrystallized fromdiisopropylether to give pale yellow crystals which were used forvarious analyses. mp 79-80° C.

Elemental Analysis for C₁₁ H₁₄ N₂ O₃ ; Calcd: C, 59.45; H, 6.35; N,12.60. Found: C, 59.68; H, 6.25; N, 12.75. IR (KBr) cm⁻¹ : 3350, 1518,1344, 1111, 1009, 864, 744; ¹ H NMR (200 MHz, CDCl₃) δ: 2.37-2.55 (4H,m), 3.59 (2H, s), 3.65-3.80 (4H, m), 7.53 (2H, d, J=8.4 Hz), 8.18 (2H,d, J=8.4 Hz).

REFERENCE EXAMPLE 11

In ethanol (300 ml) was dissolved 4-(4-nitrobenzyl)-morpholine (25.8 g),and to the mixture was added dried 10% palladium on carbon (Pd--C) (1.00g). Under hydrogen atmosphere, the mixture was stirred at roomtemperature under atmospheric pressure for 20 hours. The palladium wasfiltered off, and the filtrate was concentrated. The residue wasseparated and purified with column chromatography (ethyl acetate) togive 4-(4-aminobenzyl)-morpholine (430 mg) as pale yellow crystals.

mp 98-99° C.; Elemental Analysis for C₁₁ H₁₆ N₂ O; Calcd: C, 68.72; H,8.39; N, 14.57. Found: C, 68.57; H, 8.25; N, 14.59. IR (KBr) cm⁻¹ :3350, 2804, 1635, 1516, 1282, 1111, 1005, 860; ¹ H NMR (200 MHz, CDCl₃)δ: 2.32-2.52 (4H, m), 3.39 (2H, s), 3.45-3.80 (6H, m), 6.64 (2H, d,J=8.2 Hz), 7.09 (2H, d, J=8.2 Hz).

REFERENCE EXAMPLE 12

In THF (250 ml) was dissolved 4-nitrobenzyl bromide (25.0 g), and to themixture was added pyrrolidine (24.1 ml) at 0° C. The reaction mixturewas stirred at room temperature for 60 hours. To the mixture was addedwater (500 ml), and the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was separated and purified with column chromatography (ethylacetate) to give 1-(4-nitrobenzyl)pyrrolidine (23.5 g) as orange oil.

¹ H NMR (200 MHz, CDCl₃) δ: 1.75-1.85 (4H, m), 2.43-2.58 (4H, m), 3.71(2H, s), 7.51 (2H, d, J=8.6 Hz), 8.18 (2H, d, J=8.6 Hz).

REFERENCE EXAMPLE 13

In ethanol (100 ml) was dissolved 1-(4-nitrobenzyl)-pyrrolidine (23.5g), and to the mixture was added dried 10% palladium on carbon (1.00 g).Under hydrogen atmosphere, the mixture was stirred at room temperatureunder atmospheric pressure for 20 hours. The palladium was filtered off,and the filtrate was concentrated. The residue was separated andpurified with column chromatography (ethyl acetate/triethylamine=10/1)to give 1-(4-aminobenzyl)pyrrolidine (8.54 g) as orange oil.

¹ H NMR (200 MHz, CDCl₃) δ: 1.60-1.90 (4H, m), 2.35-2.55 (4H, m),3.45-3.70 (4H, m), 6.64 (2H, d, J=8.4 Hz), 7.11 (2H, d, J=8.4 Hz).

REFERENCE EXAMPLE 14

In THF (250 ml) was dissolved 4-nitrobenzyl bromide (25.0 g), and to themixture was added 50% dimethylamine solution (29 ml) at 0° C. Thereaction mixture was stirred at room temperature for 60 hours. To themixture was added water (500 ml), and the mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was separated and purified withcolumn chromatography (ethyl acetate) to givedimethyl-4-nitrobenzylamine (20.7 g) as orange oil.

¹ H NMR (200 MHz, CDCl₃) δ: 2.26 (6H, s), 3.52 (2H, s), 7.50 (2H, d,J=8.8 Hz), 8.19 (2H, d, J=8.8 Hz).

REFERENCE EXAMPLE 15

In ethanol (100 ml) was dissolved dimethyl-4-nitrobenzylamine (20.7 g),and to the mixture was added dried 10% palladium on carbon (1.00 g).Under hydrogen atmosphere, the mixture was stirred at room temperatureunder atmospheric pressure for 20 hours. The palladium was filtered off,and the filtrate was concentrated. The residue was separated andpurified with column chromatography (ethyl acetate) to give4-aminobenzyl-dimethylamine (8.75 g) as pale yellow oil.

¹ H NMR (200 MHz, CDCl₃) δ: 2.21 (6H, s), 3.31 (2H, s), 3.53-3.70 (2H,br), 6.65 (2H, d, J=8.4 Hz), 7.08 (2H, d, J=8.4 Hz).

REFERENCE EXAMPLE 16

In THF (250 ml) was dissolved 3-nitrobenzyl chloride (25.0 g), and tothe mixture was added piperidine (36 ml). The reaction mixture wasstirred at room temperature for 20 hours. To the mixture was added water(500 ml), and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate) to give 1-(3-nitrobenzyl)piperidine (32.2 g) as pale yellowoil.

¹ H NMR (200 MHz, CDCl₃) δ: 1.40-1.66 (6H, m), 2.33-2.44 (4H, m), 3.54(2H, s),7.47 (1H, t, J=8.0 Hz), 7.67 (1H, d, J=8.0 Hz), 8.10 (1H, d,J=8.0 Hz), 8.20 (1H, s).

REFERENCE EXAMPLE 17

In ethanol (100 ml) was dissolved 1-(3-nitrobenzyl)-piperidine (32.2 g),and to the mixture was added dried 10% palladium on carbon (1.61 g).Under hydrogen atmosphere, the mixture was stirred at room temperatureunder atmospheric pressure for 24 hours. The palladium was filtered off,and the filtrate was concentrated. The residue was recrystallized fromdiisopropylether-hexane to give 1-(3-aminobenzyl)piperidine (15.8 g) ascolorless crystals.

mp 109-110° C.; Elemental Analysis for C₁₂ H₁₈ N₂ ; Calcd: C, 75.74; H,9.53; N, 14.72. Found: C, 75.81; H, 9.13; N, 14.87. IR (KBr) cm⁻¹ :3398, 3184, 2948, 1643, 1606, 1454, 1302, 1101, 995, 795, 775, 698; ¹ HNMR (200 MHz, CDCl₃) δ: 1.35-1.65 (6H, m), 2.25-2.45 (4H, m), 3.38 (2H,s), 3.50-3.75 (2H, br), 6.57 (1H, brd, J=7.9 Hz), 6.65-6.75 (2H, m),7.08 (1H, t, J=7.9 Hz).

REFERENCE EXAMPLE 18

In DMF (100 ml) was dissolved 4-(2-bromoethyl)nitrobenzene (25.0 g), andto the solution were added piperidine (12.9 ml) and potassium carbonate(18.0 g). The mixture was stirred at 70° C. for 15 hours, and to themixture was added water (900 ml), and then the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was separated and purified withcolumn chromatography (ethyl acetate) to give1-[2-(4-nitro-phenyl)ethyl]piperidine (24.8 g) as orange oil.

¹ H NMR (200 MHz, CDCl₃) δ: 1.39-1.75 (6H, m), 2.35-2.65 (6H, m),2.85-3.00 (2H, m), 7.36 (2H, d, J=8.8 Hz), 8.14 (2H, d, J=8.8 Hz).

REFERENCE EXAMPLE 19

In ethanol (100 ml) was dissolved 1-[2-(4-nitrophenyl)ethyl]piperidine(24.8 g), and to the mixture was added dried 10% palladium oncarbon(1.24 g). Under hydrogen atmosphere, the mixture was stirred atroom temperature under atmospheric pressure for 86 hours. The palladiumwas filtered off, and the filtrate was concentrated to give1-[2-(4-aminophenyl)ethyl]-piperidine (21.7 g) as pale brown oil.

¹ H NMR (200 MHz, CDCl₃) δ: 1.40-1.80 (6H, m), 2.35-2.60 (6H, m),2.60-2.80 (2H, m), 3.40-3.70 (2H, br), 6.62 (2H, d, J=8.4 Hz), 7.00 (2H,d, J=8.4 Hz).

REFERENCE EXAMPLE 20

In methanol (35 ml) was dissolved7-phenyl-3,4-dihydro-naphthalene-2-carboxylic acid (1.50 g), and to themixture was added concentrated sulfuric acid (0.1 ml), and then themixture was refluxed for 9 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added 5% sodium hydrogencarbonate solution, and then the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was dissolved in ethyl acetate (100 ml),and to the mixture was added activated manganese dioxide (9 g). Themixture was refluxed for 48 hours and then cooled to room temperature.The manganese dioxide was filtered off, and the filtrate wasconcentrated. The residue was dissolved in methanol (15 ml), and to themixture was added 1N sodium hydroxide (10 ml). The mixture was refluxedfor 4 hours and then cooled to room temperature. The mixture wasacidified with dilute hydrochloric acid, and extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-diisopropylether to give 7-phenylnaphthalene-2-carboxylic acid(783 mg) as colorless crystals.

mp 244-245° C.; Elemental Analysis for C₁₇ H₁₂ O₂ ; Calcd: C, 82.24; H,4.87. Found: C, 82.10; H, 4.85. IR (KBr) cm⁻¹ : 3053, 1701, 1684, 1429,1302, 860, 756, 696; ¹ H NMR (200 MHz, CDCl₃) δ: 7.37-7.57 (3H, m),7.70-7.77 (2H, m), 7.86-8.02 (3H, m), 8.10-8.20 (2H, m), 8.77 (1H, s).

REFERENCE EXAMPLE 21

To a solution of 4-nitrobenzylalcohol (4.59 g) in methanol (300 ml) wasadded copper chloride (I) (17.8 g) at room temperature, and then wasgradually added potassium boron hydride (11.3 g) for 40 minutes. Thereaction mixture was stirred at room temperature for 2 hours andconcentrated under reduced pressure. To the residue was added water, andthe mixture was extracted with ethyl acetate. The organic layer wasdried with anhydrous sodium sulfate, and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=3/1) to give 4-aminobenzylalcohol(1.31 g) as pale yellow crystals.

mp 53-55° C.; Elemental Analysis for C₇ H₉ NO; Calcd: C, 68.27; H, 7.37;N, 11.37. Found: C, 68.43; H, 7.43; N, 11.49. IR (KBr) cm⁻¹ : 3375,3219, 1614, 1514, 1470, 1259, 1041, 854, 827, 748, 509; ¹ H NMR (200MHz, CDCl₃) δ: 3.50-3.85 (2H, br), 4.56 (2H, s), 6.68 (2H, d, J=8.4 Hz),7.17 (2H, d, J=8.4 Hz).

REFERENCE EXAMPLE 22

In THF (10ml) was dissolved 7-phenyl-3,4-dihydronaphthalene-2-carboxylicacid (500 mg), and to the solution were added oxalyl chloride (262 μl)and a drop of DMF. The mixture was stirred at room temperature for 1hour and concentrated under reduced pressure. The residue was dissolvedin DMF (5 ml), and to the mixture was dropwise added a solution of4-aminobenzylalcohol (246 mg) in pyridine (10 ml) at 0° C. The reactionmixture was stirred at 0° C. for 3 hours. To the mixture was added water(500 ml), and then the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-acetone togiven-[4-(hydroxymethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(486 mg) as pale brown crystals.

mp 207-210° C.; Elemental Analysis for C₂₄ H₂₁ NO₂.0.5H₂ O; Calcd: C,79.10; H, 6.08; N, 3.84. Found: C, 79.35; H, 5.97; N, 3.86. IR (KBr)cm⁻¹ : 3332, 1651, 1618, 1597, 1527, 1412, 1317, 831, 764, 700; ¹ HNMR(200 MHz, DMSO-d₆) δ: 2.50-2.66 (2H, m), 2.80-2.95 (2H, m), 4.46 (2H,s), 7.23-7.72 (13H, m), 9.91 (1H, s).

REFERENCE EXAMPLE 23

Under argon atmosphere, a mixture of7-(trifluoromethanesulfoxy)-1-tetralone (9.02 g), 4-methylphenyl borate(5.00 g), potassium carbonate (8.46 g), toluene (300 ml), ethanol (30ml) and water (30 ml) was stirred at room temperature for 30 minutes,and to the mixture was added tetrakis(triphenylphosphine)palladium (1.06g). The mixture was refluxed for 14 hours. The reaction mixture wascooled to room temperature. The organic layer was separated, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/toluene=1/10) to give 7-(4-methylphenyl)-1-tetralone (5.23 g) ascolorless crystals.

mp 86-87° C.; Elemental Analysis for C₁₇ H₁₆ O; Calcd: C, 86.41; H,6.82. Found: C, 86.30; H, 6.69. IR (KBr) cm⁻¹ : 2947, 1682, 1606, 1489,1435, 1323, 1223, 1178, 810; ¹ H NMR (200 MHz, CDCl₃) δ: 2.10-2.24 (2H,m), 2.39 (3H, s), 2.69 (2H, t, J=6.6 Hz), 3.00 (2H, t, J=6.0 Hz),7.21-7.35 (3H, m), 7.52 (2H, d, J=8.4 Hz), 7.71 (1H, dd, J=2.2, 8.2 Hz),8.27 (1H, d, J=2.2 Hz).

REFERENCE EXAMPLE 24

Under argon atmosphere, a mixture of7-(trifluoromethanesulfoxy)-1-tetralone (17.5 g), 4-fluorophenyl borate(10.0 g), potassium carbonate (16.6 g), toluene (500 ml), ethanol (50ml) and water (50 ml) was stirred at room temperature for 30 minutes,and to the mixture was added tetrakis(triphenylphosphine)palladium (2.08g). The mixture was refluxed for 14 hours. The reaction mixture wascooled to room temperature. The organic layer was separated, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/toluene=1/10) to give 7-(4-fluorophenyl)-1-tetralone (13.8 g) asbrown oil.

¹ H NMR (200 MHz, CDCl₃) δ: 2.10-2.24 (2H, m), 2.70 (2H, t, J=6.6 Hz),3.01 (2H, t, J=6.0 Hz), 7.07-7.19 (2H, m), 7.30 (1H, d, J=7.6 Hz),7.53-7.62 (2H, m), 7.67 (1H, dd, J=2.2, 8.2 Hz), 8.23 (1H, d, J=2.2 Hz).

REFERENCE EXAMPLE 25

A mixture of sodium methoxide (5.63 g), dimethyl carbonate (33 ml) and7-(4-methylphenyl)-1-tetralone (4.93 g) was refluxed for 30 minutes. Thereaction mixture was cooled to 0° C., and to the mixture was graduallyadded 3Nhydrochloricacid(80 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was dissolved in THF (30 ml), and to themixture was added sodium boron hydride (494 mg) at 0° C. and then wasdropwise added methanol (3 ml) for 30 minutes. The reaction mixture wasstirred at 0° C. for 4 hours, and to the mixture was added water (500ml). The mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasdissolved in methanol (20 ml), and to the mixture was added IN sodiumhydroxide (20 ml). The mixture was refluxed for 4 hours, cooled,acidified with concentrated hydrochloric acid, and extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was dissolved in Diglyme (20 ml), and tothe mixture was added concentrated hydrochloric acid (4 ml). The mixturewas stirred at 100° C. for 2 hours, and to the mixture was added water(500 ml). The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, andconcentrated under reduced pressure. The residue was dissolved in 0.5Nsodium hydroxide (400 ml), and the mixture was washed with diethylether.The aqueous layer was separated and acidified with concentratedhydrochloric acid. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive 7-(4-methyl-phenyl)-3,4-dihydronaphthalene-2-carboxylic acid (1.96g) as pale brown crystals.

mp 230-231° C.; Elemental Analysis for C₁₈ H₁₆ O₂ ; Calcd: C, 81.79; H,6.10. Found: C, 81.62; H, 6.11. IR (KBr) cm⁻¹ : 3023, 2908, 1697, 1682,1626, 1431, 1300, 928, 810; ¹ H NMR (200 MHz, CDCl₃) δ: 2.40 (3H, s),2.61-2.71 (2H, m), 2.89-2.98 (2H, m), 7.22-7.28 (3H, m), 7.45-7.51 (4H,m), 7.73 (1H, s).

REFERENCE EXAMPLE 26

A mixture of sodium methoxide (15.5 g), dimethyl carbonate (91 ml) and7-(4-fluorophenyl)-1-tetralone (13.8 g) was refluxed for 30 minutes. Thereaction mixture was cooled to 0° C., and to the mixture was graduallyadded 3N hydrochloric acid (200 ml). The mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was dissolved in THF (90 ml), and tothe mixture was added sodium boron hydride (1.36 g) at 0° C. and thenwas dropwise added methanol (9 ml) for 30 minutes. The reaction mixturewas stirred at 0° C. for 4 hours, and to the mixture was added water(500 ml). The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, andconcentrated under reduced pressure. The residue was dissolved inmethanol (80 ml), and to the mixture was added 1N sodium hydroxide (100ml). The mixture was refluxed for 4 hours and cooled to roomtemperature. The mixture was acidified with concentrated hydrochloricacid and extracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with anhydrous sodium sulfate,and concentrated under reduced pressure. The residue was dissolved inDiglyme (50 ml), and to the mixture was added concentrated hydrochloricacid (10 ml). The mixture was stirred at 100° C. for 2 hours, and to themixture was added water (500 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, and concentrated under reduced pressure. The residue wasdissolved in 0.5N sodium hydroxide (400 ml), and the mixture was washedwith diethylether. The aqueous layer was separated, acidified withconcentrated hydrochloric acid and extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive 7-(4-fluorophenyl)-3,4-dihydronaphthalene-2-carboxylic acid (6.0 g)as pale brown crystals.

mp 213-214° C.; Elemental Analysis for C₁₇ H₁₃ O₂ F; Calcd: C, 76.11; H,4.88. Found: C, 76.02; H, 4.97. IR (KBr) cm⁻¹ : 2953, 1695, 1518, 1431,1300, 1281, 1246, 930, 824; ¹ H NMR (200 MHz, CDCl₃) δ: 2.61-2.72 (2H,m), 2.90-2.99 (2H, m), 7.08-7.19 (2H, m), 7.23-7.29 (1H, m), 7.41-7.58(4H, m), 7.72 (1H, s).

REFERENCE EXAMPLE 27

To a mixture ofN-[4-(hydroxymethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(566 mg), lithium chloride (135 mg), triethylamine (446 μl) anddichloromethane (50 ml) was added methanesulfonyl chloride (172 μl), andthe mixture was stirred at room temperature for 2 hours. To the reactionmixture was added dilute hydrochloric acid. The organic layer wasseparated, washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was recrystallized from ethyl acetate-hexane to giveN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(494 mg) as colorless crystals.

mp 176-177° C.; Elemental Analysis for C₂₄ H₂₀ NOCl; Calcd: C, 77.10; H,5.39; N, 3.75. Found: C, 76.95; H, 5.47; N, 3.82. IR (KBr) cm⁻¹ : 3327,1649, 1618, 1527, 1412, 1317, 831, 764, 700; ¹ H NMR (200 MHz, DMSO-d₆)δ: 2.55-2.68 (2H, m), 2.85-2.95 (2H, m), 4.74 (2H, s), 7.30-7.80 (13H,m), 10.05 (1H, s).

REFERENCE EXAMPLE 28

A mixture of 4-nitrobenzylalcohol(10.0 g), tertbutyl-dimethylsilylchloride (11.8 g), imidazole (11.2 g) and DMF (50 ml) was stirred atroom temperature for 1.5 hours. To the mixture was added water (500 ml),and the mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1/7) to give tert-butyldimethyl-4-nitrobenzyloxysilane(17.5 g) as pale yellow oil.

¹ H NMR (200 MHz, CDCl₃) δ: 0.13 (6H, s), 0.96 (9H, s), 4.83 (2H, s),7.48 (2H, d, J=8.6 Hz), 8.20 (2H, d, J=8.6 Hz).

REFERENCE EXAMPLE 29

In ethanol (80 ml) was dissolvedtert-butyldimethyl-4-nitrobenzyloxysilane (16.5 g), and to the mixturewas added dried 5% palladium on carbon (0.83 g). Under hydrogenatmosphere, the mixture was stirred at room temperature underatmospheric pressure for 7.5hours. The palladium was filtered off, andthe filtrate was concentrated. The residue was separated and purifiedwith column chromatography (ethyl acetate/hexane=1/4) to give4-aminobenzyloxy-tert-butyldimethylsilane (13.8 g) as colorless oil.

IR (neat) cm⁻¹ : 3359, 2954, 2856, 1626, 1518, 1471, 1375, 1257, 1072,837, 777; ¹ H NMR (200 MHz, CDCl₃) δ: 0.07 (6H, s), 0.92 (9H, s),3.50-3.70 (2H, br), 4.62 (2H, s), 6.65 (2H, d, J=8.4 Hz), 7.11 (2H, d,J=8.4 Hz).

REFERENCE EXAMPLE 30

In THF (60 ml) was dissolved7-(4-methylphenyl)-3,4-dihydro-naphthalene-2-carboxylic acid (4.02 g).To the solution were added oxalyl chloride (1.99 ml) and a drop of DMF,and the mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(30 ml), and to the mixture was dropwise added a solution of4-amino-benzyloxy-tert-butyldimethylsilane (3.97 g) and triethylamine(2.56 ml) in THF (30 ml) at room temperature. The reaction mixture wasstirred at room temperature for 19 hours. To the mixture was added water(300 ml), and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/toluene/hexane=1/5/5). The resulting oil was dissolved inacetone (60 ml), and to the mixture was added 6N hydrochloric acid(2ml). The mixture was stirred at room temperature for 30 minutes. To thereaction mixture were added 0.5% sodium hydroxide (500 ml) anddiisopropylether (200 ml), and the mixture was stirred at roomtemperature for 5 minutes. The resulting precipitate s was filtered andrecrystallized from acetone-diisopropylether to giveN-[4-(hydroxy-methyl)phenyl]-7-(4-methylphenyl)-3,4-dihydro-naphthalene-2-carboxamide(4.54 g) as pale brown crystals.

mp 219-220° C.; Elemental Analysis for C₂₅ H₂₃ NO₂ ; Calcd: C, 81.27; H,6.27; N, 3.79. Found: C, 81.23; H,5.99; N, 3.80. IR (KBr) cm⁻¹ : 3315,1647, 1618, 1597, 1531, 1414, 1321, 810; ¹ H NMR (200 MHz, DMSO-d₆) δ:2.35 (3H, s), 2.55-2.65 (2H, m), 2.83-2.93 (2H, m), 4.46 (2H, d, J=5.6Hz), 5.13 (1H, t, J=5.6 Hz), 7.23-7.33 (5H, m), 7.44-7.58 (5H, m), 7.69(2H, d, J=8.4 Hz), 9.93 (1H, s).

REFERENCE EXAMPLE 31

To a mixture ofN-[4-(hydroxymethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(2.20 g), lithium chloride (505 mg), triethylamine (1.67 ml), DMAP[4-dimethylaminopyridine] (catalytic amount) and dichloromethane (200ml) was added methanesulfonyl chloride (645 μl), and the mixture wasstirred at room temperature for 42 hours and concentrated under reducedpressure. To the residue was added 0.5N hydrochloric acid (200 ml), andthe mixture was extracted with ethyl acetate. The organic layer wasdried with anhydrous sodium sulfate and concentrated under reducedpressure. The residue was recrystallized from ethyl acetate-hexane togiveN-[4-(chloromethyl)-phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(973 mg) as colorless crystals.

mp 178-179° C.; Elemental Analysis for C₂₅ H₂₂ NOCl; Calcd: C, 77.41; H,5.72; N, 3.61. Found: C, 77.34; H, 5.89; N, 3.65. IR (KBr) cm⁻¹ : 3332,1651, 1620, 1529, 1412, 1319, 812; ¹ H NMR (200 MHz, DMSO-d₆) δ: 2.35(3H, s), 2.55-2.68 (2H, m), 2.83-2.93 (2H, m), 4.74 (2H, s), 7.24-7.60(10H, m), 7.76 (2H, d, J=8.6 Hz), 10.04 (1H, s).

REFERENCE EXAMPLE 32

Under argon atmosphere, 6-methoxy-1-indanone (10.0 g) was dissolved inxylene (10 ml), and to the mixture was added aluminum chloride (16.4 g).The mixture was refluxed for 2 hours and then cooled to roomtemperature. To the mixture was added 3N hydrochloric acid (100 ml), andthe mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethyl acetate) togive 6-hydroxy-1-indanone (7.36 g) as pale brown crystals.

¹ H NMR (200 MHz, CDCl₃) δ: 2.67-2.76 (2H, m), 3.02-3.11 (2H, m), 5.61(1H, s), 7.10-7.21 (2H, m), 7.36 (1H, d, J=8.0 Hz).

REFERENCE EXAMPLE 33

Under argon atmosphere, 6-hydroxy-1-indanone (7.36 g) and triethylamine(20.9 ml) were dissolved in dichloromethane (120 ml), and to the mixturewas dropwise added trifluoromethanesulfonic acid anhydride (8.78 ml) at0° C. The reaction mixture was stirred at 0° C. for 1 hour, and to themixture was added water (200 ml). The organic layer was separated,washed with water, dried with anhydrous sodium sulfate and concentratedunder reduced pressure. The residue was separated and purified withcolumn chromatography (ethyl acetate/hexane=1/4) to give6-(trifluoromethanesulfoxy)-1-indanone (11.5 g) as brown oil.

¹ H NMR (200 MHz, CDCl₃) δ: 2.75-2.83 (2H, m), 3.17-3.24 (2H, m), 7.50(1H, dd, J=2.4, 8.4 Hz), 7.60 (1H, d, J=8.4 Hz), 7.64 (1H, d, J=2.4 Hz).

REFERENCE EXAMPLE 34

Under argon atmosphere, a mixture of6-(trifluoromethanesulfoxy)-1-indanone (11.5 g), 4-methylphenyl borate(6.69 g), potassium carbonate (11.3 g), toluene (400 ml), ethanol (40ml) and water (40 ml) was stirred at room temperature for 30 minutes,and to the mixture was added tetrakis(triphenylphosphine)palladium (1.42g). The mixture was refluxed for 17 hours and cooled to roomtemperature. The organic layer was separated, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/toluene=1/10) and recrystallized from ethyl acetate-hexane togive 6-(4-methylphenyl)-1-indanone (5.20 g) as pale brown crystals.

mp 121-122° C.; Elemental Analysis for C₁₆ H₁₄ O; Calcd: C, 86.45; H,6.35. Found: C, 86.46; H,6.23. IR (KBr) cm⁻¹ : 1703, 1614, 1483, 1448,1404, 1304, 814; ¹ H NMR (200 MHz, CDCl₃) δ: 2.40 (3H, s), 2.70-2.79(2H, m), 3.13-3.22 (2H, m), 7.23-7.29 (2H, m), 7.48-7.57 (3H, m), 7.83(1H, dd, J=1.8, 8.0 Hz), 7.96 (1H, s).

REFERENCE EXAMPLE 35

A solution of 6-(4-methylphenyl)-1-indanone (4.97 g) in THF (33 ml) wasdropwise added to a refluxed mixture of 60% sodium hydride (3.26 g),potassium hydride (catalytic amount), dimethyl carbonate (6.65 ml) andTHF (100 ml), and the mixture was ref luxed for 6 hours. The reactionmixture was cooled to 0° C., and to the mixture was gradually added 2Nhydrochloric acid (150 ml). The mixture was extracted with ethylacetate, and the organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethyl acetate/toluene=1/3) to give a brown solid. Thesolid was dissolved in dichloromethane (100 ml), and to the mixture wasadded sodium boron hydride (391 mg) at 0° C. and then was dropwise addedmethanol (10 ml). The reaction mixture was stirred at 0° C. for 1.5hours, and to the mixture was added water (500 ml). The mixture wasextracted with ethyl acetate, and the organic layer was washed withsaturated sodium chloride solution, dried with anhydrous sodium sulfate,and concentrated under reduced pressure. The residue was dissolved inmethanol (30 ml), and to the mixture was added 1N sodium hydroxide (40ml). The mixture was refluxed for 2 hours and cooled to roomtemperature. To the mixture was added water, and the mixture was washedwith diethylether. The aqueous layer was acidified with concentratedhydrochloric acid and extracted with ethyl acetate. The organic layerwas washed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasdissolved in Diglyme (30 ml), and to the mixture was added concentratedhydrochloric acid (6 ml). The mixture was stirred at 100° C. for 2hours, and to the solution were added 0.5% sodium hydrogen carbonatesolution (500 ml) and hexane(500 ml). The resulting precipitate wasfiltered to give 5-(4-methylphenyl)-indene-2-carboxylic acid (2.72 g) asbrown crystals.

mp 226-229° C. (decomp.); Elemental Analysis for C₁₇ H₁₄ O₂.0.1H₂ O;Calcd: C, 80.99; H, 5.68. Found: C, 80.92; H,5.55. IR (KBr) cm⁻¹ : 2999,1670, 1572, 1259, 808; ¹ H NMR (200 MHz, DMSO-d₆) δ: 2.35 (3H, s),3.63-3.70 (2H, m), 7.28 (2H, d, J=8.0 Hz), 7.53-7.73 (5H, m), 7.83 (1H,d, J=6.0 Hz).

REFERENCE EXAMPLE 36

A mixture of hexamethyleneimine (15.0 g), ethyl iodide (14.5 ml),potassium carbonate (31.3 g) and ethanol (300 ml) was refluxed for 6hours and concentrated under reduced pressure. To the residue was addeddiethylether, and insoluble material was filtered off. The filtrate wasunder reduced pressure to give l-ethylperhydroazepine (4.56 g) ascolorless oil.

bp 73-76° C./70 mmHg; IR (neat) cm⁻¹ : 2927, 1452, 1352, 1190, 1140,1093; ¹ H NMR (200 MHz, CDCl₃) δ: 1.05 (3H, t, J=7.2 Hz), 1.55-1.72 (8H,m), 2.47-2.65 (6H, m).

REFERENCE EXAMPLE 37

A mixture of hexamethyleneimine (15.0 g), 1-propyl iodide (29.5 ml),potassium carbonate (31.3 g) and ethanol (300 ml) was refluxed for 42hours and concentrated under reduced pressure. To the residue was addeddiethylether, and insoluble material was filtered off. The filtrate wasunder reduced pressure to give 1-propylperhydroazepine (2.50 g) ascolorless oil.

bp 70-74° C./50 mmHg IR (neat) cm⁻¹ : 2926, 1749, 1458, 1375, 1259,1184, 1138, 1082; ¹ H NMR (200 MHz, CDCl₃) δ: 0.87 (3H, t, J=7.5 Hz),1.40-1.80 (10H, m), 2.36-2.46 (2H, m), 2.55-2.67 (4H, m).

REFERENCE EXAMPLE 38

A mixture of heptamethyleneimine (10.0 g), ethyl iodide (8.48 ml),potassium carbonate (18.3 g) and ethanol (200 ml) was refluxed for 13hours and concentrated under reduced pressure. To the residue was addeddiethylether, and insoluble material was filtered off. The filtrate wasunder reduced pressure to give 1-ethylperhydroazocine (2.29 g) ascolorless oil.

bp 76-78° C./40 mmHg IR (neat) cm⁻¹ : 2920, 1475, 1446, 1371, 1252,1225, 1161, 1093; ¹ H NMR (200 MHz, CDCl₃) δ: 1.03 (3H, t, J=6.9 Hz),1.48-1.72 (10H, m), 2.42-2.60 (6H, m).

REFERENCE EXAMPLE 39

Under argon atmosphere, a mixture of methyl(E)-3-(trifluoromethanesulfoxy)cinnamate (9.00 g), 4-methylphenyl borate(4.73 g), potassium carbonate (8.02 g), toluene (300 ml), ethanol (30ml) and water (30 ml) was stirred at room temperature for 30 minutes. Tothe mixture was added tetrakis(triphenylphosphine)palladium (1.01 g),and the mixture was refluxed for 24 hours. The reaction mixture wascooled to room temperature, and the organic layer was separated, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was separated and purified with column chromatography (ethylacetate/toluene/hexane=1/5/5) to give colorless oil, which was dissolvedin methanol (50 ml). To the mixture was added 1N sodium hydroxide (50ml), and the mixture was refluxed for 1 hour. The reaction mixture wascooled to room temperature, acidified with concentrated hydro-chloricacid and extracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with anhydrous sodium sulfate,and concentrated under reduced pressure. The residue was recrystallizedfrom ethyl acetate-diisopropylether to give(E)-3-(4-methyl-phenyl)cinnamic acid (5.15 g) as colorless crystals.

mp 192-194° C.; Elemental Analysis for C₁₆ H₁₄ O₂. 0.1H₂ O; Calcd: C,80.04; H, 5.96. Found: C, 80.13; H, 5.94. IR (KBr) cm⁻¹ : 2922, 1687,1628, 1435, 1321, 1282, 1225, 798; ¹ H NMR (200 MHz, CDCl₃) δ: 2.41 (3H,s), 6.52 (1H, d, J=16.0 Hz), 7.23-7.30 (2H, m), 7.40-7.53 (4H, m),7.56-7.65 (1H, m), 7.73 (1H, s), 7.85 (1H, d, J=16.0 Hz).

REFERENCE EXAMPLE 40

In THF (50 ml) was dissolved (E)-3-(4-methylphenyl)-cinnamic acid (5.00g), and to the solution were added oxalyl chloride (2.38 ml) and a dropof DMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(50 ml), and to the mixture were added4-aminobenzyloxy-tert-butyl-dimethylsilane (5.48 g) and triethylamine(3.53 ml) at room temperature. The reaction mixture was stirred at roomtemperature for 3 hours, and to the mixture was added water (200 ml).The mixture was extracted with ethyl acetate, and the organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/toluene/hexane=1/5/5) to give oil, which was dissolved inacetone (50 ml). To the mixture was added 6N hydrochloric acid (1 ml),and the mixture was stirred at room temperature for 30 minutes. To thereaction mixture were added 0.5% sodium hydroxide (500 ml) anddiisopropylether (200 ml), and the mixture was stirred at roomtemperature for 5 minutes. The resulting precipitate was filtered andrecrystallized from acetone-diisopropylether to give(E)-N-[4-(hydroxymethyl)-phenyl]-3-(4-methylphenyl)-cinnamamide (6.18 g)as pale yellow crystals.

mp 220-223° C.; Elemental Analysis for C₂₃ H₂₁ NO₂ ; Calcd: C, 80.44; H,6.16; N, 4.08. Found: C, 80.12; H, 6.15; N, 4.00. IR (KBr) cm⁻¹ : 3294,1662, 1624, 1603, 1541, 1516, 1414, 1346, 1250, 1184, 999, 787; ¹ H NMR(200 MHz, DMSO-d₆) δ: 2.36 (3H, s), 4.46 (2H, s), 6.93 (1H, d, J=15.4Hz), 7.22-7.33 (4H, m), 7.46-7.71 (8H, m), 7.89 (1H, s), 10.18 (1H, s).

REFERENCE EXAMPLE 41

To a mixture of(E)-N-[4-(hydroxymethyl)phenyl]-3-(4-methylphenyl)cinnamamide (3.00 g),lithium chloride (741 mg), triethylamine (3.06 ml), DMAP(catalyticamount) and dichloro-methane (300 ml) was added methanesulfonyl chloride(1.15 ml), and the mixture was stirred at room temperature for 13 hours.To the reaction mixture was added 4N hydrochloric acid ethyl acetatesolution (3.3 ml), and the mixture was purified with columnchromatography (ethyl acetate) and recrystallized from ethylacetatediisopropylether to give(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (2.00 g) ascolorless crystals.

mp 178-180° C.; Elemental Analysis for C₂₃ H₂₀ NOCl.0.1H₂ O; Calcd: C,75.96; H, 5.60; N, 3.85. Found: C, 75.93; H, 5.50; N, 3.88. IR (KBr)cm⁻¹ : 3344, 3045, 1664, 1628, 1531, 1412, 1338, 1248, 1176, 968, 793,658; ¹ H NMR (200 MHz, CDCl₃) δ: 2.41 (3H, s), 4.58 (2H, s), 6.61 (1H,d, J=15.6 Hz), 7.25-7.31 (2H, m), 7.33-7.53 (7H, m), 7.55-7.67 (3H, m),7.74 (1H, s), 7.83 (1H, d, J=15.6 Hz).

REFERENCE EXAMPLE 42

To a solution cooled at -78° C. of 2-bromopyridine (10.0 g) indiethylether (200 ml) was dropwise added 1.6M butyllithium hexanesolution (39.6 ml) for 10 minutes. The mixture was stirred at -78° C.for 1 hour, and to the mixture was dropwise added a solution of4-nitrobenzaldehyde in THF (50 ml). The reaction mixture was stirred at-78° C. for 3 hours, and to the mixture was added water (100 ml). Themixture was extracted with ethyl acetate, and the organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/toluene=1/2) and re-crystallized from duisopropylether to give(4-nitrophenyl) -(2-pyridyl)methanol (4.50 g) as orange crystals.

mp 114-1150° C.; Elemental Analysis for C₁₂ H₁₀ N₂ O₃ ; Calcd: C, 62.61;H, 4.38; N, 12.17. Found: C, 62.61; H, 4.27; N, 12.16. IR (KBr) cm⁻¹ :3113, 2852, 1595, 1506, 1437, 1336, 1267, 1068, 1047, 1007, 847, 814,777, 756, 743, 706; ¹ H NMR (20° C. MHz, CDCl₃) δ:5.44 (1H, br s), 5.86(1H, s), 7.14-7.29 (2H, m), 7.55-7.73 (3H, m), 8.20 (2H, d, J=8.8 Hz),8.59 (1H. d, J=5.0 Hz).

REFERENCE EXAMPLE 43

In ethanol (50 ml) was dissolved (4-nitrophenyl)-(2-pyridyl)methanol(2.30 g), and to the mixture was added dried 10% palladium on carbon(0.12 g). Under hydrogen atmosphere, the mixture was stirred at roomtemperature under atmospheric pressure for 19 hours. The palladium wasfiltered off, and the filtrate was concentrated. The residue wasrecrystallized f rom ethyl acetate-hexane to give (4-aminophenyl)(2-pyridyl)methanol (1.90 g) as pale yellow crystals.

mp 139-140° C.; Elemental Analysis for C₁₂ H₁₂ N₂ O; Calcd: C. 71.98; H,6.04; N, 13.99. Found: C, 71.76; H. 6.01; N, 13.82. IR (KBr) cm⁻¹ :3292, 1612, 1589, 1512, 1473, 1439, 1263, 1055, 816, 752, 569; ¹ H NMR(200 MHz, CDCl₃) δ: 3.65 (2H, br s), 5.14 (1H, br s), 5.65 (1H, s), 6.65(2H, d, J=8.8 Hz)., 7.10-7.22 (4H, m), 7.61 (1H, dt, J=1.8, 7.6 Hz) 8.55(1H, d, J=4.8 Hz).

REFERENCE EXAMPLE 44

Under argon atmosphere, ethyl 3-hydroxycinnamate (mp 88-89° C.; 20.0 g)and triethylamine (34.5 ml) were dissolved in dichloromethane (200 ml),and to the mixture was dropwise added trifluoromethanesulfonic acidanhydride (31.6 g) at -5° C. for 40 minutes. The reaction mixture wasstirred at -5° C. to 0° C. for 20 minutes, and to the mixture was addedwater (200 ml). The organic layer was separated, washed with saturatedsodium chloride solution, dried with anhydrous magnesium sulfate andconcentrated under reduced pressure. The residue was separated andpurified with column chromatography (ethylacetate/hexane=1/4) andcrystallized from hexane to give ethyl3-(trifluoro-methanesulfoxy)cinnamate (33.5 g).

mp 52-53° C.; ¹ H NMR (200 MHz, CDCl₃) δ: 3.83 (3H, s), 6.48 (1H, d,J=16.0 Hz), 7.30 (1H, m), 7.41 (1H, t, J=1.6 Hz), 7.51 (2H, m), 7.67(1H, d, J=16.0 Hz).

REFERENCE EXAMPLE 45

Under argon atmosphere, a mixture of ethyl3-(trifluoromethanesulfoxy)cinnamate (3.10 g), 4-methylphenyl borate(1.63 g), potassium carbonate (2.76 g), toluene (100 ml), ethanol (10ml) and water (10 ml) was stirred at room temperature for 30 minutes. Tothe mixture was added tetrakis(triphenylphosphine)palladium (0.46 g),and the mixture was refluxed for 18 hours. The reaction mixture wascooled to room temperature. The organic layer was separated, washed withsaturated sodium chloride solution, dried with anhydrous magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1/6) to give ethyl 3-(4-methylphenyl)-cinnamate (2.21 g)as colorless oil. The oil (2.20 g) was dissolved in tetrahydrofuran (20ml). To the mixture was added 2N sodium hydroxide (8.7 ml), and themixture was stirred at 50° C. for 2 hours. The reaction mixture wascooled, acidified with potassium hydrogen sulfate and extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous magnesium sulfate andconcentrated under reduced pressure. The residue was washed withisopropylether to give 3-(4-methylphenyl)cinnamic acid (1.54 g) ascolorless crystals.

mp 186-187° C.; ¹ H NMR (200 MHz, CDCl₃) δ:2.41 (3H, s), 6.53 (1H, d,J=16.0 Hz), 7.28 (2H, d, J=7.4 Hz), 7.46-7.52 (4H, m), 7.50 (1H, s),7.63 (1H, m), 7.86 (1H, d, J=16.0 Hz).

REFERENCE EXAMPLE 46

Under argon atmosphere, a mixture of ethyl3-(trifluoromethanesulfoxy)cinnamate (3.10 g), 2-methylphenyl borate (mp165-166° C. ; 1.63 g), potassium carbonate (2.76 g), toluene (100 ml),ethanol (10 ml) and water (10 ml) was stirred at room temperature for 30minutes. To the mixture was added tetrakis(triphenyl-phosphine)palladium(0.46 g), and the mixture was refluxed for 18 hours. The reactionmixture was cooled to room temperature, and the organic layer wasseparated, washed with saturated sodium chloride solution, dried withanhydrous magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/hexane=1/6) to give ethyl 3-(4-methylphenyl)cinnamate (2.51 g)as pale yellow oil. The oil (2.50 g) was dissolved in tetrahydrofuran(20 ml). To the mixture was added 2N sodium hydroxide (10.0ml), and themixture was stirred at 50° C. for 2 hours. The reaction mixture wascooled, acidified with potassium hydrogen sulfate and extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous magnesium sulfate andconcentrated under reduced pressure. The residue was washed withisopropylether to give 3-(2-methylphenyl)cinnamic acid (1.96 g) ascolorless crystals.

mp 124-125° C.; ¹ H NMR (200 MHz, CDCl₃) δ: 2.27 (3H, s), 6.49 (1H, d,J=16.0 Hz), 7.23-7.30 (4H, m), 7.36-7.57 (4H, m), d, J=7.4 Hz), 7.84(1H, d, J=16.0 Hz).

REFERENCE EXAMPLE 47

Under argon atmosphere, a mixture of ethyl3-(trifluoro-methanesulfoxy)cinnamate (3.10 g), 2,5-dimethylphenylborate (mp 184-186° C. ; 1.80 g), potassium carbonate (2.76 g), toluene(100 ml), ethanol (10 ml) and water (10 ml) was stirred at roomtemperature for 30 minutes. To the mixture was addedtetrakis(triphenylphosphine)palladium (0.46 g), and the mixture wasrefluxed for 27 hours. The reaction mixture was cooled to roomtemperature, and the organic layer was separated, washed with saturatedsodium chloride solution, dried with anhydrous magnesium sulfate andconcentrated under reduced pressure. The residue was separated andpurified with column chromatography (ethyl acetate/hexane=1/6) to giveethyl 3-(2,5-dimethylphenyl)cinnamate (2.66 g) as pale yellow oil. Theoil (2.50 g) was dissolved in tetrahydrofuran (20 ml), and to themixture was added 2N sodium hydroxide (10.0 ml). The mixture was stirredat 50° C. for 2 hours, cooled, acidified with potassium hydrogen sulfateand extracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with anhydrous magnesiumsulfate and concentrated under reduced pressure. The residue was washedwith isopropylether to give 3-(2,5-dimethylphenyl)cinnamic acid (1.96 g)as colorless crystals.

mp 156-157° C.; ¹ H NMR (200 MHz, CDCl₃) δ: 2.23 (3H, s), 2.60 (3H, s),6.49 (1H, d, J=16.0 Hz), 7.06 (1H, s), 7.14 (2H, ABq, J=7.8 Hz),7.35-7.55 (4H, m), 7.36-7.57 (4H, m), 7.84 (1H, d, J=16.0 Hz).

REFERENCE EXAMPLE 48

Under argon atmosphere, a mixture of ethyl3-(trifluoromethanesulfoxy)cinnamate (3.10 g), 3-nitro-phenyl borate(2.00 g), potassium carbonate (2.76 g), toluene (100 ml), ethanol (10ml) and water (10 ml) was stirred at room temperature for 30 minutes. Tothe mixture was added tetrakis(triphenylphosphine)palladium (0.46 g),and the mixture was refluxed for 24 hours. The reaction mixture wascooled to room temperature. The organic layer was separated, washed withsaturated sodium chloride solution, dried with anhydrous magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1/6) to give ethyl 3-(3-nitrophenyl)-cinnamate (2.40 g)as pale yellow crystals. The crystals (2.40 g) were dissolved intetrahydrofuran (20 ml), and to the mixture was added 2N sodiumhydroxide (8.5 ml). The mixture was stirred at 50° C. for 2 hours,cooled, acidified with potassium hydrogen sulfate and extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous magnesium sulfate andconcentrated under reduced pressure. The residue was washed withisopropylether to give 3-(3-nitrophenyl)cinnamic acid (1.88 g) as paleyellow crystals.

mp247-248° C.; ¹ H NMR (200 MHz, DMSO-d₆) δ: 6.59 (1H, d, J=16.0 Hz),7.51-7.76 (4H, m), 7.70 (1H, d, J=16.0 Hz), 7.96 (1H, d, J=9.0 Hz), 8.09(1H, m), 8.22 (1H, m), 8.49 (1H, d, J=1.8 Hz).

WORKING EXAMPLE 1 (PRODUCTION OF COMPOUND 1)

In THF (5 ml) was dissolved7-cyclohexyl-3,4-dihydronaphthalene-2-carboxylic acid (200 mg), and tothe solution were added oxalyl chloride (82 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (5 ml), and tothe solution were added 1-(4-aminobenzyl)piperidine (164 mg) andtriethylamine (484 μl) at room temperature. The reaction mixture wasstirred at room temperature for 3 hours, and to the mixture was addedwater (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive7-cyclohexyl-N-[4-(piperidinomethyl)-phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 1) (223 mg) as colorless crystals.

mp 180-181° C,; Elemental Analysis for C₂₉ H₃₆ N₂ O₂ ; Calcd: C, 81.27;H, 8.47; N, 6.54. Found: C, 81.03; H, 8.42; N, 6.53. IR (KBr) cm⁻¹ :3430, 2931, 1645, 1597, 1514, 1412, 1317, 824; ¹ H NMR (200 MHz, CDCl₃)δ: 1.20-1.90 (16H, m), 2.30-2.57 (5H, m), 2.60-2.72 (2H, m), 2.85-2.97(2H, m), 3.46 (2H, s), 7.05-7.15 (3H, m), 7.25-7.34 (3H, m), 7.50-7.60(3H, m).

WORKING EXAMPLE 2 (PRODUCTION OF COMPOUND 2)

In DMF (2 ml) was dissolved7-cyclohexyl-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(120 mg), and to the mixture was added methyl iodide (45 μl). Themixture was stirred at room temperature for 24 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give1-[4-(7-cyclohexyl-3,4-dihydro-naphthalene-2-carboxamido) benzyl]-1-methylpiperidinium iodide (Compound 2) (148 mg) as colorless crystals.

mp 188-191° C.; Elemental Analysis for C₃₀ H₃₉ N₂ OI; Calcd: C, 63.15;H, 6.89; N, 4.91; I, 22.24. Found: C, 63.03; H, 6.93; N, 5.03; I, 22.22.IR (KBr) cm⁻¹ : 3430, 2929, 1649, 1599, 1520, 1417, 1321, 1248; ¹ H NMR(200 MHz, DMSO-d₆) δ: 1.20-1.90 (16H, m), 2.40-2.65 (3H, m), 2.75-2.95(5H, m), 3.20-3.45 (4H, m), 4.53 (2H, s), 7.14 (3H, s), 7.38 (1H, s),7.49 (2H, d, J=8.6 Hz), 7.88 (2H, d, J=8.6 Hz), 10.12 (1H, s).

WORKING EXAMPLE 3 (PRODUCTION OF COMPOUND 3)

In THF (3 ml) was dissolved7-cyclohexyl-3,4-dihydronaphthalene-2-carboxylic acid (100 mg), and tothe solution were added oxalyl chloride (41 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (3 ml), and tothe solution were added p-(4-aminobenzyl)-N,N'-diethyl-phosphondiamide(104 mg) andtriethylamine(60 μl )at room temperature. The reactionmixture was stirred at room temperature for 72 hours, and to the mixturewas added water (100 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous sodium sulfate, and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/methanol=10/1) and was recrystallized fromdiisopropylether to give7-cyclohexyl-N-[4-[bis(ethylamino)phosphorylmethyl]-phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 3) (140 mg) as colorless crystals.

mp 163-165° C.; Elemental Analysis for C₂₈ H₃₈ N₃ O₂ P; Calcd: C, 70.12;H, 7.99; N, 8.76. Found: C, 70.01; H, 7.99; N, 8.93. IR (KBr) cm⁻¹ :3250, 2926, 1645, 1599, 1514, 1414, 1321, 1250, 1182, 1126; ¹ H NMR (200MHz, CDCl₃) δ: 1.10 (6H, t, J=7.1 Hz), 1.20-1.90 (10H, m), 1.95-2.20(2H, m), 2.40-2.57 (1H, m), 2.60-2.72 (2H, m), 2.80-3.05 (7H, m), 3.12(1H, s), 7.05-7.15 (3H, m), 7.22-7.32 (3H, m), 7.59 (2H, d, J=8.2 Hz),7.83 (1H, s).

WORKING EXAMPLE 4 (PRODUCTION OF COMPOUND 4)

In THF (20 ml) was dissolved7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (1.00 g), and to thesolution were added oxalyl chloride (523 μl) and a drop of DMF. Themixture was added at room temperature for 1 hour and concentrated underreduced pressure. The residue was dissolved in THF (20 ml), and to thesolution were added 1- (4-aminobenzyl)piperidine (837 mg) andtriethylamine (673 μl) at room temperature. The reaction mixture wasstirred at room temperature for 2 hours, and to the mixture was addedwater (150 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive7-phenyl-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 4) (1.15 g) as pale brown crystals.

mp 163-164° C.; Elemental Analysis for C₂₉ H₃₀ N₂ O.0.1H₂ O; Calcd: C,82.08; H, 7.17; N, 6.60. Found: C, 81.94; H, 7.22; N, 6.49. IR (KBr)cm⁻¹ : 3336, 2935, 1651, 1527, 1412, 1317, 762, 698; ¹ H NMR (200 MHz,CDCl₃) δ: 1.35-1.70 (6H, m), 2.30-2.45 (4H, m), 2.65-2.80 (2H, m),2.92-3.04 (2H, m), 3.46 (2H, s), 7.23-7.62 (14H, m).

WORKING EXAMPLE 5 (PRODUCTION OF COMPOUND 5)

In DMF (3 ml) was dissolved7-phenyl-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(240 mg), and to the mixture was added methyl iodide (106 μl). Themixture was stirred at room temperature for 60 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give1-methyl-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]piperidiniumiodide (Compound 5) (247 mg) as colorless crystals.

mp 183-186° C.; Elemental Analysis for C₃₀ H₃₃ N₂ OI; Calcd: C, 63.83;H, 5.89; N, 4.96. Found: C, 63.54; H, 5.82; N, 5.05. IR (KBr) cm⁻¹ :3450, 1649, 1599, 1520, 1417, 1319; ¹ H NMR (200 MHz, DMSO-d₆) δ:1.40-2.00 (6H, m), 2.55-2.70 (2H, m), 2.80-3.00 (5H, m), 3.20-3.45 (4H,m), 4.53 (2H, s), 7.30-7.70 (11H, m), 7.89 (2H, d, J=8.6 Hz), 10.18 (1H,s).

WORKING EXAMPLE 6 (PRODUCTION OF COMPOUND 6)

In THF (10 ml) was dissolved7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (500 mg), and to thesolution were added oxalyl chloride (262 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (10 ml), and tothe solution were added 4-aminobenzyldimethylamine (330 mg) andtriethylamine (337 μl) at room temperature. The reaction mixture wasstirred at room temperature for 3 hours, and to the mixture was addedwater(100 ml). The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/triethylamine=20/1) and recrystallized from ethyl acetate-hexaneto giveN-[4-(dimethylaminomethyl)phenyl]-7-phenyl-3,4-dihydro-naphthalene-2-carboxamide(Compound 6) (131 mg) as colorless crystals.

mp 182-184° C.; Elemental Analysis for C₂₆ H₂₆ N₂ O.0.2H₂ O; Calcd: C,80.88; H, 6.89; N, 7.26. Found: C, 81.00; H. 6.90; N, 7.19. IR (KBr)cm⁻¹ : 3328, 1649, 1529, 1410, 1317, 762, 698; ¹ H NMR (200 MHz, CDCl₃)δ: 2.24 (6H, s), 2.65-2.80 (2H, m), 2.94-3.03 (2H, m), 3.41 (2H, s),7.25-7.63 (14H, m).

WORKING EXAMPLE 7 (PRODUCTION OF COMPOUND 7)

In THF (10 ml) was dissolved7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (500 mg), and to thesolution were added oxalyl chloride (262 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (10 ml), and tothe solution were added 1-(4-aminobenzyl)pyrrolidine (388 mg) andtriethylamine (337 μl) at room temperature. The reaction mixture wasstirred at room temperature for 3 hours, and to the mixture was addedwater (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was separated and purified with column chromatography (ethylacetate/triethylamine=20/1) and recrystallized from ethylacetate-diisopropylether to give7-phenyl-N-[4-(1-pyrrolidinylmethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 7) (107 mg) as colorless crystals.

mp 186-187° C.; Elemental Analysis for C₂₈ H₂₈ N₂ O.0.1H₂ O; Calcd: C,81.96; H, 6.93; N, 6.83. Found: C, 81.78; H, 6.84; N, 6.89. IR (KBr)cm⁻¹ : 3329, 2962, 1649, 1529, 1410, 1319, 762, 698; ¹ H NMR (200 MHz,CDCl₃) δ: 1.75-1.85 (4H, m), 2.45-2.55 (4H, m), 2.65-2.80 (2H, m),2.90-3.05 (2H, m), 3.60 (2H, s), 7.25-7.60 (14H, m).

WORKING EXAMPLE 8 (PRODUCTION OF COMPOUND 8)

In THF (10 ml) was dissolved7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (500 mg), and to thesolution were added oxalyl chloride (262 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (10 ml), and tothe solution were added 1- (4-aminobenzyl)morpholine (423 mg) andtriethylamine (337 μl) at room temperature. The reaction mixture wasstirred at room temperature for 2 hours, and to the mixture was addedwater (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was separated and purified with column chromatography (ethylacetate) and recrystallized from ethyl acetate-hexane to giveN-[4-(morpholinomethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(659 mg) as colorless crystals.

mp 186-187° C.; Elemental Analysis for C₂₈ H₂₈ N₂ O₂ ; Calcd: C, 79.22;H, 6.65; N, 6.60. Found: C, 78.89; H, 6.50; N, 6.66. IR (KBr) cm⁻¹ :3450, 1651, 1620, 1597, 1527, 1412, 1319, 1113, 764, 700; ¹ H NMR (200MHz, CDCl₃) δ: 2.38-2.47 (4H, m), 2.66-2.78 (2H, m), 2.92-3.03 (2H, m),3.48 (2H, s), 3.67-3.75 (4H, m), 7.25-7.60 (14H, m).

WORKING EXAMPLE 9 (PRODUCTION OF COMPOUND 9)

In THF (10 ml) was dissolved7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (500 mg), and to thesolution were added oxalyl chloride (262 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (10 ml), and tothe solution were added 1-[2-(4-aminophenyl)ethyl]piperidine (450 mg)and triethylamine (337 μl) at room temperature. The reaction mixture wasstirred at room temperature for 1 hour, and to the mixture was addedwater (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive7-phenyl-N-[4-(2-piperidinoethyl)phenyl]-3,4-dihydro-naphthalene-2-carboxamide(Compound 9) (576 mg) as pale brown crystals.

mp 157-159° C.; Elemental Analysis for C₃₀ H₃₂ N₂ O; Calcd: C, 82.53; H,7.39; N, 6.42. Found: C, 82.29; H, 7.24; N, 6.32. IR (KBr) cm⁻¹ : 3332,2933, 1651, 1524, 1412, 1317, 1257, 1117, 762, 698; ¹ HNMR (200 MHz,CDCl₃) δ: 1.40-1.80 (6H, m), 2.40-2.60 (6H, m), 2.65-2.85 (4H, m),2.90-3.00 (2H, m), 7.15-7.60 (14H, m).

WORKING EXAMPLE 10 (PRODUCTION OF COMPOUND 10)

In DMF (2 ml) was dissolvedN-[4-(dimethylaminomethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(80 mg), and to the mixture was added methyl iodide (39 μl). The mixturewas stirred at room temperature for 17 hours and concentrated underreduced pressure. The residue was recrystallized from methanolethylacetate to givetrimethyl[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]ammoniumiodide (Compound 10) (92 mg) as colorless crystals.

mp 190-192° C.; Elemental Analysis for C₂₇ H₂₉ N₂ OI.0.5H₂ O; Calcd: C,60.79; H, 5.67; N, 5.25. Found: C, 60.81; H, 5.59; N, 5.30. IR (KBr)cm⁻¹ : 3450, 1662, 1595, 1520, 1483, 1416, 1319, 1250, 764, 700; ¹ H NMR(200 MHz, CDCl₃) δ: 2.65-2.80 (2H, m), 2.80-2.95 (2H, m), 3.23 (9H, s),4.98 (2H, s), 7.18 (1H, d, J=8.0 Hz), 7.30-7.60 (9H, m), 7.69 (1H, s),7.82-7.90 (2H, m), 8.71 (1H, s).

WORKING EXAMPLE 11 (PRODUCTION OF COMPOUND 11)

In DMF (2 ml) was dissolved7-phenyl-N-[4-(1-pyrrolidinylmethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(70 mg), and to the mixture was added methyl iodide (32 μl). The mixturewas stirred at room temperature for 17 hours and concentrated underreduced pressure. The residue was recrystallized from methanol-ethylacetate to give1-methyl-i-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]pyrrolidiniumiodide (Compound 11) (78 mg) as pale yellow crystals.

mp 156-160° C.; Elemental Analysis for C₂₉ H₃₁ N₂ OI.1.0H₂ O; Calcd: C,61.27; H, 5.85; N, 4.93. Found: C, 61.23; H, 5.89; N, 5.04. IR (KBr)cm⁻¹ : 3442, 1655, 1593, 1520, 1416, 1317, 1248, 766, 700; ¹ H NMR (200MHz, CDCl₃) δ: 2.05-2.40 (4H, m), 2.65-2.76 (2H, m), 2.82-2.95 (2H, m),3.05 (3H, s), 3.43-3.57 (2H, m), 3.80-4.00 (2H, m), 4.98 (2H, s), 7.18(1H, d, J=8.0 Hz), 7.30-7.56 (9H, m), 7.70 (1H, s), 7.80-7.90 (2H, m),8.74 (1H, s).

WORKING EXAMPLE 12 (PRODUCTION OF COMPOUND 12)

In DMF (4 ml) was dissolvedN-[4-(morpholinomethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(450 mg), and to the mixture was added methyl iodide (198 μl). Themixture was stirred at room temperature for 18 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give4-methyl-4-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]morpholiniumiodide (Compound 12) (575 mg) as pale yellow crystals.

mp 166-170° C.; Elemental Analysis for C₂₉ H₃₁ N₂ O₂ I.0.5H₂ O; Calcd:C, 60.53; H, 5.60; N, 4.87. Found: C, 60.41; H. 5.61; N, 4.74. IR (KBr)cm⁻¹ : 3450, 1653, 1593, 1520, 1481, 1416, 1317, 1246, 1122, 887, 764,698; ¹ H NMR (200 MHz, CDCl₃) δ: 2.60-2.75 (2H, m), 2.75-2.90 (2H, m),3.22 (3H, s), 3.35-3.50 (2H, m), 3.55-3.75 (2H, m), 3.80-4.05 (4H, m),5.13 (2H, s), 7.12 (1H, d, J=7.6 Hz), 7.25-7.55 (9H, m), 7.71 (1H, s),7.80-7.87 (2H, m), 8.95 (1H, s).

WORKING EXAMPLE 13 (PRODUCTION OF COMPOUND 13)

In DMF (4 ml) was dissolved7-phenyl-N-[4-(2-piperidinoethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(350 mg), and to the mixture was added methyl iodide (150 μl). Themixture was stirred at room temperature for 14 hours and concentratedunder reduced pressure. The residue was recrystallized frommethanolethyl acetate to give1-methyl-1-[2-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamide)phenyl]ethyl]piperidiniumiodide (Compound 13) (410 mg) as pale brown crystals.

mp 219-220° C.; Elemental Analysis for C₃₁ H₃₅ N₂ OI.0.2H₂ O; Calcd: C,63.96; H, 6.13; N, 4.81. Found: C, 63.91; H, 6.06; N, 4.89. IR (KBr)cm⁻¹ : 2941, 1666, 1595, 1520, 1313, 1240, 1205, 837, 768, 702; ¹ H NMR(200 MHz, DMSO-d₆) δ: 1.45-1.90 (6H, m), 2.55-2.70 (2H, m), 2.80-3.17(7H, m), 3.25-3.60 (6H, m), 7.25-7.80 (13H, m), 9.95 (1H, s).

WORKING EXAMPLE 14 (PRODUCTION OF COMPOUND 14)

In THF (10 ml) was dissolved7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxylic acid (500 mg),and to the solution were added oxalyl chloride (248 μl) and a drop ofDMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(10 ml), and to the solution were added 1- (4-aminobenzyl)piperidine(396 mg) and triethylamine (318 μl) at room temperature. The reactionmixture was stirred at room temperature for 14 hours, and to the mixturewas added water (100 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous sodium sulfate, and concentrated under reducedpressure. The residue was recrystallized from ethylacetate-diisopropylether to give7-(4-methylphenyl)-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 14) (616 mg) as pale brown crystals.

mp 187-189° C.; Elemental Analysis for C₃₀ H₃₂ N₂ O; Calcd: C, 82.53; H,7.39; N, 6.42. Found: C, 82.26; H, 7.36; N, 6.37. IR (KBr) cm⁻¹ : 3310,2931, 1643, 1599, 1527, 1412, 1315, 1255, 806; ¹ H NMR (200 MHz, CDCl₃)δ: 1.38-1.65 (6H, m), 2.32-2.42 (7H, m), 2.65-2.77 (2H, m), 2.92-3.02(2H, m), 3.46 (2H, s), 7.20-7.34 (6H, m), 7.40-7.58 (7H, m).

WORKING EXAMPLE 15 (Production of Compound 15)

In THF (10 ml) was dissolved7-(4-fluorophenyl)-3,4-dihydronaphthalene-2-carboxylic acid (500 mg),and to the solution were added oxalyl chloride (243 μl) and a drop ofDMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(10 ml), and to the solution were added 1-(4-aminobenzyl)piperidine (389mg) and triethylamine (313 μl) at room temperature. The reaction mixturewas stirred at room temperature for 14 hours, and to the mixture wasadded water (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive7-(4-fluorophenyl)-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 15) (736 mg) as pale yellow crystals.

mp 175-176° C.; Elemental Analysis for C₂₉ H₂₉ N₂ OF.0.2H₂ O; Calcd: C,78.42; H, 6.67; N, 6.31. Found: C, 78.36; H, 6.68; N, 6.23. IR (KBr)cm⁻¹ : 3329, 2935, 1649, 1595, 1518, 1319, 1244, 824; ¹ H NMR (200 MHz,CDCl₃) δ: 1.35-1.65 (6H, m), 2.34-2.41 (4H, m), 2.67-2.77 (2H, m),2.92-3.02 (2H, m), 3.46 (2H, s), 7.07-7.58 (13H, m).

WORKING EXAMPLE 16 (Production of Compound 16)

In DMF (3 ml) was dissolved7-(4-methylphenyl)-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(400 mg), and to the mixture was added methyl iodide (171 μl). Themixture was stirred at room temperature for 18 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give1-methyl-1-[4-[7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]piperidiniumiodide (Compound 16) (490 mg) as colorless crystals.

mp 202-204° C.; Elemental Analysis for C₃₁ H₃₅ N₂ OI.0.5H₂ O; Calcd: C,63.37; H, 6.18; N, 4.77. Found: C, 63.69; H, 5.98; N, 4.87. IR (KBr)cm⁻¹ : 3450, 3294, 2941, 1649, 1622, 1599, 1520, 1417, 1319, 1248, 812;¹ H NMR (200 MHz, DMSO-d₆) δ: 1.40-2.00 (6H, m), 2.35 (3H, s), 2.55-2.67(2H, m), 2.82-2.95 (5H, m), 3.22-3.35 (4H, m), 4.53 (2H, s), 7.24-7.35(3H, m), 7.46-7.60 (7H, m), 7.89 (2H, d, J=8.8 Hz), 10.15 (1H, s).

WORKING EXAMPLE 17 (Production of Compound 17)

In DMF (3 ml) was dissolved7-(4-fluorophenyl)-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(500 mg), and to the mixture was added methyl iodide (212 μl). Themixture was stirred at room temperature for 18 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give1-[4-[7-(4-fluoro-phenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]-1-methylpiperidiniumiodide (Compound 17) (610 mg) as colorless crystals.

mp 177-180° C.; Elemental Analysis for C₃₀ H₃₂ N₂ OFI.0.2H₂ O; Calcd: C,61.48; H, 5.57; N, 4.78. Found: C, 61.38; H, 5.50; N, 4.81. IR (KBr)cm⁻¹ : 3450, 3310, 2947, 1651, 1597, 1518, 1416, 1319, 1246, 1225, 824;¹ H NMR (200 MHz, DMSO-d₆) δ: 1.40-2.00 (6H, m), 2.55-2.67 (2H, m),2.85-2.96 (5H, m), 3.20-3.38 (4H, m), 4.53 (2H, s), 7.25-7.38 (3H, m),7.46-7.60 (5H, m), 7.67-7.76 (2H, m), 7.89 (2H, d, J=8.6 Hz), 10.17 (1H,s).

WORKING EXAMPLE 18 (Production of Compound 18)

To a mixture ofN-[4-(hydroxymethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(200 mg), triethylamine (158 μl ) and THF (10 ml) was addedmethanesulfonic acid anhydride (118 mg) at 0° C., and the mixture wasstirred at room temperature for 3 hours. To the reaction mixture wasadded dilute hydrochloric acid, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was dissolved in DMF (3 ml), and to themixture was added pyridine (137tt1). The mixture was stirred at roomtemperature for 96 hours and concentrated under reduced pressure. Theresidue was recrystallized from ethyl acetate-methanol to give1-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)-benzyl]pyridiniumchloride (Compound 18) (95 mg) as colorless crystals.

mp 162-164° C.; Elemental Analysis for C₂₉ H₂₅ N₂ OCl.1.0H₂ O; Calcd: C,73.95; H, 5.78; N, 5.95; Cl, 7.53. Found: C, 74.25; H, 5.94; N, 5.92;Cl, 7.12. IR (KBr) cm¹ : 3450, 3030, 1653, 1595, 1520, 1416, 1323, 1254,1213, 762; ¹ H NMR (200 MHz, CDCl₃) δ: 2.50-2.75 (4H, m), 5.92 (2H, brs), 7.00 (1H, d, J=8.0 Hz), 7.15-7.40 (9H, m), 7.60-7.85 (5H, m),8.08-8.25 (1H, br), 9.21 (2H, br s), 9.73 (1H, br s).

WORKING EXAMPLE 19 (Production of Compound 19)

To a mixture ofN-[4-(hydroxymethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(200 mg), lithium chloride (95 mg), triethylamine (182/111) anddichloromethane (20 ml) was added methanesulfonyl chloride (174/111),and the mixture was stirred at room temperature for 2 hours. To thereaction mixture was added dilute hydrochloric acid. The organic layerwas separated, washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was dissolved in DMF (3 ml), and to the mixture was added3-lutidine (167/111). The reaction mixture was stirred at roomtemperature for 17 hours and concentrated under reduced pressure. Theresidue was recrystallized from ethyl acetate-methanol to give3-methyl-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]pyridiniumchloride (90 mg) as colorless crystals.

mp 136-140° C.; Elemental Analysis for C₃₀ H₂₇ N₂ OCl.1.5H₂ O; Calcd: C,72.94; H, 6.12; N, 5.67. Found: C, 73.19; H, 6.37; N, 5.61. IR (KBr)cm⁻¹ : 3450, 3030, 1653, 1597, 1520, 1416, 1319, 1250, 1213, 764; ¹ HNMR (200 MHz, CDCl₃) δ: 2.48 (3H, s), 2.65-2.90 (4H, m), 6.03 (2H, brs), 7.12-7.20 (1H, m), 7.25-7.55 (9H, m), 7.70-7.82 (4H, m), 7.95-8.07(1H, m), 9.29 (2H, br s), 9.35-9.50 (1H, br).

WORKING EXAMPLE 20 (Production of Compound 20)

To a mixture ofN-[4-(hydroxymethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(200 mg), lithium chloride (48 mg), triethylamine (158 μl) anddichloromethane (30 ml) was added methanesulfonyl chloride (61 μl), andthe mixture was stirred at room temperature for 2 hours. To the reactionmixture was added dilute hydrochloric acid. The organic layer wasseparated, washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was dissolved in DMF (3 ml), and to the mixture was added3,5-lutidine (193 μl). The reaction mixture was stirred at roomtemperature for 65 hours and concentrated under reduced pressure. Theresidue was recrystallized from ethyl acetate-methanol to give3,5-dimethyl-1-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 20) (186 mg) as colorless crystals.

mp 163-165° C.; Elemental Analysis for C₃₁ H₂₉ N₂ OCl.1.3H₂ O; Calcd: C,73.81; H, 6.31; N, 5.55. Found: C, 73.85; H. 6.29; N, 5.49. IR (KBr)cm⁻¹ : 3450, 3030, 1655, 1597, 1520, 1483, 1416, 1319, 1252, 766; ¹ HNMR (200 MHz, CDCl₃) δ: 2.44 (6H, s), 2.67-2.92 (4H, m), 5.99 (2H, s),7.16 (1H, d, J=7.6 Hz), 7.25-7.55 (9H, m), 7.77-7.90 (4H, m), 9.20 (1H,s), 9.72 (1H, br s).

WORKING EXAMPLE 21 (Production of Compound 21)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(140 mg), and to the mixture was added 4-cyanopyridine (117 mg). Themixture was stirred at 70° for 24 hours and concentrated under reducedpressure. The residue was recrystallized from ethyl acetate-methanol togive4-cyano-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 21) (141 mg) as pale brown crystals.

mp 163-165° C.; Elemental Analysis for C₃₀ H₂₄ N₃ OCl.0.5H₂ O; Calcd: C,73.99; H, 5.17; N, 8.63. Found: C, 73.71; H, 5.29; N, 8.47. IR (KBr)cm⁻¹ : 3430, 3024, 1653, 1597, 1524, 1416, 1319, 1252, 829, 764 ¹ H NMR(200 MHz, DMSO-d₆) δ: 2.50-2.65 (2H, m), 2.82-2.93 (2H, m), 5.92 (2H,s), 7.29-7.67 (11H, m), 7.85 (2H, d, J=8.6 Hz), 8.73 (2H, d, J=6.8 Hz),9.54 (2H, d, J=6.8 Hz), 10.19 (1H, s).

WORKING EXAMPLE 22 (Production of Compound 22)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added 3-cyanopyridine (133 mg). Themixture was stirred at 70° C. for 24 hours and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-methanol to give3-cyano-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 22) (58 mg) as pale orange crystals.

mp 158-161° C.; Elemental Analysis for C₃₀ H₂₄ N₃ OCl.1.5H₂ O; Calcd: C,71.35; H, 5.39; N, 8.32. Found: C, 71.28; H, 5.49; N, 8.40. IR (KBr)cm⁻¹ : 3450, 3028, 1653, 1597, 1520, 1416, 1319, 1252, 766; ¹ H NMR (200MHz, DMSO-d₆) δ:2.55-2.68 (2H, m), 2.82-2.95 (2H, m), 5.88 (2H, s),7.30-7.90 (13H, m), 8.32-8.42 (1H, m), 9.13 (1H, d, J=8.0 Hz), 9.47 (1H,d, J=5.8 Hz), 10.05 (1H, s), 10.21 (1H, s).

WORKING EXAMPLE 23 (Production of Compound 23)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added 3-chloropyridine (122 μl). Themixture was stirred at 70° C. for 24 hours and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-methanol to give3-chloro-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 23) (110 mg) as pale yellow crystals.

mp 136-139° C.; Elemental Analysis for C₂₉ H₂₄ N₂ OCl₂.0.5H₂ O; Calcd:C, 70.16; H, 5.08; N, 5.64. Found: C, 70.13; H, 5.03; N, 5.68. IR (KBr)cm⁻¹ : 3450, 3028, 1653, 1597, 1520, 1483, 1416, 1317, 1252, 1213, 1165,766, 700; ¹ H NMR (200 MHz, DMSO-d₆) δ: 2.55-2.68 (2H, m), 2.82-2.95(2H, m), 5.85 (2H, s), 7.30-7.70 (11H, m), 7.86 (2H, d, J=8.4 Hz),8.16-8.26 (1H, m), 8.81 (1H, d, J=7.6 Hz), 9.24 (1H, d, J=6.0 Hz), 9.72(1H, s), 10.21 (1H, s).

WORKING EXAMPLE 24 (Production of Compound 24)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(140 mg), and to the mixture was added 1-ethylpiperidine (154 μl). Themixture was stirred at room temperature for 14 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate-methanol to give1-ethyl-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]piperidiniumchloride (Compound 24) (125 mg) as colorless crystals.

mp 153-156° C.; Elemental Analysis for C₃₁ H₃₅ N₂ OCl.1.5H₂ O; Calcd: C,72.42; H, 7.45; N, 5.45. Found: C, 72.14; H, 7.41; N, 5.32. IR (KBr)cm⁻¹ : 3450, 2943, 1655, 1595, 1520, 1483, 1416, 1319, 1255, 1217, 766,700; ¹ H NMR (200 MHz, CDCl₃) δ: 1.30-1.42 (3H, m), 1.60-1.90 (6H, m),2.68-2.95 (4H, m), 3.27-3.45 (4H, m), 3.55-3.70 (2H, m), 4.75 (2H, s),7.17 (1H, d, J=7.8 Hz), 7.25-7.60(9H, m), 7.90 (1H, s), 8.03 (2H, d,J=8.6 Hz), 10.00 (1H, s).

WORKING EXAMPLE 25 (Production of Compound 25)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added triethylamine (180 μl). Themixture was stirred at room temperature for 14 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to givetriethyl[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]ammoniumchloride (Compound 25) (176 mg) as colorless crystals.

mp 205-206° C.; Elemental Analysis for C₃₀ H₃₅ N₂ OCl.0.2H₂ O; Calcd: C,75.28; H, 7.45; N, 5.85. Found: C, 75.10; H, 7.38; N, 5.91. IR (KBr)cm⁻¹ : 3450, 3007, 1655, 1599, 1519, 1483, 1416, 1319, 1252, 1215, 768,704; ¹ H NMR (200 MHz, CDCl₃) δ: 1.37 (9H, t, J=6.9 Hz), 2.72-2.96 (4H,m), 3.22 (6H, q, J=6.9 Hz), 4.62 (2H, s), 7.15-7.45 (7H, m), 7.50-7.60(3H, m), 7.99 (1H, s), 8.12 (2H, d, J=8.6 Hz), 10.19 (1H, s).

WORKING EXAMPLE 26 (Production of Compound 26)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added tripropylamine (244 μl). Themixture was stirred at room temperature for 14 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]tripropylammoniumchloride (Compound 26) (205 mg) as colorless crystals.

mp 206-207° C.; Elemental Analysis for C₃₃ H₄₁ N₂ OCl.0.5H₂ O; Calcd: C,75.33; H, 8.05; N, 5.32. Found: C, 75.59; H, 7.88; N, 5.63. IR (KBr)cm⁻¹ : 3450, 2970, 1649, 1595, 1524, 1481, 1417, 1317, 1252, 1217, 770,708; ¹ H NMR (200 MHz, CDCl₃) δ: 0.94 (9H, t, J=7.2 Hz), 1.60-1.90 (6H,m), 2.79-3.10 (10H, m), 4.64 (2H, s), 7.07 (2H, d, J=8.4 Hz), 7.20 (1H,d, J=7.8 Hz), 7.31-7.45 (4H, m), 7.54-7.60 (3H,m), 8.10 (1H, s), 8.19(2H, d, J=8.6 Hz), 10.43 (1H, s).

WORKING EXAMPLE 27 (Production of Compound 27)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added 3-ethylpyridine (146 μl). Themixture was stirred at 70° C. for 72 hours and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-methanol to give3-ethyl-1-[4-(7-phenyl-3,4-dihydro-naphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 27) (185 mg) as colorless crystals.

mp 142-145° C.; Elemental Analysis for C₃₁ H₂₉ N₂ OCl.0.5H₂ O; Calcd: C,75.98; H, 6.17; N, 5.72. Found: C, 75.96; H, 6.13; N, 5.99. IR (KBr)cm⁻¹ : 3381, 1657, 1597, 1520, 1416, 1317, 1252, 762; ¹ H NMR (200 MHz,CDCl₃) δ: 1.25 (3H, t, J=7.6 Hz), 2.64-2.88 (6H, m), 6.09 (2H, s), 7.14(1H, d, J=7.8 Hz), 7.25-7.52 (9H, m), 7.71-7.88 (4H, m), 8.04 (1H, d,J=8.0 Hz), 9.37 (1H, d, J=6.0 Hz), 9.43 (1H, s), 9.81 (1H, s).

WORKING EXAMPLE 28 (Production of Compound 28)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added 2-picoline (126 μl). The mixturewas stirred at 70° C. for 63 hours and concentrated under reducedpressure. The residue was recrystallized from ethyl acetate-methanol togive2-methyl-1-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 28) (140 mg) as pale brown crystals.

mp 152-155° C.; Elemental Analysis for C₃₀ H₂₇ N₂ OCl.1.0H₂ O; Calcd: C,74.29; H, 6.03; N, 5.78. Found: C, 74.56; H, 5.93; N, 5.80. IR (KBr)cm⁻¹ : 3402, 1630, 1597, 1520, 1414, 1319, 1250, 764, 700; ¹ H NMR (200MHz, CDCl₃) δ: 2.60-2.90 (7H, m), 6.07 (2H, s), 7.04-7.15 (3H, m),7.25-7.50 (7H, m), 7.65 (1H, d, J=7.8 Hz), 7.72-7.92 (4H, m), 8.12-8.22(1H, m), 9.63 (1H, d, J=6.2 Hz), 9.86 (1H, s).

WORKING EXAMPLE 29 (Production of Compound 29)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added thiazole (91 μl). The mixture wasstirred at 100° C. for 48 hours and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-methanol to give3-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]thiazoliumchloride (Compound 29) (133 mg) as pale brown crystals.

mp 149-152° C.; Elemental Analysis for C₂₇ H₂₃ N₂ OSCl.0.5H₂ O; Calcd:C, 69.29; H, 5.17; N, 5.99. Found: C, 69.43; H, 4.88; N, 6.12. IR (KBr)cm⁻¹ : 3419, 3026, 1649, 1597, 1520, 1414, 1317, 1252, 764, 698; ¹ H NMR(200 MHz, DMSO-d₆) δ: 2.55-2.67 (2H, m), 2.82-2.96 (2H, m), 5.78 (2H,s), 7.29-7.71 (11H, m), 7.84 (2H, d, J=8.2 Hz), 8.33-8.40 (1H, m),8.58-8.66 (1H, m), 10.18 (1H, s), 10.42 (1H, s).

WORKING EXAMPLE 30 (Production of Compound 30)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(160 mg), and to the mixture was added quinuclidine (285 mg). Themixture was stirred at 100° C. for 24 hours and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-methanol to give1-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamide)benzyl]quinuclidiumchloride (Compound 30) (62 mg) as colorless crystals.

mp 250-252° C.; Elemental Analysis for C₃₁ H₃₃ N₂ OCl.0.9H₂ O; Calcd: C,74.28; H, 7.00; N, 5.59. Found: C, 74.48; H, 7.01; N, 5.56. IR (KBr)cm⁻¹ : 3425, 2945, 1655, 1595, 1520, 1416, 1319, 1255, 833, 766, 700; ¹H NMR (200 MHz, CDCl₃) δ: 1.75-2.15 (7H, m), 2.68-2.90 (4H, m),3.40-3.70 (6H, m), 4.73 (2H, s), 7.15 (1H, d, J=7.8 Hz), 7.25-7.56 (9H,m), 7.88 (1H, s), 7.96 (2H, d, J=8.0 Hz), 9.93 (1H, s).

WORKING EXAMPLE 31 (Production of Compound 31)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added ethyl1-methylpiperidine-4-carboxylate (206 mg). The mixture was stirred atroom temperature for 15 hours and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-methanol to give4-ethoxycarbonyl-1-methyl-1-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]piperidiniumchloride (Compound 31) (185 mg, ratio of isomers=37:63) as colorlesscrystals.

mp 153-156° C.; Elemental Analysis for C₃₃ H₃₇ N₂ O₃ Cl.0.5H₂ O; Calcd:C, 71.53; H, 6.91; N, 5.06. Found: C, 71.69; H, 6.76; N, 5.11. IR (KBr)cm⁻¹ : 3388, 1726, 1655, 1595, 1520, 1483, 1416, 1319, 1254, 1214, 766,700; ¹ H NMR (200 MHz, CDCl₃) δ: 1.15-1.30 (3H, m), 2.05-2.22 (3H, m),2.65-2.92 (6H, m), 3.02 (1.11H, s), 3.13 (1.89H, s), 3.38-3.75 (3.26H,m), 3.88-4.22 (2.74H, m), 4.76 (1.26H, s), 5.09 (0.74H, s), 7.15 (1H,dd, J=4.4, 7.6 Hz), 7.25-7.55 (9H, m), 7.83 (1H, s), 7.94 (1H, d, J=8.4Hz), 8.00 (1H, d, J=8.4 Hz), 9.74 (0.63H, s), 9.84 (0.37H, s).

WORKING EXAMPLE 32 (Production of Compound 32)

In THF (10 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(300 mg), and to the mixture was added hexamethyleneimine (270 μl). Themixture was refluxed for 3.5 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added water (30 ml). Themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with anhydrous sodiumsulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/triethylamine=20/1) and recrystallized from ethyl acetate-hexaneto giveN-[4-(1-perhydroazepinylmethyl)-phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(Compound 32) (257 mg) as colorless crystals.

mp 168-170° C.; Elemental Analysis for C₃₀ H₃₂ N₂ O; Calcd: C, 82.53; H,7.39; N, 6.42. Found: C, 82.28; H, 7.26; N, 6.37. IR (KBr) cm⁻¹ : 3304,2924, 1645, 1601, 1520, 1410, 1317, 1254, 831, 762, 698; ¹ H NMR (200MHz, CDCl₃) δ: 1.61 (8H, s), 2.56-2.76 (6H, m), 2.92-3.03 (2H, m), 3.61(2H, s), 7.23-7.61 (14H, m).

WORKING EXAMPLE 33 (Production of Compound 33)

In DMF (3 ml) was dissolvedN-[4-(1-perhydro-azepinylmethyl)phenyl]-7-phenyl-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added methyl iodide (64 μl). Themixture was stirred at room temperature for 12 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate-methanol to give1-methyl-1-[4-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]perhydro-azepiniumiodide (180 mg) as colorless crystals.

mp 197-199° C.; Elemental Analysis for C₃₁ H₃₅ N₂ OI.0.5H₂ O; Calcd: C,63.37; H, 6.18; N, 4.77. Found: C, 63.39; H, 6.31; N, 4.71. IR (KBr)cm⁻¹ : 3427, 3267, 2937, 1660, 1593, 1520, 1481, 1417, 1313, 1250, 694;¹ H NMR (200 MHz, DMSO-d₆) δ: 1.50-1.70 (4H, m), 1.80-1.96 (4H, m),2.55-2.68 (2H, m), 2.83-2.97 (5H, m), 3.22-3.36 (2H, m), 3.40-3.60 (2H,m), 4.50 (2H, s), 7.30-7.70 (11H, m), 7.89 (2H, d, J=8.4 Hz), 10.19 (1H,s).

WORKING EXAMPLE 34 (Production of Compound 34)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 1-ethylpiperidine (159 μl). Themixture was stirred at room temperature for 20 hours. To the reactionmixture was added ethyl acetate (100 ml), and the resulting precipitatewas filtered to give1-ethyl-1-[4-[7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]piperidiniumchloride (Compound 34) (156 mg) as colorless crystals.

mp 207-209° C.; Elemental Analysis for C₃₂ H₃₇ N₂ OCl; Calcd: C, 76.70;H, 7.44; N, 5.59. Found: C, 76.33; H, 7.22; N, 5.67. IR (KBr) cm⁻¹ :3440, 2945, 1651, 1595, 1520, 1416, 1321, 1248, 808; ¹ H NMR (200 MHz,CDCl₃) δ: 1.36 (3H, t, J=6.0 Hz), 1.60-1.90 (6H, m), 2.37 (3H, s),2.68-2.92 (4H, m), 3.26-3.42 (4H, m), 3.52-3.70 (2H, m), 4.76 (2H, s),7.11-7.23 (3H, m), 7.31-7.52 (6H, m), 7.90 (1H, s), 8.04 (2H, d, J=8.4Hz), 10.07 (1H, s).

WORKING EXAMPLE 35 (Production of Compound 35)

In THF (15 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(300 mg), and to the mixture was added 4-benzylpiperidine (408 μl). Themixture was ref luxed for 19 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added water (100 ml). Themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with anhydrous sodiumsulfate, and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethyl acetate) andrecrystallized from ethyl acetate-hexane to giveN-[4-(4-benzylpiperidinomethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 35) (259 mg) as colorless crystals.

mp 199-201° C.; Elemental Analysis for C₃₇ H₃₈ N₂ O; Calcd: C, 84.37; H,7.27; N, 5.32. Found: C, 84.34; H, 7.18; N, 5.39. IR (KBr) cm⁻¹ : 3439,2920, 1647, 1520, 1412, 1315, 808, 700; ¹ H NMR (200 MHz, CDCl₃) δ:1.20-1.70 (5H, m), 1.80-1.97 (2H, m), 2.40 (3H, s), 2.53 (2H, d, J=6.2Hz), 2.65-2.78 (2H, m), 2.80-3.02 (4H, m), 3.45 (2H, s), 7.09-7.36 (11H,m), 7.40-7.63 (7H, m).

WORKING EXAMPLE 36 (Production of Compound 36)

In DMF (3 ml) was dissolvedN-[4-(4-benzyl-piperidinomethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added methyl iodide(53 μl). The mixturewas stirred at room temperature for 23 hours. To the reaction mixturewas added ethyl acetate(100 ml), and the resulting precipitate wasfiltered to give4-benzyl-1-methyl-1-[4-[7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]piperidiniumiodide (Compound 36) (141 mg, ratio of isomers=19:81) as colorlesscrystals.

mp 209-212° C.; Elemental Analysis for C₃₈ H₄₁ N₂ OI.0.5H₂ O; Calcd: C,67.35; H, 6.25; N, 4.13. Found: C, 67.28; H, 6.33; N, 4.08. IR (KBr)cm⁻¹ : 3439, 1659, 1593, 1520, 1416, 1317, 1250, 812; ¹ H NMR (200 MHz,DMSO-d₆) δ: 1.55-2.00 (5H, m), 2.35 (3H, s), 2.52-2.75 (4H, m),2.80-3.00 (5H, m), 3.20-3.40 (4H, m), 4.49 (1.62H, s), 4.60 (0.38H, s),7.13-7.60 (15H, m), 7.80-7.90 (2H, m), 10.15 (1H, s).

WORKING EXAMPLE 37 (Production of Compound 37)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 1-ethylperhydroazepine (98 mg).The mixture was stirred at room temperature for 15 hours. To thereaction mixture was added ethyl acetate (100 ml), and the resultingprecipitate was filtered and recrystallized from ethyl acetate-methanolto give1-ethyl-1-[4-[7-(4-methyl-phenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]perhydroazepiniumchloride (Compound 37) (137 mg) as colorless crystals.

mp 207-210° C.; Elemental Analysis for C₃₃ H₃₉ N₂ OCl.0.5H₂ O; Calcd: C,75.62; H, 7.69; N, 5.34. Found: C, 75.82; H, 7.69; N, 5.42. IR (KBr)cm⁻¹ : 3431, 2931, 1653, 1597, 1520, 1325, 1255, 808; ¹ H NMR (200 MHz,DMSO-d₆) δ: 1.40 (3H, t, J=7.lHz), 1.50-1.65 (4H, m), 1.70-1.90 (4H, m),2.35 (3H, s), 2.55-2.67 (2H, m), 2.80-2.93 (2H, m), 3.12-3.35 (4H, m),3.40-3.57 (2H, m), 4.47 (2H, s), 7.23-7.35 (3H, m), 7.50-7.60 (7H, m),7.91 (2H, d, J=8.4 Hz), 10.26 (1H, s).

WORKING EXAMPLE 38 (Production of Compound 38)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 1-propylperhydroazepine (109 mg).The mixture was stirred at room temperature for 15 hours. To thereaction mixture was added ethyl acetate (100 ml), and the resultingprecipitate was filtered to give1-[4-[7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]-1-propylperhydroazepiniumchloride (Compound 38) (163 mg) as colorless crystals.

mp 195-199° C.; Elemental Analysis for C₃₄ H₄₁ N₂ OCl.0.5H₂ O; Calcd: C,75.88; H, 7.87; N, 5.21. Found: C, 76.07; H, 7.83; N, 5.21. IR (KBr)cm⁻¹ : 3423, 2937, 1651, 1595, 1520, 1317, 1250, 814; ¹ H NMR (200 MHz,DMSO-d₆) δ: 0.93 (3H, t, J=7.2 Hz), 1.52-1.65 (4H, m), 1.75-1.93 (6H,m), 2.35 (3H, s), 2.55-2.68 (2H, m), 2.80-2.95 (2H, m), 3.00-3.13 (2H,m), 3.22-3.40 (2H, m), 3.40-3.58 (2H, m), 4.49 (2H, s), 7.23-7.35 (3H,m), 7.46-7.60 (7H, m), 7.90 (2H, d, J=8.0 Hz), 10.22 (1H, s).

WORKING EXAMPLE 39 (Production of Compound 39)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 1-ethylperhydroazocine (109 mg).The mixture was stirred at room temperature for 14 hours. To thereaction mixture was added ethyl acetate (100 ml), and the resultingprecipitate was filtered and recrystallized from ethyl acetate-methanolto give1-ethyl-1-[4-[7-(4-methyl-phenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]perhydroazociniumchloride (Compound 39) (142 mg) as colorless crystals.

mp 197-199° C.; Elemental Analysis for C₃₄ H₄₁ N₂ OCl.0.5H₂ O; Calcd: C,75,88; H, 7.87; N, 5.21. Found: C, 75.67; H, 7.88; N, 5.30. IR (KBr)cm⁻¹ : 3437, 2926, 1655, 1595, 1520, 1489, 1416, 1321, 1252, 812; ¹ HNMR (200 MHz, DMSO-d₆) δ: 1.30-2.00 (13H, m), 2.35 (3H, s), 2.55-2.70(2H, m), 2.85-3.00 (2H, m), 3.05-3.50 (6H, m), 4.44 (2H, s), 7.20-7.37(3H, m), 7.40-7.60 (7H, m), 7.92 (2H, d, J=8.6 Hz), 10.28 (1H, s).

WORKING EXAMPLE 40 (Production of Compound 40)

In THF (7 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydro-naphthalene-2-carboxamide(150 mg), and to the mixture was added 1-methylpiperazine (129 μl). Themixture was refluxed for 24 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added 5% sodium hydrogencarbonate solution (50 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethyl acetate/triethylamine=20/1) and recrystallizedfrom ethyl acetate-hexane to give7-(4-methylphenyl)-N-[4-(4-methyl-1-piperazinylmethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 40) (105 mg) as colorless crystals.

mp 174-175° C.; Elemental Analysis for C₃₀ H₃₃ N₃ O; Calcd: C, 79.79; H,7.37; N, 9.30. Found: C, 79.43; H, 7.41; N, 9.28. IR (KBr) cm⁻¹ : 3327,2941, 2794, 1643, 1524, 1315, 1163, 1011, 808; ¹ H NMR (200 MHz, CDCl₃)δ: 2.29 (3H, s), 2.35-2.60 (8H, m), 2.40 (3H, s), 2.65-2.78 (2H, m),2.90-3.02 (2H, m), 3.48 (2H, s), 7.20-7.35 (6H, m), 7.39-7.63 (7H, m).

WORKING EXAMPLE 41 (Production of Compound 41)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the solution were added 1-(2-methoxyphenyl)piperazine(97 mg) and potassium carbonate (268 mg). The mixture was stirred atroom temperature for 13 hours, and to the mixture was added water (50ml). The mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasrecrystallized from ethyl acetate-diisopropylether to giveN-[4-[1-(2-methoxyphenyl)-4-piperazinylmethyl]phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 41) (142 mg) as colorless crystals.

mp 202-205° C.; Elemental Analysis for C₃₆ H₃₇ N₃ O₂ ; Calcd: C, 79.53;H, 6.86; N, 7.73. Found: C, 79.28; H, 6.68; N, 7.66. IR (KBr) cm⁻¹ :3350, 2933, 2812, 1649, 1595, 1520, 1500, 1313, 1240, 812, 746; ¹ H NMR(200 MHz, CDCl₃) δ: 2.40 (3H, s), 2.60-2.75 (6H, m), 2.90-3.12 (6H, m),3.57 (2H, s), 3.86 (3H, s), 6.80-7.03 (4H, m), 7.20-7.28 (3H, m),7.30-7.38 (3H, m), 7.40-7.51 (4H, m), 7.53-7.63 (3H, m).

WORKING EXAMPLE 42 (Production of Compound 42)

In THF (7 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 1-(2-pyrimidyl) piperazine (190mg). The mixture was refluxed for 24 hours. The reaction mixture wascooled to room temperature, and to the mixture was added 5% sodiumhydrogen carbonate solution (50 ml). The mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was separated and purified withcolumn chromatography (ethyl acetate) and recrystallized from ethylacetate-hexane to give7-(4-methylphenyl)-N-[4-[1-(2-pyrimidyl)-4-piperazinylmethyl]-phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 42) (166 mg) as colorless crystals.

mp 203-204° C.; Elemental Analysis for C₃₃ H₃₃ N₅ O; Calcd: C, 76.87; H,6.45; N, 13.58. Found: C, 76.77; H, 6.40; N, 13.60. IR (KBr) cm⁻¹ :3367, 2935, 1649, 1585, 1516, 1448, 1358, 1313, 1255, 984, 808; ¹ H NMR(200 MHz, CDCl₃) δ: 2.40 (3H, s), 2.47-2.54 (4H, m), 2.65-2.78 (2H, m),2.93-3.03 (2H, m), 3.53 (2H, s), 3.79-3.87 (4H, m), 6.47 (1H, t, J=4.8Hz), 7.23-7.28 (3H, m), 7.30-7.38 (3H, m), 7.42-7.52 (4H, m), 7.54-7.62(3H, m), 8.30 (2H, d J=4.8 Hz).

WORKING EXAMPLE 43 (Production of Compound 43)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the solution were added 1-benzhydrylpiperazine (127 mg)and potassium carbonate (268 mg). The mixture was stirred at roomtemperature for 24 hours, and to the mixture was added water (50 ml).The mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasrecrystallized from acetone-diisopropylether to giveN-[4-(4-benzhydryl-1-piperazinyl-methyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 43) (140 mg) as colorless crystals.

mp 217-218° C.; Elemental Analysis for C₄₂ H₄₁ N₃ O; Calcd: C, 83.55; H,6.84; N, 6.96. Found: C, 83.25; H, 6.86; N, 7.06. IR (KBr) cm⁻¹ : 3417,2954, 2812, 1659, 1618, 1520, 1410, 1313, 1007, 810, 706; ¹ H NMR (200MHz, DMSO-d₆) δ: 2.20-2.65 (13H, m), 2.80-2.93 (2H, m), 3.42 (s, 2H),4.26 (1H, s), 7.10-7.70 (22H, m), 9.90 (1H, s).

WORKING EXAMPLE 44 (Production of Compound 44)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the solution were added 1-(2-furoyl)piperazinehydrochloride (109 mg) and potassium carbonate (268 mg). The mixture wasstirred at room temperature for 18 hours, and to the mixture was addedwater (50 ml). The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withanhydrous sodium sulfate, and concentrated under reduced pressure. Theresidue was purified with ethyl acetate-diisopropylether to giveN-[4-[1-(2-furoyl)-4-piperazinylmethyl]phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 44) (112 mg) as colorless amorphous.

IR (KBr) cm⁻¹ : 3309, 2920, 1618, 1518, 1489, 1437, 1313, 1184, 1001,812, 754; Elemental Analysis for C₃₄ H₃₃ N₃ O₃ ; Calcd: C, 76.81; H,6.26; N, 7.90. Found: C, 76.60; H, 6.02; N, 7.61. ¹ H NMR (200 MHz,CDCl₃) δ: 2.40 (3H, s), 2.43-2.55 (4H, m), 2.65-2.78 (2H, m), 2.90-3.03(2H, m), 3.52 (2H, s), 3.73-3.87 (4H, m), 6.44-6.49 (1H, m), 6.98 (1H,d, J=3.2 Hz), 7.20-7.68 (14H, m).

WORKING EXAMPLE 45 (Production of Compound 45)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the solution were added1-(3,4,5-trimethoxybenzyl)piperazine (138 mg) and potassium carbonate(268 mg). The mixture was stirred at room temperature for 48 hours, andto the mixture was added water (50 ml). The mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate-diisopropylether to giveN-[4-[1-(3,4,5-trimethoxybenzyl)-4-piperazinylmethyl]-phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 45) (155 mg) as pale yellow crystals.

mp 143-144° C.; Elemental Analysis for C₃₉ H₄₃ N₃ O₄ ; Calcd: C, 75.82;H, 7.02; N, 6.80. Found: C, 75.74; H, 6.85; N, 6.75. IR (KBr) cm⁻¹ :3425, 2935, 2806, 1649, 1593, 1520, 1458, 1421, 1313, 1236, 1128, 1009,810; ¹ H NMR (200 MHz, CDCl₃) δ: 2.40 (3H, s), 2.40-2.55 (8H, m),2.65-2.77 (2H, m), 2.90-3.03 (2H, m), 3.45 (2H, s), 3.51 (2H, s), 3.84(3H, s), 3.86 (6H, s), 6.56 (2H, s), 7.20-7.36 (6H, m), 7.40-7.62 (7H,m).

WORKING EXAMPLE 46 (Production of Compound 46)

In THF (7 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 1-(2-hydroxyethyl)piperazine (142μl). The mixture was refluxed for 22 hours. The reaction mixture wascooled to room temperature, and to the mixture was added 5% sodiumhydrogen carbonate solution (50 ml). The mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate-hexane to giveN-[4-[1-(2-hydroxyethyl)-4-piperazinylmethyl]phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 46) (158 mg) as colorless crystals.

mp 185-187° C.; Elemental Analysis for C₃₁ H₃₅ N₃ O₂.0.3H₂ O; Calcd: C,76.45; H, 7.37; N, 8.63. Found: C, 76.64; H, 7.13; N, 8.35. IR (KBr)cm⁻¹ : 3319, 2937, 2816, 1649, 1597, 1520, 1412, 1317, 812; ¹ H NMR (200MHz, CDCl₃) δ: 2.40 (3H, s), 2.43-2.61 (10H, m), 2.65-2.78 (2H, m),2.92-3.03 (2H, m), 3.50 (2H, s), 3.61 (2H, t, J=5.5 Hz), 7.21-7.36 (6H,m), 7.40-7.63 (7H, m).

WORKING EXAMPLE 47 (Production of Compound 47)

In THF (7 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 3-aminopyridine (109 mg). Themixture was refluxed for 45 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added 5% sodium hydrogencarbonate solution (50 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=3/1) and recrystallized from ethylacetate-hexane to give7-(4-methylphenyl)-N-[4-[N-(3-pyridyl)aminomethyl]phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 47) (14 mg) as colorless crystals.

mp 212-214° C.; IR (KBr) cm⁻¹ : 3383, 3022, 1655, 1591, 1516, 1412,1315, 1254, 808, 708; ¹ H NMR (200 MHz, CDCl₃) δ: 2.40 (3H, s),2.66-2.78 (2H, m), 2.92-3.03 (2H, m), 4.05-4.18 (1H, br), 4.30-4.37 (2H,m), 6.88 (1H, ddd, J=1.4, 2.8, 8.0 Hz), 7.08 (1H, dd, J=4.8, 8.0 Hz),7.23-7.30 (3H, m), 7.32-7.39 (3H, m), 7.41-7.51 (4H, m), 7.58-7.65 (3H,m), 7.98 (1H, dd, J=1.4, 4.8 Hz), 8.09 (1H, d, J=2.8 Hz).

WORKING EXAMPLE 48 (Production of Compound 48)

In DMF (3 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added 2-amino-1,3-propanediol (106 mg).The mixture was stirred at room temperature for 72 hours, and to themixture was added water(50 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-diisopropylether to giveN-[4-[(1,3-dihydroxy-2-propyl)aminomethyl]phenyl]-7-(4-methyl-phenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 48) (60 mg) as colorless crystals.

mp 189-193° C.; Elemental Analysis for C₂₈ H₃₀ N₂ O₃ ; Calcd: C, 75.99;H, 6.83; N, 6.33. Found: C, 75.64; H, 6.86; N, 6.11. IR (KBr) cm⁻¹ :3332, 2931, 1649, 1620, 1597, 1520, 1412, 1319, 1255, 1045, 812; ¹ H NMR(200 MHz, DMSO-d₆) δ: 2.35 (3H, s), 2.53-2.65 (2H, m), 2.80-2.93 (2H,m), 3.28-3.45 (5H, m), 3.73 (2H, s), 4.43 (2H, s), 7.20-7.35 (5H, m),7.43-7.59 (5H, m), 7.67 (2H, d, J=8.4 Hz), 9.90 (1H, s).

WORKING EXAMPLE 49 (Production of Compound 49)

In THF (10 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(300 mg), and to the mixture was added 4-hydroxypiperidine (235 mg). Themixture was refluxed for 24 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added 5% sodium hydrogencarbonate solution (50 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-hexane to giveN-[4-(4-hydroxypiperidinomethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 49) (271 mg) as colorless crystals.

mp 223-224° C.; Elemental Analysis for C₃₀ H₃₂ N₂ O₂ ; Calcd: C, 79.61;H, 7.13; N, 6.19. Found: C, 79.54; H, 7.00; N, 6.15. IR (KBr) cm⁻¹ :3321, 2937, 1651, 1622, 1597, 1520, 1412, 1319, 1070, 812; ¹ H NMR (200MHz, DMSO-d₆) δ: 1.28-1.47 (2H, m), 1.63-1.78 (2H, m), 1.88-2.08 (2H,m), 2.25-2.70 (7H, m), 2.80-2.92 (2H, m), 3.23-3.50 (2H, m), 4.50-4.58(1H, m), 7.17-7.33 (5H, m), 7.45 (1H, s), 7.48-7.60 (4H, m), 7.67 (2H,d, J=8.0 Hz), 9.92 (1H, s).

WORKING EXAMPLE 50 (Production of Compound 50)

In THF (10 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydro-naphthalene-2-carboxamide(300 mg), and to the mixture was added thiomorpholine (233 μl). Themixture was refluxed for 20 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added 5% sodium hydrogencarbonate solution (50 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-hexane to give7-(4-methylphenyl)-N-[4-(thiomorpholinomethyl)phenyl]-3,4-dihydro-naphthalene-2-carboxamide(Compound 50) (309 mg) as colorless crystals.

mp 178-180° C.; Elemental Analysis for C₂₉ H₃₀ N₂ OS; Calcd: C, 76.61;H, 6.65; N, 6.16. Found: C, 76.39; H, 6.71; N, 5.94. IR (KBr) cm⁻¹ :3307, 2910, 2810, 1648, 1599, 1520, 1412, 1315, 1257, 806; ¹ H NMR (200MHz, CDCl₃) δ: 2.40 (3H, s), 2.57-2.75 (10H, m), 2.90-3.03 (2H, m), 3.50(2H, s), 7.22-7.62 (13H, m).

WORKING EXAMPLE 51 (Production of Compound 51)

In THF (10 ml) was dissolvedN-[4-(chloromethyl)-phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(300 mg), and to the mixture was added diethanolamine (222 μl). Themixture was refluxed for 34 hours. The reaction mixture was cooled toroom temperature, and to the mixture was added 5% sodium hydrogencarbonate solution (50 ml). The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethyl acetate/triethylamine=10/1) and recrystallizedfrom ethyl acetate-hexane to giveN-[4-[N,N-bis(2-hydroxyethyl)aminomethy]phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(Compound 51) (148 mg) as colorless crystals.

mp 150-151° C.; Elemental Analysis for C₂₉ H₃₂ N₂ O₃ ; Calcd: C, 76.29;H, 7.06; N, 6.14. Found: C, 75.90; H, 7.10; N, 6.18. IR (KBr) cm⁻¹ :3307, 2943, 1645, 1599, 1524, 1412, 1321, 1255, 1036, 804; ¹ H NMR (200MHz, CDCl₃) δ: 2.40 (3H, s), 2.64-2.75 (6H, m), 2.90-3.00 (2H, m),3.58-3.70 (6H, m), 7.20-7.37 (6H, m), 7.40-7.51 (4H, m), 7.58 (2H, d,J=8.4 Hz), 7.67-7.77 (1H,

WORKING EXAMPLE 52 (Production of Compound 52)

In DMF (5 ml) was dissolvedN-[4-(chloromethyl)phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(150 mg), and to the mixture was added pyridine (94 μl). The mixture wasstirred at 70° C. for 24 hours, and to the mixture was added water (50ml). The mixture was washed with ethyl acetate. The aqueous layer wasallowed to stand at room temperature for 3 hours. The resultingprecipitate was filtered and purified with ethyl acetate-methanol togive1-[7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamido)benzyl]pyridiniumchloride (Compound 52) (74 mg) as colorless amorphous.

Elemental Analysis for C₃₀ H₂₇ N₂ OCl.0.5H₂ O; Calcd: C, 75.70; H, 5.93;N, 5.88. Found: C, 75.83; H, 6.02; N, 5.63. IR (KBr) cm⁻¹ : 3413, 1655,1595, 1518, 1414, 1317, 1248, 810; ¹ H NMR (200 MHz, DMSO-d₆) δ: 2.35(3H, s), 2.55-2.67 (2H, m), 2.80-2.93 (2H, m), 5.85 (2H, s), 7.24-7.34(3H, m), 7.50-7.60 (7H, m), 7.85 (2H, d, J=8.6 Hz), 8.14-8.25 (2H, m),8.64 (1H, t, J=7.7 Hz), 9.20-9.30 (2H, m), 10.18 (1H, s).

WORKING EXAMPLE 53 (Production of Compound 53)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.2 g) and sodium cyclohexylsulfide (0.08 g) in dimethylformamide (10ml) was stirred at room temperature for 2.5 hours. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-(cyclohexylthiomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 53) (0.19 g) as colorless crystals.

mp 161-162° C.; ¹ H-NMR (δ ppm, CDCl₃): 1.23-1.42 (6H, m), 1.63-1.75(2H, m), 1.92-2.05 (2H, m), 2.39 (3H, s), 2.49-2.59 (1H, m), 3.07 (2H,t, J=4.5 Hz), 3.73 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.2Hz), 7.22-7.34 (5H, m), 7.44-7.59 (7H, m). IR(KBr) ν: 2928, 2851, 1651cm⁻¹. Anal. for C₃₁ H₃₃ NO₂ S: Calcd. C, 76.98; H, 6.88; N, 2.90. FoundC, 76.65; H, 6.59; N, 3.09.

WORKING EXAMPLE 54 (Production of Compound 54)

In DMF (3 ml) was dissolved3,4-dihydro-N-[4-(4-hydroxypiperidinomethyl)phenyl]-7-(4-methylphenyl)-naphthalene-2-carboxamide(130 mg), and to the mixture was added methyl iodide(54 μl). The mixturewas stirred at room temperature for 17 hours, and to the mixture wasadded ethyl acetate (100 ml). The resulting precipitate was filtered andrecrystallized from ethyl acetate-methanol to give4-hydroxy-1-methyl-1-[4-[7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]-piperidiniumiodide (Compound 54) (138 mg, ratio of isomers=58:42) as colorlesscrystals.

mp 157-161° C.; Elemental Analysis for C₃₁ H₃₅ N₂ O₂ I.0.5H₂ O; Calcd:C, 61.69; H, 6.01; N, 4.64. Found: C, 61.75; H, 5.84; N, 4.64. IR (KBr)cm⁻¹ : 3396, 1655, 1595, 1520, 1416, 1319, 1250, 812; ¹ H NMR (200 MHz,DMSO-d₆) δ: 1.65-1.90 (2H, m), 1.96-2.20 (2H, m), 2.35 (3H, s),2.55-2.68 (2H, m), 2.82-3.00 (5H, m), 3.10-3.57 (4H, m), 3.70-3.90 (1H,m), 4.50-4.60 (2H, m), 5.05 (0.42H, d, J=2.8 Hz), 5.12 (0.58H, d, J=3.6Hz), 7.22-7.35 (3H, m), 7.42-7.60 (7H, m), 7.83-7.93 (2H, m), 10.18 (1H,s).

WORKING EXAMPLE 55 (Production of Compound 55)

In DMF (3 ml) was dissolved7-(4-methylphenyl)-N-[4-(thiomorpholinomethyl)phenyl]-3,4-dihydro-naphthalene-2-carboxamide(160 mg), and to the mixture was added methyl iodide(66 μl). The mixturewas stirred at room temperature for 17 hours, and to the mixture wasadded ethyl acetate (100 ml). The resulting precipitate was filtered andrecrystallized from ethyl acetate-methanol to give4-methyl-4-[4-[7-(4-methyl-phenyl)-3,4-dihydronaphthalene-2-carboxamido]benzyl]-thiomorpholiniumiodide (Compound 55) (165 mg) as colorless crystals.

mp 183-185° C.; Elemental Analysis for C₃₀ H₃₃ N₂ OSI.0.2H₂ O; Calcd: C,60.04; H, 5.61; N, 4.67. Found: C, 59.91; H, 5.52; N, 4.66. IR (KBr)cm⁻¹ : 3423, 1651, 1597, 1520, 1416, 1319, 1250, 812; ¹ H NMR (200 MHz,DMSO-d₆) δ: 2.35 (3H, s), 2.55-2.68 (2H, m), 2.83-3.30 (9H, m),3.40-3.65 (4H, m), 4.62 (2H, s), 7.25-7.35 (3H, m), 7.45-7.61 (7H, m),7.90 (2H, d, J=8.6 Hz), 10.19 (1H, s).

WORKING EXAMPLE 56 (Production of Compound 56)

In DMF (3 ml) was dissolvedN-[4-[N,N-bis(2-hydroxyethyl)aminomethyl]phenyl]-7-(4-methylphenyl)-3,4-dihydronaphthalene-2-carboxamide(100 m g), and to the mixture was added methyl iodide (41 μl). Themixture was stirred at room temperature for 22 hours. The solvent wasevaporated and the residue was purified with ethyl acetate-methanol togivebis(2-hydroxyethyl)methyl[4-[7-(4-methylphenyl)-3,4-naphthalene-2-carboxamido]-benzyl]ammoniumiodide (Compound 56) (101 mg) as colorless amorphous.

Elemental Analysis for C₃₀ H₃₅ N₂ O₃ I.0.5H₂ O; Calcd: C, 59.31; H,5.97; N, 4.61. Found: C, 59.19; H, 5.74; N, 4.68. IR (KBr) cm⁻¹ : 3365,1651, 1593, 1520, 1416, 1319, 1250, 810; ¹ H NMR (200 MHz, DMSO-d₆) δ:2.35 (3H, s), 2.55-2.67 (2H, m), 2.84-3.01 (5H, m), 3.27-3.55 (4H, m),3.88-3.98 (4H, m), 4.62 (2H, s), 5.33 (2H, t, J=4.8 Hz), 7.25-7.35 (3H,m), 7.47-7.60 (7H, m), 7.88 (2H, d, J=8.4 Hz), 10.18 (1H, s).

WORKING EXAMPLE 57 (Production of Compound 57)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the solution were added 1-(3,4-methylenedioxybenzyl)piperazine(158 mg) and potassium carbonate (382 mg). The mixture was stirred atroom temperature for 16 hours, and to the mixture was added water (50ml). The mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasrecrystallized from ethyl acetate-diisopropylether to give(E)-N-[4-[1-(3,4-methylenedioxybenzyl)-4-piperazinylmethyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 57) (266 mg) as colorless crystals.

mp 204-207° C.; Elemental Analysis for C₃₅ H₃₅ N₃ O₃.0.5H₂ O; Calcd: C,75.79; H, 6.54; N, 7.58. Found: C, 76.19; H, 6.48; N, 7.83. IR (KBr)cm⁻¹ : 2939, 2806, 1664, 1626, 1524, 1491, 1246, 1041, 1007, 970, 824,795; ¹ H NMR (200 MHz, CDCl₃) δ: 2.30-2.60 (8H, m), 2.41 (3H, s), 3.41(2H, s), 3.48 (2H, s), 5.93 (2H, s), 6.61 (1H, d, J=15.6 Hz), 6.73 (2H,s), 6.84 (1H, s), 7.23-7.32 (4H, m), 7.35-7.60 (8H, m), 7.72 (1H, s),7.81 (1H, d, J=15.6 Hz).

WORKING EXAMPLE 58 (Production of Compound 58)

In THF (10 ml) was dissolved 7-phenylnaphthalene-2-carboxylic acid (350mg), and to the solution were added oxalyl chloride (184 μl) and a dropof DMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(10 ml), and to the solution were added 1-(4-aminobenzyl)piperidine (295mg) and triethylamine (237 μl) at room temperature. The reaction mixturewas stirred at room temperature for 2 hours, and to the mixture wasadded water (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive N-[4-(piperidinomethyl)phenyl]-7-phenylnaphthalene-2-carboxamide(Compound 58) (491 mg) as pale yellow crystals.

mp 177-178° C.; Elemental Analysis for C₂₉ H₂₈ N₂ O.0.2H₂ O; Calcd: C,82.12; H, 6.75; N, 6.60. Found: C, 82.26; H, 6.80; N, 6.62. IR (KBr)cm⁻¹ : 3313, 2933, 1649, 1527, 1317, 849, 754, 692; ¹ H NMR (200 MHz,CDCl₃) δ: 1.37-1.65 (6H, m), 2.35-2.45 (4H, m), 3.48 (2H, s), 7.33-7.57(5H, m), 7.62-7.77 (4H, m), 7.83-8.01 (5H, m), 8.15 (1H, s), 8.44 (1H,s).

WORKING EXAMPLE 59 (Production of Compound 59)

In DMF (3 ml) was dissolvedN-[4-(piperidinomethyl)-phenyl]-7-phenylnaphthalene-2-carboxamide (300mg), and to the mixture was added methyl iodide (133 μl). The mixturewas stirred at room temperature for 16 hours and concentrated underreduced pressure. The residue was recrystallized from ethyl acetate togive1-[4-(7-phenylnaphthalene-2-carboxamido)benzyl]-1-methylpiperidiniumiodide (Compound 59) (374 mg) as pale yellow crystals.

mp 203-207° C.; Elemental Analysis for C₃₀ H₃₁ N₂ OI.1.0H₂ O; Calcd: C,62.07; H, 5.73; N, 4.83. Found: C, 61.82; H, 5.43; N, 4.87. IR (KBr)cm⁻¹ : 3450, 1655, 1597, 1520, 1417, 1317, 1250, 700; ¹ H NMR (200 MHz,DMSO-d₆) δ: 1.40-2.00 (6H, m), 2.94 (3H, s), 3.25-3.40 (4H, m), 4.56(2H, s), 7.40-7.60 (5H, m), 7.84-7.89 (2H, m), 7.95-8.17 (6H, m), 8.40(1H, s), 8.66 (1H, s), 10.68 (1H, s).

WORKING EXAMPLE 60 (Production of Compound 60)

In THF (15 ml) was dissolved 5-(4-methylphenyl)-indene-2-carboxylic acid(500 mg), and to the solution were added oxalyl chloride (262 μl) and adrop of DMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(15 ml), and to the solution were added 1- (4-aminobenzyl)piperidine(419 mg) and triethylamine (336 μl) at room temperature. The reactionmixture was stirred at room temperature for 16 hours, and to the mixturewas added water (100 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous sodium sulfate, and concentrated under reducedpressure. The residue was recrystallized from ethyl acetate-hexane togiveN-[4-(piperidinomethyl)phenyl]-5-(4-methylphenyl)-indene-2-carboxamide(Compound 60) (549 mg) as colorless crystals.

mp 219-220° C.; Elemental Analysis for C₂₉ H₃₀ N₂ O; Calcd: C, 82.43; H,7.16; N, 6.63. Found: C, 82.17; H, 7.13; N, 6.56. IR (KBr) cm⁻¹ : 3346,2935, 1645, 1597, 1516, 1408, 1315, 1250, 808; ¹ H NMR (200 MHz,DMSO-d₆) δ: 1.34-1.57 (6H, m), 2.25-2.40 (7H, m), 3.30-3.43 (2H, m),3.80-3.90 (2H, m), 7.20-7.32 (4H, m), 7.56-7.68 (4H, m), 7.72 (2H, d,J=8.4 Hz), 7.83 (2H, s), 9.96 (1H, s).

WORKING EXAMPLE 61 (Production of Compound 61)

In DMF (10 ml) was dissolvedN-[4-(piperidinomethyl)phenyl]-5-(4-methylphenyl)indene-2-carboxamide(400 mg), and to the mixture was added methyl iodide (177 μl). Themixture was stirred at room temperature for 86 hours and concentratedunder reduced pressure. The residue was recrystallized from ethylacetate to give1-[4-[5-(4-methylphenyl)indene-2-carboxamido]-benzyl]-1-methylpiperidiniumiodide (Compound 61) (516 mg) as pale yellow crystals.

mp 199-201° C.; Elemental Analysis for C₃₀ H₃₃ N₂ OI.0.5H₂ O; Calcd: C,62.83; H, 5.98; N, 4.88. Found: C, 62.56; H, 5.87; N, 4.97. IR (KBr)cm⁻¹ : 3450, 2947, 1651, 1595, 1520, 1416,1322, 1246, 808; ¹ H NMR (200MHz, DMSO-d₆) δ: 1.40-2.00 (6H, m), 2.36 (3H, s), 2.92 (3H, s),3.20-3.40 (4H, m), 3.80-3.90 (2H, m), 4.54 (2H, s), 7.30 (2H, d, J=8.0Hz), 7.52 (2H, d, J=8.0 Hz), 7.55-7.70 (4H, m), 7.85-7.97 (4H, m),10.20-10.25 (1H, m).

WORKING EXAMPLE 62 (Production of Compound 62)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the solution were added 1-(4-methoxyphenyl)piperazinedihydrochloride (190 mg) and potassium carbonate (382 mg). The mixturewas stirred at room temperature for 14 hours, and to the mixture wasadded water (50 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive(E)-N-[4-[1-(4-methoxyphenyl)-4-piperazinylmethyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 62) (224 mg) as colorless crystals.

mp 207-208° C.; Elemental Analysis for C₃₄ H₃₅ N₃ O₂ ; Calcd: C, 78.89;H, 6.81; N, 8.12. Found: C, 78.59; H, 6.65; N, 8.13. IR (KBr) cm⁻¹ :2937, 2812, 1662, 1626, 1512, 1248, 820, 795; ¹ H NMR (200 MHz, CDCl₃)δ: 2.41 (3H, s), 2.56-2.65 (4H, m), 3.04-3.13 (4H, m), 3.54 (2H, s),3.76 (3H, s), 6.61 (1H, d, J=15.6 Hz), 6.78-6.94 (4H, m), 7.23-7.63(12H, m), 7.73 (1H, s), 7.82 (1H, d, J=15.6 Hz).

WORKING EXAMPLE 63 (Production of Compound 63)

In DMF (3 ml) was dissolved (E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg), and to the solution were added2-(3,4-dimethoxyphenyl)ethylmethylamine (132 μl) and potassium carbonate(382 mg). The mixture was stirred at room temperature for 12 hours, andto the mixture was added water (50 ml). The mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was separated and purified withcolumn chromatography (ethyl acetate) to give colorless amorphous, whichwas dissolved in ethyl acetate (50 ml), and to the mixture was added 4Nhydrochloric acid ethyl acetate solution (0.5 ml). The resultingprecipitate was filtered and recrystallized from ethyl acetate-methanolto give(E)-N-[4-[N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylaminomethyl]phenyl]-3-(4-methylphenyl)cinnamamidehydrochloride (Compound 63) (245 mg) as colorless crystals.

mp 214-217° C.; Elemental Analysis for C₃₄ H₃₆ N₂ O₃.1.0HCl; Calcd: C,73.30; H, 6.69; N, 5.03; Cl, 6.36. Found: C, 73.00; H, 6.66; N, 4.99;Cl, 6.20. IR (KBr) cm⁻¹ : 3427, 2941, 1682, 1601, 1518, 1417, 1344,1259, 1174, 1026, 793; ¹ H NMR (200 MHz, DMSO-d₆) δ: 2.37 (3H, s),2.66-2.75 (3H, m), 2.95-3.40 (4H, m), 3.73 (3H, s), 3.75 (3H, s),4.15-4.28 (1H, m), 4.32-4.46 (1H, m), 6.77 (1H, dd, J=1.8, 8.2 Hz),6.84-6.94 (2H, m), 7.02 (1H, d, J=16.0 Hz), 7.31 (2H, d, J=7.8 Hz),7.48-7.75 (8H, m), 7.79-7.93 (3H, m), 10.56 (2H, s).

WORKING EXAMPLE 64 (Production of Compound 64)

In DMF (3 ml) was dissolved (E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg), and to the solution were addedmethylaminoacetonitrile hydrochloride (77 mg) and potassium carbonate(382 mg). The mixture was stirred at room temperature for 14 hours, andto the mixture was added water (50 ml). The mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with anhydrous sodium sulfate, and concentratedunder reduced pressure. The residue was recrystallized from ethylacetatediisopropylether to give(E)-N-[4-[N-(cyanomethyl)-N-methylaminomethyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 64) (129 mg) as colorless crystals.

mp 163-165° C.; Elemental Analysis for C₂₆ H₂₅ N₃ O.0.1H₂ O; Calcd: C,78.60; H, 6.39; N, 10.58. Found: C, 78.44; H, 6.32; N, 10.35. IR (KBr)cm⁻¹ : 3250, 3055, 1662, 1626, 1599, 1535, 1516, 1412, 1344, 1184, 982,822, 791; ¹ H NMR (200 MHz, CDCl₃) δ: 2.42 (3H, s), 2.44 (3H, s), 3.46(2H, s), 3.59 (2H, s), 6.61 (1H, d, J=15.4 Hz), 7.23-7.65 (12H, m), 7.74(1H, s), 7.83 (1H, d, J=15.4 Hz).

WORKING EXAMPLE 65 (Production of Compound 65)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the solution were added imidazole (49 mg) and potassium carbonate(382 mg). The mixture was stirred at room temperature for 18 hours, andto the mixture was added water. The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with anhydrous sodium sulfate, and concentrated underreduced pressure. The residue was recrystallized from ethylacetate-diisopropylether to give(E)-N-[4-[(imidazol-1-yl)methyl]phenyl]-3-(4-methylphenyl)-cinnamamide(Compound 65) (90 mg) as colorless crystals.

mp 198-200° C.; Elemental Analysis for C₂₆ H₂₃ N₃ O.0.3H₂ O; Calcd: C,78.29; H, 5.96; N, 10.53. Found: C, 78.26; H, 5.92; N, 10.17. IR (KBr)cm⁻¹ : 3026, 1674, 1628, 1601, 1539, 1518, 1416, 1342, 1182, 1080, 787;¹ H NMR (200 MHz, CDCl₃) δ: 2.41 (3H, s), 5.08 (2H, s), 6.67 (1H, d,J=15.4 Hz), 6.91 (1H, s), 7.09-7.16 (3H, m), 7.23-7.30 (2H, m),7.35-7.66 (8H, m), 7.72 (1H, s), 7.82 (1H, d, J=15.4 Hz), 8.00 (1H, brs).

WORKING EXAMPLE 66 (Production of Compound 66)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the solution were added 3-(hydroxymethyl)piperidine (191 mg). Themixture was stirred at room temperature for 72 hours, and to the mixturewas added water (50 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous sodium sulfate, and concentrated under reducedpressure. The residue was recrystallized from ethylacetate-diisopropylether to give(E)-N-[4-[3-(hydroxymethyl)piperidinomethyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 66) (160 mg) as colorless crystals.

mp 153-154° C.; Elemental Analysis for C₂₉ H₃₂ N₂ O₂.0.1H₂ O; Calcd: C,78.74; H, 7.34; N, 6.33. Found: C, 78.51; H, 7.32; N, 6.25. IR (KBr)cm⁻¹ : 3290, 2924, 1664, 1626, 1603, 1543, 1514, 1412, 1346, 1186, 789;¹ H NMR (200 MHz, CDCl₃) δ: 1.50-1.90 (3H, m), 2.05-2.35 (4H, m), 2.41(3H, s), 2.50-2.63 (1H, m), 2.70-2.80 (1H, m), 3.46 (2H, s), 3.50-3.71(2H, m), 6.65 (1H, d, J=15.6 Hz), 7.23-7.31 (4H, m), 7.36-7.61 (7H, m),7.70-7.87 (3H, m).

WORKING EXAMPLE 67 (Production of Compound 67)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the mixture was added 3-hydroxypiperidine(168 mg). The mixturewas stirred at room temperature for 13 hours, and to the mixture wasadded water (50 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetatediisopropylether togive(E)-N-[4-(3-hydroxypiperidinomethyl)phenyl]-3-(4-methylphenyl)cinnamamide(Compound 67) (174 mg) as colorless crystals.

mp 132-134° C.; Elemental Analysis for C₂₈ H₃₀ N₂ O₂ ; Calcd: C, 78.84;H, 7.09; N, 6.57. Found: C, 78.58; H, 7.08; N, 6.54. IR (KBr) cm⁻¹ :3427, 2937, 1660, 1628, 1601, 1539, 1412, 1344, 1184, 791; ¹ H NMR (200MHz, DMSO-d₆) δ: 1.28-1.90 (6H, m), 2.36 (3H, s), 2.59-2.68 (1H, m),2.72-2.85 (1H, m), 3.33 (2H, s), 4.56 (1H, d, J=4.8 Hz), 6.93 (1H, d,J=15.8 Hz), 7.20-7.35 (4H, m), 7.46-7.71 (8H, m), 7.89 (1H, s), 10.19(1H, s).

WORKING EXAMPLE 68 (Production of Compound 68)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the mixture was added 2-piperidinemethanol (19lmg). The mixturewas stirred at room temperature for 13 hours, and to the mixture wasadded water (50 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive(E)-N-[4-[2-(hydroxy-methyl)piperidinomethyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 68) (120 mg) as colorless crystals.

mp 137-139° C.; Elemental Analysis for C₂₉ H₃₂ N₂ O₂ ; Calcd: C, 79.06;H, 7.32; N, 6.36. Found: C, 78.73; H, 7.38; N, 6.37. IR (KBr) cm⁻¹ :3325, 2922, 1664, 1630, 1601, 1531, 1412, 1338, 1174, 974, 793; ¹ H NMR(200 MHz, CDCl) δ: 1.30-1.80 (6H, m), 2.10-2.25 (1H, m), 2.40-2.57 (1H,m), 2.41 (3H, s), 2.82-2.93 (1H, m), 3.33 (1H, d, J=13.5 Hz), 3.53 (1H,dd, J=4.0, 10.8 Hz), 3.88 (1H, dd, J=4.0, 10.8 Hz), 4.04 (1H, d, J=13.5Hz), 6.61 (1H, d, J=15.4 Hz), 7.23-7.33 (4H, m), 7.37-7.62 (8H, m), 7.74(1H, s), 7.82 (1H, d, J=15.4 Hz).

WORKING EXAMPLE 69 (Production of Compound 69)

In DMF (3 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (200 mg),and to the mixture was added 2-(2-hydroxyethyl)piperidine (214 mg). Themixture was stirred at room temperature for 18 hours, and to the mixturewas added water (50 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous sodium sulfate, and concentrated under reducedpressure. The residue was recrystallized from ethylacetate-diisopropylether to give(E)-N-[4-[2-(2-hydroxyethyl)piperidinomethyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 69) (202 mg) as colorless crystals.

mp 142-143° C.; Elemental Analysis for C₃₀ H₃₄ N₂ O₂ ; Calcd: C, 79.26;H, 7.54; N, 6.16. Found: C, 79.00; H, 7.27; N, 6.19. IR (KBr) cm⁻¹ :3300, 2935, 1666, 1628, 1603, 1541, 1516, 1412, 1344, 1182, 789; ¹ H NMR(200 MHz, CDCL3) δ: 1.30-2.13 (8H, m), 2.20-2.35 (1H, m), 2.41 (3H, s),2.73-2.87 (1H, m), 2.92-3.07 (1H, m), 3.48 (1H, d, J=13.0 Hz), 3.70-3.83(1H, m), 3.90-4.02 (1H, m), 4.14 (1H, d, J=13.0 Hz), 6.65 (1H, d, J=15.4Hz), 7.23-7.33 (4H, m), 7.38-7.64 (7H, m), 7.72-7.87 (3H, m).

WORKING EXAMPLE 70 (Production of Compound 70)

In THF (10 ml) was dissolved 3-(4-methylphenyl)cinnamic acid (0.48 g),and to the solution were added oxalyl chloride (0.35 ml) and a drop ofDMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(20 ml), and to the solution were added 1-(4-aminobenzyl)piperidine(0.38 g) and triethylamine (0.34 ml) at room temperature. The reactionmixture was stirred at room temperature for 2 hours, and to the mixturewas added water (150 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous magnesium sulfate and concentrated under reducedpressure. The residue was recrystallized from ethylacetate-diisopropylether to give(E)-N-[4-(piperidinomethyl)-phenyl]-3-(4-methylphenyl)-cinnamamide(Compound 70) (0.60 g) as pale yellow crystals.

mp 154-156° C.; Elemental Analysis for C₂₈ H₃₀ N₂ O.0.4H₂ O; Calcd: C,80.50; H, 7.43; N, 6.71. Found: C, 80.60; H, 7.28; N, 6.52. ¹ H NMR (200MHz, CDCl₃) δ: 1.44 (2H, m), 1.58 (4H, m), 2.39 (4H, m), 2.41 (3H, s),3.47 (2H, s), 6.61 (1H, d, J=15.6 Hz), 7.25-7.60 (12H, m), 7.73 (1H, s),7.82 (1H, d, J=15.6 Hz).

WORKING EXAMPLE 71 (Production of Compound 71)

In THF (10 ml) was dissolved 3-(2-methylphenyl)cinnamic acid (0.48 g),and to the solution were added oxalyl chloride (0.35 ml) and a drop ofDMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(20 ml), and to the solution were added 1-(4-aminobenzyl)piperidine(0.38 g) and triethylamine (0.34 ml) at room temperature. The reactionmixture was stirred at room temperature for 2 hours, and to the mixturewas added water (50 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous magnesium sulfate and concentrated under reducedpressure. The residue was washed with ethyl acetate-diisopropylether togive (E)-N-[4-(piperidinomethyl)phenyl]-3-(2-methyl-phenyl)-cinnamamide(Compound 71) (0.75 g) as pale yellow amorphous. Elemental Analysis forC₂₈ H₃₀ N₂ O.0.5H₂ O; Calcd: C, 80.16; H, 7.45; N, 6.68. Found: C,80.15; H, 7.38; N, 6.64. ¹ H NMR (200 MHz, CDCl₃) δ: 1.45 (2H, m), 1.58(4H, m), 2.27 (3H, s), 2.39 (2H, m), 3.47 (2H, s), 6.58 (1H, d, J=15.4Hz), 7.24-7.35 (7H, m), 7.39-7.58 (6H, m), 7.80 (1H, d, J=15.6 Hz).

WORKING EXAMPLE 72 (Production of Compound 72)

In DMF (4 ml) was dissolved(E)-N-[4-(piperidinomethyl)phenyl]-3-(4-methylphenyl)cinnamamide (0.41g), and to the mixture was added methyl iodide (0.43 g). The mixture wasstirred at room temperature for 20 hours and concentrated under reducedpressure. The residue was crystallized from ethyl acetate to give(E)-1-methyl-1-[4-(3-(4-methyl-phenyl)cinnamamido)benzyl]-piperidiniumiodide (Compound 72) (0.51 g) as pale yellow crystals.

mp 176-178° C.; Elemental Analysis for C₂₉ H₃₃ N₂ OI.1.5H₂ O; Calcd: C,60.10; H, 6.26; N, 4.83. Found: C, 60.19; H, 6.25; N, 4.95. ¹ H NMR (200MHz, DMSO-d₆) δ: 1.62 (2H, m) , 1.88 (4H, m) , 2.37 (3H, s), 2.93 (3H,s), 3.36 (4H, m), 4.55 (2H, s), 6.97 (1H, d, J=15.8 Hz), 7.31 (2H, d,J=7.6 Hz), 7.50-7.90 (11H, m), 10.44 (1H, s).

WORKING EXAMPLE 73 (Production of Compound 73)

In DMF (6 ml) was dissolved(E)-N-[4-(piperidinomethyl)phenyl]-3-(2-methylphenyl)cinnamamide (0.62g), and to the mixture was added methyl iodide (0.64 g). The mixture wasstirred at room temperature for 20 hours and concentrated under reducedpressure. The residue was solidified with ethyl acetate to give(E)-1-methyl-1-[4-(3-(2-methylphenyl)cinnamamido)benzyl]-piperidiniumiodide (Compound 73) (0.79 g) as pale yellow amorphous.

Elemental Analysis for C₂₉ H₃₃ N₂ OI.1.5H₂ O; Calcd: C, 60.10; H, 6.26;N, 4.83. Found: C, 60.00; H, 6.11; N, 5.00. ¹ H NMR (200 MHz, DMSO-d₆)δ: 1.62 (2H, m), 1.88 (4H, m) , 2.27 (3H, s), 2.93 (3H, s), 3.32 (4H,m), 4.56 (2H, s), 6.94 (1H, d, J=15.6 Hz), 7.27-7.73 (11H, m), 7.84 (2H,d, J=8.4 Hz), 10.40 (1H, s).

WORKING EXAMPLE 74 (Production of Compound 74)

In THF (10 ml) was dissolved 3-(2,5-dimethylphenyl)cinnamic acid (0.50g), and to the solution were added oxalyl chloride (0.35 ml) and a dropof DMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(20 ml), and to the solution were added 1-(4-aminobenzyl)piperidine(0.38 g) and triethylamine (0.34 ml) at room temperature. The reactionmixture was stirred at room temperature for 2 hours, and to the mixturewas added water (50 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous magnesium sulfate and concentrated under reducedpressure. The residue was washed with ethyl acetate-diisopropylether togive(E)-N-[4-(piperidinomethyl)phenyl]-3-(2,5-dimethylphenyl)cinnamamide(Compound 74) (0.75 g) as pale yellow amorphous.

Elemental Analysis for C₂₉ H₃₂ N₂ O.0.5H₂ O; Calcd: C, 80.33; H, 7.67;N, 6.46. Found: C, 80.25; H, 7.34; N, 6.68. ¹ H NMR (200 MHz, CDCl₃) δ:1.44 (2H, m), 1.61 (4H, m), 2.22 (3H, s), 2.36 (3H, s), 2.47 (4H, m),3.55 (2H, s), 6.61 (1H, d, J=15.4 Hz), 7.05-7.20 (3H, m), 7.28-7.60 (8H,m), 7.71 (1H, s), 7.79 (1H, d. J=15.4 Hz).

WORKING EXAMPLE 75 (Production of Compound 75)

In THF (10 ml) was dissolved 3-(3-nitrophenyl)cinnamic acid (0.54 g) ,and to the solution were added oxalyl chloride (0.35 ml) and a drop ofDMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(20 ml), and to the solution were added 1-(4-aminobenzyl)piperidine(0.38 g) and triethylamine (0.34 ml) at room temperature. The reactionmixture was stirred at room temperature for 2 hours, and to the mixturewas added water (50 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with anhydrous magnesium sulfate and concentrated under reducedpressure. The residue was recrystallized from ethyl acetate to give(E)-N-[4-(piperidinomethyl)phenyl]-3-(3-nitrophenyl)cinnamamide(Compound 75) (0.65 g) as pale yellow crystals.

mp 178-179° C.; Elemental Analysis for C₂₇ H₂₇ N₃ O₃.0.5H₂ O; Calcd: C,71.98; H, 6.26; N, 9.33. Found: C, 71.69; H, 6.38; N, 9.44. ¹ H NMR (200MHz, DMSO-d₆) δ: 1.51 (6H, m), 2.33 (4H, m), 3.39 (2H, s), 6.96 (1H, d,J=15.8 Hz), 7.24 (2H, d, J=8.0 Hz), 7.59-7.83 (7H, m), 8.02 (1H, s),8.18-8.30 (2H, m), 8.52 (1H, s), 10.18 (1H, s).

WORKING EXAMPLE 76 (Production of Compound 76)

In DMF (6 ml) was dissolved(E)-N-[4-(piperidinomethyl)phenyl]-3-(2,5-dimethylphenyl)cinnamamide(0.60 g), and to the mixture was added methyl iodide (0.60 g). Themixture was stirred at room temperature for 20 hours and concentratedunder reduced pressure. The residue was crystallized from ethyl acetateto give(E)-1-methyl-1-[4-(3-(2,5-dimethylphenyl)cinnamamido)benzyl]piperidiniumiodide (Compound 76) (0.66 g) as pale yellow crystals.

mp 145-147C.; Elemental Analysis for C₃₀ H₃₅ N₂ OI.1.5H₂ O; Calcd: C,60.71; H, 6.45; N, 4.72. Found: C, 61.06; H, 6.10; N, 4.74. ¹ H NMR (200MHz, DMSO-d₆) δ: 1.62 (2H, m) , 1.88 (4H, m), 2.22 (3H, s), 2.33 (3H,s), 2.93 (3H, s), 3.33 (4H, m), 4.55 (2H, s), 6.92 (1H, d, J=15.8 Hz),7.07 (1H, s), 7.15 (2H, ABq, J=7.6 Hz), 7.37 (1H, d, J=7.4 Hz),7.48-7.60 (5H, m), 7.67 (1H, d, J=15.6 Hz), 7.84 (2H, d, J=8.4 Hz),10.39 (1H, s).

WORKING EXAMPLE 77 (Production of Compound 77)

In DMF (6 ml) was dissolved(E)-N-[4-(piperidinomethyl)phenyl]-3-(3-nitrophenyl)cinnamamide (0.59g), and to the mixture was added methyl iodide (0.57 g). The mixture wasstirred at room temperature for 20 hours and concentrated under reducedpressure. The residue was crystallized from ethyl acetate to give(E)-1-methyl-1-[4-(3-(3-nitrophenyl)cinnamamido)benzyl]-piperidiniumiodide (Compound 77) (0.75 g) as pale yellow crystals.

mp 188-190° C.; Elemental Analysis for C₂₈ H₃₀ N₃ O₃ I.1.5H₂ O; Calcd:C, 55.09; H, 5.45; N, 6.88. Found: C, 54.91; H, 5.40; N, 7.23. ¹ H NMR(200 MHz, DMSO-d₆) δ: 1.65 (2H, m) , 1.90 (4H, m) , 2.94 (3H, s), 3.35(4H, m), 4.56 (2H, s), 6.99 (1H, d, J=15.8 Hz), 7.49-7.88 (9H, m), 8.04(1H, s), 8.18-8.29 (2H, m), 8.53 (1H, s), 10.45 (1H, s).

WORKING EXAMPLE 78 (Production of Compound 78)

In toluene(10 ml) was dissolved(E)-N-[4-(chloromethyl)phenyl]-3-(4-methylphenyl)cinnamamide (300 mg),and to the mixture was added tributylphosphine (248 μl). The mixture wasstirred at 80° C. for 3 days and cooled to room temperature. Theresulting precipitate was filtered and recrystallized from ethylacetate-methanol to give(E)tributyl[4-[3-(4-methylphenyl)cinnamamido]benzyl]phosphonium chloride(Compound 78) (389 mg) as colorless crystals.

mp 216-217° C.; Elemental Analysis for C₃₅ H₄₇ NOClP; Calcd: C, 74.51;H, 8.40; N, 2.48. Found: C, 74.40; H, 8.33; N, 2.63. IR (KBr) cm⁻¹ :3429, 2966, 1674, 1630, 1601, 1537, 1516, 1344, 1180, 789; ¹ H NMR (200MHz, DMSO-d₆) δ: 0.85-1.00 (9H, m), 1.30-1.60 (12H, m), 2.05-2.25 (6H,m), 2.37 (3H, s), 3.79 (2H, d, J=15.2 Hz), 7.05 (1H, d, J=15.8 Hz),7.25-7.35 (4H, m), 7.48-7.90 (9H, m), 10.61 (1H, s).

WORKING EXAMPLE 79 (Production of Compound 79)

In THF (10 ml) was dissolved (E)-3-(4-methylphenyl)cinnamic acid (400mg), and to the solution were added oxalyl chloride (220 μl) and a dropof DMF. The mixture was stirred at room temperature for 1 hour andconcentrated under reduced pressure. The residue was dissolved in THF(10 ml), and to the mixture was dropwise added a solution of(4-aminophenyl) (2-pyridyl)methanol (370 mg) and triethylamine (471 μl)in THF (15 ml) at 0° C. The reaction mixture was stirred at roomtemperature for 20 hours, and to the mixture was added water (50 ml).The mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasrecrystallized from ethyl acetate-hexane to give(E)-N-[4-[hydroxy(2-pyridyl)methyl]phenyl]-3-(4-methylphenyl)cinnamamide(Compound 79) (517 mg) as colorless crystals.

mp 162-165° C.; Elemental Analysis for C₂₈ H₂₄ N₂ O₂.0.1H₂ O; Calcd: C,79.63; H, 5.78; N, 6.63. Found: C, 79.53; H, 5.73; N, 6.58. IR (KBr)cm⁻¹ : 3257, 1659, 1626, 1597, 1531,1410, 1342, 1250, 1182, 787, 758; ¹H NMR (200 MHz, CDCl₃) δ: 2.41 (3H, s), 5.27-5.36 (1H, m), 5.70-5.77(1H, m), 6.60 (1H, d, J=15.4 Hz), 7.12-7.86 (17H, m), 8.57 (1H, d, J=4.4Hz).

WORKING EXAMPLE 80 (Production of Compound 80)

In THF (10 ml) was dissolved(E)-N-[4-[hydroxy(2-pyridyl)methyl]phenyl]-3-(4-methylphenyl)cinnamamide(200 mg), and to the mixture was added 70% mCPBA (152 mg). The mixturewas stirred at room temperature for 6 hours, and to the solution wereadded saturated sodium thiosulfate solution (10 ml) and saturatedpotassium carbonate (10 ml). The mixture was stirred at room temperaturefor 30 minutes and extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with anhydroussodium sulfate, and concentrated under reduced pressure. The residue wasrecrystallized from ethyl acetate-methanol to give(E)-N-[4-[hydroxy(1-oxido-2-pyridyl)methyl]phenyl]3-(4-methylphenyl)cinnamamide(Compound 80) (123 mg) as colorless crystals.

mp 165-167° C.; Elemental Analysis for C₂₈ H₂₄ N₂ O₃ ; Calcd: C, 77.04;H, 5.54; N, 6.42. Found: C, 76.85; H, 5.55; N, 6.42. IR (KBr) cm⁻¹ :3288, 1668, 1628, 1601, 1539,1516, 1433, 1412, 1340, 1184, 791, 768; ¹ HNMR (200 MHz, CDCl₃) δ: 2.40 (3H, s), 6.05 (1H, d, J=4.4 Hz), 6.37 (1H,d, J=4.4 Hz), 6.65 (1H, d, J=15.8 Hz), 6.99-7.06 (1H, m), 7.20-7.31 (4H,m), 7.36-7.87 (12H, m), 8.20-8.26 (1H, m).

WORKING EXAMPLE 81 (Production of Compound 81)

To 3-phenylcinnamic acid (0.62 g) were added thionyl chloride (5 ml) anddimethylformamide (catalytic amount), and the mixture was refluxed for 4hours. The solvent was evaporated, and the residue was dissolved intetrahydrofuran. The mixture was dropwise added to a suspension of1-(4-aminobenzyl)piperidine (0.5 g) and diisopropylethylamine (1.2 ml)in tetrahydrofuran (5 ml) under ice-cooling. Under nitrogen atmosphere,the mixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate). The resulting crude crystals wasrecrystallized from ethyl acetate-hexane to give1-(4-(3-phenylcinnamoylamino)benzyl)piperidine (Compound 81) (0.45 g) aspale yellow crystals.

mp 159-160° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.37-1.48 (2H, m), 1.49-1.63 (4H,m), 2.34-2.42 (4H, m), 3.45 (2H, s), 6.62 (1H, d, J=15.4 Hz), 7.23-7.63(13H, m), 7.76 (1H, s), 7.83 (1H, d, J=15.4 Hz). IR(KBr) ν: 2934, 1659,1624 cm⁻¹. Anal. for C₂₇ H₂₈ N₂ O.0.5H₂ O: Calcd. C, 79.97; H, 7.21; N,6.91. Found C, 81.09; H, 7.02; N, 6.94.

WORKING EXAMPLE 82 (Production of Compound 82)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g) and sodium phenyl sulfide (0.05 g) in dimethylformamide (10 ml)was stirred at room temperature over night. The solvent was evaporated,and to the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate-hexane to give7-(4-methylphenyl)-N-(4-(phenylthiomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 82) (0.13 g) as colorless crystals.

mp 176-177° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.07 (2H, t, J=4.5Hz), 4.10 (2H, s), 4.35 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.2 Hz),7.18-7.33 (9H, m), 7.43-7.53 (6H, m), 7.58 (1H, s). IR(KBr) ν: 1652,1515 cm⁻¹. Anal. for C₃₁ H₂₇ NO₂ S: Calcd. C, 77.96; H, 5.70; N, 2.93.Found C, 77.72; H, 5.57; N, 3.07.

WORKING EXAMPLE 83 (Production of Compound 83)

A suspension of 1-(4-(3-bromocinnamoylamino)benzyl)piperidine (0.4 g),4-fluorophenyl borate (0.14 g), 1M potassium carbonate (2 ml) andethanol (1 ml) in toluene (5 ml) was stirred under argon atmosphere atroom temperature for 30 minutes. To the suspension was addedtetrakistriphenylphosphinepalladium (0.05 g), and the mixture wasrefluxed over night. The mixture was extracted with ethyl acetate, andthe organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (methanol/triethylamine/ethyl acetate) to give crudecrystals, which were recrystallized from ethyl acetate-hexane to give1-(4-(3-(4-fluoro-phenyl)cinnamoylamino)benzyl)piperidine (Compound 83)(0.35 g) as colorless crystals.

mp 166-167° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.38-1.50 (2H, m), 1.52-1.65 (4H,m), 2.34-2.39 (4H, m), 3.45 (2H, s), 6.61 (1H, d, J=15.4 Hz), 7.10-7.19(2H, m), 7.30 (2H, d, J=8.0 Hz), 7.40-7.58 (8H, m), 7.68 (1H, s), 7.81(1H, d, J=15.4 Hz). IR(KBr) ν: 3262, 2936, 1663 cm⁻¹. Anal. for C₂₇ H₂₇FN₂ O.0.2H₂ O: Calcd. C, 77.56; H, 6.61; N, 6.70. Found C, 77.72; H,6.49; N, 6.79.

WORKING EXAMPLE 84 (Production of Compound 84)

A suspension of 1-(4-(3-bromocinnamoyl amino)benzyl)piperidine (0.4 g),4-methoxyphenyl borate (0.14 g), 1M potassium carbonate (2 ml) andethanol (1 ml) in toluene (5 ml) was stirred under argon atmosphere atroom temperature for 30 minutes. To the suspension was addedtetrakistriphenylphosphinepalladium (0.05 g), and the mixture wasrefluxed over night. The mixture was extracted with ethyl acetate, andthe organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (methanol/triethylamine/ethyl acetate) to give crudecrystals, which were recrystallized from ethyl acetate-hexane to give1-(4-(3-(4-methoxyphenyl)-cinnamoylamino)benzyl)piperidine (Compound 84)(0.38 g) as colorless crystals.

mp 150-151° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.38-1.50 (2H, m), 1.51-1.62 (4H,m), 2.35-2.40 (4H, m), 3.46 (2H, s), 3.87 (3H, s), 6.61 (1H, d, J=15.4Hz), 7.00 (2H, d, J=9.0 Hz), 7.29-7.36 (3H, m), 7.43-7.58 (7H, m), 7.71(1H, s), 7.82 (1H, d, J=15.4 Hz). IR(KBr) ν: 3264, 2936, 1663 cm⁻¹.Anal. for C₂₈ H₃₀ N₂ O₂ : Calcd. C, 78.84; H, 7.09; N, 6.57. Found C,79.07; H, 7.12; N, 6.69.

WORKING EXAMPLE 85 (Production of Compound 85)

A solution of 1-(4-(3-phenylcinnamoylamino)benzyl)piperidine (0.32 g)and methyl iodide (0.15 ml) in dimethylformamide (5 ml) was stirred overnight under nitrogen atmosphere at room temperature. The solvent wasevaporated, and to the residue was added ethyl acetate. Precipitatedcrude crystal was filtered, which were recrystallized from ethanol togive 1-methyl-1-(4-(3-phenylcinnamoylamino)-benzyl)piperidinium iodide(Compound 85) (0.26 g) as colorless crystals.

mp 194-195° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.65 (2H, m), 1.75-1.95(4H, m), 2.92 (3H, s), 3.24-3.28 (4H, m), 4.54 (2H, s), 6.97 (1H, d,J=15.8 Hz), 7.41-7.93 (14H, m), 10.44 (1H,s). IR(KBr) ν: 3241, 1682cm⁻¹. Anal. for C₂₈ H₃₁ IN₂ O: Calcd. C, 62.46; H, 5.80; N, 5.20. FoundC, 62.19; H, 5.74; N, 5.10.

WORKING EXAMPLE 86 (Production of Compound 86)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g) and sodium benzyl sulfide (0.055 g) in dimethylformamide (10ml) was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-(benzylthiomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 86) (0.17 g) as colorless crystals.

mp 145-146° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.07 (2H, t, J=4.7Hz), 3.59 (2H, s), 3.60 (2H, s), 4.35 (2H, t, J=4.7 Hz), 7.06 (1H, d,J=8.0 Hz), 7.22-7.32 (9H, m), 7.43-7.57 (6H, m), 7.61 (1H, s). IR(KBr)ν: 3028, 1646, 1515 cm⁻¹. Anal.for C₃₂ H₂₉ NO₂ S.0.5H₂ O: Calcd. C,76.77; H, 6.04; N, 2.80. Found C, 77.07; H, 5.96; N, 2.95.

WORKING EXAMPLE 87 (Production of Compound 87)

A solution of Compound 83 (0.25 g) and methyl iodide (0.2 ml) indimethylformamide (5 ml) was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added ethyl acetate.Precipitated crude crystal was filtered, which were recrystallized fromethanol to give 1-methyl-1-(4-(3-(4-fluorophenyl)cinnamoylamino)benzyl)piperidinium iodide(Compound 87) (0.27 g) as pale brown crystals.

mp 204-205° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.42-1.75 (2H, m), 1.78-1.95(4H, m), 2.91 (3H, s), 3.22-3.32 (4H, m), 4.52 (2H, s), 6.95 (1H, d,J=15.8 Hz), 7.29-7.38 (2H, m), 7.48-7.91 (11H, m), 10.44 (1H, s).IR(KBr) ν: 3237, 1682 cm⁻¹. Anal.for C₂₈ H₃₀ FIN₂ O.0.5H₂ O: Calcd. C,59.47; H, 5.53; N, 4.95. Found C, 59.49; H, 5.35; N, 4.98.

WORKING EXAMPLE 88 (Production of Compound 88)

A solution of 1-(4-(3-(4-methoxyphenyl)cinnamoylamino)benzyl)piperidine(0.32 g) and methyl iodide (0.2 ml) in dimethylformamide (5 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-hexane to give1-methyl-1-(4-(3-(4-methoxyphenyl)cinnamoylamino)benzyl)piperidiniumiodide (Compound 88) (0.33 g) as pale brown crystals.

mp 208-209° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.68 (2H, m), 1.78-1.95(4H, m), 2.91 (3H, s), 3.24-3.34 (4H, m), 3.82 (3H, s), 4.53 (2H, s),6.95 (1H, d, J=15.8 Hz), 7.06 (2H, d, J=8.6 Hz), 7.43-7.57 (4H, m),7.61-7.74 (4H, m), 7.84 (2H, d, J=8.6 Hz), 7.88 (1H, s), 10.45 (1H, s).IR(KBr) ν: 3243, 1682 cm⁻¹. Anal. for C₂₉ H₃₃ IN₂ O₂ : Calcd. C, 61.27;H, 5.85; N, 4.93. Found C, 60.87; H, 5.83; N, 4.88.

WORKING EXAMPLE 89 (Production of Compound 89)

To 3,4-dihydro-7-phenylnaphthalene-2-carboxylic acid (0.25 g) were addedthionyl chloride (5 ml) and dimethylformamide (catalytic amount), andthe mixture was refluxed for 3 hours. The solvent was evaporated, andthe residue was dissolved in tetrahydrofuran. The mixture was dropwiseadded to a suspension of2-(4-aminobenzyl)-1,3-dimethyl-1,3,2-diazaphosphorane-2-oxide (0.25 g)and diisopropylethylamine (0.5 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated. Precipitated crude crystal wasrecrystallized from ethanol-hexane to give2-(4-(3,4-dihydro-7-phenyl-naphthalene-2-carbonylamino)benzyl)-1,3-dimethyl-1,3,2-diazaphosphorinane-2-oxide(Compound 89) (0.35 g) as colorless crystals.

mp 249-250° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.10-1.30 (1H, m), 1.65-1.85 (1H,m), 2.65 (3H, s), 2.69 (3H, s), 2.73-3.07 (8H, m), 3.17 (2H, d, J=17.4Hz), 7.18 (2H, dd, J=2.6, 8.8 Hz), 7.29-7.60 (11H, m), 7.70 (1H, s).IR(KBr) ν: 3283, 2940, 2886, 2832, 1655 cm⁻¹. Anal. for C₂₉ H₃₂ N₃ O₂P.0.2H₂ O: Calcd. C, 71.21; H, 6.68; N, 8.59. Found C, 71.12; H, 6.57;N, 8.52.

WORKING EXAMPLE 90 (Production of Compound 90)

To 3,4-dihydro-7-phenylnaphthalene-2-carboxylic acid (0.35 g) were addedthionyl chloride (10 ml) and dimethylformamide (catalytic amount), andthe mixture was refluxed for 2.5 hours. The solvent was evaporated, andthe residue was dissolved in tetrahydrofuran. The mixture was dropwiseadded a suspension of2-(4-aminobenzyl)-1,3-dimethyl-1,3,2-diazaphosphorane-2-oxide (0.33 g)and diisopropylethylamine (0.75 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated. Precipitated crude crystal wasrecrystallized from ethanol-hexane to give2-(4-(3,4-dihydro-7-phenyl-naphthalene-2-carbonylamino)benzyl)-1,3-dimethyl-1,3,2-diaza-phosphorane-2-oxide(Compound 90) (0.24 g) as colorless crystals.

mp 212-213° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.61 (3H, s), 2.65-2.76 (2H, m),2.66 (3H, s), 2.94-3.07 (2H, m), 3.22 (2H, d, J=18.6 Hz), 7.19 (2H, dd,J=2.6, 8.6 Hz), 7.29-7.60 (11H, m), 7.72 (1H, s). IR(KBr) ν: 3254, 2928,2897, 1655 cm⁻¹. Anal. for C₂₈ H₃₀ N₃ O₂ P.0.5H₂ O: Calcd. C, 69.98; H,6.50; N, 8.74. Found C, 70.27; H, 6.32; N, 8.53.

WORKING EXAMPLE 91 (Production of Compound 91)

To a solution of2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.25 g) in dichloromethane (5 ml) were added oxalyl chloride (0.4 ml)and dimethylformamide (catalytic amount) under ice-cooling, and themixture was stirred at 40° C. for 1 hour. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of 1-(4-aminobenzyl)piperidine (0.17 g) anddiisopropylethylamine (0.5 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with dichloromethane, and theorganic layer was washed with water and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, andprecipitated crude crystal was recrystallized fromdichloromethane-hexane to give2-(4-methylphenyl)-N-(4-piperidinomethylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 91) (0.36 g) as colorless crystals.

mp 192-193° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.38-1.50 (2H, m), 1.50-1.63 (4H,m), 2.13-2.22 (2H, m), 2.35-2.39 (4H, m), 2.40 (3H, s), 2.72 (2H, t,J=6.4 Hz), 2.85-2.91 (2H, m), 3.46 (2H, s), 7.21-7.33 (5H, m), 7.41-7.57(6H, m), 7.63 (1H, s). IR(KBr) ν: 3352, 2932, 1647 cm⁻¹. Anal. for C₃₁H₃₄ N₂ O.0.2H₂ O: Calcd. C, 81.97; H, 7.63; N, 6.17. Found C, 81.88; H,7.52; N, 6.22.

WORKING EXAMPLE 92 (Production of Compound 92)

A solution of2-(4-methylphenyl)-N-(4-piperidino-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.26 g) and methyl iodide (0.15 ml) in dimethylformamide (15 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-ethyl acetate to give1-(N-(2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carbonyl)-4-aminobenzyl)-1-methylpiperidiniumiodide (Compound 92) (0.3 g) as colorless crystals.

mp 220-221° C.(dec.).; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.65 (2H, m),1.80-1.94 (4H, m), 1.99-2.09 (2H, m), 2.35 (3H, s), 2.64 (2H, t,J=6.lHz), 2.83-2.88 (2H, m), 2.91 (3H, s), 3.23-3.29 (4H, m), 4.53 (2H,s), 7.26-7.38 (4H, m), 7.48-7.68 (6H, m), 7.87 (2H, d, J=8.6 Hz), 10.23(1H, s). IR(KBr) ν: 3285, 2946, 1651 cm⁻¹. Anal. for C₃₂ H₃₇ IN₂ O.0.5H₂O: Calcd. C, 63.89; H, 6.37; N, 4.66. Found C, 63.94; H, 6.33; N, 4.60.

WORKING EXAMPLE 93 (Production of Compound 93)

To a solution of7-(4-methylphenyl)-N-(4-hydroxymethylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(0.2 g), triethylamine (0.21 ml) and dimethylaminopyridine (catalyticamount) in tetrahydrofuran (10 ml) was dropwise addedmethane-sulfonylchloride (0.06 ml) under ice-cooling, and the mixturewas stirred for 10 minutes. To the mixture was added piperidine (0.15ml), and the mixture was stirred at room temperature for 2 hours. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate) to give crude crystals, whichwere recrystallized from ethyl acetate-hexane to give7-(4-methylphenyl)-N-(4-piperidinomethylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 93) (0.19 g) as colorless crystals.

mp 203-204° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.35-1.50 (2H, m), 1.55-1.63 (4H,m), 2.38-2.40 (4H, m), 2.40 (3H, s), 3.08 (2H, t, J=5.7 Hz), 3.29 (2H,t, J=5.7 Hz), 3.47 (2H, s), 7.24-7.46 (7H, m), 7.50-7.58 (5H, m), 7.68(1H, s). IR(KBr) ν: 2934, 1651 cm⁻¹. Anal. for C₃₀ H₃₂ N₂ OS.0.2H₂ O:Calcd. C, 76.30; H, 6.92; N, 5.93. Found C, 76.27; H, 6.77; N, 6.06.

WORKING EXAMPLE 94 (Production of Compound 94)

A solution of7-(4-methylphenyl)-N-(4-piperidino-methyl-phenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(0.08 g) and methyl iodide (0.013 ml) in dimethylformamide (20 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-hexane to give1-(N-(7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carbonyl)-4-aminobenzyl)-1-methylpiperidiniumiodide (Compound 94) (0.077 g) as colorless crystals.

mp 196-197° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.65 (2H, m), 1.80-1.95(4H, m), 2.35 (3H, s), 2.91 (3H, s), 2.99-3.05 (2H, m), 3.15-3.29 (6H,m), 4.53 (2H, s), 7.29 (2H, d, J=8.2 Hz), 7.46-7.63 (7H, m), 7.82-7.89(3H, m), 10.34 (1H, s). IR(KBr) ν: 3284, 2947, 1652 cm¹. Anal. for C₃₁H₃₅ IN₂ OS.0.5H₂ O: Calcd. C, 60.09; H, 5.86; N, 4.52. Found C, 60.03;H, 5.57; N, 4.44.

WORKING EXAMPLE 95 (Production of Compound 95)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (1.0 g)in dichloromethane (30 ml) were added oxalyl chloride (0.93 ml) anddimethylformamide (catalytic amount), under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of 1-(4-amino-benzyl)piperidine (0.75 g)and triethylamine (1.5 ml) in tetra-hydrofuran (50 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals which wererecrystallized from ethyl acetate-hexane to give7-(4-methyl-phenyl)-N-(4-((piperidinomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 95) (1.45 g) as colorless crystals.

mp 188-189° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.40-1.47 (2H, m), 1.52-1.60 (4H,m), 2.34-2.39 (4H, m), 2.39 (3H, s), 3.07 (2H, t, J=4.4 Hz), 3.46 (2H,s), 4.36 (2H, t, J=4.4 Hz), 7.06 (1H, d, J=8.4 Hz), 7.22-7.33 (5H, m),7.43-7.58 (6H, m). IR(KBr) ν: 2935, 1652 cm⁻¹. Anal. for C₃₀ H₃₂ N₂ O₂ :Calcd. C, 79.61; H, 7.13; N, 6.19. Found C, 79.53; H, 6.91; N, 6.22.

WORKING EXAMPLE 96 (Production of Compound 96)

A solution of7-(4-methylphenyl)-N-(4-(piperidinomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(1.4 g) and methyl iodide (0.58 ml) in dimethylformamide (50 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-ethyl acetate to give1-(N-(7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl) -1-methylpiperidinium iodide (Compound 96) (1.6 g) ascolorless crystals.

mp 227-228° C.(dec.).; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.70 (2H, m),1.70-1.95 (4H, m), 2.34 (3H, s), 2.91 (3H, s), 3.00 (2H, br), 3.24-3.34(4H, m), 4.31 (2H, br), 4.53 (2H, s), 7.06 (1H, d, J=8.4 Hz), 7.27 (2H,d, J=8.0 Hz), 7.36 (1H, s), 7.48-7.59 (5H, m), 7.75 (1H, s), 7.86 (2H,d, J=8.8 Hz), 10.19 (1H, s). IR(KBr) ν: 3289, 2938, 1649 cm⁻¹. Anal. forC₃₁ H₃₅ IN₂ O₂ : Calcd. C, 62.63; H, 5.93; N, 4.71. Found C, 62.43; H,5.91; N, 4.52.

WORKING EXAMPLE 97 (Production of Compound 97)

A solution of N- (4-chloromethylphenyl) -7-(4-methyl-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide (0.15 g) and1-methylpiperidine (0.14 ml) in dimethylformamide (15 ml) was stirred atroom temperature over night. The solvent was evaporated, and to theresidue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-diethylether to give1-(N-(7- (4-methylphenyl) -2,3-dihydro-1-benzoxepin-4-carbonyl) -4-aminobenzyl) - 1 -methylpiperidinium chloride (Compound 97) (0.15 g)as colorless crystals.

mp 231-232° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.65 (2H, m), 1.80-1.95(4H, m), 2.34 (3H, s), 2.91 (3H, s), 2.97-3.05 (2H, m), 3.23-3.30 (4H,m), 4.25-4.35 (2H, m), 4.53 (2H, s), 7.06 (1H, d, J=8.4 Hz), 7.27 (2H,d, J=8.4 Hz), 7.38 (1H, s), 7.48-7.59 (5H, m), 7.75 (1H, s), 7.86 (2H,d, J=8.8 Hz), 10.23 (1H, s). IR(KBr) ν: 3227, 2969, 1665 cm⁻¹. Anal. forC₃₁ H₃₅ ClN₂ O₂.0.5H₂ O: Calcd. C, 72.71; H, 7.09; N, 5.47. Found C,72.85; H, 6.93; N, 5.48.

WORKING EXAMPLE 98 (Production of Compound 98)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.18 g) and 1-ethylpiperidine (0.31 ml) in dimethylformamide (5 ml)were stirred at 50° C. over night. The solvent was evaporated, and tothe residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-ethyl acetate to give1-(N-(7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-amino-benzyl)-1-ethylpiperidiniumchloride (Compound 98) (0.17 g) as colorless crystals.

mp 209-210° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.34 (3H, t, J=6.9 Hz),1.38-1.66 (2H, m), 1.80-1.99 (4H, m), 2.34 (3H, s), 3.00 (2H, t, J=4.2Hz), 3.13-3.31 (6H, m), 4.30 (2H, t, J=4.2 Hz), 4.50 (2H, s), 7.06 (1H,d, J=8.4 Hz), 7.27 (2H, d, J=8.0 Hz), 7.39 (1H, s), 7.46-7.59 (5H, m),7.76 (1H, d, J=2.2 Hz), 7.87 (2H, d, J=8.8 Hz), 10.24 (1H, s). IR(KBr)ν: 3202, 2946, 1645 cm⁻¹. Anal. for C₃₂ H₃₇ ClN₂ O₂.0.3H₂ O: Calcd. C,73.56; H, 7.25; N, 5.36. Found C, 73.59; H, 7.26; N, 5.32.

WORKING EXAMPLE 99 (Production of Compound 99)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (5 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of 1-(2-(4-aminophenyl)ethyl)piperidine(0.11 g) and triethylamine (0.23 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals which wererecrystallized from ethyl acetate-hexane to giveN-(4-(2-piperidinoethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 99) (0.19 g) as colorless crystals.

mp 201-202° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.45-1.48 (2H, m), 1.50-1.65 (4H,m), 2.39 (3H, s), 2.47-2.58 (6H, m), 2.76-2.84 (2H, m), 3.07 (2H, t,J=4.4 Hz), 4.36 (2H, t, J=4.4 Hz), 7.05 (1H, d, J=8.0 Hz), 7.17-7.26(4H, m), 7.43-7.51 (7H, m). IR(KBr) ν: 2933, 1652 cm⁻¹. Anal. for C₃₁H₃₄ N₂ O₂ : Calcd. C, 79.79; H, 7.34; N, 6.00. Found C, 79.63; H, 7.42;N, 6.07.

WORKING EXAMPLE 100 (Production of Compound 100)

A solution ofN-(4-(2-piperidinoethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.09 g) and methyl iodide (0.06 ml) in dimethylformamide (10 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-hexane to giveN-((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-2-(4-aminophenyl)ethyl)-N-methylpiperidiniumiodide (Compound 100) (0.12 g) as pale yellow crystals.

mp 168-169° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.65-1.95 (6H, m), 2.35 (3H, s),2.95-3.05 (4H, m), 3.25 (3H, s), 3.61-3.85 (6H, m), 4.29 (2H, t, J=4.2Hz), 7.01 (1H, d, J=8.4 Hz), 7.17-7.26 (4H, m), 7.40-7.50 (4H, m), 7.58(2H, d, J=8.4 Hz), 7.70 (1H, d, J=2.2 Hz), 8.49 (1H, br). IR(KBr) ν:2949, 1656 cm⁻¹. Anal. for C₃₂ H₃₇ IN₂ O₂.0.5H₂ O: Calcd. C, 62.24; H,6.20; N, 4.54. Found C, 61.92; H, 6.17; N, 4.57.

WORKING EXAMPLE 101 (Production of Compound 101)

To a suspension of7-(4-methylphenyl)-2-phenyl-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.1 g) in dichloro-methane (10 ml) were added oxalyl chloride (0.1 ml)and dimethylformamide (catalytic amount) under ice-cooling, and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran. Themixture was dropwise added to a solution of4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.06 g) andtriethylamine (0.12 ml) in tetrahydrofuran (5 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and the residue was purified with silica gel column(ethyl acetate) to give crude crystals, which were recrystallized fromethyl acetate-hexane to give7-(4-methylphenyl)-2-phenyl-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 101) (0.11 g) as colorless crystals.

mp 178-179° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.63-1.74 (4H, m), 2.20 (3H, s),2.40 (3H, s), 2.56-2.66 (1H, m), 3.15-3.43 (4H, m), 3.56 (2H, s),4.01-4.05 (2H, m), 5.09 (1H, dd, J=2.2, 8.4 Hz), 7.10 (1H, d, J=8.4 Hz),7.17-7.57 (16H, m). IR(KBr) ν: 2949, 2844, 1652 cm⁻¹. Anal. for C₃₇ H₃₈N₂ O₃ : Calcd. C, 79.54; H, 6.86; N, 5.01. Found C, 79.28; H, 6.96; N,4.97.

WORKING EXAMPLE 102 (Production of Compound 102)

To a suspension of7-(4-methylphenyl)-2-phenyl-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.1 g) in dichloro-methane (10 ml) were added oxalyl chloride (0.1 ml)and dimethylformamide (catalytic amount) under ice-cooling, and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran. Themixture was dropwise added to a solution of 1-(4-amino-benzyl)piperidine(0.06 g) and triethylamine (0.12 ml) in tetrahydrofuran (5 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate) to give crude crystals, which wererecrystallized from ethyl acetatehexane to give7-(4-methylphenyl)-2-phenyl-N-(4-(piperidinomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 102) (0.12 g) as colorless crystals.

mp 210-211° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.40-1.47 (2H, m), 1.52-1.62 (4H,m), 2.34-2.40 (4H, m), 2.40 (3H, s), 3.23-3.31 (2H, m), 3.45 (2H, s),5.09 (1H, dd, J=2.0, 8.8 Hz), 7.10 (1H, d, J=8.4 Hz), 7.23-7.56 (16H,m). IR(KBr) ν: 2935, 1652 cm⁻¹. Anal. for C₃₆ H₃₆ N₂ O₂ : Calcd. C,81.79; H, 6.86; N, 5.30. Found C, 81.45; H, 6.82; N, 5.28.

WORKING EXAMPLE 103 (Production of Compound 103)

A solution of7-(4-methylphenyl)-2-phenyl-N-(4-(piperidinomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.08 g) and methyl iodide (0.05 ml) in dimethylformamide (15 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-ethyl acetate to give1-(N-(7-(4-methylphenyl)-2-phenyl-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl)-1-methylpiperidiniumiodide (Compound 103) (0.057 g) as colorless crystals.

mp 232-233° C.(dec.).; ¹ H-NMR(δ ppm, DMSO-d₆): 1.45-1.70 (2H, m),1.75-1.95 (4H, m), 2.35 (3H, s), 2.91 (3H, s), 3.25-3.44 (6H, m), 4.53(2H, s), 5.12 (1H, t, J=5.0 Hz), 7.09 (1H, d, J=8.4 Hz), 7.28 (2H, d,J=8.2 Hz), 7.37-7.61 (11H, m), 7.81-7.87 (3H, m), 10.20 (1H, s). IR(KBr)ν: 2949, 1650 cm⁻¹. Anal. for C₃₇ H₃₉ IN₂ O₂.0.2H₂ O: Calcd. C, 65.91;H, 5.89; N, 4.15. Found C, 65.80; H, 5.84; N, 4.17.

WORKING EXAMPLE 104 (Production of Compound 104)

To a suspension of7-(4-methylphenyl)-2-methyl-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.1g) in dichloro-methane (5 ml) were added oxalyl chloride (0.1 ml)and dimethylformamide (catalytic amount) under ice-cooling, and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran. Themixture was dropwise added to a solution of4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.08 g) andtriethylamine (0.14 ml) in tetrahydrofuran (5 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-hexane to give7-(4-methylphenyl)-2-methyl-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 104) (0.12 g) as colorless crystals.

mp 170-171° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.54 (3H, d, J=6.4 Hz), 1.60-1.78(4H, m), 2.22 (3H, s), 2.39 (3H, s), 2.63-2.68 (1H, m), 2.85 (1H, ddd,J=2.6, 9.2, 17.6 Hz), 3.14 (1H, d, J=17.6 Hz), 3.37 (2H, dt, J=2.8, 11.3Hz), 3.58 (2H, s), 4.01-4.07 (2H, m), 4.24-4.30 (1H, m), 7.05 (1H, d,J=8.4 Hz), 7.22-7.34 (4H, m), 7.43-7.56 (7H, m). IR(KBr) ν: 2951, 2845,1651 cm⁻¹. Anal. for C₃₂ H₃₆ N₂ O₃ : Calcd. C, 77.39; H, 7.31; N, 5.64.Found C, 77.21; H, 7.43; N, 5.51.

WORKING EXAMPLE 105 (Production of Compound 105)

To a suspension of7-(4-methylphenyl)-2-methyl-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.1 g) in dichloro-methane (5 ml) were added oxalyl chloride (0.1 ml)and dimethylformamide (catalytic amount) under ice-cooling, and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran. Themixture was dropwise added to a solution of 1-(4-aminobenzyl)piperidine(0.07 g) and triethylamine (0.14 ml) in tetrahydrofuran (5 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate-hexane to give7-(4-methylphenyl)-2-methyl-N-(4-(piperidinomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 105) (0.12 g) as colorless crystals.

mp 175-176° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.40-1.45 (2H, m), 1.54 (3H, d,J=6.2 Hz), 1.53-1.61 (4H, m), 2.30-2.40 (4H, m), 2.39 (3H, s), 2.85 (1H,ddd, J=2.6, 8.8, 18.0 Hz), 3.14 (1H, d, J=18.0 Hz), 3.47 (2H, s),4.23-4.30 (1H, m), 7.05 (1H, d, J=8.8 Hz), 7.16-7.36 (4H, m), 7.43-7.55(7H, m). IR(KBr) ν: 2936, 1651 cm⁻¹. Anal. for C₃₁ H₃₄ N₂ O₂ : Calcd. C,79.79; H, 7.34; N, 6.00. Found C, 79.53; H, 7.35; N, 5.82.

WORKING EXAMPLE 106 (Production of Compound 106)

To a solution ofN-(4-(cyclohexylthiomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.19 g) in dichloromethane (5 ml) was added 70% m-chloroperbenzoic acid(0.097 g) under ice-cooling, and the mixture was stirred for 10 minutes.To the mixture was added sodium thiosulfate solution, and the mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column(methanol/dichloromethane) to give crude crystals, which wererecrystallized from ethanol to giveN-(4-(cyclohexylsulfinylmethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 106) (0.048 g) as colorless crystals.

mp 257-258° C.(dec.).; ¹ H-NMR(δ ppm, CDCl₃): 1.19-1.69 (6H, m),1.81-1.85 (3H, m), 2.01-2.08 (1H, m), 2.40 (3H, s), 2.40-2.49 (1H, m),3.08 (2H, t, J=4.6 Hz), 3.90 (2H, dd, J=13.2, 24.2 Hz), 4.35 (2H, t,J=4.6 Hz), 7.06 (1H, d, J=8.6 Hz), 7.23-7.28 (4H, m), 7.44-7.54 (4H, m),7.60 (2H, d, J=8.4 Hz), 8.07 (1H,s). IR(KBr) ν: 2930, 2853, 1659 cm⁻¹.Anal. for C₃₁ H₃₃ NO₃ S.0.3H₂ O: Calcd. C, 73.72; H, 6.71; N, 2.77.Found C, 73.66; H, 6.70; N, 2.80.

WORKING EXAMPLE 107 (Production of Compound 107)

To a solution ofN-(4-(cyclohexylsulfinylmethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.13 g) in chloroform (45 ml) was added 70% m-chloroperbenzoic acid(mCPBA) (0.097 g) under ice-cooling, and the mixture was stirred at roomtemperature for 30 minutes. To the mixture was added sodium thiosulfatesolution, and the mixture was washed with sodium hydrogen carbonatesolution and water, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethanol-hexane to giveN-(4-(cyclohexylsulfonylmethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 107) (0.11 g) as colorless crystals.

mp 250-251° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.18-1.26 (4H, m), 1.52-1.71 (2H,m), 1.87-1.94 (2H, m), 2.09-2.17 (2H, m), 2.40 (3H, s), 2.65-2.83 (1H,m), 3.08 (2H, t, J=4.6 Hz), 4.18 (2H, s), 4.37 (2H, t, J=4.6 Hz), 7.07(1H, d, J=8.4 Hz), 7.23-7.27 (2H, m), 7.38-7.53 (6H, m), 7.65 (2H, d,J=8.6 Hz), 7.70 (1H, s). IR(KBr) ν: 2932, 2857, 1667 cm⁻¹. Anal. for C₃₁H₃₃ NO₄ S. 0.2H₂ O: Calcd. C, 71.70; H, 6.48; N, 2.70. Found C, 71.70;H, 6.54; N, 2.79.

WORKING EXAMPLE 108 (Production of Compound 108)

To a solution of7-(4-methylphenyl)-N-(4-(phenylthiomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) in dichloromethane (30 ml) was added 70% m-chloroperbenzoic acid(0.046 g) at the temperature ranging from -20 to -10° C., and themixture was stirred for 30 minutes. To the mixture was added sodiumthiosulfate solution, and the mixture was concentrated and extractedwith ethyl acetate. The organic layer was washed with sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give crude crystals, which were recrystallizedfrom ethyl acetate-hexane to give7-(4-methylphenyl)-N-(4-(phenylsulfinylmethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 108) (0.11 g) as colorless crystals.

mp 127-128° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.06 (2H, t, J=4.6Hz), 4.01 (2H, s), 4.34 (2H, t, J=4.6 Hz), 6.95 (2H, d, J=8.8 Hz), 7.05(1H, d, J=8.0 Hz), 7.22-7.26 (3H, m), 7.37-7.53 (10H, m), 7.85 (1H, s).IR(KBr) ν: 3026, 2925, 1652 cm⁻¹. Anal. for C₃₁ H₂₇ NO₃ S: Calcd. C,75.43; H, 5.51; N, 2.84. Found C, 75.14; H, 5.55; N, 2.99.

WORKING EXAMPLE 109 (Production of Compound 109)

To a solution ofN-(4-(benzylthiomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.12 g) in dichloromethane (25 ml) was added 70% m-chloroperbenzoicacid (0.06 g) at the temperature ranging from -20 to -10° C., and themixture was stirred for 10 minutes. To the mixture was added sodiumthiosulfate solution, and the mixture was concentrated and extractedwith ethyl acetate. The organic layer was washed with sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give crude crystals, which were recrystallizedfrom ethyl acetate-hexane to giveN-(4-(benzylsulfinylmethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 109) (0.08 g) as colorless crystals.

mp 208-209° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.07 (2H, t, J=4.5Hz), 3.76-3.94 (4H, m), 4.35 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.2 Hz),7.23-7.27 (6H, m), 7.35-7.53 (7H, m), 7.61 (2H, d, J=8.4 Hz), 7.93 (1H,s). IR(KBr) ν: 3030, 1662 cm⁻¹. Anal. for C₃₂ H₂₉ NO₃ S.0.2H₂ O: Calcd.C, 75.18; H, 5.80; N, 2.74. Found C, 75.35; H, 5.81; N, 2.87.

WORKING EXAMPLE 110 (Production of Compound 110)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.1 g)in dichloromethane (5 ml) were added oxalyl chloride (0.1 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture was addeddropwise to a solution of 4-aminobenzyl 4-methylphenyl sulfone (0.11 g)and triethylamine (0.15 ml) intetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((4-methylphenyl)sulfonyl)-methylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 110) (0.13 g) as colorless crystals.

mp 230-231° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.40 (3H, s), 2.43 (3H, s), 3.07(2H, t, J=4.5 Hz), 4.27 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.04-7.10 (3H,m), 7.23-7.26 (5H, m), 7.43-7.55 (8H, m), 7.63 (1H, s). IR(KBr) ν: 3027,2884, 1663 cm⁻¹. Anal. for C₃₂ H₂₉ NO₄ S.0.2H₂ O: Calcd. C, 72.90; H,5.62; N, 2.66. Found C, 72.74; H, 5.73; N, 2.76.

WORKING EXAMPLE 111 (Production of Compound 111)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) and N-methylcyclopentylamine (0.07 g) in dimethylformamide (10ml) was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethanolhexane togiveN-(4-((N-cyclopentyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 111) (0.1 g) as colorless crystals.

mp 171-172° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.45-1.75 (6H, m), 1.80-1.95 (2H,m), 2.13 (3H, s), 2.39 (3H, s), 2.70-2.80 (1H, m), 3.08 (2H. t, J=4.6Hz), 3.50 (2H, s), 4.35 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.0 Hz),7.22-7.33 (4H, m), 7.43-7.58 (7H, m). IR(KBr) ν: 3340, 2958, 1646 cm⁻¹.Anal. for C₃₁ H₃₄ N₂ O₂.0.2H₂ O: Calcd. C, 79.18; H, 7.37; N, 5.96.Found C, 79.15; H, 7.18; N, 5.96.

WORKING EXAMPLE 112 (Production of Compound 112)

To a solution ofN-(4-hydroxymethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g), triethylamine (0.14 ml) and 4-dimethylaminopyridine (catalyticamount) in dichloromethane was dropwise added methanesulfonyl chloride(0.04 ml) under ice-cooling, and the mixture was stirred for 15 minutes.To the mixture was added N-methylcyclohexylamine (0.15 ml), and themixture was stirred at room temperature over night. The solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((N-cyclohexyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 112) (0.03 g) as colorless crystals.

mp 176-177° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.15-1.35 (6H, m), 1.70-1.95 (4H,m), 2.23 (3H, s), 2.39 (3H, s), 2.39-2.55 (1H, m), 3.08 (2H, t, J=4.6Hz), 3.59 (2H, s), 4.37 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.0 Hz),7.23-7.35 (5H, m), 7.44-7.58 (7H, m). IR(KBr) ν: 2930, 2853, 1651 cm⁻¹.Anal. for C₃₂ H₃₆ N₂ O₂.0.4H₂ O: Calcd. C, 78.78; H, 7.60; N, 5.74.Found C, 78.97; H, 7.49; N, 5.94.

WORKING EXAMPLE 113 (Production of Compound 113)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.09 g), N-methylcycloheptylamine (0.04 g) and potassium carbonate (0.1g) in dimethylformamide (10 ml) was stirred at room temperature overnight. The solvent was evaporated, and to the residue was added water.The mixture was extracted with ethyl acetate. The organic layer waswashed with water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give crude crystals, which were recrystallized from ethylacetate-hexane to giveN-(4-((N-cycloheptyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 113) (0.08 g) as colorless crystals.

mp 167-168° C.; ¹ H-NMR (δ ppm, CDCl₃): 1.35-1.55 (8H, m), 1.55-1.80(2H, m), 1.80-1.95 (2H, m), 2.16 (3H, s), 2.39 (3H, s), 2.55-2.70 (1H,m), 3.08 (2H, t, J=4.6 Hz), 3.49 (2H, s), 4.35 (2H, t, J=4.6 Hz), 7.05(1H, d, J=8.4 Hz), 7.22-7.33 (4H, m), 7.43-7.58 (7H, m). IR(KBr) ν:2927, 1650 cm⁻¹. Anal. for C₃₃ H₃₈ N₂ O₂.0.1H₂ O: Calcd. C, 79.83; H,7.76; N, 5.64. Found C, 79.62; H, 7.43; N, 5.53.

WORKING EXAMPLE 114 (Production of Compound 114)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g) and cyclohexylamine (0.17 ml) in dimethylformamide (10 ml) wasstirred at room temperature for 2.5 hours. The solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethanolhexane to giveN-(4-((cyclohexylamino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 114) (0.09 g) as colorless crystals.

mp 183-184° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.17-1.30 (6H, m), 1.58-1.82 (4H,m), 2.39 (3H, s), 2.45-2.60 (1H, m), 3.08 (2H, t, J=4.6 Hz), 3.81 (2H,s), 4.35 (2H, t, J=4.6 Hz), 7.05 (1H, d, J=8.4 Hz), 7.22-7.34 (5H, m),7.43-7.55 (6H, m), 7.72 (1H, s). IR(KBr) ν: 2928, 2853, 1647 cm⁻¹. Anal.for C₃₁ H₃₄ N₂ O₂.0.5H₂ O: Calcd. C, 78.28; H, 7.42; N, 5.89. Found C,78.56; H, 7.12; N, 6.01.

WORKING EXAMPLE 115 (Production of Compound 115)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g) and aniline (0.1 ml) in dimethylformamide (10 ml) was stirredat room temperature over night. The solvent was evaporated, and to theresidue was added water. The mixture was extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give crude crystals, whichwere recrystallized from ethanol-hexane to giveN-(4-((phenylamino)methyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 115) (0.1 g) as colorless crystals.

mp 157-158° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.07 (2H, t, J=4.8Hz), 4.31 (2H, s), 4.35 (2H, t, J=4.8 Hz), 6.62-6.76 (3H, m), 7.06 (1H,d, J=8.4 Hz), 7.18-7.22 (5H, m), 7.36 (2H, d, J=8.4 Hz), 7.43-7.60 (6H,m). IR(KBr) ν: 1652, 1602 cm⁻¹. Anal. for C₃₁ H₂₈ N₂ O₂ : Calcd. C,80.84; H, 6.13; N, 6.08. Found C, 80.57; H, 6.09; N, 6.06.

WORKING EXAMPLE 116 (Production of Compound 116)

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g), N-methylaniline (0.06 ml) and potassium carbonate (0.15 g) indimethylformamide (10 ml) was stirred at room temperature over night.The solvent was evaporated, and to the residue was added water. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give crude crystals, which were recrystallized from ethylacetate-hexane to giveN-(4-((N-methyl-N-phenyl)aminomethyl)phenyl)-7-(4-methyl-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 116) (0.15 g) as colorless crystals.

mp 164-165° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.00 (3H, s), 3.06(2H, t, J=4.6 Hz), 4.34 (2H, t, J=4.6 Hz), 4.51 (2H, s), 6.68-6.77 (3H,m), 7.05 (1H, d, J=8.4 Hz), 7.19-7.26 (6H, m), 7.43-7.54 (6H, m), 7.60(1H, s). IR(KBr) ν: 3344, 3020, 1644 cm⁻¹. Anal. for C₃₂ H₃₀ N₂ O₂ :Calcd. C, 80.98; H, 6.37; N, 5.90. Found C, 80.64; H, 6.32; N, 5.85.

WORKING EXAMPLE 117 (Production of Compound 117)

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g), benzylamine hydrochloride (0.5 g) and potassium carbonate (0.6g) in dimethylformamide (10 ml) was stirred at room temperature overnight. The solvent was evaporated, and to the residue was added water.The mixture was extracted with ethyl acetate. The organic layer waswashed with water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((benzylamino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 117) (0.08 g) as colorless crystals.

mp 147-148° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.08 (2H, t, J=4.6Hz), 3.80 (2H, s), 3.81 (2H, s), 4.35 (2H, t, J=4.6 Hz), 7.06 (1H, d,J=8.4 Hz), 7.22-7.36 (9H, m), 7.43-7.61 (7H, m). IR(KBr) δ: 3028, 1652cm⁻¹. Anal. for C₃₂ H₃₀ N₂ O₂.0.1H₂ O: Calcd. C, 80.68; H, 6.39; N,5.88. Found C, 80.43; H, 6.23; N, 5.95.

WORKING EXAMPLE 118 (Production of Compound 118)

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g), N-methylbenzylamine (0.05 ml) and potassium carbonate (0.1 g)in dimethylformamide (5 ml) was stirred at room temperature for 2 hours.The solvent was evaporated, and to the residue was added water. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give crude crystals, which were recrystallized from ethylacetate-hexane to giveN-(4-((N-benzyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 118) (0.09 g) as colorless crystals.

mp 157-158° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.18 (3H, s), 2.39 (3H, s), 3.06(2H, t, J=4.6 Hz), 3.50 (2H, s), 3.52 (2H, s), 4.34 (2H, t, J=4.6 Hz),7.05 (1H, d, J=8.0 Hz), 7.22-7.30 (3H, m), 7.33-7.37 (5H, m), 7.43-7.57(7H, m), 7.63 (1H, s). IR(KBr) ν: 3336, 1643 cm⁻¹. Anal. for C₃₃ H₃₂ N₂O₂.0.2H₂ O: Calcd. C, 80.52; H, 6.63; N, 5.69. Found C, 80.61; H, 6.49;N, 5.54.

WORKING EXAMPLE 119 (Production of Compound 119)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) and diisopropylamine (0.1 ml) in dimethylformamide (10 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate-hexane to giveN-(4-((diisopropylamino)methyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 119) (0.11 g) as colorless crystals.

mp 152-153° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.02 (12H, d, J=6.6 Hz), 2.39(3H, s), 2.98-3.10 (4H, m), 3.62 (2H, s), 4.35 (2H, t, J=4.8 Hz), 7.05(1H, d, J=8.6 Hz), 7.24 (2H, d, J=8.0 Hz), 7.35-7.55 (9H, m). IR(KBr) ν:2964, 1646 cm⁻¹. Anal. for C₃₁ H₃₆ N₂ O₂ : Calcd. C, 79.45; H, 7.74; N,5.98. Found C, 79.18: H, 7.66; N, 5.93.

WORKING EXAMPLE 120 (Production of Compound 120)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) and N-ethylcyclohexylamine (0.11 ml) in dimethylformamide (10ml) was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-((N-cyclohexyl-N-ethyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 120) (0.1 g) as colorless crystals.

mp 166-167° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.98 (3H, t, J=7.2 Hz), 1.02-1.26(6H, m), 1.60-1.80 (4H, m), 2.39 (3H, s), 2.48-2.59 (3H, m), 3.08 (2H,t, J=4.5 Hz), 3.59 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.05 (1H, d, J=8.4Hz), 7.24 (2H, d, J=7.6 Hz), 7.35 (2H, d, J=8.4 Hz), 7.43-7.56 (7H, m).IR(KBr) ν: 2929, 1648 cm⁻¹. Anal. for C₃₃ H₃₈ N₂ O₂.0.2H₂ O: Calcd. C,79.55; H, 7.77; N, 5.62. Found C, 79.65; H, 7.63; N, 5.66.

WORKING EXAMPLE 121 (Production of Compound 121)

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g), 4-ethyl-amino-1-benzylpiperidine (0.11 g) and potassiumcarbonate (0.05 g) in dimethylformamide (10 ml) was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from diethyl ether-hexane to giveN-(4-((N-(1-benzylpiperidin-4-yl)-N-ethyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 121) (0.13 g) as colorless crystals.

mp 121-122° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.98 (3H, t, J=7.1 Hz), 1.55-1.75(4H, m), 1.87-2.00 (2H, m), 2.39 (3H, s), 2.49-2.60 (3H, m), 2.90-2.96(2H, m), 3.08 (2H, t, J=4.4 Hz), 3.48 (2H, s), 3.60 (2H, s), 4.36 (2H,t, J=4.4 Hz), 7.06 (1H, d, J=8.2 Hz), 7.23-7.35 (9H, m), 7.44-7.55 (7H,m). IR(KBr) ν: 2939, 1652 cm⁻¹. Anal. for C₃₉ H₄₃ N₃ O₂ : Calcd. C,79.97; H, 7.40; N, 7.17. Found C, 79.95; H, 7.50; N, 7.28.

WORKING EXAMPLE 122 (Production of Compound 122)

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g), amino-methylcyclohexane (0.05 g) and potassium carbonate (0.1g) in dimethylformamide (10 ml) was stirred at room temperature overnight. The solvent was evaporated, and to the residue was added water.The mixture was extracted with ethyl acetate. The organic layer waswashed with water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((cyclohexylmethyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 122) (0.06 g) as colorless crystals.

mp 154-155° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.88-0.99 (2H, m), 1.17-1.26 (4H,m), 1.43-1.56 (1H, m), 1.65-1.78 (4H, m), 2.39 (3H, s), 2.45 (2H, d,J=6.6 Hz), 3.07 (2H, t, J=4.5 Hz), 3.76 (2H, s), 4.35 (2H, t, J=4.5 Hz),7.05 (1H, d, J=8.4 Hz), 7.22-7.33 (5H, m), 7.43-7.61 (6H, m). IR(KBr) ν:3357, 2918, 1648 cm-1. Anal. for C₃₂ H₃₆ N₂ O₂.0.2H₂ O: Calcd. C, 79.37;H, 7.58; N, 5.78. Found C, 79.58; H, 7.50; N, 5.80.

WORKING EXAMPLE 123 (Production of Compound 123)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) and 1-methyl-4-methylaminopiperidine (0.1 ml) indimethylformamide (5 ml) was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-((N-methyl-N-(1-methylpiperidin-4-yl))aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 123) (0.03 g) as colorless crystals.

mp 183-184° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.67-2.05 (6H, m), 2.20 (3H, s),2.28 (3H, s), 2.39 (3H, s), 2.38-2.45 (1H, m), 2.91-2.96 (1H, m), 3.08(2H, t, J=4.6 Hz), 3.56 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.06 (1H, d,J=8.0 Hz), 7.22-7.33 (4H, m), 7.44-7.59 (7H, m). IR(KBr) ν: 2939, 2785,1652 cm⁻¹. Anal. for C₃₂ H₃₇ N₃ O₂ : Calcd. C, 77.54; H, 7.52; N, 8.48.Found C, 77.34; H, 7.57; N, 8.56.

WORKING EXAMPLE 124 (Production of Compound 124)

To a solution of7-(4-(4-methylpiperazin-1-yl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.12 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline(0.08 g) and 1-hydroxybenzotriazole(0.05 g) in dimethylformamide (15 ml)was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydro-chloride(0.1 g), under ice-cooling. Under nitrogen atmosphere, the mixture wascooled to room temperature. To the mixture were added4-dimethylaminopyridine (catalytic amount) and triethylamine (0.14 ml),and the mixture was stirred overnight. The solvent was evaporated, andto the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/ methanol/triethylamine)to give crude crystals, which were recrystallized from ethylacetate-hexane to give7-(4-(4-methylpiperazin-1-yl)phenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 124) (0.15 g) as colorless crystals.

mp 220-221° C.; ¹ H -NMR(δ ppm, CDCl₃): 1.64-1.75 (4H, m), 2.22 (3H, s),2.37 (3H, s), 2.58-2.71 (5H, m), 3.08 (2H, t, J=4.6 Hz), 3.25-3.32 (4H,m), 3.37 (2H, dt, J=2.8, 11.4 Hz), 3.58 (2H, s), 4.01-4.07 (2H, m), 4.35(2H, t, J=4.6 Hz), 6.97-7.06 (3H, m), 7.32 (2H, d, J=8.4 Hz), 7.41-7.58(7H, m). IR(KBr) ν: 2946, 2841, 1663 cm⁻¹. Anal. for C₃₅ H₄₂ N₄ O₃.0.5H₂O: Calcd. C, 73.01; H, 7.53; N, 9.73. Found C, 73.25; H, 7.46; N, 9.72.

WORKING EXAMPLE 125 (Production of Compound 125)

A solution ofN-(4-((N-(1-t-butoxycarbonylpiperidin-4-yl)-N-methylamino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.14 g) and trifluoro-acetic acid (5 ml) in dichloromethane (20 ml) wasstirred at room temperature for 1.5 hours. The reaction mixture wasneutralized with sodium hydrogen carbonate solution, and the solvent wasevaporated. To the residue was added water, and the mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethanol-hexane togiveN-(4-((N-methyl-N-(piperidin-4-yl))aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 125) (0.08 g) as colorless crystals.

mp 129-130° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.68-1.95 (4H, m), 2.22 (3H, s),2.39 (3H, s), 2.61-2.79 (3H, m), 3.08 (2H, t, J=4.5 Hz), 3.25-3.33 (2H,m), 3.58 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.4 Hz),7.23-7.33 (4H, m), 7.44-7.60 (7H, m). IR(KBr) ν: 2929, 1683 cm⁻¹.

WORKING EXAMPLE 126 (Production of Compound 126) and WORKING EXAMPLE 127(Production of Compound 127)

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g), N,4-dimethylcyclohexylamine hydrochloride (0.08 g) andpotassium carbonate (0.17 g) in dimethylformamide (10 ml) was stirred atroom temperature over night. The solvent was evaporated, and to theresidue was added water. The mixture was extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate)to give each of crude crystals, whichwas recrystallized from ethyl acetate-hexane to give each isomer ofN-(4-((N-methyl-N-(4-methylcyclohexyl))amino-methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 126 (0.05 g), Compound 127(0.03 g)) as colorless crystals.

(Compound 126):

mp 144-145° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.96 (3H, d, J=6.8 Hz), 1.40-1.80(9H, m), 2.17 (3H, s), 2.20-2.40 (1H, m), 2.39 (3H, s), 3.08 (2H, t,J=4.5 Hz), 3.55 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.05 (1H, d, J=8.4 Hz),7.22-7.34 (4H, m), 7.43-7.58 (7H, m). IR(KBr) ν: 2927, 1650 cm⁻¹. Anal.for C₃₃ H₃₆ N₂ O₂.0.2H₂ O: Calcd. C, 79.55; H, 7.77; N, 5.62. Found C,79.59; H, 7.68; N, 5.84.

(Compound 127):

mp 183-184° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.87 (3H, d, J=6.6 Hz), 0.89-1.02(2H, m), 1.26-1.89 (7H, m), 2.20 (3H, s), 2.20-2.40 (1H, m), 2.39 (3H,s), 3.08 (2H, t, J=4.6 Hz), 3.56 (2H, s), 4.36 (2H, t, J=4.6 Hz), 7.06(1H, d, J=8.4 Hz), 7.22-7.34 (5H, m), 7.44-7.55 (6H, m). IR(KBr) ν:2925, 1654 cm⁻¹. Anal. for C₃₃ H₃₈ N₂ O₂.0.2H₂ O: Calcd. C, 79.55; H,7.77; N, 5.62. Found C, 79.48; H, 7.70; N, 5.83.

WORKING EXAMPLE 128 (Production of Compound 128)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (7 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.12 g) andtriethylamine (0.23 ml) in tetrahydrofuran (10 ml), underice-cooling.Undernitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-hexane to giveN-(4-(N-methyl-(N-tetrahydropyran-4-yl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 128) (0.19 g) as colorless crystals.

mp 162-163° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.59-1.74 (4H, m), 2.20 (3H, s),2.39 (3H, s), 2.58-2.66 (1H, m), 3.07 (2H, t, J=4.5 Hz), 3.37 (2H, dt,J=2.8, 11.0 Hz), 3.56 (2H, s), 4.01-4.06 (2H, m), 4.35 (2H, t, J=4.5Hz), 7.05 (1H, d, J=8.4 Hz), 7.22-7.33 (4H, m), 7.43-7.56 (6H, m), 7.62(1H, s). IR(KBr) ν: 3296, 2950, 1654 cm⁻¹. Anal. for C₃₁ H₃₄ N₂ O₃.0.2H₂O: Calcd. C, 76.58; H, 7.13; N, 5.76. Found C, 76.51; H, 7.07; N, 5.53.

WORKING EXAMPLE 129 (Production of Compound 129)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (5 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-(N-methyl-N-(tetrahydropyran-3-yl)aminomethyl)aniline (0.13 g) andtriethylamine (0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling,and the mixture was stirred under nitrogen atmosphere at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate) to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((N-tetrahydropyran-3-yl-N-methyl)aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 129) (0.18 g) as colorless crystals.

mp 158-159° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.57-1.75 (3H, m), 2.00-2.05 (1H,m), 2.21 (3H, s), 2.39 (3H, s), 2.55-2.68 (1H, m), 3.08 (2H, t, J=4.7Hz), 3.22-3.39 (2H, m), 3.59 (2H, s), 3.84-3.90 (1H, m), 4.04-4.07 (1H,m), 4.37 (2H, t, J=4.7 Hz), 7.06 (1H, d, J=8.0 Hz), 7.23-7.32 (4H, m),7.44-7.55 (7H, m). IR(KBr) ν: 2941, 1652 cm⁻¹. Anal. for C₃₁ H₃₄ N₂ O₃ :Calcd. C, 77.15; H, 7.10; N, 5.80. Found C, 77.12; H, 7.02; N, 5.88.

WORKING EXAMPLE 130 (Production of Compound 130)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (7 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount), under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-indan-2-yl-N-methyl)aminomethyl)aniline (0.14 g) andtriethyl-amine (0.23 ml) in tetrahydrofuran (15 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-ethanol-hexane to giveN-(4-((N-indan-2-yl-N-methyl)amino-methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 130) (0.23 g) as colorless crystals.

mp 204-205° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.19 (3H, s), 2.39 (3H, s),2.94-3.18 (6H, m), 3.41-3.48 (1H, m), 3.57 (2H, s), 4.36 (2H, t, J=4.7Hz), 7.06 (1H, d, J=8.4 Hz), 7.16-7.22 (6H, m), 7.33-7.57 (9H, m).IR(KBr) ν: 1654 cm⁻¹. Anal. for C₃₅ H₃₄ N₂ O₂.0.2H₂ O: Calcd. C, 81.11;H, 6.69; N, 5.41. Found C, 81.06; H, 6.57; N, 5.49.

WORKING EXAMPLE 131 (Production of Compound 131)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (6 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of(E)-4-((N-4-t-butylcyclohexyl-N-methyl)aminomethyl)aniline (0.15 g) andtriethylamine (0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling.Undernitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-hexane to give(E)-N-(4-((N-(4-t-butylcyclohexyl)-N-methyl)aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 131) (0.22 g) as colorless crystals.

mp 225-226° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.84 (9H, s), 0.95-1.05 (2H, m),1.22-1.33 (2H, m), 1.82-1.95 (5H, m), 2.20 (3H, s), 2.30-2.45 (1H, m),2.39 (3H, s), 3.08 (2H, t, J=4.6 Hz), 3.55 (2H, s), 4.36 (2H, t, J=4.6Hz), 7.06 (1H, d, J=8.0 Hz), 7.22-7.34 (4H, m), 7.44-7.55 (7H, m).IR(KBr) ν: 2943, 1652 cm⁻¹. Anal. for C₃₆ H₄₄ N₂ O₂ : Calcd. C, 80.56;H, 8.26; N, 5.22. Found C, 80.30; H, 8.42; N, 5.32.

WORKING EXAMPLE 132 (Production of Compound 132)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (6 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount), under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of(Z)-4-((N-4-t-butylcyclohexyl-N-methyl)aminomethyl)aniline (0.15 g) andtriethylamine (0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromdiethyl ether-hexane to give(Z)-N-(4-((N-(4-t-butylcyclohexyl)-N-methyl)aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 132) (0.2 g) as colorless crystals.

mp 169-170° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.89 (9H, s), 1.05-1.20 (1H, m),1.36-1.50 (6H, m), 2.06 (3H, s), 2.06-2.14 (2H, m), 2.30-2.32 (1H, m),2.39 (3H, s), 3.09 (2H, t, J=4.8 Hz), 3.50 (2H, s), 4.37 (2H, t, J=4.8Hz), 7.06 (1H, d, J=8.4 Hz), 7.23-7.35 (4H, m), 7.44-7.54 (7H, m).IR(KBr) ν: 2941, 1648 cm⁻¹. Anal. for C₃₆ H₄₄ N₂ O₂.0.2H₂ O: Calcd. C,80.02; H, 8.28; N, 5.18. Found C, 80.23; H, 8.30; N, 5.22.

WORKING EXAMPLE 133 (Production of Compound 133)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (6 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-(3,5-dimethylcyclohexyl)-N-methyl)aminomethyl)aniline (0.13 g) andtriethylamine (0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromdiethyl ether-hexane to giveN-(4-((N-methyl-N-(3,5-dimethylcyclohexyl))aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 133) (0.22 g) as colorless crystals.

mp 135-136° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.45-0.68 (1H, m), 0.84 (3H, s),0.87 (3H, s), 0.96-1.03 (2H, m), 1.65-2.05 (5H, m), 2.06 (3H, s), 2.39(3H, s), 2.39-2.42 (1H, m), 3.08 (2H, t, J=4.7 Hz), 3.50 (2H, s), 4.36(2H, t, J=4.7 Hz), 7.06 (1H, d, J=8.4 Hz), 7.16-7.32 (4H, m), 7.44-7.54(7H, m). IR(KBr) ν: 2947, 1652 cm⁻¹. Anal. for C₃₄ H₄₀ N₂ O₂ : Calcd. C,80.28; H, 7.93; N, 5.51. Found C, 80.19; H, 7.95; N, 5.54.

WORKING EXAMPLE 134 (Production of Compound 134)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (6 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-(3,5-dimethylcyclohexyl)-N-methyl)aminomethyl)aniline (0.13 g) andtriethylamine (0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-hexane to giveN-(4-((N-methyl-N-(3,5-dimethylcyclohexyl))aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 134) (0.2 g) as colorless crystals.

mp 173-174° C.; ¹ H-NMR(⁶ ppm, CDCl₃): 0.43-0.60 (1H, m), 0.81-0.99 (2H,m), 0.91 (3H, s), 0.95 (3H, s), 1.30-1.58 (3H, m), 1.79-1.84 (2H, m),2.19 (3H, s), 2.39 (3H, s), 2.48-2.60 (1H, m), 3.08 (2H, t, J=4.6 Hz),3.55 (2H, s), 4.36 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.4 Hz), 7.22-7.33(4H, m), 7.44-7.55 (7H, m). IR(KBr) ν: 2950, 1652 cm⁻¹. Anal. for C₃₄H₄₀ N₂ O₂.0.2H₂ O: Calcd. C, 79.71; H, 7.95; N, 5.47. Found C, 79.83; H,7.83; N, 5.54.

WORKING EXAMPLE 135 (Production of Compound 135)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.12 g)in dichloromethane (5 ml) were added oxalyl chloride (0.11 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-(3,5-dimethylcyclohexyl)-N-methyl)aminomethyl)aniline (0.1 g) andtriethylamine (0.17 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and the residue was purified with silica gel column(ethyl acetate) to give crude crystals, which were recrystallized fromdiethyl ether-hexane to giveN-(4-((N-methyl-N-(3,5-dimethylcyclohexyl))aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 135) (0.08 g) as pale yellow crystals.

mp 99-100° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.82-1.13 (8H, m), 1.40-1.53 (2H,m), 1.64-1.85 (3H, m), 2.08-2.18 (1H, m), 2.18 (3H, s), 2.39 (3H, s),2.69-2.81 (1H, m), 3.08 (2H, t, J=4.8 Hz), 3.54 (2H,s), 4.35 (2H, t,J=4.8 Hz), 7.05 (1H, d, J=8.2 Hz), 7.22-7.33 (4H, m), 7.43-7.58 (7H, m).IR(KBr) ν: 2923, 1652 cm⁻¹. Anal. for C₃₄ H₄₀ N₂ O₂.0.5H₂ O: Calcd. C,78.88; H, 7.98; N, 5.41. Found C, 78.88; H, 7.74; N, 5.50.

WORKING EXAMPLE 136 (Production of Compound 136)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (5 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-methyl-N-n-propyl)aminomethyl)aniline (0.1 g) and triethylamine(0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from diethyl ether-hexane to giveN-(4-((N-methyl-N-n-propyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 136) (0.1 g) as colorless crystals.

mp 142-143° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.90 (3H, t, J=7.3 Hz), 1.48-1.59(2H, m), 2.19 (3H, s), 2.29-2.37 (2H, m), 2.39 (3H, s), 3.08 (2H, t,J=4.4 Hz), 3.47 (2H, s), 4.36 (2H, t, J=4.4 Hz), 7.06 (2H, d, J=8.4 Hz),7.22-7.33 (4H, m), 7.43-7.57 (7H, m). IR(KBr) ν: 2962, 1652, 1517 cm⁻¹.Anal. for C₂₉ H₃₂ N₂ O₂.0.2 H₂ O: Calcd. C, 78.42; H, 7.35; N, 6.31.Found C, 78.41; H, 7.21; N, 6.26.

WORKING EXAMPLE 137 (Production of Compound 137)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) and N-methyl-n-butylamine (0.06 g) in dimethylformamide (10 ml)was stirred at room temperature over night. The solvent was evaporated,and to the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate-hexane to giveN-(4-((N-n-butyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 137) (0.09 g) as colorless crystals.

mp 138-139° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.91 (3H, t, J=7.2 Hz), 1.27-1.55(4H, m), 2.19 (3H, s), 2.33-2.39 (2H, m), 2.39 (3H, s), 3.08 (2H, t,J=4.5 Hz), 3.47 (2H, s), 4.36 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.2 Hz),7.22-7.33 (4H, m), 7.44-7.58 (7H, m). IR(KBr) ν: 2956, 2931, 1652 cm⁻¹.Anal. for C₃₀ H₃₄ N₂ O₂.0.2H₂ O: Calcd. C, 78.64; H, 7.57; N, 6.11.Found C, 78.83; H, 7.44; N, 6.19.

WORKING EXAMPLE 138 (Production of Compound 138)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (5 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-isopropyl-N-methyl)aminomethyl)aniline (0.1 g) and triethylamine(0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-((N-isopropyl-N-methyl)-aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 138) (0.18 g) as colorless crystals.

mp 181-182° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.07 (6H, d, J=6.6 Hz), 2.15 (3H,s), 2.39 (3H, s), 2.83-2.96 (1H, m), 3.08 (2H, t, J=4.7 Hz), 3.49 (2H,s), 4.36 (2H, t, J=4.7 Hz), 7.06 (1H, d, J=8.4 Hz), 7.22-7.34 (4H, m),7.44-7.55 (7H, m). IR(KBr) ν: 2968, 1652 cm⁻¹. Anal. for C₂₉ H₃₂ N₂ O₂ :Calcd. C, 79.06; H, 7.32; N, 6.36. Found C, 78.87; H, 7.30; N, 6.33.

WORKING EXAMPLE 139 (Production of Compound 139)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (5 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-sec-butyl-N-methyl)aminomethyl)aniline (0.12 g) and triethylamine(0.23 ml) in tetrahydrofuran (10 ml), under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethyl acetate) togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-((N-sec-butyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 139) (0.12 g) as colorless crystals.

mp 152-153° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.89-1.01 (6H, m), 1.22-1.39 (1H,m), 1.50-1.67 (1H, m), 2.13 (3H, s), 2.39 (3H, s), 2.54-2.65 (1H, m),3.08 (2H, t, J=4.7 Hz), 3.44 (1H, d, J=13.2 Hz), 3.56 (1H, d, J=13.2Hz), 4.36 (2H, t, J=4.7 Hz), 7.06 (2H, d, J=8.0 Hz), 7.22-7.35 (4H, m),7.44-7.54 (7H, m). IR(neat) ν: 2964, 1652 cm⁻¹. Anal. for C₃₀ H₃₄ N₂O₂.0.2H₂ O: Calcd. C, 78.64; H, 7.57; N, 6.11. Found C, 78.88; H, 7.39;N, 6.16.

WORKING EXAMPLE 140 (Production of Compound 140)

A solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) and N-methylisobutylamine (0.06 g) in dimethylformamide (10 ml)was stirred at room temperature over night. The solvent was evaporated,and to the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate-hexane to giveN-(4-((N-isobutyl-N-methyl)aminomethyl)phenyl)-7-(4-methyl-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 140) (0.08 g) as colorless crystals.

mp 137-138° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.90 (6H, d, J=6.6 Hz), 1.78-1.88(1H, m), 2.10 (2H, d, J=7.4 Hz), 2.16 (3H, s), 2.39 (3H, s), 3.08 (2H,t, J=4.6 Hz), 3.44 (2H, s), 4.36 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.0Hz), 7.23-7.34 (4H,m), 7.44-7.57 (7H, m). IR(KBr) ν: 2954, 1652 cm⁻¹.Anal. for C₃₀ H₃₄ N₂ O₂ : Calcd. C, 79.26; H, 7.54; N, 6.16. Found C,78.99; H, 7.38; N, 6.21.

WORKING EXAMPLE 141 (Production of Compound 141)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.1 g)in dichloromethane (5 ml) were added oxalyl chloride (0.1 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-t-butyl-N-methyl)amino-methyl)aniline (0.08 g) and triethylamine(0.12 ml) in tetrahydrofuran (10 ml), under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-((N-t-butyl-N-methyl)amino-methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 141) (0.12 g) as colorless crystals.

mp 122-123° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.16 (9H, s), 2.09 (3H, s), 2.39(3H, s), 3.08 (2H, t, J=4.7 Hz), 3.49 (2H, s), 4.36 (2H, t, J=4.7 Hz),7.06 (1H, d, J=8.4 Hz), 7.23-7.36 (4H, m), 7.44-7.54 (7H, m). IR(KBr) ν:2971, 1651, 1599, 1516 cm⁻¹. Anal. for C₃₀ H₃₄ N₂ O₂ : Calcd. C, 79.26;H, 7.54; N, 6.16. Found C, 79.16; H, 7.55; N, 5.98.

WORKING EXAMPLE 142 (Production of Compound 142)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.1 g)in dichloromethane (5 ml) were added oxalyl chloride (0.1 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-methyl-N-(pentan-3-yl))aminomethyl)aniline (0.08 g) andtriethylamine (0.12 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-hexane to giveN-(4-((N-methyl-N-(pentan-3-yl))aminomethyl)phenyl)-7-(4-methyl-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 142) (0.12 g) as colorless crystals.

mp 133-134° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.94 (6H, t, J=7.5 Hz), 1.26-1.53(4H, m), 2.13 (3H, s), 2.24-2.31 (1H, m), 2.40 (3H, s), 3.09 (2H, t,J=4.4 Hz), 3.55 (2H, s), 4.37 (2H, t, J=4.4 Hz), 7.06 (1H, d, J=8.4 Hz),7.17-7.36 (4H, m), 7.44-7.54 (7H, m). IR(KBr) ν: 2930, 1649, 1597, 1518cm⁻¹. Anal. for C₃₁ H₃₆ N₂ O₂ : Calcd. C, 79.45; H, 7.74; N, 5.98. FoundC, 79.06; H, 7.56; N, 5.98.

WORKING EXAMPLE 143 (Production of Compound 143)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.1 g)in dichloromethane (5 ml) were added oxalyl chloride (0.1 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-((N-methyl-N-(norbornan-2-yl))aminomethyl)aniline (0.09 g) andtriethylamine (0.12 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and the residue was purified with silica gel column(ethyl acetate/hexane). The purified product was dissolved in ethylacetate (10 ml), and to the mixture was added 4N hydrochloric acid-ethylacetate solution (0.2 ml) under ice-cooling. The solvent was evaporatedto give crude crystals, which were recrystallized from ethanol-hexane togiveN-(4-((N-methyl-N-(norbornan-2-yl))aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamidehydrochloride (Compound 143) (0.16 g) as colorless crystals.

mp 268-269° C.(dec.).; ¹ H-NMR(δ ppm, DMSO-d₆): 1.24-1.55 (6H, m),1.99-2.15 (3H, m), 2.28 (1H, br), 2.34 (3H, s), 2.51-2.63 (3H, m), 2.82(1H, br), 3.00 (2H, br), 4.04-4.45 (4H, m), 7.06 (1H, d, J=8.4 Hz), 7.33(2H, d, J=7.8 Hz), 7.38 (1H, s), 7.48-7.59 (5H, m), 7.75-7.85 (3H, m),9.52 (0.5H, br), 9.83 (0.5H, br), 10.18 (1H, s). IR(KBr) ν: 2957, 2492,1661 cm⁻¹. Anal. for C₃₃ H₃₇ ClN₂ O₂.0.2H₂ O: Calcd. C, 74.40; H, 7.08;N, 5.26. Found C, 74.34; H, 7.05; N, 5.19.

WORKING EXAMPLE 144 (Production of Compound 144)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (5 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-(2-(N-cyclohexyl-N-methyl)aminoethyl)aniline (0.15 g) andtriethylamine (0.23 ml) in tetrahydrofuran (15 ml),underice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-hexane to giveN-(4-(2-((N-cyclohexyl-N-methyl)amino)ethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 144) (0.23 g) as colorless crystals.

mp 154-155° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.18-1.30 (6H, m), 1.65-1.80 (4H,m), 2.35 (3H, s), 2.39 (3H, s), 2.39-2.50 (1H, m), 2.66-2.73 (4H, m),3.08 (2H, t, J=4.6 Hz), 4.36 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.4 Hz),7.18-7.26 (4H, m), 7.44-7.55 (7H, m). IR(KBr) ν: 2929, 2854, 1648 cm⁻¹.Anal. for C₃₃ H₃₈ N₂ O₂.0.3H₂ O: Calcd. C, 79.26; H, 7.78; N, 5.60.Found C, 79.26; H, 7.48; N, 5.62.

WORKING EXAMPLE 145 (Production of Compound 145)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.1 g)in dichloromethane (5 ml) were added oxalyl chloride (0.1 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of 4-(1-hydroxy-2-piperidino-ethyl)aniline(0.09 g) and triethylamine (0.12 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-(1-hydroxy-2-piperidinoethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 145) (0.14 g) as colorless crystals.

mp 212-213° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.44-1.52 (2H, m), 1.56-1.69 (4H,m), 2.32-2.47 (4H, m), 2.40 (3H, s), 2.65-2.74 (2H, m), 3.08 (2H, t,J=4.5 Hz), 4.37 (2H, t, J=4.5 Hz), 4.72 (1H, dd, J=3.8, 10.0 Hz), 7.06(1H, d, J=8.4 Hz), 7.25 (2H, d, J=7.4 Hz), 7.35-7.59 (9H, m). IR(KBr) ν:2936, 1651, 1520 cm⁻¹. Anal. for C₃₁ H₃₄ N₂ O₃ : Calcd. C, 77.15; H,7.10; N, 5.80. Found C, 76.95; H, 7.34; N, 5.69.

WORKING EXAMPLE 146 (Production of Compound 146)

To a solution of 7-(3-pyridyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.15 g), 4-(N-methyl-N-(tetra-hydropyran-4-yl)aminomethyl)aniline(0.12 g) and triethylamine (0.16 ml) in dimethylformamide (50 ml) wasadded diethyl cyano-phosphate (0.1 ml) under ice-cooling, and themixture was stirred under nitrogen atmosphere at room temperature overnight. The solvent was evaporated, and the residue was purified withsilica gel column (methanol/ethyl acetate/triethylamine) to give crudecrystals, which were recrystallized from ethanol-hexane to give7-(3-pyridyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)-methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 146) (0.06 g) as colorless crystals.

mp 158-159° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.64-1.71 (4H, m), 2.23 (3H, s),2.65-2.75 (1H, m), 3.11 (2H, t, J=4.8 Hz), 3.37 (2H, dt, J=2.4, 11.0Hz), 3.60 (2H, s), 4.01-4.07 (2H, m), 4.38 (2H, t, J=4.8 Hz), 7.12 (1H,d, J=8.4 Hz), 7.31-7.40 (3H, m), 7.44-7.58 (4H, m), 7.66 (1H, br), 7.84(1H, d, J=7.6 Hz), 8.58 (1H, d, J=4.8 Hz), 8.82 (1H, d, J=2.2 Hz).IR(KBr) ν: 2949, 2845, 1661 cm⁻¹. Anal. for C₂₉ H₃₁ N₃ O₃.0.5H₂ O:Calcd. C, 72.78; H, 6.74; N, 8.78. Found C, 72.72; H, 6.72; N, 8.95.

WORKING EXAMPLE 147 (Production of Compound 147)

To a solution of 7-(4-pyridyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.15 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline(0.12 g) and triethylamine (0.16 ml) in dimethylformamide (50 ml) wasadded diethyl cyano-phosphate (O.1 ml) under ice-cooling, and themixture was stirred under nitrogen atmosphere at room temperature overnight. The solvent was evaporated, and the residue was purified withsilica gel column (methanol/ethyl acetate/triethylamine) to give crudecrystals, which were recrystallized from ethanol-hexane to give7-(4-pyridyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 147) (0.07 g) as pale brown crystals.

mp 186-187° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.67-1.73 (4H, m), 2.23 (3H, s),2.60-2.75 (1H, m), 3.11 (2H, t, J=4.6 Hz), 3.37 (2H, dt, J=3.0, 11.0Hz), 3.60 (2H, s), 4.01-4.07 (2H, m), 4.38 (2H, t, J=4.6 Hz), 7.12 (1H,d, J=8.0 Hz), 7.34 (2H, d, J=8.4 Hz), 7.45-7.51 (3H, m), 7.55-7.59 (3H,m), 7.82 (1H, br), 8.64 (2H, d, J=5.8 Hz). IR(KBr) ν: 2948, 1659 cm⁻¹.Anal. for C₂₉ H₃₁ N₃ O₃.0.5H₂ O: Calcd. C, 72.78; H, 6.74; N, 8.78.Found C, 72.64; H, 6.51; N, 8.85.

WORKING EXAMPLE 148 (Production of Compound 148)

To a solution of 7-(2-furyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.15 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.15g) and triethylamine (0.25 ml) in dimethylformamide (10 ml) was addeddiethyl cyanophosphate (0.13 ml) under ice-cooling, and the mixture wasstirred under nitrogen atmosphere at room temperature over night. Thesolvent was evaporated, and the residue was purified with silica gelcolumn (methanol/ethyl acetate/triethylamine) to give crude crystals,which were recrystallized from ethyl acetatehexane to give7-(2-furyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 148) (0.1 g) as brown crystals.

mp 166-167° C.(dec.).; ¹ H-NMR(δ ppm, CDCl₃): 1.64-1.78 (4H, m), 2.22(3H, s), 2.60-2.75 (1H, m), 3.06 (2H, t, J=4.6 Hz), 3.37 (2H, dt, J=3.0,11.1 Hz), 3.59 (2H, s), 4.02-4.07 (2H, m), 4.33 (2H, t, J=4.6 Hz), 6.46(1H, dd, J=1.8, 3.3 Hz), 6.56 (1H, d, J=3.3 Hz), 7.01 (2H, d, J=8.4 Hz),7.21 (1H, s), 7.32 (2H, d, J=8.6 Hz), 7.44 (1H, d, J=1.8 Hz), 7.50-7.62(4H, m), 7.73 (1H, s). IR(KBr) ν: 2951, 1659 cm⁻¹. Anal. for C₂₈ H₃₀ N₂O₄.0.5H₂ O: Calcd. C, 71.93; H, 6.68; N, 5.99. Found C, 71.97; H, 6.52;N, 6.08.

WORKING EXAMPLE 149 (Production of Compound 149)

To a solution of7-(4-dimethylaminophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.15 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.11g) and triethylamine (0.2 ml) in dimethylformamide (15 ml) was addeddiethyl cyano-phosphate (0.11 ml) under ice-cooling, and the mixture wasstirred under nitrogen atmosphere at room temperature over night. Thesolvent was evaporated, and the residue was purified with silica gelcolumn (methanol/ethyl acetate/triethylamine) to give crude crystals,which were recrystallized from ethyl acetate-hexane to give7-(4-dimethylaminophenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 149) (0.07 g) as pale brown crystals.

mp 208-209° C.(dec.).; ¹ H-NMR(δ ppm, CDCl₃): 1.63-1.78 (4H, m), 2.20(3H, s), 2.59-2.70 (1H, m), 2.98 (6H, s), 3.04 (2H, t, J=4.5 Hz), 3.36(2H, dt, J=2.6, 11.0 Hz), 3.56 (2H, s), 4.00-4.06 (2H, m), 4.31 (2H, t,J=4.5 Hz), 6.78 (2H, d, J=8.8 Hz), 7.01 (1H, d, J=8.0 Hz), 7.24-7.31(3H, m), 7.39-7.46 (4H, m), 7.55 (2H, d, J=8.4 Hz), 7.79 (1H, s).IR(KBr) ν: 2949, 2845, 1659 cm⁻¹. Anal. for C₃₂ H₃₇ N₃ O₃.0.3H₂ O:Calcd. C, 74.33; H, 7.33; N, 8.13. Found C, 74.11; H, 7.22; N, 8.21.

WORKING EXAMPLE 150 (Production of Compound 150)

To a solution of7-(4-(pyrrolidin-1-yl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.15 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline(0.1 g) and 1-hydroxybenzotriazole (0.07 g) in dimethylformamide (10 ml)was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydro-chloride(0.13 g) under ice-cooling, and the mixture was stirred under nitrogenatmosphere at room temperature for 3 hours. To the mixture were added4-dimethylaminopyridine (catalytic amount) and1,8-diazabicyclo[5.4.0]-7-undecene (0.2 ml), and the mixture was stirredover night. The solvent was evaporated, and the residue was purifiedwith silica gel column (methanol/ethyl acetate/triethylamine) to givecrude crystals, which were recrystallized from ethanol-hexane to give7-(4-(pyrrolidin-1-yl)phenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)-methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 150) (0.08 g) as colorless crystals.

mp 210-211° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.69-1.78 (8H, m), 1.99-2.06 (4H,m), 2.21 (3H, s), 2.55-2.70 (1H, m), 3.07 (2H, t, J=4.5 Hz), 3.30-3.38(4H, m), 3.38-3.57 (2H, m), 3.57 (2H, s), 4.01-4.06 (2H, m), 4.35 (2H,t, J=4.5 Hz), 6.63 (2H, d, J=8.8 Hz), 7.02 (1H, d, J=8.4 Hz), 7.31 (2H,d, J=8.4 Hz), 7.40-7.48 (4H, m), 7.54 (2H, d, J=8.4 Hz), 7.61 (1H, s).IR(KBr) ν: 2951, 2841, 1653 cm⁻¹. Anal. for C₃₄ H₃₉ N₃ O₃ : Calcd. C,75.95; H, 7.31; N, 7.81. Found C, 75.70; H, 7.10; N, 7.83.

WORKING EXAMPLE 151 (Production of Compound 151)

To a solution of7-(4-piperidinophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.1 g) and1-hydroxy-benzotriazole (0.07 g) in dimethylformamide (10 ml) was added1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (0.13 g)under ice-cooling. Under nitrogen atmosphere, the mixture was warmed toroom temperature. To the mixture were added 4-dimethylaminopyridine(catalytic amount) and triethylamine (0.18 ml), and the mixture wasstirred over night. The solvent was evaporated, and to the residue wasadded water. The mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give crude crystals, which were recrystallizedfrom ethyl acetate-hexane to give7-(4-piperidinophenyl)-N-(4-((N-methyl-N-tetrahydro-pyran-4-yl)amino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 151) (0.18 g) as colorless crystals.

mp 197-198° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.58-1.70 (2H, m), 1.70-1.73 (4H,m), 2.21 (3H, s), 2.55-2.70 (1H, m), 3.08 (2H, t, J=4.6 Hz), 3.18-3.23(4H, m), 3.37 (2H, dt, J=2.4, 11.0 Hz), 3.57 (2H. s), 4.01-4.07 (2H, m),4.35 (2H, t, J=4.6 Hz), 6.63 (2H, d, J=8.8 Hz), 6.97-7.05 (3H, m), 7.31(2H, d, J=8.4 Hz), 7.43-7.57 (7H, m). IR(KBr) ν: 2938, 2847, 1651 cm⁻¹.Anal. for C₃₅ H₄₁ N₃ O₃.0.5H₂ O: Calcd. C, 74.97; H, 7.55; N, 7.49.Found C, 75.26; H, 7.53; N, 7.63.

WORKING EXAMPLE 152 (Production of Compound 152)

To a solution of7-(4-morpholinophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.1 g) and1-hydroxybenzotriazole (0.06 g) in dimethylformamide (15 ml) was added1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (0.12 g)under ice-cooling. Under nitrogen atmosphere, the mixture was warmed toroom temperature. To the mixture were added 4-dimethylaminopyridine(catalytic amount) and triethylamine (0.18 ml), and the mixture wasstirred over night. The mixture was poured into water and was extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated to givecrude crystals, which were recrystallized from ethyl acetate-hexane togiveN-(4-((N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)phenyl)-7-(4-morpholinophenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 152) (0.17 g) as pale brown crystals.

mp 238-239° C.(dec.).; ¹ H-NMR(δ ppm, CDCl₃): 1.58-1.77 (4H, m), 2.21(3H, s), 2.55-2.75 (1H, m), 3.08 (2H, t, J=4.6 Hz), 3.19-3.24 (4H, m),3.37 (2H, dt, J=3.0, 11.3 Hz), 3.57 (2H, s), 3.87-3.91 (4H, m),4.01-4.11 (2H, m), 4.36 (2H, t, J=4.6 Hz), 6.98 (2H, d, J=9.0 Hz), 7.05(1H, d, J=8.4 Hz), 7.27-7.34 (3H, m), 7.42-7.57 (6H, m). IR(KBr) ν:2961, 2847, 1660 cm⁻¹. Anal. for C₃₄ H₃₉ N₃ O₄.0.5H₂ O: Calcd. C, 72.57;H, 7.16; N, 7.47. Found C, 72.79; H, 7.08; N, 7.35.

WORKING EXAMPLE 153 (Production of Compound 153)

To a solution of7-(4-(1-imidazolyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.13 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.11g) and 1-hydroxybenzotriazole (0.07 g) in dimethylformamide (20 ml) wasadded 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.13g) under ice-cooling. Undernitrogen atmosphere, the mixture was warmedto room temperature. To the mixture were added 4-dimethylaminopyridine(catalytic amount) and triethylamine (0.2 ml), and the mixture wasstirred over night. The solvent was evaporated, and the residue wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethanolhexane to give7-(4-(1-imidazolyl)phenyl)-N-(4-((N-tetra-hydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 153) (0.11 g) as pale yellow crystals.

mp 194-195° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.63-1.80 (4H, m), 2.21 (3H, s),2.59-2.70 (1H, m), 3.10 (2H, t, J=4.6 Hz), 3.37 (2H, dt, J=2.6, 11.8Hz), 3.58 (2H, s), 4.00-4.08 (2H, m), 4.39 (2H, t, J=4.6 Hz), 7.11 (1H,d, J=8.2 Hz), 7.23-7.24 (1H, m), 7.30-7.34 (4H, m), 7.42-7.46 (3H, m),7.51 (1H, s), 7.57 (2H, d, J=8.6 Hz), 7.65 (2H, d, J=8.6 Hz), 7.84 (1H,br), 7.91 (1H, s). IR(KBr) ν: 2949, 2843, 1651 cm⁻¹. Anal. for C₃₃ H₃₄N₄ O₃.0.2H₂ O: Calcd. C, 73.64; H, 6.44; N, 10.41. Found C, 73.63; H,6.23; N, 10.46.

WORKING EXAMPLE 154 (Production of Compound 154)

To a solution of7-(4-dimethylaminophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.1 g), 1-(4-aminobenzyl)phosphorinane-1-oxide (0.08 g) and1-hydroxybenzotriazole (0.05 g) in dimethylformamide (7 ml) was added1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.1 g)under ice-cooling. Under nitrogen atmosphere, the mixture was warmed toroom temperature. To the mixture were added 4-dimethylaminopyridine(catalytic amount) and triethylamine (0.15 ml), and the mixture wasstirred over night. The solvent was evaporated, and the residue wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethanol-hexane to give7-(4-dimethylaminophenyl)-N-(4-((1-oxophosphorinan-1-yl)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 154) (0.12 g) as colorless crystals.

mp 293-294° C.(dec.).; ¹ H-NMR(δ ppm, CDCl₃): 1.35-1.55 (2H, m),1.60-1.75 (6H, m), 1.75-2.05 (2H, m), 3.00 (6H, s), 3.09 (2H, t, J=4.7Hz), 3.13 (2H, d, J=13.6 Hz), 4.35 (2H, t, J=4.7 Hz), 6.80 (2H, d, J=8.8Hz), 7.03 (1H, d, J=8.4 Hz), 7.21-7.27 (3H, m), 7.41-7.51 (4H, m), 7.60(2H, d, J=8.2 Hz), 8.24 (1H, br). IR(KBr) ν: 2940, 1665 cm⁻¹. Anal. forC₃₁ H₃₅ N₂ O₃ P: Calcd. C, 72.35; H, 6.86; N, 5.44. Found C, 72.00; H,6.84; N, 5.45.

WORKING EXAMPLE 155 (Production of Compound 155)

To a solution of7-(4-dimethylaminophenyl)-N-(4-((1-oxophosphorinan-1-yl)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) in ethanol was added 4N hydrochloric acid-ethyl acetate (0.2 ml)under ice-cooling. The solvent was evaporated, and the residue wascrystallized from ethanol and diethylether to give7-(4-dimethylaminophenyl)-N-(4-((1-oxophosphorinan-1-yl)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamidehydrochloride (Compound 155) (0.1 g) as colorless crystals.

mp 162-163° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.40-1.50 (2H,m), 1.50-1.90(8H,m), 2.99 (2H, br), 3.04 (6H, s), 3.16 (2H, d, J=13.6 Hz), 4.30 (2H,br), 7.05 (1H, d, J=8.8 Hz), 7.20-7.25 (4H, m), 7.35 (1H, s), 7.54 (1H,dd, J=2.2, 8.2, 8.8 Hz), 7.63-7.69 (4H, m), 7.74 (1H, d, J=2.2 Hz), 9.97(1H, s). Anal. for C₃₁ H₃₅ N₂ O₃ P.HCl.2H₂ O: Calcd. C, 63.42; H, 6.87;N, 4.77. Found C, 63.45; H, 6.99; N, 4.39.

WORKING EXAMPLE 156 (Production of Compound 156)

In methanol (100 ml) and ethyl acetate (150 ml) was dissolvedN-(4-(1-(tert-butoxycarbonyl)piperidin-2-ylcarbonyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(1.0 g), and to the mixture was added hydrochloric acid (17 ml). Themixture was stirred at room temperature for 2 hours, concentrated andneutralized with sodium hydrogen carbonate solution. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethanol-ethylacetate-hexane to giveN-(4-(piperidin-2-ylcarbonyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 156) (0.6 g) as colorless crystals.

mp 195-196° C.(dec.).; ¹ H-NMR(δ ppm, CDCl₃): 1.26-1.49 (2H, m),1.50-1.70 (2H, m), 1.87-1.94 (2H, m), 2.39 (3H, s), 2.79 (1H, t, J=12.0Hz), 3.08 (2H, t, J=4.4 Hz), 3.26 (1H, d, J=12.0 Hz), 4.26-4.37 (3H, m),7.06 (1H, d, J=8.4 Hz), 7.24 (2H, d, J=8.4 Hz), 7.30 (1H, s), 7.43-7.53(4H, m), 7.71 (2H, d, J=8.8 Hz), 7.90-7.95 (3H, m). IR(KBr) ν: 2934,1674 cm⁻¹. Anal. for C₃₀ H₃₀ N₂ O₃.0.3H₂ O: Calcd. C, 76.34; H, 6.53; N,5.94. Found C, 76.35; H, 6.44; N, 5.88.

WORKING EXAMPLE 157 (Production of Compound 157)

In dichloromethane (35 ml) was dissolvedN-(4-(piperidin-2-ylcarbonyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.3 g), and to the solution were added methyl iodide (0.08 ml) anddiisopropylethylamine (0.17 ml). The mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/methanol/triethylamine) to give crudecrystals, which were recrystallized from ethyl acetate-hexane to giveN-(4-(1-methylpiperidin-2-ylcarbonyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 157) (0.17 g) as colorless crystals.

mp 162-163. ¹ H-NMR(δ ppm, CDCl₃): 1.27-1.45 (2H, m), 1.50-1.90 (4H, m),2.04-2.20 (1H, m), 2.21 (3H, s), 2.39 (3H, s), 3.00-3.05 (1H, m), 3.08(2H, t, J=4.6 Hz), 3.48 (1H, d, J=7.6 Hz), 4.36 (2H, t, J=4.6 Hz), 7.06(1H, d, J=8.0 Hz), 7.25 (2H, d, J=12.4 Hz), 7.43-7.51 (4H, m), 7.69 (2H,d, J=8.8 Hz), 7.81 (1H, s), 8.18 (2H, d, J=8.4 Hz). IR(KBr) ν: 2940,1667 cm⁻¹. Anal. for C₃₁ H₃₂ N₂ O₃ : Calcd. C, 77.47; H, 6.71; N, 5.83.Found C, 77.22; H, 6.71; N, 5.63.

WORKING EXAMPLE 158 (Production of Compound 158)

In methanol (40 ml) was dissolvedN-(4-(1-methylpiperidin-2-ylcarbonyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.1 g) under ice-cooling, and to the mixture was added sodium boronhydride (10 mg). The mixture was stirred for 15 minutes, and to themixture was added water. The mixture was concentrated and extracted withethyl acetate. The organic layer was washed with water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/methanol/triethylamine)to give crude crystals, which were recrystallized from ethanol-ethylacetate-hexane to giveN-(4-(hydroxy(1-methylpiperidin-2-yl)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 158) (0.07 g) as colorless crystals.

mp 195-196. ¹ H-NMR(δ ppm, CDCl₃): 0.95-1.05 (2H, m), 1.25-1.40 (2H, m),2.04-2.30 (4H, m), 2.39 (3H, s), 2.50 (3H, s), 2.95-3.01 (1H, m), 3.08(2H, t, J=4.6 Hz), 4.36 (2H, t, J=4.6 Hz), 5.16 (1H, d, J=3.0 Hz), 7.06(1H, d, J=8.4 Hz), 7.24 (2H, d, J=8.0 Hz), 7.33 (2H, d, J=8.4 Hz),7.43-7.52 (4H, m), 7.56 (2H, d, J=8.4 Hz), 7.61 (1H, s). IR(KBr) ν:3287, 2938, 1647 cm⁻¹. Anal. for C₃₁ H₃₄ N₂ O₃.0.6H₂ O: Calcd. C, 75.46;H, 7.19; N, 5.68. Found C, 75.36; H, 7.33; N, 5.76.

WORKING EXAMPLE 159 (Production of Compound 159)

Under nitrogen atmosphere, oxalyl chloride (0.31 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydrobenzoxepine-4-carboxylic acid(0.65 g) in tetrahydrofuran (10 ml) at room temperature. To the mixturewas added a drop of DMF,and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (15 ml). To the solution were addedtriethylamine (0.65 ml) and 2-(4-aminophenyl) pyridine (J. Chem. Soc.,p.1511, 1960) (0.44 g) at 0° C., and the mixture was stirred at roomtemperature for 2 hours. The reaction mixture was added to vigorouslystirred water to stop the reaction. The mixture was extracted with ethylacetate. Precipitated crystal was collected by filtration to giveN-[4-(2-pyridyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 159) (185.9 mg) as colorless crystals. The mother liquor wasconcentrated and recrystallized from ethyl acetate-tetrahydrofuran togiveN-[4-(2-pyridyl)-phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 159) (0.58 g) as pale yellow crystals.

m.p. 228-229° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.09 (2H, t,J=4.4 Hz), 4.36 (2H, t, J=4.4 Hz), 7.06 (1H, d, J=8.2 Hz), 7.16-7.32(4H, m), 7.42-7.56 (4H, m), 7.68-7.82 (5H, m), 8.02 (2H, dd, J=8.8, 2.0Hz), 8.65-8.73 (1H, dt, J=4.8, 1.4 Hz). IR (KBr) 3338, 1645, 1593, 1516,1493, 1466, 1435, 1323, 1248, 810, 777 cm⁻¹ ; Elemental Analysis for C₂₉H₂₄ N₂ O₂ ; Calcd. C, 80.53; H, 5.59; N, 6.48: Found. C, 80.46; H, 5.62;N, 6.46.

WORKING EXAMPLE 160 (Production of Compound 160)

To a suspension ofN-[4-(2-pyridyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(400 mg) in dichloromethane (10 ml) was added 3-chloroperbenzoic acid(70%, 0.25 g) at 0° C., and the mixture was stirred at room temperaturefor 70 hours. To the mixture was added sodium thiosulfate solution, andthe mixture was stirred for minutes. The mixture was extracted withdichloromethane. The organic layer was washed with saturated sodiumbicarbonate solution and saturated sodium chloride solution, and driedwith magnesium sulfate. The mixture was concentrated, purified withcolumn chromatography (ethanol/ethyl acetate=1:1) to give crystals,which were dissolved in chloroform. The mixture was concentrated, and tothe residue was added ethanol. Precipitated crystal was collected byfiltration to give crystals, which were washed with ethanol to giveN-[4-(1-oxidopyridin-2-yl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 160) (60 mg) as colorless crystals.

m.p. 254° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 2.40 (3H, s), 3.06 (2H,t, J=4.4 Hz), 4.36 (2H, t, J=4.4 Hz), 7.00-7.14 (2H, m), 7.16-7.30 (4H,m), 7.38-7.51 (5H, m), 7.67 (2H, d, J=8.6 Hz), 7.78 (2H, d, J=8.8 Hz),8.19 (1H, d, J=7.0 Hz), 8.38-8.48 (1H, m). IR (KBr) 3334, 3039, 1653,1487, 1240, 814, 760 cm⁻¹ ; Elemental Analysis for C₂₉ H₂₄ N₂ O₃.0.5H₂O; Calcd. C, 76.13; H, 5.51; N, 6.12: Found. C, 75.82; H, 5.27; N, 6.18.

WORKING EXAMPLE 161 (Production of Compound 161)

Under nitrogen atmosphere, oxalyl chloride (0.19 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.40 g) in tetra-hydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (6 ml). To the solution were addedtriethylamine (0.40 ml) and a solution of 2-(4-aminobenzyl)pyridine(0.29 g) in tetrahydrofuran (5 ml) at 0° C., and the mixture was stirredat room temperature for 2 hours. The reaction mixture was added tovigorously stirred water to stop the reaction. The mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate, concentrated andrecrystallized from ethyl acetate to giveN-[4-(2-pyridylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 161) (303 mg) as colorless crystals.

m.p. 189-190° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.06 (2H, t,J=4.6 Hz), 4.14 (2H, s), 4.35 (2H, t, J=4.6 Hz), 7.03-7.16 (3H, m),7.18-7.31 (5H, m), 7.40-7.64 (8H, m), 8.52-8.58 (1H, m). IR (KBr) 3338,1645, 1510, 1493, 1414, 1313, 1252, 1234, 816, 750 cm⁻¹ ; ElementalAnalysis for C₃₀ H₂₆ N₂ O₂ ; Calcd. C, 80.69; H, 5.87; N, 6.27: Found.C, 80.63; H, 5.80; N, 6.37.

WORKING EXAMPLE 162 (Production of Compound 162)

To a solution ofN-[4-(2-pyridylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(200 mg) in tetrahydrofuran (10 ml) was added 3-chloro-perbenzoic acid(70%, 0.18 g) at 0° C., and the mixture was stirred at room temperaturefor 17 hours. To the reaction mixture was added sodium thio-sulfatesolution, and the mixture was stirred for a few minutes. The mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium bicarbonate solution and saturated sodium chloridesolution, dried with magnesium sulfate and concentrated to givecrystals, which were collected by filtration and was recrystallized fromethanol to giveN-[4-(1-oxidopyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 162) (124 mg) as colorless crystals.

m.p. 188-190° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.09 (2H, t,J=4.6 Hz), 4.24 (2H, s), 4.36 (2H, t, J=4.6 Hz), 6.90-7.01 (1H, m), 7.06(1H, d, J=8.4 Hz), 7.11-7.16 (2H, m), 7.22-7.29 (5H, m), 7.43-7.51 (4H,m), 7.54-7.76 (3H, m), 8.24-8.31 (1H, m). IR (KBr) 3319, 1666, 1601,1517, 1491, 1412, 1319, 1246, 813 cm⁻¹ ; Elemental Analysis for C₃₀ H₂₆N₂ O₃.0.3H₂ O; Calcd. C, 77.00; H, 5.73; N, 5.99: Found. C, 76.98; H,5.59; N, 6.10.

WORKING EXAMPLE 163 (Production of Compound 163)

Under nitrogen atmosphere, oxalyl chloride (0.07 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (144.8 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.14 ml) and a solution of 4-aminobenzyldiethylphosphineoxide (120 mg) in tetrahydrofuran (5 ml) at 0° C. and the mixture wasstirred at room temperature for 1 hour. The reaction mixture was addedto vigorously stirred water to stop the reaction. The mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with magnesium sulfate,concentrated and recrystallized from ethanol-tetrahydrofuran to giveN-(4-diethylphosphorylmethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 163) (157 mg) as colorless crystals.

m.p. 240-241° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.13 (6H, dt, J=16.4, 8.0Hz), 1.53-1.72 (4H, m), 2.39 (3H, s), 3.06-3.13 (4H, m), 4.36 (2H, t,J=4.8 Hz), 7.06 (1H, d, J=8.4 Hz), 7.22-7.27 (5H, m), 7.44-7.52 (4H, m),7.58 (2H, d, J=8.4 Hz), 7.98 (1H, s). IR (KBr) 3263, 1653, 1599, 1516,1491, 1410, 1319, 1250, 1173, 1132, 843, 808 cm⁻¹ ; Elemental Analysisfor C₂₉ H₃₂ NO₃ P; Calcd. C, 73.55; H, 6.81; N, 2.96; P, 6.54: Found. C,73.23; H, 6.64; N, 3.01; P, 6.63.

WORKING EXAMPLE 164 (Production of Compound 164)

Under nitrogen atmosphere, oxalyl chloride (0.28 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.60 g) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.60 ml) and 3-(4-aminophenyl)pyridine (J. Chem. Soc.,p.1511, 1960) (0.40 g) at 0° C., and the mixture was stirred at roomtemperature for 2 hours. The reaction mixture was added to vigorouslystirred water to stop the reaction. The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate, concentrated and recrystallizedfrom ethanol to giveN-[4-(3-pyridyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 164) (750 mg) as yellow crystals.

m.p. 214-216° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.07-3.11(2H, m), 4.34-4.39 (2H, m), 7.06 (1H, d, J=8.2 Hz), 7.18-7.63 (10H, m),7.71-7.90 (4H, m), 8.57-8.59 (1H, m), 8.85 (1H, d, J=1.8 Hz). IR (KBr)3313, 1666, 1524, 1493, 1321, 1244, 808 cm⁻¹ ; Elemental Analysis forC₂₉ H₂₄ N₂ O₂.0.2H₂ O; Calcd. C, 79.87; H, 5.64; N, 6.42: Found. C,80.00; H, 5.59; N, 6.00.

WORKING EXAMPLE 165 (Production of Compound 165)

To a solution ofN-[4-(3-pyridyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(400 mg) in tetrahydrofuran (50 ml) was added 3-chloro-perbenzoic acid(70%, 0.34 g) at 0° C., and the mixture was stirred at room temperaturefor 68 hours. To the reaction mixture was added sodium thiosulfatesolution, and the mixture was stirred for a few minutes and extractedwith dichloromethane. The organic layer was washed with saturated sodiumbicarbonate solution and saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethanol/ethyl acetate=1:1), andrecrystallized from ethanol-chloroform to giveN-[4-(1-oxidopyridin-3-yl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 165) (216 mg) as pale yellow crystals.

m.p. 262° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 2.40 (3H, s), 3.10 (2H,t, J=4.4 Hz), 4.38 (2H, t, J=4.4 Hz), 7.07 (1H, d, J=8.4 Hz), 7.23-7.36(4H, m), 7.42-7.58 (7H, m), 7.76 (2H, dd, J=8.8, 2.0 Hz), 7.88 (1H, brs), 8.16-8.20 (1H, m), 8.43-8.47 (1H, m). IR (KBr) 3313, 1655, 1599,1525, 1491, 1244, 1203, 814 cm⁻¹ ; Elemental Analysis for C₂₉ H₂₄ N₂O₃.0.1H₂ O; Calcd. C, 77.35; H, 5.42; N, 6.22: Found. C, 77.13; H, 5.28;N, 6.21.

WORKING EXAMPLE 166 (Production of Compound 166)

Under nitrogen atmosphere, oxalyl chloride (0.19 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.40 g) in tetra-hydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were added at 0°C. triethylamine (0.40 ml) and (4-aminophenyl)-(2-pyridyl)methanol (0.31g), and the mixture was stirred at room temperature for 18 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate, concentrated and recrystallized from ethanol-ethylacetate to giveN-[4-[hydroxy(2-pyridyl)-methyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 166) (549 mg) as pale yellow crystals.

m.p. 215-217° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.06 (2H, t,J=4.4 Hz), 4.34 (2H, t, J=4.4 Hz), 5.26-5.38 (1H, m), 5.70-5.78 (1H, m),7.03-7.27 (6H, m), 7.33-7.79 (10H, m), 8.57 (1H, d, J=4.8 Hz). IR (KBr)3392, 1651, 1537, 1514, 1493, 1319, 1248 cm⁻¹ ; Elemental Analysis forC₃₀ H₂₆ N₂ O₃.0.2H₂ O; Calcd. C, 77.30; H, 5.71; N, 6.01: Found. C,77.21; H, 5.75; N, 5.86.

WORKING EXAMPLE 167 (Production of Compound 167)

To a solution ofN-[4-[hydroxy(2-pyridyl)methyl]-phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(351.3 mg) in tetrahydrofuran (20 ml) was added 3-chloroperbenzoic acid(70%, 0.28 g) at 0° C., and the mixture was stirred at room temperaturefor 16 hours. To the reaction mixture was added sodium thiosulfatesolution, and the mixture was stirred for a few minutes. The mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium bicarbonate solution and saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. The residue wasseparated and purified with column chromatography(ethanol-diethylether=1:1), and recrystallized from ethanol to giveN-[4-[hydroxy(1-oxidopyridin-2-yl)methyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 167) (184 mg) as colorless crystals.

m.p. 208-210° C.; ¹ H-NMR (200 MHz, CDC₃) δ 2.40 (3H, s), 3.09 (2H, t,J=4.4 Hz), 4.37 (2H, t, J=4.5 Hz), 6.07 (1H, d, J=4.5 Hz), 6.41 (1H, d,J=4.6 Hz), 6.93-6.98 (1H, m), 7.06 (1H, d, J=8.4 Hz), 7.20-7.31 (5H, m),7.41-7.55 (6H, m), 7.65 (2H, d, J=8.8 Hz), 7.73 (1H, br s), 8.24-8.28(1H, m). IR (KBr) 3427, 1645, 1599, 1531, 1514, 1491, 1317, 1263 cm⁻¹ ;Elemental Analysis for C₃₀ H₂₆ N₂ O₄.0.1H₂ O; Calcd. C, 75.01; H, 5.50;N, 5.83: Found. C, 74.96; H, 5.36; N, 5.73.

WORKING EXAMPLE 168 (Production of Compound 168)

Under nitrogen atmosphere, oxalyl chloride (0. 2 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (400 mg) in tetra-hydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.4 ml) and 4-amino-benzyldipropylphosphine oxide (0.38g) at 0° C., and the mixture was stirred at room temperature for 5hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethanol/ethyl acetate=1:5), andrecrystallized from ethanol to giveN-(4-dipropyl-phosphorylmethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 168) (456 mg) as colorless crystals.

m.p. 219-220° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 0.84-0.98 (6H, m),1.41-1.63 (8H, m), 2.39 (3H, s), 3.02 (2H, d, J=13.2 Hz), 3.09 (2H, t,J=4.4 Hz), 4.35 (2H, t, J=4.4 Hz), 7.06 (1H, d, J=8.0 Hz), 7.13-7.29(5H, m), 7.44-7.48 (3H, m), 7.53 (1H, d, J=2.2 Hz), 7.61 (2H, d, J=8.0Hz), 8.64 (1H, s). IR (KBr) 3386, 2960, 1653, 1518, 1491, 1319, 1248,1185, 1128, 849 cm⁻¹ ; Elemental Analysis for C₃₁ H₃₆ NO₃ P.0.3H₂ O;Calcd. C, 73.44; H, 7.28; N, 2.76; P, 6.11: Found. C, 73.35; H, 7.40; N,2.62; P, 6.35.

WORKING EXAMPLE 169 (Production of Compound 169)

Under nitrogen atmosphere, oxalyl chloride (0.17 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (350 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.35 ml) and(4-aminophenyl)(3-methoxy-pyridin-2-yl)methanol (316 mg) at 0° C., andthe mixture was stirred at room temperature for 16 hours. The reactionmixture was added to vigorously stirred water to stop the reaction. Themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated. The residue was separated and purified with columnchromatography (ethyl acetate), and recrystallized fromtetrahydrofuran-hexane to giveN-[4-[hydroxy(3-methoxy-pyridin-2-yl)methyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 169) (509 mg) as colorless crystals.

m.p. 232-233° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.05 (2H, t,J=4.8 Hz), 3.77 (3H, s), 4.34 (2H, t, J=4.8 Hz), 5.51 (1H, d, J=6.8 Hz),5.93 (1H, d, J=6.8 Hz), 7.05 (1H, d, J=8.0 Hz), 7.10-7.26 (5H, m),7.34-7.54 (9H, m), 8.18 (1H, d, J=5.2 Hz). IR (KBr) 3354, 1651, 1518,1491, 1412, 1311, 1279, 1240, 1211, 1022, 816 cm⁻¹ ; Elemental Analysisfor C₃₁ H₂₈ N₂ O₄ ; Calcd. C, 75.59; H, 5.73; N, 5.69: Found. C, 75.47:H, 5.61; N, 5.70.

WORKING EXAMPLE 170 (Production of Compound 170)

To a solution ofN-[4-[hydroxy-(3-methoxypyridin-2-yl)methylphenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(350 mg) in tetrahydrofuran (30 ml) was added 3-chloroperbenzoic acid(70%, 0.26 g) at 020 C., and the mixture was stirred at room temperaturefor 64 hours. To the mixture was added sodium thiosulfate, and themixture was stirred for a few minutes and extracted with ethyl acetate.The organic layer was washed with saturated sodium bicarbonate solutionand saturated sodium chloride solution, dried with magnesium sulfate andconcentrated under reduced pressure. The residue was separated andpurified with column chromatography (ethyl acetate→ethanol/ethylacetate=1:4) recrystallized from tetra-hydrofuran-hexane to giveN-[4-[hydroxy(3-methoxy-1-oxidopyridin-2-yl)methyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 170) (168 mg) as colorless crystals.

m.p. 242° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.06 (2H,t, J=4.4 Hz), 3.97 (3H, s), 4.35 (2H, t, J=4.4 Hz), 6.34 (1H, d, J=11.4Hz), 6.97 (1H, d, J=7.8 Hz), 7.05 (1H, d, J=8.2 Hz), 7.14-7.27 (4H, m),7.42-7.53 (8H, m), 7.61 (1H, br s), 7.84 (1H, d, J=6.6 Hz), 7.87 (1H, d,J=11.2 Hz). IR (KBr) 3493, 3294, 2953, 1657, 1601, 1516, 1493, 1323,1207, 1184, 1088, 1043, 817 cm⁻¹ ; Elemental Analysis for C₃₁ H₂₈ N₂O₅.0.2H₂ O; Calcd. C, 72.70; H, 5.59; N, 5.47: Found. C, 72.53; H, 5.64;N, 5.36.

WORKING EXAMPLE 171 (Production of Compound 171)

Under nitrogen atmosphere, oxalyl chloride (0.12 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (250 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.25 ml) and 1-(4-aminobenzyl)-phosphorane-1-oxide (204.8mg) at 0° C., and the mixture was stirred at room temperature 18 hours.The reaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate, and the organiclayer was washed with saturated sodium chloride solution, concentratedand recrystallized from ethanol to giveN-(4-(tetramethylene)phosphoryl-methylphenyl)-7-(4-methylphenyl)-2,3-dihydro-benzoxepine-4-carboxamide(Compound 171) (316 mg) as colorless crystals.

m.p. 273-275° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.43-1.97 (8H, m), 2.40(3H, s), 3.09 (2H, t, J=4.4 Hz), 3.20 (2H, d, J=14.4 Hz), 4.40 (2H, t,J=4.4 Hz), 7.06 (1H, d, J=8.4 Hz), 7.18-7.29 (5H, m), 7.44-7.54 (4H, m),7.60 (2H, d, J=8.0 Hz), 8.12-8.23 (1H, m). IR (KBr) 3223, 2952, 1653,1518, 1491, 1321, 1254, 1186, 810 cm⁻¹ ; Elemental Analysis for C₂₉ H₃₀NO₃ P; Calcd. C, 73.87; H, 6.41; N, 2.97; P, 6.57: Found. C, 73.79; H,6.33; N, 3.00; P, 6.59.

WORKING EXAMPLE 172 (Production of Compound 172)

Under nitrogen atmosphere, oxalyl chloride (0.47 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (1.0 g) in tetrahydrofuran (20 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (20 ml) at 0° C. To the solution were addedtriethylamine (1.0 ml) and 2-(4-aminobenzyl)-3-methoxymethoxypyridine(0.96 g), and the mixture was stirred at room temperature for 4 hours.The reaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethyl acetate/hexane=2:1) to giveN-[4-(3-methoxymethoxy-pyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 172) (1.63 g) as orange crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 6 2.39 (3H, s), 3.03 (2H, t, J=4.4 Hz), 3.37(3H, s), 4.18 (2H, s), 4.32 (2H, t, J=4.4 Hz), 5.17 (2H, s), 7.03 (1H,d, J=8.0 Hz), 7.10 (1H, dd, J=8.4, 4.8 Hz), 7.19-7.51 (12H, m), 7.62(1H, br s), 8.20 (1H, dd, J=4.8, 1.2 Hz). IR (KBr) 3275, 2945, 1659,1516, 1444, 1406, 1491, 1313, 1240, 1153, 982. 814 cm⁻¹ ;

WORKING EXAMPLE 173 (Production of Compound 173)

To a solution ofN-[4-(3-methoxymethoxypyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(300 mg) in tetrahydrofuran (10 ml) was added 3-chloroperbenzoic acid(70%, 0.22 g) at 0° C., and the mixture was stirred at room temperaturefor 18 hours. To the mixture was added sodium thiosulfate, and themixture was stirred for a few minutes. The mixture was extracted withethyl acetate, and the organic layer was washed with saturated sodiumbicarbonate solution and saturated sodium chloride solution, dried withmagnesium sulfate and concentrated under reduced pressure. The residuewas separated and purified with column chromatography (ethanol/ethylacetate=1:15→1:10), and recrystallized from ethanol to giveN-[4-(1-oxido-3-methoxymethoxypyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 173) (203 mg) as colorless crystals.

m.p. 206-208° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 3.06 (2H, t,J=4.6 Hz), 3.44 (3H, s), 4.35 (2H, t, J=4.6 Hz), 4.37 (2H, s), 5.24 (2H,s), 6.96-7.08 (3H, m), 7.19-7.27 (4H, m), 7.38-7.52 (7H, m), 7.62 (1H,br s), 7.99 (1H, dd, J=5.0, 2.2 Hz). IR (KBr) 3305, 1653, 1601, 1516,1491, 1321, 1244, 1053, 818 cm⁻¹ ; Elemental Analysis for C₃₂ H₃₀ N₂O₅.0.2H₂ O; Calcd. C, 73.04; H, 5.82; N, 5.32: Found. C, 72.96; H, 5.72;N, 5.30.

WORKING EXAMPLE 174 (Production of Compound 174)

To a solution ofN-[4-(3-methoxymethoxypyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(1.00 g) in ethanol(20 ml) was added concentrated hydrochloric acid (5.0ml), and the mixture was stirred at room temperature for 4 days. To themixture was added saturated sodium bicarbonate solution at 0° C. to makethe solution pH 6-7, and precipitated crystal was collected byfiltration to giveN-[4-(3-hydroxypyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 174) (693 mg) as pale yellow crystals.

m.p. 285-288° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.34 (3H, s), 2.97 (2H,t, J=4.4 Hz), 4.00 (2H, s), 4.28 (2H, t, J=4.4 Hz), 7.02-7.32 (8H, m),7.49-7.64 (5H, m), 7.73 (1H, d, J=2.2 Hz), 7.95 (1H, dd, J=4.4, 1.4 Hz),9.86 (1H, br s). IR (KBr) 3390, 3028, 1651, 1510, 1408, 1284, 1236, 808cm⁻¹ ; Elemental Analysis for C₃₀ H₂₆ N₂ O₃.0.2H₂ O; Calcd. C, 77.30; H,5.71; N, 6.01: Found. C, 77.20; H, 5.63; N, 5.89.

WORKING EXAMPLE 175 (Production of Compound 175)

To a suspension ofN-[4-(3-hydroxypyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(400 mg) in tetrahydrofuran (30 ml) was added 3-chloroperbenzoic acid(70%, 0.32 g) at 0° C., and the mixture was stirred at room temperaturefor 15 hours. To the mixture was added sodium thiosulfate, and themixture was stirred for a few minutes and extracted with ethyl acetate.The organic layer was washed with saturated sodium bicarbonate solutionand saturated sodium chloride solution, dried with magnesium sulfate,concentrated under reduced pressure and recrystallized from ethanol togiveN-[4-(1-oxido-3-hydroxypyridin-2-ylmethyl)phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 175) (262 mg) as pale yellow crystals.

m.p. 254° C.(dec.); ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.34 (3H, s), 2.92-3.02(2H, m), 4.14 (2H, s), 4.23-4.34 (2H, m), 6.87 (1H, d, J=7.4 Hz), 7.04(1H, d, J=8.6 Hz), 7.11 (1H, dd, J=8.4, 6.6 Hz), 7.18-7.36 (5H, m),7.48-7.61 (5H, m), 7.73 (1H, d, J=2.2 Hz), 7.83 (1H, dd, J=6.4, 1.0 Hz),9.88 (1H, s). IR (KBr) 3180, 3102, 1651, 1601, 1537, 1516, 1493, 1437,1227, 1036, 816 cm⁻¹ ; Elemental Analysis for C₃₀ H₂₆ N₂ O₄.0.2H₂ O;Calcd. C, 74.73; H, 5.52; N, 5.81: Found. C, 74.63; H, 5.35; N, 5.55.

WORKING EXAMPLE 176 (Production of Compound 176)

Under nitrogen atmosphere, oxalyl chloride (0.12 ml) was added to asolution of 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (250 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated. The residue wasdissolved in tetrahydrofuran (15 ml), and to the solution were addedtriethylamine (0.25 ml) and 1-(4-aminobenzyl)phosphorinane-1-oxide(219.0 mg) at 0° C. The mixture was stirred at room temperature for 4hours, added to vigorously stirred water to stop the reaction andextracted with chloroform. The organic layer was washed with saturatedsodium chloride solution, dried with magnesium sulfate, concentrated andrecrystallized from ethanol to giveN-(4-(pentamethylene)phosphorylmethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 176) (253 mg) as colorless crystals.

m.p. 283-286° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.32-2.09 (10H, m), 2.39(3H, s), 3.04-3.18 (4H, m), 4.36 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.4Hz), 7.19-7.29 (5H, m), 7.44-7.48 (3H, m), 7.53 (1H, d, J=2.6 Hz), 7.59(2H, d, J=8.4 Hz), 8.09 (1H, br s). IR (KBr) 3217, 2927, 1655, 1599,1516, 1493, 1321, 1255, 1236, 1167, 1134, 847, 810 cm⁻¹ ; ElementalAnalysis for C₃₀ H₃₂ NO₃ P; Calcd. C, 74.21; H, 6.64; N, 2.88; P, 6.38:Found. C, 73.96; H, 6.53; N, 3.11; P, 6.56.

WORKING EXAMPLE 177 (Production of Compound 177)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of 7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (120 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.12 ml) and4-[N-methyl-N-(tetrahydro-pyran-4-yl)aminomethyl]aniline (99 mg) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was purified with columnchromatography (ethanol/ethyl acetate=1:5) and recrystallized from ethylacetate to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 177) (99 mg) as colorless crystals.

m.p. 181-182° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.28 (3H, t, J=7.6 Hz),1.60-1.82 (4H, m), 2.21 (3H, s), 2.57-2.61 (1H, m), 2.69 (2H, q, J=7.6Hz), 3.09 (2H, t, J=4.6 Hz), 3.37 (2H, dt, J=3.3, 11.1 Hz), 3.58 (2H,s), 3.98-4.09 (2H, m), 4.37 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.4 Hz),7.23-7.36 (5H, m), 7.44-7.58 (7H, m). IR (KBr) 3305, 2960, 1647, 1539,1514, 1491, 1321, 820 cm⁻¹ ; Elemental Analysis for C₃₂ H₃₆ N₂ O₃ ;Calcd. C, 77.39; H, 7.31; N, 5.64: Found. C, 77.38; H, 7.24; N, 5.66.

WORKING EXAMPLE 178 (Production of Compound 178)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of 7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (120 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated. The residue wasdissolved in tetrahydrofuran (20 ml), and to the solution were addedtriethylamine (0.12 ml) and 1-(4-aminobenzyl)phosphorinane-1-oxide (100mg) at 0° C., and the mixture was stirred at room temperature for 5hours. The reaction mixture was added to vigorously stirred water tostop the reaction, and the mixture was extracted with chloroform. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue was purified withcolumn chromatography (ethanol/ethyl acetate=1:5→1:4) and recrystallizedfrom ethanol to giveN-(4-(pentamethylene)phosphorylmethylphenyl)-7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 178) (88 mg) as colorless crystals.

m.p. 287-288° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.28 (3H, t, J=7.4 Hz),1.42-2.16 (10H, m), 2.70 (2H, q, J=7.4 Hz), 3.05-3.19 (4H, m), 4.37 (2H,t, J=4.6 Hz), 7.06 (1H, d, J=8.4 Hz), 7.21-7.31 (5H, m), 7.43-7.62 (6H,m), 7.84 (1H, br s). IR (KBr) 3392, 1655, 1599, 1533, 1516, 1493, 1321,1255, 1167, 847, 824 cm⁻¹ ; Elemental Analysis for C₃₁ H₃₄ NO₃ P; Calcd.C, 74.53; H, 6.86; N, 2.80; P, 6.20: Found. C, 74.23; H, 6.78: N, 2.89;P, 6.07.

WORKING EXAMPLE 179 (Production of Compound 179)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of7-(4-tert-butylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (130mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.12 ml) and4-(N-methyl-N-(tetrahydro-pyran-4-yl)aminomethyl]aniline (98 mg) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was purified with columnchromatography (ethanol/ethyl acetate=1:4) and recrystallized from ethylacetate to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-tert-butylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 179) (126 mg) as colorless crystals.

m.p. 193-194° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.37 (9H, s), 1.60-1.82(4H, m), 2.21 (3H, s), 2.56-2.75 (1H, m), 3.09 (2H, t, J=4.6 Hz),3.29-3.45 (2H, m), 3.58 (2H, s), 3.97-4.09 (2H, m), 4.37 (2H, t, J=4.6Hz), 7.06 (1H, d, J=8.0 Hz), 7.23-7.35 (3H, m), 7.41-7.58 (9H, m). IR(KBr) 3342, 2949, 1647, 1512, 1406, 1313, 1240, 1136, 822 cm⁻¹ ;Elemental Analysis for C₃₄ H₄₀ N₂ O₃ ; Calcd. C, 77.83; H, 7.68; N,5.34: Found. C, 77.69; H, 7.71; N, 5.39.

WORKING EXAMPLE 180 (Production of Compound 180)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of7-(4-tert-butylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (130mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated. The residue was dissolvedin dichloromethane (10 ml), and to the solution were added triethylamine(0.12 ml) and 1-(4-aminobenzyl)phosphorinane-1-oxide (99 mg) at 0° C.,and the mixture was stirred at room temperature for 4 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction, and the mixture was extracted with dichloromethane. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue was purified withcolumn chromatography (ethanol/ethyl acetate=1:4) and recrystallizedfrom ethanol to giveN-(4-(pentamethylene)phosphorylmethylphenyl)-7-(4-tert-butylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 180) (106 mg) as colorless crystals.

m.p. 292-294° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.36 (9H, s), 1.39-2.10 (10H, m), 3.04-3.19 (4H, m), 4.36 (2H, t, J=4.6 Hz), 7.06 (1H, d, J=8.2Hz), 7.19-7.30 (3H, m), 7.41-7.63 (8H, m), 8.24 (1H, br s). IR (KBr)3236, 1664, 1516, 1491, 1311, 1252, 1232, 1163, 1132, 845, 824 cm⁻¹ ;Elemental Analysis for C₃₃ H₃₈ NO₃ P; Calcd. C, 75.12; H, 7.26; N, 2.65;P, 5.87: Found. C, 74.82; H, 7.25; N, 2.73; P, 5.99.

WORKING EXAMPLE 181 (Production of Compound 181)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of 7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (120 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.12 ml) and4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (97 mg) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was purified with columnchromatography (ethanol/ethyl acetate=1:4) and recrystallized from ethylacetatediethylether to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 181) (67 mg) as colorless crystals.

m.p. 191-192° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.61-1.83 (4H, m), 2.21(3H, s), 2.54-2.74 (1H, m), 3.09 (2H, t, J=4.7 Hz), 3.31-3.44 (2H, m),3.58 (2H, s), 3.97-4.09 (2H, m), 4.37 (2H, t, J=4.7 Hz), 7.08 (1H, d,J=8.2 Hz), 7.23-7.58 (12H, m). IR (KBr) 3309, 1643, 1520, 1485, 1319,1246, 816 cm⁻¹ ; Elemental Analysis for C₃₀ H₃₁ N₂ O₃ Cl; Calcd. C,71.63; H, 6.21; N, 5.57; Cl, 7.05: Found. C, 71.32; H, 6.21; N, 5.60 ;Cl, 6.81.

WORKING EXAMPLE 182 (Production of Compound 182)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of 7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (120 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated. The residue wasdissolved in dichloromethane (10 ml). To the solution were addedtriethylamine (0.12 ml) and 1-(4-aminobenzyl)phosphorinane-1-oxide (98mg) at 0° C., and the mixture was stirred at room temperature for 3hours. The reaction mixture was added to vigorously stirred water tostop the reaction, and the mixture was extracted with dichloro-methane.The organic layer was washed with saturated sodium chloride solution,dried with magnesium sulfate and concentrated. The residue was purifiedwith column chromatography (ethanol/ethyl acetate=1:4) andrecrystallized from ethanol to giveN-(4-pentamethylenephosphorylmethylphenyl)-7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 182) (69 mg) as colorless crystals.

m.p. 270-272° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.31-2.10 (10H, m),3.04-3.18 (4H, m), 4.37 (2H, t, J=4.6 Hz), 7.07 (1H, d, J=8.4 Hz),7.19-7.29 (3H, m), 7.38-7.52 (6H, m), 7.58 (2H, d, J=8.4 Hz), 8.07 (1H,br s). IR (KBr) 3230, 2935, 1655, 1599, 1516, 1483, 1317, 1254, 1230,1157, 824 cm⁻¹ ; Elemental Analysis for C₂₉ H₂₉ NO₃ ClP.0.5H₂ O; Calcd.C, 67.64; H, 5.87; N, 2.72; Cl, 6.88; P, 6.01: Found. C, 67.55; H, 5.81;N, 2.79; Cl, 6.67; P, 6.11.

WORKING EXAMPLE 183 (Production of Compound 183)

Under nitrogen atmosphere, oxalyl chloride (0.05 ml) was added to asolution of7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(130 mg) in tetrahydrofuran (10 ml) at room temperature. To the mixturewas added a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.1 ml) and4-[N-methyl-N-(tetrahydropyran-4-yl)amino-methyl]aniline (95 mg) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was purified with columnchromatography (ethanol/ethyl acetate=1:4) and recrystallized from ethylacetate-hexane to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 183) (91mg) as colorless crystals.

m.p. 205-209° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.69-1.82 (4H, m), 2.21(3H, s), 2.55-2.74 (1H, m), 3.10 (2H, t, J=4.7 Hz), 3.31-3.44 (2H, m),3.58 (2H, s), 3.99-4.11 (2H, m), 4.39 (2H, t, J=4.7 Hz), 7.11 (1H, d,J=8.4 Hz), 7.25-7.34 (3H, m), 7.46-7.58 (5H, m), 7.62-7.71 (4H, m). IR(KBr) 3315, 2958, 2846, 1643, 1522, 1327, 1165, 1115, 1072, 835, 822cm⁻¹ ; Elemental Analysis for C₃₁ H₃₁ N₂ O₃ F₃ ; Calcd. C, 69.39; H,5.82; N, 5.22; F, 10.62; Found. C, 69.21; H, 5.79; N, 5.24; F, 10.60.

WORKING EXAMPLE 184 (Production of Compound 184)

Under nitrogen atmosphere, oxalyl chloride (0.05 ml) was added to asolution of7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(130 mg) in tetrahydrofuran (10 ml) at room temperature. To the mixturewas added a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.1 ml) and 1-(4-aminobenzyl)phosphorinane-1-oxide (94.5mg) at 0° C., and the mixture was stirred at room temperature for 3hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue wag purified withcolumn chromatography (ethanol/ethyl acetate=1:4) and recrystallizedfrom ethyl acetate-hexane to giveN-(4-(pentamethylene)phosphorylmethylphenyl)-7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 184) (111 mg) as colorless crystals.

m.p. 269° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 1.19-2.08 (10H, m),3.03-3.16 (4H, m), 4.38 (2H, t, J=4.6 Hz), 7.10 (1H, d, J=8.4 Hz),7.15-7.30 (3H, m), 7.48 (1H, dd, J=8.4, 2.2 Hz), 7.52-7.73 (7H, m),8.39-8.46 (1H, m). IR (KBr) 3221, 2937, 1657, 1533, 1516, 1327, 1257,1167, 1128, 1072, 849, 825 cm⁻¹ ; Elemental Analysis for C₃₀ H₂₉ NO₃ F₃P.0. 2H₂ O; Calcd. C, 66.34; H, 5.46; N, 2.58: Found. C, 66.21; H, 5.62;N, 2.61.

WORKING EXAMPLE 185 (Production of Compound 185)

Under nitrogen atmosphere, oxalyl chloride (0.08 ml) was added to asolution of 7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (154.8 mg) in tetrahydro-furan (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated. The residue wasdissolved in tetrahydrofuran (20 ml), and to the solution were addedtriethylamine (0.2 ml) and4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (121 mg) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was purified with columnchromatography (ethanol/ethyl acetate=1:4) and recrystallized fromethanol to give7-(4-ethoxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 185) (202 mg) as colorless crystals.

m.p. 174-176° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.44 (3H, t, J=7.0 Hz),1.62-1.82 (4H, m), 2.21 (3H, s), 2.55-2.72 (1H, m), 3.08 (2H, t, J=4.8Hz), 3.31-3.44 (2H, m), 3.57 (2H, s), 3.97-4.10 (2H, m), 4.08 (2H, q,J=7.0 Hz), 4.36 (2H, t, J=4.8 Hz), 6.96 (2H, d, J=8.8 Hz), 7.05 (1H, d,J=8.4 Hz), 7.24-7.58 (10H, m). IR (KBr) 3327, 2947, 1645, 1608, 1514,1495, 1240, 1180, 1051, 822 cm⁻¹ ; Elemental Analysis for C₃₂ H₃₆ N₂ O₄; Calcd. C, 74.97; H, 7.08; N, 5.46: Found. C, 74.88; H, 7.27; N, 5.50.

WORKING EXAMPLE 186 (Production of Compound 186)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of7-(4-trifluoromethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(150 mg) in tetrahydrofuran (10 ml) at room temperature. To the mixturewas added a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.12 ml) and4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (104 mg) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethanol/ethyl acetate=1:4), andrecrystallized from ethyl acetate-hexane to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-trifluoromethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 186) (143 mg) as colorless crystals.

m.p. 187-188° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.62-1.82 (4H, m), 2.21(3H, s), 2.55-2.74 (1H, m), 3.10 (2H, t, J=4.7 Hz), 3.29-3.45 (2H, m),3.57 (2H, s), 3.99-4.10 (2H, m), 4.38 (2H, t, J=4.7 Hz), 7.09 (1H, d,J=8.4 Hz), 7.22-7.35 (3H, m), 7.40-7.60 (9H, m). IR (KBr) 3319, 2960,2845, 1643, 1520, 1493, 1319, 1261, 1205, 1163, 835, 810 cm⁻¹ ;Elemental Analysis for C₃₁ H₃₁ N₂ O₄ F₃ ; Calcd. C, 67.38; H, 5.65; N,5.07; F, 10.31: Found. C, 67.39; H, 5.38; N, 5.07; F, 10.18.

WORKING EXAMPLE 187 (Production of Compound 187)

Under nitrogen atmosphere, oxalyl chloride (0.07 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (125 mg) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.14ml) and (4-aminobenzyl)diethylphosphine oxide (120 mg) intetrahydrofuran (5 ml) at 0° C., and the mixture was stirred at roomtemperature for 1.5 hours. The reaction mixture was added to vigorouslystirred water to stop the reaction. The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate, concentrated and recrystallizedfrom ethanol-ethyl acetate to give(E)-N-(4-diethylphosphorylmethylphenyl)-3-(4-methylphenyl)cinnamamide(Compound 187) (125 mg) as pale yellow crystals.

m.p. 197-198° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.13 (6H, dt, J=16.6, 8.0Hz), 1.55-1.71 (4H, m), 2.41 (3H, m), 3.08 (2H, d, J=13.2 Hz), 6.81 (1H,d, J=15.4 Hz), 7.15-7.30 (4H, m), 7.41-7.62 (7H, m), 7.74-7.84 (2H, m),8.93-9.02 (1H, m). IR (KBr) 3242, 1678, 1630, 1603, 1541, 1514, 1409,1344, 1250, 1165, 1130, 985, 847, 791 cm⁻¹ ; Elemental Analysis for C₂₇H₃₀ NO₂ P.0. 3H₂ O; Calcd. C, 74,22; H, 7.06; N, 3.21; P, 7.09: Found.C, 73.96; H, 6.77; N, 3.34; P, 7.01.

WORKING EXAMPLE 188 (Production of Compound 188)

Under nitrogen atmosphere, oxalyl chloride (0.27 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (0.50 g) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.60ml) and 2-(4-aminophenyl)pyridine (0.39 g), and the mixture was stirredat room temperature for 2 hours. The reaction mixture was added tovigorously stirred water to stop the reaction. The mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate, concentrated underreduced pressure and recrystallized from tetrahydrofuran-hexane (1:1) togive (E)-N-[4-(2-pyridyl)-phenyl]-3-(4-methylphenyl)cinnamamide(Compound 188) (561 mg) as pale yellow crystals.

m.p. 220-222° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.42 (3H, s), 6.63 (1H, d,J=15.4 Hz), 7.18-7.31 (3H, m), 7.44-7.63 (6H, m), 7.70-7.83 (5H, m),7.85 (1H, d, J=15.4 Hz), 8.02 (2H, d, J=8.8 Hz), 8.66-8.72 (1H, m). IR(KBr) 3286, 1657, 1622, 1597, 1524, 1462, 1333, 1180, 970, 787 cm⁻¹ ;Elemental Analysis for C₂₇ H₂₂ N₂ O.0.1H₂ O; Calcd. C, 82.67; H, 5.70;N, 7.14: Found. C, 82.45; H, 5.70; N, 7.13.

WORKING EXAMPLE 189 (Production of Compound 189)

To a solution of(E)-N-[4-(2-pyridyl)phenyl]-3-(4-methylphenyl)cinnamamide (350 mg) intetrahydrofuran (10 ml) and dichloromethane (30 ml) was added3-chloro-perbenzoic acid (70%, 0.27 g) at 0° C., and the mixture wasstirred at room temperature for 2 days. To the reaction mixture wasadded sodium thiosulfate solution, and the mixture was stirred for a fewminutes and extracted with dichloromethane. The organic layer was washedwith saturated sodium bicarbonate solution and saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. The residue waspurified with column chromatography (ethanol/ethyl acetate=1:1)concentrated to give crystals, which were recrystallized fromethanol-chloroform to give(E)-N-[4-(1-oxidopyridin-2-yl)phenyl]-3-(4-methylphenyl)cinnamamide(Compound 189) (188 mg) as pale yellow crystals.

m.p. 240-241° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.43 (3H, s), 6.63 (1H, d,J=15.4 Hz), 6.98-7.07 (1H, m), 7.24-7.35 (4H, m), 7.37-7.68 (10H, m),7.78 (1H, d, J=15.4 Hz), 8.33-8.36 (1H, m), 8.58-8.66 (1H, m). IR (KBr)3300, 1680, 1630, 1595, 1529, 1475, 1342, 1225, 970, 837, 766 cm⁻¹ ;Elemental Analysis for C₂₇ H₂₂ N₂ O₂ ; Calcd. C, 79.78; H, 5.46; N,6.89: Found. C, 79.71; H, 5.39 : N, 6.93.

WORKING EXAMPLE 190 (Production of Compound 190)

Under nitrogen atmosphere, oxalyl chloride (0.22 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (0.40 g) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.50ml) and 2-(4-amino-benzyl)pyridine (0.34 g) in tetrahydrofuran (5 ml) at0° C., and the mixture was stirred at room temperature for 2 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate, concentrated and recrystallized from ethylacetate-hexane to give(E)-N-[4-(2-pyridylmethyl)phenyl]-3-(4-methylphenyl)-cinnamamide(Compound 190) (490 mg) as yellow crystals.

m.p. 169-171° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.41 (3H, s), 4.14 (2H, s),6.60 (1H, d, J=15.4 Hz), 7.10-7.15 (2H, m), 7.22-7.28 (4H, m), 7.42-7.63(9H, m), 7.71 (1H, br s), 7.80 (1H, d, J=15.4 Hz), 8.53-8.58 (1H, m). IR(KBr) 3238, 1673, 1630, 1601, 1539, 1512, 1348, 1248, 1174, 976, 791,760 cm⁻¹ ; Elemental Analysis for C₂₈ H₂₄ N₂ O.0.1H₂ O; Calcd. C, 82.77;H, 6.00; N, 6.89: Found. C, 82.73; H, 5.89; N, 6.97.

WORKING EXAMPLE 191 (Production of Compound 191)

To a solution of(E)-N-[4-(2-pyridylmethyl)phenyl]-3-(4-methylphenyl)cinnamamide (302 mg)in tetrahydrofuran (10 ml) was added 3-chloroperbenzoic acid (70%, 0.27g) at 0° C., and the mixture was stirred at room temperature for 18hours. To the reaction mixture was added sodium thiosulfate solution,and the mixture was stirred for a few minutes. The mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumbicarbonate solution and saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was recrystallized fromethanol to give(E)-N-[4-(1-oxidopyridin-2-ylmethyl)phenyl]-3-(4-methylphenyl)cinnamamide(Compound 191) (180 mg) as pale yellow crystals.

m.p. 183-185° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.41 (3H, s), 4.24 (2H, s),6.64 (1H, d, J=15.4 Hz), 6.96-7.01 (1H, m), 7.12-7.17 (2H, m), 7.22-7.30(4H, m), 7.40-7.51 (4H, m), 7.54-7.63 (3H, m), 7.66-7.74 (2H, m), 7.82(1H, d, J=15.4 Hz), 8.29-8.31 (1H, m). IR (KBr) 3255, 1684, 1605, 1541,1514, 1412, 1346, 1244, 839, 785 cm⁻¹ ; Elemental Analysis for C₂₈ H₂₄N₂ O₂ ; Calcd. C, 79.98; H, 5.75; N, 6.66: Found. C, 80.18; H, 5.63; N,6.69.

WORKING EXAMPLE 192 (Production of Compound 192)

Under nitrogen atmosphere, oxalyl chloride (0.27 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (0.50 g) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.60ml) and 3-(4-aminophenyl)pyridine (0.39 g) at 0° C., and the mixture wasstirred at room temperature for 18 hours. The reaction mixture was addedto vigorously stirred water to stop the reaction. The mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with magnesium sulfate andconcentrated. The residue was purified with column chromatography (ethylacetate) to give yellow crystals, which were recrystallized fromtetra-hydrofuran-ethanol to give(E)-N-[4-(3-pyridyl)phenyl]-3-(4-methylphenyl)cinnamamide (Compound 192)(447 mg) as pale yellow crystals.

m.p. 213-214° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.15 (3H, s), 6.65 (1H, d,J=15.4 Hz), 7.26-7.64 (11H, m), 7.75-7.90 (5H, m), 8.59 (1H, dd, J=4.8,1.8 Hz), 8.85 (1H, d, J=1.8 Hz). IR (KBr) 3344, 1660, 1626, 1525, 1481,1335, 1171, 978, 795 cm⁻¹ ; Elemental Analysis for C₂₇ H₂₂ N₂ O; Calcd.C, 83.05; H, 5.68; N, 7.17: Found. C, 83.01; H, 5.82; N, 7.23.

WORKING EXAMPLE 193 (Production of Compound 193)

To a solution of(E)-N-[4-(3-pyridyl)phenyl]-3-(4-methylphenyl)cinnamamide (250 mg) intetrahydrofuran (20 ml) was added 3-chloroperbenzoic acid (70%, 0.24 g)at 0° C., and the mixture was stirred at room temperature for 18 hours.To the reaction mixture was added sodium thiosulfate solution, and themixture was stirred for a few minutes and extracted withdichloromethane. The organic layer was washed with saturated sodiumbicarbonate solution and saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was recrystallized fromethanol-tetrahydrofuran-acetone to give(E)-N-[4-(1-oxidopyridin-3-yl)phenyl]-3-(4-methylphenyl)cinnamamide(Compound 193) (208 mg) as pale yellow crystals. ¹ H-NMR (200 MHz,DMSO-d₆) δ 2.38 (3H, s), 6.95 (1H, d, J=15.7 Hz), 7.31 (2H, d, J=8.1Hz), 7.45-7.57 (2H, m), 7.59-7.94 (12H, m), 8.19 (1H, d, J=6.5 Hz), 8.58(1H, s). IR (KBr) 3423, 1672, 1597, 1531, 1477, 1340, 1201, 901, 835,793 cm⁻¹ ;

WORKING EXAMPLE 194 (Production of Compound 194)

Under nitrogen atmosphere, oxalyl chloride (0.19 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (340 mg) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.4ml) and 4-aminobenzyl-dipropylphosphine oxide (0.38 g) at 0° C., and themixture was stirred at room temperature for 18 hours. The reactionmixture was added to vigorously stirred water to stop the reaction. Themixture was extracted with ethyl acetate. The organic layer wasconcentrated. The residue was recrystallized from ethanol to give(E)-N-(4-dipropylphosphorylmethylphenyl)-3-(4-methylphenyl)cinnamamide(Compound 194) (489 mg) as colorless crystals.

m.p. 225-227° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 0.87-1.00 (6H, m),1.37-1.63 (8H, m), 2.37 (3H, s), 3.07 (2H, d, J=15.0 Hz), 6.93 (1H, d,J=16.0 Hz), 7.16-7.25 (2H, m), 7.30 (2H, d, J=8.0 Hz), 7.50-7.71 (9H,m), 7.89 (1H, br s). IR (KBr) 3232, 1676, 1624, 1605, 1545, 1512, 1338,1151 cm⁻¹ ; Elemental Analysis for C₂₉ H₃₄ NO₂ P; Calcd. C, 75.79; H,7.46; N, 3.05; P, 6.74: Found. C, 75.60; H, 7.68; N, 2.99; P, 6.83.

WORKING EXAMPLE 195 (Production of Compound 195)

Under nitrogen atmosphere, oxalyl chloride (0.11 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (200 mg) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.25ml) and 1-(4-aminobenzyl)phosphorane-1-oxide (193 mg) at 0° C., and themixture was stirred at room temperature for 18 hours. The reactionmixture was added to vigorously stirred water to stop the reaction. Themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution and concentrated. The residuewas recrystallized from ethanol to give(E)-N-(4-(tetramethylene)phosphoryl-methylphenyl)-3-(4-methylphenyl)cinnamamide(Compound 195) (221 mg) as colorless crystals.

m.p. 273-275° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.48-2.04 (8H, m), 2.41(3H, s), 3.19 (2H, d, J=13.6 Hz), 6.78 (1H, d, J=15.8 Hz), 7.14-7.31(4H, m), 7.43-7.59 (7H, m), 7.73-7.76 (1H, m), 7.79 (1H, d, J=15.8 Hz),8.75-8.84 (1H, m). IR (KBr) 3232, 1676, 1628, 1603, 1543, 1512, 1410,1341, 1171, 985, 868, 793 cm⁻¹ ; Elemental Analysis for C₂₇ H₂₈ NO₂P.0.3H₂ O; Calcd. C, 74.56; H, 6.62; N, 3.22; P, 7.12: Found. C, 74.36;H, 6.64; N, 3.20; P, 7.06.

WORKING EXAMPLE 196 (Production of Compound 196)

Under nitrogen atmosphere, oxalyl chloride (0.12 ml) was added to asolution of (E)-3-(4-methylphenyl)cinnamic acid (220 mg) intetrahydrofuran (10 ml) at room temperature. To the mixture was added adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated. The residue was dissolved intetrahydrofuran (20 ml), and to the solution were added triethylamine(0.26 ml) and 1-(4-amino-benzyl)phosphorinane-1-oxide (226 mg) at 0° C.The mixture was stirred at room temperature for 20 hours. The reactionmixture was added to vigorously stirred water to stop the reaction, andthe mixture was extracted with chloroform. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated. The residue was recrystallized from ethanol to give(E)-N-(4-(pentamethylene)phosphorylmethylphenyl)-3-(4-methylphenyl)cinnamamide(Compound 196) (271 mg) as colorless crystals.

m.p. 273-276° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.43-2.08 (10H, m), 2.41(3H, s), 3.13 (2H, d, J=12.8 Hz), 6.81 (1H, d, J=15.8 Hz), 7.14-7.30(4H, m), 7.41-7.61 (7H, m), 7.76 (1H, s), 7.80 (1H, d, J=15.8 Hz),8.72-8.87 (1H, m). IR (KBr) 3242, 1676, 1628, 1603, 1539, 1514, 1344,1174, 1155, 1126, 991, 789 cm⁻¹ ; Elemental Analysis for C₂₈ H₃₀ NO₂P.1.5H₂ O; Calcd. C, 71.47; H, 7.06; N, 2.98; P, 6.58: Found. C, 71.53;H, 6.99; N, 2.87; P, 6.76.

WORKING EXAMPLE 197 (Production of Compound 197)

Under nitrogen atmosphere, oxalyl chloride (0.20 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (300mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.31 ml) and 1-(4-aminobenzyl)piperidine (0.24 g) at 0°C., and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was concentrated. The residue was separated and purified withcolumn chromatography (ethanol/ethyl acetate=1:5) to giveN-[4-(1-piperidinylmethyl)phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 197) (324 mg) as yellow crystals.

m.p. 196-197° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.41-1.71 (6H, m),2.34-2.43 (7H, m), 3.46 (2H, s), 5.12 (2H, d, J=1.4 Hz), 6.95 (1H, d,J=8.0 Hz), 7.14 (1H, br s), 7.23-7.29 (3H, m), 7.31-7.38 (2H, m),7.40-7.46 (6H, m). IR (KBr) 3361, 1643, 1601, 1529, 1485, 1317, 1254,810 cm⁻¹ ; Elemental Analysis for C₂₉ H₃₀ N₂ O₂.0.1H₂ O; Calcd. C,79.10; H, 6.91; N, 6.36: Found. C, 78.85; H, 6.90; N, 6.26.

WORKING EXAMPLE 198 (Production of Compound 198)

To a solution ofN-[4-(1-piperidinylmethyl)phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(200 mg) in DMF (3 ml) was added methyl iodide (0.1 ml) at roomtemperature, and the mixture was stirred for 20 hours. To the mixturewas added ethyl acetate. Precipitated crystal was collected byfiltration and recrystallized from chloroform-ethanol to give1-[4-[N-[6-(4-methylphenyl)-2H-1-benzopyran-3-carbonyl]-amino]benzyl]-1-methylpiperidiniumiodide (Compound 198) (188 mg) as yellow crystals.

m.p. 210° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 1.62-2.01 (6H, m), 2.36(3H, s), 3.06 (3H, br s), 3.34-3.49 (2H, m), 3.60-3.76 (2H, m), 4.97(2H, br s), 5.04 (2H, br s), 6.85 (1H, d, J=8.4 Hz), 7.17 (2H, d, J=8.2Hz), 7.37-7.42 (3H, m), 7.47-7.52 (3H, m), 7.83-7.91 (3H, m), 9.00 (1H,br s). IR (KBr) 3246, 1668, 1527, 1483, 1319, 1248, 808 cm⁻¹ ; ElementalAnalysis for C₃₀ H₃₃ N₂ O₂ I.0.2H₂ O; Calcd. C, 61.69; H, 5.76; N, 4.80:Found. C, 61.53; H, 5.72; N, 4.85.

WORKING EXAMPLE 199 (Production of Compound 199)

Under nitrogen atmosphere, oxalyl chloride (0.26 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (0.52g) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated. The residue was dissolvedin tetrahydrofuran (6 ml), and to the solution were added triethylamine(0.60 ml) and 2-(4-aminobenzyl)pyridine (0.40 g) in tetrahydrofuran (5ml), and the mixture was stirred at room temperature for 3 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated under reduced pressure. The residuewas separated and purified with column chromatography (ethylacetate/hexane=2:1) and concentrated to give crystals, which wererecrystallized from ethanol-ethyl acetate) to giveN-[4-(2-pyridylmethyl)phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 199) (353.2 mg) as yellow crystals, which were similarlyrecrystallized to give the second crystals (208 mg).

m.p. 184-187° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, m), 4.14 (2H, s),5.10 (2H, d, J=1.4 Hz), 6.93 (1H, d, J=8.4 Hz), 7.09-7.15 (3H, m),7.19-7.32 (5H, m), 7.37-7.66 (7H, m), 8.53-8.57 (1H, m). IR (KBr) 3296,1639, 1599, 1531, 1514, 1473, 1325, 1259 cm⁻¹ ; Elemental Analysis forC₂₉ H₂₄ N₂ O₂ ; Calcd. C, 80.53; H, 5.59; N, 6.48: Found. C, 80.24; H,5.75; N, 6.43.

WORKING EXAMPLE 200 (Production of Compound 200)

To a solution ofN-[4-(2-pyridylmethyl)phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(250 mg) in tetrahydrofuran (10 ml) was added 3-chloroperbenzoic acid(70%, 0.21 g) at 0° C., and the mixture was stirred at room temperaturefor 14 hours. To the reaction mixture was added sodium thiosulfatesolution, and the mixture was stirred for a few minutes. The mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium bicarbonate solution and saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. The residue wasseparated and purified with column chromatography (ethanol/ethylacetate=1:3) concentrated to give crystals, which were recrystallizedfrom chloroform-ethanol to giveN-[4-(1-oxidopyridin-2-ylmethyl)phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 200) (191 mg) as pale yellow crystals.

m.p. 261-263° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.40 (3H, s), 4.25 (2H, s),5.11 (2H, s), 6.92-7.01 (2H, m), 7.13-7.67 (14H, m), 8.29 (1H, t, J=4.2Hz). IR (KBr) 3302, 1660, 1605, 1537, 1520, 1250 cm⁻¹ ; ElementalAnalysis for C₂₉ H₂₄ N₂ O₃ ; Calcd. C, 77.66; H, 5.39; N, 6.25: Found.C, 77.90; H, 5.37; N, 6.21.

WORKING EXAMPLE 201 (Production of Compound 201)

Under nitrogen atmosphere, oxalyl chloride (0.19 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (380mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.4 ml) and 4-aminobenzyldipropylphosphine oxide (0.38 g)at 0° C., and the mixture was stirred at room temperature for 3 hours.The reaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was concentrated, and the residue was recrystallized from ethanolto giveN-(4-dipropylphosphoryl-methylphenyl)-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 201) (460 mg) as pale yellow crystals.

m.p. 192-194° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 0.83-0.97 (6H, m),1.39-1.68 (8H, m), 2.39 (3H, s), 3.05 (2H, d, J=13.2 Hz), 5.12 (2H, d,J=0.8 Hz), 6.94 (1H, d, J=8.4 Hz), 7.11-7.28 (4H, m), 7.31-7.50 (5H, m),7.61 (2H, d, J=8.4 Hz), 9.13-9.24 (1H, m). IR (KBr) 3265, 1664, 1628,1603, 1539, 1514, 1487, 1325, 1252, 1167, 851 cm⁻¹ ; Elemental Analysisfor C₃₀ H₃₄ NO₃ P; Calcd. C, 73.90; H, 7.03; N, 2.87; P, 6.35: Found. C,73.95; H, 6.87; N, 2.84; P, 6.41.

WORKING EXAMPLE 202 (Production of Compound 202)

Under nitrogen atmosphere, oxalyl chloride (0.19 ml) was added to asolution of 6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxylicacid (400 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in tetrahydrofuran (10 ml). To the solution were addedtriethylamine (0.4 ml) and (4-aminophenyl)-(2-pyridyl)methanol (310 mg)at 0° C., and the mixture was stirred at room temperature for 20 hours.The reaction mixture was added to vigorously stirred water to stop thereaction. was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated. Precipitated crystal was recrystallized fromtetrahydrofuran-hexane to giveN-[4-[hydroxy(2-pyridyl)methyl]-phenyl]-6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxamide(Compound 202) (470 mg) as yellow crystals.

m.p. 202-205° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.47 (3H, d, J=6.6 Hz),2.39 (3H, s), 5.29-5.38 (1H, m), 5.48 (1H, q, J=6.6 Hz), 5.74 (1H, brs), 6.94 (1H, d, J=8.0 Hz), 7.08-7.26 (5H, m), 7.33-7.67 (10H, m), 8.57(1H, d, J=4.6 Hz). IR (KBr) 3255, 1647, 1597, 1518, 1485, 1412, 1317,1255, 812, 756 cm⁻¹ ; Elemental Analysis for C₃₀ H₂₆ N₂ O₃.0.2H₂ O;Calcd. C, 77.30; H, 5.70; N, 6.01: Found. C, 77.31; H, 5.60; N, 6.21.

WORKING EXAMPLE 203 (Production of Compound 203)

To a solution ofN-[4-[hydroxy(2-pyridyl)methyl]phenyl]-6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxamide(300 mg) in tetrahydrofuran (10 ml) was added 3-chloroperbenzoic acid(70%, 0.24 g) at 0° C., and the mixture was stirred at room temperaturefor 24hours. To the mixture was added sodium thiosulfate, and themixture was stirred for a few minutes. was extracted with ethyl acetate.The organic layer was washed with saturated sodium bicarbonate solutionand saturated sodium chloride solution, dried with magnesium sulfate andconcentrated. The residue was separated and purified with columnchromatography (ethanol/ethyl acetate=1:2) to give crystals, which wererecrystallized from ethanol-ethyl acetate to giveN-[4-[hydroxy(1-oxidopyridin-2-yl)-methyl]phenyl]-6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxamide(Compound 203) (129 mg) as pale yellow crystals.

m.p. 230-232° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.49 (3H, d, J=6.6 Hz),2.40 (3H, s), 5.50 (1H, q, J=6.6 Hz), 6.07 (1H, d, J=4.5 Hz), 6.40 (1H,d, J=4.5 Hz), 6.93-6.97 (2H, m), 7.12 (1H, s), 7.22-7.29 (4H, m), 7.35(1H, d, J=2.2 Hz), 7.42-7.50 (5H, m), 7.64 (2H, d, J=8.4 Hz), 7.73 (1H,br s), 8.24-8.28 (1H, m). IR (KBr) 3311, 1664, 1603, 1535, 1485, 1321,1252, 812 cm⁻¹ ; Elemental Analysis for C₃₀ H₂₆ N₂ O₄.0.3H₂ O; Calcd. C,74.46; H, 5.54; N, 5.79: Found. C, 74.41; H, 5.46; N, 5.78.

WORKING EXAMPLE 204 (Production of Compound 204)

Under nitrogen atmosphere, oxalyl chloride (0.11 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (230mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated. The residue was dissolvedin tetra-hydrofuran (20 ml), and to the solution were addedtriethylamine (0.25 ml) and 1-(4-aminobenzyl)phosphorane-1-oxide (200mg) at 0° C., and the mixture was stirred at room temperature for 20hours. The reaction mixture was added to vigorously stirred water tostop the reaction. Precipitated crystal was collected by filtration togiveN-(4-tetramethylenephosphorylmethylphenyl)-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 204) (181 mg) as colorless crystals.

m.p.>300° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.49-2.04 (8H, m), 2.40 (3H,s), 3.22 (2H, d, J=14.4 Hz), 5.12 (2H, s), 6.94 (1H, d, J=8.4 Hz),7.21-7.29 (4H, m), 7.34-7.50 (5H, m), 7.58 (2H, d, J=8.4 Hz), 8.04-8.07(1H, m). IR (KBr) 3236, 1657, 1601, 1535, 1518, 1487, 1323, 1255, 1180,810 cm⁻¹ ; Elemental Analysis for C₂₈ H₂₈ NO₃ P.0.3H₂ O; Calcd. C,72.65; H, 6.23; N, 3.03; P, 6.69: Found. C, 72.30; H, 5.90; N, 3.00; P,6.98.

WORKING EXAMPLE 205 (Production of Compound 205)

Under nitrogen atmosphere, oxalyl chloride (0.12 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (240mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated. The residue was dissolvedin tetra-hydrofuran (20 ml), and to the solution were addedtriethylamine (0.25 ml) and 1-(4-aminobenzyl)phosphorinane-1-oxide (221mg) at 0° C., and the mixture was stirred at room temperature for 3hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with chloroform. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was recrystallized from ethanol to giveN-(4-(pentamethylene)phosphorylmethylphenyl)-6-(4-methylphenyl)-2H-1-benzo-pyran-3-carboxamide(Compound 205) (257 mg) as yellow crystals.

m.p. 268° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 1.39-2.15 (10H, m), 2.40(3H, s), 3.14 (2H, d, J=12.8 Hz), 5.12 (2H, s), 6.94 (1H, d, J=8.0 Hz),7.18-7.49 (9H, m), 7.59 (2H, d, J=8.4 Hz), 8.54 (1H, br s). IR (KBr)3296, 1660, 1533, 1514, 1323, 1255, 1163, 845, 812 cm⁻¹ ; ElementalAnalysis for C₂₉ H₃₀ NO₃ P; Calcd. C, 73.87; H, 6.41; N, 2.97; P, 6.57:Found. C, 74.20; H, 6.39; N, 2.78; P, 6.45.

WORKING EXAMPLE 206 (Production of Compound 206)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (120mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated. The residue was dissolvedin tetra-hydrofuran (20 ml). To the solution were added triethylamine(0.2 ml) and 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-aniline(109 mg) at 0° C., and the mixture was stirred at room temperature for 4hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography(ethanol/ethyl acetate=1:4), and recrystallized from ethylacetate-hexane to giveN-[4-[N-methyl-N-(tetrahydro-pyran-4-yl)aminomethyl]-phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 206) (117 mg) as pale yellow crystals.

m.p. 143-145° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.62-1.84 (4H, m), 2.21(3H, s), 2.40 (3H, s), 2.56-2.74 (1H, m), 3.28-3.45 (2H, m), 3.57 (2H,s), 3.98-4.11 (2H, m), 5.12 (2H, d, J=1.0 Hz), 6.94 (1H, d, J=8.4 Hz),7.15 (1H, br s), 7.21-7.37 (5H, m), 7.39-7.59 (6H, m). IR (KBr) 3280,2937, 2848, 1649, 1597, 1539, 1489, 1336, 1257, 1138, 1007, 810 cm⁻¹ ;Elemental Analysis for C₃₀ H₃₂ N₂ O₃ ; Calcd. C, 76.90; H, 6.88; N,5.98: Found. C, 76.56; H, 6.87; N, 6.00.

WORKING EXAMPLE 207 (Production of Compound 207)

Under nitrogen atmosphere, oxalyl chloride (0.06 ml) was added to asolution of 6-(4-methylphenyl)-2H-1-benzo-pyran-3-carboxylic acid (120m)in tetrahydrofuran (10 ml) at room temperature. To the mixture was addeda drop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (20 ml). To the solution were added triethylamine (0.13ml) and 4-[N-methyl-N-(tetrahydrothiopyran-4-yl)amino-methyl]aniline(117 mg) at 0° C., and the mixture was stirred at room temperature for 4hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography(ethanol/ethyl acetate=1:4), and recrystallized from ethylacetate-hexane to giveN-[4-[N-methyl-N-(tetrahydrothiopyran-4-yl)aminomethyl]phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide(Compound 207) (125 mg) as pale yellow crystals.

m.p. 169-171° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.63-1.80 (2H, m),2.09-2.24 (2H, m), 2.21 (3H, s), 2.40 (3H, s), 2.42-2.56 (1H, m),2.64-2.74 (4H, m), 3.57 (2H, s), 5.12 (2H, d, J=1.0 Hz), 6.94 (1H, d,J=8.8 Hz), 7.15 (1H, br s), 7.23-7.36 (5H, m), 7.39-7.57 (6H, m). IR(KBr) 3286, 2922, 1649, 1597, 1539, 1336, 1319, 1261, 808 cm⁻¹ ; C₃₀ H₃₂N₂ O₂ S; Calcd. C, 74.35; H, 6.65; N, 5.78; S, 6.62: Found. C, 74.25; H,6.47; N, 5.91; S, 6.52.

WORKING EXAMPLE 208 (Production of Compound 208)

To a solution of (E)-3-[5-(4-methylphenyl)thiophen-2-yl]acrylic acid(400 mg) in tetrahydrofuran (10 ml) was added oxalyl chloride (0.22 ml)at room temperature. To the mixture was added a drop of DMF, and themixture was stirred for 1 hour. Under reduced pressure, the solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (20 ml). Tothe solution were added triethylamine (0.46 ml) and4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (0.40 g) at 0°C., and the mixture was stirred at room temperature for 18 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with chloroform. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasrecrystallized from ethanol to give(E)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-3-[5-(4-methylphenyl)thiophen-2-yl]-acrylicamide (Compound 208) (293 mg) as yellow crystal.

m.p. 199-201° C.; ¹ H-NMR (200 MHz, CD₃ OD) δ 1.57-1.95 (4H, m), 2.32(3H, s), 2.36 (3H, s), 2.74-2.96 (1H, m), 3.32-3.47 (2H, m), 3.76 (2H,s), 3.96-4.09 (2H, m), 6.55 (1H, d, J=15.2 Hz), 7.23 (2H, d, J=8.4 Hz),7.29-7.36 (4H, m), 7.56 (2H, d, J=8.0 Hz), 7.66 (2H, d, J=8.4 Hz), 7.75(1H, d, J=15.2 Hz). IR (KBr) 3359, 1668, 1608, 1554, 1512, 1363, 802cm⁻¹ ; Elemental Analysis for C₂₇ H₃₀ N₂ O₂ S.1.2H₂ O; Calcd. C, 69.26;H, 6.97; N, 5.98: Found. C, 69.28; H, 6.90; N, 6.06.

WORKING EXAMPLE 209 (Production of Compound 209)

To a solution of (E)-3-[5-(4-methylphenyl)thiophen-2-yl]acrylic acid(150 mg) in tetrahydrofuran (10 ml) was added oxalyl chloride (0.1 ml)at room temperature. To the mixture was added a drop of DMF, and themixture was stirred for 1 hour. Under reduced pressure, the solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (30 ml). Tothe solution were added triethylamine (0.2 ml) and1-(4-aminobenzyl)phosphorinane-1-oxide (150 mg) at 0° C., and themixture was stirred at room temperature for 16 hours. The reactionmixture was added to vigorously stirred water to stop the reaction. Themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated under reduced pressure. The residue was recrystallizedfrom ethanol to give(E)-N-(4-pentamethylenephosphorylmethylphenyl)-3-[5-(4-methylphenyl)-thiophen-2-yl]acrylicamide (Compound 209) (172 mg) as yellow crystals.

m.p. 294-297° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.35-2.13 (10H, m), 2.29(3H, s), 3.06 (2H, d, J=13.0 Hz), 6.36-6.48 (1H, m), 7.06-7.17 (6H, m),7.38-7.49 (4H, m), 7.73 (1H, d, J=15.0 Hz). IR (KBr) 3048, 1672, 1606,1541, 1512, 1348, 1151, 804 cm⁻¹ ; Elemental Analysis for C₂₆ H₂₈ NO₂SP; Calcd. C, 69.47; H, 6.28; N, 3.12; P, 6.89: Found. C, 69.48; H,6.23; N, 3.20; P, 7.17.

WORKING EXAMPLE 210 (Production of Compound 210)

To a solution of (E)-3-[5-(4-methylphenyl)furan-2-yl]acrylic acid (200mg), 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (212 mg)and triethylamine (0.15 ml) in DMF (10 ml) was added diethylcyanophosphate (0.16 ml) at 0° C., and the mixture was stirred at roomtemperature for 3 hours. To the mixture was added ethyl acetate, and themixture was washed with water and saturated sodium chloride solution,dried with magnesium sulfate and concentrated. The residue was separatedand purified with column chromatography (ethanol/ethylacetate=1:50→1:25→1:10) to give(E)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-3-[5-(4-methylphenyl)furan-2-yl]acrylicamide (Compound 210) (87 mg) as brown amorphous.

¹ H-NMR (200 MHz, CDCl₃) δ 1.53-1.85 (4H, m), 2.21 (3H, s), 2.38(3H, s),2.54-2.72 (1H, m), 3.31-3.44 (2H, m), 3.56 (2H, s), 3.98-4.11 (2H, m),6.52 (1H, d, J=15.4 Hz), 6.67-6.69 (2H, m), 7.22 (2H, d, J=8.0 Hz), 7.29(2H, d, J=8.4 Hz), 7.41 (1H, s), 7.48-7.64 (5H, m).

WORKING EXAMPLE 211 (Production of Compound 211)

To a solution of (E)-3-[5-(4-methylphenyl)furan-2-yl]acrylic acid (150mg), 1-(4-aminobenzyl)phosphorinane-1-oxide (161 mg) and triethylamine(0.11 ml) in DMF (10 ml) was added diethyl cyanophosphate (0.12 ml) at0° C., and the mixture was stirred at room temperature for 3 hours. Tothe mixture was added ethyl acetate, and the mixture was washed withwater and saturated sodium chloride solution, dried with magnesiumsulfate and concentrated. The residue was separated and purified withcolumn chromatography (ethanol/ethyl acetate=1:10→1:5→1:4) to give(E)-N-(4-(pentamethylene)phosphorylmethylphenyl)-3-[5-(4-methylphenyl)furan-2-yl]acrylicamide (Compound 211) (53 mg) as brown crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.43-2.09 (1OH, m), 2.39 (3H, s), 3.15 (2H,d, J=13.2 Hz), 6.58-6.70 (3H, m), 7.16-7.29 (4H, m), 7.48-7.65 (5H, m),8.24-8.35 (1H, m). IR (KBr) 3292, 1672, 1614, 1541, 1512, 1489, 1412,1335, 1244, 1120, 787 cm⁻¹ ;

WORKING EXAMPLE 212 (Production of Compound 212)

Under nitrogen atmosphere, oxalyl chloride (0.16 ml) was added to asolution of (E)-3-[4-(4-methylphenyl)thiophen-2-yl]acrylic acid (300 mg)in tetrahydrofuran (10 ml) at room temperature. To the mixture was addeda drop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (10 ml). To the solution were added triethylamine (0.4ml) and 4-[N-methyl-N-(tetrahydro-pyran-4-yl)aminomethyl]-aniline (298mg) at 0° C., and the mixture was stirred at room temperature for 3hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with chloroform. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography(ethanol/ethyl acetate:1:4), and recrystallized from ethanol to givepale yellow crystals, which were recrystallized fromtetrahydrofuran-hexane to give(E)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-3-[4-(4-methylphenyl)thiophen-2-yl]acrylamide(Compound 212) (261 mg) as pale yellow crystals.

m.p. 188-190° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.45-1.83 (4H, m), 2.20(3H, s), 2.38 (3H, s), 2.55-2.73 (1H, m), 3.31-3.44 (2H, m), 3.56 (2H,s), 3.99-4.10 (2H, m), 6.38 (1H, d, J=15.2 Hz), 7.20-7.32 (5H, m),7.41-7.58 (6H, m), 7.89 (1H, d, J=15.2 Hz). IR (KBr) 3329, 2954, 1668,1608, 1554, 1512, 1412, 1360, 1342, 1254, 1174, 1159, 984, 816 cm⁻¹ ;Elemental Analysis for C₂₇ H₃₀ N₂ O₂ S1.0H₂ O; Calcd. C, 69.80; H, 6.94;N, 6.03: Found. C, 69.94; H, 6.85; N, 5.98.

WORKING EXAMPLE 213 (Production of Compound 213)

Under nitrogen atmosphere, oxalyl chloride (0.08 ml) was added to asolution of (E)-3-[4-(4-methylphenyl)thiophen-2-yl]acrylic acid (150 mg)in tetrahydrofuran (10 ml) at room temperature. To the mixture was addeda drop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (20 ml). To the solution were added triethylamine (0.2ml) and 1-(4-aminobenzyl)-phosphorinane-1-oxide (150 mg) at 0° C., andthe mixture was stirred at room temperature for 4 hours. The reactionmixture was added to vigorously stirred water to stop the reaction. Themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated under reduced pressure. The residue was recrystallizedfrom ethanol to give(E)-N-(4-(penta-methylene)phosphorylmethylphenyl)-3-[4-(4-methylphenyl)thiophen-2-yl]acrylicamide (Compound 213) (138 mg) as pale yellow crystals.

m.p. 279° C.(dec.); ¹ H-NMR (200 MHz, CDCl₃) δ 1.49-2.23 (1OH, m), 2.38(3H, s), 3.15 (2H, d, J=12.8 Hz), 6.61 (1H, d, J=15.2 Hz), 7.13-7.28(4H, m), 7.38-7.57 (6H, m), 7.86 (1H, d, J=15.2 Hz), 9.09-9.20 (1H, m).

IR (KBr) 3392, 2935, 1672, 1618, 1543, 1512, 1336, 1250, 1161, 818 cm⁻¹; Elemental Analysis for C₂₆ H₂₈ NO₂ SP.0.3H₂ O; Calcd. C, 68.64; H,6.34; N, 3.08; P, 6.81: Found. C, 68.44; H, 6.30; N, 3.06; P, 6.65.

WORKING EXAMPLE 214 (Production of Compound 214)

Under nitrogen atmosphere, oxalyl chloride (0.12 ml) was added to asolution of2-(4-methylphenyl)-7,8-dihydro-6H-cyclohepta[b]thiophene-5-carboxylicacid (250 mg) in tetrahydrofuran (10 ml) at room temperature. To themixture was added a drop of DMF, and the mixture was stirred for 2hours. Under reduced pressure, the solvent was evaporated, and theresidue was dissolved in tetrahydrofuran (20 ml). To the solution wereadded triethylamine (0.25 ml) and4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (215 mg) at 0°C., and the mixture was stirred at room temperature for 4 hours. Thereaction mixture was added to vigorously stirred water to stop thereaction. The mixture was extracted with chloroform. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated. The residue was purified with columnchromatography (ethanol/ethyl acetate=1:4) and recrystallized fromethanol to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2-(4-methylphenyl)-7,8-dihydro-6H-cyclohepta[b]thiophene-5-carboxamide(Compound 214) (319 mg) as colorless crystals.

m.p. 201-203° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.62-1.84 (4H, m),2.06-2.18 (2H, m), 2.21 (3H, s), 2.36 (3H, s), 2.53-2.71 (1H, m),2.79-2.87 (2H, m), 3.06-3.15 (2H, m), 3.31-3.44 (2H, m), 3.57 (2H, s),3.97-4.08 (2H, m), 7.08 (1H, s), 7.14-7.22 (3H, m), 7.30 (2H, d, J=8.8Hz), 7.43 (2H, d, J=8.0 Hz), 7.50-7.56 (3H, m). IR (KBr) 3311, 2943,1649, 1518, 1408, 1311, 810 cm⁻¹ ; Elemental Analysis for C₃₀ H₃₄ N₂ O₂S; Calcd. C, 74.04; H, 7.04; N, 5.76; S, 6.59: Found. C, 73.92; H, 6.85;N, 5.70; S, 6.53.

WORKING EXAMPLE 215 (Production of Compound 215)

To a solution of (E)-3-[5-(4-methylphenyl)pyridin-3-yl]acrylic acid (150mg), 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (168 mg)and triethylamine (0.10 ml) in DMF (10 ml) was added diethylcyanophosphate (0.12 ml) at 0° C., and the mixture was stirred at roomtemperature for 3 hours and concentrated under reduced pressure. To theresidue was added water, the mixture was extracted with chloroform. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography(ethanol/ethyl acetate=1:2) to give(E)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-3-[5-(4-methylphenyl)pyridin-3-yl]acrylicamide (Compound 215) (24 mg) as yellow solid.

¹ H-NMR (200 MHz, CDCl₃) δ 1.66-1.83 (4H, m), 2.21 (3H, s), 2.43 (3H,s), 2.53-2.74 (1H, m), 3.30-3.45 (2H, m), 3.57 (2H, s), 3.99-4.10 (2H,m), 6.69 (1H, d, J=15.5 Hz), 7.24-7.37 (4H, m), 7.41-7.63 (5H, m), 7.82(1H, d, J=15.5 Hz), 7.95-8.01 (1H, m), 8.74 (1H, d, J=1.8 Hz), 8.81 (1H,d, J=2.2 Hz). IR (KBr) 3242, 3190, 1678, 1606, 1545, 1514, 1348, 976,816 cm⁻¹.

WORKING EXAMPLE 216 (Production of Compound 216)

To a solution of 6-(4-methylphenyl)-2-methylquinoline-3-carboxylic acid(120 mg) and 1-hydroxybenzotriazole (88 mg) in DMF (5 ml) was added1-ethyl-3-(3'-dimethylaminopropyl)carbodiimide hydrochloride (125 mg) atroom temperature, and the mixture was stirred for 2 hours. To themixture was added a solution of4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (105 mg) andtriethylamine (0.2 ml) in DMF (5 ml), and the mixture was stirred for 18hours and concentrated under reduced pressure. To the residue was addedwater, and the mixture was extracted with chloroform. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethanol/ethylacetate=1:2), and recrystallized from ethyl acetate-hexane to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-6-(4-methylphenyl)-2-methylquinoline-3-carboxamide(Compound 216) (82 mg) as pale yellow crystals.

m.p. 157-160° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.49-1.85 (4H, m), 2.23(3H, s), 2.43 (3H, s), 2.54-2.76 (1H, m), 2.89 (3H, s), 3.31-3.47 (2H,m), 3.60 (2H, s), 4.00-4.11 (2H, m), 7.25-7.41 (4H, m), 7.55-7.71 (4H,m), 7.83 (1H, br s), 7.88 (1H, d, J=1.8 Hz), 8.01 (1H, dd, J=8.8, 1.8Hz), 8.09 (1H, d, J=8.8 Hz), 8.21 (1H, s). IR (KBr) 3311, 2958, 1657,1520, 1313, 110, 847, 812 cm⁻¹ ; Elemental Analysis for C₃₁ H₃₃ N₃O₂.0.3H₂ O; Calcd. C, 76.76; H, 6.98; N, 8.66: Found. C, 76.68; H, 7.07;N, 8.80.

WORKING EXAMPLE 217 (Production of Compound 217)

In THF (20 ml) was dissolved7-phenyl-3,4-dihydronaphthalene-2-carboxylic acid (1.00 g), and to thesolution were added oxalyl chloride (523 μl) and a drop of DMF. Themixture was stirred at room temperature for 1 hour and concentratedunder reduced pressure. The residue was dissolved in THF (20 ml), and tothe solution were added 1-(3-aminobenzyl)piperidine (837 mg) andtriethylamine (673 μl) at room temperature. The reaction mixture wasstirred at room temperature for 2 hours, and to the mixture was addedwater (100 ml). The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith anhydrous sodium sulfate, and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-diisopropylether togive7-phenyl-N-[3-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(Compound 217) (1.29 g) as pale yellow crystals.

mp 152-153° C.; Elemental Analysis for C₂₉ H₃₀ N₂ O.0.1H₂ O; Calcd: C,82.08; H, 7.17; N, 6.60. Found: C, 81.97; H, 7.27; N, 6.47. IR (KBr)cm⁻¹ : 3373, 2933, 1645, 1543, 1487, 1439, 770, 696 ¹ H NMR (200 MHz,CDCl₃) δ: 1.35-1.70 (6H, m), 2.32-2.45 (4H, m), 2.65-2.80 (2H, m),2.92-3.03 (2H, m), 3.48 (2H, s), 7.08 (1H, d, J=7.6 Hz), 7.25-7.50 (10H,m), 7.52-7.67 (3H, m).

WORKING EXAMPLE 218 (Production of Compound 218)

In DMF (3 ml) was dissolved7-phenyl-N-[3-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide(200 mg), and to the mixture was added methyl iodide (88 μl). Themixture was stirred at room temperature for 15 hours and concentratedunder reduced pressure. The residue was recrystallized frommethanol-ethyl acetate to give1-methyl-1-[3-(7-phenyl-3,4-dihydronaphthalene-2-carboxamido)benzyl]-piperidiniumiodide (Compound 218) (211 mg) as colorless crystals.

mp 208-209° C.; Elemental Analysis for C₃₀ H₃₃ N₂ OI; Calcd: C, 63.83;H, 5.89; N, 4.96. Found: C, 63.58; H, 5.89; N, 4.95. IR (KBr) cm⁻¹ :3450, 1657, 1520, 1483, 1439, 1250, 1215, 766, 702; ¹ H NMR (200 MHz,DMSO-d₆) δ: 1.40-2.00 (6H, m), 2.55-2.70 (2H, m), 2.80-3.00 (5H, m),3.20-3.40 (4H, m), 4.57 (2H, s), 7.20-7.82 (12H, m), 8.03 (1H, s), 10.14(1H, s).

WORKING EXAMPLE 219 (Production of Compound 219)

To a solution of2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.2 g) in dichloromethane (5 ml) were added oxalyl chloride (0.19 ml)and dimethylformamide (catalytic amount) under ice-cooling, and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran. Themixture was added to a solution of4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.17 g) andtriethylamine (0.3 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and precipitated crude crystal was recrystallized fromethyl acetate-hexane to give2-(4-methylphenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methyl-amino)methyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 219) (0.29 g) as colorless crystals.

mp 161-162° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.59-1.77 (4H, m), 2.13-2.21 (2H,m), 2.21 (3H, s), 2.40 (3H, s), 2.55-2.75 (3H, m), 2.86-2.92 (2H, m),3.37 (2H, dt, J=2.8, 10.9 Hz), 3.57 (2H, s), 4.01-4.07 (2H, m),7.21-7.33 (4H, m), 7.41-7.58 (7H, m), 7.63 (1H, s). IR(KBr) ν: 2938,1651 cm⁻¹. Anal. for C₃₂ H₃₆ N₂ O₂ : Calcd. C,79.97; H,7.55; N,5.83.Found C,79.63; H,7.43; N,5.64.

WORKING EXAMPLE 220 (Production of Compound 220)

A solution of2-(4-methylphenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.11 g) and methyl iodide (0.02 ml) in dimethylformamide (4 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which was recrystallized from ethanol-ethyl acetate to giveN,N-dimethyl-N-(4-((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)aminobenzyl)-N-(4-tetrahydropyranyl)ammoniumiodide (Compound 220) (0.13 g) as pale yellow crystals.

mp 157-158° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.80-2.20 (6H, m), 2.35 (3H,s), 2.64 (2H, t, J=6.6 Hz), 2.80-2.88 (2H, m), 2.88 (6H, s), 3.33-3.40(2H, m), 3.50-3.65 (1H, m), 4.02-4.09 (2H, m), 4.47 (2H, s), 7.26-7.37(4H, m), 7.50-7.60 (5H, m), 7.66 (1H, s), 7.88 (2H, d, J=8.8 Hz), 10.22(1H, s). IR(KBr) ν: 1659 cm⁻¹. Anal. for C₃₃ H₃₉ IN₂ O₂.0.5H₂ O: Calcd.C,62.76; H,6.38; N,4.44. Found C,62.69; H,6.38; N,4.21.

WORKING EXAMPLE 221 (Production of Compound 221)

A solution of7-(4-piperidinophenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.2 g) and methyl iodide (0.025 ml) in dimethylformamide (5 ml) wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. Precipitated crude crystal wasfiltered, which were recrystallized from ethanol-ethyl acetate to givedimethyl(N-(7-(4-piperidinophenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl)-4-tetrahydropyranylammoniumiodide (Compound 221) (0.1 g) as yellow crystals.

mp 189-190° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.50-1.70(6H,m), 1.75-2.00(2H,m), 2.05-2.25 (2H, m), 2.88 (6H, s), 2.99 (2H, br), 3.16-3.19 (4H, m),3.26-3.33 (2H, m), 3.50-1.70 (1H, m), 4.01-4.15 (2H, m), 4.29 (2H, br),4.47 (2H, s), 7.00 (2H, d, J=8.8 Hz), 7.03 (1H, d, J=8.4 Hz), 7.35 (1H,s), 7.50-7.57 (5H, m), 7.68 (1H, d, J=2.6 Hz), 7.86 (2H, d, J=8.4 Hz),10.19 (1H, s). IR(KBr) ν: 2936, 1659 cm³¹ 1. Anal. for C₃₆ H₄₄ IN₃ O₃.H₂O: Calcd. C,60.76; H,6.51; N,5.90. Found C,60.57; H,6.60; N,5.85.

WORKING EXAMPLE 222 (Production of Compound 222)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.3 g)in dichloromethane (10 ml) were added oxalyl chloride (0.28 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of4-(N-methyl-N-(tetrahydrothiopyran-4-yl)-aminomethyl)aniline (0.26 g)and triethylamine (0.5 ml) in tetrahydrofuran (20 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature for 7 hours. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate) to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((N-tetrahydrothiopyran-4-yl-N-methyl)amino-methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 222) (0.47 g) as colorless crystals.

mp 180-181° C.; ¹ H-NMR(δ ppm, CDC₃): 1.60-1.85 (2H, m), 2.10-2.15 (2H,m), 2.21 (3H, s), 2.39 (3H, s), 2.40-2.50 (1H, m), 2.66-2.72 (4H, m),3.08 (2H, t, J=4.6 Hz), 3.57 (2H, s), 4.36 (2H, t, J=4.6 Hz), 7.06 (1H,d, J=8.4 Hz), 7.24 (2H, d, J=8.0 Hz), 7.31 (2H, d, J=8.4 Hz), 7.43-7.57(7H, m). IR(KBr) ν: 2934, 1653 cm⁻¹ ; Anal. for C₃₁ H₃₄ N₂ O₂ S: Calcd.C,74.66; H,6.87; N,5.62. Found C,74.46; H,6.72; N,5.42.

WORKING EXAMPLE 223 (Production of Compound 223)

A solution ofN-(4-((N-tetrahydrothiopyran-4-yl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.11 g) and methyl iodide (0.025 ml) in dimethylformamide (5 ml) wasstirred at room temperature over night. The solvent was evaporated, andthe residue was purified with silica gel column (chloroform/methanol) togivedimethyl-(N-(7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl)-4-tetrahydrothiopyranylammoniumiodide (Compound 223) (0.09 g) as colorless crystals.

mp 185-186° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 1.75-2.00 (2H, m), 2.34(3H, s), 2.55-2.75 (4H, m), 2.75-2.85 (2H, m), 2.90 (6H, s), 3.00 (2H,br), 3.14-3.25 (1H, m), 4.31 (2H, br), 4.47 (2H, s), 7.07 (1H, d, J=8.4Hz), 7.27 (2H, d, J=7.8 Hz), 7.36 (1H, s), 7.50-7.59 (5H, m), 7.74 (1H,d, J=2.2 Hz), 7.86 (2H, d, J=8.8 Hz), 10.19 (1H, s). IR(KBr) ν: 2901,1659 cm⁻¹. Anal. for C₃₂ H₃₇ N₂ O₂ SI.H₂ O: Calcd. C,58.36; H,5.97;N,4.25. Found C,58.62; H,6.04; N,4.29.

WORKING EXAMPLE 224 (Production of Compound 224)

To a solution of2-(4-piperidinophenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (0.45 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline(0.31 g) and 1-hydroxybenzotriazole (0.18 g) in dimethyl-formamide (20ml) was added 1-ethyl-3-(3-dimethylamino-propyl)carbodiimidehydro-chloride (0.37 g) under ice-cooling. Under nitrogen atmosphere,the mixture was warmed to room temperature. To the mixture were added4-dimethylaminopyridine (catalytic amount) and triethylamine (0.54 ml),and the mixture was stirred over night. The solvent was evaporated, andto the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/methanol/triethylamine)to give crude crystals, which were recrystallized from ethylacetate-hexane to give2-(4-piperidinophenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide(Compound 224) (0.44 g) as pale orange crystals.

mp 170-171° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.59-1.65 (2H, m), 1.65-1.80 (8H,m), 2.05-2.21 (2H, m), 2.21 (3H, s), 2.55-2.68 (1H, m), 2.71 (2H, t,J=6.3 Hz), 2.84-2.90 (2H, m), 3.19-3.24 (4H, m), 3.37 (2H, dt, J=2.8,11.2 Hz), 4.01-4.11 (2H, m), 7.00 (2H, d, J=8.8 Hz), 7.20 (1H, d, J=7.6Hz), 7.31 (2H, d, J=8.4 Hz), 7.41-7.51 (4H, m), 7.56 (2H, d, J=8.4 Hz),7.63 (1H, s). IR(KBr) ν: 2936, 1661 cm⁻¹. Anal. for C₃₆ H₄₃ N₃ O₂.0.2H₂O: Calcd. C,78.14; H,7.91; N,7.59. Found C,78.09; H,7.93; N,7.55.

WORKING EXAMPLE 225 (Production of Compound 225)

A solution of2-(4-piperidinophenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methylamino)methyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.2 g) and methyl iodide (0.025 ml) in dimethylformamide (10 ml) wasstirred at room temperature over night. The solvent was evaporated, andthe residue was purified with silica gel column (chloroform/methanol) togive crude crystals, which were recrystallized from ethanol-hexane togivedimethyl-(N-(2-(4-piperidinophenyl)-6,7-dihydro-5H-benzocycloheptene-8-carbonyl)-4-aminobenzyl)-4-tetrahydropyranylammoniumiodide (Compound 225) (0.15 g) as pale brown crystals.

mp 177-178 C.; ¹ H-NMR(δ ppm, DMSO-d₆): 1.50-1.70 (6H, m), 1.80-1.95(2H, m), 2.00-2.10 (2H, m), 2.10-2.20 (2H, m), 2.60-2.70 (2H, m),2.75-2.87 (2H, m), 2.88 (6H, s), 3.14-3.24 (6H, m), 3.53-3.65 (1H, m),4.00-4.15 (2H, m), 4.46 (2H, s), 7.00 (2H, d, J=8.8 Hz), 7.26 (1H, d,J=8.0 Hz), 7.36 (1H, s), 7.46-7.62 (6H, m), 7.87 (2H, d, J=8.8 Hz),10.22 (1H, s). IR(KBr) ν: 2934, 1655 cm⁻¹. Anal. for C₃₇ H₄₆ N₁₃ O₂.H₂O: Calcd. C,62.62; H,6.82; N,5.92. Found C,62.32; H,6.71; N,5.92.

WORKING EXAMPLE 226 (Production of Compound 226)

Under nitrogen atmosphere, oxalyl chloride (0.05 ml) was added to asolution of7-(4-methylthiophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (80.6mg) in tetrahydrofuran (10 ml) at room temperature. To the mixture wasadded a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated. The residue was dissolvedin tetrahydrofuran (20 ml). To the solution were added triethylamine(0.1 ml) and 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline(62.5 mg) at 0° C., and the mixture was stirred at room temperature for3 hours. The reaction mixture was added to vigorously stirred water tostop the reaction. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue was purified withcolumn chromatography (ethanol/ethyl acetate=1:4) and recrystallizedfrom ethanol to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-7-(4-methylthiophenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 226) (85 mg) as colorless crystals.

m.p. 180-186° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.53-1.81 (4H, m), 2.21(3H, s), 2.52 (3H, s), 2.54-2.73 (1H, m), 3.08 (2H, t, J=4.6 Hz),3.31-3.43 (2H, m), 3.57 (2H, s), 3.98-4.10 (2H, m), 4.36 (2H, t, J=4.6Hz), 7.06 (1H, d, J=8.4 Hz), 7.23-7.36 (4H, m), 7.41-7.63 (8H, m). IR(KBr) 3319, 2947, 1645, 1516, 1485, 1315, 1248, 1140, 1086, 812 cm⁻¹ ;Elemental Analysis for C₃₁ H₃₄ N₂ O₃ S.0.2H₂ O; Calcd. C, 71.84; H,6.69; N, 5.40; S, 6.19: Found. C, 71.75; H, 6.70; N, 5.38; S, 6.24.

REFERENCE EXAMPLE 49

To 3-bromocinnamic acid (2.0 g) were added thionyl chloride (25 ml) anddimethylformamide (catalytic amount), and the mixture was refluxed for1.5 hours. The solvent was evaporated, and the residue was dissolved intetrahydrofuran. The mixture was dropwise added to a suspension of1-(4-aminobenzyl)piperidine (1.7 g) and diisopropylethylamine (4 ml) intetrahydrofuran (5 ml) under ice-cooling. Under nitrogen atmosphere, themixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate) to give crude crystals, whichwere recrystallized from ethyl acetate-hexane to give1-(4-(3-bromocinnamoylamino)benzyl)piperidine (1.8 g) as colorlesscrystals.

mp 144-145° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.37-1.49 (2H, m), 1.52-1.63 (4H,m), 2.34-2.39 (4H, m), 3.45 (2H, s), 6.54 (1H, d, J=15.5 Hz), 7.21-7.33(3H, m), 7.41-7.57 (5H, m), 7.67 (1H, d, J=15.5 Hz), 7.69 (1H, s).IR(KBr) ν: 3270, 2934, 1663 cm³¹ 1. Anal. for C₂₁ H₂₃ BrN₂ O.0.2H₂ O:Calcd. C,62.60; H,5.85; N,6.95. Found C,62.67; H,5.79; N,6.93.

REFERENCE EXAMPLE 50

To 3-phenylcinnamic acid (0.24 g) were added thionyl chloride (10 ml)and dimethylformamide (catalytic amount), and the mixture was refluxedfor 2 hours. The solvent was evaporated, and the residue was dissolvedin tetrahydrofuran. The mixture was dropwise added to a suspension of2-(4-aminobenzyl)-1,3,2-dioxaphosphorinane-2-oxide (0.2 g) anddiisopropylethylamine (0.8 ml) in tetrahydrofuran (20 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and precipitated crude crystal wasrecrystallized from ethanol-hexane to give2-(4-(3-phenylcinnamoylamino)benzyl)-1,3,2-dioxaphosphorinane-2-oxide(0.32 g) as colorless crystals.

mp 204-205r° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.84-1.88 (2H, m), 3.24 (2H, d,J=21.2 Hz), 4.07-4.22 (2H, m), 4.34-4.44 (2H, m), 6.74 (1H, d, J=15.8Hz), 7.23 (2H, dd, J=2.6, 8.8 Hz), 7.38-7.63 (10H, m), 7.77 (1H, s),7.81 (1H, d, J=15.8 Hz), 8.16 (1H, br). IR(KBr) ν: 3059, 1680 cm⁻¹.Anal. for C₂₅ H₂₄ NO₄ P: Calcd. C,69.28; H,5.58; N,3.23. Found C,68.82;H,5.58; N,3.30.

REFERENCE EXAMPLE 51

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.15 g)in dichloromethane (7 ml) were added oxalyl chloride (0.14 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of2-(4-aminobenzyl)-1,3,2-dioxaphosphorinane-2-oxide (0.13 g) andtriethylamine (0.23 ml) in tetrahydrofuran (20 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedwater. The mixture was extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give crude crystals, which were recrystallized fromethyl acetate-ethanol-hexane to give2-(4-(7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonylamino)benzyl)-1,3,2-dioxaphosphorinane-2-oxide(0.23 g) as colorless crystals.

mp 268-269° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.75-1.87 (2H, m), 2.40 (3H, s),3.09 (2H, t, J=4.5 Hz), 3.24 (2H, d, J=21.6 Hz), 4.02-4.19 (2H, m),4.34-4.50 (4H, m), 7.06 (1H, d, J=8.4 Hz), 7.23-7.32 (4H, m), 7.44-7.60(6H, m), 7.81 (1H, s). IR(KBr) ν: 1652 cm⁻¹. Anal. for C₂₈ H₂₆ NO₅ P:Calcd. C,68.70; H,5.77; N,2.86. Found C,68.54; H,5.71; N,2.86.

REFERENCE EXAMPLE 52

A suspension ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.18 g), 1-t-butoxycarbonyl-4-methylaminopiperidine (0.19 g) andpotassium carbonate (0.18 g) in dimethylformamide (10 ml) was stirred atroom temperature over night. The solvent was evaporated, and to theresidue was added water. The mixture was extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-((N-(1-t-butoxycarbonylpiperidin-4-yl)-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.25 g) as colorless crystals.

mp 203-204° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.37-1.70 (4H, m), 1.46 (9H, s),1.77-1.83 (2H, m), 2.19 (3H, s), 2.39 (3H, s), 2.52-2.74 (3H, m), 3.08(2H, t, J=4.6 Hz), 3.56 (2H, s), 4.18 (1H, br), 4.36 (2H, t, J=4.6 Hz),7.06 (1H, d, J=8.4 Hz), 7.22-7.33 (5H, m), 7.43-7.61 (6H, m). IR(KBr) ν:2977, 2933, 1695, 1668 cm³¹ 1. Anal. for C₃₆ H₄₃ N₃ O₄ : Calcd. C,74.33;H,7.45; N,7.22. Found C,74.00; H,7.41; N,7.26.

REFERENCE EXAMPLE 53

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.6 g)in dichloromethane (25 ml) were added oxalyl chloride (0.56 ml) anddimethyl-formamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran. The mixture wasdropwise added to a solution of(4-aminophenyl)[1-(tert-butoxycarbonyl)piperidin-2-yl]methanone (0. 72g) and triethylamine (0.9 ml) in tetrahydrofuran (50 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate-hexane to giveN-(4-(1-(tertbutoxycarbonyl)piperidin-2-ylcarbonyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(1.1 g) as pale yellow crystals.

mp 223-224° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.44 (9H, br), 1.44-1.65 (4H, m),1.70-1.95 (1H, m), 2.00-2.20 (1H, m), 2.39 (3H, s), 3.08 (2H, t, J=4.4Hz), 5.60 (1H, br), 7.06 (1H, d, J=8.4 Hz), 7.25 (2H, d, J=11.8 Hz),7.44-7.53 (4H, m), 7.65 (1H, br), 7.69 (1H, br), 7.82 (1H, br), 7.94(2H, d, J=8.8 Hz). IR(KBr) ν: 2942, 1678 cm⁻¹. Anal. for C₃₅ H₃₈ N₂O₅.0.3H₂ O: Calcd. C,73.48; H,6.80; N,4.90. Found C,73.51; H,6.60;N,4.68.

REFERENCE EXAMPLE 54

To a mixture of 3-bromobenzaldehyde (10 g) andmethoxy-carbonylmethylenetriphenylphosphine (20 g) was added toluene(150 ml), and the mixture was refluxed under nitrogen atmosphere for 2hours. The solvent was evaporated, and the organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/hexane) to give methyl 3-bromocinnamate (10.7 g) as colorlesscrystals.

¹ H-NMR(δ ppm, CDCl₃): 3.82 (3H, s), 6.44 (1H, d, J=16.0 Hz), 7.27 (1H,d, J=15.6 Hz), 7.43-7.54 (2H, m), 7.62 (1H, d, J=16.0 Hz), 7.66-7.68(1H, m). IR(KBr) ν: 1734, 1717 cm⁻¹. Anal. for C₁₀ H₉ BrO₂ : Calcd.C,49.82; H,3.76. Found C,49.90; H,3.90.

REFERENCE EXAMPLE 55

In a solution of methanol (200 ml) and 2N sodium hydroxide (50 ml) wasdissolved methyl 3-bromocinnamate (10.7 g), and the mixture was stirredat room temperature over night, concentrated and neutralized with 1Nhydrochloric acid. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give 3-bromophenylcinnamic acid(9.2 g) as colorless crystals.

¹ H-NMR(δ ppm, CDCl₃): 6.45 (1H, d, J=15.8 Hz), 7.28 (1H, t, J=7.7 Hz),7.45-7.56 (2H, m), 7.67-7.75 (2H, m). IR(KBr) ν: 1688 cm⁻¹. Anal. for C₉H₇ BrO₂ : Calcd. C,47.61; H,3.11. Found C,47.57; H,3.10.

REFERENCE EXAMPLE 56

A suspension of methyl 3-bromocinnamate (3.8 g), phenyl borate (2.0 g),1M potassium carbonate (20 ml) and ethanol (10 ml) in toluene(100 ml)was stirred under argon atmosphere at room temperature for 30 minutes.To the reaction mixture was added tetrakistriphenylphosphinepalladium(0.9 g), and the mixture was refluxed over night and extracted withethyl acetate. The organic layer was washed with water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/hexane) to give colorlesscrystals (3.6 g), 1.8 g of which was dissolved in a solution of methanol(100 ml) and 1N sodium hydroxide (20 ml). The mixture was stirred atroom temperature over night, concentrated, neutralized with 1Nhydrochloric acid and extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give 3-phenylcinnamic acid (1.5 g) as colorlesscrystals.

¹ H-NMR(δ ppm, CDCl₃): 6.54 (1H, d, J=16.0 Hz), 7.39-7.67 (8H, m),7.76-7.77 (1H,m), 7.87 (1H,d,J=16.0 Hz). IR(KBr) ν 1709 cm⁻¹. Anal. forC₁₅,H₁₂ O₂ : Calcd. C,80.34; H,5.39. Found C,80.62; H,5.40.

REFERENCE EXAMPLE 57

To 4-nitrobenzylphosphonic acid (0.5 g) were added thionyl chloride (5ml) and dimethylformamide (catalytic amount), and the mixture wasrefluxed under nitrogen atmosphere for 4 hours. The solvent wasevaporated, and to the residue was added toluene. The solvent wasevaporated. The residue was dissolved in tetrahydrofuran (15 ml), andthe mixture was cooled to -78° C. under nitrogen atmosphere. To themixture was dropwise added dimethylpropanediamine (0.3 ml) dissolved intetrahydrofuran (2 ml) and then triethylamine (1.6 ml), and the mixturewas gradually warmed to room temperature and stirred at room temperatureover night. The solvent was evaporated, and the residue was purifiedwith silica gel column (ethyl acetate/methanol/triethylamine) to givecolorless crystals, which were dissolved in ethanol (15 ml). To themixture was added 10% palladium on carbon (0.04 g), and catalytichydrogenation was carried out at room temperature for 3.5 hours. Thecatalyst was filtered off, and the solvent was evaporated to give2-(4-aminobenzyl)-1,3-dimethyl-1,3,2-diazaphosphorinane-2-oxide (0.3 g)as colorless crystals.

¹ H-NMR(δ ppm, CDCl₃): 1.09-1.27 (1H, m), 1.68-1.85 (1H, m), 2.65 (3H,s), 2.69 (3H, s), 2.72-3.01 (4H, m), 3.08 (2H, d, J=17.4 Hz), 6.65 (2H,d, J=8.1 Hz), 6.96 (2H, dd, J=2.4, 8.1 Hz). IR(KBr) ν: 3339, 2897, 1615cm⁻¹. Anal. for C₁₂ H₂₀ N₃ OP.0.3H₂ O: Calcd. C, 55.72; H, 8.03; N,16.24. Found C, 55.69; H, 7.98; N, 16.13.

REFERENCE EXAMPLE 58

To 4-nitrobenzylphosphonic acid (0.5 g) were added thionyl chloride (5ml) and dimethylformamide (catalytic amount), and the mixture wasrefluxed for 3 hours under nitrogen atmosphere. The solvent wasevaporated, and to the residue was added toluene. The solvent wasevaporated. The residue was dissolved in tetrahydrofuran (5 ml), and themixture was cooled to -78° C. under nitrogen atmosphere. To the mixturewas dropwise added dimethylethylenediamine (0.25 ml) dissolved intetrahydrofuran (2 ml), and then triethylamine (1.5 ml), and the mixturewas gradually warmed to room temperature and stirred at room temperatureover night. The solvent was evaporated, and the residue was purifiedwith silica gel column (ethyl acetate/methanol/triethylamine) to givecolorless crystals, which were dissolved in ethanol (15 ml). To themixture was added 10% palladium on carbon (0.05 g), and catalytichydrogenation was carried out at room temperature for 3 hours. Thecatalyst was filtered off, and the solvent was evaporated to give2-(4-aminobenzyl)-1,3-dimethyl-1,3,2-diazaphosphorane-2-oxide (0.3 g) asyellow crystals.

¹ H-NMR(δ ppm, CDCl₃): 2.61 (3H, s), 2.63-2.71 (2H, m), 2.66 (3H, s),3.00-3.07 (2H, m), 3.13 (2H, d, J=18.2 Hz), 6.63 (2H, d, J=8.5 Hz), 6.97(2H, dd, J=2.4, 8.5 Hz). IR(KBr) ν: 3341, 2895, 1632 cm⁻¹. Anal. for C₁₁H₁₈ N₃ OP.0.5H₂ O: Calcd. C, 53.22; H, 7.71; N, 16.93. Found C, 53.23;H, 7.53; N, 16.83.

REFERENCE EXAMPLE 59

A suspension of ³ -bromo-6,7,8,9-tetrahydro-5H-benzocycloheptan-5-one(4.6 g; L. A. M. Cornelius and D. W. Combs, Synth. Commun. (1994),24(19), 2777-2788), 4-methylphenyl borate (3.8 g), 2M potassiumcarbonate (30 ml) and ethanol (30 ml) in toluene (100 ml) was stirredunder argon atmosphere at room temperature for 30 minutes. To thereaction mixture was added tetrakistriphenylphosphinepalladium (1.5 g),and the mixture was refluxed over night and extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/hexane) to give palebrown oil (5.7 g), to which were added sodium methoxide (6.2 g) anddimethyl carbonate (100 ml). The mixture was refluxed under nitrogenatmosphere for 8 hours and poured into 1N hydrochloric acid underice-cooling. The mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. The solvent was evaporated, andthe residue was purified with silica gel column (ethyl acetate/hexane)to give brown oil (5.5 g), which was dissolved in dichloromethane (20ml). To the mixture was dropwise added sodium boron hydride dissolved inmethanol, under ice-cooling. After starting materials disappeared, waterwas added to the reaction mixture, and the mixture was concentrated andextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. The solvent was evaporated, and to the residue wereadded iN sodium hydroxide (40 ml), methanol (40 ml) and diethylether(100 ml). The mixture was heated to 50° C. for 30 minutes andconcentrated. To the residue was added 1N sodium hydroxide, and themixture was extracted with water, washed with ethyl acetate andacidified with hydrochloric acid. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Thesolvent was evaporated, and the residue was dissolved in Diglyme(20 ml).To the mixture was added hydrochloric acid (5 ml), and the mixture washeated to 100° C. for 6 hours and poured into water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. The solvent was evaporated to give2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.3 g) as colorless crystals.

¹ H-NMR(δ ppm, CDCl₃): 2.07-2.16 (2H, m), 2.40 (3H, s), 2.70 (2H, t,J=6.6 Hz), 2.86-2.91 (2H, m), 7.21-7.28 (3H, m), 7.44-7.56 (4H, m), 7.91(1H, s). IR(KBr) ν: 2930, 1678 cm⁻¹. Anal. for C₁₉ H₁₈ O₂ : Calcd. C,81.99; H, 6.52. Found C, 81.64; H, 6.41.

REFERENCE EXAMPLE 60

In dimethylformamide (100 ml) was added 4-bromothiophenol (25 g). To thesolution were added ethyl 4-bromobutyrate (30 g) and potassium carbonate(36 g), and the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed with andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. The solvent was evaporated, and to the residue were added 1Nsodium hydroxide (240 ml) and methanol (120 ml). The mixture was stirredat room temperature over night and concentrated. The residue wasdissolved in water, and the mixture was washed with ethyl acetate. Theaqueous layer was acidified with hydrochloric acid under ice-cooling.The mixture was extracted with ethyl acetate. The organic layer waswashed with and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. The solvent was evaporated to givecolorless crystals (32 g), to which was added polyphosphoric acid (250g), and the mixture was stirred at 100° C. for 1 hour and poured intoice-water. The mixture was extracted with ethyl acetate. The organiclayer was washed with water, sodium hydrogen carbonate solution, waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. The solvent was evaporated to give brown crystals(13.6 g), to which were added sodium methoxide (14.2 g) and dimethylcarbonate (200 ml), and the mixture was refluxed under nitrogenatmosphere for 8 hours. Under ice-cooling, the mixture was poured into1N hydrochloric acid. The mixture was extracted with ethyl acetate. Theorganic layer was washed with and saturated sodium chloride solution,and dried with anhydrous magnesium sulfate. the solvent was evaporatedto give brown crystals (11.5 g), which were dissolved in dichloromethane(100 ml). To the mixture was dropwise added sodium boron hydridedissolved in methanol, under ice-cooling. After starting materialsdisappeared, water was added to the reaction mixture, and the mixturewas concentrated and extracted with ethyl acetate. The organic layer waswashed with and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. The solvent was evaporated, and to theresidue were added 1N sodium hydroxide (100 ml), methanol (100 ml) anddiethylether (500 ml). The mixture was stirred at room temperature for1.5 hours and concentrated. To the residue was added 1N sodiumhydroxide, and the mixture was extracted with water, washed withdiethylether and acidified with hydrochloric acid. The mixture wasextracted with ethyl acetate. The organic layer was washed with andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. The solvent was evaporated, and the residue was dissolved inDiglyme (100 ml). To the mixture was added hydrochloric acid (20 ml),and the mixture was heated to 110° C. for 2.5 hours and poured intowater. The mixture was extracted with ethyl acetate. The organic layerwas washed with and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. The solvent was evaporated to givecolorless crystal (1.1 g), 1 g of which was suspended dichloromethane(15 ml). To the suspension were added oxalyl chloride (1 ml) anddimethylformamide (catalytic amount) under ice-cooling, and the mixturewas stirred at room temperature for 2.5 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran. Themixture was dropwise added to a solution of4-(tertbutyldimethylsilyloxy)aniline (0.76 g) and triethylamine (1.6 ml)in tetrahydrofuran (20 ml), under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive brown oil (1.8 g), to which were added 4-methylphenyl borate (0.5g), 1M potassium carbonate (15 ml), ethanol (15 ml) and toluene(500 ml),and the mixture was stirred under argon atmosphere at room temperaturefor 30 minutes. To the mixture was addedtetrakistriphenylphosphinepalladium (0.2 g), and the mixture wasrefluxed over night. The mixture was extracted with ethyl acetate, andthe organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystals (1.3g), which were dissolved in ethyl acetate (50 ml). To the mixture wasadded hydrochloric acid (5 ml), and the mixture was stirred at roomtemperature for 1.5 hours, washed with sodium hydrogen carbonatesolution, water, saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give7-(4-methylphenyl)-N-(4-hydroxymethylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(1.0 g) as colorless crystals.

¹ H-NMR(δ ppm, CDCl₃): 2.40 (3H, s), 3.08 (2H, t, J=5.8 Hz), 3.29 (2H,t, J=5.8 Hz), 4.69 (2H, s), 7.24-7.28 (2H, m), 7.35-7.62 (10H, m), 7.71(1H, br). IR(KBr) ν: 3314, 2928, 1649 cm⁻¹. Anal. for C₂₅ H₂₃ NO₂S.0.2H₂ O: Calcd. C, 74.12; H, 5.82; N, 3.46. Found C, 74.10; H, 5.65;N, 3.47.

REFERENCE EXAMPLE 61

In dimethylformamide (100 ml) was dissolved 4-bromophenol (17.3 g). Tothe solution were added ethyl 4-bromobutyrate (21.2 g) and potassiumcarbonate (25 g), and the mixture was stirred at room temperature overnight. The solvent was evaporated, and to the residue was added water.The mixture was extracted with ethyl acetate. The organic layer waswashed with and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. The solvent was evaporated, and to theresidue were added 3N sodium hydroxide (100 ml)and methanol (60 ml). Themixture was stirred at 70° C. for 30 minutes and concentrated. Theresidue was dissolved in water, and the mixture was washed withdiethylether. The aqueous layer was acidified with hydrochloric acidunder ice-cooling, and the mixture was extracted with ethyl acetate. Theorganic layer was washed with and saturated sodium chloride solution,and dried with anhydrous magnesium sulfate. The solvent was evaporatedto give colorless crystal (23.9 g), to 10 g of which was addedpolyphosphoric acid (120 g). The mixture was stirred at 100° C. for45minutes and poured into ice-water. The mixture was extracted with ethylacetate. The organic layer was washed with water, sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. The solvent was evaporated, andthe residue was purified with silica gel column (ethyl acetate/hexane)to give 7-bromo-2,3,4,5-tetrahydrobenzoxepin-5-one as yellow oil (6.5g).

¹ H-NMR(δ ppm, CDCl₃): 2.15-2.29 (2H, m), 2.89 (2H, t, J=7.0 Hz), 4.24(2H, t, J=6.6 Hz), 6.97 (1H, d, J=8.8 Hz), 7.50 (1H, dd, J=2.6, 8.1 Hz),7.87 (1H, d, J=2.6 Hz). IR(neat) ν: 2969, 1686 cm⁻¹.

REFERENCE EXAMPLE 62

To 7-bromo-2,3,4,5-tetrahydrobenzoxepin-5-one (6.5 g) were added4-methylphenyl borate (4.1 g), 2M potassium carbonate (30 ml), ethanol(30 ml) and toluene (100 ml), and the mixture was stirred under argonatmosphere at room temperature for 30 minutes. To the mixture was addedtetrakistriphenylphosphinepalladium (1.3 g), and the mixture wasrefluxed over night and extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and the residue was purified with silica gel column(ethyl acetate/hexane) to give pale yellow crystal (5.7 g), to 3.6 g ofwhich was added sodium methoxide (3.9 g) and dimethyl carbonate (50 ml).Under nitrogen atmosphere, the mixture was refluxed for 8 hours andpoured into 1N hydrochloric acid under ice-cooling. The mixture wasextracted with ethyl acetate. The organic layer was washed with andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate, and the solvent was evaporated. The residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystal (3.5g), 1.8 g of which was dissolved in dichloromethane (25 ml). To themixture was dropwise added sodium boron hydride dissolved in methanol,under ice-cooling. After starting materials disappeared, water was addedto the reaction mixture, and the mixture was concentrated and extractedwith ethyl acetate. The organic layer was washed with and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate,and the solvent was evaporated. To the residue were added 1N sodiumhydroxide (50 ml), methanol (25 ml) and diethylether (25 ml), and themixture was stirred at room temperature for 30 minutes and concentrated.To the mixture was added 1N sodium hydroxide, and the mixture wasextracted with water, washed with diethylether and acidified withhydrochloric acid. The mixture was extracted with ethyl acetate. Theorganic layer was washed with and saturated sodium chloride solution,and dried with anhydrous magnesium sulfate. The solvent was evaporated,and the residue was dissolved in Diglyme (25 ml). To the mixture wasadded hydrochloric acid (5 ml), and the mixture was heated at 100° C.for 40 minutes and poured into water. The mixture was extracted withethyl acetate. The organic layer was washed with and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Thesolvent was evaporated to give7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (1.2 g)as colorless crystals.

mp 255-256° C.; ¹ H-NMR((δ ppm, CDCl₃): 2.40 (3H, s), 3.02 (2H, t, J=4.6Hz), 4.33 (2H, t, J=4.6 Hz), 7.05 (1H, d, J=8.6 Hz), 7.24 (2H, d, J=8.2Hz), 7.46 (2H, d, J=8.2 Hz), 7.47-7.56 (2H, m), 7.78 (1H, s). IR(KBr) ν:2996, 1694 cm⁻¹. Anal. for C₁₈ H₁₆ O₃ : Calcd. C, 77.12; H, 5.75. FoundC, 76.91; H, 5.75.

REFERENCE EXAMPLE 63

In dichloromethane (10 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (1.0 g)and to the suspension were added oxalyl chloride (1 ml) anddimethylformamide (catalytic amount) under ice-cooling. The mixture wasstirred at room temperature for 3 hours. The solvent was evaporated, andthe residue was dissolved in tetrahydrofuran. The mixture was dropwiseadded to a solution of 4-(tert-butyldimethyl-silyloxy)aniline (0.93 g)and triethylamine (1.5 ml) in tetrahydrofuran (15 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and to the residuewas added water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless oil (1.88 g),which was dissolved in ethyl acetate (20 ml). To the mixture was addedhydrochloric acid (5 ml), and the mixture was stirred at roomtemperature 1.5 hours. The mixture was washed with sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to give colorless crystals (0.9 g), whichwas suspended in dichloromethane (60 ml). To the suspension were addedlithium chloride (0.1 g) and triethylamine (1 ml). To the mixture wasdropwise added methanesulfonylchloride (0.3 ml) under ice-cooling, andthe mixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethyl acetate) togiveN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.4 g).

¹ H-NMR(δ ppm, CDCl₃): 2.39 (3H, s), 3.08 (2H, t, J=4.6 Hz), 4.36 (2H,t, J=4.6 Hz), 4.59 (2H, s), 7.06 (1H, d, J=8.4 Hz), 7.22-7.26 (2H, m),7.36-7.53 (6H, m), 7.60 (2H, d, J=8.4 Hz), 7.65 (1H, s). IR(KBr) ν:3025, 1649 cm⁻¹.

REFERENCE EXAMPLE 64

In tetrahydrofuran (50 ml) were suspended p-nitro-phenethylbromide (2.3g) and sodium iodide (1.5 g). To the suspension was added piperidine (4ml), and the mixture was stirred at room temperature over night. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive yellow oil (2.3 g), which was dissolved in ethanol (50 ml). To themixture was added 10% palladium on carbon (0.23 g), and catalytichydrogenation was carried out at room temperature over night. Thecatalyst was filtered off, and the solvent was evaporated to give1-(2-(4-aminophenyl)ethyl)piperidine (2.0 g) as yellow oil.

¹ H-NMR(δ ppm, CDCl₃): 1.43-1.50 (2H, m), 1.56-1.67 (4H, m), 2.42-2.53(6H, m), 2.67-2.75 (2H, m), 3.55 (2H, br), 6.62 (2H, d, J=8.4 Hz), 6.99(2H, d, J=8.4 Hz). IR(neat) ν: 2935, 1623 cm⁻¹.

REFERENCE EXAMPLE 65

To 5'-bromo-2'-hydroxyacetophenone (10 g) were added4-methylphenylborate (6.7 g), 2M potassium carbonate (70 ml), ethanol(70 ml) and toluene (200 ml), and the mixture was stirred under argonatmosphere at room temperature for 30 minutes. To the mixture was addedtetrakistriphenylphosphinepalladium (2.1 g), and the mixture was refluxed over night. The mixture was extracted with ethyl acetate, and theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give pale yellow crystal(7.4 g), 2.3 g of which was dissolved in pyridine (15 ml). To themixture was added benzoyl chloride (1.4 ml), and the mixture was stirredat room temperature for 30 minutes. The solvent was evaporated, and tothe residue was added water. The mixture was extracted with ethylacetate, and the organic layer was washed with water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated to give colorlesscrystals (3.0 g), 2.9 g of which was dissolved in pyridine (25 ml). Tothe mixture was added potassium hydroxide (0.7 g) little by little at50° C. The mixture was stirred at 50° C. for 1 hour, and the solvent wasevaporated. To the residue was added 10% acetic acid under ice-cooling,and the mixture was extracted with ethyl acetate. The organic layer waswashed with water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give yellow crystal (2.3 g), to which was added sulfuricacid (0.37 ml) and acetic acid (15 ml). The mixture was refluxed for 1hour and poured into ice-water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give colorless crystal(2.1 g), which was dissolved in dimethylsulfoxide (150 ml). To themixture was dropwise added a solution which was prepared by adding asolution of trimethylsulfoxonium iodide (2.3 g) in dimethylsulfoxide (60ml) dropwise to a suspension of sodium hydride (60%, 0.44 g) indimethylsulfoxide (10 ml) and stirring the mixture under nitrogenatmosphere at room temperature for 40 minutes. The mixture was stirredat room temperature for 3 hours and further stirred at 50° C. for 2hours. The mixture was poured into water, and the mixture was extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue was purified with silica gel column (ethyl acetate/hexane) togive pale yellow crystals (1.7 g), to which were added tributyltinhydride (2.1 ml), 2,2'-azobis (isobutyro-nitrile) (0.64 g) and toluene(50 ml). The mixture was stirred under nitrogen atmosphere at 100° C.for 1 hour, washed with water and saturated sodium chloride solution,and dried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to give colorless crystals (0.65 g), towhich were added sodium methoxide (0.54 g) and dimethyl carbonate (25ml). The mixture was refluxed under nitrogen atmosphere for 8 hours andpoured into 1N hydrochloric acid under ice-cooling. The mixture wasextracted with ethyl acetate. The organic layer was washed with andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. The solvent was evaporated to give pale brown oil (0.76 g),which was dissolved in dichloromethane (50 ml). To the mixture wasdropwise added the solution of sodium boron hydride in methanol at -10°C. After starting materials disappeared, water was added to the reactionmixture, and the mixture was concentrated extracted with ethyl acetate.The organic layer was washed with and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate, and the solventwas evaporated. To the residue were added 1N sodium hydroxide (20 ml)and methanol (200 ml), and the mixture was stirred at room temperaturefor 3 hours, concentrated and acidified with hydrochloric acid. Themixture was extracted with ethyl acetate. The organic layer was washedwith and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate, and the solvent was evaporated. The residue wasdissolved in Diglyme (50 ml), and to the mixture was added hydrochloricacid (10 ml). The mixture was stirred at 100° C. for 30 minutes andpoured into water. The mixture was extracted with ethyl acetate. Theorganic layer was washed with and saturated sodium chloride solution,and dried with anhydrous magnesium sulfate. The solvent was evaporatedto give7-(4-methylphenyl)-2-phenyl-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.4 g) as colorless crystals.

mp 296-297° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.40 (3H, s), 3.10-3.39 (2H, m),5.02 (1H, dd, J=1.8, 8.8 Hz), 7.10 (1H, d, J=8.4 Hz), 7.12-7.27 (2H, m),7.35-7.53 (8H, m), 7.58 (1H, d, J=2.2 Hz), 7.86 (1H, d, J=2.0 Hz).IR(KBr) ν: 1673 cm⁻¹. Anal. for C₂₄ H₂₀ O₃.0.1H₂ O: Calcd. C, 80.47; H,5.68. Found C, 80.41; H, 5.73.

REFERENCE EXAMPLE 66

In 1,2-dichloroethane (100 ml) were suspended p-nitrobenzylaminehydrochloride (7.5 g), 4H-tetrahydropyran-4-one (4.0 g) andtriethylamine (5.6 ml), and to the suspension was added sodiumtriacetoxy boron hydride (11.8 g) under ice-cooling. The mixture wasstirred under nitrogen atmosphere at room temperature for 5 hours. Tothe mixture were added 37% formalin (3.6 ml) and sodium triacetoxy boronhydride (11.8 g) under ice-cooling, and the mixture was stirred undernitrogen atmosphere at room temperature for 4 hours. The solvent wasevaporated, and the residue was neutralized with sodium hydroxide. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give brown oil (10 g), to which were added reduced iron (9g) and acetic acid (200 ml). The mixture was stirred at room temperatureover night. The solvent was evaporated, and to the residue was addedethyl acetate. The precipitate was filtered off, and the filtrate waswashed with sodium hydrogen carbonate solution, water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated to give4-(N-methyl-N-(tetrahydro-pyran-4-yl)aminomethyl)aniline (7.3 g) ascolorless crystals.

mp 93-94° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.65-1.76 (4H, m), 2.19 (3H, s),2.58-2.68 (1H, m), 3.36 (2H, dt, J=3.2, 11.3 Hz), 3.48 (2H, s), 3.60(2H, br), 4.00-4.05 (2H, m), 6.65 (2H, d, J=8.4 Hz), 7.09 (2H, d, J=8.4Hz). IR(KBr) ν: 2952, 2844, 2788, 1613 cm⁻¹. Anal. for C₁₃ H₂₀ N₂O.0.1H₂ O: Calcd. C, 70.30; H, 9.17; N, 12.61. Found C, 70.21; H, 8.85;N, 12.64.

REFERENCE EXAMPLE 67

In methanol (20 ml) was dissolved ethyl levulinate (10 g), and to themixture was added sodium boron hydride (0.7 g) at -78° C. The mixturewas warmed to room temperature, and to the mixture was added ammoniumchloride solution. The mixture was concentrated, extracted withdiethylether, and dried with anhydrous magnesium sulfate. The solventwas evaporated to give colorless oil (9.3 g), which was dissolved intetrahydrofuran (50 ml). To the mixture was added triethylamine (10.6ml) under ice-cooling, and to the mixture was dropwise addedmethane-sulfonylchloride (4.9 ml). The mixture was warmed to roomtemperature, and the solvent was evaporated. To the residue were addedsodium iodide (11.4 g) and acetone (50 ml), and the mixture was stirredat 50° C. for 2 hours. The solvent was evaporated, and to the residuewas added ethyl acetate. The precipitate was filtered off, and thesolvent was evaporated. The residue was purified with silica gel column(ethyl acetate/hexane) to give colorless oil (7.0 g), which wasdissolved in dimethylformamide (20 ml). The mixture was dropwise addedto a solution of methyl 5-bromosalicylate (1.8 g) and sodium hydride(60%, 0.33 g) in dimethylformamide (20 ml), under ice-cooling, and themixture was stirred at 50° C. over night. The solvent was evaporated,and to the residue was added water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/hexane) to give colorlessoil (1.1 g), which was dissolved in tetrahydrofuran (20 ml). The mixturewas dropwise added to a solution of lithium diisopropylamine, which wasprepared by diisopropylamine (0.37 g) and a solution of n-butyl lithiumin hexane (1.6M, 2.1 ml), in tetrahydrofuran, at -78° C. The mixture wasstirred at room temperature under argon atmosphere over night and pouredinto water. The mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to give colorless oil (0.3 g), which wasdissolved in dichloromethane (25 ml). The mixture was dropwise added toa solution of sodium boron hydride in methanol at -10° C. After startingmaterials disappeared, water was added to the reaction mixture, and themixture was concentrated and extracted with ethyl acetate. The organiclayer was washed with and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. The solvent was evaporated, and theresidue was dissolved in dichloromethane (25 ml). To the mixture wasadded triethylamine (0.74 ml), and to the mixture was dropwise addedmethanesulfonylchloride (0.15 ml) under ice-cooling. The mixture wasstirred at room temperature under nitrogen atmosphere over night, washedwith water and dried with anhydrous magnesium sulfate. The solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/hexane) to give colorless crystals (0.2 g), to which were added4-methylphenyl borate (0.1 g), 1M potassium carbonate (2.5 ml), ethanol(2.5 ml) and toluene (15 ml). The mixture was stirred under argonatmosphere at room temperature for 30 minutes, and to the mixture wasadded tetrakistriphenylphosphinepalladium (0.03 g). The mixture wasrefluxed over night and extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and the residue was purified with silica gel column(ethyl acetate/hexane) to give colorless crystals (0.2 g), to which wereadded 1N sodium hydroxide (5 ml) and methanol (50 ml). The mixture wasref luxed for 30 minutes, concentrated, acidified with hydrochloric acidand extracted with ethyl acetate. The organic layer was washed with andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. The solvent was evaporated to give7-(4-methylphenyl)-2-methyl-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.2 g) as colorless crystals.

mp 224-225° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.53 (3H, d, J=6.2 Hz), 2.40 (3H,s), 2.81 (1H, ddd, J=2.2, 8.8, 18.0 Hz), 3.08 (1H, d, J=18.0 Hz),4.17-4.27 (1H, m), 7.04 (1H, d, J=8.2 Hz), 7.24 (2H, d, J=7.4 Hz),7.44-7.52 (4H, m), 7.77 (1H, d, J=2.2 Hz). IR(KBr) ν: 2973, 1674 cm⁻¹.Anal. for C₁₉ H₁₈ O₃ : Calcd. C, 77.53; H, 6.16. Found C, 77.60; H,6.14.

REFERENCE EXAMPLE 68

In ethanol (10 ml) and ethyl acetate (60 ml) was dissolved4-methylphenyl 4-nitrobenzyl sulfone (0.5 g; G. Bram et al., Synthesis,1987, 56-59). To the mixture was added 10% palladium on carbon (0.05 g)and catalytic hydrogenation was carried out at room temperature overnight. The catalyst was filtered off, and the solvent was evaporated togive 4-aminobenzyl 4-methylphenyl sulfone (0.4 g) as colorless crystals.

¹ H-NMR(δ ppm, CDCl₃): 2.42 (3H, s), 4.18 (2H, s), 6.56 (2H, d, J=8.4Hz), 6.86 (2H, d, J=8.4 Hz), 7.24 (2H, d, J=8.2 Hz), 7.52 (2H, d, J=8.2Hz). IR(KBr) ν: 3443, 3370, 2926, 1612 cm⁻¹. Anal. for C₁₄ H₁₅ NOS,0.2H₂ O: Calcd. C, 63.47; H, 5.86; N, 5.29. Found C, 63.63; H, 5.86; N,5.09.

REFERENCE EXAMPLE 69

In 1,2-dichloroethane (50 ml) were suspended cyclo-pentanone (1 g),methylamine hydrochloride (1.6 g) and triethylamine (3.4 ml), and to thesuspension was added sodium triacetoxy boron hydride (3.5 g) underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The mixture was neutralized with sodiumhydroxide, concentrated and extracted with water. The aqueous layer waswashed with ethyl acetate. The aqueous layer was saturated with sodiumchloride and extracted with diethylether. The organic layer was driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give N-methylcyclopentylamine (0.5 g) as colorlessoil.

¹ H-NMR(δ ppm, CDCl₃): 1.21-1.86 (8H, m), 2.40 (3H, s), 2.94-3.01 (1H,m).

REFERENCE EXAMPLE 70

In 1,2-dichloroethane (50 ml) were suspended cyclo-heptanone (2 g),methylamine hydrochloride (3 g) and triethylamine (6.2 ml), and to thesuspension was added sodium triacetoxy boron hydride (5.3 g) underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature over night. The solvent was evaporated, and the residue wasneutralized with sodium hydroxide. The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give N-methylcycloheptylamine(1.8 g) as colorless oil.

¹ H-NMR(δ ppm, CDCl₃): 1.26-1.70 (10H, m), 1.77-1.89 (2H, m), 2.40 (3H,s), 2.47-2.58 (1H, m). IR(KBr) ν: 2933, 2860 cm⁻¹.

REFERENCE EXAMPLE 71

In tetrahydrofuran (100 ml) were added 4-amino-1-benzyl-piperidine (10g) and triethylamine (36 ml), and to the mixture was dropwise addedacetyl chloride (4.1 ml) under ice-cooling. The mixture was stirred atroom temperature for 1 hour, and the solvent was evaporated. To theresidue was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give colorless crystal (2.6 g),which was dissolved in tetrahydrofuran (10 ml). Under ice-cooling,borane methylsulfide (2.2 ml) was dropwise added to the solution. Undernitrogen atmosphere, the mixture was refluxed for 5 hours. Underice-cooling, methanol (10 ml) was added to the mixture, and the mixturewas stirred at room temperature for 1 hour. To the mixture was added 4Nhydrochloric acid-ethyl acetate, and the mixture was refluxed for 1hour. The solvent was evaporated, and to the residue was added 1N sodiumhydroxide. The mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give 4-ethylamino-1-benzylpiperidine (1.2 g)as colorless oil.

¹ H-NMR(δ ppm, CDCl₃): 1.10 (3H, t, J=7.2 Hz), 1.28-1.47 (2H, m),1.82-1.88 (2H, m), 1.95-2.07 (2H, m), 2.40-2.51 (1H, m), 2.66 (2H, q,J=7.2 Hz), 2.82-2.88 (2H, m), 3.50 (2H, s), 7.20-7.33 (5H, m).

REFERENCE EXAMPLE 72

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), 4-(4-methylpiperazin-1-yl)phenyl borate (0.44 g), 1M potassiumcarbonate (6 ml) and ethanol (6 ml) was added toluene (50 ml), and themixture was stirred under argon atmosphere at room temperature for 30minutes. To the mixture was added tetrakistriphenylphosphinepalladium(0.07 g), and the mixture was refluxed over night and extracted withethyl acetate. The organic layer was washed with water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate) to give colorlesscrystals (0.39 g), which were dissolved in 1N sodium hydroxide (15 ml)and methanol (100 ml). The mixture was refluxed for 2 hours,concentrated and neutralized with hydrochloric acid to precipitate7-(4-(4-methylpiperazin-1-yl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.33 g) as colorless crystals.

mp 278-279° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 2.24 (3H, s), 2.45-2.52(4H, m), 2.87 (2H, t, J=4.0 Hz), 3.15-3.20 (4H, m), 4.23 (2H, t, J=4.8Hz), 6.97-7.01 (3H, m), 7.49-7.62 (4H, m), 7.70 (1H, d, J=2.2 Hz).IR(KBr) ν: 1692 cm⁻¹. Anal. for C₂₂ H₂₄ N₂ O₃.0.5H₂ O: Calcd. C, 70.76;H, 6.75; N, 7.50. Found C, 70.87; H, 6.50; N, 7.56.

REFERENCE EXAMPLE 73

In 1,2-dichloroethane (35 ml) were suspended 4-methylcyclohexanone (2.5g), methylamine hydrochloride (1.6 g) and triethylamine (3.3 ml), and tothe suspension was added sodium triacetoxy boron hydride (6.6 g) underice-cooling. The mixture was stirred under nitrogen atmosphere at roomtemperature over night. The solvent was evaporated, and the residue wasneutralized with sodium hydroxide. The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated. To the residue was added 4Nhydrochloric acid-ethyl acetate, and the solvent was evaporated to giveN, 4-dimethyl-cyclohexylamine hydrochloride (2.6 g) as colorlesscrystals.

¹ H-NMR(δ ppm, CDCl₃): 0.90 (1.5H, d, J=6.6 Hz), 1.01 (1.5H, d, J=6.6Hz), 1.45-2.10 (8H, m), 2.19-2.26 (1H, m), 2.61-2.68 (3H, m), 3.03 (1H,br). Anal. for C₈ H₁₈ ClN: Calcd. C, 58.70; H, 11.08; N, 8.56. Found C,58.42; H, 10.91; N, 8.48.

REFERENCE EXAMPLE 74

In 1,2-dichloroethane (25 ml) were suspended p-nitrobenzylaminehydrochloride (1.2 g), tetrahydropyran-3-one (0.6 g; Numata et al.,JP-A-63-170372) and triethylamine (0.9 ml), and to the suspension wasadded sodium triacetoxy boron hydride (1.8 g) under ice-cooling. Undernitrogen atmosphere, the mixture was stirred at room temperature overnight. Under ice-cooling, to the mixture were added 37% formalin (0.6ml) and sodium triacetoxy boron hydride (1.8 g). Under nitrogenatmosphere, the mixture was stirred at room temperature over night, andthe solvent was evaporated. The residue was neutralized with sodiumhydroxide, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to give pale yellow oil (1.0 g), to whichwas added reduced iron (0.6 g) and acetic acid (50 ml). The mixture wasstirred at room temperature over night. The solvent was evaporated, andto the residue was added ethyl acetate. The precipitate was filteredoff, and the filtrate was washed with sodium hydrogen carbonatesolution, water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give4-(N-methyl-N-(tetrahydropyran-3-yl)aminomethyl)aniline (0.3 g) as brownoil.

¹ H-NMR(δ ppm, CDCl₃): 1.46-1.75 (3H, m), 1.95-2.01 (1H, m), 2.19 (3H,s), 2.55-2.68 (1H, m), 3.21-3.40 (2H, m), 3.49 (2H, s), 3.59 (2H, br),3.83-3.89 (1H, m), 4.00-4.08 (1H, m), 6.64 (2H, d, J=8.4 Hz), 7.07 (2H,d, J=8.4 Hz). IR(neat) ν: 2941, 2846, 1615 cm⁻¹.

REFERENCE EXAMPLE 75

In 1,2-dichloroethane (50 ml) were suspended 2-amino-indanehydrochloride (1.0 g), p-nitrobenzaldehyde (0.9 g) and triethylamine(0.9 ml), and to the mixture was added sodium triacetoxy boron hydride(1.8 g) under ice-cooling. Under nitrogen atmosphere, the mixture wasstirred at room temperature over night. Under ice-cooling, to themixture were added 37% formalin (0. 6 ml) and sodium triacetoxy boronhydride (1.8 g). Under nitrogen atmosphere, the mixture was stirred atroom temperature over night, and the solvent was evaporated. The residuewas neutralized with sodium hydroxide, and the mixture was extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated to givecolorless crystals (1.7 g), which was dissolved in ethanol (50 ml) andethyl acetate (50 ml). To the mixture was added 10% palladium on carbon(0.15 g), and catalytic hydrogenation was carried out at roomtemperature for 1 hour. The catalyst was filtered off, and the solventwas evaporated. The residue was purified with silica gel column (ethylacetate) to give 4-((N-indan-2-yl-N-methyl)aminomethyl)aniline (0.6 g)as colorless crystals.

mp 95-96° C.; ¹ H-NMR(δ ppm, CDCl₃): 2.17 (3H, s), 2.91-3.16 (4H, m),3.32-3.43 (1H, m), 3.47 (2H, s), 3.61 (2H, br), 6.66 (2H, d, J=8.8 Hz),7.10-7.22 (6H, m). IR(KBr) ν: 2782, 1623 cm⁻¹. Anal. for C₁₇ H₂₀N₂.0.2H₂ O: Calcd. C, 79.77; H, 8.03; N, 10.94. Found C, 79.87; H, 8.04;N, 10.75.

REFERENCE EXAMPLE 76

In 1,2-dichloroethane (50 ml) were suspended p-nitrobenzylaminehydrochloride (1.9 g), 4-t-butylcyclohexanone (1.5 g) and triethylamine(1.4 ml), and to the suspension was added sodium triacetoxy boronhydride (3 g) under ice-cooling. Under nitrogen atmosphere, the mixturewas stirred at room temperature over night. Under ice-cooling, to themixture were added 37% formalin (0.9 ml) and sodium triacetoxy boronhydride (3 g). Under nitrogen atmosphere, the mixture was stirred atroom temperature over night, and the solvent was evaporated. The residuewas neutralized with sodium hydroxide, and the mixture was extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue was purified with silica gel column (ethyl acetate/hexane)y togive (E)-N-(4-t-butylcyclohexyl)-N-methyl-N-(4-nitro-benzyl)amine (0.3g) as colorless crystals and(Z)-N-(4-t-butylcyclohexyl)-N-methyl-N-(4-nitrobenzyl)amine (2.4 g) asyellow oil. (E)-N-(4-t-butylcyclohexyl)-N-methyl-N-(4-nitrobenzyl)amine:

mp 96-97° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.85 (9H, s), 0.94-1.05 (3H, m),1.20-1.40 (2H, m), 1.80-2.00 (4H, m), 2.19 (3H, s), 2.29-2.44 (1H, m),3.65 (2H, s), 7.51 (2H, d, J=8.4 Hz), 8.17 (2H, d, J=8.4 Hz). IR(KBr) ν:2941, 1604, 1513 cm⁻¹. Anal. for C₁₈ H₂₈ N₂ O₂ : Calcd. C, 71.02; H,9.27; N, 9.20. Found C, 70.77; H, 9.26; N, 9.32.

(Z)-N-(4-t-butylcyclohexyl)-N-methyl-N-(4-nitrobenzyl)amine:

¹ H-NMR(δ ppm, CDCl₃): 0.89 (9H, s), 1.15-1.20 (1H, m), 1.30-1.54 (6H,m), 1.97-2.10 (2H, m), 2.08 (3H, s), 2.38 (1H, br), 3.61 (2H, s), 7.52(2H, d, J=8.4 Hz), 8.18 (2H, d, J=8.4 Hz). IR(neat) ν: 2943, 1606, 1521cm⁻¹.

REFERENCE EXAMPLE 77

In ethanol (25 ml) and ethyl acetate (25 ml) was dissolved(E)-N-(4-t-butylcyclohexyl)-N-methyl-N-(4-nitrobenzyl)amine (0.3 g). Tothe mixture was added 10% palladium on carbon (0.03 g) and catalytichydrogenation was carried out at room temperature for 1 hour. Thecatalyst was filtered off, and the solvent was evaporated. The residuewas purified with silica gel column (ethylacetate/methanol/triethylamine) to give(E)-4-((N-4-t-butylcyclohexyl-N-methyl)aminomethyl)aniline (0.2 g) ascolorless crystals.

mp 87-88° C.; ¹ H-NMR(δ ppm, CDCl₃): 0.84 (9H, s), 0.93-1.03 (2H, m),1.15-1.40 (2H, m), 1.81-1.96 (5H, m), 2.19 (3H, s), 2.30-2.45 (1H, m),3.48 (2H, s), 3.60 (2H, br), 6.65 (2H, d, J=8.4 Hz), 7.10 (2H, d, J=8.4Hz). IR(KBr) ν: 2927, 1614, 1517 cm⁻¹. Anal. for C₁₈ H₃₀ N₂.0.2H₂ O:Calcd. C, 77.75; H, 11.02; N, 10.07. Found C, 77.87; H, 10.93; N, 10.16.

REFERENCE EXAMPLE 78

In acetic acid (70 ml) was dissolved(Z)-N-(4-t-butylcyclohexyl)-N-methyl-N-(4-nitrobenzyl)amine (1.2 g), andto the mixture was added reduced iron (1.1 g). The mixture was stirredat room temperature over night. The solvent was evaporated, and to theresidue was added ethyl acetate. The precipitate was filtered off, andthe filtrate was washed with sodium hydrogen carbonate solution, waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethyl acetate togive (Z)-4-((N-4-t-butylcyclohexyl-N-methyl)aminomethyl)aniline (0.7 g)as yellow oil.

¹ H-NMR(δ ppm, CDCl₃): 0.87 (9H, s), 1.00-1.20 (1H, m), 1.25-1.56 (6H,m), 2.04 (3H, s), 2.04-2.13 (2H, m), 2.26-2.29 (1H, m), 3.40 (2H, s),3.58 (2H, br), 6.65 (2H, d, J=8.4 Hz), 7.10 (2H, d, J=8.4 Hz). IR(neat)ν: 2941, 1623, 1515 cm⁻¹.

REFERENCE EXAMPLE 79

In 1,2-dichloroethane (70 ml) were suspended p-nitrobenzylaminehydrochloride (3.8 g), 3,5-dimethylcyclohexanone (2.5 g) andtriethylamine (2.8 ml). Under ice-cooling, to the mixture was addedsodium triacetoxy boron hydride (5.9 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. Under ice-cooling,to the mixture were added 37% formalin (1.8 ml) and sodium triacetoxyboron hydride (5.9 g). Under nitrogen atmosphere, the mixture wasstirred at room temperature over night. The solvent was evaporated, andthe residue was neutralized with sodium hydroxide. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/hexane) to give 3 isomers ofN-methyl-N-(3,5-dimethylcyclohexyl)-N-(4-nitrobenzyl)amine (4.3 g;(31-a), 0.7 g; (31-b), 0.2 g; (31-c)) as each yellow oil.

31-a: ¹ H-NMR(δ ppm, CDCl₃): 0.53-0.74 (1H, m), 0.84 (3H, s), 0.87 (3H,s), 0.93-1.07 (2H, m), 1.73-1.99 (5H, m), 2.06 (3H, s), 2.49 (1H, t,J=2.8 Hz), 3.60 (2H, s), 7.50 (2H, d, J=8.8 Hz), 8.17 (2H, d, J=8.8 Hz).IR(neat) ν: 2949, 1606, 1521 cm⁻¹.

31-b: ¹ H-NMR(δ ppm, CDCl₃): 0.51 (1H, q, J=12.0 Hz), 0.80-1.02 (2H, m),0.92 (3H, s), 0.95 (3H, s), 1.34-1.53 (2H, m), 1.58-1.66 (1H, m),1.78-1.84 (2H, m), 2.19 (3H, s), 2.53 (1H, tt, J=3.3, 11.7 Hz), 3.65(2H, s), 7.51 (2H, d, J=8.8 Hz), 8.17 (2H, d, J=8.8 Hz). IR(neat) ν:2949, 1606, 1519 cm⁻¹.

31-c: ¹ H-NMR(δ ppm, CDCl₃): 0.80-1.13 (8H, m), 1.38-1.52 (2H, m),1.62-1.68 (2H, m), 1.80-1.86 (1H, m), 2.08-2.17 (1H, m), 2.18 (3H, s),2.74 (1H, tt, J=3.5, 11.9 Hz), 3.64 (2H, s), 7.51 (2H, d, J=8.4 Hz),8.17 (2H, d, J=8.4 Hz). IR(neat) ν: 2920, 1606, 1521 cm⁻¹.

REFERENCE EXAMPLE 80

In ethanol (50 ml) and ethyl acetate (50 ml) was dissolvedN-methyl-N-(3,5-dimethylcyclohexyl)-N-(4-nitrobenzyl)amine (2.0 g;(31-a)). To the mixture was added 10% palladium on carbon (0.2 g) andcatalytic hydrogenation was carried out at room temperature for 1 hour.The catalyst was filtered off, and the solvent was evaporated. Theresidue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give4-((N-(3,5-dimethylcyclohexyl)-N-methyl)aminomethyl)aniline (0.2 g) aspale yellow oil.

¹ H-NMR(δ ppm, CDCl₃): 0.58 (1H, q, J=11.7 Hz), 0.83 (3H, s), 0.86 (3H,s), 0.93-1.00 (2H, m), 1.69-2.04 (5H, m), 2.04 (3H, s), 2.24-2.40 (1H,m), 3.41 (2H, s), 3.50 (2H, br), 6.64 (2H, d, J=8.6 Hz), 7.08 (2H, d,J=8.6 Hz). IR(neat) ν: 2947, 1623 cm⁻¹.

REFERENCE EXAMPLE 81

In acetic acid (30 ml) was dissolvedN-methyl-N-(3,5-dimethylcyclohexyl)-N-(4-nitrobenzyl)amine (0.7 g;(31-b)), and to the mixture was added reduced iron (0.7 g). The mixturewas stirred at room temperature over night. The solvent was evaporated,and to the residue was added ethyl acetate. The precipitate was filteredoff, and the filtrate was washed with sodium hydrogen carbonatesolution, water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give4-((N-(3,5-dimethylcyclohexyl)-N-methyl)aminomethyl)aniline (0.4 g) asyellow oil.

¹ H-NMR(δ ppm, CDCl₃): 0.50 (1H, q, J=12.0 Hz), 0.80-1.03 (1H, m), 0.91(3H, s), 0.94 (3H, s), 1.22-1.50 (3H, m), 1.55-1.64 (1H, m), 1.78-1.84(2H, m), 2.17 (3H, s), 2.53 (1H, tt, J=3.3, 11.8 Hz), 3.46 (2H, s), 3.58(2H, br), 6.64 (2H, d, J=8.6 Hz), 7.09 (2H, d, J=8.6 Hz). IR(neat) ν:2949, 1621 cm⁻¹.

REFERENCE EXAMPLE 82

In acetic acid (15 ml) was dissolvedN-methyl-N-(3,5-dimethylcyclohexyl)-N-(4-nitrobenzyl)amine (0.2 g;(31-c)), and to the mixture was added reduced iron (0.2 g). The mixturewas stirred at room temperature over night. The solvent was evaporated,and to the residue was added ethyl acetate. The precipitate was filteredoff, and the filtrate was washed with sodium hydrogen carbonatesolution, water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/methanol/triethyl-amine) to give4-((N-(3,5-dimethylcyclohexyl)-N-methyl)aminomethyl)aniline (0.1 g) asbrown oil.

¹ H-NMR(δ ppm, CDCl₃): 0.87-1.15 (7H, m), 1.35-1.55 (2H, m), 1.60-1.70(2H, m), 1.75-1.90 (1H, m), 2.05-2.19 (2H, m), 2.17 (3H, s), 2.75 (1H,tt, J=3.3, 12.1 Hz), 3.45 (2H, s), 3.60 (2H, br), 6.64 (2H, d, J=8.3Hz), 7.09 (2H, d, J=8.3 Hz).

REFERENCE EXAMPLE 83

In 1,2-dichloroethane (50 ml) were dissolved n-propyl-amine (1.1 g) andp-nitrobenzaldehyde (2.3 g). Under ice-cooling, to the mixture was addedsodium triacetoxy boron hydride (4.5 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. Under ice-cooling,to the mixture were added 37% formalin (1.7 ml) and sodium triacetoxyboron hydride (4.5 g). Under nitrogen atmosphere, the mixture wasstirred at room temperature over night, and the solvent was evaporated.The residue was neutralized with sodium hydroxide, and the mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/hexane) to give pale yellow oil (2.3 g), which was dissolved intetrahydrofuran (10 ml). The mixture was dropwise added to a solution,which was prepared by adding dropwise lithium aluminum hydride (0.5 g)to a solution of titanium tetrachloride (2 ml) in tetrahydrofuran (50ml), under ice-cooling, and stirring the mixture at room temperature for15 minutes, under ice-cooling. The mixture was stirred at roomtemperature for 30 minutes, and to the mixture were added water (50 ml)and ammonia solution (50 ml). The mixture was concentrated and extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give4-((N-methyl-N-n-propyl)aminomethyl)aniline (0.25 g) as yellow oil.

¹ H-NMR(δ ppm, CDCl₃): 0.88 (3H, t, J=7.3 Hz), 1.43-1.61 (2H, m), 2.16(3H, s), 2.30 (2H, t, J=7.7 Hz), 3.37 (2H, s), 3.59 (2H, br), 6.64 (2H,d, J=8.0 Hz), 7.08 (2H, d, J=8.0 Hz). IR(neat) ν: 2960, 1623, 1517 cm⁻¹.

REFERENCE EXAMPLE 84

In 1,2-dichloroethane (50 ml) were dissolved isopropylamine (1 g) andp-nitrobenzaldehyde (2.3 g), and to the mixture was added sodiumtriacetoxy boron hydride (4.5 g) under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night.Under ice-cooling, to the mixture were added 37% formalin (1.5 ml) andsodium triacetoxy boron hydride (4.5 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. The solvent wasevaporated, and the residue was neutralized with sodium hydroxide. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/hexane) to give yellow oil (2.8 g), 1.5 g of which was dissolvedin ethanol (25 ml) and ethyl acetate (25 ml). To the mixture was added10% palladium on carbon (0.15 g), and catalytic hydrogenation wascarried out at room temperature for 1 hour. The catalyst was filteredoff, and the solvent was evaporated. The residue was purified withsilica gel column (ethyl acetate/methanol/triethylamine) to give4-((N-isopropyl-N-methyl)aminomethyl)aniline (0.17 g) as pale yellowoil.

¹ H-NMR(δ ppm, CDCl₃): 1.05 (6H, d, J=6.6 Hz), 2.13 (3H, s), 2.81-2.95(1H, m), 3.40 (2H, s), 3.60 (2H, br), 6.65 (2H, d, J=8.4 Hz), 7.10 (2H,d, J=8.4 Hz). IR(neat) ν: 2966, 1623, 1517 cm⁻¹.

REFERENCE EXAMPLE 85

In 1,2-dichloroethane (50 ml) were dissolved 1-methylpropylamine (1.3 g)and p-nitrobenzaldehyde (2.3 g), and to the mixture was added sodiumtriacetoxy boron hydride (4.5 g) under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night.Under ice-cooling, to the mixture were added 37% formalin (1.7 ml) andsodium triacetoxy boron hydride (4.5 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. The solvent wasevaporated, and the residue was neutralized with sodium hydroxide. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give brown oil (3.4 g), 2.0 g of which was dissolved intetra-hydrofuran (20 ml). The mixture was dropwise added to a solution,which was prepared by adding dropwise lithium-aluminum hydride (0.7 g)to a solution of titanium tetrachloride (3 ml) in tetrahydrofuran (50ml) under ice-cooling and stirring the mixture at room temperature for15 minutes, under ice-cooling. The mixture was stirred at roomtemperature over night, and, to the mixture were added water (75 ml) andammonia solution (75 ml). The mixture was extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/methanol/triethylamine) to give4-((N-sec-butyl-N-methyl)aminomethyl)aniline (0.8 g) as yellow oil.

¹ H-NMR(δ ppm, CDCl₃): 0.87-0.99 (6H, m), 1.22-1.37 (1H, m), 1.53-1.63(1H, m), 2.11 (3H, s), 2.53-2.63 (1H, m), 3.34 (1H, d, J=12.8 Hz), 3.46(1H, d, J=12.8 Hz), 3.57 (2H, br), 6.64 (2H, d, J=8.4 Hz), 7.11 (2H, d,J=8.4 Hz). IR(neat) ν: 2962, 2933, 2873, 1617, 1517 cm⁻¹.

REFERENCE EXAMPLE 86

In 1,2-dichloroethane (70 ml) were dissolved t-butylamine (1.6 g) andp-nitrobenzaldehyde (3.0 g), and to the mixture was added sodiumtriacetoxy boron hydride (5.9 g) under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature over night.Under ice-cooling, to the mixture were added 37% formalin (2 ml) andsodium triacetoxy boron hydride (5.9 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. The solvent wasevaporated, and the residue was neutralized with sodium hydroxide. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, to give brown oil (4.4 g), which was dissolved in aceticacid (50 ml). To the mixture was added reduced iron (3.2 g), and themixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added ethyl acetate. The precipitatewas filtered off, and the filtrate was washed with sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give4-((N-t-butyl-N-methyl)aminomethyl)aniline (2.2 g) as brown oil.

¹ H-NMR(δ ppm, CDCl₃): 1.14 (9H, s), 2.07 (3H, s), 3.38 (2H, s), 3.57(2H, br), 6.64 (2H, d, J=8.4 Hz), 7.11 (2H, d, J=8.4 Hz). IR(neat) ν:2971, 1622, 1516 cm⁻¹.

REFERENCE EXAMPLE 87

In 1,2-dichloroethane (70 ml) were suspended p-nitrobenzylaminehydrochloride (3.8 g) and 3-pentanone (1.7 g), and to the suspension wasadded triethylamine (2.8 ml). Under ice-cooling, to the mixture wasadded sodium triacetoxy boron hydride (5.9 g). Under nitrogenatmosphere, the mixture was stirred at room temperature over night.Under ice-cooling, to the mixture were added 37% formalin (1.8 ml) andsodium triacetoxy boron hydride (5.9 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. The solvent wasevaporated, and the residue was neutralized with sodium hydroxide. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give pale yellow oil (4.6 g), which was dissolved inacetic acid (100 ml). To the mixture was added reduced iron (4.7 g), andthe mixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added ethyl acetate. The precipitatewas filtered off, and the filtrate was washed with sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give4-((N-methyl-N-(pentan-3-yl))-aminomethyl)aniline (3.3 g) as pale brownoil.

¹ H-NMR(δ ppm, CDCl₃): 0.92 (6H, t, J=7.3 Hz), 1.20-1.59 (4H, m), 2.10(3H, s), 2.18-2.29 (1H, m), 3.44 (2H, s), 3.57 (2H, br), 6.64 (2H, d,J=8.4 Hz), 7.11 (2H, d, J=8.4 Hz). IR(neat) ν: 2959, 1622, 1516 cm⁻¹.

REFERENCE EXAMPLE 88

In 1,2-dichloroethane (70 ml) were suspended p-nitrobenzylaminehydrochloride (3.8 g) and norcamphor (2.2 g), and to the suspension wasadded triethylamine (2.8 ml). Under ice-cooling, to the mixture wasadded sodium triacetoxy boron hydride (5.9 g). Under nitrogenatmosphere, the mixture was stirred at room temperature over night.Under ice-cooling, to the mixture were added 37% formalin (1.8 ml) andsodium triacetoxy boron hydride (5.9 g). Under nitrogen atmosphere, themixture was stirred at room temperature over night. The solvent wasevaporated, and the residue was neutralized with sodium hydroxide. Themixture was extracted with ethyl acetate. The organic layer was washedwith water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give pale yellow oil (5.2 g), which was dissolved inacetic acid (100 ml). To the mixture was added reduced iron (5 g), andthe mixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added ethyl acetate. The precipitatewas filtered off, and the filtrate was washed with sodium hydrogencarbonate solution, water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give4-((N-methyl-N-(norbornan-2-yl))amino-methyl)aniline (4.0 g) as palebrown oil.

¹ H-NMR(δ ppm, CDCl₃): 0.94-1.04 (1H, m), 1.22-1.55 (5H, m), 1.68-1.97(2H, m), 2.00 (3H, s), 2.16 (1H, br), 2.37 (2H, br), 3.22 (1H, d, J=12.8Hz), 3.42 (1H, d, J=12.8 Hz), 3.58 (2H, br), 6.64 (2H, d, J=8.4 Hz),7.09 (2H, d, J=8.4 Hz). IR(neat) ν: 2949, 1622, 1516 cm⁻¹.

REFERENCE EXAMPLE 89

To a mixture of p-nitrophenethylbromide (2.3 g), N-methylcyclohexylamine(2.8 g), potassium carbonate (6.6 g) and sodium iodide (1.5 g) was addeddimethylformamide (50 ml), and the mixture was stirred at 50° C. overnight. The solvent was evaporated, and to the residue was added water.The mixture was extracted with ethyl acetate. The organic layer waswashed with water and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give yellow oil (2.2 g), which wasdissolved in ethanol (50 ml). To the mixture was added 10% palladium oncarbon (0.2 g), and catalytic hydrogenation was carried out at roomtemperature over night. The catalyst was filtered off, and the solventwas evaporated to give 4-(2-(N-cyclohexyl-N-methyl)aminoethyl)aniline(1.9 g) as pale yellow oil.

¹ H-NMR(δ ppm, CDCl₃): 1.05-1.30 (6H, m), 1.60-1.79 (4H, m), 2.33 (3H,s), 2.33-2.45 (1H, m), 2.61-2.63 (4H, m), 3.55 (2H, br), 6.63 (2H, d,J=8.4 Hz), 6.99 (2H, d, J=8.4 Hz). IR(neat) ν: 2929, 1625, 1517 cm⁻¹.

REFERENCE EXAMPLE 90

In ethanol (15 ml) were dissolved p-nitrostyreneoxide (0.5 g; E.Borredon et al., J. Org. Che., 1990, 55, 501-504) and piperidine (0.36ml), and the mixture was refluxed for 1 hour. The solvent was evaporatedto give yellow crystals (0.53 g), which was dissolved in ethanol (50ml). To the mixture was added 5% palladium on carbon (0.05 g), andcatalytic hydrogenation was carried out at room temperature 1.5 hours.The catalyst was filtered off, and the solvent wasevaporated,4-(1-hydroxy-2-piperidinoethyl)aniline (0.4 g) as colorlesscrystals.

mp 75-76° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.40-1.50 (2H, m), 1.55-1.70 (4H,m), 2.31-2.41 (4H, m), 2.62-2.75 (2H, m), 3.61 (2H, br), 4.61 (1H, dd,J=6.2, 8.0 Hz), 6.66 (2H, d, J=8.4 Hz), 7.15 (2H, d, J=8.4 Hz). IR(KBr)ν: 2936, 1622, 1518 cm⁻¹. Anal. for C₁₃ H₂₀ N₂ O: Calcd. C, 70.87; H,9.15; N, 12.72. Found C, 71.02; H, 9.10; N, 13.01.

REFERENCE EXAMPLE 91

In dimethylformamide (50 ml) were dissolved methyl 5-bromosalicylate (5g), ethyl 4-bromobutyrate (4.2 g) and potassium carbonate (7.5 g), andthe mixture was stirred at room temperature over night. The solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/hexane) to give colorless oil (6.5 g), which was dissolved intetrahydrofuran (20 ml). The mixture was dropwise added to a solution oflithium diisopropylamine in tetrahydrofuran prepared by diisopropylamine(3.2 ml) and n-butyllithium in hexane (1.6M, 13 ml), at -78° C. Themixture was stirred at room temperature under argon atmosphere overnight and poured into water. The mixture was extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give oil, which wasdissolved in dichloromethane (100 ml). The mixture was dropwise added toa solution of sodium boron hydride in methanol at -15° C. After startingmaterials disappeared, water was added to the reaction mixture, and themixture was concentrated and extracted with ethyl acetate. The organiclayer was washed with and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. The solvent was evaporated, and theresidue was dissolved in dichloromethane (100 ml). To the mixture wasadded triethylamine (7.9 ml), and to the mixture was dropwise addedmethanesulfonylchloride (2.2 ml) under ice-cooling. The mixture wasstirred at room temperature under nitrogen atmosphere over night, and tothe mixture was added water. The mixture was concentrated and extractedwith ethyl acetate. The organic layer was washed with and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.The solvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to give ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (2.3 g) as colorlesscrystals.

mp 86-87° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.35 (3H, t, J=7.2 Hz), 2.98 (2H,t, J=4.7 Hz), 4.23-4.33 (4H, m), 6.86 (1H, d, J=8.8 Hz), 7.32 (1H, dd,J=2.6, 8.8 Hz), 7.46-7.47 (2H, m).

REFERENCE EXAMPLE 92

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), diethyl (3-pyridyl)-borane (0.26 g), 1M potassium carbonate (6ml) and ethanol (6 ml) was added toluene (50 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphinepalladium (0.07 g), andthe mixture was refluxed over night. The mixture was extracted withethyl acetate, and the organic layer was washed with water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/hexane) to give colorlesscrystals (0.28 g), which were dissolved in 1N sodium hydroxide (10 ml)and methanol (50 ml). The mixture was stirred at room temperature overnight, concentrated and neutralized with hydrochloric acid toprecipitate 7-(3-pyridyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.3 g) as colorless crystals.

mp>300° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 2.89 (2H, t, J=4.6 Hz), 4.27 (2H,t, J=4.6 Hz), 7.09 (1H, d, J=8.4 Hz), 7.46 (1H, dd, J=4.6, 7.8 Hz),7.64-7.69 (2H,m), 7.90 (1H, d, J=2.2 Hz), 8.10 (1H, dt, J=7.8, 1.5 Hz),8.54 (1H, dd, J=1.5, 4.6 Hz), 8.92 (1H, d, J=2.2 Hz). IR(KBr) ν: 1699cm⁻¹. Anal. for C₁₆ H₁₃ NO₃.0.2H₂ O: Calcd. C, 70.94; H, 4.99; N, 5.17.Found C, 70.71; H, 5.00; N, 5.17.

REFERENCE EXAMPLE 93

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(1.0 g), 4-pyridyl borate (0.46 g), 1M potassium carbonate (11 ml) andethanol (11 ml) was added toluene (80 ml), and the mixture was stirredunder argon atmosphere at room temperature for 30 minutes. To themixture was added tetrakistriphenylphosphinepalladium (0.16 g), and themixture was refluxed over night and extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless oil (0.52 g),which was dissolved in 1N sodium hydroxide (18 ml) and methanol (100ml). The mixture was stirred at room temperature over night,concentrated and neutralized with hydrochloric acid to precipitate7-(4-pyridyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.34 g) ascolorless crystals.

mp 277-278° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 2.89 (2H, t, J=4.8 Hz),4.28 (2H, t, J=4.8 Hz), 7.10 (1H, d, J=8.6 Hz), 7.68 (1H, s), 7.74-7.79(3H, m), 8.02 (1H, d, J=2.2 Hz), 8.61 (2H, d, J=5.6 Hz). Anal. for C₁₆H₁₃ NO₃.0.1H₂ O: Calcd. C, 71.42; H, 4.94; N, 5.21. Found C, 71.30; H,4.80; N, 5.05.

REFERENCE EXAMPLE 94

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), 2-furyl borate (0.22 g), 1M potassium carbonate (6 ml) andethanol (6 ml) was added toluene (50 ml) and, the mixture was stirredunder argon atmosphere at room temperature for 30 minutes. To themixture was added tetrakistriphenylphosphinepalladium (0.07 g), and themixture was refluxed over night and extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystals(0.37 g), which were dissolved in 1N sodium hydroxide (10 ml) andmethanol (50 ml). The mixture was stirred at room temperature overnight, concentrated and acidified with hydrochloric acid. The mixturewas extracted with ethyl acetate. The organic layer was washed withwater and saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive 7-(2-furyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.3 g) ascolorless crystals.

mp 234-235° C.(dec.). ¹ H-NMR(δ ppm, CDCl₃): 3.02 (2H, t, J=4.7 Hz),4.32 (2H, t, J=4.7 Hz), 6.47 (1H, dd, J=1.5, 3.2 Hz), 6.58 (1H, dd,J=0.7, 3.2 Hz), 7.02 (1H, d, J=8.6 Hz), 7.46 (1H, dd, J=0.7, 1.5 Hz),7.57 (1H, dd, J=2.2, 8.6 Hz), 7.68 (1H, d, J=2.2 Hz), 7.77 (1H, s).IR(KBr) ν: 1686 cm⁻¹. Anal. for C₁₅ H₁₂ O₄ : Calcd. C, 70.31; H, 4.72.Found C, 70.31; H, 4.73.

REFERENCE EXAMPLE 95

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), 4-dimethylaminophenyl borate (0.3 g), 1M potassium carbonate (6ml) and ethanol (6 ml) was added toluene (50 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphinepalladium (0.07 g), andthe mixture was ref luxed over night and extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give pale yellow crystals(0.45 g), which were dissolved in 1N sodium hydroxide (15 ml), methanol(100 ml) and tetrahydrofuran (25 ml). The mixture was stirred at roomtemperature over night, concentrated and neutralized with hydrochloricacid to precipitate7-(4-dimethylaminophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.4 g) as pale yellow crystals.

mp 281-282° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 2.87 (2H, t, J=4.6 Hz),2.93 (6H, s), 4.23 (2H, t, J=4.6 Hz), 6.78 (2H, d, J=8.8 Hz), 6.99 (1H,d, J=8.4 Hz), 7.47-7.54 (3H, m), 7.62 (1H, s), 7.67 (1H, d, J=2.2 Hz).IR(KBr) ν: 1676 cm⁻¹. Anal. for C₁₉ H₁₉ NO₃ : Calcd. C, 73.77; H, 6.19;N, 4.53. Found C, 73.57; H, 6.22; N, 4.64.

REFERENCE EXAMPLE 96

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g),4-(pyrrolidin-1-yl)phenylborate (0.35 g), 1M potassium carbonate(6 ml) and ethanol (6 ml) was added toluene (50 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphinepalladium (0.07 g), andthe mixture was refluxed over night and extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give pale yellow crystals(0.55 g), which were dissolved in 1N sodium hydroxide (15 ml), methanol(25 ml) and tetrahydrofuran (25 ml). The mixture was stirred at roomtemperature over night, concentrated and neutralized with hydrochloricacid to precipitate7-(4-(pyrrolidin-1-yl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.5 g) as pale yellow crystals.

mp 266-267° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 1.94-2.00 (4H, m), 2.87(2H, t, J=4.4 Hz), 3.25-3.30 (4H, m), 4.22 (2H, t, J=4.4 Hz), 6.59 (2H,d, J=8.8 Hz), 6.98 (1H, d, J=8.4 Hz), 7.45-7.52 (3H, m), 7.61 (1H, s),7.65 (1H, d, J=2.2 Hz). IR(KBr) ν: 1678 cm⁻¹. Anal. for C₂₁ H₂₁NO₃.0.2H₂ O: Calcd. C, 74.40; H, 6.36; N, 4.13. Found C, 74.49; H, 6.39;N, 4.47.

REFERENCE EXAMPLE 97

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), 4-piperidinophenyl borate (0.38 g), 1M potassium carbonate (6ml) and ethanol (6 ml) was added toluene (50 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphinepalladium (0.07 g), andthe mixture was refluxed over night and extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystals(0.62 g), which were dissolved in 1N sodium hydroxide (10 ml), methanol(25 ml) and tetrahydrofuran (25 ml). The mixture was stirred at roomtemperature over night, concentrated and neutralized with hydrochloricacid to precipitate7-(4-piperidino-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.6g) as pale yellow crystals.

mp 262-263° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 1.50-1.75 (6H, m), 2.87(2H, t, J=4.8 Hz), 3.15-3.19 (4H, m), 4.23 (2H, t, J=4.8 Hz), 6.96 (2H,d, J=8.8 Hz), 7.00 (1H, d, J=8.4 Hz), 7.51 (1H, dd, J=2.4, 8.4 Hz), 7.52(2H, d, J=8.8 Hz), 7.62 (1H, s), 7.68 (1H, d, J=2.4 Hz). IR(KBr) ν:2932, 1690 cm⁻¹.

REFERENCE EXAMPLE 98

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), 4-morpholinophenyl borate (0.39 g), 1M potassium carbonate (6ml) and ethanol (6 ml) was added toluene (50 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphinepalladium (0.07 g), andthe mixture was refluxed for 4 hours and extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystals(0.54 g), which were dissolved in 1N sodium hydroxide (15 ml), methanol(100 ml) and tetrahydrofuran (100 ml). The mixture was stirred at roomtemperature over night, concentrated and neutralized with hydrochloricacid to precipitate7-(4-morpholino-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.44 g) as colorless crystals.

mp 291-292° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 2.87 (2H, t, J=4.8 Hz),3.12-3.17 (4H, m), 3.73-3.78 (4H, m), 4.23 (2H, t, J=4.8 Hz), 7.00 (3H,d, J=8.4 Hz), 7.51 (1H, dd, J=2.4, 8.4 Hz), 7.56 (2H, d, J=8.8 Hz), 7.60(1H, s), 7.69 (1H, d, J=2.4 Hz). Anal. for C₂₁ H₂₁ NO₄ : Calcd. C,71.78: H, 6.02: N, 3.99. Found C, 71.42; H, 6.19; N, 4.16.

REFERENCE EXAMPLE 99

To a mixture of ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.5 g), 4-(1-imidazolyl)phenyl borate (0.38 g), 1M potassium carbonate(7 ml) and ethanol (7 ml) was added toluene (50 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphinepalladium (0. 07 g), andthe mixture was refluxed for 4 hours and extracted with ethyl acetate.The organic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate) to give colorless crystals (0.53 g),which were dissolved in 1N sodium hydroxide (10 ml) and methanol (50ml). The mixture was stirred at room temperature over night,concentrated and neutralized with hydrochloric acid to precipitate7-(4-(1-imidazolyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.44 g) as colorless crystals.

mp>300° C.; ¹ H-NMR(δ ppm, DMSO-d₆): 2.89 (2H, t, J=4.5 Hz), 4.26 (2H,t, J=4.5 Hz), 7.07 (1H, d, J=8.4 Hz), 7.13 (1H, s), 7.55-7.68 (3H, m),7.73 (2H, d, J=8.8 Hz), 7.81 (1H, s), 7.85 (2H, d, J=8.8 Hz), 8.33 (1H,s). Anal. for C₂₀ H16N₂ O₃.0.3H₂ O: Calcd. C, 71.12; H, 4.95; N, 8.29.Found C, 71.15; H, 4.84; N, 8.21.

REFERENCE EXAMPLE 100

In 1,2-dichloroethane (100 ml) was suspended p-nitrobenzylaminehydrochloride (8.1 g), 4H-tetrahydrothiopyran-4-one (5.0 g) andtriethylamine (6 ml), and to the suspension was added sodium triacetoxyboron hydride (12.8 g) under ice-cooling. Under nitrogen atmosphere, themixture was stirred at room temperature for 9 hours. Under ice-cooling,to the mixture were added 37% formalin (3.9 ml) and sodium triacetoxyboron hydride (12.8 g). Under nitrogen atmosphere, the mixture wasstirred at room temperature over night. The solvent was evaporated, andthe residue was neutralized with sodium hydroxide. The mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive yellow oil (11.5 g), to which were added reduced iron (12 g) andacetic acid (200 ml). The mixture was stirred at room temperature overnight. The solvent was evaporated, and to the residue was added ethylacetate. The precipitate was filtered off, and the filtrate was washedwith sodium hydrogen carbonate solution, water and saturated sodiumchloride solution, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate/methanol/triethylamine)to give 4-(N-methyl-N-(tetrahydrothiopyran-4-yl)aminomethyl)aniline (8.8g) as pale yellow crystals.

mp 88-89° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.65-1.84 (2H, m), 2.10-2.18 (2H,m), 2.19 (3H, s), 2.45 (1H, tt, J=3.2, 13.0 Hz), 2.65-2.71 (4H, m), 3.47(2H, s), 3.61 (2H, br), 6.64 (2H, d, J=8.4 Hz), 7.08 (2H, d, J=8.4 Hz).IR(KBr) ν: 2932, 1620 cm⁻¹. Anal. for C₁₃ H₂₀ N₂ S: Calcd. C, 66.06; H,8.53; N, 11.85. Found C, 66.03; H, 8.35; N, 11.78.

REFERENCE EXAMPLE 101

A mixture of sodium methoxide (12.5 g) and dimethyl carbonate (150 ml)was added to 3-bromo-6,7,8,9-tetrahydro-5H-benzocycloheptan-5-one (10.8g), and the mixture was refluxed for 8 hours under nitrogen atmosphere.Under ice-cooling, the mixture was poured into 1N hydrochloric acid, andthe mixture was extracted with ethyl acetate. The organic layer waswashed with and saturated sodium chloride solution, and dried withanhydrous magnesium sulfate. The solvent was evaporated to give brownoil (13.1 g), which was dissolved in dichloromethane (150 ml). To themixture was dropwise added sodium boron hydride dissolved in methanol,under ice-cooling. After starting materials disappeared, water was addedto the reaction mixture, and the mixture was concentrated and extractedwith ethyl acetate. The organic layer was washed with and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.The solvent was evaporated, and the residue was dissolved indichloromethane (150 ml). To the mixture was added triethylamine (29ml), and to the mixture was dropwise added methane-sulfonylchloride (5.3ml) under ice-cooling. The mixture was stirred at room temperature undernitrogen atmosphere over night, and to the mixture was added water. Themixture was concentrated and extracted with ethyl acetate. The organiclayer was washed with and saturated sodium chloride solution, and driedwith anhydrous magnesium sulfate. The solvent was evaporated, and theresidue was purified with silica gel column (ethyl acetate/hexane) togive methyl 2-bromo-6,7-dihydro-5H-benzo-cycloheptene-8-carboxylate (1.7g) as colorless crystals.

mp 83-84° C.; ¹ H-NMR(δ ppm, CDCl₃): 1.97-2.10 (2H, m), 2.62 (2H, t,J=6.6 Hz), 2.72-2.78 (2H, m), 3.82 (3H, s), 7.02 (1H, d, J=8.0 Hz), 7.32(1H, dd, J=2.2, 8.0 Hz), 7.45 (1H, d, J=2.2 Hz), 7.60 (1H,s). IR(KBr) ν:2946, 1713 cm⁻¹. Anal. for C₁₃ H₁₃ BrO₂ : Calcd. C, 55.54; H, 4.66.Found C, 55.56; H, 4.75.

REFERENCE EXAMPLE 102

To a mixture of methyl2-bromo-6,7-dihydro-5H-benzocycloheptene-8-carboxylate (0.5 g),4-piperidinophenyl borate (0.4 g), 1M potassium carbonate (6 ml) andethanol (6 ml) was added toluene (50 ml), and the mixture was stirredunder argon atmosphere at room temperature for 30 minutes. To themixture was added tetrakistriphenylphosphinepalladium (0.08 g), and themixture was refluxed over night and extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystals(0.45 g), which were dissolved in 1N sodium hydroxide (15 ml), methanol(50 ml) and tetrahydrofuran (50 ml). The mixture was refluxed at roomtemperature for 2 hours, concentrated and neutralized with hydrochloricacid to precipitate2-(4-piperidinophenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (0.46 g) as colorless crystals.

mp 219-220° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆): 1.50-1.70(6H,m),1.85-2.05(2H,m), 2.56 (2H, t, J=6.4 Hz), 2.80-2.82 (2H, s), 3.13-3.25(4H, m), 6.99 (2H, d, J=8.7 Hz), 7.23 (1H, d, J=8.0 Hz), 7.47 (1H, dd,J=1.8, 8.0 Hz), 7.54 (2H, d, J=8.7 Hz), 7.60 (1H, d, J=1.8 Hz), 7.70(1H, s). Anal. for C₂₃ H₂₅ NO₂.0.2H₂ O: Calcd. C, 78.69; H, 7.29; N,3.99. Found C, 78.82; H, 7.38; N, 3.89.

REFERENCE EXAMPLE 103

To a mixture of N-t-butoxycarbonylpiperidin-4-one (3 g; M. S. Ashwood etal., J. Chem. Soc. Perkin Trans. 1, 1995, 641-644) and methylaminehydrochloride (1 g) were added triethylamine (2.1 ml) and1,2-dichloroethane(50 ml). Under ice-cooling, to the mixture was addedsodium triacetoxy boron hydride (4.5 g), and the mixture was stirredunder nitrogen atmosphere at room temperature for 4 hours. The mixturewas neutralized with sodium hydroxide, concentrated and extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give1-t-butoxy-carbonyl-4-methylaminopiperidine (3.1 g) as colorless oil.

¹ H-NMR(δ ppm, CDCl₃): 1.13-1.33 (3H, m), 1.33-1.54 (3H, m), 1.45 (9H,s), 1.83-1.88 (2H, m), 2.44 (3H, s), 2.44-2.56 (1H, m), 2.73-2.87 (2H,m), 4.01 (1H, br).

REFERENCE EXAMPLE 104

In chlorobenzene (100 ml) was dissolved 2-bromo-4'-acetophenone (25.1g), and the mixture was dropwise added to a suspension ofhexamethylenetetramine (15.9 g) in chlorobenzene (100 ml). The mixturewas stirred under nitrogen atmosphere at 60° C. for 4 hours and cooledto precipitate crystals, which were filtered and washed with ethanol anddiethylether. The resulting crystals were added little by little to amixture of 95% ethanol (100 ml) and hydrochloric acid (50 ml), and themixture was stirred at room temperature over night. Precipitated crystalwas filtered and washed with diethylether. To the crystal was addeddi-t-butyl bicarbonate (32 g), triethylamine (29 ml) and dichloromethane(500 ml), and the mixture was stirred at room temperature for 2 hours,washed with water, 10% citric acid and water, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/hexane) to give yellow solid (24.9 g), 12 g of which wasdissolved in ethanol (200 ml) and ethyl acetate (50 ml). To the mixturewas added 10% palladium on carbon (1.2 g) and catalytic hydrogenationwas carried out at room temperature for 6 hours. The catalyst wasfiltered off, and the solvent was evaporated to give colorless crystals(6.5 g), 4 g of which was dissolved in dimethylformamide (50 ml). To themixture was added sodium hydride (60%, 1.4 g) at -3° C., and the mixturewas stirred for 20 minutes. To the mixture was dropwise added1,4-dibromobutane (2.1 ml), and the mixture was stirred underice-cooling for 1.5 hours. To the mixture was ammonium chloridesolution, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, (4-aminophenyl)[1-(tert-butoxycarbonyl)piperidin-2-yl]methanone (2.1 g) as pale yellowcrystals.

mp 187-188° C. ¹ H-NMR(δ ppm, CDCl₃): 1.42 (9H, br), 1.43 (2H, br), 1.80(1H, br), 2.05 (1H, br), 3.22 (1H, br), 3.95 (1H, br), 4.09 (2H, br),5.55 (1H, br), 6.63 (2H, d, J=8.4 Hz), 7.79 (2H, d, J=8.4 Hz). IR(KBr)ν: 3362, 2942, 1682cm⁻¹. Anal. for C₁₇ H₂₄ N₂ O₃.0.1H₂ O: Calcd. C,66.69; H, 7.97; N, 9.15. Found C, 66.60; H, 7.91; N, 8.87.

REFERENCE EXAMPLE 105

A mixture of 2-(4-nitrobenzyl)pyridine (J. Chem. Soc., p549, 1929) (1.50g) and 5% Pd-C (0.15 g) in ethanol (30 ml) was vigorously stirred underhydrogen atmosphere for 8 hours, and the Pd-C was filtered off. Thefiltrate was concentrated under reduced pressure, and the residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:1→2:1) to give 2-(4-aminobenzyl)-pyridine (1.09 g) asyellow oil.

¹ H-NMR (200 MHz, CDCl₃) δ 3.41-3.75 (2H, m), 4.05 (2H, s), 6.50-6.69(2H, m), 6.97-7.16 (4H, m), 7.51-7.60 (1H, m), 8.48-8.57 (1H, m). IR(neat) 3338, 3213, 3008, 1622, 1593, 1516, 1471, 1433, 1281, 754 cm⁻¹.

REFERENCE EXAMPLE 106

Under nitrogen atmosphere, to a solution of ethyl magnesium chloride intetrahydrofuran (1.58M, 95 ml) was added diethyl phosphite (6.91 g)under ice-cooling, and the mixture was stirred at room temperature for 1hour. To the mixture was added benzyl bromide (7.2 ml), and the mixturewas refluxed for 4 hours. The reaction mixture was vigorously stirredand concentrated hydrochloric acid-ice was added to the mixture to stopthe reaction. The mixture was extracted with diethylether andconcentrated. To the residue was added chloroform, and the mixture waswashed with water and concentrated under reduced pressure. The residuewas separated and purified with column chromatography (ethylacetate/ethanol=3:1→2:1) to give benzyldiethylphosphine oxide (1.45 g)as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.17 (6H, dt, J=16.6, 8.0 Hz), 1.57-1.75 (4H,m), 3.14 (2H, d, J=14.4 Hz), 7.19-7.40 (4H, m). IR (KBr) 3396, 2974,16445, 1495, 1458, 1410, 1242, 1159, 1124, 1034, 829, 789, 702 cm⁻¹.

REFERENCE EXAMPLE 107

To a mixture of nitric acid (0.4 ml) and concentrated sulfuric acid (3ml) was added benzyldiethylphosphine oxide (1.05 g) at 0° C., and themixture was stirred at 50° C. for 1 hour. The reaction mixture was addedto ice-water, and ammonia solution was added to the solution toneutralize the solution, which was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethyl acetate/ethanol=3:2→1:1) togive 4-nitrobenzyldiethylphosphine oxide (518 mg) as pale yellowcrystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.18 (6H, dt, J=17.0, 8.0 Hz), 1.64-1.86 (4H,m), 3.23 (2H, d, J=13.6 Hz), 7.49 (2H, dd, J=8.8, 1.6 Hz), 8.20 (2H, d,J=8.8 Hz). IR (KBr) 1599, 1506, 1340, 1169, 864, 773, 694, 501 cm⁻¹.

REFERENCE EXAMPLE 108

A mixture of 4-nitrobenzyldiethylphosphine oxide (0.4 g) and 10% Pd-C(0.06 g) in ethanol (10 ml) was vigorously stirred under hydrogenatmosphere for 16 hours, and the Pd-C was filtered off. The filtrate wasconcentrated under reduced pressure to give4-aminobenzyldiethylphosphine oxide (349 mg) as brown oil.

¹ H-NMR (200 MHz, CDCl₃) δ 1.16 (6H, dt, J=16.6, 7.8 Hz), 1.56-1.76 (4H,m), 3.02 (2H, d, J=14.4 Hz), 6.64 (2H, d, J=8.4 Hz), 7.03 (2H, dd,J=8.4, 1.8 Hz). IR (neat) 3336, 1630, 1614, 1516, 1460, 1408, 1284,1157, 1126, 841, 791, 768, 540 cm⁻¹.

REFERENCE EXAMPLE 109

Under nitrogen atmosphere, to a solution of propyl magnesium bromide intetrahydrofuran (2M, 250 g) was added diethyl phosphite (18.0 g) underice-cooling, and the mixture was stirred at room temperature for 3hours. To the reaction mixture was added benzyl bromide (24.7 ml), andthe mixture was refluxed for 5 hours. The reaction mixture wasvigorously stirred and added to concentrated hydrochloric acid-ice tostop the reaction. The mixture was extracted with ethyl acetate andconcentrated. The residue was separated and purified with columnchromatography (ethyl acetate ethyl acetate/ethanol=3:1) to givebenzyldipropylphosphine oxide (25.33 g) as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 0.94-1.09 (6H, m), 1.49-1.75 (8H, m), 3.15(2H, d, J=14.6 Hz), 7.19-7.39 (5H, m). IR (KBr) 3425, 2964, 1645, 1603,1497, 1456, 1242, 1161, 1126, 1080, 1030, 843 cm⁻¹.

REFERENCE EXAMPLE 110

To a mixture of nitric acid (3.6 ml) and concentrated sulfuric acid (22ml) was added benzyldipropylphosphineoxide (10.75 g) at 0° C., and themixture was stirred at 60° C. for 1.5 hours. The reaction mixture wasadded to ice-water, and ammonia solution was added to the mixture toneutralize the solution, which was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethyl acetate/ethanol=9:1→4:1) togive 4-nitrobenzyldipropylphosphine oxide (3.77 g) as pale yellowcrystals.

¹ H-NMR (200 MHz, CDCl₃) δ 0.96-1.09 (6H, m), 1.51-1.75 (8H, m), 3.20(2H, d, J=13.6 Hz), 7.47 (2H, dd, J=8.8, 2.0 Hz), 8.21 (2H, d, J=8.8Hz). IR (KBr) 1527, 1431, 1352, 1028 cm⁻¹.

REFERENCE EXAMPLE 111

A mixture of 4-nitrobenzyldipropylphosphine oxide (3.0 g) and 5% Pd-C(0.3 g)in ethanol (50 ml) was vigorously stirred under hydrogenatmosphere for 16 hours, and the Pd-C was filtered off. The filtrate wasconcentrated under reduced pressure. The residue was separated andpurified with column chromatography (ethanol/ethyl acetate=1:5→1:4) andrecrystallized from ethanol-ethyl acetate to give4-aminobenzyldipropylphosphine oxide (1.78 g) as colorless crystals.

m.p. 104-106° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 0.88-1.12 (6H, m),1.43-1.72 (8H, m), 3.01 (2H, d, J=14.8 Hz), 3.52-3.76 (2H, m), 6.65 (2H,d, J=8.6 Hz), 7.01 (2H, dd, J=8.6, 2.0 Hz). IR (KBr) 3348, 3209, 2058,1608, 1512, 1155, 1126, 852 cm⁻¹ ; Elemental Analysis for C₁₃ H₂₂ NOP;Calcd. C, 65.25; H, 9.27; N, 5.85; P, 12.94: Found. C, 65.16; H, 9.04;N, 5.91; P, 12.94.

REFERENCE EXAMPLE 112

Under nitrogen atmosphere, to a solution of 2-bromo-3-hydroxypyridine(10.00 g) in DMF (100 ml) was added sodium hydride (60% oil, 2.5 g) at0° C., and the mixture was stirred for 30 minutes. To the reactionmixture was added methyl iodide (4.0 ml), and the mixture was stirred atroom temperature for 2 hours. To the reaction mixture was added water,and the mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated. Under reduced pressure, the residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:2) to give 2-bromo-3-methoxypyridine (9.24 g) ascolorless crystals.

m.p. 41-43° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 3.92 (3H, s), 7.15 (1H, dd,J=8.0, 1.4 Hz), 7.24 (1H, dd, J=8.0, 4.4 Hz), 7.99 (1H, dd, J=4.4, 1.4Hz). IR (KBr) 3055, 1562, 1468, 1414, 1298, 1205, 1078, 1049, 791, 667cm⁻¹ ; Elemental Analysis for C₆ H₆ NO; Calcd. C, 38.33; H, 3.22 N,7.45: Found. C, 38.35; H, 3.07; N, 7.28.

REFERENCE EXAMPLE 113

To a solution of 2-bromo-3-methoxypyridine (1.00 g) in diethylether (20ml) was added a solution of n-butyllithium in hexane (1.6M, 3.7 ml) at-78° C., and the mixture was stirred for 1 hour to prepare the lithiumsalt, which was dropwise added to a solution of 4-nitrobenzaldehyde(0.81 g) in tetrahydrofuran (10 ml) cooled at -78° C. The mixture wasstirred at -78° C. To the reaction mixture was added water to stop thereaction, and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. Under reduced pressure, the residuewas separated and purified with column chromatography (ethylacetate/hexane=1:3→1:1) to give3-methoxypyridin-2-yl)-(4-nitrophenyl)methanol (742 mg) as pale yellowcrystals.

m.p. 137-138° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 3.81 (3H, s), 5.64 (1H, d,J=6.8 Hz), 6.02 (1H, d, J=6.8 Hz), 7.17 (1H, dd, J=8.4, 1.4 Hz), 7.27(1H, dd, J=8.4, 4.6 Hz), 7.58 (2H, dd, J=7.0, 2.0 Hz), 8.15 (2H, dd,J=7.0, 2.0 Hz), 8.21 (1H, dd, J=4.6, 1.4 Hz). IR (KBr) 3348, 1524, 1464,1344, 1284, 1053, 1020, 837, 797, 744, 689 cm⁻¹ ; Elemental Analysis forC₁₃ H₁₂ N₂ O₄ ; Calcd. C, 60.00; H, 4.65; N, 10.76: Found. C, 59.97; H,4.57; N, 10.82.

REFERENCE EXAMPLE 114

A mixture of (3-methoxypyridin-2-yl)-(4-nitrophenyl)methanol (600 mg)and 5% Pd-C (0.06 g) in ethanol (20 ml)was vigorously stirred underhydrogen atmosphere for 3 hours, and the Pd-C was filtered off. Thefiltrate was concentrated under reduced pressure to give(4-aminophenyl)-(3-methoxypyridin-2-yl)-methanol (483 mg) as pale yellowcrystals.

¹ H-NMR (200 MHz, CDCl₃) δ 3.51-3.65 (2H, m), 3.75 (3H, s), 5.33 (1H, d,J=7.1 Hz), 5.85 (1H, d, J=7.1 Hz), 6.60 (2H, dd, J=6.6, 1.8 Hz),7.08-7.23 (4H, m), 8.17 (1H, dd, J=4.6, 1.4 Hz). IR (KBr) 3458, 3463,3323, 1626, 1614, 1518, 1454, 1427, 1279, 1178, 1038, 835, 804 cm⁻¹.

REFERENCE EXAMPLE 115

A solution of diethyl benzylphosphonate (25 g) in methanol (10 ml) andconcentrated hydrochloric acid (500 ml) solution was refluxed for 4days. The mixture was cooled to room temperature, and precipitatedcrystal was collected by filtration to give benzylphosphonic acid (11.17g) as colorless crystals.

m.p. 171-173° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.96 (2H, d, J=21.6 Hz),7.13-7.34 (5H, m). IR (KBr) 2779, 2330, 1497, 1458, 1263, 1074, 993,943, 781, 694, 527, 428 cm⁻¹. Elemental Analysis for C₇ H₉ O₃ P; Calcd.C, 48.85; H, 5.27; P, 18.00: Found. C, 48.75; H, 5.01; P, 17.78.

REFERENCE EXAMPLE 116

Under nitrogen atmosphere, to a mixture of magnesium (3.39 g) and apiece of iodine in diethylether (16 ml) was dropwise added a solution of1,4-dibromobutane (5.55 ml) and 1,2-dibromoethane (2 ml) in diethylether(80 ml) at 40° C. for 1 hour. The mixture was refluxed for 1 hour,cooled to room temperature and allowed to stand for 2 hours. The upperlayer of diethylether was removed through cannula, to obtain thedi-Grignard reagent, which was dissolved in dichloro-methane (210 ml).The resulting di-Grignard reagent as it is was used for the followingreaction. To benzyl phosphonate (8.0 g) was added thionyl chloride (40ml) and then 2 drops of DMF, and the mixture was refluxed for 4 hoursand concentrated under reduced pressure. The residue was dissolved indichloromethane (210 ml), and the mixture was cooled to 0° C. To themixture was dropwise added a solution of the above di-Grignard reagentin dichloromethane, which was cooled to 0° C., through cannula for 1hour, and the mixture was stirred at room temperature for 16 hours. Tothe reaction mixture were added 10% ammonium chloride solution (100 ml)and saturated sodium chloride solution, and the mixture was extractedwith dichloromethane. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethanol/ethyl acetate=1:4) to give1-benzyl-phosphorane-1-oxide (4.83 g) as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.40-2.08 (8H, m), 3.27 (2H, d, J=15.0 Hz),7.11-7.42 (5H, m). IR (KBr) 2951, 1643, 1495, 1454, 1406, 1265, 1236,1165, 1120, 702 cm.sup.⁻¹.

REFERENCE EXAMPLE 117

To 1-benzylphosphorane-1-oxide (4.17 g) were added nitric acid (1.7 ml)and sulfuric acid (11 ml) at 0° C., and the mixture was stirred at50-60° C. for 2 hours. The reaction mixture was added to crushed ice andneutralized with ammonia solution. The mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. Under reducedpressure, The residue was separated and purified with columnchromatography (ethanol/ethyl acetate=1:4→1:1) togivel-(4-nitro-benzyl)phosphorane-1-oxide (2.22 g) as yellow crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.55-2.13 (8H, m), 3.32 (2H, d, J=13.8 Hz),7.50 (2H, dd, J=8.8, 1.8 Hz), 8.22 (2H, d, J=8.8 Hz). IR (KBr) 3402,2954, 1514, 1346, 1171, 860, 700 cm⁻¹.

REFERENCE EXAMPLE 118

A mixture of 1-(4-nitrobenzyl)phosphorane-1-oxide (1.80 g) and 10% Pd-C(0.2 g) in ethanol (30 ml) was vigorously stirred under hydrogenatmosphere for 24 hours, and the catalyst was filtered off. The filtratewas concentrated and purified with column chromatography (ethanol/ethylacetate=1:2) and recrystallized from ethanol-diethylether to give1-(4-aminobenzyl)phosphorane-1-oxide (0.90 g) as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.32-2.02 (8H, m), 3.16 (2H, d, J=14.6 Hz),3.52-3.74 (2H, m), 6.65 (2H, d, J=8.4 Hz), 7.04 (2H, dd, J=8.4, 2.2 Hz).IR (KBr) 3386, 3338, 3228, 1641, 1612, 1516, 1296, 1263, 1174, 1124, 833cm⁻¹.

REFERENCE EXAMPLE 119

Under nitrogen atmosphere, to a solution of2-bromo-3-methoxymethoxypyridine (10.00 g) in diethylether (150 ml) wasadded a solution of n-butyllithium in hexane (1.6M, 31.5 ml) at -78° C.,and the mixture was stirred for 1 hour to prepare the lithium salt. Theresulting lithium salt was dropwise added to a solution of4-nitrobenzaldehyde (6.93 g) in tetrahydrofuran (100 ml) cooled at -78°C., and the mixture was stirred at the same temperature for 3 hours. Tothe reaction mixture was added water to stop the reaction, and themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated under reduced pressure. The residue was separated andpurified with column chromatography (ethyl acetate/hexane=1:3→1:2) togive (3-methoxymethoxypyridin-2-yl)-(4-nitrophenyl)-methanol (11.78 g)as yellow oil.

¹ H-NMR (200 MHz, CDCl₃) δ 3.27 (3H, s), 5.12 (1H, d, J=7.0 Hz), 5.20(1H, d, J=7.0 Hz), 5.70 (1H, d, J=7.0 Hz), 6.02 (1H, d, J=7.0 Hz), 7.25(1H, dd, J=8.4, 4.4 Hz), 7.42 (1H, dd, J=8.4, 1.4 Hz), 7.58 (2H, d,J=8.8 Hz), 8.15 (2H, d, J=8.8 Hz), 8.27 (1H, dd, J=4.4, 1.4 Hz). IR(neat) 3390, 1522, 1448, 1348, 1155, 1084, 1055, 980, 824, 849, 800,744, 700 cm⁻¹.

REFERENCE EXAMPLE 120

A mixture of (3-methoxymethoxypyridin-2-yl)-(4-nitrophenyl)methanol(11.78 g) and 10% Pd-C (1.2 g) in ethanol (100 ml) was vigorouslystirred under hydrogen atmosphere for 24 hours. The catalyst wasfiltered of, and the filtrate was concentrated under reduced pressure.The residue was separated and purified with column chromatography (ethylacetate/hexane=1:1→2:1) to give2-(4-aminobenzyl)-3-methoxymethoxypyridine (2.92 g) as orange oil.

¹ H-NMR (200 MHz, CDCl₃) δ 3.37 (3H, s), 4.08 (2H, s), 5.16 (2H, s),6.59 (2H, dd, J=8.4, 2.0 Hz), 7.04-7.19 (3H, m), 7.33 (1H, dd, J=8.4,1.2 Hz), 8.18 (1H, dd, J=4.8, 1.2 Hz). IR (neat) 3433, 3352, 3219, 1620,1514, 1446, 1265, 1153, 1082, 985, 922, 798 cm⁻¹.

REFERENCE EXAMPLE 121

Under nitrogen atmosphere, to a mixture of magnesium (3.2 g) and a pieceof iodine in diethylether (20 ml) was dropwise added to a solution of1,5-dibromopentane (13.21 g) and 1,2-dibromoethane (1.21 ml) indiethylether (80 ml) at 40° C. for 1 hour. The mixture was refluxed for1 hour, cooled to room temperature and allowed to stand for 2 hours. Theupper layer of diethylether was removed through cannula, to obtain thedi-Grignard reagent, which was dissolved in dichloromethane (250 ml).The resulting di-Grignard reagent as it is was used for the followingreaction. To benzylphosphonic acid (10.0 g) was added thionyl chloride(30 ml) and then a drop of DMF, and the mixture was refluxed for 3 hoursand concentrated under reduced pressure. The residue was dissolved indichloromethane (210 ml), and the mixture was cooled to 0° C. To themixture was dropwise added a solution of the above di-Grignard reagentin dichloromethane, which was cooled to 0° C., through cannula for 1hour, and the mixture was stirred at room temperature for 20 hours. Tothe reaction mixture were added 10% ammonium chloride solution (100 ml)and saturated sodium chloride solution, and the mixture was extractedwith dichloromethane. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethanol/ethyl acetate=1:3→1:2) to give1-benzylphosphorinane-1-oxide (5.39 g) as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.36-2.18 (10H, m), 3.17 (2H, d, J=14.0 Hz),7.23-7.42 (5H, m). IR (KBr) 2939, 2912, 2886, 1493, 1452, 1404, 1232,1161, 827, 700 cm⁻¹.

REFERENCE EXAMPLE 122

To a solution of diethyl benzylphosphonate (2.5 g) in tetrahydrofuran(500 ml) was added Red-Al (70% toluene solution) (3.8 g) at roomtemperature, and the mixture was stirred until gas production stopped.To the reaction mixture was added 1,5-dibromopentane (25.18 g), and themixture was stirred at 50-60° C. for 16 hours. To the reaction mixturewas added water (20 ml), and precipitate was removed by filtration. Thefiltrate was concentrated under reduced pressure, and the residue wasseparated and purified with column chromatography (ethylacetate→ethanolethyl acetate=1:2) to give 1-benzylphosphorinane-1-oxide(8.41 g) as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.36-2.18 (10H, m), 3.17 (2H, d, J=14.0 Hz),7.23-7.42 (5H, m). IR (KBr) 2939, 2912, 2886, 1493, 1452, 1404, 1232,1161, 827, 700 cm⁻¹.

REFERENCE EXAMPLE 123

To 1-benzylphosphorinane-1-oxide (5.39 g) were added nitric acid (1.94ml) and sulfuric acid (15 ml) at 0° C., and the mixture was stirred at50-60° C. for 2hours. The reaction mixture was added to crushedice-water, neutralized with ammonia solution and extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethanol/ethyl acetate=1:3→1:2) to give1-(4-nitrobenzyl)-phosphorinane-1-oxide (2.47 g) as pale yellowcrystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.46-2.18 (10H, m), 3.28 (2H, d, J=13.6 Hz),7.48 (2H, dd, J=8.8, 2.2 Hz), 8.21 (2H, d, J=8.8 Hz). IR (KBr) 2926,1599, 1516, 1348, 1230, 1159, 1132, 864, 822, 696 cm⁻¹.

REFERENCE EXAMPLE 124

A mixture of 1-(4-nitrobenzyl)phosphorinane-1-oxide (2.25 g) and 10%Pd-C (0.2 g) in ethanol (30 ml) was vigorously stirred under hydrogenatmosphere for 24 hours. The catalyst was filtered off, and the filtratewas concentrated recrystallized from ethanol-diethylether to give1-(4-aminobenzyl)-phosphorinane-1-oxide (1.5 g) as pale yellow crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.27-2.16 (10H, m), 3.06 (2H, d, J=13.8 Hz),3.53-3.80 (2H, m), 6.65 (2H, d, J=8.3 Hz), 7.05 (2H, dd, J=8.3, 2.0 Hz).IR (KBr) 3386, 3334, 3224, 2939, 1639, 1612, 1514, 1296, 1225, 1153,1120, 841 cm⁻¹.

REFERENCE EXAMPLE 125

Under argon atmosphere, to a solution of 4-ethylbromobenzene (10.0 g) intetrahydrofuran (60 ml) was added n-butyllithium (1.6M hexane solution)(37.2 ml) at -78° C., and the mixture was stirred for 1 hour. To thereaction mixture was dropwise added a solution of tributyl borate (13.68g) in tetrahydrofuran (30 ml), and the reaction mixture was warmed toroom temperature and stirred at room temperature for 2 hours. To thereaction mixture was added 10% sulfuric acid (100 ml), and the mixturewas stirred for 1 hour. The mixture was extracted with ethyl acetate.The organic layer was washed with saturated sodium chloride solution,dried with magnesium sulfate and concentrated under reduced pressure.The residue was dissolved in acetone (30 ml), and to the mixture wasadded 10% sulfuric acid (50 ml). The mixture was stirred at roomtemperature for 16 hours, and under reduced pressure acetone wasevaporated. The mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated under reduced pressure. The residuewas separated and purified with column chromatography (ethylacetate/hexane=1:2) to give crude 4-ethylphenyl borate (0.91 g) ascolorless solid. Under argon atmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg), the abovecrude 4-ethylphenyl borate (0.32 g) and potassium carbonate (0.49 g) intoluene-ethanol-water (20-2-2 ml) was stirred at room temperature for 1hour. To the reaction mixture was addedtetrakistriphenyl-phosphinepalladium (0.06 g), and the mixture wasrefluxed for 18 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:15) to give ethyl7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (464 mg) ascolorless crystals.

m.p. 81-83° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.28 (3H, t, J=7.6 Hz), 1.36(3H, t, J=7.2 Hz), 2.69 (2H, q, J=7.6 Hz), 3.00 (2H, t, J=5.2 Hz), 4.29(2H,q, J=7.2 Hz), 4.30 (2H, t, J=5.2 Hz), 7.04 (1H, d, J=8.4 Hz), 7.27(2H, d, J=8.6 Hz), 7.44-7.51 (3H, m), 7.55 (1H, d, J=2.6 Hz), 7.65 (1H,br s). IR (KBr) 1699, 1493, 1302, 1254, 1213, 1012, 822 cm⁻¹. ElementalAnalysis for C₂₁ H₂₂ O₃ ; Calcd. C, 78.23; H, 6.88: Found. C, 78.05; H,6.61.

REFERENCE EXAMPLE 126

To a solution of ethyl7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (430 mg) inethanol (20 ml) was added 1N sodium hydroxide (4.0 ml) at roomtemperature, and the mixture was stirred for 24 hours and concentratedunder reduced pressure. To the residue was added 1N hydrochloric acid(15 ml), and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated to give crystals, which werecollected by filtration to give7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (328 mg)as colorless crystals.

m.p. 241-243° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.28 (3H, t, J=7.8 Hz),2.70 (2H, q, J=7.8 Hz), 3.02 (2H, t, J=4.8 Hz), 4.33 (2H, t, J=4.8 Hz),7.05 (1H, d, J=8.4 Hz), 7.27 (2H, d, J=8.0), 7.46-7.56 (4H, m), 7.78(1H, br s). IR (KBr) 2966, 1689, 1491, 1437, 1263, 1230, 822 cm⁻¹.Elemental Analysis for C₁₉ H₁₈ O₃ ; Calcd. C, 77.53; H, 6.16: Found. C,77.52; H, 6.27.

REFERENCE EXAMPLE 127

Under argon atmosphere, to a solution of 4-tert-butylbromobenzene (10.0g) in diethylether (50 ml) was added n-butyllithium (1.6M, hexanesolution) (32.3 ml) at -78° C., and the mixture was stirred for 1 hour.To the reaction mixture was dropwise added trimethyl boric acid (16 ml)in diethylether (30 ml), and the mixture was warmed to room temperatureand stirred at room temperature 16 hours. To the reaction mixture wereadded 1N hydrochloric acid (50 ml) and water, and the mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with magnesium sulfate andconcentrated under reduced pressure. The residue was separated andpurified with column chromatography (ethyl acetate/hexane=1:9) to givecrude 4-tert-phenyl borate(0.84 g) as pale yellow oil. Under argonatmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg), the abovecrude 4-tert-butylphenyl borate(0.59 g) and potassium carbonate (0.47 g)in toluene-ethanol-water (20-2-2 ml) was stirred at room temperature for1 hour. To the reaction mixture was added tetrakistriphenylphosphinepalladium (0.06 g), and the mixture was refluxed for 20 hours and cooledto room temperature. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:19) to give ethyl7-(4-tert-butyl-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (504 mg)as colorless oil.

¹ H-NMR (200 MHz, CDCl₃) δ 1.36 (9H, s), 1.36 (3H, t, J=7.2 Hz), 3.00(2H, t, J=4.7 Hz), 4.29 (2H, q, J=7.2 Hz), 4.30 (2H, t, J=4.7 Hz), 7.04(1H, d, J=8.2 Hz), 7.42-7.56 (6H, m), 7.65 (1H, br s). IR (neat) 1731,1491, 1298, 1246, 1211, 1184, 1090, 1018, 824 cm⁻¹.

REFERENCE EXAMPLE 128

To a solution of ethyl7-(4-tert-butylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (503.8mg) in ethanol (10 ml)was added 1N sodium hydroxide (2.0 m) at roomtemperature, and the mixture was stirred for 64 hours and concentratedunder reduced pressure. To the residue was added 1N hydrochloric acid(15 ml), and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The resulting crystal was collectedby filtration to give7-(4-tert-butylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (396mg) as colorless crystals.

m.p. 259-261° C.; ¹ H-NMR (200 MHz, CDCl) δ 1.37 (9H, s), 3.03 (2H, t,J=4.4 Hz), 4.34 (2H, t, J=4.4 Hz), 7.06 (1H, d, J=8.4 Hz), 7.41-7.58(6H, m), 7.79 (1H, br s). IR (KBr) 2951, 1678, 1489, 1263, 829, 820 cm⁻¹; Elemental Analysis for C₂₁ H₂₂ O₃ ; Calcd. C, 78.23; H, 6.88: Found.C, 78.10; H, 6.81.

REFERENCE EXAMPLE 129

Under argon atmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg),4-chloro-phenyl borate (289 mg) and potassium carbonate (464 mg) intoluene-ethanol-water (20-2-2 ml) was stirred at room temperature for 1hour. To the reaction mixture was addedtetrakistriphenyl-phosphinepalladium (0.06 g), and the mixture wasrefluxed for 24 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:19) to give ethyl7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (459 mg) ascolorless crystals.

m.p. 131-134° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.36 (3H, t, J=7.2 Hz),3.01 (2H, t, J=5.0 Hz), 4.23-4.34 (4H, m), 7.05 (1H, d, J=8.4 Hz),7.37-7.52 (6H, m), 7.64 (1H, s). IR (KBr) 1705, 1485, 1302, 1255, 1213,820 cm⁻¹ ; Elemental Analysis for C₁₉ H₁₇ O₃ Cl; Calcd. C, 69.41; H,5.21; Cl, 10.78: Found. C, 69.16; H, 5.12; Cl, 10.85.

REFERENCE EXAMPLE 130

To a solution of ethyl7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (400 mg) intetrahydrofuran-ethanol (10-10 ml) was added 1N sodium hydroxide (2.0ml) at room temperature, and the mixture was stirred for 42 hours andconcentrated under reduced pressure.

To the residue was added 1N hydrochloric acid (15 ml), and the mixturewas extracted with ethyl acetate. The organic layer was washed withsaturated sodium chloride solution, dried with magnesium sulfate andconcentrated. The resulting crystal was collected by filtration to give7-(4-chlorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (342 mg)as colorless crystals.

m.p. 263-264° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 3.03 (2H, t, J=4.7 Hz),4.34 (2H, t, J=4.7 Hz), 7.07 (1H, d, J=8.4 Hz), 7.35-7.55 (6H, m), 7.76(1H, br s). IR (KBr) 2959, 1680, 1483, 1267, 1230, 818 cm⁻¹ ; ElementalAnalysis for C₁₇ H₁₃ O₃ Cl; Calcd. C, 69.89; H, 4.36; Cl, 11.79: Found.C, 67.55; H, 4.19; Cl, 11.46.

REFERENCE EXAMPLE 131

Under argon atmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg),4-trifluoromethylphenyl borate (351.5 mg) and potassium carbonate (0.47g) in toluene-ethanol-water (20-2-2 ml) was stirred at room temperaturefor 1 hour. To the reaction mixture was addedtetrakistriphenylphosphinepalladium (0.06 g), and the mixture wasrefluxed for 20 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:10) to give ethyl7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (489mg) as colorless crystals.

m.p. 107-110° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.37 (3H, t, J=7.2 Hz),2.99-3.05 (2H, m), 4.29 (2H, q, J=7.2 Hz), 4.33 (2H, t, J=4.8 Hz), 7.09(1H, d, J=8.4 Hz), 7.49 (1H, dd, J=8.4, 2.4 Hz), 7.58 (1H, d, J=2.4 Hz),7.62-7.73 (5H, m). IR (KBr) 1701, 1329, 1257, 1126, 1107, 1068, 1012,822 cm⁻¹ ; Elemental Analysis for C₂₀ H₁₇ O₃ F₃ ; Calcd. C, 66.30; H,4.73; F, 15.73: Found. C, 66.40; H, 4.63; F, 15.44.

REFERENCE EXAMPLE 132

To a solution of ethyl7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (440mg) in tetrahydrofuran-ethanol (10-10 ml) was added 1N sodium hydroxide(4.0 ml) at room temperature, and the mixture was stirred for 20 hoursand concentrated under reduced pressure. To the residue was added 1Nhydrochloric acid (5 ml), and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. The resultingcrystal was collected by filtration to give7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(392 mg) as colorless crystals.

m.p. 273-276° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.89 (2H, t, J=4.4 Hz),4.28 (2H, t, J=4.4 Hz), 7.09 (1H, d, J=8.4 Hz), 7.61-7.70 (2H, m), 7.78(2H, d, J=8.4 Hz), 7.92-7.96 (3H, m). IR (KBr) 2979, 1689, 1329, 1263,1134, 1072, 831 cm⁻¹ ; Elemental Analysis for C₁₈ H₁₃ O₃ F₃ ; Calcd. C,64.67; H, 3.92: Found. C, 64.62; H, 3.89.

REFERENCE EXAMPLE 133

Under argon atmosphere, to a solution of 4-bromophenetole (26.4 g) intetrahydrofuran (200 ml) was dropwise added n-butyl-lithium (1.6M,hexane solution) (90.3 ml) at -78° C. for 50 minutes, and the mixturewas stirred for 30 minutes. To the reaction mixture was dropwise added asolution of trimethyl borate (40.8 g) in tetrahydrofuran (40 ml) for 30minutes, and the mixture was stirred for 30 minutes, warmed to roomtemperature, and further stirred for 1.5 hours. To the reaction mixturewas added 10% sulfuric acid (182 ml) for 40 minutes or more, and themixture was stirred 1.5 hours, extracted with ethyl acetate, washed withsaturated sodium chloride solution, dried with magnesium sulfate andconcentrated under reduced pressure. The residue was crystallized fromdiisopropylether-hexane to give 4-ethoxyphenyl borate (15.5 g) ascolorless crystals. Under argon atmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (504.5 mg), the above4-ethoxyphenyl borate (310 mg) and potassium carbonate (0.47 g) intoluene-ethanol-water (20-2-2 ml) was stirred at room temperature for 1hour. To the reaction mixture was addedtetrakistriphenylphosphinepalladium (0.06 g), and the mixture wasrefluxed for 20 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:9-1:5) to give ethyl7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (468 mg) ascolorless crystals.

m.p. 124-127° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.36 (3H, t, J=7.2 Hz),1.44 (3H, t, J=7.0 Hz), 3.00 (2H, t, J=4.0 Hz), 4.08 (2H, q, J=7.0 Hz),4.28 (2H, q, J=7.2 Hz), 4.30 (2H, t, J=4.0 Hz), 6.96 (2H, dd, J=6.6, 2.2Hz), 7.02 (1H, d, J=8.4 Hz), 7.41 (1H, d, J=2.6 Hz), 7.44-7.51 (3H, m),7.65 (1H, br s). IR (KBr) 1701, 1493, 1254, 1215, 1014, 824 cm⁻¹ ;Elemental Analysis for C₂₁ H₂₂ O₄ ; Calcd. C, 74.54; H, 6.55: Found. C,74.42; H, 6.47.

REFERENCE EXAMPLE 134

To a solution of ethyl7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (447.8 mg) inethanol (20 ml) was added 2N sodium hydroxide (2.0 ml) at roomtemperature, and the mixture was stirred for 20 hours and concentratedunder reduced pressure. To the residue was added 1N hydrochloric acid (5ml), and the mixture was extracted with ethyl acetate and concentrated.The resulting crystal was collected by filtration to give7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (380 mg)as colorless crystals.

m.p. 269-271° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 1.35 (3H, t, J=7.0 Hz),2.81-2.94 (2H, m), 4.06 (2H, q, J=7.0 Hz), 4.18-4.31 (2H, m), 6.94-7.00(3H, m), 7.49-7.79 (5H, m). IR (KBr) 2980, 1678, 1610, 1493, 1431, 1265,1232, 1182, 1049, 926, 829, 810 cm⁻¹ ; Elemental Analysis for C₁₉ H₁₈ O₄; Calcd. C, 73.53; H, 5.85: Found. C, 73.44; H, 5.77.

REFERENCE EXAMPLE 135

Under argon atmosphere, to a solution of 4-trifluoromethoxybromobenzene(10.0 g) in tetrahydrofuran (75 ml) was dropwise added n-butyllithium(1.6M, hexane solution) (28.5 ml) at -78° C. for 20 minutes, and themixture was stirred for 40 minutes. To the reaction mixture was dropwiseadded a solution of trimethyl borate (12.9 g) in tetrahydrofuran (12 ml)for 15 minutes, and the mixture was stirred at -78° C. for 30 minutesand at room temperature for 1 hour. To the reaction mixture was addedwas dropwise added 10% sulfuric acid (57.6 ml) for 15 minutes, and themixture was stirred for 2 hours, extracted with ethyl acetate, washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated under reduced pressure. The residue was crystallizedfrom hexane to give 4-trifluoromethoxyphenyl borate (2. 7 g) ascolorless crystals. Under argon atmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg), the above4-trifluoromethoxyphenyl borate (380 mg) and potassium carbonate (0.46g) in toluene-ethanol-water (20-2-2 ml) was stirred at room temperaturefor 1 hour. To the reaction mixture was addedtetrakistriphenylphosphinepalladium (0.06 g), and the mixture wasrefluxed for 18 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:10) to give ethyl7-(4-trifluoromethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(379 mg) as colorless crystals.

m.p. 59-63° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.36 (3H, t, J=7.1 Hz), 3.01(2H, t, J=4.8 Hz), 4.24-4.34 (4H, m), 7.06 (1H, d, J=8.4 Hz), 7.22-7.31(2H, m), 7.44 (1H, dd, J=8.4, 2.2 Hz), 7.52 (1H, d, J=2.2 Hz), 7.57 (2H,d, J=8.8 Hz), 7.64 (1H, br s). IR (KBr) 1701, 1489, 1304, 1257, 1227,1211, 1182, 1134, 1014, 833, 808 cm⁻¹ ; Elemental Analysis for C₂₀ H₁₇O₄ F₃ ; Calcd. C, 63.49; H, 4.53: Found. C, 63.68; H, 4.47.

REFERENCE EXAMPLE 136

To a solution of ethyl7-(4-trifluoromethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(323.9 mg) in tetrahydrofuran-ethanol (5-5 ml) was added 1N sodiumhydroxide (2.0 ml) at room temperature, and the mixture was stirred for5 days and concentrated under reduced pressure. To the residue 1Nhydrochloric acid (5 ml) was added, and the mixture was extracted withethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated. Theresulting crystal was collected by filtration to give7-(4-trifluoromethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(282 mg) as colorless crystals.

m.p. 252-254° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 3.03 (2H, t, J=4.6 Hz),4.34 (2H, t, J=4.6 Hz), 7.08 (1H, d, J=8.4 Hz), 7.28 (2H, d, J=8.8 Hz),7.47 (1H, dd, J=8.4, 2.2 Hz), 7.54 (1H, d, J=2.2 Hz), 7.59 (2H, d, J=8.8Hz), 7.78 (1H, br s). IR (KBr) 2981, 1691, 1493, 1290, 1261, 1213, 1169,835 cm⁻¹ ; Elemental Analysis for C₁₈ H₁₃ O₄ F₃ ; Calcd. C, 61.72; H,3.74; F, 16.27: Found. C, 61.61; H, 3.72; F, 16.06.

REFERENCE EXAMPLE 137

To a solution of 5-bromosalicylaldehyde (10.0 g) and tert-butyl acrylate(17.5 ml) in tert-butanol (100 ml) was added potassium tert-butoxide(1.67 g) at room temperature, and the mixture was refluxed for 66 hoursand cooled to room temperature. To the mixture was added ethyl acetate,and the mixture was washed with water, 1N sodium hydroxide and saturatedsodium chloride solution, dried with magnesium sulfate and concentrated.The residue was separated and purified with column chromatography (ethylacetate/hexane=1:19) to give tert-butyl6-bromo-2H-1-benzopyran-3-carboxylate (10.86 g) as pale yellow crystals.

m.p. 96-97° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.53 (9H, s), 4.95 (2H, d,J=0.8 Hz), 6.72 (1H, d, J=8.4 Hz), 7.21-7.30 (3H, m). IR (KBr) 1699,1479, 1331, 1288, 1159, 1088, 816 cm⁻¹ ; Elemental Analysis for C₁₄ H₁₅O₃ Br; Calcd. C, 54.04; H, 4.86; Br, 25.68: Found. C, 53.98; H, 4.86;Br, 25.90.

REFERENCE EXAMPLE 138

Under argon atmosphere, a solution of tert-butyl6-bromo-2H-1-benzopyran-3-carboxylate (5.00 g), 4-methylphenyl borate(2.62 g) and potassium carbonate (4,44 g) in toluene-ethanol-water(160-16-16 ml) was stirred at room temperature for 1 hour. To thereaction mixture was added tetrakistriphenylphosphinepalladium (0.56 g),and the mixture was refluxed for 14 hours and cooled to roomtemperature. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:19) to give pale yellow crystals, which wererecrystallized from ethanol to give tert-butyl6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylate (3.84 g) as pale yellowcrystals.

m.p. 80-82° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.54 (9H, s), 2.39 (3H, s),4.98 (2H, d, J=1.4 Hz), 6.94 (1H, d, J=8.2 Hz), 7.23 (2H, d, J=8.0 Hz),7.33 (1H, d, J=2.2 Hz), 7.36-7.45 (4H, m). IR (KBr) 1705, 1367, 1340,1311, 1251, 1159, 1133, 1003, 808 cm⁻¹ ; Elemental Analysis for C₂₁ H₂₂O₃ ; Calcd. C, 78.23; H, 6.88: Found. C, 78.07; H, 6.89.

REFERENCE EXAMPLE 139

To tert-butyl 6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylate (3.00 g)was added 4N hydrochloric acid-ethyl acetate (10 ml) at roomtemperature, and the mixture was stirred for 16 hours. To the reactionmixture was added hexane, and crystal was collected by filtration andwashed with hexane to give6-(4-methylphenyl)-2H-1-benzopyran-3-carboxylic acid (2.14 g) as paleyellow crystals.

m.p. 236-237° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.40 (3H, s), 5.05 (2H, d,J=1.4 Hz), 6.94 (1H, d, J=8.2 Hz), 7.23-7.27 (2H, m), 7.37 (1H, d, J=2.2Hz), 7.41-7.52 (3H, m), 7.63 (1H, br s). IR (KBr) 3022, 1689, 1633,1485, 1442, 1306, 1242, 812 cm⁻¹ ; Elemental Analysis for C₁₇ H₁₄ O₃ ;Calcd. C, 76.68; H, 5.30: Found. C, 76.51; H, 5.03.

REFERENCE EXAMPLE 140

To a solution of 5-bromo-salicylaldehyde (10.0 g) and ethyl crotonate(11.36 g) in tert-butanol (50 ml) was added potassium tert-butoxide(1.12 g) at room temperature, and the mixture was refluxed for 3 days.To the reaction mixture was added water, and the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated. Theresidue was separated and purified with column chromatography (ethylacetate/hexane=1:10→1:5) to give pale yellow liquid (5.75 g). Theresulting compound was used for the following reaction withoutsubjecting to further purification. Under nitrogen atmosphere, to asolution of the above crude product (5.5 g) and triethylamine (7.3 ml)in dichloro-methane (50 ml) was added methane-sulfonyl chloride (2.0 ml)at 0° C., and the mixture was stirred at 0° C. for 10 minutes and thenat room temperature for 18 hours. To the reaction mixture was addedwater, and the mixture was extracted with diethylether. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated. The residue was separated andpurified with column chromatography (ethyl acetate/hexane=1:15) to givecrude product (4.85 g) as pale yellow oil. The resulting compound wasused for the following reaction without subjecting to furtherpurification. Under argon atmosphere, a solution of the above crudeproduct (4.7 g), 4-methylphenyl borate (2.58 g) and potassium carbonate(4.4 g) in toluene-ethanol-water (160-16-16 ml) was stirred at roomtemperature for 1 hour. To the reaction mixture was addedtetrakistriphenylphosphinepalladium (0.54 g), and the mixture wasrefluxed for 20 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated. The residue was separated and purified withcolumn chromatography (ethyl acetate/hexane=1:15) to give ethyl6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxylate (3.63 g) aspale yellow crystals.

m.p. 82-84° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.35 (3H, t, J=7.2 Hz), 1.40(3H, d, J=6.6 Hz), 2.39 (3H, s), 4.29 (2H, q, J=7.2 Hz), 5.40 (1H, q,J=6.6 Hz), 6.92 (1H, d, J=8.4 Hz), 7.24 (2H, d, J=8.2 Hz), 7.36 (1H, d,J=2.2 Hz), 7.40-7.49 (4H, m). IR (KBr) 1699, 1485, 1296, 1244, 1217,1190, 1136, 1047, 804, 764, 511 cm⁻¹ ; Elemental Analysis for C₂₀ H₂₀ O₃; Calcd. C, 77.90; H, 6.54: Found. C, 77.79; H, 6.46.

REFERENCE EXAMPLE 141

To a solution of ethyl6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxylate (3.0 g) inethanol-tetrahydrofuran (30-30 ml) was added 1N sodium hydroxide (12 ml)at room temperature, and the mixture was stirred for 16 hours. Underreduced pressure, the solvent was evaporated and acidified with 1Nhydrochloric acid. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution anddried with magnesium sulfate. Under reduced pressure, the solvent wasevaporated to give6-(4-methylphenyl)-2-methyl-2H-1-benzopyran-3-carboxylic acid (2.15 g)as yellow crystals.

m.p. 190-192° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.43 (3H, d, J=6.6 Hz),2.39 (3H, s), 5.40 (1H, q, J=6.6 Hz), 6.94 (1H, d, J=8.4 Hz), 7.24 (2H,d, J=8.0 Hz), 7.38 (1H, d, J=2.2 Hz), 7.44 (2H, d, J=8.0 Hz), 7.50 (1H,dd, J=8.4, 2.2 Hz), 7.60 (1H, s). IR (KBr) 2983, 1680, 1635, 1485, 1421,1298, 1261, 1190, 808 cm⁻¹ ; Elemental Analysis for C₁₈ H₁₆ O₃ ; Calcd.C, 77.12; H, 5.75: Found. C, 77.25; H, 5.63.

REFERENCE EXAMPLE 142

A solution of 5-bromo-2-thiophenecarboxyaldehyde (6.08 g) and methyl(triphenylphosphoranilidene)acetate (11.12 g) in toluene (60 ml) wasrefluxed under nitrogen atmosphere for 2 hours and cooled. To themixture was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:15→1:9) and recrystallized fromethyl acetate to give methyl (E)-3-(5-bromothiophen-2-yl)-acrylate (7.44g) as pale yellow crystals.

m.p. 60-62° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 3.79 (3H, s), 6.13 (1H, d,J=15.8 Hz), 6.96-7.05 (2H, m), 7.66 (1H, d, J=15.8 Hz). IR (KBr) 1724,1624, 1417, 1257, 1203, 1165, 968, 802, 486 cm⁻¹ ; Elemental Analysisfor C₈ H₇ O₂ SBr; Calcd. C, 38.88; H, 2.86; S, 12.98; Br, 32.34: Found.C, 38.95; H, 2.83; S, 13.13; Br, 32.36.

REFERENCE EXAMPLE 143

Under argon atmosphere, a solution of methyl(E)-3-(5-bromothiophen-2-yl)acrylate (4.0 g), 4-methylphenyl borate(2.64 g) and potassium carbonate (4.48 g) in toluene-ethanol-water(160-16-16 ml) was stirred at room temperature for 1 hour. To thereaction mixture was added tetrakistriphenylphosphinepalladium (0.56 g),and the mixture was refluxed for 16 hours and cooled to roomtemperature. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure to give crude product (5.24 g). To a solution of the resultingcarboxylic acid ester (5.24 g) in tetrahydrofuran (100 ml) was added lNsodium hydroxide (20 ml) at room temperature, and the mixture wasstirred for 5 days. To the reaction mixture was added water, and themixture was washed with ethyl acetate. The aqueous layer was acidifiedwith concentrated hydrochloric acid, and the mixture was extracted withethyl acetate, washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure to give(E)-3-[5-(4-methylphenyl)-thiophen-2-yl]acrylic acid (1.9 g) as yellowcrystals.

m.p. 223-225° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.38 (3H, s), 6.21 (1H, d,J=15.8 Hz), 7.16-7.27 (4H, m), 7.52 (2H, d, J=8.0 Hz), 7.84 (1H, d,J=15.8 Hz). IR (KBr) 2968, 1666, 1606, 1413, 1261, 1230, 804 cm⁻¹ ;Elemental Analysis for C₁₄ H₁₂ O₂ S; Calcd. C, 38.83; H, 4.95; S, 13.12:Found. C, 68.76; H, 5.07; S, 13.28.

REFERENCE EXAMPLE 144

To a suspension of 5-bromo-2-furancarboxylic acid (5.00 g) andN-hydroxysuccinimide (3.31 g) in acetonitrile (50 ml) was added1-ethyl-3-(3'-dimethylaminopropyl)-carbodiimide hydrochloride (5.52 g)at room temperature, and the mixture was stirred for 2 hours. To thereaction mixture was added a suspension of N,O-dimethylhydroxyl-aminehydrochloride (2.81 g) and triethylamine (10 ml) in acetonitrile (20ml), and the mixture was stirred for 1 hour. To the reaction mixturewere added 1,8-diazabicyclo-[5.4.0]-7-undecene (4.3 ml) and DMF (50 ml),and the mixture was stirred for 3 hours and concentrated under reducedpressure. To the residue was added water, and the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated underreduced pressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:4→1:3→1:2) to giveN-methyl-N-methoxy-5-bromofuran-2-carboxamide (2.77 g) as pale yellowoil.

¹ H-NMR (200 MHz, CDCl₃) δ 3.34 (3H, s), 3.77 (3H, s), 6.45 (1H, d,J=3.6 Hz), 7.09 (1H, d, J=3.6 Hz). IR (neat) 2974, 2937, 1647, 1475,1416, 1385, 1211, 1024, 985, 926, 796, 739 cm⁻¹.

REFERENCE EXAMPLE 145

Under argon atmosphere, a solution ofN-methyl-N-methoxy-5-bromofuran-2-carboxamide (2.77 g), 4-methylphenylborate (1.93 g) and potassium carbonate (3.27 g) intoluene-ethanol-water (110-11-11 ml) was stirred at room temperature for1 hour. To the reaction mixture was addedtetrakistriphenylphosphinepalladium (0.41 g), and the mixture wasrefluxed for 20 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:5→1:2→1:1) to giveN-methyl-N-methoxy-5-(4-methylphenyl)furan-2-carboxamide (2.65 g) ascolorless crystals.

m.p. 54-58° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.38 (3H, s), 3.38 (3H, s),3.82 (3H, s), 6.69 (1H, d, J=3.8 Hz), 7.20-7.26 (3H, m), 7.68 (2H, d,J=8.6 Hz). IR (neat) 1632, 1487, 1381, 1032, 987, 798, 739, 557, 494cm⁻¹ ; Elemental Analysis for C₁₄ H₁₅ NO₃ ; Calcd. C, 68.56; H, 6.16; N,5.71: Found. C, 68.22; H, 6.02; N, 5.47.

REFERENCE EXAMPLE 146

Under nitrogen atmosphere, to a solution ofN-methyl-N-methoxy-5-(4-methylphenyl)furan-2-carboxamide (2.5 g) intetrahydrofuran (20 ml) was added duisobutylaluminum hydride (1.01Mtoluene solution) (15 ml) at -78° C., and the mixture was stirred at-78° C. for 10 minutes and then at 0° C. for 15 minutes. To the reactionmixture was added 1N hydrochloric acid to stop the reaction, and themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:5→1:4) to give crude product(1.49 g). A solution of the crude aldehyde (1.49 g) and methyl(triphenylphosphoranilidene)acetate (2.67 g) in toluene (30 ml) wasrefluxed under nitrogen atmosphere for 1 hour and cooled. To the mixturewas added water, and the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/hexane=1:9→1:5) to give methyl(E)-3-[5-(4-methylphenyl)furan-2-yl]acrylate (1.63 g) as pale yellowcrystals.

m.p. 113-115° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.38 (3H, s), 3.80 (3H, s),6.39 (1H, d, J=15.5 Hz), 6.68 (2H, s), 7.22 (2H, d, J=8.4 Hz), 7.44 (1H,d, J=15.5 Hz), 7.62 (2H, d, J=8.4 Hz). IR (KBr) 1716, 1632, 1304, 1201,1161, 798 cm⁻¹ ; Elemental Analysis for C₁₅ H₁₄ O₃ ; Calcd. C, 74.36; H,5.82: Found. C, 74.36; H, 5.75.

REFERENCE EXAMPLE 147

To a solution of methyl (E)-3-[5-(4-methylphenyl)-furan-2-yl]acrylate(1.49 g) in tetrahydrofuran-ethanol (10-10 ml) was added 2N sodiumhydroxide (4 ml) at room temperature, and the mixture was stirred for 24hours. The reaction mixture was acidified with 1N hydrochloric acid, andthe mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure to give(E)-3-[5-(4-methylphenyl)-furan-2-yl]acrylic acid (0.93 g) as colorlesscrystals.

m.p. 183-184° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.39 (3H, s), 6.39 (1H, d,J=15.4 Hz), 6.70 (1H, d, J=3.4 Hz), 6.75 (1H, d, J=3.4 Hz), 7.23 (2H, d,J=8.2 Hz), 7.52 (1H, d, J=15.4 Hz), 7.64 (1H, d, J=8.2 Hz). IR (KBr)2964, 1678, 1624, 1419, 1308, 1261, 785 cm⁻¹ ; Elemental Analysis forC₁₄ H₁₂ O₃ ; Calcd. C, 73.67; H, 5.30: Found. C, 73.42; H, 5.15.

REFERENCE EXAMPLE 148

A solution of 4-bromo-2-thiophenecarboxyaldehyde (4.77 g) and methyl(triphenylphosphoranilidene)acetate (8.44 g) in toluene (50 ml) wasrefluxed under nitrogen atmosphere for 3 hours and cooled. To themixture was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:15) to give methyl(E)-3-(4-bromothiophen-2-yl)acrylate (5.55 g) as pale yellow crystals.

m.p. 63-67° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 3.80 (3H, s), 6.25 (1H, d,J=15.8 Hz), 7.16 (1H, d, J=0.8 Hz), 7.26 (1H, d, J=0.8 Hz), 7.68 (1H, d,J=15.8 Hz). IR (KBr) 1713, 1630, 1304, 1257, 1165, 958, 828 cm⁻¹ ;Elemental Analysis for C₈ H₇ O₂ SBr; Calcd. C, 38.88; H, 2.86; S, 12.98;Br, 32.34: Found. C, 38.78; H, 2.83; S, 12.98; Br, 32.27.

REFERENCE EXAMPLE 149

Under argon atmosphere, a solution of methyl(E)-3-(4-bromothiophen-2-yl)acrylic acid (3.0 g), 4-methylphenyl borate(1.82 g) and potassium carbonate (3.36 g) in toluene-ethanol-water(120-12-12 ml) was stirred at room temperature for 1 hour. To thereaction mixture was added tetrakistriphenylphosphinepalladium (0.42 g),and the mixture was refluxed for 24 hours and cooled to roomtemperature. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:9→1:5→1:2) to give methyl(E)-3-[4-(4-methylphenyl)thiophen-2-yl)acrylate (2.40 g) as pale yellowcrystals.

m.p. 116-118° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.38 (3H, s), 3.80 (3H, s),6.27 (1H, d, J=15.8 Hz), 7.21 (2H, d, J=7.8 Hz), 7.43-7.50 (4H, m), 7.80(1H, d, J=15.8 Hz). IR (KBr) 1713, 1622, 1506, 1423, 1302, 1240, 1192,1159, 966, 847, 916, 760 cm⁻¹ ; Elemental Analysis for C₁₅ H₁₄ O₂ S;Calcd. C, 69.74; H, 5.46; S, 12.41: Found. C, 69.54; H, 5.47; S, 12.24.

REFERENCE EXAMPLE 150

To a solution of methyl (E)-3-[4-(4-methylphenyl)-thiophen-2-yl)acrylate(2.40 g) in tetrahydrofuran (50 ml) was added 2N sodium hydroxide (6.0ml) at room temperature, and the mixture was stirred for 6 days.Precipitated crystal was collected by filtration and washed withtetrahydrofuran. To the crystals was added 1N hydrochloric acid (20 ml),and the mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure to give(E)-3-[4-(4-methylphenyl)thiophen-2-yl]acrylic acid (1.24 g) as paleyellow crystals.

m.p. 206-207° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.38 (3H, s), 6.28 (1H, d,J=15.6 Hz), 7.23 (2H, d, J=8.0 Hz), 7.47 (2H, d, J=8.0 Hz), 7.49 (1H,s), 7.55 (1H, d, J=1.4 Hz), 7.90 (1H, d, J=15.6 Hz). IR (KBr) 2970,2918, 1682, 1622, 1306, 1196, 966, 818, 764 cm⁻¹ ; Elemental Analysisfor C₁₄ H₁₂ O₂ S; Calcd. C, 68.83; H, 4.95; S, 13.12: Found. C, 68.66 :H, 4.77 : S, 13.08.

REFERENCE EXAMPLE 151

Under nitrogen atmosphere, to a solution of ethyl chloroformylbutyrate(25.0 g) in 1,2-dichloroethane (150 ml) was dropwise added a solution oftin tetrachloride (76.6 g) in 1,2-dichloroethane (50 ml) at 0° C. andthen a solution of 2-bromothiophene (22.8 g) in 1,2-dichloroethane (20ml), and the mixture was stirred at room temperature for 2 hours. Thereaction mixture was vigorously stirred and added to ice-concentratedhydrochloric acid to stop the reaction. The mixture was stirred for 30minutes and extracted with dichloromethane. The organic layer was washedwith saturated sodium bicarbonate solution and saturated sodium chloridesolution, dried with magnesium sulfate and concentrated. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:5) to give ethyl 5-(5-bromothiophen-2-yl)-5-oxovalerate(28.1 g) as colorless crystals.

m.p. 53-54° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.26 (3H, t, J=7.2 Hz),1.97-2.12 (2H, m), 2.41 (2H, t, J=7.2 Hz), 2.92 (2H, t, J=7.3 Hz), 4.14(2H, q, J=7.2 Hz), 7.10 (1H, d, J=4.0 Hz), 7.47 (1H, d, J=4.0 Hz). IR(KBr) 1726, 1664, 1419, 1281, 1184, 980, 812 cm⁻¹ ; Elemental Analysisfor C₁₁ H₁₃ O₃ SBr; Calcd. C, 43.29; H, 4.29; S, 10.51; Br, 26.18:Found. C, 43.54; H, 4.20; S, 10.64; Br, 26.24.

REFERENCE EXAMPLE 152

Under argon atmosphere, a solution of ethyl5-(5-bromothiophen-2-yl)-5-oxovalerate (10.09 g), 4-methylphenyl borate(5.39 g) and potassium carbonate (9.14 g) in toluene-ethanol-water(320-32-32 ml) was stirred at room temperature for 1 hour. To thereaction mixture was added tetrakistriphenylphosphinepalladium (1.14 g),and the mixture was refluxed for 8 hours and cooled to room temperature.The organic layer was washed with saturated sodium chloride solution,dried with magnesium sulfate and concentrated under reduced pressure.The residue was separated and purified with column chromatography (ethylacetate/hexane=1:4→1:3→1:2→1:1) to give ethyl5-[5-(4-methylphenyl)thiophen-2-yl]-5-oxovalerate (10.23 g) as colorlesscrystals.

m.p. 120-121° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.26 (3H, t, J=7.2 Hz),2.01-2.15 (2H, m), 2.38 (3H, s), 2.44 (2H, t, J=7.4 Hz), 2.97 (2H, t,J=7.2 Hz), 4.15 (2H, q, J=7.2 Hz), 7.22 (2H, d, J=7.9 Hz), 7.27 (1H, d,J=4.1 Hz), 7.55 (2H, d, J=7.9 Hz), 7.68 (1H, d, J=4.1 Hz). IR (KBr)1722, 1647, 1448, 1286, 1173, 816 cm⁻¹ ; Elemental Analysis for C₁₈ H₂₀O₃ S; Calcd. C, 68.33; H, 6.37; S, 10.13: Found. C, 68.40; H, 6.26; S,10.11.

REFERENCE EXAMPLE 153

To a solution of ethyl 5-[5-(4-methylphenyl)thiophen-2-yl]-5-oxovalerate(4.50 g) in trifluoroacetic acid (7.66 ml) was added triethylsilane(5.7ml) at room temperature, and the mixture was stirred for 4 days. To thereaction mixture was added ethyl acetate, and the mixture was madealkaline with saturated sodium bicarbonate solution. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:9) to give crude ethyl5-[5-(4-methyl-phenyl)thiophen-2-yl]valerate. To a solution of the crudeethyl 5-[5-(4-methylphenyl)thiophen-2-yl]valerate in tetrahydrofuran (50ml) was added 1N sodium hydroxide (20 ml) at room temperature, and themixture was stirred for 24 hours. To the reaction mixture was addedwater, and the mixture was washed with diethylether. The aqueous layerwas acidified with 1N hydrochloric acid, and the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated underreduced pressure to precipitate crystals, which were collected byfiltration and washed with hexane to give5-[5-(4-methylphenyl)-thiophen-2-yl]valeric acid (2.88 g) as colorlesscrystals.

m.p. 124-127° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.67-1.82 (4H, m), 2.35(3H, s), 2.36-2.45 (2H, m), 2.78-2.90 (2H, m), 6.73 (1H, d, J=3.6 Hz),7.07 (1H, d, J=3.6 Hz), 7.15 (2H, d, J=8.4 Hz), 7.44 (2H, d, J=8.4 Hz).IR (KBr) 2941, 1693, 1512, 1429, 1408, 1317, 1267, 1203, 945, 797, 771cm⁻¹ ; Elemental Analysis for C₁₆ H₁₈ O₂ S; Calcd. C, 70.04; H, 6.61; S,11.69: Found. C, 69.79; H, 6.37; N, 11.62.

REFERENCE EXAMPLE 154

Under nitrogen atmosphere, to a solution of5-[5-(4-methylphenyl)thiophen-2-yl]valeric acid (2.60 g) intetrahydrofuran (30 ml) was added oxalyl chloride (1.24 ml) at roomtemperature and then a drop of DMF, and the mixture was stirred 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in dichloromethane(30 ml). To the mixture was added tintetra-chloride (1.5 ml) at 0° C., and the mixture was stirred at roomtemperature for 3 hours. The reaction mixture was added to water to stopthe reaction, and the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/hexane=1:9→1:5) to give2-(4-methylphenyl)-4-oxo-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene(2.07 g) as pale yellow crystals.

m.p. 82-84° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.82-2.06 (4H, m), 2.35 (3H,s), 2.71-2.78 (2H, m), 3.06-3.12 (2H, m), 7.17 (2H, d, J=8.2 Hz), 7.44(2H, d, J=8.2 Hz), 7.57 (1H, s). IR (KBr) 2927, 1662, 1390, 1176,810cm⁻¹ ; Elemental Analysis for C₁₆ H₁₆ OS; Calcd. C, 74.96; H, 6.29;S, 12.51: Found. C, 74.89 : H, 6.20 : S, 12.53.

REFERENCE EXAMPLE 155

To a solution of2-(4-methylphenyl)-4-oxo-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene(2.62 g) and dimethyl carbonate (2.6 ml) in tetrahydrofuran (50 ml) wasadded potassium tert-butoxide (1.38 g) at room temperature, and themixture was refluxed for 1 hour. To the reaction mixture were addedpotassium tert-butoxide (1.4 g) and dimethyl carbonate (5 ml), and themixture was refluxed for 2 hours and cooled to room temperature. To themixture was added 1N hydrochloric acid (150 ml) at 0° C., and themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated under reduced pressure to give crude products (3.30 g).

To the crude products (3.30 g) in dichloromethane (50 ml) was addedsodium boron hydride (0.77 g) at room temperature and then methanol (8ml) at -15° C. for 30 minutes, and the mixture was stirred for 2 hours.To the reaction mixture was added water, and the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated sodiumchloride solution, dried with magnesium sulfate and concentrated underreduced pressure to give crude product (2.95 g). To a solution of thecrude product (2.95 g) and triethylamine (7 ml) in dichloromethane (20ml) was added methanesulfonyl chloride (1.2 ml) at 0° C., and themixture was stirred at room temperature for 17 hours. To the reactionmixture was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The concentrate was purified with column chromatography (ethylacetate/hexane=1:9) to give methyl2-(4-methyl-phenyl)-7,8-dihydro-6H-cyclohepta[b]thiophene-5-carboxylate(884 mg) as yellow crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.98-2.11 (2H, m), 2.36 (3H, s), 2.79 (2H, t,J=5.5 Hz), 3.09 (2H, t, J=5.6 Hz), 3.79 (3H, s), 7.08 (1H, s), 7.17 (2H,d, J=8.1 Hz), 7.42 (2H, d, J=8.1 Hz), 7.60 (1H, s).

REFERENCE EXAMPLE 156

To a solution of methyl2-(4-methylphenyl)-7,8-dihydro-6H-cyclohepta[b]thiophene-5-carboxylate(803 mg) in ethanol-tetrahydrofuran (5-10 ml) was added 2N sodiumhydroxide (2 ml) at room temperature, and the mixture was stirred for 5days and concentrated under reduced pressure. To the residue was added1N hydrochloric acid (10 ml), and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure to precipitate crystals, which were collected by filtration andwashed with diisopropylether to give2-(4-methylphenyl)-7,8-dihydro-6H-cyclohepta[b]thiophene-5-carboxylicacid (650 mg) as pale yellow crystals.

m.p. 250-251° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.00-2.14 (2H, m), 2.36(3H, s), 2.75-2.85 (2H, m), 3.07-3.16 (2H, m), 7.10 (1H, s), 7.18 (2H,d, J=8.0 Hz), 7.43 (2H, d, J=8.0 Hz), 7.72 (1H, s). IR (KBr) 2910, 2831,1670, 1614, 1423, 1287, 1242, 810cm⁻¹ ; Elemental Analysis for C₁₇ H₁₆O₂ S; Calcd. C, 71.80; H, 5.67; S, 11.28: Found. C, 71.74; H, 5.64; S,11.06.

REFERENCE EXAMPLE 157

To a suspension of 5-bromonicotinic acid (5.0 g) andN-hydroxysuccinimide (4.27 g) in acetonitrile (60 ml) was added1-ethyl-3-(3'-dimethylaminopropyl)carbodiimide hydrochloride (7.12 g) atroom temperature, and the mixture was stirred for 30 minutes. To thereaction mixture were added N,O-dimethyl-hydroxylamine hydrochloride(2.66 g) and triethylamine (10 ml), and the mixture was stirred for 64hours and concentrated under reduced pressure. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated sodium chloride solution, dried withmagnesium sulfate and concentrated under reduced pressure. The residuewas separated and purified with column chromatography (ethylacetate/hexane=2:1) to giveN-methyl-N-methoxy-5-bromopyridine-3-carboxamide (3.71 g) as pale yellowoil.

¹ H-NMR (200 MHz, CDCl₃) δ 3.40 (3H, s), 3.58 (3H, s), 8.19 (1H, dd,J=2.2, 1.8 Hz), 8.76 (1H, d, J=2.2 Hz), 8.88 (1H, d, J=1.8 Hz). IR(neat) 1647, 1412, 1381, 1221, 1099, 1020, 982, 897, 773, 739, 969, 667,575, 461 cm⁻¹.

REFERENCE EXAMPLE 158

Under argon atmosphere, a solution ofN-methyl-N-methoxy-5-bromopyridine-3-carboxamide (3.70 g),4-methyl-phenyl borate (2.26 g) and potassium carbonate (4.17 g) intoluene-ethanol-water (100-10-10 ml) was stirred at room temperature for1 hour. To the reaction mixture was addedtetrakistriphenylphosphinepalladium (0.52 g), and the mixture wasrefluxed for 16 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:2→1:1) to giveN-methyl-N-methoxy-5-(4-methylphenyl)pyridine-3-carboxamide (3.97 g) asyellow oil.

¹ H-NMR (200 MHz, CDCl₃) δ 2.42 (3H, s), 3.42 (3H, s), 3.60 (3H, s),7.30 (2H, d, J=8.3 Hz), 7.51 (2H, d, J=8.3 Hz), 8.20 (1H, t, J=2.1 Hz),8.89-8.81 (2H, m). IR (neat) 1647, 1431, 1379, 1203, 982, 818, 743, 540,426 cm⁻¹.

REFERENCE EXAMPLE 159

Under nitrogen atmosphere, to a solution ofN-methyl-N-methoxy-5-(4-methylphenyl)pyridine-3-carboxamide (3.95 g) intetrahydrofuran (30 ml) was dropwise added diisobutylaluminum hydride(1.0M toluene solution) (30 ml) at -78° C., and the mixture was stirredat the same temperature for 2 hours. To the reaction mixture was added1N hydrochloric acid to stop the reaction. To the mixture was addedethyl acetate, and the mixture was made alkaline with 1N sodiumhydroxide. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:2→1:1) to give5-(4-methylphenyl)pyridine-3-carboxyaldehyde (1.82 g) as colorlesscrystals.

m.p. 60-61° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.43 (3H, s), 7.33 (2H, d,J=7.8 Hz), 7.54 (2H, d, J=7.8 Hz), 8.33 (1H, dd, J=2.2, 2.0 Hz), 9.03(1H, d, J=2.0 Hz), 9.07 (1H, d, J=2.2 Hz), 10.19 (1H, s). IR (KBr) 1701,1186, 818, 725, 806 cm⁻¹ ; Elemental Analysis for C₁₃ H₁₁ NO; Calcd. C,79.17; H, 5.62; N, 7.10: Found. C, 79.24; H, 5.64; N, 7.01.

REFERENCE EXAMPLE 160

A solution of 5-(4-methylphenyl)pyridine-3-carboxyaldehyde (1.82 g) andmethyl (triphenylphosphoranilidene)-acetate (3.46 g) in toluene (20 ml)was refluxed under nitrogen atmosphere for 4 hours and cooled. To themixture was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The residue was separated and purified with columnchromatography (ethyl acetate/hexane=1:2→1:1) to give methyl(E)-3-[5-(4-methylphenyl)pyridin-3-yl]acrylate (2.34 g) as colorlesscrystals.

m.p. 141-144° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.43 (3H, s), 3.84 (3H, s),6.59 (1H, d, J=16.0 Hz), 7.32 (2H, d, J=7.9 Hz), 7.50 (2H, d, J=7.9 Hz),7.76 (1H, d, J=16.0 Hz), 7.98 (1H, dd, J=2.2, 2.0 Hz), 8.70 (1H, d,J=2.0 Hz), 8.82 (1H, d, J=2.2 Hz). IR (KBr) 1718, 1639, 1431, 1335,1196, 1176, 995, 816 cm⁻¹ ; Elemental Analysis for C₁₆ H₁₅ NO₂ ; Calcd.C, 75.87; H, 5.97; N, 5.53: Found. C, 75.82; H, 5.86; N, 5.47.

REFERENCE EXAMPLE 161

To a solution of methyl (E)-3-[5-(4-methylphenyl)-pyridin-3-yl]acrylate(2.25 g) in tetrahydrofuran (20 ml) was added 1N sodium hydroxide (11ml) at room temperature, and the mixture was stirred for 5 days. To thereaction mixture was added 1N hydrochloric acid (12 ml), and the mixturewas concentrated under reduced pressure to precipitate crystals, whichwere collected by filtration and washed with water and diethylether togive (E)-3-[5-(4-methylphenyl)pyridin-3-yl]acrylic acid (1.92 g) ascolorless crystals.

m.p. 208-211° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.37 (3H, s), 6.85 (1H,d, J=16.2 Hz), 7.33 (2H, d, J=8.6 Hz), 7.66-7.74 (3H, m), 8.40-8.45 (1H,m), 8.81 (1H, d, J=1.8 Hz), 8.89 (1H, d, J=2.2 Hz). IR (KBr) 3030, 1672,1635, 1435, 1331, 1302, 987, 820 cm⁻¹ ; Elemental Analysis for C₁₅ H₁₃NO₂ ; Calcd. C, 75.30; H, 5.48; N, 5.85: Found. C, 74.99; H, 5.39; N,5.94.

REFERENCE EXAMPLE 162

To DMF (7.18 ml) was dropwise added phosphoryl chloride (8.64 ml) at 0°C., and the mixture was stirred at room temperature for 30 minutes. Tothe mixture was added methyl acetoacetate (10 ml) at 0° C., and themixture was stirred at room temperature for 2hours. The mixture wascooled to 0° C., and to the mixture was added 4-bromoaniline (16.78 g),and the mixture was stirred at 90° C. for 4 hours. To the reactionmixture was added chloroform, and the mixture was neutralized with 8Nsodium hydroxide. The organic layer was washed with water and saturatedsodium chloride solution, dried with magnesium sulfate and concentratedunder reduced pressure. The residue was separated and purified withcolumn chromatography (ethyl acetate/hexane=1:2) and was recrystallizedfrom ethyl acetate-hexane to give methyl6-bromo-2-methylquinoline-3-carboxylate (6.02 g) as pale yellowcrystals.

m.p. 150-151° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.97 (3H, s), 3.99 (3H, s),7.84 (1H, dd, J=9.0, 2.0 Hz), 7.92 (1H, d, J=9.0 Hz), 8.02 (1H, d, J=2.0Hz), 8.65 (1H, s). IR (KBr) 1726, 1423, 1396, 1277, 1238, 1219, 1134,1074, 829 cm⁻¹ ; Elemental Analysis for C₁₂ H₁₀ NO₂ Br; Calcd. C, 51.45;H, 3.60; N, 5.00: Found. C, 51.57; H, 3.55; N, 5.17.

REFERENCE EXAMPLE 163

Under argon atmosphere, a solution of methyl6-bromo-2-methylquinoline-3-carboxylate (1.22 g), 4-methylphenyl borate(0.65 g) and potassium carbonate (1.18 g) in toluene-ethanol-water(40-4-4 ml) was stirred at room temperature for 1 hour. To the reactionmixture was added tetrakistriphenylphosphinepalladium (0.15 g), and themixture was refluxed for 18 hours and cooled to room temperature. Theorganic layer was washed with saturated sodium chloride solution, driedwith magnesium sulfate and concentrated under reduced pressure. Theresidue was separated and purified with column chromatography (ethylacetate/hexane=1:1) to give methyl6-(4-methylphenyl)-2-methylquinoline-3-carboxylate (1.27 g) as colorlesscrystals.

m.p. 84-87° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.43 (3H, s), 3.01 (3H, s),4.00 (3H, s), 7.32 (2H, d, J=8.0 Hz), 7.61 (2H, d, J=8.0 Hz), 8.01-8.12(3H, m), 8.79 (1H, s). IR (KBr) 1732, 1440, 1277, 1213, 1068, 814 cm⁻¹ ;Elemental Analysis for C₁₉ H₁₇ NO₂ ; Calcd. C, 78.33; H, 5.88; N, 4.81:Found. C, 77.98; H, 6.02; N, 4.75.

REFERENCE EXAMPLE 164

To a solution of methyl6-(4-methylphenyl)-2-methylquinoline-3-carboxylate (0.99 g) intetrahydrofuranethanol (5-5 ml) was added 2N sodium hydroxide (2 ml) atroom temperature, and the mixture was stirred for 2 days. To thereaction mixture was added 1N hydrochloric acid (4 ml), and the mixturewas concentrated under reduced pressure to precipitate crystals, whichwere collected by filtration and washed with ethanol and diethylether togive 6-(4-methylphenyl)-2-methylquinoline-3-carboxylic acid (648 mg) ascolorless crystals.

m.p. 273° C. (dec.); ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.38 (3H, s), 2.89(3H, s), 7.34 (2H, d, J=8.3 Hz), 7.74 (2H, d, J=8.3 Hz), 8.02 (1H, d,J=8.8 Hz), 8.15 (1H, dd, J=8.8, 2.1 Hz), 8.37 (1H, d, J=2.1 Hz), 8.90(1H, s). IR (KBr) 2918, 1703, 1570, 1495, 1257, 1227, 1180, 1151, 1065,812, 770 cm⁻¹ ; Elemental Analysis for C₁₈ H₁₅ NO₂ ; Calcd. C, 77.96; H,5.45; N, 5.05: Found. C, 77.74; H, 5.34; N, 5.12.

REFERENCE EXAMPLE 165

Under argon atmosphere, a solution of ethyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (1.0 g),4-methylthiophenyl borate (622 mg) and potassium carbonate (0.93 g) intoluene-ethanol-water (30-3-3 ml) was stirred at room temperature for 1hour. To the reaction mixture was addedtetrakistriphenyl-phosphinepalladium (117 mg), and the mixture wasrefluxed for 16 hours. To the reaction mixture was addedtetrakistriphenyl-phosphinepalladium (0.13 g), and the mixture wasrefluxed for 24 hours and cooled to room temperature. The organic layerwas washed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:10) to give ethyl7-(4-methylthiophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (442 mg)as colorless crystals.

¹ H-NMR (200 MHz, CDCl₃) δ 1.36 (3H, t, J=7.0 Hz), 2.52 (3H, s), 3.00(2H, t, J=4.8 Hz), 4.29 (2H, q, J=7.0 Hz), 4.30 (2H, t, J=4.8 Hz), 7.04(1H, d, J=8.4 Hz), 7.32 (2H, d, J=8.8 Hz), 7.42-7.54 (4H, m), 7.65 (1H,br s). IR (KBr) 1705, 1489, 1302, 1250, 1230, 1200, 1090, 1063, 1011,813 cm⁻¹.

REFERENCE EXAMPLE 166

To a solution of ethyl7-(4-methylthiophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (132 mg)in ethanol-tetrahydrofuran (5 ml-5 ml) was added 1N sodium hydroxide(1.0 ml) at room temperature, and the mixture was stirred for 20 hoursand concentrated under reduced pressure. To the residue was added 1Nhydrochloric acid (2 ml) and the mixture was extracted with ethylacetate. The organic layer was washed with saturated sodium chloridesolution, dried with magnesium sulfate and concentrated under reducedpressure. The resulting crystal was collected by filtration to give7-(4-methylthiophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (113mg) as colorless crystals.

¹ H-NMR (200 MHz, DMSO-d₆) δ 2.51 (3H, s,), 2.89 (2H, t, J=4.4 Hz), 4.25(2H, t, J=4.4 Hz), 7.04 (1H, d, J=8.4 Hz), 7.33 (2H, d, J=8.4 Hz), 7.58(1H, dd, J=8.4, 2.4 Hz), 7.61-7.70 (3H, m), 7.80 (1H, d, J=2.4 Hz). IR(KBr) 2974, 1689, 1493, 1263, 1213, 1169, 1020, 833 cm⁻¹.

REFERENCE EXAMPLE 167

To a solution of 4-nitrobenzylalcohol (50 g, 0.326 mol) in ethyl acetate(EtOAc) (200 ml) were added 3,4-dihydropyran (35.7 ml, 0.392 mol) andCSA (camphor sulfonic acid) (379 mg, 1.63 mmol) under stirring at roomtemperature, and the mixture was stirred at room temperature for 1 hour.After the reaction completed, the reaction mixture was neutralized withsaturated NaHCO₃ solution and separated ethyl acetate layer was driedwith MgSO₄ and concentrated under reduced pressure. The residue waspurified with silica gel column chromatography to give4-(2-tetrahydropyranyloxymethyl)nitrobenzene (74.5 g, 96%) as syrup.

¹ H-NMR (200 MHz, CDCl₃) δ 1.55-2.05 (6H, m), 3.51-3.62 (1H, m),3.83-3.94 (1H, m) , 4.61 (1H, d, J=13.6 Hz), 4.74 (1H, t, J=3.2 Hz),4.93 (1H, d, J=13.4 Hz), 7.51-7.56 (2H, d, J=8.8 Hz), 8.18-8.24 (2H, m).

REFERENCE EXAMPLE 168

To a solution of 4-(2-tetrahydropyranyloxymethyl)nitrobenzene (59.7 g,0.256 mol) in ethanol (EtOH) (300 ml) was added under nitrogenatmosphere at room temperature 10% Pd/C (5.97 g), and catalytichydrogenation was carried out. The mixture was stirred at roomtemperature for 24 hours. After the reaction completed, the catalyst wasfiltered off, and the organic layer was concentrated under reducedpressure. The residue was purified with silica gel column chromatographyto give 4-(2-tetrahydropyranyloxymethyl)aniline (39.7 g, 76%) as syrup.

¹ -NMR (200 MHz, CDCl₃) δ: 1.45-1.95 (6H, m), 3.00-3.60 (3H, br m),3.87-4.14 (1H, m), 4.39 (1H, d, J=11.4 Hz), 4.68 (1H, d, J=11.4 Hz),4.71 (1H, m), 6.65-6.69 (2H, m), 7.15-7.19 (2H, m).

REFERENCE EXAMPLE 169

To a solution of2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(35.0 g, 0.126 mol) in tetrahydrofuran (THF) (280 ml) were added (COCl)₂(21.9 ml, 0.251 mol) and DMF (0.7 ml) at 0° C. Under nitrogenatmosphere, the mixture was stirred at room temperature for 4 hours.After the reaction completed, The solvent was evaporated, and to theresidue was added THF (315 ml). To a solution of the acid chloride wasadded a solution of 4-(2-tetrahydropyranyloxymethyl)aniline (28.1 g,0.138 mol) and triethylamine (Et₃ N) (26.3 ml, 0.189 mol) in THF (105ml) at 0° C., and the mixture was stirred under nitrogen atmosphere, atroom temperature for 2 hours. After the reaction completed, to themixture was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with saturated NaCl solution anddried with MgSO₄. The solvent was evaporated and the residue wasdissolved in methanol (MeOH) (470 ml). To the mixture was dropwise added6N HCl (5.9 ml) at room temperature, and the mixture was stirred for 1hour. After the reaction completed, the mixture was neutralized withsaturated NaHCO₃ solution, and the solvent was removed. The residue waswashed with water and then acetone/isopropylether (10:1; 60 ml), and theresulting precipitate was filtered, which was dissolved in THF. Themixture was dried with MgSO₄, and the solvent was evaporated. Theresulting powder was washed twice with hexane:ethyl acetate (10:1; 50ml) to giveN-(4-hydroxymethylphenyl)-3-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-6-carboxamide(26.8 g, 56%) as white powder.

¹ H-NMR (200 MHz, CDCl₃) δ: 2.10-2.22 (2H, m), 2.39 (3H, s), 2.71 (2H,br t, J=6.4), 2.84-2.91 (2H, m), 4.67 (2H, s), 7.20-7.26 (2H, m),7.33-7.51 (7H, m), 7.61 (2H, d, J=8.4), 7.71 (1H, br s).

REFERENCE EXAMPLE 170

To a solution ofN-(4-hydroxymethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(10.0 g, 26.1 mmol) and pyridine (0.1 ml) in chloroform (150 ml) wasdropwise added a solution of thionyl chloride (3.4 ml, 39.2 mmol)inchloroform (90 ml), and the mixture was stirred under nitrogenatmosphere at room temperature for 17 hours. After the reactioncompleted, water was added to the mixture, and the mixture was extractedwith chloroform. The organic layer was washed with saturated sodiumchloride solution and dried with anhydrous magnesium sulfate. Thesolvent was evaporated, and the resulting powder was washed with hexaneto giveN-(4-chloromethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(10.2 g, 97%) as colorless powder.

¹ H-NMR (200 MHz, CDCl₃) δ: 2.05-2.21 (2H, m), 2.40 (3H, s), 2.71 (2H,br t, J=6.4), 2.84-2.91 (2H, m), 4.58 (2H, s), 7.20-7.27 (2H, m),7.35-7.52 (7H, m), 7.59-7.65 (2H, m), 7.71 (1H, br s). Anal. for C₂₆ H₂₄NOCl.0.25H₂ O: Calcd: C; 76.83, H; 6.08, N; 3.45. Found: C; 76.55, H;6.00, N; 3.53.

REFERENCE EXAMPLE 171

To a solution of tetrahydro-4H-pyran-4-one (60 g, 0.6 mol) and water (5ml) in DMF (70 ml, 0.90 mol) was added formic acid (46 ml, 1.2 mol), andthe mixture was stirred at 140° C. for 23 hours. After the reactioncompleted, reflux apparatus was changed to evaporation apparatus, crudeamine was obtained by evaporation (74.6 g). b.p. 117-123° C. (27 mm).

To an aqueous solution (100 ml) of the crude amine (30 g) was dropwiseadded 6N HCl (5 drops), and the mixture was washed twice withdichloromethane. The aqueous layer was adjusted to pH 11 with sodiumhydroxide. To the mixture was added NaCl, and the mixture was extractedwith dichloromethane three times. The organic layer was dried withpotassium carbonate, and the solvent was evaporated. The residue waspurified with evaporation to giveN,N-dimethyl-N-tetrahydropyran-4-ylamine (10.4 g, 29%) as colorless oil.

b.p. 75-82° C.(29 mm). ¹ H-NMR (200 MHz, CDCl₃) δ:1.40-1.82 (4H, m),2.28 (6H, s), 2.25-2.40 (1H, m), 3.37 (2H, ddd, J=11.8, 11.8 and 2.2),3.97-4.05 (2H, m).

REFERENCE EXAMPLE 172

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.6 g,2.1 mmol) in tetrahydrofuran (10 ml) were added oxalyl chloride (0.33ml, 4.3 mmol) and N,N-dimethylformamide (1 drop) at 0° C., and themixture was stirred at room temperature for 2.5 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (6 ml). Tothe mixture was dropwise added4-(tert-butyldimethylsilyloxymethyl)aniline (0.56 g, 2.4 mmol) andtriethylamine (0.36 ml, 2.6 mmol) in tetrahydrofuran (2 ml) at 0° C.,and the mixture was stirred at room temperature for 16 hours. To thereaction mixture was added water, and the mixture was extracted withethyl acetate. The extract was washed with saturated sodium chloridesolution and dried with magnesium sulfate. The solvent was evaporated,and the residue was subjected to silica gel column chromatography. Crudeamide (1.1 g) was obtained from fractions of hexane:ethyl acetate=5:1.This product was dissolved in acetone (8 ml), and to the mixture wasdropwise added 6N hydrochloric acid. The mixture was stirred for 1 hour.To the mixture were added 1% sodium hydrogen carbonate (100 ml) anddiisopropylether (100 ml), and precipitate was filtered, which weredissolved in acetone. The mixture was dried with magnesium sulfate, andthe solvent was evaporated. The resulting powder was recrystallized fromacetone-diisopropyl-ether to giveN-(4-hydroxymethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.87 g) as colorless crystals.

¹ H-NMR (CDCl₃) δ:2.39 (3H, s), 3.08 (2H, br t, J=4.4), 4.36 (2H, t,J=4.4), 4.68 (2H, s), 7.06 (2H, d, J=8.4), 7.18-7.61 (10H, m), 7.24 (2H,d, J=8.4). Anal. for C₂₅ H₂₃ NO₃ : Calcd: C; 77.90, H; 6.01, N; 3.63.Found: C; 77.91, H; 6.10, N; 3.55.

REFERENCE EXAMPLE 173

To a solution ofN-(4-hydroxymethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(412 mg, 1.07 mmol) and pyridine (1 drop) in chloroform (5 ml) wasdropwise added thionyl chloride (0.14 ml, 1.61 mmol), and the mixturewas stirred for 2 hours. The mixture was diluted with water andextracted with chloroform. The extract was washed with saturated sodiumchloride solution and dried with magnesium sulfate. The solvent wasevaporated, and the resulting powder was washed with hexane-ethylacetate (1:1) to giveN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(380 mg, 88%) as colorless powder.

m.p. 164° C.; ¹ H-NMR (CDCl₃) δ:3.29 (3H, s), 3.07 (2H, t, J=4.8), 4.36(2H, t, J=4.8), 4.59 (2H, s), 7.05 (1H, d, J=8.2), 7.22-7.26 (2H, m),7.36-7.52 (6H, m), 7.57-7.62 (3H, m). Anal. for C₂₅ H₂₂ NO₂ Cl: Calcd:C; 74.34, H; 5.49, N; 3.47. Found: C; 74.00, H; 5.42, N; 3.29.

REFERENCE EXAMPLE 174

To a suspension of 1,4-cyclohexanedione monoethyleneketal (3.82 g, 24.6mmol) and dimethylamine hydrochloride (2.00 g, 24.6 mmol) in1,2-dichloroethane (50 ml) were dropwise added triethylamine (4.2 ml,29.6 mmol) and DBU (1,8-diazabicyclo-[5.4.0]-7-undecene) (4.4 ml), andthe mixture was stirred for 10 minutes. To the mixture was addedtriacetoxyborohydride (7.68 g, 34.4 mmol), and the mixture was stirredfor 4.5 hours. Precipitate was filtered off, and the filtrate wasconcentrated to give crude product (6.34 g), which was dissolved inwater (10 ml). To the mixture was dropwise added concentratedhydro-chloric acid (6 ml), and the mixture was stirred for 48 hours. Thereaction mixture was diluted with water and washed twice with ether. Theaqueous layer was made basic with sodium hydroxide and extracted withether twice. The extract was washed with saturated sodium chloridesolution, dried with potassium carbonate and purified by evaporation togive 4-dimethylaminocyclohexanone (0.59 g, 17%).

b.p.142-5° C.; ¹ H-NMR (CDCl₃) δ:1.69-2.13 (4H, m), 2.32 (6H, s),2.20-2.41 (2H, m), 2.44-2.64 (3H, m).

REFERENCE EXAMPLE 175

To a solution of7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (2.38 g)in THF (50 ml) were added oxalyl chloride (1.4 ml) and DMF (2 drops) atroom temperature, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved inTHF (50 ml). To the mixture was dropwise added a solution oftriethylamine (2.1 ml) and 4-aminobenzyloxy-tert-butyldimethylsilane(2.00 g) in THF (10 ml) at 0° C., and the mixture was stirred at roomtemperature for 18 hours. To the reaction mixture was added water, andthe mixture was extracted with ethyl acetate. The organic layer waswashed with saturated sodium chloride solution, dried with magnesiumsulfate and concentrated under reduced pressure. The residue wasseparated and purified with column chromatography (ethylacetate/hexane=1:4) to give pale yellow crystals (3.99 g), which weredissolved in acetone (50 ml). To the mixture was added 6N hydrochloricacid (1.3 ml) at room temperature, and the mixture was stirred for 1hour. To the reaction mixture were added 5% sodium hydrogen carbonatesolution (15 ml) and diisopropylether (100 ml). Precipitate wascollected by filtration and washed with water and diisopropylether. Theresulting solid was dissolved in THF, dried with magnesium sulfate andconcentrated under reduced pressure to give crystals, which wererecrystallized from THF to give7-(4-ethoxyphenyl)-N-(4-hydroxymethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(2.65 g) as colorless crystals.

m.p. 208-210° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ:1.35 (3H, t, J=7.0 Hz),2.93-3.03 (2H, m), 4.06 (2H, q, J=7.0 Hz), 4.45 (2H, br s), 5.01-5.18(1H, m), 6.98-7.05 (3H, m), 7.25-7.34 (3H, m), 7.49-7.71 (6H, m), 9.92(1H, s). IR (KBr) ν: 3363, 3290, 1659, 1612, 1525, 1493, 1242, 1227, 825cm⁻¹ ; Anal. for C₂₆ H₂₅ NO₄ ; Calcd: C, 75.16; H, 6.06; N, 3.37; Found:C, 75.16; H, 6.08; N, 3.31.

REFERENCE EXAMPLE 176

To a suspension of7-(4-ethoxyphenyl)-N-(4-hydroxymethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(2.55 g) and pyridine (2 drops) in chloroform (50 ml) was added thionylchloride (0.8 ml) at room temperature, and the mixture was stirred for20 hours. To the reaction mixture was added water and then THF, and themixture was extracted with ethyl acetate. The organic layer was washedwith saturated sodium chloride solution, dried with magnesium sulfateand concentrated under reduced pressure to give solid, which wasdissolved in THF and ethyl acetate. The mixture was concentrated underreduced pressure to give crystals, which were collected by filtrationand washed with diisopropylether to giveN-(4-chloromethylphenyl)-7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(2.42 g) as colorless crystals.

m.p. 187-189° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ: 1.35 (3H, t, J=7.0 Hz),2.93-3.04 (2H, m), 4.06 (2H, q, J=7.0 Hz), 4.23-4.34 (2H, m), 4.74 (2H,s), 6.98-7.06 (3H, m), 7.35-7.42 (3H, m), 7.52 (1H, dd, J=8.4, 2.2 Hz),7.59 (2H, d, J=8.8 Hz), 7.70-7.74 (3H, m), 10.04 (1H, s). IR (KBr) ν:3400, 1659, 1610, 1525, 1493, 1242, 1047, 822 cm⁻¹ ; Anal. for C₂₆ H₂₄NO₃ Cl; Calcd: C, 71.97; H, 5.57; N, 3.23; Found: C, 71.96; H, 5.54; N,3.04. Working Example 227 (Production of Compound 227)

To solution of7-(4-ethoxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(111 mg) in DMF (5 ml) was added methyl iodide (0.04 ml) at roomtemperature, and the mixture was stirred for 8 hours. Under reducedpressure, the mixture was concentrated, and to the residue was addedethyl acetate to precipitate solid, which was collected by filtrationand recrystallized from ethanol-ethyl acetate to givedimethyl-[4-N-[7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl]aminobenzyl]-4-tetrahydropyranylammoniumiodide (97 mg) as pale yellow crystals.

m.p. 152-158° C.; ¹ H-NMR (200 MHz, CDCl₃) δ: 1.41 (3H, t, J=7.0 Hz),1.68-1.98 (2H, m), 2.10-2.26 (2H, m), 2.94 (6H, s), 2.98-3.08 (2H, m),3.35-3.59 (3H, m), 3.96-4.16 (2H, m), 4.03 (2H, q, J=7.0 Hz), 4.19-4.31(2H, m), 4.84 (2H, s), 6.91 (2H, d, J=8.8 Hz), 6.97 (1H, d, J=8.4 Hz),7.38 (1H, dd, J=8.4, 2.2 Hz), 7.44-7.57 (5H, m), 7.69 (1H, d, J=2.2 Hz),7.80 (2H, d, J=8.4 Hz), 8.01 (1H, s). IR (KBr) ν: 3440, 1657, 1605,1520, 1491, 1317, 1240 cm⁻¹ ; Anal. for C₃₃ H₃₉ N₂ O₄ I.1.0OH₂ O; Calcd:C, 58.93; H, 6.14; N, 4.16; Found: C, 58.86; H, 6.18; N, 4.19.

WORKING EXAMPLE 228 (Production of Compound 228)

To a solution of7-(4-ethylphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(125 mg) in DMF (5 ml) was added methyl iodide (0.04 ml) at roomtemperature, and the mixture was stirred for 20 hours. Under reducedpressure, the mixture was concentrated, and to the residue was addedethyl acetate to precipitate solid, which was collected by filtrationand recrystallized from acetone-diethylether→ethanol-diethyl-ether) togivedimethyl-[4-N-[7-(4-ethylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl]aminobenzyl]-4-tetrahydropyranylammoniumiodide (68 mg) as pale yellow crystals.

m.p. 156-160° C.; ¹ H-NMR (200 MHz, CDCl₃) δ: 1.25 (3H, t, J=7.6 Hz),1.69-1.93 (2H, m), 2.13-2.28 (2H, m), 2.66 (2H, q, J=7.6 Hz), 2.95 (6H,s), 3.00-3.09 (2H, m), 3.39-3.56 (2H, m), 4.02-4.34 (5H, m), 4.86 (2H,s), 6.99 (1H, d, J=8.4 Hz), 7.18-7.28 (3H, m), 7.39-7.56 (5H, m),7.69-7.73 (1H, m), 7.79 (2H, d, J=8.8 Hz), 8.78 (1H, s). IR (KBr) ν:3429, 1657, 1301, 1520, 1491, 1412, 1319, 1244, 827 cm⁻¹ ; Anal. for C₃₃H₃₉ N₂ O₃ I.1.0OH₂ O; Calcd: C, 60.37 : H, 6.29; N, 4.27; Found: C,60.40; H, 6.24; N, 4.10.

WORKING EXAMPLE 229 (Production of Compound 229)

To a solution ofN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(113.6 mg) in DMF (5 ml) was added methyl iodide (0.04 ml) at roomtemperature, and the mixture was stirred for 24 hours. Under reducedpressure, the mixture was concentrated, and to the residue was addedethyl acetate to precipitate solid, which was collected by filtrationand recrystallized from acetone-diethylether→ethanol-diethyl-ether) togivedimethyl-[4-N-[7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl]aminobenzyl]-4-tetrahydropyranylammoniumiodide (99 mg) as pale yellow crystals.

m.p. 213° C. (dec.); ¹ H-NMR (200 MHz, DMSO-d₆) δ: 1.42-1.66 (2H, m),1.75-1.88 (2H, m), 2.55 (6H, s), 2.62-2.72 (2H, m), 2.94-3.35 (3H, m),3.68-3.81 (2H, m), 3.96-4.08 (2H, m), 4.13 (2H, s), 6.80 (1H, d, J=8.8Hz), 7.05 (1H, s), 7.21 (2H, d, J=8.4 Hz), 7.34-7.40 (1H, m), 7.44-7.63(7H, m), 9.89 (1H, s). IR (KBr) ν: 3277, 1649, 1510, 1520, 1491, 1325,1255, 1120, 843 cm⁻¹ ; Anal. for C₃₂ H₃₄ N₂ O₃ F₃ I.0.2H₂ O; Calcd: C,56.35; H, 5.08; N, 4.11; Found: C, 56.21; H, 5.16; N, 4.11.

REFERENCE EXAMPLE 177

In 1,2-dichloroethane(400 ml) was suspended p-nitrobenzylaminehydrochloride (30.8 g), 1,4-cyclohexane-dione monoethyleneketal (25.4 g)and triethylamine (23 ml), and to the suspension was added sodiumtriacetoxy boron hydride (50.9 g) under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature for 2.5 hours.Under ice-cooling , 37% formalin (14.6 ml) and sodium triacetoxy boronhydride (50.9 g) were added to the mixture. Under nitrogen atmosphere,the mixture was stirred at room temperature overnight. The mixture wasneutralized with sodium hydrogen carbonate and extracted with1,2-dichloroethane. The organic layer was washed with sodium chloridesolution and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give yellow solid (47.5 g), 44 gof which was dissolved in (660 ml). To the mixture was added reducediron (32 g) little by little, and the mixture was stirred at roomtemperature overnight. The solvent was evaporated, and to the residuewas added ethyl acetate. The precipitate was filtered off, and thefiltrate was made alkaline with potassium carbonate and extracted withethyl acetate. The organic layer was washed with water and saturatedsodium chloride solution and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column chromatography (ethylacetate/triethylamine/methanol) to give4-((N-(4,4-ethylenedioxycyclohexyl)-N-methyl)aminomethyl)aniline (34.1g) as brown oil.

¹ H-NMR(CDCl₃) δ: 1.36-1.93 (8H, m), 2.17 (3H, s), 2.43-2.57 (1H, m),3.46 (2H, s), 3.60 (2H, br), 3.94 (4H, s), 6.64 (2H, d, J=8.4 Hz), 7.09(2H, d, J=8.4 Hz). IR(neat) ν: 2946, 1615 cm⁻¹.

WORKING EXAMPLE 230 (Production of Compound 230)

In dichloromethane (400 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (17.0 g),and to the suspension were added oxalyl chloride (10.3 ml) anddimethylformamide (catalytic amount) under ice-cooling. The mixture wasstirred at room temperature for 2 hours, and the solvent was evaporated.The residue was dissolved in tetrahydrofuran (300 ml), and the mixturewas dropwise added to a solution of4-((N-(4,4-ethylenedioxycyclohexyl)-N-methyl)aminomethyl)-aniline (16.75g) and triethylamine (25 ml) in tetrahydrofuran (200 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature overnight, and the solvent was evaporated. To the residuewas added water, and the mixture was extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate to giveN-(4-((N-(4,4-ethylenedioxycyclohexyl)-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(17.1 g) as colorless crystals.

mp 192-193° C.; ¹ H-NMR(CDCl₃) δ: 1.48-1.86 (8H, m), 2.20 (3H, s), 2.39(3H, s), 2.45-2.60 (1H, m), 3.08 (2H, t, J=4.5 Hz), 3.56 (2H, s), 3.95(4H, s), 4.36 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.4 Hz), 7.23-7.33 (4H,m), 7.44-7.56 (7H, m). IR(KBr) ν: 2948, 1651 cm⁻¹. Anal. for C₃₄ H₃₈ N₂O₄ : Calcd: C, 75.81; H, 7.11; N, 5.20. Found: C, 75.51; H, 6.99; N,5.29.

WORKING EXAMPLE 231 (Production of Compound 231)

In acetic acid (100 ml) and 1N hydrochloric acid (200 ml) was dissolvedN-(4-((N-(4,4-ethylenedioxycyclohexyl)-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(17.1 g), and the mixture was stirred at 100° C. for 1.5 hours andconcentrated. The residue was neutralized with 1N sodium hydroxide andextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated togive crude crystals, which were recrystallized from ethylacetate-methanol to giveN-(4-((N-(4-oxocyclohexyl)-N-methyl)aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(12 g) as colorless crystals.

mp 149-150° C.; ¹ H-NMR(CDCl₃) δ: 1.78-2.13 (4H, m), 2.23 (3H, s),2.25-2.35 (2H, m), 2.39 (3H, s), 2.45-2.57 (2H, m), 2.84-2.94 (1H, m),3.08 (2H, t, J=4.4 Hz), 3.59 (2H, s), 4.35 (2H, t, J=4.4 Hz), 7.06 (1H,d, J=8.OHz), 7.22-7.34 (4H, m), 7.43-7.57 (6H, m), 7.65 (1H, s). IR(KBr)ν: 2946, 1713 cm⁻¹. Anal. for C₃₂ H₃₄ N₂ O₃ ; Calcd: C, 77.70; H, 6.93;N, 5.66. Found: C, 77.45; H, 6.78; N, 5.65.

REFERENCE EXAMPLE 178

To a mixture of methyl2-bromo-6,7-dihydro-5H-benzocycloheptene-8-carboxylate (0.5 g),4-(1-pyrrolidinyl)phenyl borate(0.37 g), 1M potassium carbonate (6 ml)and ethanol(6 ml) was added toluene (50 ml), and the mixture was stirredunder argon atmosphere at room temperature for 30 minutes. To themixture was added tetrakistriphenylphosphinepalladium (0.08 g), and themixture was refluxed for 6 hours and extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to give colorless crystals(0.48 g), which were dissolved in 1N sodium hydroxide (15 ml), methanol(50 ml) and tetrahydrofuran (50 ml). The mixture was stirred at roomtemperature overnight, concentrated and neutralized with hydrochloricacid to precipitate2-(4-(1-pyrrolidinyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (0.46 g) as pale yellow crystals.

mp 242-243° C.(dec.). ¹ H-NMR(DMSO-d₆) δ: 1.93-2.00 (6H,m), 2.56 (2H, t,J=5.8 Hz), 2.76-2.82 (2H, m), 3.23-3.35 (4H, m), 6.60 (2H, d, J=8.8 Hz),7.20 (1H, d, J=8.2 Hz), 7.44 (1H, dd, J=1.0, 8.2 Hz), 7.53 (2H, d, J=8.8Hz), 7.56 (1H, d, J=1.0 Hz), 7.69 (1H, s). Anal. for C₂₂ H₂₃ NO₂.0.1H₂ :Calcd: C, 78.82; H, 6.98; N, 4.18. Found: C, 78.92; H, 6.95; N, 4.15.

WORKING EXAMPLE 232 (Production of Compound 232)

To a solution of2-(4-(1-pyrrolidinyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (0.45 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline(0.33 g) and 1-hydroxybenzotriazole (0.18 g) in dimethylformamide (20ml) was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimidehydrochloride (0.39 g) under ice-cooling. Under nitrogen atmosphere, thereaction mixture was cooled to room temperature, and to the mixture wereadded 4-dimethylaminopyridine (catalytic amount) and triethylamine (0.56ml). The mixture was stirred overnight, poured into water and extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give crude crystals, which wererecrystallized from ethyl acetate-hexane to give2-(4-(1-pyrrolidinyl)phenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methyl)aminomethyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.28 g) as colorless crystals.

mp 124-125° C.; ¹ H-NMR(CDCl₃) δ: 1.66-1.77 (4H, m), 1.99-2.06 (4H, m),2.11-2.18 (2H, m), 2.21 (3H, s), 2.55-2.75 (3H, m), 2.84-2.90 (2H, m),3.30-3.44 (6H, m), 3.58 (2H, s), 4.00-4.14 (2H, m), 6.64 (2H, d, J=9.0Hz), 7.19 (1H, d, J=8.0 Hz), 7.31 (2H, d, J=8.5 Hz), 7.39-7.51 (4H, m),7.57 (2H, d, J=8.5 Hz), 7.64 (1H, s). IR(KBr) ν: 2946, 2843, 1651, 1611cm⁻¹. Anal. for C₃₅ H₄₁ N₃ O₂.0.2H₂ O; Calcd: C, 77.95; H, 7.74; N,7.79. Found: C, 77.76; H, 7.59; N, 7.79.

REFERENCE EXAMPLE 179

In 1,2-dichloroethane (50 ml) were dissolved p-nitrobenzaldehyde (5 g)and 3-amino-1-propanol (2.5 g), and to the mixture was added sodiumtriacetoxy boron hydride (9.8 g) under ice-cooling. Under nitrogenatmosphere, the mixture was stirred at room temperature for 5 hours.Under ice-cooling ,to the mixture was added 37% formalin(3 ml) andsodium triacetoxy boron hydride (9.8 g). Under nitrogen atmosphere, themixture was stirred at room temperature overnight. To the mixture wasadded water, and the mixture was concentrated, neutralized with aqueoussodiumhydroxide and extracted with ethyl acetate. The organic layer waswashed with water and sodium chloride solution and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/methanol/triethylamine) to give yellow oil (5.0 g), 2.5 g ofwhich was dissolved in ethanol (50 ml) and catalytic hydrogenation wascarried out with 5% palladium on carbon (0.2 g) for 1.5 hours. Thecatalyst was filtered off, and the solvent was evaporated. The residuewas purified with silica gel column (ethylacetate/methanol/triethylamine) to give4-((N-3-hydroxypropyl-N-methyl)aminomethyl)-aniline (1.5 g) as paleyellow oil.

¹ H-NMR(CDCl₃) δ: 1.67-1.78 (2H, m), 2.21 (3H, s), 2.62 (2H, t, J=5.5Hz), 3.41 (2H, s), 3.65 (2H, br), 3.77 (2H, t, J=5.1 Hz), 6.65 (2H, d,J=8.4 Hz), 7.07 (2H, d, J=8.4 Hz). IR(neat) ν: 3347, 2948, 2799, 1615cm⁻¹.

WORKING EXAMPLE 233 (Production of Compound 233)

In dichloromethane (5 ml) was suspended2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.3 g), and to the suspension were added oxalyl chloride (0.28 ml) anddimethylformamide (catalytic amount) under ice-cooling. The mixture wasstirred at room temperature for 1.5 hours, and the solvent wasevaporated. The residue was dissolved in tetrahydrofuran (15 ml), andthe mixture was dropwise added to a solution of4-((N-3-hydroxypropyl-N-methyl)aminomethyl)aniline (0.23 g) andtriethylamine (0.45 ml) in tetrahydrofuran (15 ml) under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureovernight, and the solvent was evaporated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/methanol/triethylamine) to give crude crystals,which were recrystallized from ethyl acetate-hexane to giveN-(4-((N-3-hydroxypropyl-N-methyl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.32 g) as colorless crystals.

mp 139-140° C.; ¹ H-NMR(CDCl₃) δ: 1.72-1.81 (2H, m), 2.13-2.19 (2H, m),2.25. (3H, s), 2.40 (3H, s), 2.63-2.75 (4H, m), 2.86-2.92 (2H, m), 3.53(2H, s), 3.79 (2H, t, J=5.4 Hz), 7.21-7.32 (3H, m), 7.42-7.52 (6H, m),7.58 (2H, d, J=8.4 Hz), 7.66 (1H, s). IR(KBr) ν: 2936, 1651 cm⁻¹. Anal.for C₃₀ H₃₄ N₂ O₂.0.5H₂ O: Calcd: C, 77.72; H, 7.61; N, 6.04. Found: C,77.94; H, 7.62; N, 6.15.

WORKING EXAMPLE 234 (Production of Compound 234)

In dichloromethane(12 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.4 g),and to the suspension were added oxalyl chloride (0.37 ml) anddimethylformamide (catalytic amount) under ice-cooling. The mixture wasstirred at room temperature for 2 hours, and the solvent was evaporated.The residue was dissolved in tetrahydrofuran (15 ml), and the mixturewas dropwise added to a solution of4-((N-3-hydroxy-propyl-N-methyl)aminomethyl)aniline (0.33 g) andtri-ethylamine (0.6 ml) in tetrahydrofuran(15 ml) under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureovernight, and the solvent was evaporated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/methanol/triethylamine) to give crude crystals,which were recrystallized from ethyl acetate-hexane to giveN-(4-((N-3-hydroxypropyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.39 g) as colorless crystals.

mp 119-120° C.; ¹ H-NMR(CDCl₃) δ: 1.68-1.80 (2H, m), 2.24 (3H, s), 2.39(3H, s), 2.65 (2H, t, J=5.8 Hz), 3.07 (2H, t, J=4.6 Hz), 3.52 (2H, s),3.77 (2H, t, J=5.2 Hz), 4.35 (2H, t, J=4.6 Hz), 7.05 (1H, d, J=8.4 Hz),7.22-7.31 (3H, m), 7.43-7.52 (5H, m), 7.57 (2H, d, J=8.4 Hz), 7.78(1H,s). IR(KBr) ν: 3287, 2948, 1649 cm⁻¹. Anal. for C₂₉ H₃₂ N₂ O₃.0.2H₂O: Calcd: C, 75.69; H, 7.10; N, 6.09. Found: C, 75.58; H, 6.93; N, 6.08.

WORKING EXAMPLE 235 (Production of Compound 235)

In dichloromethane (10 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (0.3g), and to the suspension were added oxalyl chloride (0.27 ml) anddimethylformamide (catalytic amount) under ice-cooling. The mixture wasstirred at room temperature for 2 hours, and the solvent was evaporated.The residue was dissolved in tetrahydrofuran (15 ml), and the mixturewas dropwise added to a solution of4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.25 g) andtriethylamine (0.42 ml) in tetrahydrofuran(15 ml) under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureovernight, and the solvent was evaporated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give crude crystals, which were recrystallizedfrom ethyl acetate-hexane to give7-(4-methylphenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methyl)aminomethyl)phenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(0.45 g) as colorless crystals.

mp 177-178° C.; ¹ H-NMR(CDCl₃) δ: 1.63-1.77 (4H, m), 2.21 (3H, s), 2.40(3H, s), 2.57-2.70 (1H, m), 3.08 (2H, t, J=5.8 Hz), 3.26-3.44 (4H, m),3.57 (2H, s), 4.01-4.11 (2H, m), 7.24-7.34 (3H, m), 7.40-7.57 (8H, m),7.70 (1H, s). IR(KBr) ν: 2949, 1651 cm⁻¹. Anal. for C₃₁ H₃₄ N₂ O₂S.0.3H₂ O: Calcd: C, 73.86; H, 6.92; N, 5.56. Found: C, 73.93; H, 6.73;N, 5.82.

WORKING EXAMPLE 236 (Production of Compound 236)

In dichloromethane (6 ml) was suspended2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.25 g), and to the suspension were added oxalyl chloride (0.24 ml) anddimethylformamide (catalytic amount) under ice-cooling. The mixture wasstirred at room temperature for 1.5 hours, and the solvent wasevaporated. The residue was dissolved in tetrahydrofuran (15 ml, and themixture was dropwise added to a solution of4-((N-methyl-N-(pentan-3-yl))aminomethyl)aniline (0.2 g) andtriethylamine (0.38 ml) in tetrahydrofuran (15 ml) under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperaturefor 5 hours, and the solvent was evaporated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give crude crystals, which were recrystallizedfrom ethyl acetate-hexane to giveN-(4-((N-methyl-N-(pentan-3-yl))aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.23 g) as colorless crystals.

mp 112-113° C.; ¹ H-NMR(CDCl₃) δ: 0.94 (6H, t, J=7.3 Hz), 1.26-1.54 (4H,m), 2.14 (3H, s), 2.14-2.32 (3H, m), 2.40 (3H, s), 2.72 (2H, t, J=6.4Hz), 2.86-2.91 (2H, m), 3.55 (2H, s), 7.21-7.27 (3H, m), 7.31-7.56 (8H,m), 7.62 (1H, s). IR(KBr) ν: 2930, 1651 cm⁻¹. Anal. for C₃₂ H₃₈ N₂ O:Calcd: C, 82.36; H, 8.21; N, 6.00. Found: C, 82.30; H, 8.05; N, 5.90.

REFERENCE EXAMPLE 180

To a mixture of3-(4-methylphenyl)-6,7,8,9-tetrahydro-5H-benzocycloheptan-5-one (0.5 g),potassium carbonate (1.65 g) and 18-crown-6 (1.05 g) was addeddimethylsulfoxide (10 ml). Under carbon dioxide atmosphere, the mixturewas stirred at room temperature for 20 hours, poured into water,acidified with hydrochloric acid and extracted with ethyl acetate. Theorganic layer was washed with water and subjected to back extractionwith sodium hydroxide and water. The aqueous layer was collected,acidified with hydrochloric acid and extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. The solvent wasevaporated to precipitate colorless crystals (0.42 g), which werefiltered with hexane and dissolved in ethanol (40 ml). To the mixturewas added sodium boron hydride (0.54 g), and the mixture was stirred atroom temperature for 1 hour. To the mixture was added water, and themixture was concentrated, was acidified with hydrochloric acid andextracted with ethyl acetate. The organic layer was washed with waterand saturated sodium chloride solution and dried with anhydrous agnesiumsulfate. The solvent was evaporated to give colorless crystals (0.41 g),which were dissolved in 80% formic acid (40 ml). The mixture was stirredat 100° C. for 2.5 hours and concentrated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution anddried with anhydrous magnesium sulfate. The solvent was evaporated, andthe residue was purified with silica gel column (ethyl acetate/hexane)to give 2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (0.14 g) as colorless crystals.

¹ H-NMR(CDCl₃) δ: 2.04-2.18 (2H, m), 2.40 (3H, s), 2.70 (2H, t, J=6.8Hz), 2.86-2.91 (2H, m), 7.21-7.28 (3H, m), 7.44-7.56 (4H, m), 7.91 (1H,s).

REFERENCE EXAMPLE 181

In dimethylsulfoxide (15 ml) were dissolved3-(4-methylphenyl)-6,7,8,9-tetrahydro-5H-benzocycloheptan-5-one (0.5 g)and 18-crown-6 (1.05 g). Under ice-cooling, potassium t-butoxide (1.65g) was added to the solution. Under carbon dioxide atmosphere, themixture was stirred at room temperature for 3 hours, poured into water,acidified with hydrochloric acid and extracted with ethyl acetate. Theorganic layer was washed with water and subjected to back extractionwith sodium hydroxide and water. The aqueous layer was collected,acidified with hydrochloric acid and extracted with ethyl acetate. Theorganic layer was washed with water and saturated sodium chloridesolution and dried with anhydrous magnesium sulfate. The solvent wasevaporated to precipitate colorless crystals (0.47 g), which werefiltered with hexane and dissolved in ethanol (40 ml). To the mixturewas added sodium boron hydride (0.58 g), and the mixture was stirred atroom temperature for 1 hour. To the mixture was added water, and themixture was concentrated, acidified with hydrochloric acid and extractedwith ethyl acetate. The organic layer was washed with water andsaturated sodium chloride solution and dried with anhydrous magnesiumsulfate. The solvent was evaporated to precipitate colorless crystals(0.46 g), which were filtered with hexane. To the crystals was added 80%formic acid (10 ml), and the mixture was refluxed for 1.5 hours. To themixture was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with water and subjected to backextraction with sodium hydroxide and water. The aqueous layer wascollected, acidified with hydrochloric acid and extracted with ethylacetate. The organic layer was washed with water and saturated sodiumchloride solution and dried with anhydrous magnesium sulfate. Thesolvent was evaporated to precipitate2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.22 g) as colorless crystals.

¹ H-NMR(CDCl₃) δ: 2.04-2.16 (2H, m), 2.40 (3H, s), 2.69 (2H, t, J=6.7Hz), 2.86-2.91 (2H, m), 7.21-7.278 (3H, m), 7.44-7.56 (4H, m), 7.89 (1H,s).

WORKING EXAMPLE 237 (Production of Compound 237)

In dimethylformamide (100 ml) was dissolved7-(4-methylphenyl)-N-(4-((N-(4-oxocyclohexyl)-N-methyl)-aminomethyl)-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(7.5 g), and to the mixture was added methyl iodide (4.7 ml). Undernitrogen atmosphere, the mixture was stirred at room temperatureovernight. The solvent was evaporated, and to the residue was addedacetone to givedimethyl-(N-(7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl)-N-(4-oxocyclohexyl)ammoniumiodide (8.9 g) as colorless crystals.

¹ H-NMR(DMSO-d₆) δ: 2.09-2.24 (2H, m), 2.34 (3H, s), 2.41-2.61 (6H, m),2.97 (6H, s), 2.97-3.00 (2H, m), 3.79-3.90 (1H, m), 4.31 (2H, t, J=4.4Hz), 4.56 (2H, s), 7.07 (1H, d, J=8.4 Hz), 7.27 (2H, d, J=8.2 Hz), 7.37(1H, s), 7.55-7.60 (5H, m), 7.75 (1H, d, J=2.2 Hz), 7.88 (2H, d, J=8.8Hz), 10.20 (1H, s).

WORKING EXAMPLE 238 (Production of Compound 238)

In dimethylformamide (5 ml) was dissolved in2-(4-(1-pyrrolidinyl)phenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methyl)aminomethyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.15 g), and to the mixture was added methyl iodide (0.02 ml). Undernitrogen atmosphere, the mixture was stirred at room temperatureovernight. To the mixture was added ethyl acetate, and crude crystal wasfiltered. The crude crystal was recrystallized from ethanol-ethylacetate to givedimethyl-(N-(2-(4-(1-pyrrolidinyl)phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carbonyl)-4-aminobenzyl)-4-tetrahydropyranylammoniumiodide (0.05 g) as pale brown powder.

¹ H-NMR(DMSO-d₆) δ: 1.80-2.20 (10H, m), 2.63 (2H, t, J=5.6 Hz),2.81-2.84 (2H, m), 2.88 (6H, s), 3.24-3.44 (6H, m), 3.54-3.65 (1H, m),4.02-4.11 (2H, m), 4.46 (2H, s), 6.62 (2H, d, J=9.0 Hz), 7.25 (1H, d,J=7.8 Hz), 7.36-7.60 (7H, m), 7.88 (2H, d,J=8.4 Hz), 10.22 (1H, s).IR(KBr) ν: 2967, 1663, 1609 cm⁻¹. Anal. for C₃₆ H₄₄ IN₃ O₂.H₂ O: Calcd:C, 62.15; H, 6.66; N, 6.04. Found: C, 61.89; H, 6.30; N, 5.97.

WORKING EXAMPLE 239 (Production of Compound 239)

In dimethylformamide (5 ml) was dissolvedN-(4-((N-3-hydroxypropyl-N-methyl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.2 g), and to the mixture was added methyl iodide (0.04 ml). Undernitrogen atmosphere, the mixture was stirred at room temperatureovernight. The solvent was evaporated, and to the residue was addedethyl acetate to give crude crystals, which were filtered andrecrystallized from ethanol-ethyl acetate to giveN-(3-hydroxypropyl)-N,N-dimethyl-(N-(2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carbonyl)-4-aminobenzyl)ammoniumiodide (0.05 g) as colorless crystals.

mp 210-213° C.; ¹ H-NMR(CDCl₃ +CD₃ OD) δ: 2.00-2.20 (4H, m), 2.40 (3H,s), 2.71 (2H, t, J=6.6 Hz), 2.87-2.92 (2H, m), 3.10 (6H, s), 3.54-3.65(2H, m), 3.73 (2H, t, J=5.3 Hz), 4.63 (2H, s), 7.22-7.27 (3H, m),7.43-7.58 (7H, m), 7.80 (2H, d, J=8.4 Hz), 9.21 (1H, s). IR(KBr) ν:3337, 2934, 1653 cm⁻¹. Anal. for C₃₁ H₃₇ IN₂ O₂.0.5H₂ O: Calcd: C,61.49; H, 6.33; N, 4.63. Found: C, 61.55; H, 6.22; N, 4.74.

WORKING EXAMPLE 240 (Production of Compound 240)

In dimethylformamide (5 ml) was dissolvedN-(4-((N-3-hydroxypropyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.14 g), and to the mixture was added methyl iodide (0.04 ml). Undernitrogen atmosphere, the mixture was stirred at room temperatureovernight. The solvent was evaporated, and to the residue was addedethyl acetate to give crude crystals, which were filtered andrecrystallized from ethanol-ethyl acetate to givedimethyl-3-hydroxypropyl-(N-(7-(4-methylphenyl)-2.3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl)ammoniumiodide (0.15 g) as colorless crystals.

mp 216-219° C.; ¹ H-NMR(CDCl₃ +CD₃ OD) δ: 2.00-2.20 (2H, m), 2.40 (3H,s), 3.06-3.10 (2H, m), 3.10 (6H, s), 3.51-3.61 (2H, m), 3.73 (2H, t,J=5.4 Hz), 4.37 (2H, t, J=4.6 Hz), 4.61 (2H, s), 7.07 (1H, d, J=8.4 Hz),7.25 (2H, d, J=8.2 Hz), 7.46-7.59 (7H, m), 7.81 (2H, d, J=8.2 Hz) , 9.54(1H, s). IR(KBr) ν: 3306, 1651 cm¹. Anal. for C₃₀ H₃₅ IN₂ O₃.0.5H₂ O:Calcd: C, 59.31; H, 5.97; N, 4.61. Found: C, 59.36; H, 5.95; N, 4.75.

WORKING EXAMPLE 241 (Production of Compound 241)

In dimethylformamide (5 ml) was dissolved7-(4-methylphenyl)-N-(4-((N-tetrahydropyran-4-yl-N-methyl)-aminomethyl)-phenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(0.19 g), and to the mixture was added methyl iodide (0.03 ml). Undernitrogen atmosphere, the mixture as stirred at room temperatureovernight. The solvent was evaporated, and to the residue was addedethyl acetate to give crude crystals, which were filtered andrecrystallized from ethanol-hexane to givedimethyl-(N-(7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carbonyl)-4-aminobenzyl)-N-(4-tetrahydropyranyl)ammoniumiodide (0.2 g) as colorless crystals.

mp 220-222° C.(dec.). ¹ H-NMR(DMSO-d₆) δ: 1.78-1.95 (2H, m), 2.05-2.20(2H, m), 2.35 (3H, s), 2.88 (6H, s), 2.95-3.05 (2H, m), 3.21-3.32 (4H,m), 3.50-3.65 (1H, m), 4.05-4.15 (2H, m), 4.46 (2H, s), 7.29 (2H, d,J=8.0 Hz), 7.46-7.63 (7H, m), 7.81-7.90 (3H, m), 10.34 (1H, s). IR(KBr)ν: 2924, 1657 cm⁻¹.

WORKING EXAMPLE 242 (Production of Compound 242)

In dimethylformamide (5 ml) was dissolvedN-(4-((N-methyl-N-(pentan-3-yl))aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.17 g), and to the mixture was added methyl iodide (0.08 ml). Undernitrogen atmosphere, the mixture was stirred at 45° C. overnight. Thesolvent was evaporated, and to the residue was added ethyl acetate togive crude crystals, which were filtered and recrystallized fromethanol-ethyl acetate to givedimethyl-(N-(2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carbonyl)-4-aminobenzyl)-N-(pentan-3-yl)ammoniumiodide (0.15 g) as colorless crystals.

mp 190-194° C.(dec.). ¹ H-NMR(CDCl₃) δ: 1.15 (6H, t, J=7.4 Hz),1.67-1.82 (2H, m), 2.05-2.25 (4H, m), 2.39 (3H, s), 2.73 (2H, t, J=6.6Hz), 2.80-2.90 (2H, m), 3.11 (6H, s), 3.40-3.51 (1H, m), 4.91 (2H, s),7.18-7.26 (3H, m), 7.44 (1H, dd, J=1.8, 8.4 Hz), 7.49 (2H, d, J=8.4 Hz),7.57-7.62 (4H, m), 7.80 (2H, d, J=8.4 Hz), 8.35 (1H,s). IR(KBr) ν: 2936,1659 cm⁻¹. Anal. for C₃₃ H₄₁ IN₂ O.0.5H₂ O: Calcd: C, 64.18; H, 6.85; N,4.54. Found: C, 63.84; H, 6.73; N, 4.47.

REFERENCE EXAMPLE 182

In DMF (50 ml) was dissolved N-cyclohexyl-N-methylamine (12.5 g, 0.11mol), and to the solution were added potassium carbonate (27.6 g, 0.20mol) and 4-nitrobenzylbromide (21.6 g, 0.10 mol). The mixture wasstirred at room temperature for 5 hours. Under reduced pressure, thereaction mixture was concentrated. To the residue was added ethylacetate, and the mixture was extracted with water. The ethyl acetatelayer was washed with saturated sodium chloride solution, dried withMgSO₄ and concentrated under reduced pressure. The residue was purifiedwith silica gel column chromatography (ethyl acetate/hexane) to giveN-cyclohexyl-N-methyl-N-(4-nitrobenzyl)amine (24.8 g).

¹ H-NMR (200 MHz, CDCl₃) δ: 1.0-1.95 (10H, m), 2.19 (3H, s), 3.66 (2H,s) , 7.51 (2H, d, J=8.8 Hz), 8.17 (2H, d, J=8.8 Hz).

REFERENCE EXAMPLE 183

To a solution of N-cyclohexyl-N-methyl-N-(4-nitrobenzyl)amine (12.4 g,50.0 mmol) in methanol(250 ml) were added nickel bromide (1.09 g, 5.0mmol) and then sodium boron hydride (7.57 g, 200 mmol) at 0° C., and themixture was stirred at room temperature for 30 minutes. To the mixturewere added nickel bromide (0.55 g, 2.5 mmol) and then sodium boronhydride (3.78 g, 100 mmol) at 0° C., and the mixture was stirred at roomtemperature for 30 minutes. To the reaction mixture was added water (100ml), and the mixture was concentrated under reduced pressure. To theresidue was added ethyl acetate, and insoluble material was filtered offwith Celite. The filtrate was washed with ethyl acetate, and the ethylacetate layer was dried with MgSO₄ and concentrated under reducedpressure. The residue was washed with hexane to give4-(N-cyclohexyl-N-methylaminomethyl)aniline (3.99 g, 37%).

¹ H-NMR (200 MHz, CDCl₃) δ: 1.0-1.95 (10H, m), 2.17 (3H, s), 2.3-2.55(1H, m), 3.46 (2H, s), 3.59 (2H, br s) , 6.65 (2H, d, J=8.5 Hz), 7.10(2H, d, J=8.5 Hz).

WORKING EXAMPLE 243 (Production of Compound 243)

To a solution of7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.28 g),4-(N-cyclohexyl-N-methylaminomethyl)aniline (0.24 g) and1-hydroxybenzotriazole (0.15 g) in dimethylformamide (10 ml) was added1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.29 g)under ice-cooling. Under nitrogen atmosphere, the mixture was cooled toroom temperature, and to the mixture were added 4-dimethylaminopyridine(3 mg) and triethylamine (0.42 ml). The mixture was stirred for 20hours, poured into water, and extracted with ethyl acetate. The organiclayer was washed with water and saturated sodium chloride solution anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was washed with ethyl acetateand dried to giveN-(4-(N-cyclohexyl-N-methylaminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.40 g).

¹ H-NMR(CDCl₃) δ: 1.0-1.95 (10H, m), 2.20 (3H, s), 2.35-2.55 (1H, m),2.40 (3H, s), 3.0-3.15 (2H, m), 3.56 (2H, s), 4.3-4.45 (2H, m), 7.06(1H, d, J=8.4 Hz), 7.2-7.6 (11H, m).

WORKING EXAMPLE 244 (Production of Compound 244)

In dimethylformamide (7 ml) was dissolvedN-(4-(N-cyclohexyl-N-methylaminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.15 g), and to the mixture was added methyl iodide (0.06 ml). Undernitrogen atmosphere, the mixture was stirred at room temperature for 20hours. The solvent was evaporated, and to the residue was added ethylacetate to give crude crystals, which were filtered and recrystallizedfrom ethanol to giveN-cyclohexyl-N,N-dimethyl-N-((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl)ammoniumiodide (0.15 g).

¹ H-NMR(CDCl₃) δ: 1.0-1.8 (6H, m), 1.9-2.05 (2H, m), 2.25-2.45 (2H, m),2.36 (3H, s), 2.95-3.15 (8H, m), 3.45-3.7 (1H, m), 4.2-4.35 (2H, m),4.83 (2H, s), 6.99 (1H, d, J=8.4 Hz), 7.21 (2H, d, J=7.6 Hz), 7.35-7.6(6H, m), 7.74 (1H, d, J=2.2 Hz), 7.85 (2H, d, J=8.6 Hz), 8.79 (1H, s).IR(KBr) ν: 1659, 1609, 1593, 1518, 1493 cm⁻¹.

WORKING EXAMPLE 245 (Production of Compound 245)

In dimethylformamide (5 ml) was dissolvedN-(4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)phenyl)-7-(4-morpholino-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.20 g), and to the mixture was added methyl iodide (0.03 ml). Undernitrogen atmosphere, the mixture was stirred at room temperature for 32hours. The solvent was evaporated, and the residue was purified withsilica gel column chromatography (dichloromethane/methanol). The desiredfraction was concentrated, and to the residue was added ethyl acetate.Insoluble material was filtered and recrystallized from ethanol to givedimethyl-N-(7-(4-morpholinophenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl-N-(4-tetrahydropyranyl)ammoniumiodide (0.18 g).

¹ H-NMR(CDCl₃) δ: 1.6-2.0 (2H, m), 2.1-2.3 (2H, m), 2.92 (6H, s),2.95-3.2 (6H, m), 3.35-3.55 (2H, m), 3.8-3.9 (4H, m), 4.0-4.35 (5H, m),4.84 (2H, s), 6.85-7.05 (3H, m), 7.35-7.85 (9H, m), 8.92 (1H, s).IR(KBr) ν: 1659, 1609, 1520, 1495 cm⁻¹.

REFERENCE EXAMPLE 184

In tetrahydrofuran(100 ml) was dissolved1,2-methlenedioxy-4-bromobenzene (24.0 g), and to the mixture wasdropwise added n-butyllithium (1.6M hexane solution, 82 ml) at -55° C.or less. The mixture was stirred at -70° C. or less for 30 minutes. Theresulting solution was dropwise added to a solution of trimethyl borate(18.6 g) in tetrahydrofuran (50 ml) at -60° C. or less through cannula,and the mixture was stirred at -70° C. or less for 1 hour and then for 2hours while warming the mixture to room temperature. To the reactionmixture were added 1N hydrochloric acid (130 ml) and diethylether (150ml), and the organic layer was separated. The organic layer was washedwith water and saturated sodium chloride solution and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated. The residue was washed with diisopropylether to give3,4-methlenedioxyphenyl borate (6.79 g).

¹ H-NMR(DMSO-d₆) δ: 5.99 (2H, s), 6.8-6.95 (1H, m), 7.25-7.45 (2H, m).

REFERENCE EXAMPLE 185

To a mixture of methyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(0.57 g), 3,4-methlenedioxyphenyl borate(0.47 g) and sodium carbonate(0.42 g) were added water (2 ml) and 1,2-dimethoxyethane(12 ml). Underargon atmosphere, the mixture was stirred at room temperature for 30minutes, and to the mixture was addedtetrakistriphenylphosphinepalladium (0.16 g). The mixture was stirred at80° C. for 14 hours and extracted with ethyl acetate. The organic layerwas washed with water and saturated sodium chloride solution and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated, and the residue was purified with silica gel column(ethyl acetate/hexane) to give methyl7-(3,4-methlenedioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(0.43 g).

¹ H-NMR(CDCl₃) δ: 2.95-3.10 (2H, m), 3.83 (3H, s), 4.25-4.35 (2H, m),6.01 (2H, s), 6.87 (1H, d, J=8.6 Hz), 6.95-7.10 (3H, m), 7.40 (1H, dd,J=8.4, 2.4 Hz), 7.47 (1H, d, J=2.2 Hz), 7.65 (1H, s).

REFERENCE EXAMPLE 186

To methyl7-(3,4-methlenedioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(0.40 g) were added methanol (5 ml) and 1N sodium hydroxide (3.7 ml),and the mixture was stirred at room temperature for 20 hours. To themixture was added 1N hydrochloric acid (3.7 ml). and the mixture wasconcentrated under reduced pressure. Precipitate was washed with waterand diethylether and dried under reduced pressure to give7-(3,4-methylene-dioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (0.32 g).

¹ H-NMR(DMSO-d₆) δ: 2.80-2.95 (2H, m), 4.15-4.35 (2H, m), 6.05 (2H, s),6.97 (1H, d, J=8.lHz), 7.01 (1H, d, J=8.4 Hz), 7.16 (1H, dd, J=8.1, 1.7Hz), 7.29 (1H, d, J=1.7 Hz), 7.53 (2H, dd, J=8.4, 2.3 Hz), 7.63 (1H, s),7.74 (1H, d, J=2.3 Hz).

WORKING EXAMPLE 246 (Production of Compound 246)

To a solution of7-(3,4-methlenedioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(0.14 g), 4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.11g) and 1-hydroxy-benzotriazole (0.15 g) in dimethylformamide (10 ml) wasadded 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.13g) under ice-cooling. Under nitrogen atmosphere, the reaction mixturewas warmed to room temperature. To the mixture were added4-dimethylaminopyridine (3 mg) and triethylamine (0.19 ml), and themixture was stirred for 18 hours, poured into water, and extracted withethyl acetate. The organic layer was washed with water and saturatedsodium chloride solution, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate) to give7-(3,4-methlenedioxyphenyl)-4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.19 g).

1H-NMR(CDCl₃) δ: 1.55-1.85 (4H, m), 2.21 (3H, s), 2.55-2.80 (1H, m),3.00-3.15 (2H, m), 3.30-3.45 (2H, m), 3.58 (2H, s), 3.95-4.15 (2H, m),4.30-4.45 (2H, m), 6.01 (2H, s), 6.88 (1H, d, J=8.6 Hz), 6.95-7.10 (3H,m), 7.20-7.65 (7H, m). IR(KBr) ν: 1653, 1597, 1514, 1483 cm⁻¹.

WORKING EXAMPLE 247 (Production of Compound 247)

In dimethylformamide (5 ml) was dissolved7-(3,4-methlenedioxyphenyl)-4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(95 mg), and to the mixture was added methyl iodide (0.012 ml). Undernitrogen atmosphere, the mixture was stirred at room temperature for 18hours. The solvent was evaporated, and to the residue was added ethylacetate. Insoluble material was filtered and recrystallized from ethanolto givedimethyl-N-(7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzoxepin-4-carbonyl)-4-aminobenzyl-N-(4-tetrahydropyranyl)ammoniumiodide (101 mg).

¹ H-NMR(CDCl₃) δ: 1.7-2.0 (2H, m), 2.15-2.3 (2H, m), 2.85-3.1 (8H, m),3.4-3.55 (2H, m), 4.0-4.35 (5H, m), 4.85 (2H, s), 5.96 (2H, s), 6.81(1H, d, J=7.8 Hz), 6.9-7.1 (3H, m), 7.25-7.7 (5H, m), 7.83 (2H, d, J=8.2Hz), 8.89 (1H, s). IR(KBr) ν: 1659, 1609, 1520, 1495 cm⁻¹.

WORKING EXAMPLE 248 (Production of Compound 248)

In aqueous methanol was dissolvedN,N-dimethyl-N-(4-(((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)amino)benzyl)-N-(4-tetrahydropyranyl)ammoniumiodide (19 g), and the mixture was subjected to ion exchange resin(DOWEXI-x8, 100-200 mesh, Cl⁻ type) column, which was eluted withaqueous methanol. The solvent of the desired fractions was evaporated,and to the residue was added acetone to give crude crystals, which wererecrystallized from ethanol to giveN,N-dimethyl-N-(4-(((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)amino)benzyl)-N-(4-tetrahydropyranyl)ammoniumchloride (10.1 g) as colorless crystals.

mp 226-232° C.(dec.). ¹ H-NMR(CDCl₃ +CD₃ OD) δ: 1.80-2.00 (2H, m),2.07-2.26 (4H, m), 2.39 (3H, s), 2.72 (2H, t, J=6.6 Hz), 2.85-2.91 (2H,m), 3.00 (6H, s), 3.54 (2H, t, J=11.3 Hz), 4.00-4.21 (3H, m), 4.70 (2H,s), 7.21-7.29 (3H, m), 7.42-7.56 (7H, m), 7.81 (2H, d, J=8.4 Hz), 9.06(1H, s). IR(KBr) ν: 2934, 1655 cm⁻¹. Anal. for C₃₃ H₃₉ ClN₂ O₂ : Calcd:C, 74.62; H, 7.40; N, 5.27; Cl, 6.67. Found: C, 74.35; H, 7.33; N, 5.20;Cl, 6.80.

WORKING EXAMPLE 248a (Production of Compound 248)

To a solution ofN-(4-chloromethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(9.38 g, 23.3 mmol) in DMF (50 ml) was dropwise added a solution ofN,N-dimethyl-N-tetrahydropyran-4-ylamine (4.5 g, 35.0 mmol) in DMF (50ml). Under nitrogen atmosphere, the mixture was stirred for 23 hours.The solvent was evaporated to give powder, which was washed with acetoneand dried. The resulting colorless powder was recrystallized fromethanol to giveN,N-dimethyl-N-(4-(((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)amino)benzyl)-N-(4-tetrahydropyranyl)ammoniumchloride (Compound 248) (10.6 g, 86%) as colorless powder.

WORKING EXAMPLE 249 (Production of Compound 249)

In aqueous acetonitrile was dissolvedN,N-dimethyl-N-(4-(((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)amino)benzyl)-N-(4-oxocyclohexyl)ammoniumiodide (22.8 g), and the mixture was subjected to ion exchange resin(DOWEX-SBR, Cl⁻ type) column, which was eluted with aqueousacetonitrile. The solvent of the desired fractions was evaporated, andthe residue was dissolved in water. The mixture was subjected tofreeze-drying to giveN,N-dimethyl-N-(4-(((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)amino)benzyl)-N-(4-oxocyclohexyl)ammoniumchloride (Compound 249) (16.1 g) as colorless powder.

¹ H-NMR(DMSO-d₆) δ: 2.05-2.25 (2H, m), 2.34 (3H, s), 2.41-2.61 (6H, m),2.97 (6H, s), 2.97-3.00 (2H, m), 3.75-3.90 (1H, m), 4.30 (2H, t, J=4.4Hz), 4.57 (2H, s), 7.06 (1H, d, J=8.4 Hz), 7.27 (2H, d, J=7.8 Hz), 7.45(1H, s), 7.53-7.60 (5H, m), 7.78 (1H, d, J=2.2 Hz), 7.92 (2H, d, J=8.4Hz), 10.34 (1H, s). IR(KBr) ν: 3025, 2967, 1717, 1655 cm⁻¹. Anal. forC₃₃ H₃₇ ClN₂ O₃.0.5H₂ O: Calcd: C, 71.53; H, 6.91; N, 5.06; Cl, 6.40.Found: C, 71.21; H, 6.94; N, 4.94; Cl, 6.24.

WORKING EXAMPLE 249a (Production of Compound 249)

To a solution ofN-(4-chloromethylphenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(214 mg, 0.530 mmol) in N,N-dimethylformamide (1 ml) was dropwise addeda solution of 4-dimethylaminocyclohexanone (112 mg, 0.795 mmol) inN,N-dimethylformamide (1 ml). Under nitrogen atmosphere, the mixture wasstirred for 14 hours. The solvent was evaporated to give crude product,which was washed with ether to giveN,N-dimethyl-N-(4-(((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)amino)benzyl)-N-(4-oxocyclohexyl)ammoniumchloride (Compound 249) (305 mg) as colorless powder.

WORKING EXAMPLE 250 (Production of Compound 250)

To a solution ofN-(4-chloromethylphenyl)-7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(2.38 g) in DMF (20 ml) was addedN,N-dimethyl-N-tetrahydropyran-4-ylamine (1.42 g) at room temperature,and the mixture was stirred for 14 hours. To the reaction mixture wasadded ethyl acetate (100 ml) to precipitate crystals, which werecollected by filtration. The crystal was washed with ethyl acetate togive crude product as pale yellow crystals, which were recrystallizedfrom ethanol to give asN-(4-(((7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)amino)benzyl)-N,N-dimethyl-N-(4-tetrahydropyranyl)ammoniumchloride (Compound 250) (1.29 g) colorless crystals.

m.p. 200-204° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ: 1.35 (3H, t, J=7.0 Hz),1.75-1.98 (2H, m), 2.06-2.24 (2H, m), 2.88 (6H, s), 2.94-3.05 (2H, m),3.28-3.43 (2H, m), 3.49-3.69 (1H, m), 3.99-4.13 (2H, m), 4.07 (2H, q,J=7.0 Hz), 4.23-4.35 (2H, m), 4.47 (2H, s), 6.98-7.07 (3H, m), 7.37 (1H,s), 7.50-7.61 (5H, m), 7.72 (1H, d, J=2.2 Hz), 7.87 (2H, d, J=8.4 Hz),10.22 (1H, s). IR (KBr) ν: 3425, 1647, 1603, 1520, 1489, 1407, 1317,1294, 1240, 831 cm⁻¹ ; Anal. for C₃₃ H₃₉ N₂ O₄ Cl; Calcd: C, 70.38; H,6.98; N, 4.97; Cl, 6.30 Found: C, 70.49; H, 7.08; N, 4.94; Cl, 6.19.

WORKING EXAMPLE 250a (Production of Compound 250)

In aqueous methanol was dissolvedN-(4-(((7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)-amino)benzyl)-N,N-dimethyl-N-(4-tetrahydropyranyl)ammoniumiodide (26.6 g), and the mixture was subjected to ion exchange resin(DOWEX-SBR, Cl⁻ type) column, which was eluted with aqueous methanol.The solvent of the desired fractions was evaporated, and to the residuewas added acetone to give crude crystals, which were recrystallized fromethanol to giveN-(4-(((7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)amino)benzyl)-N,N-dimethyl-N-(4-tetrahydropyranyl)ammoniumchloride (Compound 250) (16.6 g) as colorless crystals.

WORKING EXAMPLE 251 (Production of Compound 251)

To a solution ofN-(4-((N-tetrahydrothiopyran-4-yl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.2 g) in dichloromethane (10 ml) was added mCPBA (0.1 g) at -10 to-20° C., and the mixture was stirred for 30 minutes. To the mixture wasadded sodium thiosulfate solution, and the mixture was concentrated andextracted with ethyl acetate. The organic layer was washed with sodiumhydrogen carbonate solution, water and saturated brine and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate) to giveN-(4-((N-(1-oxotetrahydrothiopyran-4-yl)-N-methyl)aminomethyl)phenyl)7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 251) (E,Z mixture: 0.12 g) as colorless powder.

¹ H-NMR(δ ppm, CDCl₃) 1.80-1.97 (2H, m), 2.17 (1.4H, S), 2.28 (1.6H, s),2.37-2.51 (3H, m), 2.39 (3H, S), 2.56-2.73 (2H, m), 3.08 (2H, t, J=4.7Hz), 3.15-3.28 (2H, m), 3.54 (0.9H, s), 3.63 (1.1H, s), 4.36 (2H, t,J=4.7 Hz), 7.06 (1H, d, J=8.4 Hz), 7.23-7.34 (4H, m), 7.44-7.57 (6H, m),7.64 (1H, s). IR(KBr) ν: 3279, 2946, 1651 cm⁻¹. Anal. Calcd. for C₃₁ H₃₄N₂ O₃ S: C, 72.34; H, 6.66; N, 5.44. Found C, 72.31; H, 6.66; N, 5.35.

WORKING EXAMPLE 252 (Production of Compound 252)

To a suspension of2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.15 g) in dichloromethane (5 ml) were added under ice-cooling oxalylchloride (0.15 ml) and dimethylformamide (catalytic amount), and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (15 ml).The mixture was added dropwise, under ice-cooling, to a mixture of1-(4-aminobenzyl)phosphorinane-1-oxide (0.13 g) and triethylamine (0.23ml) in tetrahydrofuran (15 ml). Under nitrogen atmosphere, the mixturewas stirred at room temperature overnight. The mixture was poured intowater and extracted with ethyl acetate. The organic layer was washedwith water and saturated brine, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated to givecrude crystals, which were recrystallized from ethanol/hexane to give2-(4-methylphenyl)-N-(4-((1-oxophosphorinane-1-yl)methyl)-phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 252) (0.16 g) as colorless crystals.

mp 282-283° C.(dec.). ¹ H-NMR(δ ppm, CDCl₃) 1.40-1.60 (2H, m), 1.70-1.80(6H, m), 1.80-2.20 (4H, m), 2.40 (3H, s), 2.72 (2H, t, J=6.6 Hz),2.86-2.95 (2H, m), 3.16 (2H, d, J=13.6 Hz), 7.15-7.26 (4H, m), 7.42-7.52(5H, m), 7.60 (2H, d, J=8.0 Hz), 7.80 (1H, s). IR(KBr) ν: 2932, 1659cm⁻¹. Anal. Calcd. for C₃₁ H₃₄ NO₂ P.0.2H₂ O: C, 76.43; H, 7.12; N,2.87. Found C, 76.20; H, 7.31; N, 3.00.

WORKING EXAMPLE 253 (Production of Compound 253)

To a suspension of2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.3 g) in dichloromethane (5 ml) were added under ice-cooling oxalylchloride (0.3 ml) and dimethylformamide (catalytic amount), and themixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (10 ml).The mixture was added dropwise, under ice-cooling, to a mixture of4-(N-methyl-N-(tetrahydrothiopyran-4-yl)-aminomethyl)aniline (0.27 g)and triethylamine (0.45 ml) in tetrahydrofuran (10 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature for 4 hours. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was washed withwater and saturated brine, and dried with anhydrous magnesium sulfate.Under reduced pressure, the solvent was evaporated to give crudecrystals, which were recrystallized from ethyl acetate/hexane to giveN-(4-((N-tetrahydrothiopyran-4-yl-N-methyl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 253) (0.45 g) as colorless crystals.

mp 177-178° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.65-1.85 (2H, m), 2.14-2.20 (2H,m), 2.22 (3H, s), 2.40 (3H, s), 2.47-2.53 (1H, m), 2.68-2.72 (6H, m),2.86-2.92 (2H, m), 3.58 (2H, s), 7.21-7.27 (2H, m), 7.31 (2H, d, J=8.4Hz), 7.42-7.52 (5H, m), 7.56 (2H, d, J=8.4 Hz), 7.63 (1H, s). IR(KBr) ν:2932, 1651 cm⁻¹ ; Anal. Calcd. for C₃₂ H₃₆ N₂ OS.0.2H₂ O: C, 76.82; H,7.33; N, 5.60. Found C, 76.89; H, 7.35; N, 5.64.

WORKING EXAMPLE 254 (Production of Compound 254a and 254b)

To a solution ofN-(4-((N-tetrahydrothiopyran-4-yl-N-methyl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.3 g) in dichloromethane (20 ml) was added mCPBA (0.18 g) at -10 to-20° C., and the mixture was stirred for 1.5 hours. To the mixture wasadded sodium thiosulfate solution, and the mixture was concentrated andextracted with ethyl acetate. The organic layer was washed with sodiumhydrogen carbonate solution, water and saturated brine, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate) to give two kinds of crudecrystals, each of which was recrystallized from ethylacetate/ethanol/hexane to give (E) or(Z)-N-(4-((N-(1-oxotetrahydrothiopyran-4-yl)-N-methyl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 254a) (76 mg) and (Z) or(E)-N-(4-((N-(1-oxotetrahydrothiopyran-4-yl)-N-methyl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 254b) (0.11 g) as colorless crystals, respectively.

Compound 254a:

mp 218-219° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.80-2.00 (2H, m), 2.10-2.20 (2H,m), 2.19 (3H, s), 2.25-2.39 (2H, m), 2.40 (3H, S), 2.61-2.76 (5H, m),2.86-2.92 (2H, m), 3.23-3.33 (2H, m), 3.57 (2H, s), 7.22-7.31 (4H, m),7.42-7.52 (5H, m), 7.58 (2H, d, J=8.4 Hz), 7.66 (1H, s). Anal. Calcd.for C₃₂ H₃₆ N₂ O₂ S.0.2H₂ O: C, 74.44; H, 7.11; N, 5.43. Found C, 74.43;H, 7.18; N, 5.66.

Compound 254b:

mp 216-218° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.80-2.00 (3H, m), 2.10-2.25 (3H,m), 2.35 (3H, s), 2.40 (3H, S), 2.44-2.53 (2H, m), 2.69-2.76 (3H, m),2.86-2.92 (2H, m), 3.07-3.17 (2H, m), 3.71 (2H, s), 7.22-7.27 (2H, m),7.35-7.52 (7H, m), 7.60 (2H, d, J=8.4 Hz), 7.73 (1H, s).

WORKING EXAMPLE 255 (Production of Compound 255)

In dichloromethane (5 ml) was suspended2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.3 g), and to the mixture were added, under ice-cooling, oxalylchloride (0.3 ml) and dimethylformamide (catalytic amount). The mixturewas stirred at room temperature for 2 hours, and the solvent wasevaporated. The residue was dissolved in tetrahydrofuran (15 ml), andthe solution was added dropwise, under ice-cooling, to a solution of4-(N-ethyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (0.27 g) andtriethylamine (0.45 ml) in tetrahydrofuran (10 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (ethyl acetate) to give crude crystals,which were recrystallized from ethyl acetate/hexane to giveN-(4-((N-ethyl-N-tetrahydropyran-4-yl)aminomethyl)phenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 255) (0.38 g) as colorless crystals.

mp 122-123° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.01 (3H, t, J=7.1 Hz), 1.62-1.72(4H, m), 2.13-2.19 (2H, m), 2.40 (3H, s), 2.57 (2H, q, J=7.1 Hz),2.69-2.76 (3H, m), 2.86-2.92 (2H, m), 3.34 (2H, dt, J=3.4, 10.9 Hz),3.62 (2H, s), 3.97-4.04 (2H, m), 7.21-7.28 (3H, m), 7.35 (2H, d, J=8.6Hz), 7.42-7.57 (6H, m), 7.62 (1H, s). IR(KBr) ν: 2936, 1651 cm⁻¹. Anal.Calcd. for C₃₃ H₃₈ N₂ O: C, 80.13; H, 7.74; N, 5.66. Found C, 79.96; H,7.77; N, 5.38.

WORKING EXAMPLE 256 (Production of Compound 256)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (0.3 g)in dichloromethane (6 ml) were added, under ice-cooling, oxalyl chloride(0.25 ml) and dimethylformamide (catalytic amount), and the mixture wasstirred at room temperature for 1.5 hours. The solvent was evaporated,and the residue was dissolved in tetrahydrofuran (15 ml). The mixturewas added dropwise, under ice-cooling, to a solution of4-((N-methyl-N-(pentan-3-yl).)aminomethyl)-aniline (0.23 g) andtriethylamine (0.42 ml) in tetrahydrofuran (15 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate/hexane to giveN-(4-((N-methyl-N-(pentan-3-yl)amino)methyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 256) (0.34 g) as colorless crystals.

mp 136-137° C.; ¹ H-NMR(δ ppm, CDCl₃) 0.94 (6H, t, J=7.3 Hz), 1.26-1.54(4H, m), 2.13 (3H, s), 2.17-2.32 (1H, m), 2.40 (3H, s), 3.08 (2H, t,J=5.9 Hz), 3.29 (2H, t, J=5.9 Hz), 3.55 (2H, s), 7.24-7.28 (2H, m),7.31-7.40 (3H, m), 7.44-7.57 (6H, m), 7.66 (1H, s). IR(KBr) ν: 2959,2928, 1651 cm⁻¹. Anal. Calcd. for C₃₁ H₃₆ N₂ OS: C, 76.82; H, 7.49; N,5.78. Found C, 76.77; H, 7.21; N, 5.63.

WORKING EXAMPLE 257 (Production of Compound 257)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.25 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.23ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (20 ml), and the mixture wasadded dropwise, under ice-cooling, to a solution of2-(N-(4-aminobenzyl)-N-methylamino)-1,3-propanediol (0.21 g) andtriethylamine (0.37 ml) in tetrahydrofuran (10 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (methanol/triethylamine/ethyl acetate)to give crude crystals, which were recrystallized from ethyl acetate/ethanol/hexane to giveN-(4-((N-bis(hydroxymethyl)methyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 257) (0.22 g) as colorless crystals.

mp 199-201° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.30 (3H, s), 2.39 (3H, s),2.96-3.03 (1H, m), 3.08 (2H, t, J=4.5 Hz), 3.61-3.73 (4H, m), 3.78 (2H,s), 4.36 (2H, t, J=4.5 Hz), 7.06 (1H, d, J=8.4 Hz), 7.23-7.32 (4H, m),7.44-7.58 (6H, m), 7.62 (1H, s). IR(KBr) ν: 3260, 2928, 1653 cm⁻¹. Anal.Calcd. for C₂₉ H₃₂ N₂ O₄.0.2H₂ O: C, 73.15; H, 6.86; N, 5.88. Found C,73.20; H, 6.86; N, 5.91.

WORKING EXAMPLE 258 (Production of Compound 258)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.3 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.28ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (20 ml), and the mixture wasadded dropwise, under ice-cooling, to a solution ofN-(4-aminobenzyl)sarcosine methyl ester (0.25 g) and triethylamine (0.45ml) in tetrahydrofuran (10 ml). Under nitrogen atmosphere, the mixturewas stirred at room temperature overnight. The solvent was evaporated,and to the residue was added water. The mixture was extracted with ethylacetate, and the organic layer was with water and saturated brine, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to give crude crystals, which wererecrystallized from ethyl acetate/hexane to giveN-(4-((N-methoxycarbonylmethyl-N-methyl)aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 258) (0.38 g) as colorless crystals.

mp 135-136° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.39 (3H, s), 2.39 (3H, s), 3.08(2H, t, J=4.4 Hz), 3.26 (2H, s), 3.65 (2H, s), 3.72 (3H, s), 4.36 (2H,t, J=4.4 Hz), 7.06 (1H, d, J=8.4 Hz), 7.22-7.36 (4H, m), 7.43-7.60 (7H,m). IR(KBr) ν: 3262, 2951, 1740 cm⁻¹. Anal. Calcd. for C₂₉ H₃₀ N₂ O₄ :C, 74.02; H, 6.43; N, 5.95. Found C, 74.07; H, 6.47; N, 5.94.

WORKING EXAMPLE 259 (Production of Compound 259)

In methanol (20 ml) and THF (10 ml) was dissolvedN-(4-((N-methoxycarbonylmethyl-N-methyl)aminomethyl)-phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.24 g), and to the mixture was added 1N sodium hydroxide solution (3.0ml). The mixture was stirred at room temperature overnight andconcentrated. The residue was neutralized with 1N hydrochloric acid, andprecipitated materials were filtered and dissolved in methanol. Themixture was filtered, and to the filtrate was added 4N hydrochloricacid-ethyl acetate. The solvent was evaporated, and the residue waspurified with methanol/diethylether to giveN-(4-((N-carboxymethyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamidehydrochloride (Compound 259) (0.21 g) as pale yellow amorphous.

¹ H-NMR(δ ppm, DMSO-d₆) 2.34 (3H, s), 2.76 (3H, s), 2.99 (2H, br), 3.36(2H, br), 4.02 (2H, s), 4.30 (2H, br), 7.06 (1H, d, J=8.4 Hz), 7.27 (2H,d, J=7.8 Hz), 7.38 (1H, s), 7.48 (2H, d, J=8.6 Hz), 7.55-7.59 (3H, m),7.76 (1H, d, J=2.2 Hz), 7.82 (2H, d, J=8.6 Hz), 10.18 (1H, s). IR(KBr)ν: 1744 cm⁻¹. Anal. Calcd. for C₂₈ H₂₉ ClN₂ O₄.0.5H₂ O:] C, 66.99; H,6.02; N, 5.58. Found C, 66.93; H, 5.87; N, 5.11.

WORKING EXAMPLE 260 (Production of Compound 260)

In dichloromethane (10 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (0.3g), and to the mixture were added, under ice-cooling, oxalyl chloride(0.25 ml) and dimethylformamide (catalytic amount). The mixture wasstirred at room temperature for 2 hours, and the solvent was evaporated.The residue was dissolved in tetrahydrofuran (20 ml), and the mixturewas added dropwise, under ice-cooling, to a solution ofN-(4-aminobenzyl)sarcosine methyl ester (0.23 g) and triethylamine (0.42ml) in tetrahydrofuran (10 ml). Under nitrogen atmosphere, the mixturewas stirred at room temperature overnight. The solvent was evaporated,and to the residue was added water. The mixture was extracted with ethylacetate, and the organic layer was with water and saturated brine, anddried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to give crude crystals, which were recrystallizedfrom ethyl acetate/hexane to giveN-(4-((N-methoxycarbonylmethyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 260) (0.43 g) as colorless crystals.

mp 148-150° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.39 (3H, s), 2.40 (3H, s), 3.08(2H, t, J=6.0 Hz), 3.26 (2H, s), 3.29 (2H, t, J=6.0 Hz), 3.66 (2H, s),3.72 (3H, s), 7.24-7.58 (11 H, m), 7.67 (1H, s). IR(KBr) ν: 1738 cm⁻¹.Anal. Calcd. for C₂₉ H₃₀ N₂ O₃ S: C, 71.58; H, 6.21; N, 5.76. Found C,71.75; H, 5.95; N, 5.60.

WORKING EXAMPLE 261 (Production of Compound 261)

In methanol (20 ml) and THF (10 ml) was dissolvedN-(4-((N-methoxycarbonylmethyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(0.23 g), and to the mixture was added 1N sodium hydroxide solution (2.4ml). The mixture was stirred at room temperature overnight, concentratedand neutralized with 1N hydrochloric acid. Precipitated materials werefiltered, washed with water and recrystallized from ethanol/hexane togiveN-(4-((N-carboxymethyl-N-methyl)aminomethyl)phenyl)-7-(4-methyl-phenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 261) (0.16 g) as colorless crystals.

mp 243-245° C.; ¹ H-NMR(δ ppm, DMSO-d₆) 2.34 (6H, br), 3.00 (2H, br),3.16 (2H, br), 3.22 (2H, br), 3.80 (2H, br), 7.20-7.35 (4H, m),7.45-7.72 (7H, m), 7.82 (1H, s), 10.14 (1H, s). Anal. Calcd. for C₂₈ H₂₈N₂ O₃ S.0.5H₂ O: C, 69.83; H, 6.07; N, 5.82. Found C, 69.62; H, 5.92; N,5.58.

WORKING EXAMPLE 262 (Production of Compound 262)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (0.2g), and to the mixture were added, under ice-cooling, oxalyl chloride(0.18 ml) and dimethylformamide (catalytic amount). The mixture wasstirred at room temperature for 2 hours, and the solvent was evaporated.The residue was dissolved in tetrahydrofuran (20 ml), and the mixturewas added dropwise, under ice-cooling, to a solution of1-(N-(4-aminobenzyl)-N-methylamino)-3-propanol (0.15 g) andtriethylamine (0.28 ml) in tetrahydrofuran (10 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with silica gel column (methanol/triethylamine/ethyl acetate)to give crude crystals, which were recrystallized from ethylacetate/hexane to giveN-(4-((N-3-hydroxypropyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 262) (0.16 g) as colorless crystals.

mp 147-148° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.69-1.80 (2H, m), 2.25 (3H, s),2.40 (3H, s), 2.67 (2H, t, J=5.6 Hz), 3.08 (2H, t, J=5.9 Hz), 3.28 (2H,t, J=5.9 Hz), 3.53 (2H, s), 3.78 (2H, t, J=5.3 Hz), 7.24-7.32 (3H, m),7.41-7.50 (4H, m), 7.53-7.60 (4H, m), 7.81 (1H, s). IR(KBr) ν: 3266,2948, 1649 cm⁻¹. Anal. Calcd. for C₂₉ H₃₂ N₂ O₂ S.0.3H₂ O: C, 72.86; H,6.87; N, 5.86. Found C, 72.90; H, 6.70; N, 6.05.

WORKING EXAMPLE 263 (Production of Compound 263)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.2 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.19ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (20 ml), and the mixture wasadded dropwise, under ice-cooling, to a solution of4-((N-3-methoxypropyl-N-methyl)aminomethyl)aniline (0.16 g) andtriethylamine (0.3 ml) in tetrahydrofuran (10 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate/hexane to giveN-(4-((N-3-methoxypropyl-N-methyl)aminomethyl)phenyl)-7-(4-methyl-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 263) (0.28 g) as colorless crystals.

mp 121-123° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.75-1.84 (2H, m), 2.19 (3H, s),2.40 (3H, s), 2.45 (2H, t, J=7.3 Hz), 3.09 (2H, t, J=4.6 Hz), 3.33 (3H,s), 3.43 (2H, t, J=6.6 Hz), 3.47 (2H, s), 4.37 (2H, t, J=4.6 Hz), 7.06(1H, d, J=8.2 Hz), 7.23-7.33 (4H, m), 7.44-7.56 (7H, m). IR(KBr) ν:2934, 1653 cm⁻¹. Anal. Calcd. for C₃₀ H₃₄ N₂ O₃ : C, 76.57; H, 7.28; N,5.95. Found C, 76.41; H, 7.24; N, 6.02.

WORKING EXAMPLE 264 (Production of Compound 264)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (0.15g), and to the mixture were added, under ice-cooling, oxalyl chloride(0.15 ml) and dimethylformamide (catalytic amount). The mixture wasstirred at room temperature for 2 hours, and the solvent was evaporated.The residue was dissolved in tetrahydrofuran (15 ml), and the mixturewas added dropwise, under ice-cooling, to a solution of4-((N-3-methoxypropyl-N-methyl)aminomethyl)aniline (0.12 g) andtriethylamine (0.21 ml) in tetrahydrofuran (10 ml). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added water. The mixturewas extracted with ethyl acetate, and the organic layer was with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give crude crystals,which were recrystallized from ethyl acetate/hexane to giveN-(4-((N-3-methoxypropyl-N-methyl)aminomethyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 264) (0.18 g) as colorless crystals.

mp 128-129° C.; ¹ H-NMR((δ ppm, CDCl₃) 1.70-1.87 (2H, m), 2.19 (3H, s),2.40 (3H, s), 2.45 (2H, t, J=8.4 Hz), 3.08 (2H, t, J=5.6 Hz), 3.29 (2H,t, J=5.6 Hz), 3.33 (3H, s), 3.43 (2H, t, J=6.4 Hz), 3.47 (2H, s),7.24-7.33 (3H, m), 7.40-7.58 (8H, m), 7.68 (1H, s). IR(KBr) ν: 2924,1651 cm⁻¹. Anal. Calcd. for C₃₀ H₃₄ N₂ O₂ S: C, 74.04; H, 7.04; N, 5.76.Found C, 73.80; H, 6.95; N, 5.87.

WORKING EXAMPLE 265 (Production of Compound 265)

In dichloromethane (5 ml) was suspended2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid(0.2 g), and to the mixture were added, under ice-cooling, oxalylchloride (0.19 ml) and dimethylformamide (catalytic amount). The mixturewas stirred at room temperature for 2 hours, and the solvent wasevaporated. The residue was dissolved in tetrahydrofuran (15 ml), andthe mixture was added dropwise, under ice-cooling, to a solution of(4-aminophenyl)-(2-pyridyl)methanol (0.15 g) and triethylamine (0.3 ml)in tetrahydrofuran (15 ml). Under nitrogen atmosphere, the mixture wasstirred at room temperature overnight. The solvent was evaporated, andto the residue was added water. The mixture was extracted with ethylacetate, and the organic layer was washed with water and saturatedbrine, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated to give crude crystals, which wererecrystallized from ethyl acetate/hexane to give2-(4-methylphenyl)-N-(4-hydroxy(2-pyridyl)methylphenyl)-6,7-dihydro-5H-benzocyclo-heptene-8-carboxamide(Compound 265) (0.30 g) as colorless crystals.

mp 195-196° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.12-2.18 (2H, m), 2.39 (3H, s),2.71 (2H, t, J=6.2 Hz), 2.85-2.91 (2H, m), 5.31 (1H, d, J=3.8 Hz), 5.75(1H, d, J=3.8 Hz), 7.12-7.26 (4H, m), 7.35-7.67 (11H, nm), 8.57 (1H, d,J=5.4 Hz). IR(KBr) ν: 2930, 1651 cm⁻¹. Anal. Calcd. for C₃₁ H₂₈ N₂O₂.0.2H₂ O: C, 80.21; H, 6.17; N, 6.04. Found C, 80.15; H, 6.05; N,6.13.

WORKING EXAMPLE 266 (Production of Compound 266)

In dichloromethane (25 ml) was dissolved2-(4-methyl-phenyl)-N-(4-hydroxy(2-pyridyl)methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(0.2 g), and to the mixture was added, under ice-cooling, mCPBA (0.14g). The mixture was stirred at room temperature overnight, and to themixture was added sodium thiosulfate solution. The mixture wasconcentrated and extracted with ethyl acetate. The organic layer waswashed with sodium hydrogen carbonate solution, water and saturatedbrine, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (methanol/triethylamine/ethyl acetate) to give crudecrystals, which were recrystallized from ethyl acetate/hexane to give2-(4-methylphenyl)-N-(4-hydroxy(1-oxidepyridin-2-yl)methyl-phenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 266) (0.12 g) as colorless crystals.

mp 127-128° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.14-2.20 (2H, m), 2.40 (3H, s),2.73 (2H, t, J=6.4 Hz), 2.87-2.92 (2H, m), 6.07 (1H, s), 6.40 (1H, br),6.93-6.98 (1H, m), 7.22-7.28 (4H, m), 7.43-7.53 (7H, m), 7.67 (2H, d,J=8.8 Hz), 7.75 (1H, s), 8.24-8.28 (1H, m). IR(KBr) ν: 2928, 1651 cm⁻¹.Anal. Calcd. for C₃₁ H₂₈ N₂ O₃.0.5H₂ O: C, 76.68; H, 6.02; N, 5.77.Found C, 76.59; H, 6.00; N, 5.65.

WORKING EXAMPLE 267 (Production of Compound 267)

In dimethylformamide (5 ml) was dissolvedN-(4-(piperidin-2-ylcarbonyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(0.2 g), and to the mixture were added sodium hydrogen carbonate (0.05g) and methyl iodide (0.1 ml). Under nitrogen atmosphere, the mixturewas stirred at room temperature overnight. The solvent was evaporated,and to the residue was added ethyl acetate to give crude crystals, whichwere recrystallized from ethanol/ethyl acetate to giveN,N-dimethyl-2-(4-((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carbonyl)amino)benzoyl)piperidiniumiodide (Compound 267) (0.16 g) as colorless powder.

mp 236-237° C.(dec.). ¹ H-NMR(δ ppm, CDCl₃) 1.75-2.10 (4H, m), 2.15-2.38(2H, m), 2.38 (3H, s), 3.07 (2H, t, J=4.6 Hz), 3.43 (3H, s), 3.53 (3H,s), 3.62-3.68 (1H, m), 4.34 (2H, t, J=4.6 Hz), 4.68 (1H, br), 6.41-6.45(1H, m), 7.03 (1H, d, J=8.4 Hz), 7.22 (2H, d, J=8.0 Hz), 7.43-7.52 (4H,m), 7.73 (1H, d, J=2.2 Hz), 7.95 (2H, d, J=9.2 Hz), 8.34 (2H, d, J=8.8Hz), 8.59 (1H, s). IR(KBr) ν: 2955, 1674 cm⁻¹. Anal. Calcd. for C₃₂ H₃₅IN₂ O₃.0.5H₂ O: C, 60.86; H, 5.75; N, 4.44. Found C, 60.89; H, 5.49; N,4.52.

WORKING EXAMPLE 268 (Production of Compound 268)

To a solution of 2-methyl-6-(4-methylphenyl)-quinoline-3-carboxylic acid(120 mg) and 1-hydroxybenzotriazole (88 mg) in DMF (5 ml) was added atroom temperature 1-ethyl-3-(3'-dimethylaminopropyl)carbodiimidehydrochloride (125 mg), and the mixture was stirred for 1 hour. To themixture was added a solution of 1-(4-aminobenzyl)phosphorinane-1-oxide(109 mg) and triethylamine (0.1 ml) in DMF (3 ml), and the mixture wasstirred for 3 days. Under reduced pressure, the mixture wasconcentrated, and to the residue was added water. The mixture wasextracted with chloroform, and the organic layer was washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the residue was separatedand purified with column chromatography (ethanol/ethyl acetate=1:2) andrecrystallized from (ethanol/ethyl acetate) to give pale yellow crystalsof2-methyl-6-(4-methylphenyl)-N-(pentamethylenephosphorylmethylphenyl)quinoline-3-carboxamide(Compound 268) (116.1 mg).

m.p. 273-275° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.01-1.84 (10H, m), 2.44(3H, s), 2.90 (3H, s), 3.04 (2H, d, J=12.6 Hz), 7.17-7.25 (2H, m), 7.32(2H, d, J=7.9 Hz), 7.61 (2H, d, J=7.9 Hz), 7.69 (2H, d, J=8.2 Hz),7.99-8.13 (3H, m), 8.30 (1H, s), 9.44 (1H, br s). IR (KBr) 3024, 1664,1601, 1539, 1516, 1319, 1159, 847, 816 cm⁻¹ ; Anal. Calcd. for C₃₀ H₃₁N₂ O₂ P.0.3H₂ O; Calcd. C, 73.84; H, 6.53; N, 5.74; P, 6.35. Found. C,73.67; H, 6.58; N, 5.67; P, 6.27.

WORKING EXAMPLE 269 (Production of Compound 269)

Under nitrogen atmosphere, to a solution of(E)-3-[5-(4-isopropylphenyl)thiophen-2-yl]acrylic acid (130 mg) in THF(10 ml) was added at room temperature oxalyl chloride (0.07 ml) and thena drop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved inTHF (20 ml). To the mixture were added1-(4-aminobenzyl)phosphorinane-1-oxide (117 mg) and triethylamine (0.15ml) at 0° C., and the mixture was stirred at room temperature for 4hours. The mixture was added to vigorously stirred water to stop thereaction and extracted with ethyl acetate. The organic layer was washedwith saturated brine, dried with magnesium sulfate, concentrated andpurified with column chromatography (ethanol/ethyl acetate=1:4) andrecrystallized from ethanol/ethyl acetate to give yellow crystals of(E)-3-[5-(4-methylphenyl)thiophen-2-yl]-N-(pentaethylenephosphorylmethylphenyl)acrylamide(Compound 269) (60.5 mg).

m.p. 295° C.(dec.) ¹ H-NMR (200 MHz, CDCl₃) δ 1.28 (6H, d, J=7.0 Hz),1.51-2.10 (10H, m), 2.89-3.00 (1H, m), 3.15 (2H, d, J=13.2 Hz), 6.48(1H, d, J=15.0 Hz), 7.15-7.33 (6H, m), 7.50-7.62 (4H, m), 7.82 (1H, d,J=15.0 Hz), 8.37-8.59 (1H, m). IR (KBr) 3057, 1672, 1618, 1543, 1510,1412, 1356, 1327, 1250, 1232, 1165, 960, 852, 829, 793 cm⁻¹ ; Anal.Calcd. For C₂₈ H₃₂ NO₂ SP; Calcd. C, 70.41; H, 6.75; N, 2.93. Found. C,70.06; H, 6.82; N, 2.98.

WORKING EXAMPLE 270 (Production of Compound 270)

Under nitrogen atmosphere, to a solution of(E)-3-[5-(4-tert-butylphenyl)thiophen-2-yl]acrylic acid (120 mg) in THF(10 ml) were added at room temperature oxalyl chloride (0.06 ml) and adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved inTHF (20 ml). To the mixture were added at 0° C.1-(4-aminobenzyl)phosphorinane-1-oxide (104 mg) and triethylamine (0.12ml), and the mixture was stirred at room temperature for 18 hours. Themixture was added to vigorously stirred water to stop the reaction andextracted with ethyl acetate. The organic layer was washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the residue was purifiedwith column chromatography (ethanol/ethyl acetate=1:4) andrecrystallized from ethanol to give yellow crystals of(E)-N-(4-pentamethylenephosphorylmethylphenyl)-3-[5-(4-tert-butylphenyl)thiophen-2-yl]acrylamide(Compound 270) (82.1mg).

m.p. >300° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.35 (9H, s), 1.50-2.22 (10H,m), 3.15 (2H, d, J=13.2 Hz), 6.53 (1H, d, J=15.4 Hz), 7.12-7.30 (4H, m),7.42 (2H, d, J=8.4 Hz), 7.49-7.60 (4H, m), 7.82 (1H, d, J=15.4 Hz),8.79-8.98 (1H, m). IR (KBr) 3238, 1672, 1618, 1543, 1514, 1358, 1252,1167, 852, 793 cm⁻¹ ; Anal. Calcd. For C₂₉ H₃₄ NO₂ SP; Calcd. C, 70.85;H, 6.97; N, 2.85; P, 6.30. Found. C, 70.61; H, 6.90; N, 2.89; P, 6.17.

WORKING EXAMPLE 271 (Production of Compound 271)

Under nitrogen atmosphere, to a solution of2-(4-methylphenyl)benzofuran-5-carboxylic acid (130 mg) in THF (10 ml)were added at room temperature oxalyl chloride (0.07 ml) and a drop ofDMF, and the mixture was stirred for 1 hour. Under reduced pressure, thesolvent was evaporated, and the residue was dissolved in THF (20 ml). Tothe mixture were added at 0° C. 1-(4-aminobenzyl)phosphorinane-1-oxide(126 mg) and triethyl-amine (0.15 ml), and the mixture was stirred atroom temperature for 3 hour. The mixture was added to vigorously stirredwater to stop the reaction and extracted with ethyl acetate. The organiclayer was washed with saturated brine, dried with magnesium sulfate andconcentrated. The resulting crystals were recrystallized from ethanol togive colorless crystals of2-(4-methylphenyl)-N-(4-pentamethylenephosphorylmethylphenyl)benzofuran-5-carboxamide(Compound 271) (134.6 mg).

m.p. 297-296° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.42-2.16 (10H, m), 2.42(3H, s), 3.17 (2H, d, J=13.2 Hz), 7.04 (1H, s), 7.24-7.33 (4H, m), 7.58(1H, d, J=8.6 Hz), 7.67 (2H, d, J=8.4 Hz), 7.76-7.85 (3H, m), 8.14 (1H,d, J=1.8 Hz), 8.15-8.19 (1H, m). IR (KBr) 3390, 2929, 1657, 1524, 1323,1230, 1161, 1132, 849, 824, 800, 760 cm⁻¹ ; Anal. Calcd. For C₂₈ H₂₈ NO₃P; Calcd. C, 73.51; H, 6.17; N, 3.06. Found. C, 73.45 : H, 5.89 : N,2.83.

WORKING EXAMPLE 272 (Production of Compound 272)

To a solution of 2-(4-methylphenyl)benzofuran-6-carboxylic acid (130 mg)in THF (10 ml) were added oxalyl chloride (0.07 ml) and a drop ofdimethylformamide at room temperature, and the mixture was stirred for 1hour. Under reduced pressure, the solvent was evaporated, and theresidue was dissolved in THF (20 ml). To the mixture were added at 0° C.1-(4-aminobenzyl)phosphorinane-1-oxide (126 mg) and triethylamine (0.15ml), and the mixture was stirred at room temperature for 20 hours. Themixture was added to vigorously stirred water to stop the reaction andextracted with dichloromethane, and the organic layer was washed withsaturated brine. Under reduced pressure, the mixture was concentrated,and the residue was recrystallized from ethanol to give pale yellowcrystals of2-(4-methyl-phenyl)-N-(4-pentamethylenephosphorylmethylphenyl)benzofuran-6-carboxamide(Compound 272) (149.9 mg).

m.p. >300° C.; IR (KBr) 3224, 1651, 1535, 1512, 1323, 1165, 845, 820cm⁻¹ ; Anal. Calcd. For C₂₈ H₂₈ NO₃ P; Calcd. C, 73.51; H, 6.17; N,3.06. Found. C, 73.50; H, 6.17; N, 2.92.

WORKING EXAMPLE 273 (Production of Compound 273)

To a solution of7-(4-methylsulfonylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(100 mg) in THF (10 ml) were added at room temperature oxalyl chloride(0.05 ml) and a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the solvent was evaporated, and the residue wasdissolved in THF (20 ml). To the mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)-aminomethyl]aniline (71 mg) andtriethylamine (0.1 ml), and the mixture was stirred at room temperaturefor 16 hours. The mixture was added to vigorously stirred water to stopthe reaction and extracted with ethyl acetate. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the residue waspurified with column chromatography (ethanol/ethyl acetate=1:3) andrecrystallized from ethanol to give colorless crystals of7-(4-methylsulfonylphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 273) (123 mg).

m.p. 233-235° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.62-1.82 (4H, m), 2.21(3H, s), 2.56-2.73 (1H, m), 3.04-3.15 (2H, m), 3.10 (3H, s), 3.31-3.43(2H, m), 3.57 (2H, s), 3.99-4.09 (2H, m), 4.39 (2H, t, J=4.5 Hz), 7.12(1H, d, J=8.4 Hz), 7.24-7.35 (3H, m), 7.46-7.60 (5H, m), 7.74 (2H, d,J=8.6 Hz), 8.00 (2H, d, J=8.6 Hz). IR (KBr) 3292, 1645, 1524, 1308, 1144cm⁻¹ ; Anal. Calcd. for C₃₁ H₃₄ N₂ O₅ S; Calcd. C, 68.11; H, 6.27; N,5.12; S, 5.87. Found. C, 67.94; H, 6.40; N, 5.09; S, 5.90.

WORKING EXAMPLE 274 (Production of Compound 274)

Under nitrogen atmosphere, to a solution of(E)-3-[5-(4-isopropylphenyl)thiophen-2-yl]acrylic acid (130 mg) in THF(10 ml) were added at room temperature oxalyl chloride (0.07 ml) and adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved inTHF (20 ml). To the mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (116 mg) andtriethylamine (0. 15 ml), and the mixture was stirred at roomtemperature for 4 hour. The mixture was added to vigorously stirredwater to stop the reaction and extracted with ethyl acetate. The organiclayer was washed with saturated brine, dried with magnesium sulfate,concentrated and purified with column chromatography (ethanol/ethylacetate=1:4) and recrystallized from ethyl acetate/hexane to give yellowcrystals of(E)-3-(5-(4-isopropylphenyl)thiophen-2-yl]-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]acrylamide(Compound 274) (162.9 mg).

m.p. 187-189° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.27 (6H, d, J=6.8 Hz),1.54-1.84 (4H, m), 2.21 (3H, s), 2.55-2.72 (1H, m), 2.84-3.01 (1H, m),3.30-3.44 (2H, m), 3.56 (2H, s), 3.97-4.10 (2H, m), 6.31 (1H, d, J=15.4Hz), 7.19-7.35 (7H, m), 7.49-7.61 (4H, m), 7.84 (1H, d, J=15.4 Hz). IR(KBr) 3315, 1664, 1606, 1535, 1512, 1408, 1335, 1169, 829, 804 cm⁻¹ ;Anal. Calcd. for C₂₉ H₃₄ N₂ O₂ S; Calcd. C, 73.38; H, 7.22; N, 5.90; S,6.76. Found. C, 73.12; H, 7.34; N, 5.88; S, 6.83.

WORKING EXAMPLE 275 (Production of Compound 275)

A solution of7-(4-methylthiophenyl)-N-[4-[N-methyl-N-(4-tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(110 mg) and sodium periodate (48 mg) in methanol/water (40/15 ml) wasstirred at room temperature for 2 days. Under reduced pressure, themixture was concentrated, and to the residue was added water. Themixture was extracted with chloroform. The organic layer was washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the residue was purifiedwith column chromatography (ethanol/ethyl acetate=1:1) andrecrystallized from ethanol/ethyl acetate to give colorless crystals of7-(4-methylsulfinylphenyl)-N-[4-[N-methyl-N-(4-tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 275) (15.5 mg).

¹ H-NMR (200 MHz, CDCl₃) δ 1.52-1.83 (4H, m), 2.21 (3H, s), 2.52-2.74(1H, m), 2.77 (3H, s), 3.10 (2H, t, J=4.4 Hz), 3.29-3.43 (2H, m), 3.57(2H, s), 3.98-4.10 (2H, m), 4.39 (2H, t, J=4.4 Hz), 7.11 (1H, d, J=8.0Hz), 7.23-7.35 (3H, m), 7.44-7.63 (5H, m), 7.71 (4H, s). IR (KBr) 3327,1649, 1515, 1410, 1315, 1240, 1038, 822 cm⁻¹.

WORKING EXAMPLE 276 (Production of Compound 276)

Under nitrogen atmosphere, to a solution of(E)-3-[5-(4-tert-butylphenyl) thiophen-2-yl]acrylic acid (130 mg) in THF(10 ml) were added at room temperature oxalyl chloride (0.06 ml) and adrop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved inTHF (20 ml). To the mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (109 mg) andtriethylamine (0. 13 ml) and the mixture was stirred at room temperaturefor 6 days. The mixture was added to vigorously stirred water to stopthe reaction and extracted with ethyl acetate. The organic layer waswashed with saturated brine, dried with magnesium sulfate andconcentrated. The residue was purified with column chromatography(ethanol/ethyl acetate=1:4) and recrystallized from ethyl acetate/hexaneto give yellow crystals of(E)-3-[5-(4-tert-butylphenyl)thiophen-2-yl]-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]acrylamide(Compound 276) (107.3 mg).

m.p. 216-220° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.35 (9H, s), 1.50-1.86(4H, m), 2.21 (3H, s), 2.51-2.76 (1H, m), 3.30-3.45 (2H, m), 3.57 (2H,s), 3.99-4.10 (2H, m), 6.32 (1H, d, J=14.8 Hz), 7.21-7.35 (5H, m), 7.43(2H, d, J=8.4 Hz), 7.51-7.61 (4H, m), 7.84 (1H, d, J=14.8 Hz). IR (KBr)3320, 1666, 1606, 1535, 1335, 831 cm⁻¹ ; Anal. Calcd. for C₃₀ H₃₆ N₂ O₂S.0.1H₂ O; Calcd. C, 73.46; H, 7.44; N, 5.71. Found. C, 73.41; H, 7.41;N, 5.83.

WORKING EXAMPLE 277 (Production of Compound 277)

Under nitrogen atmosphere, to a solution of2-(4-methylphenyl)benzofuran-5-carboxylic acid (200 mg) in THF (10 ml)were added at room temperature oxalyl chloride (0.1 ml) and a drop ofDMF, and the mixture was stirred for 1 hour. Under reduced pressure, thesolvent was evaporated, and the residue was dissolved in THF (20 ml). Tothe mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (192 mg) andtriethylamine (0. 22 ml), and the mixture was stirred at roomtemperature for 18 hours. The mixture was added to vigorously stirredwater to stop the reaction and extracted with chloroform. The organiclayer was washed with saturated brine, dried with magnesium sulfate andconcentrated. The resulting crystals were recrystallized from ethanol togive colorless crystals of2-(4-methylphenyl)-N-[4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)phenyl]benzofuran-5-carboxamide(Compound 277) (295.8 mg).

m.p. 233-236° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.62-1.83 (4H, m), 2.22(3H, s), 2.42 (3H, s), 2.57-2.72 (1H, m), 3.32-3.44 (2H, m), 3.59 (2H,s), 3.99-4.09 (2H, m), 7.03 (1H, s), 7.31-7.36 (4H, m), 7.56-7.64 (3H,m), 7.76-7.82 (3H, m), 7.87 (1H, s), 8.11 (1H, d, J=1.4 Hz). IR (KBr)3388, 2943, 1647, 1597, 1525, 1408, 1319, 1148, 794 cm⁻¹ ; Anal. Calcd.For C₂₉ H₃₀ N₂ O₃ ; Calcd. C, 76.63; H, 6.65; N, 6.16, Found. C, 76.61;H, 6.47; N, 6.00.

WORKING EXAMPLE 278 (Production of Compound 278)

To a solution of 2-(4-methylphenyl)benzofuran-6-carboxylic acid (200 mg)in THF (10 ml) were added at room temperature oxalyl chloride (0.1 ml)and a drop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved inTHF (20 ml). To the mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (192 mg) andtriethylamine (0.22 ml), and the mixture was stirred at room temperaturefor 4 hour. The mixture was added to vigorously stirred water to stopthe reaction and extracted with dichloromethane. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the residue waspurified with column chromatography (ethanol/ethyl acetate=1:4→1:2→2:1)and recrystallized from ethanol to give pale yellow crystals of2-(4-methylphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]benzofuran-6-carboxamide(Compound 278) (280 mg).

m.p. 224-227° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.41-1.82 (4H, m), 2.22(3H, s), 2.42 (3H, s), 2.56-2.74 (1H, m), 3.32-3.44 (2H, m), 3.59 (2H,s), 3.98-4.12 (2H, m), 7.02 (1H, s), 7.25-7.37 (4H, m), 7.61-7.66 (3H,m), 7.72-7.81 (3H, m), 7.92 (1H, s), 8.07 (1H, s). IR (KBr) 3304, 1647,1520, 1313, 822 cm⁻¹ ; Anal. Calcd. for C₂₉ H₃₀ N₂ O₃ ; Calcd. C, 76.63;H, 6.65; N, 6.16. Found. C, 76.79; H, 6.39; N, 6.13.

WORKING EXAMPLE 279 (Production of Compound 279)

To a solution of(E)-3-[5-(4-methylphenyl)thiophen-2-yl]-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]acrylamide(100 mg) in DMF (3 ml) was added at room temperature methyl iodide (0.5ml), and the mixture was stirred for 2 days. Under reduced pressure, themixture was concentrated, and to the residue was added acetonitrile. Theresulting crystals were collected by filtration to give yellow crystalsofN,N-dimethyl-N-[4-[[(E)-3-[5-(4-methylphenyl)thiophen-2-yl]-2-propenoyl]amino]benzyl]-4-tetrahydropyranylammonium iodide (Compound 279) (101.1 mg).

m.p. 212-216° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 1.74-1.99 (2H, m),2.09-2.22 (2H, m), 2.34 (3H, s), 2.87 (6H, br s), 3.24-3.42 (2H, m),3.48-3.66 (1H, m), 4.00-4.11 (2H, m), 4.46 (2H, s), 6.58 (1H, d, J=15.4Hz), 7.27 (2H, d, J=7.9 Hz), 7.44-7.58 (4H, m), 7.61 (2H, d, J=7.9 Hz),7.76 (1H, d, J=15.4 Hz), 7.82 (2H, d, J=8.8 Hz), 10.43 (1H, s). IR (KBr)3165, 1675, 1606, 1525, 1155, 814 cm⁻¹ ; Anal. Calcd. for C₂₈ H₃₃ N₂ O₂SI.0.5H₂ O; Calcd. C, 56.28; H, 5.74; N, 4.69. Found. C, 56.04; H, 5.71;N, 4.71.

WORKING EXAMPLE 280 (Production of Compound 280)

To a solution of(E)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-3-[5-(4-isopropylphenyl)thiophen-2-yl]acrylamide(80 mg) in DMF (5 ml) was added at room temperature methyl iodide (0.04ml), and the mixture was stirred for 3 days. Under reduced pressure, thesolvent was evaporated, and to the residue was added acetonitrile. Theresulting crystals were collected by filtration to give yellow crystalsofN,N-dimethyl-N-[4-[[(E)-3-[5-(4-isopropylphenyl)thiophen-2-yl]-2-propenoyl]amino]benzyl]-4-tetrahydropyranylammonium iodide (Compound 280) (76.9 mg).

m.p. 217-220° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 1.23 (6H, d, J=7.0 Hz),1.72-2.01 (2H, m), 2.08-2.23 (2H, m), 2.79-3.01 (1H, m), 2.87 (6H, s),3.25-3.44 (2H, m), 3.49-3.68 (1H, m), 3.99-4.12 (2H, m), 4.46 (2H, s),6.58 (1H, d, J=15.4 Hz), 7.33 (2H, d J=8.5 Hz), 7.44-7.57 (4H, m), 7.63(2H, d, J=8.5 Hz), 7.76 (1H, d, J=15.4 Hz), 7.82 (2H, d, J=8.8 Hz),10.42 (1H, s). IR (KBr) 3298, 1654, 1608, 1527, 1452, 1417, 1323, 1252,1163, 843, 802 cm¹ ; Anal. Calcd. for C₃₀ H₃₇ N₂ O₂ SI; Calcd. C, 58.44;H, 6.05; N, 4.54. Found. C, 58.24; H, 5.83; N, 4.27.

WORKING EXAMPLE 281 (Production of Compound 281)

To a solution of2-(4-methylphenyl)-N-[4-(N-methyl-N-(tetrahydropyran-4-yl)aminomethyl)phenyl]-benzofuran-5-carboxamide(120 mg) in DMF (20 ml) was added at room temperature methyl iodide(0.04 ml), and the mixture was stirred for 24 hours. Under reducedpressure, the solvent was evaporated, and to the residue was addedethanol. The resulting crystals were collected by filtration to giveyellow crystals ofN,N-dimethyl-N-[4-[[2-(4-methylphenyl)benzofuran-5-carbonyl]amino]-benzyl]-4-tetrahydropyranylammonium iodide (Compound 281) (142.lmg).

m.p. 208-212° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 1.71-2.01 (2H, m),2.12-2.23 (2H, m), 2.39 (3H, s), 2.89 (6H, s), 3.10-3.43 (2H, m),3.48-3.69 (1H, m), 4.03-4.15 (2H, m), 4.48 (2H, s), 7.36 (2H, d, J=8.0Hz), 7.53-7.59 (3H, m), 7.77 (1H, d J=8.4 Hz), 7.85-7.99 (5H, m), 8.29(1H, d, J=1.8 Hz), 10.52 (1H, s). IR (KBr) 3277, 1643, 1595, 1525, 1468,1416, 1325, 842, 820, 789, 762 cm⁻¹ ; Anal. Calcd. for C₃₀ H₃₃ N₂ O₃I.1.0H₂ O; Calcd. C, 58.64; H, 5.74; N, 4.56. Found. C, 58.98; H, 5.62;N, 4.55.

WORKING EXAMPLE 282 (Production of Compound 282)

To a solution of7-(4-methoxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (150mg) in THF (10 ml) were added at room temperature oxalyl chloride (0.13ml) and a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in THF (20 ml). To the mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (116 mg) andtriethylamine (0.2 ml), and the mixture was stirred at room temperaturefor 4 hours. The mixture was added to vigorously stirred water to stopthe reaction and extracted with ethyl acetate. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the residue waspurified with column chromatography (ethanol/ethyl acetate=1:4) andrecrystallized from ethanol/diethylether to give pale yellow crystals of7-(4-methoxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 282) (128.5 mg).

m.p.162'164° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.61-1.83 (4H, m), 2.21 (3H,s), 2.55-2.72 (1H, m), 3.05-3.10 (2H, m), 3.26-3.44 (4H, m), 3.57 (2H,s), 3.86 (3H, s), 3.96-4.09 (2H, m), 6.98 (2H, d, J=8.8 Hz), 7.32 (2H,d, J=8.4 Hz), 7.35-7.43 (2H, m), 7.48-7.57 (6H, m), 7.68 (1H, br s). IR(KBr) 3332, 1647, 1515, 1248, 818 cm⁻¹ ; Anal. Calcd. for C₃₁ H₃₄ N₂ O₃S; Calcd. C, 72.34; H, 6.66; N, 5.44. Found. C, 72.25; H, 6.67; N, 5.43.

WORKING EXAMPLE 283 (Production of Compound 283)

To a solution of7-(4-methoxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (200mg) in THF (10 ml) were added at room temperature oxalyl chloride (0.30ml) and a drop of DMF, and the mixture was stirred for 1 hour. Underreduced pressure, the solvent was evaporated, and the residue wasdissolved in THF (20 ml). To the mixture were added at 0° C.4-[N-(4,4-ethylenedioxycyclohexyl)-N-methylaminomethyl]aniline (0.20 g)and triethylamine (0.3 ml), and the mixture was stirred at roomtemperature for 4 hours. The mixture was added to vigorously stirredwater to stop the reaction and extracted with ethyl acetate. The organiclayer was washed with saturated brine and dried with magnesium sulfate.Under reduced pressure, the mixture was concentrated, and the residuesolid was recrystallized from acetone/diethylether to give pale yellowcrystals ofN-[4-[N-(4,4-ethylenedioxycyclohexyl)-N-methylaminomethyl]phenyl]-7-(4-methoxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 283) (226.4 mg).

m.p. 198-201° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.45-1.91 (8H, m), 2.21(3H, s), 2.44-2.65 (1H, m), 3.03-3.10 (2H, m), 3.26-3.31 (2H, m), 3.57(2H, s), 3.86 (3H, s), 3.95 (4H, s), 6.98 (2H, d, J=8.8 Hz), 7.32 (2H,d, J=8.4 Hz), 7.37-7.43 (2H, m), 7.46-7.60 (6H, m), 7.68 (1H, br s). IR(KBr) 3359, 1651, 1514, 1252, 1103, 1030, 926, 830 cm⁻¹ ; Anal. Calcd.for C₃₄ H₃₈ N₂ O₄ S.0.3H₂ O; Calcd. C, 70.88; H, 6.75; N, 4.86. Found.C, 70.86; H, 6.70; N, 4.77.

WORKING EXAMPLE 284 (Production of Compound 284)

To a solution ofN-[4-[N-(4,4-ethylenedioxycyclohexyl)-N-methylaminomethyl]phenyl]-7-(4-methoxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(130 mg) in THF (15 ml) was added at room temperature 6N hydrochloricacid (1 ml), and the mixture was stirred for 66 hours. To the mixturewas added sodium bicarbonate solution, and extracted with ethyl acetate.The organic layer was washed with saturated brine and magnesium sulfate.Under reduced pressure, the mixture was concentrated, and the resultingsolid was recrystallized from ethyl acetate/hexane to give pale yellowcrystals of 7-(4-methoxyphenyl)-N-[4-[N-methyl-N-(4-oxocyclohexyl)aminomethyl]phenyl]-2,3-dihydro-1-benzothiepine-4-carboxamide (Compound284) (78.3 mg).

m.p. 133-139° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.74-2.19 (4H, m), 2.23(3H, s), 2.30-2.59 (4H, m), 2.81-2.97 (1H, m), 3.04-3.10 (2H, m),3.26-3.32 (2H, m), 3.60 (2H, s), 3.86 (3H, s), 6.98 (2H, d, J=9.2 Hz),7.33 (2H, d, J=8.4 Hz), 7.38-7.43 (2H, m), 7.48-7.58 (6H, m), 7.71 (1H,br s). IR (KBr) 3273, 1711, 1651, 1605, 1515, 1408, 1317, 1248, 1180,820 cm⁻¹ ; Anal. Calcd. for C₃₂ H₃₄ N₂ O₃ S.0.2H₂ O ; Calcd. C, 72.48;H, 6.54; N, 5.28. Found. C, 72.33; H, 6.42; N, 5.13.

WORKING EXAMPLE 285 (Production of Compound 285)

To a solution of 7- (4-morpholinophenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (150 mg) and1-hydroxy-benzotriazole (0.11 g) in DMF (5 ml) was added at roomtemperature 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride(0.16 g), and the mixture was stirred for 1 hour. To the mixture wasadded a solution of4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (135 mg) andtriethylamine (0.11 ml) in DMF (5 ml), and the mixture was stirred for18 hours. Under reduced pressure, the mixture was concentrated, and tothe mixture was added water. The mixture was extracted with ethylacetate, and the organic layer was washed with saturated brine and driedwith magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with column chromatography(ethanol/ethyl acetate=1:2) to give yellow crystals ofN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-morpholinophenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 285) (113.9 mg).

m.p. 255-259° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.63-1.84 (4H, m), 2.21(3H, s), 2.55-2.76 (1H, m), 3.02-3.10 (2H, m), 3.19-3.46 (8H, m), 3.58(2H, s), 3.85-3.93 (4H, m), 3.98-4.10 (2H, m), 6.99 (2H, d, J=9.2 Hz),7.32 (2H, d, J=8.4 Hz), 7.37-7.45 (2H, m), 7.49-7.58 (6H, m), 7.67 (1H,br s). IR (KBr) 3288, 1653, 1606, 1522, 1232, 1119, 928, 816 cm⁻¹ ;Anal. Calcd. for C₃₄ H₃₉ N₃ OS.0.5H₂ O ; Calcd. C, 70.56; H, 6.97; N,7.26. Found. C, 70.43; H, 6.83; N, 7.22.

WORKING EXAMPLE 286 (Production of Compound 286)

To a solution of7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylicacid (150 mg) in THF (10 ml) was added at room temperature oxalylchloride (0.08 ml) and a drop of DMF, and the mixture was stirred for 1hour. Under reduced pressure, the solvent was evaporated, and theresidue was dissolved in THF (20 ml). To the mixture were added at 0° C.4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (112 mg) andtriethylamine (0.13 ml), and the mixture was stirred at room temperaturefor 18 hours. The mixture was added to vigorously stirred water to stopthe reaction and extracted with ethyl acetate. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the residue waspurified with column chromatography (ethanol/ethyl acetate=1:3) andrecrystallized from ethanol to give colorless crystals of7-(3,4-methylenedioxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 286) (183.2 mg).

m.p. 193-194° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.52-1.83 (4H, m), 2.21(3H, s), 2.54-2.72 (1H, m), 3.04-3.10 (2H, m), 3.23-3.44 (4H, m), 3.57(2H, s), 3.98-4.09 (2H, m), 6.01 (2H, s), 6.88 (1H, d, J=8.8 Hz),7.01-7.07 (2H, m), 7.29-7.38 (4H, m), 7.46-7.58 (4H, m), 7.68 (1H, brs). IR (KBr) 3334, 1647, 1506, 1475, 1408, 1313, 1232, 1041, 818 cm⁻¹ ;Anal. Calcd. for C₃₁ H₃₂ N₂ O₄ S; Calcd. C, 70.43; H, 6.10; N, 5.30.Found. C, 70.28; H, 5.94; N, 5.14.

WORKING EXAMPLE 287 (Production of Compound 287)

To a solution of7-(4-ethoxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (200 mg)in THF (10 ml) were added at room temperature oxalyl chloride (0.11 ml)and a drop of DMF, and the mixture was stirred for 1 hour. Under reducedpressure, the mixture was concentrated, and the residue was dissolved inTHF (20 ml). To the mixture was added a solution of added at 0° C.4-[N-(4,4-ethylenedioxycyclohexyl)-N-methylaminomethyl]aniline (0.19 g)and triethylamine (0.18 ml) in THF (5 ml), and the mixture was stirredat room temperature for 16 hours. To the mixture was added water, andthe mixture was extracted with ethyl acetate. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the solvent was evaporated, and the residue waspurified with column chromatography (ethanol/ethyl acetate=1:3) andrecrystallized from ethyl acetate/diisopropylether) to give colorlesscrystals of7-(4-ethoxyphenyl)-N-[4-[N-(4,4-ethylenedioxycyclohexyl)-N-methylaminomethyl]-phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 287) (119.1 mg). The mother liquor was concentrated to givecrude product (91.5 mg).

m.p. 172-174° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.44 (3H, t, J=7.0 Hz),1.51-1.88 (8H, m), 2.20 (3H, s), 2.44-2.64 (1H, m), 3.08 (2H, t, J=4.6Hz), 3.56 (2H, s), 3.95 (4H, s), 4.08 (2H, q, J=7.0 Hz), 4.36 (2H, t,J=4.6 Hz), 6.96 (2H, d, J=9.0 Hz), 7.05 (1H, d, J=8.4 Hz), 7.32 (2H, d,J=8.4 Hz), 7.40-7.56 (8H, m). IR (KBr) 3350, 1651, 1515, 1493, 1242,1101, 922, 829, 802 cm⁻¹ ; Anal. Calcd. for C₃₅ H₄₀ N₂ O₅ ; Calcd. C,73.92; H, 7.09; N, 4.93. Found. C, 73.82; H, 7.01; N, 4.90.

WORKING EXAMPLE 288 (Production of Compound 288)

To a solution of7-(4-ethoxyphenyl)-N-[4-[N-(4,4-ethylenedioxycyclohexyl)-N-methylaminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(151.5 mg) in THF (10 ml) was added at room temperature 3N hydrochloricacid (2 ml), and the mixture was stirred for 22 hours. To the mixturewas added saturated sodium bicarbonate solution, and the mixture wasextracted with ethyl acetate. The organic layer was washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated to give colorless solid, whichwas recrystallized from ethyl acetate/diisopropylether to give colorlesscrystals of 7-(4-ethoxyphenyl)-N-[4-[N-methyl-N-(4-oxocyclohexyl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide (Compound288) (103.5 mg).

m.p. 146-148° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.44 (3H, t, J=7.0 Hz),1.80-2.19 (4H, m), 2.23 (3H, s), 2.29-2.59 (4H, m), 2.83-2.98 (1H, m),3.04-3.12 (2H, m), 3.61 (2H, s), 4.08 (2H, q, J=7.0 Hz), 4.34-4.39 (2H,m), 6.96 (2H, d, J=8.8 Hz), 7.05 (1H, d, J=8.4 Hz), 7.33 (2H, d, J=8.0Hz), 7.41-7.57 (8H, m). IR (KBr) 3329, 1709, 1645, 1518, 1495, 1242, 825cm⁻¹ ; Anal. Calcd. for C₃₃ H₃₆ N₂ O₄.0.25H₂ O; Calcd. C, 74.91; H,6.95; N, 5.29. Found. C, 74.68; H, 6.92; N, 5.28.

WORKING EXAMPLE 289 (Production of Compound 289)

To a solution of4-[1-(4-methylphenylsulfonyl)-piperidin-4-yl]-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (200 mg) in THF (10 ml) were added at room temperature oxalylchloride (0.08 ml) and a drop of DMF, and the mixture was stirred for 1hour. Under reduced pressure, the mixture was concentrated, and theresidue was dissolved in THF (20 ml). To the mixture was added at 0° C.a solution of 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-aniline(114 mg) and triethylamine (0.2 ml) in THF (5 ml), and the mixture wasstirred at room temperature for 3 hours. To the mixture was added water,and the mixture was extracted with ethyl acetate. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the residue waspurified with column chromatography (ethanol/ethyl acetate=1:3) andrecrystallized from ethanol to give colorless crystals of4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-6,7-dihydro-5H-benzocycloheptene-8-carboxamide(Compound 289) (203.5 mg).

m.p. 175-176° C.; ¹ H-NMR(200 MHz, CDCl₃) δ 1.66-1.81 (4H,m),1.83-1.92(4H, m), 2.04-2.17 (2H, m), 2.21 (3H, s), 2.26-2.43 (3H, m),2.45 (3H, s), 2.65-2.71 (2H, m), 2.76-2.86 (2H, m), 3.30-3.45 (2H, m),3.57 (2H, s), 3.87-4.10 (4H, m), 6.97-7.13 (3H, m), 7.29-7.37 (5H, m),7.55 (2H, d, J=8.4 Hz), 7.58 (1H, s), 7.68 (2H, d, J=8.2 Hz). IR (KBr)3346, 1647, 1518, 1344, 1159, 926, 725, 546 cm⁻¹ ; Anal. Calcd. for C₃₇H₄₅ N₃ O₄ S; Calcd. C, 70.78; H, 7.22; N, 6.69. Found. C, 70.71; H,7.14; N, 6.46.

WORKING EXAMPLE 290 (Production of Compound 290)

In THF (3.4 ml) was dissolved7-(5-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (340mg), and to the mixture were added oxalyl chloride (0.198 ml) and DMF(one drop) while stirring at room temperature. The mixture was stirredat room temperature for 2 hours. Under reduced pressure, the solvent wasremoved, and the resulting residue was dissolved in THF (5.1 ml). Themixture was added dropwise to a solution of4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (308 mg) andtriethylamine (0.473 ml) in THF (5.1 ml), under ice-cooling, and themixture was stirred at room temperature for 13 hours. The mixture waspoured into water, extracted with ethyl acetate, washed with saturatedbrine and dried with magnesium sulfate. Under reduced pressure, thesolvent was removed, and the resulting residue was purified with silicagel column chromatography (ethyl acetate/ethanol=2/1) and recrystallizedfrom hexane/ethyl acetate to giveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(5-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 290) (20 mg).

m.p. 129-130° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.50-1.82 (4H, m),2.21 (3H,s),2.31 (3H, s),2.65 (1H, m), 3.08 (2H, t, J=4.6 Hz), 3.37 (2H, dt,J=11.2, 3.2 Hz), 3.58 (2H, s), 4.04 (2H, m), 4.37 (2H, t, J=4.6 Hz),6.92 (1H, d, J=5.2 Hz), 7.04 (1H, d, J=5.2 Hz), 7.18-7.52 (7H, m),7.51-7.56 (2H, m); IR (KBr)3294,1653,1597,1514,1498,1456,1406,1315,1248,733 cm⁻¹.

WORKING EXAMPLE 291 (Production of Compound 291)

In THF (10 ml) was dissolved7-(3-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (240 mg), andto the mixture were added oxalyl chloride (0.15 ml) and DMF (one drop)while stirring at room temperature, and the mixture was stirred at roomtemperature for 1.5 hours. Under reduced pressure, the solvent wasremoved, and the resulting residue in THF (6 ml) was added dropwise to asolution of 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (247mg) and triethylamine (0.35 ml) in THF (10 ml), under ice-cooling, andthe mixture was stirred at room temperature for 14 hours. The mixturewas poured into water, extracted with ethyl acetate, washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the solvent was removed, and the resulting residue waspurified with silica gel column chromatography (ethylacetate/ethanol=2/1) and recrystallized from hexane/ethyl acetate togiveN-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(3-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 291) (180 mg).

m.p. 194-195° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.60-1.84 (4H, m),2.22 (3H,s),2.69 (1H, m), 3.09 (2H, t, J=4.6 Hz), 3.36 (2H, dt, J=11.2, 2.6 Hz),3.60 (2H, s), 4.04 (2H, m), 4.34 (2H, t, J=4.6 Hz), 7.03 (1H, d, J=8.4Hz), 7.25-7.42 (7H, m), 7.47 (1H, dd, J=8.4, 2.2 Hz), 7.54 (1H, s), 7.58(1H, s), 7.67 (1H, s); IR (KBr)3306,1645,1604,1514,1496,1456,1408,1321,1230,781cm⁻¹ ; Anal. Calcd. forC₂₈ H₃₀ N₂ O₃ S; Calcd. C, 70.86; H, 6.37; N, 5.90. Found. C, 70.74; H,6.16; N, 5.92.

WORKING EXAMPLE 292 (Production of Compound 292)

In THF 10 ml was dissolved in7-(4-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (250mg), and to the mixture were added oxalyl chloride (0.145 ml) and DMF(one drop) while stirring at room temperature, and the mixture wasstirred at room temperature for 2 hours. Under reduced pressure, thesolvent was removed, and the resulting residue in methylene chloride (10ml) was added dropwise to a solution of4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (250 mg) andtriethylamine (0.35 ml) in THF(5 ml), under ice-cooling, and the mixturewas stirred at room temperature for 13 hours. The mixture was pouredinto water, extracted with ethyl acetate, washed with saturated brineand dried with magnesium sulfate. Under reduced pressure, the solventwas removed, and the resulting residue was purified with silica gelcolumn chromatography (ethyl acetate/ethanol=2/1) and recrystallizedfrom hexane/ethyl acetate to giveN-[4-[N-methyl-N-(tetra-hydropyran-4-yl)aminomethyl]phenyl]-7-(4-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 292) (185 mg).

m.p. 147-148° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.60-1.80 (4H, m), 2.21(3H, s), 2.31 (3H, s), 2.64 (1H, m), 3.06 (2H, t, J=4.2 Hz), 3.37 (2H,dt, J=11.4, 2.8 Hz), 3.57 (2H, s), 4.04 (2H, m), 4.33 (2H, t, J=4.2 Hz),6.82 (1H, d, J=1.2 Hz), 6.99 (1H, d, J=8.4 Hz), 7.04 (1H, d, J=1.2 Hz),7.19 (1H, s), 7.41-7.57 (5H, m), 7.67 (1H, s); IR (KBr) 3292, 1653,1597, , 1514, 1456, 1406, 1315, 1246, 733cm⁻¹ ; Anal. Calcd. for C₂₉ H₃₂N₂ O₃ S.0.5H₂ O; Calcd. C, 69.99; H, 6.68; N, 5.63. Found. C, 69.85; H,6.43; N, 5.68.

WORKING EXAMPLE 293 (Production of Compound 293)

In THF (5.0 ml) was dissolved7-(4-fluorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (137 mg),and to the mixture were added DMF (one drop) and oxalyl chloride (0.085ml). The mixture was stirred at room temperature for 1 hour, and thesolvent was removed under reduced pressure. The residue was dissolved inTHF (5.0 ml), and to the mixture was added a solution of4-[(N-methyl-N-tetrahydropyran-4-yl)aminomethyl]aniline (117 mg) andtriethylamine (0.135 ml) in THF (5.0 ml). The mixture was stirred atroom temperature for 1 hour, and to the mixture was added water (50 ml).The mixture was extracted with ethylacetate (100 ml and 50 ml), and theorganic layer was dried with anhydrous magnesium sulfate. The solventwas removed under reduced pressure, and the residue was purified withsilica gel column chromatography and recrystallized to give7-(4-fluorophenyl)-N-[4-[(N-methyl-N-tetrahydropyran-4-yl)aminomethyl]-phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 293) (149 mg, 64%) as pale yellow needle crystals.

mp 177-178° C.; IR (KBr) 3351, 2938, 1649, 1632, 1595, 1518, 1491, 1412,1316, 1219, 829cm⁻¹. ¹ H NMR (200 MHz, CDCl₃) δ 1.69-1.77 (4H, m), 2.21(3H, s), 2.60-2.70 (1H, m), 3.09 (2H, t, J=4.2 Hz), 3.37 (2H, td,J=11.1, 2.9 Hz), 3.58 (2H, s), 4.04 (2H, d, J=10.6 Hz), 4.37 (2H, t,J=4.7 Hz), 7.04-7.16 (3H, m), 7.29-7.56 (8H, m). Anal. Calcd. for C₃₀H₃₁ FN₂ O₃ : C, 74.05, H, 6.42, N, 5.76. Found : C, 73.90, H, 6.35, N,5.53.

WORKING EXAMPLE 294 (Production of Compound 294)

To a suspension of 6-(4-methylphenyl)-2H-thiochromene-3-carboxylic acid(0.36 g, 1.28 mmol) in dichloromethane (5 ml) were added at 0° C.oxalate chloride (0.33 ml, 3.84 mmol) and N,N-dimethylformamide (onedrop), and the mixture was stirred at room temperature for 1 hour. Thesolvent was evaporated, and the residue was dissolved in tetrahydrofuran(3 ml). To the mixture was added dropwise a solution of aniline (0.31 g,1.41 mmol) and triethylamine (0.54 ml, 3.84 mmol) in tetrahydrofuran (2ml), and the mixture was stirred for 3 hours. To the mixture was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with saturated brine and dried with magnesium sulfate.The solvent was evaporated, and the resulting powder was washed withhexane to give6-(4-methylphenyl)-N-(4-((N-methyl-N-tetrahydropyran-4-yl)amino)-methyl)phenyl-2H-thiochromene-3-carboxamide(Compound 294) (0.45 g, 72%) as pale yellow powder.

m.p. 200° C.; ¹ H-NMR (DMSO-d₆) δ: 7.32-7.36 (3H, m), 7.21-7.28 (4H, m),7.07 (1H, d, J=8.2), 6.92-6.99 (4H, m), 3.50-3.66 (2H, m), 3.48 (2H, s),3.20 (2H, s), 2.86-3.00 (2H, m), 2.20-2.37 (1H, m), 2.03 (3H, s), 1.78(3H, s), 1.08-1.46 (4H, m). Anal. Calcd for C₃₀ H₃₂ N₂ O₂ S.0.25H₂ O: C;73.66, H; 6.70, N; 5.73. Found: C; 73.84, H; 6.60, N; 5.84.

WORKING EXAMPLE 295 (Production of Compound 295)

To a suspension of 6-(4-methylphenyl)-2H-thiochromene-3-carboxylic acid(226 mg, 0.785 mmol) in tetrahydrofuran (7 ml) were added oxalylchloride (0.21 ml, 2.35 mmol) and N,N-dimethylformamide (one drop), andthe mixture was stirred at room temperature for 1 hour. Under reducedpressure, the solvent was evaporated, and the residue was dissolved intetrahydrofuran (5 ml). To the mixture was added dropwise a solution of(E)-4-((N-(4-hydroxycyclohexyl)-N-methyl)aminomethyl)aniline (202 mg,0.864 mmol) and triethylamine (0.33 ml, 2.35 mmol) in tetrahydrofuran (2ml), and the mixture was stirred for 15 hours. To the mixture was addedwater, and the mixture was extracted with ethyl acetate. The extract waswashed with saturated brine and dried with magnesium sulfate. Thesolvent was evaporated, and the residue was purified with silica gelcolumn chromatography [ethyl acetate:ethanol (2:1)] to give(E)-N-(4-((N-(4-hydroxycyclohexyl)-N-methyl)amino)methyl)phenyl-6-(4-methylphenyl)-2H-thiochromene-3-carboxamide (Compound295) (160 mg, 41%), which was recrystallized from ethyl acetate/hexaneto give yellow crystals.

m.p. 149° C.; ¹ H-NMR (CDCl₃) δ: 7.73 (1H, br s), 7.42-7.58 (6H, m),7.22-7.38 (5H, m), 3.81 (2H, d, J=0.8), 3.59 (2H, s), 3.55-3.68 (1H, m),2.42-2.61 (1H, m), 2.40 (3H, s), 2.21 (3H, s), 1.86-2.20 (4H, m),1.23-1.57 (4H, m). Anal. Calcd for C₃₁ H₃₄ N₂ O₄ S.1.25H₂ O: C; 71.44,H; 7.06, N; 5.37. Found: C; 71.12, H; 6.53, N;5.51.

WORKING EXAMPLE 296 (Production of Compound 296)

To a suspension of 6-(4-methylphenyl)-2H-thiochromene-3-carboxylic acid(204 mg, 0.708 mmol) in tetrahydrofuran (6 ml) were added oxalylchloride (0.19 ml) and N,N-dimethylformamide (one drop), and the mixturewas stirred at room temperature for 1 hour. Under reduced pressure, thesolvent was evaporated, and the residue was dissolved in tetrahydrofuran(5 ml). To the mixture was added dropwise a solution of4-((N-(2-methoxy-ethyl)-N-methyl)aminomethyl)aniline (153 mg, 0.802mmol) and triethylamine (0.30 ml) in tetrahydrofuran (2 ml), and themixture was stirred for 15 hours. To the mixture was added water, andthe mixture was extracted with ethyl acetate. The extract was washedwith saturated brine and dried with magnesium sulfate. The solvent wasevaporated, and the residue was purified with silica gel columnchromatography [ethyl acetate:ethanol (2:1)] to giveN-(4-(N-(4-methoxyethyl)-N-methyl)aminomethyl)-phenyl-6-(4-methylphenyl)-2H-thiochromene-3-carboxamide(Compound 296) (170 mg, 52%), which was recrystallized from ethylacetate/hexane to give yellow crystals.

m.p. 101° C.; ¹ H-NMR (CDCl₃) δ: 7.67 (1H, br s), 7.41-7.57 (6H, m),7.20-7.38 (5H, m), 3.82 (2H, t, J=0.8), 3.56 (2H, s), 3.53 (2H, t,J=5.8), 3.35 (3H, s), 2.61 (2H, t, J=5.8), 2.40 (3H, s), 2.28 (3H, s).Anal. Calcd for C₂₈ H₃₀ N₂ O₂ S.0.25H₂ O: C; 72.62, H; 6.64, N; 6.05.Found: C; 72.43, H; 6.39, N; 6.36.

WORKING EXAMPLE 297 (Production of Compound 297)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (292mg, 0.987 mmol) in tetrahydrofuran (10 ml) were added at 0° C. oxalylchloride (0.26 ml) and N,N-dimethylformamide (one drop), and the mixturewas stirred at room temperature for 1.5 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (8 ml). Tothe residue was added dropwise a solution of4-((N-(3-ethoxycarbonylethyl)-N-methyl)aminomethyl)aniline (233 mg,0.987 mmol) and triethylamine (0.42 ml) in tetrahydrofuran (2 ml) at 0°C., and the mixture was stirred at room temperature for 17 hours. To themixture was added water, and the mixture was extracted with ethylacetate. The extract was washed with saturated brine and dried withmagnesium sulfate. The solvent was evaporated, and the residue waspurified with silica gel column chromatography [ethyl acetate] to giveN-(4-(N-(3-ethoxycarbonylethyl)-N-methyl)aminomethyl)phenyl-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 297) (408 mg, 80%), which was recrystallized fromacetone/ethanol to give colorless crystals.

m.p. 124° C.; ¹ H-NMR (CDCl₃) δ: 7.89 (1H, br s), 7.38-7.58 (7H, m),7.22-7.30 (4H, m), 4.14 (2H, q, J=7.4), 3.48 (2H, s), 3.25 (2H, dt,J=5.4, 1.4) 3.05 (2H, t, J=5.4), 2.74 (2H, t, J=6.8), 2.51 (2H, t,J=6.8), 2.39 (3H, s), 2.19 (3H, s), 1.25 (3H, t, J=7.4). Anal. Calcd forC₃₁ H₃₄ N₂ O₃ S: C; 72.34, H; 6.66, N; 5.44. Found: C; 72.32, H; 6.43,N; 5.45.

WORKING EXAMPLE 298 (Production of Compound 298)

To a suspension of7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylic acid (222mg, 0.750 mmol) in tetrahydrofuran (7 ml) was added at 0° C. oxalylchloride (0.26 ml, 2.97 mmol) and N,N-dimethylformamide (one drop), andthe mixture was stirred at room temperature for 2 hours. The solvent wasevaporated, and the residue was dissolved in tetrahydrofuran (5 ml). Tothe residue was added dropwise a solution of aniline (149 mg, 0.825mmol) and triethylamine (0.31 ml, 2.25 mmol) in tetrahydrofuran (2 ml)at 0° C., and the mixture was stirred at room temperature for 3 days. Tothe mixture was added water, and the mixture was extracted with ethylacetate. The extract was washed with saturated brine and dried withmagnesium sulfate. The solvent was evaporated, and the residue waspurified with silica gel column chromatography [ethylacetate:methanol:triethylamine (5:1:0.6)] to giveN-(4-(N-(2-hydroxyethyl)-N-methyl)aminomethyl)phenyl-7-(4-methylphenyl)-2,3-dihydro-1-benzothiepine-4-carboxamide(Compound 298) (310 mg, 90%).

m.p. 138° C.; ¹ H-NMR (CDCl₃) δ: 7.74 (1H, br s), 7.40-7.59 (7H, m),7.23-7.32 (4H, m), 3.64 (2H, t, J=5.2), 3.58 (2H, s), 3.28 (2H, t,J=5.6), 3.07 (2H, t, J=5.6), 2.62 (2H, t, J=5.2). Anal. Calcd for C₃₁H₃₄ N₂ O₃ S: C; 72.34, H; 6.66, N; 5.44. Found: C; 72.32, H; 6.43, N;5.45.

WORKING EXAMPLE 299 (Production of Compound 299)

To a suspension of 6-(4-methylphenyl)-2-pyridineacrylic acid (160 mg,0.67 mmol) in DMF (5 ml) were added at 0° C. 1-hydroxybenzotriazole (99mg, 0.73 mmol), 4-[N-methyl-N-(4-tetrahydropyranyl)aminomethyl]aniline(162 mg, 0.74 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimidehydrochloride (192 mg, 1.00 mmol), triethylamine (0.28 ml, 2.01 mmol)and 4-dimethylaminopyridine (10 mg) in this order, and the mixture wasstirred at room temperature for 17 hours. The mixture was concentratedunder reduced pressure, and to the residue was added ethyl acetate (40ml). The mixture was washed with water (5 ml, 3 ml×2), saturated sodiumbicarbonate solution (3 ml×3) and saturated brine (3 ml) in this order.The organic layer was dried with anhydrous sodium sulfate andconcentrated under reduced pressure, and the residue was purified withcolumn chromatography (silica gel 15 g, ethylacetate/methanol=9/1). Thedesired fraction was concentrated under reduced pressure to giveN-[4-[N-methyl-N-(4-tetrahydropyranyl)aminomethyl]phenyl]-6-(4-methylphenyl)-2-pyridineacrylamide(Compound 299) (259 mg, 0.59 mmol, 88%). IR (KBr): 1667, 1634, 1601,1537, 1514 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.55-1.85 (4H, m), 2.21 (3H, s),2.43 (3H, s), 2.55-2.75 (1H, m), 3.30-3.45 (2H, m), 3.58 (2H, s),3.95-4.10 (2H, m), 7.20-7.50 (5H, m), 7.45-7.85 (6H, m), 7.98 (2H, d,J=8.2 Hz).

WORKING EXAMPLE 300 (Production of Compound 300)

In DMF (5 ml) was dissolved7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid, and to the mixture were added 1-hydroxybenzotriazole (67 mg, 0.50mmol), 4-[N-methyl-N-(4-tetrahydropyranyl)-aminomethyl]aniline (109 mg,0.49 mmol), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride(130 mg, 0.68 mmol), triethylamine (0.189 ml, 1.36 mmol) and4-dimethylaminopyridine (3 mg). The mixture was stirred at roomtemperature for 18 hours and concentrated under reduced pressure. To theresidue was added ethyl acetate (60 m), and the mixture was washed withwater (5 ml×3), saturated sodium bicarbonate solution (3 ml×3) andsaturated brine (5 ml) in this order. The organic layer was dried withanhydrous sodium sulfate and concentrated under reduced pressure. Theresidue was purified with column chromatography (silica gel 15 g, ethylacetate). The desired fraction was concentrated under reduced pressure,and to the residue was added ethyl acetate. Insoluble materials werefiltered, and the insoluble materials were washed with ethyl acetate anddried under reduced pressure to give7-(3,4-methylenedioxyphenyl)-N-[4-[N-methyl-N-(4-tetrahydropyranyl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 300) (187 mg, 0.36 mmol, 81%).

IR (KBr): 1653, 1597, 1514 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.55-1.85 (4H, m),2.21 (3H, s), 2.55-2.80 (1H, m), 3.00-3.15 (2H, m), 3.30-3.45 (2H, m),3.58 (2H, s), 3.95-4.15 (2H, m), 4.30-4.45 (2H, m), 6.01 (2H, s), 6.88(1H, d, J=8.6 Hz), 6.95-7.10 (3H, m), 7.20-7.65 (7H, m).

WORKING EXAMPLE 301 (Production of Compound 301)

In DMF (6 ml) was dissolved7-morpholino-2,3-dihydro-1-benzoxepine-4-carboxylic acid (200 mg, 0.73mmol), and to the mixture were added at 0° C. 1-hydroxybenzotriazole(108 mg, 0.80 mmol),4-[N-methyl-N-(4-tetrahydropyranyl)-aminomethyl]aniline (176 mg, 0.80mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (209mg, 1.09 mmol), triethylamine (0.304 ml, 2.18 mmol) and4-dimethylaminopyridine (3 mg). The mixture was stirred at roomtemperature for 13 hours and concentrated under reduced pressure. To theresidue was added ethyl acetate (40 ml), and the mixture was washed withwater (5 ml×3), saturated sodium bicarbonate solution (5 ml×3) andsaturated brine (5 ml) in this order. The organic layer was dried withanhydrous sodium sulfate and concentrated under reduced pressure. Theresidue was purified with column chromatography (silica gel 15 g, ethylacetate/methanol=1/0→9/1). The desired fraction was concentrated underreduced pressure, and to the residue was added diethylether. Insolublematerials were filtered, and the insoluble materials were washed withdiethylether and dried under reduced pressure to giveN-[4-[N-methyl-N-(4-tetrahydropyranyl)aminomethyl]phenyl]-7-morpholino-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 301) (248 mg, 0.52 mmol, 71%).

IR (KBr): 1655, 1597, 1507 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.5-1.85 (4H, m),2.21 (3H, s), 2.55-2.75 (1H, m), 3.0-3.15 (6H, m), 3.3-3.45 (2H, m),3.57 (2H, s), 3.8-3.9 (4H, m), 3.95-4.1 (2H, m), 4.29 (2H, t, J=4.7 Hz),6.8-7.0 (3H, m), 7.15-7.35 (3H, m), 7.5-7.6 (2H+1H(amide-H), m).

WORKING EXAMPLE 302 (Production of Compound 302)

In DMF (6 ml) was dissolved7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (140 mg,0.50 mmol), and to the mixture were added at 0° C.1-hydroxy-benzotriazole (74 mg, 0.55 mmol),4-[N-(2-pyrimidinyl)-aminomethyl]aniline (100 mg, 0.50 mmol) and1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (144 mg,0.75 mmol). The mixture was stirred at room temperature for 22 hours andconcentrated under reduced pressure. To the residue was added ethylacetate (40 ml), and the mixture was washed with water (5 ml), saturatedsodium bicarbonate solution (5 ml×3) and saturated brine (5 ml) in thisorder. The organic layer was dried with anhydrous sodium sulfate andconcentrated to about 3 ml under reduced pressure. Precipitatedinsoluble materials were filtered and the insoluble materials werewashed with ethyl acetate and dried under reduced pressure to giveN-[4-[N-(2-pyrimidinyl)-aminomethyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 302) (129 mg, 0.28 mmol, 56%).

IR (KBr): 1647, 1591, 1518 cm⁻¹. ¹ H-NMR (DMSO-d₆) δ: 2.34 (3H, s),2.9-3.05 (2H, m), 4.2-4.35 (2H, m), 4.46 (2H, d, J=6.6 Hz), 6.57 (1H, t,J=4.8 Hz), 7.04 (1H, d, J=8.4 Hz), 7.2-7.35 (5H, m), 7.5-7.75 (7H, m),8.27 (2H, d, J=4.8 Hz), 9.91 (1H, s).

WORKING EXAMPLE 303 (Production of Compound 303)

To a mixture of7-(2-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (180 mg, 0.66 mmol),4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-aniline (160 mg, 0.73mmol), 1-hydroxybenzotriazole (98 mg, 0.73 mmol) and DMF (10 ml) wereadded at 0° C. 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimidehydrochloride (190 mg, 0.99 mmol) and triethylamine (0.276 ml, 1.98mmol), and the mixture was stirred at room temperature for 24 hours. Themixture was concentrated under reduced pressure, and to the residue wasadded ethyl acetate (40 ml). The mixture was washed with saturatedsodium bicarbonate solution (5 ml×3) and saturated brine (5 ml) in thisorder. The organic layer was dried with anhydrous sodium sulfate andconcentrated under reduced pressure, and the residue was purified withcolumn chromatography (silica gel 15 g, ethyl acetate). The desiredfraction was concentrated under reduced pressure, and to the residue wasadded ethyl acetate. Insoluble materials were filtered, and theinsoluble materials were washed with ethyl acetate and dried underreduced pressure to give7-(2-methyl-1H-tetrazol-5-yl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 303) (217 mg, 0.46 mmol, 69%).

IR (KBr): 1647, 1628, 1611, 1595, 1522 cm⁻¹. ¹ H-NMR (DMSO-d₆) δ:1.35-1.8 (4H, m), 2.10 (3H, s), 2.4-2.7 (1H, m), 2.9-3.1 (2H, m),3.15-3.4 (2H, m), 3.52 (2H, s), 3.8-4.0 (2H, m), 4.25-4.45 (2H, m), 4.42(3H, s), 7.16 (1H, d, J=8.4 Hz), 7.26 (2H, d, J=8.4 Hz), 7.40 (1H, s),7.66 (2H, d, J=8.4 Hz), 7.92 (1H, dd, J=1.9, 8.4 Hz), 8.19 (1H, d, J=1.9Hz).

WORKING EXAMPLE 304 (Production of Compound 304)

To a mixture of7-(1-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (69 mg, 0.25 mmol),4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline (61 mg, 0.28mmol), 1-hydroxybenzotriazole (38 mg, 0.28 mmol) and DMF (4 ml) wereadded at 0° C. 1-[3-(dimethylamino)-propyl]-3-ethylcarbodiimidehydrochloride (97 mg, 0.51 mmol) and triethylamine (0.106 ml, 0.76mmol), and the mixture was stirred at room temperature for 2 days. Themixture was concentrated under reduced pressure, and to the residue wasadded ethyl acetate. The mixture was washed with saturated sodiumbicarbonate solution. The organic layer was dried with anhydrous sodiumsulfate and concentrated under reduced pressure. The residue waspurified with column chromatography (silica gel 10 g, ethyl acetate).The desired fraction was concentrated under reduced pressure, and to theresidue was added ethyl acetate. Insoluble materials were filtered andthe insoluble materials were washed with ethyl acetate and dried underreduced pressure to give7-(1-methyl-1H-tetrazol-5-yl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]-phenyl]-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 304) (84 mg, 0.18 mmol, 70%).

IR (KBr): 1649, 1630, 1597, 1518 cm⁻¹. ¹ H-NMR (DMSO-d₆) δ: 1.35-1.8(4H, m), 2.10 (3H, s), 2.45-2.7 (1H, m), 2.95-3.1 (2H, m), 3.15-3.4 (2H,m), 3.51 (2H, s), 3.8-4.0 (2H, m), 4.20 (3H, s), 4.3-4.45 (2H, m), 7.22(1H, d, J=8.4 Hz), 7.26 (2H, d, J=8.6 Hz), 7.35 (1H, s), 7.64 (2H, d,J=8.6 Hz), 7.76 (1H, dd, J=2.2, 8.4 Hz), 7.99 (1H, d, J=2.2 Hz).

WORKING EXAMPLE 305 (Production of Compound 305)

In DMF (12.0 ml) was dissolved1-methyl-7-(4-methylphenyl)-2,3-dihydro-1-benzoazepine-4-carboxylic acidhydrochloride (386 mg), and to the mixture was added thionyl chloride(0.26 ml). The mixture was stirred at room temperature for 30 minutes,and the solvent was evaporated under reduced pressure. The residue wasdissolved in dichloromethane (10.0 ml). Thus prepared acid chloridesolution was added dropwise at 0° C. to a solution of4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]aniline (310 mg) andtriethylamine (0.82 ml) in dichloromethane (4.0 ml). The mixture wasstirred at 0° C. for 10 minutes and then at room temperature for 22hours. To the mixture was added water (100 ml), and the mixture wasextracted with dichloromethane (100 ml; twice). The organic layer wasdried with anhydrous magnesium sulfate, and the solvent was evaporatedunder reduced pressure. The residue was purified with silica gel columnchromatography (75 g, ethyl acetate:ethanol=9:1) and recrystallized fromethanol to give1-methyl-7-(4-methylphenyl)-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(Compound 305) (250 mg, 43%).

mp 178-181° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.64-1.76 (4H, m), 2.21 (3H,s), 2.38 (3H, s), 2.66 (1H, septet, J=5.3 Hz), 2.96 (2H, t, J=4.4 Hz),3.09 (3H, s), 3.30-3.43 (2H +2H, m), 3.58 (2H, s), 4.01-4.06 (2H, m),6.88 (1H, d, J=8.6 Hz), 7.23 (2H, d, J=8.0 Hz), 7.30 (2H, d, J=8.4 Hz),7.42, (1H, s), 7.461 (2H, d, J=8.2 Hz), 7.466 (1H, dd, J=8.3, 2.3 Hz),7.535 (2H, d, J=8.4 Hz), 7.539 (1H, d, J=2.6 Hz), 7.58 (1H, s). IR (KBr)3337, 2949, 2851, 1653, 1516, 1501, 1341, 1304, 1238, 818, 521 cm⁻¹.Anal. Calcd. for C₃₂ H₂₇ N₃ O₂ : C, 77.54; H, 7.52; N, 8.48. Found: C,77.51; H, 7.43; N, 8.44.

WORKING EXAMPLE 306 (Production of Compound 306)

In water:ethanol:toluene (1:1:10, 18.0 ml) were dissolved 4-ethoxyphenylborate (252 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]-methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(613 mg), and to the mixture was added potassium carbonate (420 mg). Themixture was stirred under argon atmosphere for 30 minutes, and to themixture was added tetrakistriphenylphosphine palladium (59 mg). Underargon atmosphere, the mixture was refluxed for 17 hours. The mixture wasdiluted with ethyl acetate (200 ml) and washed with water (50 ml) andsaturated brine (50 ml). The organic layer was dried with anhydrousmagnesium sulfate, and the solvent was evaporated under reducedpressure. The residue was purified with silica gel column chromatography(75 g, ethyl acetate:ethanol=9:1) and recrystallized from ethanol togive7-(4-ethoxyphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]2,3-dihydro-1-benzoazepine-4-carboxamide(Compound 306) (230 mg, 35%).

mp 150.5-152° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.44 (3H, t, J=7.0 Hz),1.64-1.77 (4H, m), 2.21 (3H, s), 2.57-2.72 (1H, m), 2.96 (2H, t, J=4.5Hz), 3.08 (3H, s), 3.31-3.43 (2H+2H, m), 3.57 (2H, s), 4.01-4.09 (2H,m), 4.07 (2H, q, J=7.0 Hz), 6.88 (1H, d, J=8.4 Hz), 6.95 (2H, d, J=8.8Hz), 7.30 (2H, d, J=8.6 Hz), 7.40-7.55 (1H+1H+1H+1H, concealed under7.45 and 7.53), 7.47 (2H, d, J=9.0 Hz), 7.53 (2H, d, J=8.8 Hz). IR (KBr)3372, 2955, 2847, 1680, 1605, 1595, 1518, 1503, 1314, 1240, 1194, 812cm⁻¹. Anal. Calcd. for C₃₃ H₃₉ N₃ O₃.0.5H₂ O: C, 74.13; H, 7.54; N,7.86. Found: C, 74.34; H, 7.31; N, 7.96.

WORKING EXAMPLE 307 (Production of Compound 307)

In water:ethanol:toluene (1:1:10, 18.0 ml) were dissolved 4-ethylphenylborate (227 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]-methyllphenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(611 mg), and to the mixture was added potassium carbonate (418 mg). Themixture was stirred under argon atmosphere for 30 minutes, and to themixture was added tetrakistriphenylphosphine palladium (59 mg). Underargon atmosphere, the mixture was ref luxed for 17 hours, and themixture was diluted with ethyl acetate (200 ml) and washed with water(50 ml) and saturated brine (50 ml). The organic layer was dried withanhydrous magnesium sulfate, and the solvent was evaporated underreduced pressure. The residue was purified with silica gel columnchromatography (75 g, ethyl acetate:ethanol=9:1) and recrystallized fromethanol to give7-(4-ethylphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(Compound 307) (252 mg, 39%).

mp 164-165° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.27 (3H, t, J=7.6 Hz),1.66-1.76 (4H, m), 2.21 (3H, s), 2.54-2.70 (1H, m), 2.69 (2H, q, J=7.7Hz), 2.96 (2H, t, J=4.7 Hz), 3.09 (3H, s), 3.29-3.43 (4H, m), 3.57 (2H,s), 4.01-4.06 (2H, m), 6.89 (1H, d, J=8.6 Hz), 7.26 (2H, d, J=8.4 Hz),7.30 (2H, d, J=8.8 Hz), 7.40 (1H, s), 7.48 (1H, dd, J=8.6, 2.2 Hz), 7.49(2H, d, J=9.2 Hz), 7.54 (2H, d, J=8.8 Hz), 7.55 (1H, d, J=2.2 Hz), 1Hwas concealed under 7.40-7.56. IR (KBr) 3364, 2946, 2851, 1653, 1514,1341, 1304, 1233, 1188, 824, 575, 519 cm⁻¹. Anal. Calcd. for C₃₃ H₃₉ N₃O₂ : C, 77.76; H, 7.71; N, 8.24. Found: C, 77.81; H, 7.64; N, 8.27.

WORKING EXAMPLE 308 (Production of Compound 308)

In water:ethanol:toluene (1:1:10, 18.0 ml) were dissolved4-trifluorophenyl borate (190 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)-amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(403 mg), and to the mixture was added potassium carbonate (276 mg). Themixture was stirred under argon atmosphere for 30 minutes, and to themixture was added tetrakistriphenylphosphine palladium (39 mg). Underargon atmosphere, the mixture was refluxed for 17 hours, and the mixturewas diluted with ethyl acetate (200 ml) and washed with water (50 ml)and saturated brine (50 ml). The organic layer was dried with anhydrousmagnesium sulfate, and the solvent was evaporated under reducedpressure. The residue was purified with silica gel column chromatography(75 g, ethyl acetate:ethanol=9:1) and recrystallized from ethanol togive1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]-methyl]phenyl]-7-(4-trifluoromethylphenyl)-2,3-dihydro-1-benzoazepine-4-carboxamide(Compound 308) (177 mg, 39%).

mp 187.5-188.5° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.69-1.77 (4H, m), 2.21(3H, s), 2.57-2.72 (1H, m), 2.98 (2H, t, J=4.6 Hz), 3.12 (3H, s), 3.37(2H, td, J=11.2, 3.3 Hz), 3.38 (2H, t, J=4.7 Hz), 3.57 (2H, s),4.01-4.06 (2H, m), 6.91 (1H, d, J=8.4 Hz), 7.30 (2H, d, J=8.4 Hz), 7.42(1H, s), 7.49 (1H, dd, J=8.4, 2.2 Hz), 7.54 (2H, d, J=8.4 Hz), 7.55 (1H,s), 7.58 (1H, d, J=2.2 Hz), 7.66 (4H, s). IR (KBr) 2949, 2847, 1651,1603, 1516, 1325, 1163, 1115, 1073, 847, 812cm⁻¹. Anal. Calcd. for C₃₂H₃₃ F₃ N₃ O₂ : C, 69.93; H, 6.24; N, 7.65. Found: C, 69.66; H, 6.20; N,7.71.

WORKING EXAMPLE 309 (Production of Compound 309)

In water:ethanol:toluene (1:1:10, 18.0 ml) were dissolved4-(4-morpholino)phenyl borate (208 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(406 mg), and to the mixture was added potassium carbonate (278 mg). Themixture was stirred under argon atmosphere for 30 minutes, and to themixture was added tetrakistriphenylphosphine palladium (39 mg). Underargon atmosphere, the mixture was ref luxed for 17 hours, and themixture was diluted with ethyl acetate (200 ml) and washed with water(50 ml) and saturated brine (50 ml). The organic layer was dried withanhydrous magnesium sulfate, and the solvent was evaporated underreduced pressure. The residue was purified with silica gel columnchromatography (75 g, ethyl acetate:ethanol=9:1) and recrystallized fromethanol to give1-methyl-N-[4-[[N-methyl-N-(tetrahydro-pyran-4-yl)amino]methyl]phenyl]-[4-(4-morpholino)-phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(Compound 309) (247 mg, 52%).

mp 209-211° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.64-1.77 (4H, m), 2.21 (3H,s), 2.57-2.75 (1H, m), 2.96 (2H, t, J=5.2 Hz), 3.09 (3H, s), 3.20 (2H,t, J=4.8 Hz), 3.18-3.22 (2H, m), 3.33-3.43 (4H, m), 3.58 (2H, s), 3.89(4H, t, J=4.8 Hz), 4.01-4.06 (2H, m), 6.88 (1H, d, J=8.4 Hz), 6.97 (2H,d, J=8.8 Hz), 7.30 (2H, d, J=8.8 Hz), 7.41-7.56 (8H, m). IR (KBr) 2953,2847, 1653, 1607, 1514, 1505, 1311, 1232, 1119, 926, 814, 735cm⁻¹. Anal.Calcd. for C₃₅ H₄₂ N₄ O₅ : C, 74.18; H, 7.47; N, 9.89. Found: C, 74.17;H, 7.39; N, 9.98.

REFERENCE EXAMPLE 187

In 1,2-dichloroethane (50 ml) were suspendedp-nitrobenzylaminehydrochloride (3.77 g), 4H-tetrahydropyran-4-one (2 g)and triethylamine (2.8 ml), and to the mixture was added, underice-cooling, triacetoxy sodium boron hydride (5.92 g). Under nitrogenatmosphere, the mixture was stirred at room temperature for 4 hours, andto the mixture were added, under ice-cooling, acetaldehyde (1.5 ml) andtriacetoxy sodium boron hydride (5.92 g). Under nitrogen atmosphere, themixture was stirred at room temperature overnight. The solvent wasevaporated, and the residue was neutralized with sodium hydroxidesolution. The mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated brine and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethylacetate/hexane) to giveN-(4-nitrobenzyl)-N-(tetrahydropyran-4-yl)ethylamine (4.0 g) as yellowoil.

¹ H-NMR(δ ppm, CDCl₃) 1.01 (3H, t, J=6.9 Hz), 1.52-1.73 (4H, m), 2.59(2H, q, J=6.9 Hz), 2.68-2.83 (1H, m), 3.34 (2H, dt, J=3.6, 11.2 Hz),3.73 (2H, s), 3.99-4.06 (2H, m), 7.54 (2H, d, J=9.0 Hz), 8.16 (2H, d,J=9.0 Hz). IR(neat) ν: 2951, 2841, 1599, 1520cm⁻¹.

REFERENCE EXAMPLE 188

In acetic acid (100 ml) was dissolvedN-(4-nitrobenzyl)-N-(tetrahydropyran-4-yl)ethylamine (4.0 g), and to themixture was added reduced iron (4.2 g). The mixture was stirred at roomtemperature overnight. The solvent was evaporated, and to the residuewas added ethyl acetate. The precipitates were filtered off, and thefiltrate was washed with sodium hydroxide solution, water and saturatedbrine, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (methanol/triethylamine/ethyl acetate) to give4-(N-ethyl-N-(tetrahydropyran-4-yl)aminomethyl)aniline (2.3 g) as redoil.

¹ H-NMR(δ ppm, CDCl₃) 1.00 (3H, t, J=7.1 Hz), 1.52-1.70 (4H, m), 2.54(2H, q, J=7.1 Hz), 2.66-2.82 (1H, m), 3.26-3.39 (2H, m), 3.52 (2H, s),3.59 (2H, br), 3.95-4.04 (2H, m), 6.64 (2H, d, J=8.5 Hz), 7.12 (2H, d,J=8.5 Hz).

REFERENCE EXAMPLE 189

In 1,2-dichloroethane (75 ml) were suspended p-nitrobenzaldehyde (5 g)and 2-amino-1,3-propanediol (3.0 g), and to the mixture was added, underice-cooling, triacetoxy sodium boron hydride (9.8 g). Under nitrogenatmosphere, the mixture was stirred at room temperature for 3.5 hours.To the mixture were added, under ice-cooling, 37% formalin (3 ml) andtriacetoxy sodium boron hydride (9.8 g), and the mixture was stirred,under nitrogen atmosphere, at room temperature overnight. To the mixturewas added water, and the mixture was concentrated. The residue wasneutralized with sodium hydroxide solution, saturated with sodiumhydrochloride and extracted with ethyl acetate. The organic layer wasdried with anhydrous magnesium sulfate, and the solvent was evaporatedunder reduced pressure. The residue was purified with silica gel column(ethyl acetate) to give2-(N-methyl-N-(4-nitro-benzyl)amino)-1,3-propanediol (3.0 g) as paleyellow crystals.

mp 65-66° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.31 (3H, s), 2.93-3.06 (1H, m),3.64-3.80 (4H, m), 3.92 (2H, s), 7.49 (2H, d, J=8.8 Hz), 8.20 (2H, d,J=8.8 Hz). IR(KBr) ν: 3349, 2942, 2884, 1520cm⁻¹. Anal. Calcd. for C₁₁H₁₆ N₂ O₄ : C, 54.99; H, 6.71; N, 11.66. Found: C, 55.14; H, 6.61; N,11.55.

REFERENCE EXAMPLE 190

In ethanol (50 ml) was dissolved2-(N-methyl-N-(4-nitrobenzyl)amino)-1,3-propanediol (2.9 g), andcatalytic reduction was carried out with 5% palladium carbon (0.15 g) atroom temperature for 2 hours. The catalyst was filtered off, and thesolvent of the filtrate was evaporated. The residue was purified withsilica gel column (methanol/triethylamine/ethyl acetate) to give2-(N-(4-aminobenzyl)-N-methylamino)-1,3-propanediol (0.6 g) as paleyellow amorphous.

¹ H-NMR(δ ppm, CDCl₃) 2.26 (3H, s), 2.37 (2H, br), 2.91-2.99 (1H, m),3.55-3.73 (6H, m), 6.65 (2H, d, J=8.4 Hz), 7.08 (2H, d, J=8.4 Hz).IR(KBr) ν: 3347, 2942, 2880, 1615cm⁻¹. Anal. Calcd. for C₁₁ H₁₈ N₂O₂.0.1H₂ O: C, 62.30; H, 8.65; N, 13.21. Found: C, 62.37; H, 8.79; N,13.24.

REFERENCE EXAMPLE 191

In 1,2-dichloroethane (50 ml) were suspended p-nitrobenzaldehyde (5 g),sarcosine methyl ester hydrochloride (4.6 g) and triethylamine (4.6 ml),and to the mixture was added, under ice-cooling, triacetoxy sodium boronhydride (9.8 g). Under nitrogen atmosphere, the mixture was stirred atroom temperature for 4 hours. To the mixture was added water, and themixture was concentrated, neutralized with sodium hydroxide solution andextracted with ethyl acetate. The organic layer was washed with waterand brine, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column (ethyl acetate/hexane) to giveN-(4-nitrobenzyl)sarcosine methyl ester (6.3 g) as colorless oil.

¹ H-NMR(δ ppm, CDCl₃) 2.39 (3H, m), 3.33 (2H, s), 3.73 (3H, s), 3.80(2H, s), 7.55 (2H, d, J=8.8 Hz), 8.19 (2H, d, J=8.8 Hz). IR(neat) ν:2951, 2847, 1748cm⁻¹.

REFERENCE EXAMPLE 192

In acetic acid (100 ml) was dissolved N-(4-nitrobenzyl)sarcosine methylester (5.96 g), and to the mixture was added little by little reducediron (7 g). The mixture was stirred at room temperature overnight. Thesolvent was evaporated, and to the residue was added ethyl acetate. Theprecipitates were filtered off, and the filtrate was washed with sodiumhydroxide solution, water and saturated brine, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the resulting residue was purified with silica gel columnchromatography (ethyl acetate/hexane) to give N-(4-aminobenzyl)sarcosinemethyl ester (3.0 g) as red oil.

¹ H-NMR(δ ppm, CDCl₃) 2.36 (3H, m), 3.22 (2H, s), 3.55 (2H, s), 3.65(2H, br), 3.70 (3H, s), 6.65 (2H, d, J=8.6 Hz), 7.11 (2H, d, J=8.6 Hz).IR(neat) ν: 3364, 2949, 1744cm⁻¹.

REFERENCE EXAMPLE 193

In 1,2-dichloroethane (50 ml) were dissolved p-nitrobenzaldehyde (5 g)and 3-methoxypropylamine (3.1 g), and to the mixture was added, underice-cooling, triacetoxy sodium boron hydride (9.8 g). Under nitrogenatmosphere, the mixture was stirred at room temperature for 3 hours, andto the mixture were added, under ice-cooling, 37% formalin (3 ml) andtriacetoxy sodium boron hydride (9.8 g). Under nitrogen atmosphere, themixture was stirred at room temperature for 3 hours, and to the mixturewas added water. The mixture was concentrated, neutralized with sodiumhydroxide solution and extracted with ethyl acetate. The organic layerwas washed with water and subjected to back extraction with iNhydrochloric acid. The aqueous layer was washed with ethyl acetate,neutralized with 1N sodium hydroxide solution and extracted with ethylacetate. The organic layer was washed with water and saturated brine,and dried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated to giveN-(3-methoxypropyl)-N-methyl-4-nitrobenzylamine (5.6 g) as yellow oil.

¹ H-NMR(δ ppm, CDCl₃) 1.72-1.85 (2H, m), 2.20 (3H, s), 2.47 (2H, t,J=7.3 Hz), 3.33 (3H, s), 3.43 (2H, t, J=6.4 Hz), 3.58 (2H, s), 7.50 (2H,d, J=9.0 Hz), 8.18 (2H, d, J=9.0 Hz). IR(neat) ν: 2805, 1605, 1520cm⁻¹.

REFERENCE EXAMPLE 194

In acetic acid (70 ml) was dissolvedN-(3-methoxypropyl)-N-methyl-4-nitrobenzylamine (5.5 g), and to themixture was added little by little reduced iron (6.4 g). The mixture wasstirred at room temperature overnight. The solvent was evaporated, andto the residue was added ethyl acetate. The precipitates were filteredoff, the filtrate was washed with sodium hydroxide solution, water andsaturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give4-((N-3-methoxypropyl-N-methyl)aminomethyl)aniline (4.4 g) as red oil.

¹ H-NMR(δ ppm, CDCl₃) 1.71-1.85 (2H, m), 2.16 (3H, s), 2.42 (2H, t,J=7.4 Hz), 3.32 (3H, s), 3.37 (2H, s), 3.41 (2H, t, J=6.6 Hz), 3.61 (2H,br), 6.64 (2H, d, J=8.4 Hz), 7.08 (2H, d, J=8.4 Hz). IR(neat) ν: 2946,2795, 1615cm⁻¹.

REFERENCE EXAMPLE 195

In ethanol (50 ml) was dissolved7-(4-methylphenyl)-2,3,4,5-tetrahydro-1-benzoxepin-5-one (1 g), and tothe mixture was added, under ice-cooling, sodium boron hydride (0.3 g).The mixture was stirred at room temperature for 30 minutes, and to themixture was added water. The mixture was concentrated and extracted withethyl acetate. The organic layer was washed with water and concentrated.The residue was dissolved in bis(2-methoxyethyl)ether (20 ml), and tothe mixture was added hydrochloric acid (5 ml). The mixture was stirredat 75° C. for 1 hour, poured into water and extracted with ethylacetate. The organic layer was washed with water and saturated brine,and dried with anhydrous magnesium sulfate. The solvent was evaporated,and the precipitated 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine (0.78g) was filtered with hexane to give colorless crystals.

mp 98-100° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.38 (3H, s), 2.65-2.74 (2H, m),4.27 (2H, t, J=4.9 Hz), 6.01 (1H, dt, J=11.7, 4.4 Hz), 6.39 (1H, d,J=11.7 Hz), 7.01 (1H, d, J=8.0 Hz), 7.23 (2H, d, J=8.2 Hz), 7.31-7.38(2H, m), 7.45 (2H, d, J=8.0 Hz). IR(KBr) ν: 3025, 1491cm⁻¹. Anal. Calcd.for C₁₇ H₁₆ O: C, 86.41; H, 6.82. Found: C, 86.17; H, 6.61.

REFERENCE EXAMPLE 196

Under ice-cooling, to dimethylformamide (0.2 ml) was added dropwisesulfuryl chloride (0.17 ml), and the mixture was stirred, under nitrogenatmosphere, at room temperature for 10 minutes. To the mixture was added7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine (0.3 g), and the mixturewas stirred, under nitrogen atmosphere, at 90° C. for 3 hours. To themixture was added ice-water, and the mixture was extracted with ethylacetate. The organic layer was washed with water and saturated brine,and dried with anhydrous magnesium sulfate. The solvent was evaporatedto give 7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-sulfonylchloride(0.36 g) as pale yellow crystals.

mp 162-166° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.40 (3H, s), 3.27 (2H, t, J=4.7Hz), 4.41 (2H, t, J=4.7 Hz), 7.11 (1H, d, J=9.6 Hz), 7.26 (2H, d, J=8.2Hz), 7.44 (2H, d, J=8.2 Hz), 7.57-7.62 (2H, m), 7.70 (1H, s). IR(KBr) ν:3027, 1634, 1493cm⁻¹. Anal. Calcd. for C₁₇ H₁₅ ClO₃ S: C, 60.98; H,4.52. Found: C, 61.14; H, 4.26.

REFERENCE EXAMPLE 197

Under argon atmosphere, a solution of ethyl(E)-3-(5-bromothiophen-2-yl)acrylate (1.00 g), 4-isopropylphenyl borate(0.86 g) and potassium carbonate (1.12 g) in toluene/ethanol/water(40/4/4 ml) was stirred at room temperature for 1 hour. To the mixturewas added tetrakistriphenylphosphine palladium (0.14 g), and the mixturewas refluxed for 18 hours and then cooled to room temperature. Theorganic layer was washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the mixture was concentrated, and theresidue was purified with column chromatography (ethylacetate/hexane=1:9) to give pale yellow crystals of methyl(E)-3-[5-(4-isopropylphenyl)-thiophen-2-yl]acrylate (0.83 g).

m.p. 117-119° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.27 (6H, d, J=6.8 Hz),2.94-3.00 (1H, m), 3.80 (3H, s), 6.22 (1H, d, J=15.8 Hz), 7.24-7.28 (4H,m), 7.54 (2H, d, J=7.8 Hz), 7.76 (1H, d, J=15.8 Hz). IR (KBr) 1718,1622, 1436, 1306, 1230, 1203, 1165, 806 cm⁻¹ ; Anal. Calcd. for C₁₇ H₁₈O₂ S; Calcd. C, 71.30; H, 6.33; S, 11.20. Found. C, 71.22; H. 6.33; S,11.23.

REFERENCE EXAMPLE 198

To a solution of methyl(E)-3-(5-(4-isopropylphenyl)-thiophen-2-yl]acrylate (0.75 mg) inTHF/ethanol (10/10 ml) was added at room temperature 2N sodium hydroxidesolution (2.0 ml), and the mixture was stirred for 20 hours. Underreduced pressure, the mixture was concentrated, and to the residue wasadded 1N hydrochloric acid (10 ml). The mixture was extracted with ethylacetate, and the organic layer was washed with saturated brine, driedwith magnesium sulfate and concentrated. The resulting crystals werecollected by filtration to give pale yellow crystals of(E)-3-[5-(4-isopropylphenyl)thiophen-2-yl]acrylic acid (639.7 mg).

m.p. 216-219° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.28 (6H, d, J=7.0 Hz),2.86-3.01 (1H, m), 6.22 (1H, d, J=15.7 Hz), 7.23-7.33 (4H, m), 7.56 (2H,d, J=8.4 Hz), 7.85 (1H, d, J=15.7 Hz). IR (KBr) 2966, 1668, 1608, 1414,1302, 1263, 1228, 804 cm⁻¹ ; Anal. Calcd. for C₁₆ H₁₆ O₂ S; Calcd. C,70.56; H, 5.92; S, 11.77. Found. C, 70.23; H, 5.94; S, 11.62.

REFERENCE EXAMPLE 199

Under argon atmosphere, a solution of methyl(E)-3-(5-bromothiophen-2-yl)acrylate (0.23 g), 4-tert-butylphenyl borate(0.3 g) and potassium carbonate (0.26 g) in toluene/ethanol/water(20/2/2 ml) was stirred at room temperature for 1 hour. To the mixturewas added tetrakistriphenylphosphine palladium (32 mg), and the mixturewas refluxed for 18 hours and then cooled to room temperature. To theorganic layer was added ethyl acetate, and the mixture was washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the residue was purifiedwith column chromatography (ethyl acetate/hexane=1:9) to give paleyellow crystals of methyl(E)-3-[5-(4-tert-butylphenyl)thiophen-2-yl]acrylate (240 mg). Thiscompound was used for the following reaction, without subjecting furtherpurification.

¹ H-NMR (200 MHz, CDCl₃) δ 1.34 (9H, s), 3.80 (3H, s), 6.22 (1H, d,J=15.8 Hz), 7.21-7.30 (2H, m), 7.42 (2H, d, J=8.7 Hz), 7.55 (2H, d,J=8.7 Hz), 7.76 (1H, d, J=15.8 Hz). IR (KBr) 1716, 1622, 1436, 1302,1232, 1207, 1165, 972, 806 cm⁻¹.

REFERENCE EXAMPLE 200

To a solution of methyl(E)-3-[5-(4-tert-butylphenyl)-thiophen-2-yl]acrylate (190 mg) ofTHF/ethanol (15/15 ml) was added at room temperature 2N sodium hydroxidesolution (2.0 ml), and the mixture was stirred 18 hours. To the mixturewas added 1N hydrochloric acid (5 ml), and the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated brineand dried with magnesium sulfate. Under reduced pressure, the mixturewas concentrated, and the precipitated crystals were collected byfiltration, which were washed with hexane to give yellow crystals of(E)-3-[5-(4-tert-butylphenyl)thiophen-2-yl]acrylic acid (149.7 mg). Thiscompound was used for the following reaction, without subjecting furtherpurification.

¹ H-NMR (200 MHz, CDCl) δ 1.35 (9H, s), 6.22 (1H, d, J=15.6 Hz),7.20-7.29 (2H, m), 7.43 (2H, d, J=8.8 Hz), 7.56 (2H, d, J=8.8 Hz), 7.85(1H, d, J=15.6 Hz). IR (KBr) 2962, 1678, 1612, 1414, 1302, 1232, 806cm⁻¹ ;

REFERENCE EXAMPLE 201

To a solution of 4'-methylacetophenone (10.0 g) in ethanol (100 ml) wereadded at room temperature an aqueous solution (50 ml) of hydroxyaminehydrochloride (7.77 g) and sodium acetate (9.63 g), and the mixture wasrefluxed for 24 hours and then cooled. The mixture was concentrated, andto the residue was added iN hydrochloric acid (150 ml). The mixture wasextracted with ethyl acetate, washed with saturated brine and dried withmagnesium sulfate. Under reduced pressure, the mixture was concentrated,and the residue was purified with column chromatography (ethylacetate/hexane=1:3) to give colorless crystals of4'-methylacetophenonoxime (10.89 g).

¹ H-NMR (200 MHz, CDCl₃) δ 2.28 (3H, s), 2.37 (3H, s), 7.19 (2H, d,J=8.1 Hz), 7.53 (2H, d, J=8.1 Hz), 8.55-8.69 (1H, m).

REFERENCE EXAMPLE 202

To a solution of 4'-methylacetophenonoxime (10.46 g) in DMF (250 ml) wasadded at 0° C. sodium hydride (60%, 3.08 g), and the mixture was stirredat room temperature for 1 hour. To the mixture was added a solution of4-fluorobenzaldehyde (9.57 g) in THF (300 ml), and the mixture wasstirred for 5 days. To the mixture was added 1N hydrochloric acid (200ml), and the mixture was extracted with ethyl acetate. The organic layerwas washed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the residue waspurified with column chromatography (ethyl acetate/hexane=1:5) to givecolorless crystals of4-(4'-methyl-α-methylbenzylideneaminoxy)benzaldehyde (11.23 g).

m.p. 96-98° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.41 (3H, s), 2.47 (3H, s),7.25 (2H, d, J=7.8 Hz), 7.43 (2H, d, J=8.8 Hz), 7.69 (2H, d, J=7.8 Hz),7.88 (2H, d, J=8.8 Hz), 9.93 (1H, s). IR (KBr) 1699, 1597, 1576, 1498,1232, 1207, 1149, 916, 820 cm⁻¹ ; Anal. Calcd. for C₁₆ H₁₅ NO₂ ; Calcd.C, 75.87; H, 5.97; N, 5.53. Found. C, 75.73; H, 6.04; N, 5.48.

REFERENCE EXAMPLE 203

A solution of 4-(4'-methyl-α-methylbenzylideneaminoxy)benzaldehyde (5.0g) in 1N hydrochloric acid/acetic acid (80 ml) was stirred at 100-110°C. for 24 hours and then cooled to room temperature. To the mixture wasadded water, and the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the mixture was concentrated, and theresidue was purified with column chromatography (ethylacetate/hexane=1:9) to give colorless crystals of2-(4-methylphenyl)benzofuran-5-aldehyde (1.50 g).

m.p. 162-164° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.41 (3H, s), 7.06 (1H, s),7.28 (2H, d, J=8.0 Hz), 7.62 (1H, d, J=8.4 Hz), 7.77 (2H, d, J=8.0 Hz),7.84 (1H, dd, J=8.4, 1.8 Hz), 8.11 (1H, d, J=1.8 Hz), 10.06 (1H, s). IR(KBr) 1697, 1292, 1271, 824, 798 cm⁻¹ ; Anal. Calcd. For C₁₆ H₁₂ O₂ ;Calcd. C, 81.34; H, 5.12. Found. C, 81.21; H, 5.11.

REFERENCE EXAMPLE 204

To a solution of 2-(4-methylphenyl)benzofuran-5-carbaldehyde (500 mg)and 1-methylcyclohexene (1.2 ml) in DMF (15 ml) was added a solution (9ml) of sodium chlorite (80%, 1.5 g) and sodium dihydrogenphosphate (1.5g) at room temperature, and the mixture was stirred for 3 hours. To themixture was added 1N hydrochloric acid, and the mixture was extractedwith ethyl acetate. The organic layer was washed with sodium thiosulfateand saturated brine, and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the precipitated crystalswere collected by filtration, which were washed with diethylether togive colorless crystals of 2-(4-methylphenyl)benzofuran-5-carboxylicacid (395 mg).

m.p. 279-283° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.38 (3H, s), 7.34 (2H, d,J=8.2 Hz), 7.48 (1H, s), 7.70 (1H, d, J=8.8 Hz), 7.84 (2H, d, J=8.2 Hz),7.92 (1H, dd, J=8.8, 1.2 Hz), 8.26 (1H, d, J=1.2 Hz). IR (KBr) 2989,1689, 1416, 1291, 768 cm⁻¹ ; Anal. Calcd. for C₁₆ H₁₂ O₃ ; Calcd. C,76.18; H, 4.79. Found. C, 76.11; H, 4.74.

REFERENCE EXAMPLE 205

To a solution of ethyl vanillate (2.50 g) and triethylamine (3.6 ml) indichloromethane (50 ml) was added at 0° C. trifluoromethanesulfonic acidanhydride (2.6 ml), and the mixture was stirred for 1.5 hours. To themixture was added water (15 ml), and the mixture was extracted withethyl acetate. The organic layer was washed with saturated brine anddried with magnesium sulfate. Under reduced pressure, the mixture wasconcentrated, and the residue was purified with column chromatography(ethyl acetate/hexane=1:15) to give yellow oil of ethyl3-methoxy-4-trifluoromethane-sulfonyloxybenzoate (3.96 g).

¹ H-NMR (200 MHz, CDCl₃) δ 1.41 (3H, t, J=7.1 Hz), 3.99 (3H, s), 4.41(2H, q, J=7.1 Hz), 7.28 (1H, d, J=7.6 Hz), 7.67-7.72 (2H, m). IR (neat)1726, 1606, 1502, 1466, 1427, 1292, 1246, 1207, 1142, 1109, 1030, 833,768, 617 cm⁻¹.

REFERENCE EXAMPLE 206

To a solution of ethyl 3-methoxy-4-trifluoromethanesulfonyloxybenzoate(3.95 g), 4-methylphenylacetylene (1.54 g) and triethylamine (5.0 ml) inDMF (40 ml) was added bistriphenylphosphine palladium dichloride (0.25g), and the mixture was stirred at 100° C. for 3 hours and then cooledto room temperature. To the mixture was added water, and the mixture wasextracted with diethylether. The organic layer was washed with saturatedbrine and dried with magnesium sulfate. Under reduced pressure, themixture was concentrated, and the residue was purified with columnchromatography (ethyl acetate/hexane=1:9) and recrystallized from ethylacetate/hexane to give pale yellow crystals of ethyl3-methoxy-4-[2-(4-methylphenyl)ethynyl]-benzoate (2.02 g).

m.p. 71-73° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.41 (3H, t, J=7.1 Hz), 2.37(3H, s), 3.97 (3H, s), 4.39 (2H, q, J=7.1 Hz), 7.16 (2H, d, J=7.9 Hz),7.47 (2H, d, J=7.9 Hz), 7.53 (1H, d, J=8.0 Hz), 7.57 (1H, d, J=1.6 Hz),7.63 (1H, dd, J=8.0, 1.6 Hz). IR (KBr) 1711, 1410, 1294, 1236, 1099,1036, 812, 762 cm⁻¹ ; Anal. Calcd. for C₁₉ H₁₈ O₃ ; Calcd. C, 77.53; H,6.16. Found. C, 77.48; H, 6.01.

REFERENCE EXAMPLE 207

A mixture of ethyl 3-methoxy-4-(4-methylphenyl)ethynylbenzoate (1.5 g)and pyridinium chloride (9.0 g) was stirred at 200° C. for 2 hours, andthen cooled to 100° C. To the mixture was added DMF (20 ml), and themixture was cooled to room temperature. To the mixture was added 1Nhydrochloric acid, and the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the mixture was concentrated, and theprecipitated crystals were collected by filtration, which were washedwith diethylether and hexane to give pale yellow crystals of2-(4-methylphenyl)benzofuran-6-carboxylic acid (0.84 g).

m.p. 270-272° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.38 (3H, s), 7.35 (2H,d, J=8.2 Hz), 7.47 (1H, s), 7.72 (1H, d, J=8.0 Hz), 7.85-7.89 (3H, m),8.11 (1H, s). IR (KBr) 2972, 1677, 1612, 1498, 1413, 1300, 1230, 798cm⁻¹ ; Anal. Calcd. For C₁₆ H₁₂ O₃ ; Calcd. C, 76.18; H, 4.79. Found. C,76.05; H, 4.54.

REFERENCE EXAMPLE 208

To a solution of ethyl7-(4-methylthiophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (198.5mg) in THF (20 ml) was added at 0° C. 70% 3-chloroperbenzoic acid (317mg), and the mixture was stirred at 0° C. for 30 minutes and then atroom temperature for 1 hour. To the mixture was added sodium thiosulfatesolution, and the mixture was stirred for a few minutes and thenextracted with ethyl acetate. The organic layer was washed withsaturated sodium bicarbonate solution and saturated brine, and driedwith magnesium sulfate. Under reduced pressure, the mixture wasconcentrated, and the residue was purified with column chromatography(ethyl acetate/hexane=1:1) to give colorless crystals of ethyl7-(4-methylsulfonylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(221.8 mg).

m.p. 150-153° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.37 (3H, t, J=7.2 Hz),3.03 (2H, t, J=4.5 Hz), 3.10 (3H, s), 4.30 (2H, q, J=7.2 Hz), 4.33 (2H,t, J=4.5 Hz), 7.10 (1H, d, J=8.4 Hz), 7.50 (1H, dd, J=8.4, 2.2 Hz), 7.60(1H, d, J=2.2 Hz), 7.65 (1H, s), 7.75 (2H, d, J=8.4 Hz), 8.01 (2H, d,J=8.4 Hz). IR (KBr) 1693, 1595, 1485, 1302, 1252, 1230, 1213, 1146,1092, 825 cm⁻¹ ; Anal. Calcd. for C₂₀ H₂₀ O₅ S; Calcd. C, 64.50; H,5.41; S, 8.61. Found. C, 64.36; H, 5.40; S, 8.53.

REFERENCE EXAMPLE 209

To a solution of ethyl7-(4-methylsulfonylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (180mg) in THF/ethanol (5/5 ml) was added at room temperature 1N sodiumhydroxide solution (1 ml), and the mixture was stirred for 4 days. Tothe mixture was added 1N hydrochloric acid (10 ml), and the mixture wasconcentrated under reduced pressure. The residue was extracted withethyl acetate. Under reduced pressure, the mixture was concentrated. Theresulting crystals were collected by filtration, which were washed withwater, ethanol and diethylether to give colorless crystals of7-(4-methyl-sulfonylphenyl)-2,3-dihydrobenzoxepine-4-carboxylic acid(148.2 mg).

m.p. 275° C. (dec.); ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.84-2.94 (2H, m),3.25 (3H, s), 4.23-4.34 (2H, m), 7.10 (1H, d, J=8.4 Hz), 7.64-7.75 (2H,m), 7.92-8.04 (5H, m). IR (KBr) 3018, 1674, 1308, 1267, 1147, 829, 783,760, 636, 546cm⁻¹ ; Anal. Calcd. for C₁₈ H₁₆ O₅ S.0.2H₂ O; Calcd. C,62.13; H, 4.75; S, 9.21. Found. C, 62.19; H, 4.69; S, 9.06.

REFERENCE EXAMPLE 210

A mixture of 4-bromothiophenol (24,8 g), ethyl 4-bromo-butyrate (30.7 g)and potassium carbonate (36.2 g) in DMF (100 ml) was stirred at roomtemperature overnight. Under reduced pressure, the solvent wasevaporated, and to the residue was added water. The mixture wasextracted with ethyl acetate, and the organic layer was washed withsaturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and to the residue was wereadded methanol (120 ml) and 1N sodium hydroxidesolution(240 ml). Themixture was stirred at room temperature overnight, and to the mixturewas added water. The mixture was washed with ethyl acetate, and to theaqueous layer was added concentrated hydrochloric acid to make thesolution acidic. The mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the solvent was evaporated to colorlessprism of 4-(4-bromophenylthio)butyric acid (31.8 g).

¹ H-NMR(200 MHz, CDCl₃) δ 1.87-2.02 (2H, m), 2.53 (2H, t, J=7.1 Hz),2.96 (2H, t, J=7.2 Hz), 7.21 (2H, d, J=8.8 Hz), 7.41 (2H, d, J=8.8 Hz).IR (KBr) 1699 cm⁻¹ ; Anal. Calcd. for C₁₀ H₁₁ O₂ BrS; Calcd. C, 43.65;H, 4.03. Found. C, 43.70; H, 3.93.

REFERENCE EXAMPLE 211

A mixture of 4-(4-bromophenylthio)butyric acid (31.8 g) andpolyphosphoric acid (250 g) was stirred at 100° C. for 1 hour. Themixture was added to ice/water and extracted with ethyl acetate. Theorganic layer was washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the solvent was evaporated to givebrown prismof 7-bromo-2,3,4,5-tetrahydro-1-benzo-thiepin-5-one (13.6 g).

¹ H-NMR(200 MHz, CDCl₃) δ 2.22-2.35(2H, m), 2.94-3.08(4H, m), 7.33 (1H,d, J=8.0 Hz), 7.44 (1H, dd, J=8.0, 2.6 Hz), 7.96 (1H, d, J=2.6 Hz). IR(KBr) 1682 cm⁻¹ ; Anal. Calcd. for C₁₀ H₉ OBrS; Calcd. C, 46.71; H,3.53. Found. C, 46.71; H, 3.45.

REFERENCE EXAMPLE 212

To a solution of 7-bromo-2,3,4,5-tetrahydro-1-benzothiepin-5-one (13.5g) in dimethyl carbonate (200 ml) was added at room temperature sodiummethoxide (14.2 g), and the mixture was refluxed for 8 hours undernitrogen atmosphere. To the mixture was added 1N hydrochloric acid, andthe mixture was extracted with ethyl acetate. The organic layer waswashed with water and saturated brine, and dried with magnesium sulfate.Under reduced pressure, the solvent was evaporated to give brown prismof methyl 7-bromo-5-oxo-2,3,4,5-tetrahydro-1-benzothiepine-4-carboxylate(11.5 g).

¹ H-NMR(200 MHz, CDCl₃) δ 2.40-2.84(6H, m), 3.16-3.27(2H, m), 3.75 (3H,s), 4.47-4.56 (1H, m), 7.33 (1H, d, J=8.4 Hz), 7.47 (1H, dd, J=8.4, 2.6Hz), 7.99 (1H, d, J=2.6 Hz). IR (KBr) 1750 cm⁻¹ ; Anal. Calcd. for C₁₂H₁₁ O₃ BrS; Calcd. C, 45.73; H, 3.52. Found. C, 46.01; H. 3.48.

REFERENCE EXAMPLE 213

A solution of methyl7-bromo-5-oxo-2,3,4,5-tetrahydro-1-benzothiepine-4-carboxylate (24.94 g)in THF (200 ml) was cooled to -20° C., and to the mixture was addeddropwise a solution of sodium boro hydride (2.99 g) in methanol (30 ml).While the temperature of the mixture was kept at -15 to 20° C., themixture was stirred for 1 hour. To the mixture was added water, and themixture was extracted with ethyl acetate. The organic layer was washedwith saturated brine and dried with magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue (24.38 g) wasdissolved in THF (200 ml). To the mixture was added triethylamine (26ml) and then to the mixture was added dropwise at 0° C. methanesulfonylchloride (9.2 ml). The mixture was stirred at 0° C. for 30 minutes andthen at room temperature for 15 hours. To the mixture was added dropwise1,8-diaza-bicyclo[5,4,0]-7-undecene (17.9 g), and the mixture wasstirred for 3 hours. To the mixture was added water, and the mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the residue was purifiedwith column chromatography (ethyl acetate/hexane=:10). Under reducedpressure, the mixture was concentrated, and the resulting crystals wererecrystallized from ethyl acetate/hexane to give pale yellow crystals ofmethyl 7-bromo-2,3-dihydro-1-benzothiepine-4-carboxylate (11.00 g).

m.p. 94-95° C.; ¹ H-NMR (200 MHz, CDCl₃) 62.94-3.00 (2H, m), 3.15-3.21(2H, m), 3.83 (3H, s), 7.28-7.33 (2H, m), 7.51 (1H, d, J=1.2 Hz), 7.70(1H, s). Anal. Calcd. for C₁₂ H₁₀ O₂ BrS; Calcd. C, 48.17; H, 3.71.Found. C, 48.37; H, 3.77.

REFERENCE EXAMPLE 214

Under argon atmosphere, a mixture of methyl7-bromo-2,3-dihydro-1-benzothiepine-4-carboxylate (1.5 g),4-methoxyphenyl borate (0.84 g) and potassium carbonate (1.39 g) intoluene/ethanol/water (50/5/5 ml) was stirred at room temperature for 1hour. To the mixture was added tetrakistriphenylphosphine palladium(0.17 g), and the mixture was refluxed for 24 hours and then cooled. Themixture was extracted with ethyl acetate, washed with saturated brineand dried with magnesium sulfate. Under reduced pressure, the mixturewas concentrated, and the residue was purified with columnchromatography (ethyl acetate/hexane=1:15 1:9 1:4 1:2) to give paleyellow crystals of methyl7-(4-methoxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylate (1.40 g).

m.p. 117-120° C. ¹ H-NMR (200 MHz, CDCl₃) δ 2.97-3.04(2H, m),3.19-3.25(2H, m), 3.84 (3H, s), 3.86 (3H, s), 6.98 (2H, d, J=8.8 Hz),7.39 (1H, dd, J=8.0, 2.2 Hz), 7.48-7.54 (3H, m), 7.57 (1H, d, J=2.2 Hz),7.88 (1H, br s). IR (KBr) 1716, 1630, 1606, 1520, 1479, 1431, 1281,1250, 1221, 1186, 1020, 835, 814 cm⁻¹ ; Anal. Calcd. for C₁₉ H₁ O₃ S;Calcd. C, 69.91; H, 5.56. Found. C, 70.22; H, 5.65.

REFERENCE EXAMPLE 215

To a solution of methyl7-(4-methoxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylate (0.50 g)in ethanol/THF (10/10 ml) was added at room temperature 1N sodiumhydroxide solution (2 ml), and the mixture was stirred for 18 hours. Tothe mixture was added 1N hydrochloric acid (2 ml). Under reducedpressure, the mixture was concentrated. To the mixture was added water,and the precipitates were collected by filtration, which were washedwith 2-propanol, diethylether and hexane to give pale yellow solid of7-(4-methoxyphenyl)-2,3-dihydro-1-benzo-thiepine-4-carboxylic acid (508mg). This compound was used for the following reaction, withoutsubjecting further purification.

¹ H-NMR (200 MHz, DMSO-d₆) δ 2.87 (2H, t, J=5.7 Hz), 3.11 (2H, t, J=5.7Hz), 3.80 (3H, s), 7.01 (2H, d, J=8.8 Hz), 7.33-7.42 (2H, m), 7.50-7.55(2H, m), 7.62 (2H, d, J=8.8 Hz). IR (KBr) 3356, 1633, 1608, 1518, 1358,1246, 1178, 1020, 825 cm⁻¹ ;

REFERENCE EXAMPLE 216

Under argon atmosphere, a mixture of methyl7-bromo-2,3-dihydro-1-benzothiepine-4-carboxylate (0.70 g),4-morpholinophenyl borate (581.3 mg) and potassium carbonate (0.65 g) intoluene/ethanol/water (20/2/2 ml) was stirred at room temperature for 1hour. To the mixture was added tetrakistriphenylphosphine palladium(0.14 g), and the mixture was refluxed for 20 hours and then cooled. Themixture was extracted with ethyl acetate, washed with saturated brineand dried with magnesium sulfate. Under reduced pressure, the mixturewas concentrated, and the residue was purified with columnchromatography (ethyl acetate/dichloromethane=1:4) to give yellowcrystals of methyl7-(4-morpholinophenyl)-2,3-dihydro-1-benzo-thiepine-4-carboxylate (664.4mg).

m.p. 154-156° C.; ¹ H-NMR(200 MHz, CDCl₃) δ 2.97-3.02 (2H, m), 3.20-3.25(6H, m), 3.84 (3H, s), 3.87-3.91 (4H, m), 6.98 (2H, d, J=8.8 Hz),7.35-7.43 (1H, m), 7.49-7.58 (4H, m), 7.88 (1H, s). IR (KBr) 1709, 1606,1520, 1448, 1274, 1242, 1232, 120, 926, 816 cm⁻¹ ; Anal. Calcd. for C₂₂H₂₃ NO₃ S; Calcd. C, 69.26; H, 6.08; N, 3.67. Found. C, 69.43; H, 6.01;N, 3.81.

REFERENCE EXAMPLE 217

To a solution of methyl7-(4-morpholinophenyl)-2,3-dihydro-1-benzothiepine-4-carboxylate (0.55g) in ethanol/THF (30/30 ml) was added at room temperature 1N sodiumhydroxide solution (1.8 ml), and the mixture was stirred for 6 days andthen refluxed for 2 hours. To the mixture was added 1N hydrochloric acid(1.8 ml). The resulting solid was collected by filtration, which waswashed with ethanol and diethylether to give yellow powder of7-(4-morpholinophenyl)-2,3-dihydro-1-benzo-thiepine-4-carboxylic acid(502.2 mg).

m.p. 280° C. (dec.); ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.88 (2H, t, J=5.3Hz), 3.05-3.25 (6H, m), 3.67-3.82 (4H, m), 7.02 (2H, d, J=8.7 Hz),7.43-7.54 (2H, m), 7.61 (2H, d, J=8.7 Hz), 7.75 (1H, s), 7.81 (1H, s).IR (KBr) 2967, 1709, 1684, 1608, 1520, 1232, 1120, 926, 814 cm⁻¹ ; Anal.Calcd. for C₂₁ H₂₁ NO₃ S; Calcd. C, 68.64; H, 5.76; N, 3.81. Found. C,68.68; H, 5.62; N, 3.69.

REFERENCE EXAMPLE 218

Under argon atmosphere, a mixture of methyl7-bromo-2,3-dihydro-1-benzothiepine-4-carboxylate (1.5 g),3,4-methylenedioxyphenyl borate (0.92 g) and potassium carbonate (1.39g) in toluene/ethanol/water (50/5/5 ml) was stirred at room temperaturelhours. To the mixture was added tetrakistriphenylphosphine palladium(0.29 g), and the mixture was refluxed for 16 hours and cooled. Themixture was extracted with ethyl acetate, washed with saturated brineand dried with magnesium sulfate. Under reduced pressure, the mixturewas concentrated, and the residue was purified with columnchromatography (ethyl acetate/hexane=1:2) to give pale yellow crystalsof methyl7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzo-thiepine-4-carboxylate(1.55 g).

m.p. 126-129° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 2.97-3.06(2H, m),3.19-3.24(2H, m), 3.84 (3H, s), 6.01 (2H, s), 6.88 (1H, d, J=8.8 Hz),7.02-7.08 (2H, m), 7.35 (1H, dd, J=8.0, 1.8 Hz), 7.50 (1H, d, J=8.4 Hz),7.53 (1H, d, J=1.8 Hz), 7.87 (1H, br s). IR (KBr) 1709, 1471, 1435,1248, 1223, 1186, 1034, 928, 804 cm⁻¹ ; Anal. Calcd. for C₁₉ H₁₆ O₄ S;Calcd. C, 67.04; H, 4.74. Found. C, 67.19; H, 4.61.

REFERENCE EXAMPLE 219

To a solution of methyl7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylate(0.6 g) in ethanol/THF (10/10 ml) was added at room temperature 1Nsodium hydroxide solution (2 ml), and the mixture was stirred for 64hours. To the mixture was added iN hydrochloric acid (3 ml), and themixture was concentrated. The resulting solid was collected byfiltration, which was washed with water, 2-propanol and diisopropyletherto give pale yellow powder of7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzothiepine-4-carboxylicacid (510.6 mg).

m.p. 227-229° C.; ¹ H-NMR (200 MHz, DMSO-d₆) δ 2.86-2.92 (2H, m),3.14-3.20 (2H, m), 6.07 (2H, s), 6.99 (1H, d, J=8.2 Hz), 7.21 (1H, dd,J=8.2, 1.8 Hz), 7.33 (1H, d, J=1.8 Hz), 7.44-7.53 (2H, m), 7.77-7.82(2H, m). IR (KBr) 2895, 1672, 1473, 1288, 1252, 1225, 1039, 933, 806cm⁻¹ ; Anal. Calcd. for C₁₈ H₁₄ O₄ S; Calcd. C, 66.24; H, 4.32. Found.C, 66.01; H, 4.44.

REFERENCE EXAMPLE 220

To a suspension of 4-phenylpiperidine (5.0 g) in acetonitrile (100 ml)was added triethylamine (8.64 ml) and then was added dropwise at 0° C. asolution of p-toluene-sulfonyl chloride (6.50 g) in acetonitrile (30ml). The mixture was stirred at 0° C. for 2 hours. Under reducedpressure, the solvent was evaporated, and to the residue was water. Themixture was extracted with ethyl acetate, and the organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the resultingcrystals were collected by filtration, which were washed with hexane togive colorless crystals of 1-(4-methylphenylsulfonyl)-4-phenylpiperidine(8.93 g).

m.p. 153-154° C.; ¹ H-NMR(200 MHz, CDCl₃) δ 1.83-1.95(4H, m),2.26-2.43(3H, m), 2.45 (3H, s), 3.87-3.99 (2H, m), 7.13-7.30 (5H, m),7.35 (2H, d, J=8.0 Hz), 7.69 (2H, d, J=8.0 Hz). IR (KBr) 1336, 1165,1092, 933, 725, 700, 651, 577, 546 cm⁻¹ ; Anal. Calcd. for C₁₈ H₂₁ NO₂S; Calcd. C, 68.54; H, 6.71; N, 4.44. Found. C, 68.31; H, 6.64; N, 4.40.

REFERENCE EXAMPLE 221

To a solution of 1-(4-methylphenylsulfonyl)-4-phenylpiperidine (1.0 g)and 1,1-dichloromethylmethylether (0. 57 ml) in dichloromethane (5 ml)was added at 0° C. a solution of titanium tetrachloride (0.7 ml) indichloromethane (5 ml), and the mixture was stirred at room temperaturefor 2 hours. The mixture was added to stirred ice/water to stop thereaction. The mixture was extracted with ethyl acetate. The organiclayer was washed with sodium bicarbonate solution and saturated brineand dried with magnesium sulfate. Under reduced pressure, the mixturewas concentrated, and the residue was purified with columnchromatography (ethyl acetate/hexane=1:4→1:2) to give pale yellowcrystals of 4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]benzaldehyde(0.381 g). (469.4 mg of the starting materials were collected).

m.p. 134-137° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.75-1.96 (4H, m),2.29-2.58 (3H, m), 2.46 (3H, s), 3.90-4.03 (2H, m), 7.29-7.37 (4H, m),7.69 (2H, d, J=8.4 Hz), 7.82 (2H, d, J=8.4 Hz), 9.97 (1H, s). IR (KBr)1697, 1603, 1333, 1159, 937, 721, 581, 546 cm⁻¹ ; Anal. Calcd. for C₁₉H₂₁ NO₃ S; Calcd. C, 66.45; H, 6.16; N, 4.08. Found. C, 66.31; H, 6.08;N, 4.38.

REFERENCE EXAMPLE 222

To a suspension of (3-carboxypropyl)triphenylphosphonium bromide (16.5g) in THF (170 ml) was added at room temperature potassium t-butoxide(8.63 g), and the mixture was stirred at 60° C. for 10 minutes and thencooled to room temperature. To the mixture was added a solution of4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]benzaldehyde (4.40 g) in THF(20 ml), and the mixture was stirred at 60° C. for 1 hour. To themixture was added water (80 ml) and the mixture was extracted withtoluene (80 ml). To the aqueous layer was added 1N hydrochloric acid tomake the solution pH 3, and the mixture was extracted with ethylacetate. The organic layer was washed three times with 2% sodiumbicarbonate solution, and then with 1N hydrochloric acid and saturatedbrine (×3). Under reduced pressure, the mixture was concentrated, andthe residue was dissolved in THF (150 ml). To the mixture was added Pd-C(0.5 g), and the mixture was stirred under hydrogen atmosphere for 5hours. By filtration Pd-C was removed, and the filtrate was concentratedunder reduced pressure. The resulting crystals were collected byfiltration, which were washed with hexane to give colorless crystals of5-[4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]phenyl]pentanoic acid(4.63 g).

m.p. 164-170° C.; ¹ H-NMR(200 MHz, CDCl₃) δ 1.58-1.70(4H, m),1.79-1.91(4H, m), 2.25-2.42 (5H, m), 2.45 (3H, s), 2.54-2.65 (2H, m),3.84-3.97 (2H, m), 7.04 (2H, d, J=8.2 Hz), 7.10 (2H, d, J=8.2 Hz), 7.34(2H, d, J=8.3 Hz), 7.68 (2H, d, J=8.3 Hz). IR (KBr) 2937, 1703, 1335,1163, 926, 725, 546 cm⁻¹ ; Anal. Calcd. for C₂₃ H₂₉ NO₄ S; Calcd. C,66.48: H, 7.03; N, 3.37. Found. C, 66.66; H, 7.00; N, 3.50.

REFERENCE EXAMPLE 223

To a solution of5-[4-[1-(4-methylphenylsulfonyl)-piperidin-4-yl]phenyl]pentanoic acid(0.50 g) in THF (10 ml) were added at room temperature oxalyl chloride(0.21 ml) and a drop of DMF, and the mixture was stirred for 1 hour.Under reduced pressure, the mixture was concentrated, and the residuewas dissolved in dichloromethane (10 ml). To the mixture was added at 0°C. aluminum chloride (0.35 g), and the mixture was stirred at 0° C. for30 minutes and then at room temperature for 5 minutes. The mixture wasadded to ice/water, and the mixture was extracted with ethyl acetate.The organic layer was washed with 1N hydrochloric acid, saturated sodiumbicarbonate solution and saturated brine, and dried with magnesiumsulfate. Under reduced pressure, the mixture was concentrated, and theresidue was purified with column chromatography (ethylacetate/hexane=1:2) to give colorless crystals of3-[1-(4-methylphenylsulfonyl)-piperidin-4-yl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one(0.32 g).

m.p. 165-169° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.74-1.93 (8H, m),2.24-2.43 (3H, m), 2.46 (3H, s), 2.68-2.76 (2H, m), 2.85-2.95 (2H, m),3.85-4.00 (2H, m), 7.14 (1H, d, J=8.0 Hz), 7.22 (1H, dd, J=8.0, 1.8 Hz),7.35 (2H, d, J=8.2 Hz), 7.50 (1H, d, J=1.8 Hz), 7.68 (2H, d, J=8.2 Hz).IR (KBr) 1674, 1333, 1242, 1161, 1093, 933, 721, 546 cm⁻¹ ; Anal. Calcd.for C₂₃ H₂₇ NO₃ S; Calcd. C, 69.49; H, 6.85; N, 3.52. Found. C, 69.10;H, 6.62; N, 3.71.

REFERENCE EXAMPLE 224

To a solution of3-[1-(4-methylphenylsulfonyl)-piperidin-4-yl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one(3.25 g) in dimethyl carbonate (50 ml) was added at room temperaturesodium methoxide (2.21 g), and the mixture was refluxed for 4.5 hoursand cooled to room temperature. To the mixture was added 1N hydrochloricacid (100 ml), and the mixture was extracted with ethyl acetate. Theorganic layer was washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the mixture was concentrated to givecrude product (3.91 g). The resulting crude product was dissolved in THF(150 ml), and to the mixture was added at -40° C. a solution of sodiumboro hydride (0.31 g) in methanol (10 ml). The mixture was stirred at-10 to -20° C. for 1 hour. To the mixture was added a solution of sodiumboro hydride (0.31 g) in methanol (10 ml), and the mixture was stirredfor 1.5 hours. To the mixture was added acetone (2 ml), and the mixturewas stirred for 30 minutes. To the mixture was added water, and themixture was extracted with ethyl acetate. The organic layer was washedwith saturated brine and dried with magnesium sulfate. Under reducedpressure, the mixture was concentrated, and the residue was dissolved inTHF (40 ml). To the mixture was added triethylamine (3.42 ml). To themixture was added at 0° C. methanesulfonyl chloride (0.95 ml), and themixture was stirred at 0° C. for 30 minutes and then at room temperaturefor 30 minutes. To the mixture was added1,8-diazabicyclo[5,4,0]-7-undecene (3.7 ml), and the mixture was stirredfor 14 hours. To the mixture was added, and the mixture was extractedwith ethyl acetate. The organic layer was washed with saturated brineand dried with magnesium sulfate. Under reduced pressure, the mixturewas concentrated, and the residue was purified with columnchromatography (ethyl acetate/hexane=1:2) to give colorless crystals ofmethyl4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]-6,7-dihydro-5H-benzocyclo-heptene-8-carboxylate(2.01 g).

m.p. 169-173° C.; ¹ H-NMR(200 MHz, CDCl₃) δ 1.75-1.92(2H, m),1.95-2.09(2H, m), 2.26-2.43 (3H, m), 2.45 (3H, s), 2.62 (2H, t, J=6.2Hz), 2.75-2.80 (2H, m), 3.81 (3H, s), 3.87-3.98 (2H, m), 6.98-7.10 (3H,m), 7.35 (2H, d, J=8.6 Hz), 7.65 (1H, s), 7.68 (2H, d, J=8.6 Hz). IR(KBr) 1709, 1433, 1336, 1234, 1198, 1161, 1092, 933, 721, 548 cm⁻¹ ;Anal. Calcd. for C₂₅ H₂₉ NO₄ S; Calcd. C, 68.31; H, 6.65; N, 3.19.Found. C, 68.23; H, 6.60; N, 3.04.

REFERENCE EXAMPLE 225

To a solution of methyl4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]-6,7-dihydro-5H-benzocyclo-heptene-8-carboxylate(1.0 g) in ethanol/THF (20/40 ml) was added at room temperature INsodium hydroxide solution (2.7 ml), and the mixture was stirred for 13hours. Under reduced pressure, the mixture was concentrated. To themixture was added water, and the mixture was washed with ethyl acetate.To the aqueous layer was added 1N hydrochloric acid (5 ml), and themixture was extracted with ethyl acetate/THF. The organic layer waswashed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the mixture was concentrated, and the resultingcolorless crystals were collected by filtration, which were washed withhexane to give colorless crystals of4-[1-(4-methylphenylsulfonyl)piperidin-4-yl]-6,7-dihydro-5H-benzocycloheptene-8-carboxylicacid (565.4 mg).

m.p. 255-257° C.; ¹ H-NMR (200 MHz, CDCl₃) δ 1.74-1.94 (4H, m),1.96-2.11 (2H, m), 2.28-2.48 (3H, m), 2.46 (3H, s), 2.65 (2H, t, J=6.6Hz), 2.78-2.84 (2H, m), 3.87-4.01 (2H, m), 7.00-7.12 (3H, m), 7.35 (2H,d, J=8.2 Hz), 7.72 (2H, d, J=8.2 Hz), 7.77 (1H, s). IR (KBr) 3008, 1674,1352, 1294, 1273, 1255, 1163, 931, 721, 548 cm⁻¹ ; Anal. Calcd. for C₂₄H₂₇ NO₄ S; Calcd. C, 67.74; H, 6.40; N, 3.29. Found. C, 67.97; H, 6.69;N, 311.

REFERENCE EXAMPLE 226

In THF (126 ml) was dissolved 5-bromo-2-methylthiophene (10.5 g), and tothe mixture was added dropwise at -78° C. 1.6N n-butyl lithium/hexane(40.8 ml). The mixture was stirred for 1 hour, and to the mixture wasadded dropwise a solution of trimethyl borate (18.5 g) in THF (40 ml).The mixture was stirred for 15 minutes and warmed to room temperature.To the mixture was added 10% sulfuric acid (63 ml), and the mixture wasstirred for 15 minutes. The mixture was extracted with ethyl acetate,washed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the solvent was removed, and the resulting residue waswashed with isopropylether to give 5-methyl-2-thienyl borate (4.6 g).

¹ H-NMR (200 MHz, CDCl₃) δ 2.59 (3H, s),6.93 (1H, d, J=3.4 Hz), 7.79(1H, d, J=3.4 Hz).

REFERENCE EXAMPLE 227

In toluene/ethanol/water (10/1/1) (24 ml) was dissolved methyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (560 mg), and to themixture were added 5-methyl-2-thienyl borate (875 mg) and potassiumcarbonate (1.56 g). The mixture was stirred at room temperature for 30minutes. To the mixture was added tetrakistriphenylphosphine palladium(260 mg), and the mixture was stirred at 100° C. for 24 hours and cooledto room temperature. The mixture was extracted with ethyl acetate,washed with saturated brine and dried with magnesium sulfate. Underreduced pressure, the solvent was removed, and the resulting residue waspurified with silica gel column chromatography (hexane/acetone=12/1) togive methyl7-(5-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (345 mg).

¹ H-NMR (200 MHz, CDCl₃) δ 2.28 (3H, s), 2.99 (2H, t, J=4.8 Hz), 3.83(3H, s), 4.28 (2H, t, J=4.8 Hz), 6.82 (1H, d, J=1.2 Hz), 7.05 (1H, d,J=8.4 Hz), 7.45 (1H, dd, J=8.4, 2.4), 7.54 (1H, d, J=2.4 Hz), 7.61 (1H,s).

REFERENCE EXAMPLE 228

In THF (10.5 ml) and methanol (5.2 ml) was dissolved methyl7-(5-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4- carboxylate (525mg), and to the mixture was added 1N sodium hydroxide (10.5 ml). Themixture was stirred at room temperature for 2 hours. Under reducedpressure, the organic solvent was removed, and to the residue was addedethyl acetate. The mixture was extracted with water, and to the aqueouslayer was added 6N hydrochloric acid to make the solution pH 4-5, whichwas extracted with ethyl acetate, washed with saturated brine and driedwith magnesium sulfate. Under reduced pressure, the solvent was removedto give 7-(5-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (410 mg).

¹ H-NMR (200 MHz, DMSO-d₆) δ 2.23 (3H, s), 2.87 (2H, t, J=4.4 Hz), 4.24(2H, t, J=4.4 Hz), 6.99 (1H, d, J=8.4 Hz), 7.07 (1H, s), 7.31 (1H, d,J=1.4 Hz), 7.49 (1H, dd, J=8.4, 2.2 Hz), 7.58 (1H, s), 7.74 (1H, d,J=2.2 Hz).

REFERENCE EXAMPLE 229

In toluene/ethanol/water (10/1/1) (12 ml) was dissolved methyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (700 mg), and to themixture were added 3-thienyl borate (422 mg) and potassium carbonate(0.98 g). The mixture was stirred at room temperature for 30 minutes,and to the mixture was added tetrakistriphenylphosphine palladium (136mg). The mixture was stirred at 100° C. for 13 hours and cooled to roomtemperature, and the mixture was extracted with ethyl acetate, washedwith saturated brine and dried with magnesium sulfate. Under reducedpressure, the solvent was removed, and the resulting residue waspurified with silica gel column chromatography (hexane/acetone=3/1) togive methyl 7-(3-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (610mg).

¹ H-NMR (200 MHz, CDCl₃) δ 3.00 (2H, t, J=4.2 Hz), 3.83 (3H, s), 4.30(2H, t, J=4.2 Hz), 7.01 (1H, d, J=8.4 Hz), 7.33-7.40 (3H, m), 7.49 (1H,dd, J=8.4. 2.4), 7.66 (1H, d , J=2.4 Hz), 7.64 (1H, s).

REFERENCE EXAMPLE 230

In THF (24 ml) and methanol (6 ml) was dissolved methyl7-(3-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (610 mg), and tothe mixture was added 1N sodium hydroxide (12 ml). The mixture wasstirred at room temperature for 3 hours. Under reduced pressure, theorganic solvent was removed, and to the residue was added ethyl acetate.The mixture was extracted with water, and to the aqueous layer was added6N hydrochloric acid to make the solution pH 4-5, which was extractedwith ethyl acetate, washed with saturated brine and dried with magnesiumsulfate. Under reduced pressure, the solvent was removed to give7-(3-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (500 mg).

¹ H-NMR (200 MHz, DMSO-d₆) δ 2.87 (2H, t, J=4.6 Hz), 4.24 (2H, t, J=4.6Hz), 7.00 (1H, d, J=8.4 Hz), 7.60-7.85 (4H, m), 7.84-7.89 (2H, m).

REFERENCE EXAMPLE 231

In ether (160 ml) was dissolved 3-methylthiophene (20 g), and to themixture was added N,N,N,N-tetramethylethylenediamine (26 g). To themixture was added dropwise at room temperature 1.6N n-butyllithium/hexane (140 ml), and the mixture was refluxed for 30 minutes.The mixture was cooled to -70° C., and to the mixture was added dropwisea solution of trimethyl borate (63.5 g) in THF (64 ml). The mixture wasstirred for 30 minutes and warmed to room temperature. To the mixturewas added 10% sulfuric acid (285 ml), and the mixture was stirred for 15minutes. The mixture was washed with water and dried with magnesiumsulfate. Under reduced pressure, the solvent was removed, and theresulting residue was washed with isopropylether to give4-methyl-2-thienyl borate (6.0 g).

¹ H-NMR(200 MHz, CDCl₃) δ 2.36 (3H, s), 7.35 (1H), 7.78 (1H, s)

REFERENCE EXAMPLE 232

In toluene/ethanol/water (10/1/1) (8.4 ml) was dissolved methyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg), and to themixture were added 4-methyl-2-thienyl borate (334 mg) and potassiumcarbonate (651 g). The mixture was stirred at room temperature for 30minutes, and to the mixture was added tetrakistriphenylphosphinepalladium (97 mg). The mixture was stirred at 100° C. for 24 hours andcooled to room temperature. The mixture was extracted with ethylacetate, washed with saturated brine and dried with magnesium sulfate.Under reduced pressure, the solvent was removed, and the resultingresidue was purified with silica gel column chromatography(hexane/acetone=8/1) to give methyl7-(4-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (432 mg).

¹ H-NMR (200 MHz, CDCl₃) δ 2.28 (3H, s), 2.99 (2H, t, J=4.8 Hz), 3.83(3H, s), 4.28 (2H, t, J=4.8 Hz),6.82 (1H, d, J=1.2 Hz), 7.05 (1H,d,,J=8.4 Hz), 7.45 (1H, dd, J=8.4,2.4 Hz), 7.54 (1H, d, J=2.4 Hz), 7.61(1H, s).

REFERENCE EXAMPLE 233

In THF (10 ml) was dissolved methyl7-(4-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (420 mg),and to the mixture was added 1N sodium hydroxide (8.4 ml). The mixturewas stirred at room temperature for 15 hours. Under reduced pressure,the organic solvent was removed, and to the residue was added ethylacetate. The mixture was extracted with water, and to the aqueous layerwas added 6N hydrochloric acid to make the solution pH 4-5, which wasextracted with ethyl acetate, washed with saturated brine and dried withmagnesium sulfate. Under reduced pressure, the solvent was removed togive 7-(4-methyl-2-thienyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid(320 mg).

¹ H-NMR (200 MHz, DMSO-d₆) δ 2.23 (3H, s), 2.87 (2H, t, J=4.4 Hz), 4.24(2H, t, J=4.4 Hz), 6.99 (1H, d, J=8.4 Hz), 7.07 (1H, s), 7.31 (1H, d,J=1.4 Hz), 7.49 (1H, dd, J=8.4, 2.2 Hz), 7.58 (1H, s), 7.74 (1H, d,J=2.2 Hz).

REFERENCE EXAMPLE 234

To methyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (500 mg) wereadded 4-fluorophenyl borate (272 mg), potassium carbonate (537 mg),water (1.5 ml), ethanol (1.5 ml) and toluene (15 ml). Under argonatmosphere, the mixture was stirred at room temperature for 1 hour, andto the mixture was added tetrakistriphenylphosphine palladium (61 mg, 3mol %). Under argon atmosphere, the mixture was ref luxed for 21 hours,and to the mixture was added ethyl acetate (100 ml). The mixture waswashed with water (50 ml) and saturated brine (50 ml), and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasremoved, and the residue was purified with silica gel columnchromatography to give methyl7-(4-fluorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate (310 mg, 59%)as pale yellow crystals.

¹ H NMR (200 MHz, CDCl₃) δ 3.01 (2H, t, J=4.1 Hz), 3.83 (3H, s), 4.31(2H, t, J=4.8 Hz), 7.03-7.17 (3H, m), 7.40-7.54 (4H, m), 7.66 (1H, s).

REFERENCE EXAMPLE 235

To methyl 7-(4-fluorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(0.27 g) were added THF (5.0 ml), ethanol (10.0 ml) and 2N sodiumhydroxide solution (1.0 ml), and the mixture was stirred at roomtemperature for 19 hours. Under reduced pressure, the solvent wasremoved, and the residue was diluted with water (100 ml). The aqueouslayer was made acidic with hydrochloric acid, and the mixture wasextracted with ethyl acetate (100 ml). The organic layer was dried withanhydrous magnesium sulfate, and the solvent was removed under reducedpressure. The residue was crystallized and washed with hexane to give7-(4-fluorophenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.22 g,86%) as white crystals.

¹ H NMR (200 MHz, CDCl₃) δ 3.03 (2H, t, J=4.8 Hz), 4.33 (2H, t, J=4.6Hz), 7.05-7.17 (3H, m), 7.43-7.55 (4H, m), 7.76 (1H, s).

REFERENCE EXAMPLE 236

To 4-bromophenoxybutyric acid (75.0 g) was added polyphosphoric acid(873 g), and the mixture was stirred at 100° C. for 45 minutes. Themixture was poured into ice (about 1.5 kg), and the mixture wasextracted with ethyl acetate (1.5 L and 0.5 L). The organic layer waswashed with water (400 ml×3 ), 1N sodium hydroxide solution (400 ml×2),saturated sodium hydrogen carbonate solution (400 ml×2), water (400ml×3) and saturated brine (400 ml×3), and dried with anhydrous magnesiumsulfate. The solvent was removed under reduced pressure to give7-bromo-2,3,4,5-tetrahydro-1-benzoxepin-5-one (38.6 g, 55%, 132.5°C./0.33 mmHg) as pale yellow oil.

REFERENCE EXAMPLE 237

To a solution of 5-bromo-2-fluorobenzaldehyde (0.49 g, 2.62 mmol) andethyl 3-mercaptopropionate (0.37 ml, 2.88 mmol) in N,N-dimethylformamide(10 ml) was added potassium carbonate (0.90 g, 6.55 mmol), and themixture was stirred at room temperature for 1 hour and then at 70° C.for 15 hours. The mixture was poured into ice-water, and made pH 4 with1N hydrochloric acid. The aqueous layer was extracted with ethylacetate, and the organic layer was washed with water and saturatedbrine, and dried with magnesium sulfate. The solvent was evaporated, andthe residue was purified with silica gel column chromatography[hexane:ethyl acetate (5:1)] to give ethyl6-bromo-2H-thiochromene-3-carboxylate (0.45 g, 58%) as yellow powder, apart of which was recrystallized from ethanol to give pale yellowneedles.

m.p. 87° C.; ¹ H-NMR (CDCl₃) δ: 7.47 (1H, br s), 7.26-7.38 (2H, m), 7.14(1H, d, J=8.0), 4.31 (2H, q, J=7.4), 3.73 (2H, d, J=1.2), 1.36 (3H, d,J=7.4). Anal. Calcd for C₁₂ H₁₁ BrO₂ S: C; 48.17, H; 3.71. Found: C;48.07, H; 3.77.

REFERENCE EXAMPLE 238

A solution of ethyl 6-bromo-2H-thiochromene-3-carboxylate (1.00 g, 3.34mmol), 4-methylphenyl borate (0.55 g, 4.01 mmol) andtetrakistriphenylphosphine palladium (0.19 g, 0.167 mmol) in 2M sodiumcarbonate (3.5 ml), ethanol (3 ml) and toluene (25 ml) was stirred at80° C. for 24 hours. To the mixture was added water, and the mixture wasextracted with ethyl acetate. The organic layer was washed with 0.5Nhydrochloric acid and saturated brine, and dried with magnesium sulfate.The solvent was evaporated, and the residue was purified with silica gelcolumn chromatography [hexane:ethyl acetate (5:1)] to give ethyl6-(4-methylphenyl)-2H-thiochromene-3-carboxylate (1.02 g, 99%) as yellowpowder.

m.p. 87° C.; ¹ H-NMR (CDCl₃) δ: 7.62 (1H, br s), 7.40-7.46 (4H, m),7.22-7.31 (3H, m), 4.31 (2H, q, J=7.0), 3.77 (2H, d, J=1.0), 2.40 (3H,s), 1.37 (3H, t, J=7.0). Anal. Calcd for C₁₉ H₁₈ O₂ S: C; 73.52, H;5.84. Found: C; 73.51, H; 5.65.

REFERENCE EXAMPLE 239

To a solution of ethyl 6-(4-methylphenyl)-2H-thiochromene-3-carboxylate(2.12 g, 6.84 mmol) in tetrahydrofuran (20 ml) and acetonitrile (20 ml)was added dropwise 1N sodium hydroxide (7 ml), and the mixture wasstirred at 60° C. for 2.5 hours. The solvent was evaporated, and theresidue was dissolved in diethylether. The mixture was extracted withwater. The organic layer was extracted with 0.5N sodium hydroxide, andboth of the aqueous layers were made pH 3 with 6N hydrochloric acid. Themixture was extracted with ethyl acetate, and the organic layer waswashed with saturated brine and dried with magnesium sulfate. Thesolvent was evaporated to give6-(4-methyl-phenyl)-2H-thiochromene-3-carboxylic acid (1.83 g, 95%) asyellow powder.

m.p. 244° C.; ¹ H-NMR (DMSO-d₆) δ: 7.44 (1H, d, J=1.8), 7.21-7.32 (4H,m), 7.05 (1H, d, J=8.4), 6.95 (2H, d, J=8.2), 3.41 (2H, d, J=1.0), 2.02(3H, s). Anal. Calcd for C₁₇ H₁₄ O₂ S.0.25H₂ O: C; 71.18, H; 5.09.Found: C; 70.90, H; 4.80.

REFERENCE EXAMPLE 240

To asolution of 4-nitrobenzaldehyde (6.0 g, 37.7 mmol) and ethylβ-aminopropionate hydrochloride (6.1 g, 37.7 mmol) in 1,2-dichloroethane(120 ml) was added triethylamine (5.3 ml, 37.7 mmol) and at 0° C. wasadded little by little triacetoxy boro hydride (11.8 g, 52.8 mmol). Themixture was stirred at room temperature for 1 hour, and to the mixturewas added 37% formalin (4.0 ml, 49.0 mmol) and then at 0° C. triacetoxyboro hydride (11.8 g, 52.8 mmol). The mixture was stirred at roomtemperature for 14 hours, and the mixture was neutralized with saturatedsodium hydrogen carbonate and extracted with dichloromethane. Theextract was washed with saturated brine and dried with magnesiumsulfate. The solvent was evaporated to give crude product, which waspurified with silica gel column chromatography [hexane:ethyl acetate(3:2)] to give ethyl 3-(N-methyl-N-(4-nitrobenzyl))aminopropionate (9.34g, 93%) as pale yellow oil.

¹ H-NMR (CDCl₃) δ: 8.17 (2H, dd, J=8.8, 1.8), 7.49 (2H, d, J=8.8), 4.15(2H, q, J=7.4), 3.61 (2H, s), 2.76 (2H, t, J=7.2), 2.52 (2H, t, J=7.2),2.22 (3H, s), 1.26 (3H, t, J=7.4). Anal. Calcd for C₁₃ H₁₈ N₂ O₄ : C;58.63, H; 6.81, N; 10.52. Found: C; 58.24, H; 6.78, N; 10.23.

REFERENCE EXAMPLE 241

To a solution of 4-nitrobenzaldehyde (2.0 g, 13.2 mmol) and2-methoxyethylamine (1.15 ml, 13.2 mmol) in 1,2-dichloroethane (40 ml)was added triethylamine (1.9 ml), and at 0° C. was added little bylittle triacetoxy boro hydride (4.1 g). The mixture was stirred at roomtemperature for 1 hour was stirred, and to the mixture was added 37%formalin (1.4 ml) and then at 0° C. triacetoxy boro hydride (4.1 g). Themixture was stirred at room temperature for 14 hours, neutralized withsaturated sodium hydrogen carbonate solution and extracted withdichloromethane. The extract was washed with saturated brine and driedwith magnesium sulfate. The solvent was evaporated to give crude productwhich was purified with silica gel column chromatography [hexane:ethylacetate (1:2)] to give4-((N-(2-methoxyethyl)-N-methyl)aminomethyl)nitrobenzene (2.75 g, 93%)as pale yellow oil.

¹ H-NMR (CDCl₃) δ: 8.18 (2H, d, J=8.8), 7.53 (2H, d, J=8.8), 3.66 (2H,s), 3.53 (2H, t, J=5.6), 3.35 (3H, s), 2.63 (2H, t, J=5.6), 2.28 (3H,s). Anal. Calcd for C₁₄ H₂₀ N₂ O₃ : C; 63.62, H; 7.63, N; 10.60. Found:C; 63.54, H; 7.59, N; 10.51.

REFERENCE EXAMPLE 242

To a solution of 4-nitrobenzaldehyde (1.76 g, 11.7 mmol) and4-aminocyclohexanol (1.34 g, 13.2 mmol) in 1,2-dichloroethane (30 ml)was added triethylamine (1.6 ml) and at 0° C. was added little by littletriacetoxy boro hydride (3.7 g). The mixture was stirred at roomtemperature for 1 hour, and to the mixture was added 37% formalin (1.2ml) and then at 0° C. triacetoxy boro hydride (3.7 g). The mixture wasstirred at room temperature for 14 hours, neutralized with saturatedsodium hydrogen carbonate and extracted with dichloromethane. Theextract was washed with saturated brine and dried with magnesiumsulfate. The solvent was evaporated to give crude product, which waspurified with silica gel column chromatography [ethyl acetate:ethanol(2:1)] to give(E)-4-((N-(4-hydroxy-cyclohexyl)-N-methyl)aminomethyl)nitrobenzene (2.08g, 67%) as pale yellow crystals, a part of which was recrystallized fromether/hexane to give pale yellow needles.

m.p. 87° C.; ¹ H-NMR (CDCl₃) δ: 8.17 (2H, d, J=8.6), 7.51 (2H, d,J=8.6), 3.51-3.65 (1H, m), 2.39-2.56 (1H, m), 2.18 (3H, s), 1.83-2.12(4H, m), 1.20-1.51 (4H, m). Anal. Calcd for C₁₄ H₂₀ N₂ O₃ : C; 63.62, H;7.63, N; 10.68. Found: C; 63.54, H; 7.59, N; 10.51.

REFERENCE EXAMPLE 243

To a solution of(E)-4-((N-(4-hydroxycyclohexyl)-N-methyl)aminomethyl)nitrobenzene (1.07g, 4.05 mmol) in ethyl acetate (30 ml) was added 5%-Pd/C (0.43 g), andthe mixture was stirred under hydrogen atmosphere for 3.5 hours. Themixture was filtered with sellaite, and the filtrate was concentrated.The resulting residue was purified with silica gel column chromatography[ethyl acetate:methanol:triethylamine (9:1:0.02) to give(E)-4-((N-(4-hydroxy-cyclohexyl)-N-methyl)aminomethyl)aniline (0.27 g,28%) as yellow powder.

m.p. 105° C.; ¹ H-NMR (CDCl₃) δ: 7.09 (2H, d, J=8.6), 6.65 (2H, d,J=8.6), 3.46-3.70 (1H, m), 3.45 (2H, s), 2.35-2.53 (1H, m), 2.16 (3H,s), 1.84-2.10 (4H, m), 1.19-1.51 (4H, m).

REFERENCE EXAMPLE 244

To a solution of ethyl 3-(N-methyl-N-(4-nitrobenzyl))aminopropionate(1.51 g, 5.68 mmol) in acetic acid (30 ml) was added iron (1.27 g, 22.7mmol), and the mixture was stirred for 14 hours. The solvent wasevaporated, and the precipitates were filtered with sellaite and washedwith ethyl acetate. The filtrate was diluted with water, made basic withpotassium carbonate and extracted with ethyl acetate. The extracted waswashed with saturated brine and dried with magnesium sulfate. Thesolvent was evaporated, and the residue was purified with silica gelcolumn chromatography [ethyl acetate:ethanol (2:1)] to give ethyl3-(N-methyl-N-(4-aminobenzyl))aminopropianate (0.70 g, 52%) as brownoil.

¹ H-NMR (CDCl₃) δ: 7.07 (2H, d, J=8.6), 6.64 (2H, d, J=8.6), 4.13 (2H,q, J=6.8), 3.41 (2H, s), 3.30-3.60 (2H, m), 2.73 (2H, t, J=7.4), 2.51(2H, t, J=7.4), 2.19 (3H, s), 1.25 (3H, t, J=6.8).

REFERENCE EXAMPLE 245

To a solution of4-((N-(2-methoxyethyl)-N-methyl)aminomethyl)nitrobenzene (1.1 g, 4.91mmol) in acetic acid (20 ml) was added iron (1.1 g, 19.6 mmol), and themixture was stirred for 15 hours. The solvent was evaporated, and theprecipitates were filtered with sellaite and washed with ethyl acetate.The filtrate was diluted with water, made basic with potassium carbonateand extracted with ethyl acetate. The extract was washed with saturatedbrine and dried with magnesium sulfate. The solvent was evaporated, andthe residue was purified with silica gel column chromatography [ethylacetate:methanol:triethylamine (7:1:0.02)] to give4-((N-(2-methoxyethyl)-N-methyl)aminomethyl)aniline (880 mg, 92%) asbrown oil.

¹ H-NMR (CDCl₃) δ: 7.09 (2H, d, J=8.4), 6.64 (2H, d, J=8.4), 3.50 (2H,t, J=5.8), 3.45 (2H, s), 3.33 (3H, s), 2.57 (2H, t, J=5.8), 2.24 (3H,s).

REFERENCE EXAMPLE 246

To a solution of 4-nitrobenzaldehyde (6.04 g, 40.0 mmol),N-methylethanolamine (3.00 g, 40.0 mmol) and triethylamine (5.6 ml, 40.0mmol) in tetrahydrofuran (200 ml) was added triacetoxy boro hydride(26.8 g, 120 mmmol), and the mixture was stirred for 21 hours. Themixture was diluted with ethyl acetate, and washed with saturated sodiumhydrogen carbonate and saturated brine. The extract was dried, and thesolvent was evaporated to give crude product, which was purified withsilica gel column chromatography [ethyl acetate:ethanol (4:1)] to give4-((N-(2-hydroxyethyl)-N-methyl)nitrobenezene (7.08 g, 84%) as yellowoil.

¹ H-NMR (CDCl₃) δ: 8.20 (2H, d, J=8.8), 7.50 (2H, d, J=8.8), 3.68 (2H,s), 3.68 (2H, t, J=5.6), 2.64 (2H, t, J=5.6), 2.52-2.70 (1H, m), 2.26(3H, s).

REFERENCE EXAMPLE 247

To a solution of4-((N-(2-hydroxyethyl)-N-methyl)aminomethyl)nitrobenzene (2.95 g, 14.1mmol) in acetic acid (60 ml) was added iron (3.14 g, 56.2 mmol), and themixture was stirred for 23 hours. The solvent was evaporated, and theprecipitates were filtered with sellaite and washed with ethyl acetate.The filtrate was diluted with water, made pH 10 with potassium carbonateand extracted with ethyl acetate. The extract was washed with saturatedbrine and dried with magnesium sulfate. The solvent was evaporated, andthe residue was purified with silica gel column chromatography [ethylacetate:methanol:triethylamine (5:1:0.3)] to give4-((N-(2-hydroxyethyl)-N-methyl)aminomethyl)aniline (1.25 g, 49%) asbrown oil.

¹ H-NMR (CDCl₃) δ: 7.07 (2H, d, J=8.4), 6.65 (2H, d, J=8.4), 3.61 (2H,t, J=5.2), 3.46 (2H, s), 2.57 (2H, t, J=5.2), 2.20 (3H, s).

REFERENCE EXAMPLE 248

To THF(60 ml) was added at -70° C. n-butyllithium (1.59M hexanesolution, 63 ml, 100 mmol). To the mixture was added dropwise (takingabout 1 hour) a solution of 2,6-dibromopyridine (23.69 g, 100 mmol) inTHF (140 ml) at -60° C., and the mixture was stirred at -70° C. for 15minutes. To the mixture was added DMF (12 ml), and the mixture wasstirred at the same temperature for 15 minutes. To the mixture was added20% ammonium chloride solution (100 ml), and the organic layer wasseparated. The aqueous layer extracted with ethyl acetate (100 ml), andthe organic layer was mixed with the previous organic layer. The organiclayer was dried with anhydrous sodium sulfate and concentrated underreduced pressure. The residue was purified with column chromatography(silica gel 150 g, ethyl acetate/hexane=1/20), and the desired fractionwas concentrated under reduced pressure. To the residue was addeddiisopropylether (15 ml), and insoluble materials were filtered, whichwere washed with diisopropylether (5 ml×3) and dried under reducedpressure to give 6-bromo-2-pyridinecarbaldehyde (2.05 g, 11.0 mmol,11%).

IR (KBr): 1732 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 7.65-8.00 (3H, m), 10.01 (1H,s).

REFERENCE EXAMPLE 249

In THF (10 ml) was suspended sodiumhydride (60%, 440 mg, 11.0 mmol), andto the mixture was added at -30° C. a solution of diethylphosphonoethylacetate (2.47 g, 11.0 mmol) in THF (10 ml). The mixture was stirred atthe same temperature for 30 minutes, and to the mixture was added at-30° C. a solution of 6-bromo-2-pyridinecarbaldehyde (1.86 g, 10.0 mmol)in THF (10 ml). While warming the temperature of the mixture from -30°C. to -10° C., the mixture was stirred for 1.5 hours. To the mixture wasadded diethylether (40 ml), and the mixture was washed with water (20ml, 5 ml×2) and saturated brine (5 ml). The organic layer was dried withanhydrous magnesium sulfate and concentrated under reduced pressure. Tothe residue was added hexane (10 ml), and the mixture was cooled to 0°C. The precipitated insoluble materials were filtered, which were washedwith hexane cooled to 0° C., and dried under reduced pressure to giveethyl 6-bromo-2-pyridineacrylate (2.00 g, 7.81 mmol, 78%).

IR (KBr): 1717, 1703 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.34 (3H, t, J=7.1 Hz),4.28 (2H, q, J=7.1 Hz), 6.96 (1H, d, 15.8 Hz), 7.30-7.65 (4H, m).

REFERENCE EXAMPLE 250

In 1,2-dimethoxyethane (4 ml) were dissolved ethyl6-bromo-2-pyridineacrylate (512 mg, 2.00 mmol) and 4-methylphenyl borate(299 mg, 2.20 mmol), and to the mixture were added sodium carbonate (424mg, 4.00 mmol), water (2 ml) and tetrakis-(triphenylphosphine)palladium(116 mg, 0.10 mmol). The mixture was stirred at 80° C. for 10 hours. Tocomplete the reaction, 4-tolyl borate (150 mg, 1.10 mmol) andtetrakis(triphenyl-phosphine)palladium (116 mg, 0.10 mmol) were added at80° C. to the mixture, and the mixture was stirred for 14 hours. To themixture was added ethyl acetate (30 ml), and the mixture was water (5ml×2) and saturated brine (5 ml). The organic layer was dried withanhydrous magnesium sulfate and concentrated under reduced pressure. Theresidue was purified with column chromatography (silica gel 15 g, ethylacetate/hexane=1/19), and the desired fraction was concentrated underreduced pressure to give ethyl 6-(4-methylphenyl)-2-pyridineacrylate(495 mg, 1.85 mmol, 93%).

IR (KBr): 1713 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.36 (3H, t, J=7.1 Hz), 2.42(3H, s), 4.30 (2H, q, J=7.1 Hz), 7.10 (1H, d, 15.6 Hz), 7.25-7.35 (3H,m), 7.65-7.85 (3H, m), 7.99 (2H, d, J=8.2 Hz).

REFERENCE EXAMPLE 251

In methanol (5 ml) was suspended ethyl6-(4-methylphenyl)-2-pyridineacrylate (465 mg, 1.74 mmol), and to themixture was added at 0° C. 1N sodium hydroxide solution (5.22 ml). Themixture was stirred at room temperature for 20 hours. To the mixture wasadded at 0° C. 1N hydrochloric acid (5.22 ml), and methanol wasevaporated under reduced pressure. The aqueous layer extracted withethyl acetate (30 ml, 20 ml). The organic layer was dried with anhydroussodium sulfate and concentrated under reduced pressure. To the residuewas added diisopropylether(5 ml), and Insoluble materials were filtered,which were washed with diisopropylether and dried under reduced pressureto give 6-(4-methylphenyl)-2-pyridineacrylic acid (344 mg, 1.44 mmol,83%).

¹ H-NMR (CDCl₃) δ: 2.43 (3H, s), 7.15 (1H, d, 15.5 Hz), 7.25-7.40 (1H,m), 7.31 (2H, d, J=8.5 Hz), 7.70-7.85 (2H, m), 7.84 (1H, d, J=15.5 Hz),8.00 (2H, d, J=8.5 Hz).

REFERENCE EXAMPLE 252

In 1,2-dimethoxyethane(12 ml) were dissolved methyl7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate (566 mg, 2.00 mmol) and3,4-methylenedioxyphenyl borate (465 mg, 2.80 mmol). To the mixture wereadded sodium carbonate (424 mg, 4.00 mmol), water (2 ml) andtetrakis(triphenylphosphine)palladium (162 mg, 0.14 mmol), and themixture was stirred at 80° C. for 14 hours. To the mixture was addedethyl acetate (30 ml), and the mixture was extracted with water (5 ml×2)and saturated brine (5 ml). The organic layer was dried with anhydrousmagnesium sulfate and concentrated under reduced pressure. The residuewas purified with column chromatography (silica gel 15 g, ethylacetate/hexane=1/19), and the desired fraction was concentrated underreduced pressure. To the residue was added diisopropylether, and theinsoluble materials were filtered, which were washed withdiisopropylether and dried under reduced pressure to give methyl7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(434 mg, 1.34 mmol, 67%).

IR (KBr): 1705 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 2.95-3.10 (2H, m), 3.83 (3H, s),4.25-4.35 (2H, m), 6.01 (2H, s), 6.87 (1H, d, J=8.6 Hz), 6.95-7.10 (3H,m), 7.40 (1H, dd, J=8.4, 2.4 Hz), 7.47 (1H, d, J=2.2 Hz), 7.65 (1H, s).

REFERENCE EXAMPLE 253

In methanol (5 ml) was suspended7-(3,4-methylenedioxy-phenyl)-2,3-dihydro-1-benzoxepine-4-carboxylate(399 mg, 1.23 mmol), and to the mixture was added 1N sodium hydroxidesolution (3.69 ml). The mixture was stirred at room temperature for 20hours, and to the mixture was added 1N hydrochloric acid (3.69 ml). Themixture was concentrated under reduced pressure, and to the residue wasadded water. Insoluble materials were filtered, which were washed withwater and diethylether and dried under reduced pressure to give7-(3,4-methylenedioxyphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid(321 mg, 1.03 mmol, 84%).

¹ H-NMR (DMSO-d₆) δ: 2.80-2.95 (2H, m), 4.15-4.35 (2H, m), 6.05 (2H, s),6.97 (1H, d, J=8.1 Hz), 7.01 (1H, d, J=8.4 Hz), 7.16 (1H, dd, J=8.1, 1.7Hz), 7.29 (1H, d, J=1.7 Hz), 7.53 (1H, dd, J=8.4, 2.3 Hz), 7.63 (1H, s),7.74 (1H, d, J=2.3 Hz).

REFERENCE EXAMPLE 254

In THF (100 ml) was dissolved 1,2-methylenedioxy-4-bromobenzene (24.00g, 119 mmol), and to the mixture was added dropwise at -55° C. or lessn-butyllithium (1.6M hexane solution, 82 ml, 131 mmol). The mixture wasstirred at -70° C. for 30 minutes, and the resulting mixture was addeddropwise at -60° C. or less to a solution of trimethyl borate (18.61 g,179 mmol) in tetrahydrofuran (50 ml) with using cannula. The mixture wasstirred at -70° C. for 1 hour and then for 2 hours with warming to roomtemperature. To the mixture were added 1N hydrochloric acid (130 ml) anddiethylether (150 ml), and the organic layer was separated. The organiclayer was washed with water (50×2 ml) and saturated brine (50 ml), driedwith anhydrous magnesium sulfate and concentrated under reducedpressure. To the residue was added diisopropylether (40 ml), andinsoluble materials were filtered, which were washed withdiisopropylether (30 ml×4) and dried under reduced pressure to give3,4-methylenedioxyphenyl borate (6.79 g, 40.9 mmol, 34%).

¹ H-NMR (DMSO-d₆) δ: 5.99 (2H, s), 6.8-6.95 (1H, m), 7.25-7.45 (2H, m).

REFERENCE EXAMPLE 255

In methanol (250 ml) was suspended 5-nitrosalicylic acid (50.0 g, 273mmol), and to the mixture was added sulfuric acid (6 ml). The mixturewas stirred at 100° C. for 24 hours and the cooled to room temperature.The precipitated insoluble materials were filtered, which were washedwith hydrous methanol (containing 20% of water) and methanol, and driedunder reduced pressure to give methyl 5-nitrosalicylate (38.5 g, 195mmol, 72%).

¹ H-NMR (CDCl₃) δ: 4.04 (3H, s), 7.10 (1H, d, J=9.5 Hz), 8.35 (1H, dd,J=2.7, 9.5 Hz), 8.81 (1H, d, J=2.7 Hz), 11.45 (1H, s, OH).

REFERENCE EXAMPLE 256

In DMF (50 ml) was dissolved methyl 5-nitrosalicylate (1.97 g, 10.0mmol), and to the mixture were added ethyl 4-bromobutyrate (1.57 ml,11.0 mmol) and potassium carbonate (2.76 g, 20.0 mmol). The mixture wasstirred at 110° C. for 5 hours, and the mixture was concentrated underreduced pressure. To the residue was added ethyl acetate, and themixture was washed with water and 10% potassium carbonate solution. Theorganic layer was dried with anhydrous magnesium sulfate andconcentrated under reduced pressure. The residue was purified withcolumn chromatography (silica gel 30 g, ethyl acetate/hexane=1/5→1/3),and the desired fraction was concentrated under reduced pressure to giveethyl 4-(2-methoxycarbonyl-4-nitrophenoxy)butyrate (2.51 g, 8.06 mmol,81%).

¹ H-NMR (CDCl₃) δ: 1.26 (3H, t, J=7.2 Hz), 2.1-2.3 (2H, m), 2.60 (2H, t,J=7.1 Hz), 3.93 (3H, s), 4.15 (2H, q, J=7.2 Hz), 4.23 (2H, t, J=6.1 Hz),7.06 (1H, d, J=9.4 Hz), 8.35 (1H, dd, J=2.8, 9.4 Hz), 8.71 (1H, d, J=2.8Hz).

REFERENCE EXAMPLE 257

In THF (25 ml) was dissolved ethyl4-(2-methoxycarbonyl-4-nitrophenoxy)butyrate (2.37 g, 7.61 mmol), and tothe mixture was added 10% palladium-carbon (containing 50% water, 0.94g). The mixture was subjected to catalytic reduction at room temperaturefor 4 hours. Insoluble materials were filtered off, and the filtrate wasdried with anhydrous magnesium sulfate and concentrated under reducedpressure to give ethyl 4-(4-amino-2-methoxycarbonylphenoxy)butyrate(2.20 g).

IR (KBr): 1730 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.25 (3H, t, J=7.2 Hz), 2.0-2.2(2H, m), 2.56 (2H, t, J=7.3 Hz), 3.88 (3H, s), 4.00 (2H, t, J=6.0 Hz),4.14 (2H, q, J=7.2 Hz), 6.75-6.9 (2H, m), 7.1-7.2 (1H, m).

REFERENCE EXAMPLE 258

A mixture of ethyl 4-(4-amino-2-methoxycarbonylphenoxy)butyrate (2.20g), bis(2-chloroethyl)ether (0.915 ml, 7.81 mmol),potassiumcarbonate(3.24 g, 23.4 mmol), sodium iodide (2.34 g, 15.6 mmol)and DMF (20 ml) was stirred at 70° C. for 24 hours, and the mixture wasconcentrated under reduced pressure. To the residue was added water, andthe mixture was extracted with ethyl acetate. The organic layer wasdried with anhydrous sodium sulfate and concentrated under reducedpressure. The residue was purified with column chromatography (silicagel 30 g, ethyl acetate/hexane=1/4), and the desired fraction wasconcentrated under reduced pressure to give ethyl4-(2-methoxycarbonyl-4-morpholinophenoxy)butyrate (2.18 g).

IR (KBr): 1732 cm⁻¹. ¹ H-NMR (CDCl₃) δ:1.25 (3H, t, J=7.1 Hz), 2.0-2.2(2H, m), 2.57 (2H, t, J=7.1 Hz), 3.0-3.15 (4H, m), 3.8-3.9 (4H, m), 3.89(3H, s), 4.04 (2H, t, J=6.0 Hz), 4.14 (2H, q, J=7.1 Hz), 6.92 (1H, d,J=9.0 Hz), 7.04 (1H, dd, J=3.1, 9.0 Hz), 7.36 (1H, d, J=3.1 Hz).

REFERENCE EXAMPLE 259

In THF (15 ml) was dissolved diisopropylamine (1.018 ml), and to themixture was added dropwise at 0° C. n-butyl lithium (4.2 ml). Themixture was stirred at the same temperature for 30 minutes. To themixture was added dropwise a solution of ethyl4-(2-methoxycarbonyl-4-morpholinophenoxy)butyrate (1829 mg, 5.18 mmol)in THF (5 ml) at -78° C., ice bath was removed, and the mixture wasstirred for 7 hours. To the mixture was added at 0° C. 10% ammoniumchloride solution (30 ml), and the mixture was extracted with ethylacetate (30 ml×3). The organic layer was dried with anhydrous sodiumsulfate and concentrated under reduced pressure. The residue waspurified with column chromatography (silica gel 50 g, ethylacetate/hexane=1/5), and the desired fraction was concentrated underreduced pressure to give ethyl7-morpholino-5-oxo-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxylate (924mg, 2.89 mmol, 56%).

REFERENCE EXAMPLE 260

In THF (10 ml) was dissolved ethyl7-morpholino-5-oxo-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxylate (924mg, 2.89 mmol), and to the mixture was added at -30° C. a solution ofsodium boro hydride (164 mg, 4.34 mmol) in methanol (3 ml). The mixturewas stirred at -20° C. to -15° C. for 30 minutes, and the mixture wascooled to -50° C., to which was added water (15 ml). The mixture wasextracted with ethylacetate (15 ml×3), and the organic layer was driedwith anhydrous magnesium sulfate and concentrated under reducedpressure. The residue was dissolved in THF (10 ml), and to the mixturewere added at 0° C. triethylamine (2.02 ml, 14.5 mmol)andmethanesulfonylchloride (0.336 ml, 4.34 mmol). The mixture wasstirred at room temperature for 17 hours and concentrated under reducedpressure. To the residue was added water (15 ml), and the mixture wasextracted with ethyl acetate (20 ml×3). The organic layer was dried withanhydrous sodium sulfate and concentrated under reduced pressure. Theresidue was purified with column chromatography (silica gel 30 g, ethylacetate/ hexane=1/5), and the desired fraction was concentrated underreduced pressure to give ethyl7-morpholino-2,3-dihydro-1-benzoxepine-4-carboxylate (691 mg, 2.28 mmol,79%).

IR (KBr): 1703 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 1.35 (3H, t, J=7.2 Hz), 2.9-3.0(2H, m), 3.05-3.15 (4H, m), 3.8-3.9 (4H, m), 4.22 (2H, t, J=4.8 Hz),4.28 (2H, q, J=7.2 Hz), 6.8-7.0 (3H, m), 7.54 (1H, s).

REFERENCE EXAMPLE 261

In methanol (8 ml) was dissolved ethyl7-morpholino-2,3-dihydro-1-benzoxepine-4-carboxylate (800 mg, 2.64mmol), and to the mixture was added 1N sodium hydroxide solution (8 ml).The mixture was stirred at room temperature for 12 hours, and to themixture was added 1N hydrochloric acid (8 ml). The organic solvent wasevaporated under reduced pressure, and the precipitated insolublematerials were filtered, which were washed with water anddiisopropylether and dried under reduced pressure to give7-morpholino-2,3-dihydro-1-benzoxepine-4-carboxylic acid (649 mg, 2.36mmol, 89%).

¹ H-NMR (CDCl₃) δ: 2.97 (2H, t, J=4.5 Hz), 3.05-3.15 (4H, m), 3.8-3.95(4H, m), 4.25 (2H, t, J=4.5 Hz), 6.8-7.0 (3H, m), 7.67 (1H, s).

REFERENCE EXAMPLE 262

A mixture of 4-nitrobenzylamine (6.09 g, 40.0 mmol), 2-chloropyrimidine(4.82 g, 42.1 mmol), triethylamine (11.2 ml, 80.4 mmol) and ethanol (120ml) was stirred at 110° C. for 24 hours, and the mixture wasconcentrated under reduced pressure. To the residue was added water, andthe mixture wasextractedwithethylacetate-THF. Theorganiclayerwas driedwith anhydrous sodium sulfate and concentrated under reduced pressure.The residue was recrystallized from ethyl acetate-ethanol to giveN-(4-nitrobenzyl)-N-(2-pyrimidinyl)amine (0.99 g, 4.3 mmol, 11%).

¹ H-NMR (CDCl₃) δ: 4.77 (2H, d, J=6.4 Hz), 5.59 (1H, m), 6.62 (1H, t,J=4.9 Hz), 7.51 (2H, d, J=8.6 Hz), 8.19 (2H, d, J=8.6 Hz), 8.30 (2H, d,J=4.9 Hz).

REFERENCE EXAMPLE 263

In THF (20 ml) and methanol (20 ml) was dissolvedN-(4-nitrobenzyl)-N-(2-pyrimidinyl)amine (921 mg, 4.00 mmol), and to themixture were added at 0° C. nickel bromide (137 mg) and sodium borohydride(955 mg). The mixture was stirred at room temperature for 30minutes and concentrated under reduced pressure. To the residue wereadded ethyl acetate, THF and water, and the insoluble materials werefiltered off. The aqueous layer was extracted with ethyl acetate-THF,and the organic layer was dried with anhydrous sodium sulfate andconcentrated under reduced pressure. The residue was purified withcolumn chromatography (silica gel 30 g, ethyl acetate/hexane=1/1), andthe desired fraction was concentrated under reduced pressure. To theresidue was added diethylether, and the insoluble materials werefiltered, which were washed with diethylether and dried under reducedpressure to give 4-[N-(2-pyrimidinyl)aminomethyl]aniline (208 mg, 1.04mmol, 26%).

¹ H-NMR (CDCl₃) δ: 4.50 (2H, d, J=5.4 Hz), 5.32 (1H, m), 6.54 (1H, t,J=4.7 Hz), 6.66 (2H, d, J=8.3 Hz), 7.15 (2H, d, J=8.3 Hz), 8.29 (2H, d,J=4.7 Hz).

REFERENCE EXAMPLE 264

A mixture of methyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate(1416 mg, 5.00 mmol), zinc cyanide (352 mg, 3.00 mmol),tetrakis(triphenylphosphine)palladium (347 mg, 0.30 mmol) and DMF(10 ml)was stirred at 80° C. for 3 hours. The mixture was concentrated underreduced pressure, and to the residue was added ethyl acetate. Insolublematerials were filtered off, which were washed with ethyl acetate. Thefiltrate was concentrated under reduced pressure. The resulting crudeproduct was recrystallized from ethyl acetate to give methyl7-cyano-2,3-dihydro-1-benzoxepine-4-carboxylate (800 mg, 3.49 mmol,70%).

IR (KBr): 2222, 1721 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 2.95-3.1 (2H, m), 3.84(3H, s), 4.3-4.4 (2H, m), 7.05 (1H, d, J=8.8 Hz), 7.50 (1H, dd, J=2.0,8.8 Hz), 7.52 (1H, s), 7.66 (1H, d, J=2.0 Hz).

REFERENCE EXAMPLE 265

In toluene (15 ml) was suspended methyl7-cyano-2,3-dihydro-1-benzoxepine-4-carboxylate (642 mg, 2.80 mmol), andto the mixture were added trimethylsilylazide (0.929 ml, 7.00 mmol) anddibutyl tin oxide (70 mg, 0.28 mmol). The mixture was stirred at 100° C.for 24 hours and concentrated under reduced pressure. To the residue wasadded methanol, and the mixture was concentrated under reduced pressure.To the residue was added ethyl acetate, and the mixture was extractedwith saturated sodium bicarbonate solution (30 ml, 10 ml×2). To theaqueous layer was added 6N hydrochloric acid to make the solution aboutpH 1, and the mixture was extracted with ethyl acetate and THF ((30 ml50ml) and (10 ml/10 ml)×2). The organic layer was dried with anhydrousmagnesium sulfate and concentrated under reduced pressure, to theresidue was added ethyl acetate. Insoluble materials were filtered,which were washed with ethyl acetate and dried under reduced pressure togive methyl 7-(1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate(662 mg, 2.43 mmol, 87%).

¹ H-NMR (DMSO-d₆) δ: 2.85-3.0 (2H, m), 3.78 (3H, s), 4.25-4.4 (2H, m),7.21 (1H, d, J=8.6 Hz), 7.60 (1H, s), 7.94 (1H, dd, J=2.1, 8.6 Hz), 8.16(1H, d, J=2.1 Hz).

REFERENCE EXAMPLE 266

In DMF (6 ml) was dissolved methyl7-(1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate (400 mg,1.47 mmol),and to the mixture was added at 0° C. sodium hydride (60%, 90mg, 2.3 mmol). The mixture was stirred at the same temperature for 15minutes, and to the mixture was added at OC methyl iodide (0.28 ml, 4.4mmol). While the temperature of the mixture was warmed from 0° C. toroom temperature, the mixture was stirred for 3 hours. To the mixturewas added at 0° C. water (30 ml), and the mixture was extracted withethyl acetate. The organic layer was dried with anhydrous sodium sulfateand concentrated under reduced pressure. The residue was purified withcolumn chromatography (silica gel 40 g, ethyl acetate/hexane=1/8→1/2),and the first eluted desired fraction was concentrated under reducedpressure to give methyl7-(2-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate(334 mg, 1.17 mmol, 79%). The second eluted desired fraction wasconcentrated under reduced pressure to give methyl7-(1-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate(76 mg, 0.27 mmol, 18%).

Methyl7-(2-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate;

IR (KBr): 1705 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 2.95-3.1 (2H, m), 3.83 (3H, s),4.25-4.4 (2H, m), 4.39 (3H, s), 7.09 (1H, d, J=8.4 Hz), 7.69 (1H, s),8.00 (1H, dd, J=2.2, 8.4 Hz), 8.15 (1H, d, J=2.2 Hz). Methyl7-(1-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate;

IR (KBr): 1705 cm⁻¹. ¹ H-NMR (CDCl₃) δ: 3.0-3.1 (2H, m), 3.84 (3H, s),4.3-4.45 (2H, m), 4.20 (3H, s), 7.17 (1H, d, J=8.4 Hz), 7.61 (1H, s),7.63 (1H, dd, J=2.2, 8.4 Hz), 7.75 (1H, d, J=2.2 Hz).

REFERENCE EXAMPLE 267

In methanol (7 ml) and THF (7 ml) was suspended methyl7-(2-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate(324 mg, 1.13 mmol), and to the mixture was added 1N sodium hydroxidesolution (3.4 ml). The mixture was stirred at 50° C. for 4 hours, and tothe mixture was added, under ice-cooling, 1N hydrochloric acid (3.4 ml).The mixture was concentrated under reduced pressure, and to the residuewas added water. Insoluble materials were filtered, which were washedwith water and dried under reduced pressure to give7-(2-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (295 mg, 1.08 mmol, 96%).

REFERENCE EXAMPLE 268

In methanol (3 ml) and THF (3 ml) was dissolved methyl7-(2-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylate(76 mg, 0.27 mmol), and to the mixture was added 1N sodium hydroxidesolution (0.8 ml). The mixture was stirred at 50° C. for 4 hours, and tothe mixture was added, under ice-cooling, 1N hydrochloric acid (0.8 ml).The mixture was concentrated under reduced pressure, and to the residuewas added water. Insoluble materials were filtered, which were washedwith water and dried under reduced pressure to give7-(1-methyl-1H-tetrazol-5-yl)-2,3-dihydro-1-benzoxepine-4-carboxylicacid (69 mg, 0.25 mmol, 95%).

REFERENCE EXAMPLE 269

In THF (500 ml) was dissolved 4-[(benzyloxy) carbonyl]-aminobutyric acid(25.0 g) , and to the mixture was gradually added at -5° C. methyliodide (37.4 g). Under nitrogen atmosphere, the mixture was stirred at0° C. for 15 minutes and then at room temperature for 24 hours. To themixture was added ethyl acetate (300 ml) and then water (800 ml). Themixture was made pH 11 with sodium hydroxide and washed with ether (400ml×2). The aqueous layer was made pH 2 with concentrated hydrochloricacid and extracted with ethyl acetate (1000 ml and 500 ml×3). Theorganic layer was washed with 1M sodium thiosulf ate solution (300 ml)and dried with magnesium sulfate. The solvent was evaporated underreduced pressure to give 4-[(benzyloxy)carbonyl]-4-methyl-aminobutyricacid (26.3 g).

¹ H NMR (200 MHz, CDCl₃) δ 1.88 (2H, m), 2.35-2.37 (2H, m), 2.93 (3H, s), 3.36 (2H, t, J=6.6 Hz), 5.13 (2H, s) , 7.35 (5H, s).

REFERENCE EXAMPLE 270

To dichloromethane (1000 ml) was added at room temperature anhydrousmagnesium sulfate (50.6 g) and then concentrated sulfuric acid (6.0 ml).The mixture was stirred at room temperature for 15 minutes, and to themixture was added 4-[(benzyloxy)carbonyl]-4-methylaminobutyric acid(26.3 g) and then tert-butanol (50.5 ml). The mixture was sealedcompletely and stirred at room temperature for 18 hours. To the mixturewas added saturated sodium hydrogen carbonate solution to dissolve allof the magnesium sulfate, and the mixture was stirred. The organic layerwas separated, washed with saturated brine (400 ml) and dried withanhydrous magnesium sulfate. The solvent was evaporated under reducedpressure, and the residue was purified with silica gel columnchromatography (250 g, hexane:ethyl acetate=5:1) to give tert-butyl4-[(benzyloxy)-carbonyl]-4-methylaminobutyrate (17.2 g, 53%).

¹ H NMR (200 MHz, CDCl₃) δ 1.44 (9H, s), 1.82 (2H, quint, J=6.6 Hz),2.21 (2H, t, J=6.2 Hz), 2.93 (3H, s), 3.31 (2H, t, J=7.1 Hz), 5.13 (2H,s), 7.35 (5H, s).

REFERENCE EXAMPLE 271

In methanol (70 ml) was dissolved tert-butyl4-[(benzyloxy)carbonyl]-4-methylaminobutyrate (6.06 g), and to themixture was added 10% palladium-carbon (580 mg). Under hydrogenatmosphere, the mixture was stirred at room temperature for 3 hours, and10% palladium-carbon was removed. The solvent was evaporated underreduced pressure to give tert-butyl 4-methylaminobutyrate (3.35 g, 98%).¹ H NMR (200 MHz, CDCl₃) δ 1.45 (9H, s), 1.72 (1H, brs), 1.77 (2H,quint, J=7.2 Hz), 2.27 (2H, t, J=7.3 Hz), 2.43 (3H, s), 2.61 (2H, t,J=7.1 Hz).

REFERENCE EXAMPLE 272

In DMF (5.0 ml) was dissolved tert-butyl 4-methylaminobutyrate (1050mg), and to the mixture was added at room temperature a solution of5-bromo-2-fluorobenzaldehyde (1025 mg) in DMF (1.0 ml) and thenpotassium carbonate (837 mg). The mixture was stirred at 70° C. for 60hours, and to the mixture was added at room temperature water (50 ml).The mixture was extracted with ethyl acetate (50 ml×3), and the organiclayer was washed with saturated brine (50 ml×3) and dried with anhydrousmagnesium sulfate. The solvent was evaporated under reduced pressure,and the residue was purified with silica gel column chromatography (75g, hexane:ethyl acetate=10:1) to give tert-butyl4-(4-bromo-2-formyl-N-methylanilino) butyrate (1620 mg, 90%).

¹ H NMR (200 MHz, CDCl₃) δ 1.42 (9H, s), 1.88 (2H, quint, J=7.4 Hz),2.22 (2H, t, J=7.3 Hz), 2.88 (3H, s), 3.14 (2H, t, J=7.3 Hz), 7.01 (1H,d, J=8.6 Hz), 7.55 (1H, dd, J=8.7, 2.5 Hz), 7.88 (1H, d, J=2.6 Hz),10.19 (1H, s).

REFERENCE EXAMPLE 273

In tert-butanol (250 ml) was dissolved tert-butyl4-(4-bromo-2-formyl-N-methylanilino)butyrate (4.54 g) and tert-butoxypotassium (1.43 g), and the mixture was refluxed for 1 hour and cooled.To the mixture was added water (500 ml), and the mixture was extractedwith ethyl acetate (500 ml×2). The aqueous layer was made weakly acidicwith 1N hydrochloric acid (about 12.5 ml), and the mixture was extractedwith ethyl acetate (500 ml). Both of these organic layer was washed withsaturated brine (250 ml) and dried with anhydrous magnesium sulfate. Thesolvent was evaporated under reduced pressure, and the residue waspurified with silica gel column chromatography (200 g, hexane:ethylacetate=10:1→1:1) to give tert-butyl7-bromo-1-methyl-2,3-dihydro-1-benzoazepine-4-carboxylate (3.33 g, 77%)and 7-bromo-1-methyl-2,3-dihydro-1H-1-benzoazepine-4-carboxylic acid(0.60 g, 17%).

tert-butyl 7-bromo-1-methyl-2,3-dihydro-1-benzoazepine-4-carboxylate.

¹ HNMR (200 MHz, CDCl₃) δ 1.53 (9H, s), 2.80 (2H, t, J=4.8 Hz), 3.00(3H, s), 3.21 (2H, t, J=4.7 Hz), 6.65 (1H, d, J=8.8 Hz), 7.25 (1H, dd,J=8.8, 2.2 Hz), 7.39 (1H, d, J=2.6 Hz), 7.46 (1H, s).

7-bromo-1-methyl-2,3-dihydro-1H-1-benzoazepine-4-carboxylic acid; ¹ HNMR (200 MHz, CDCl₃) δ 2.85 (2H, t, J=4.8 Hz), 3.03 (3H, s), 3.25 (2H,t, J=4.9 Hz), 6.67 (1H, d, J=9.2 Hz), 7.29 (1H, dd, J=8.8, 2.2 Hz), 7.44(1H, d, J=2.6 Hz), 7.67 (1H, s).

REFERENCE EXAMPLE 274

In water:ethanol:toluene (1:1:10, 18.0 ml) were dissolved 4-methylphenylborate (276 mg) and tert-butyl7-bromo-1-methyl-2,3-dihydro-1-benzoazepine-4-carboxylate (571 mg), andto the mixture was added potassium carbonate (560 mg). The mixture wasstirred under argon atmosphere for 30 minutes, and to the mixture wasadded tetrakistriphenylphosphine palladium (78 mg). Under argonatmosphere, the mixture was refluxed for 19.5 hours. The mixture wasdiluted with ethyl acetate (300 ml) and washed with water (100 ml) andsaturated brine (100 ml). The organic layer was dried with anhydrousmagnesium sulfate. The solvent was evaporated under reduced pressure,and the residue was purified with silica gel column chromatography (120g, hexane→hexane:ethyl acetate=10:1) to give tert-butyl1-methyl-7-(4-methylphenyl)-2,3-dihydro-1-benzoazepine-4-carboxylate(422 mg, 72%).

¹ H NMR (200 MHz, CDCl₃) δ 1.54 (9H, s), 2.38 (3H, s), 2.83 (2H, t,J=4.9 Hz), 3.06 (3H, s), 3.28 (2H, t, J=4.9 Hz), 6.85 (1H, d, J=8.4 Hz),7.23 (2H, d, J=8.0 Hz), 7.447 (1H, dd, J=8.6, 2.4 Hz), 7.463 (2H, d,J=8.2 Hz), 7.53 (1H, d, J=2.2 Hz), 7.67 (1H, s).

REFERENCE EXAMPLE 275

In ethyl acetate (7.0 ml) was dissolved tert-butyl1-methyl-7-(4-methylphenyl)-2,3-dihydro-1-benzoazepine-4-carboxylate(490 mg), and to the mixture was added 4N hydrochloric acid (ethylacetate) (7.0 ml). The mixture was stirred at room temperature for 20hours. The solvent was evaporated under reduced pressure, and theresidue was washed with hexane (10 ml×3) to give1-methyl-7-(4-methylphenyl)-2,3-dihydro-1-benzoazepine-4-carboxylic acidhydrochloride (443 mg, 96%).

mp 249-252° C. (decomp.). ¹ H NMR (200 MHz, DMSO-d₆) δ 2.32 (3H, s),2.75 (2H, t, J=4.6 Hz), 3.03 (3H, s), 3.25 (2H, t, J=4.9 Hz), 6.92 (1H,d, J=8.6 Hz), 7.22 (2H, d, J=8.2 Hz), 7.53 (1H, dd, J=8.8, 2.4 Hz), 7.55(2H, d, J=8.2 Hz), 7.65 (1H, d, J=2.4 Hz), 7.68 (1H, s). IR (KBr) 3021,2469, 1707, 1466, 1190, 1107, 810, 530 cm⁻¹. Anal. Calcd. for C₁₉ H₁₉NO₂.HCl.0.3H₂ O: C, 68.08; H, 6.19; N, 4.18. Found: C, 67.97; H, 6.13;N, 4.05.

REFERENCE EXAMPLE 276

In DMF (12.0 ml) was dissolved7-bromo-1-methyl-2,3-dihydro-1-benzoazepine-4-carboxylic acidhydrochloride (600 mg), and to the mixture was added thionyl chloride(0.39 ml). The mixture was stirred at room temperature for 15 minutes.The solvent was evaporated under reduced pressure, and the residue wasdissolved in dichloromethane (14.0 ml). The thus obtained acid chloridesolution was added dropwise at 0° C. to a solution of4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]aniline (562 mg) andtriethylamine (1.48 ml) in dichloromethane (5.5 ml). The mixture wasstirred at 0° C. for 10 minutes and then at room temperature for 5hours. To the mixture was added water (100 ml), and the mixture wasextracted with dichloromethane (100 ml×3). The organic layer was driedwith anhydrous magnesium sulfate. The solvent was evaporated underreduced pressure, and the residue was purified with silica gel columnchromatography (150 g, ethyl acetate:ethanol=10:1) to give7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]-phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide(767 mg, 75%).

mp 62-64° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.63-1.79 (4H, m), 2.21 (3H,s), 2.57-2.72 (1H, m), 2.94 (2H, t, J=4.2 Hz), 3.03 (3H, s), 3.27-3.44(2H +2H, m), 3.57 (2H, s), 4.00-4.07 (2H, m), 6.70 (1H, d, J=8.8 Hz),7.20 (1H, s), 7.26-7.303 (2H, m), 7.301 (1H, dd, J=8.6, 2.4 Hz), 7.42(1H, d, J=2.6 Hz), 7.50-7.55 (1H+2H, m). IR (KBr) 3264, 2949, 2843,1655, 1597, 1514, 1499, 1406, 1314, 1246, 1182, 810 cm⁻¹. Anal. Calcd.for C₂₅ H₃₀ N₃ O₂ Br.0.25H₂ O: C, 61.41; H, 6.29; N, 8.59. Found: C,61.45; H, 6.25; N, 8.32.

WORKING EXAMPLE 310 (Production of Compound 310)

In hydrous methanol was dissolvedN,N-dimethyl-N-(4-(((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)amino)benzyl)tetrahydro-2H-pyran-4-aminiumiodide (14.2 g), and the mixture was subjected to ion exchange resin(DOWEX SBR, 20-50 mesh, Cl⁻ type) column and eluted with hydrousmethanol. The solvent of the resulting fraction was evaporated, and tothe residue was added acetone to give crude crystals, which wererecrystallized from ethanol to giveN,N-dimethyl-N-(4-(((7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl)carbonyl)-amino)benzyl)tetrahydro-2H-pyran-4-aminiumchloride (Compound 310) (10.4 g) as colorless crystals.

mp 232-237° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆) 1.76-2.00 (2H, m),2.14-2.20 (2H, m), 2.35 (3H, s), 2.89 (6H, s), 3.01 (2H, t, J=4.5 Hz),3.29-3.46 (2H, m), 3.55-3.69 (1H, m), 4.04-4.09 (2H, m), 4.31 (2H, t,J=4.5 Hz), 4.50 (2H, s), 7.06 (1H, d, J=8.4 Hz), 7.27 (2H, d, J=8.4 Hz),7.46 (1H, s), 7.53-7.59 (5H, m), 7.79 (1H, d, J=2.2 Hz), 7.92 (2H, d,J=8.4 Hz), 10.34 (1H, s). IR(KBr) ν: 2973, 2849, 1645, 1516cm⁻¹. Anal.Calcd. for C₃₂ H₃₇ ClN₂ O₃ :

C, 72.10; H, 7.00; N, 5.25; Cl,6.65. Found C, 72.03; H, 6.83; N, 5.38;Cl,6.47.

WORKING EXAMPLE 311 (Production of Compound 311)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.25 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.16ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (20 ml), and the mixture wasadded dropwise to a solution of4-((N,N-bis(2-methoxyethyl)amino)methyl)aniline (0.24 g) andtriethylamine (0.4 ml) in tetrahydrofuran (10 ml) under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureovernight, and the solvent was evaporated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer washed with water and saturated brine, and dried with anhydrousmagnesium sulfate. Under reduced pressure, the solvent was evaporated,and the residue was purified with silica gel column (ethyl acetate) togive crude crystals, which were recrystallized from ethyl acetate-hexaneto giveN-(4-((N,N-bis(2-methoxyethyl)amino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 311) (0.25 g) as colorless crystals.

mp 110-112° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.39 (3H, s), 2.74 (4H, t, J=6.0Hz), 3.07 (2H, t, J=4.4 Hz), 3.32 (6H, s), 3.48 (4H, t, J=6.0 Hz), 3.69(2H, s), 4.35 (2H, t, J=4.4 Hz), 7.05 (1H, d, J=8.0 Hz), 7.24 (2H, d,J=8.4 Hz), 7.33 (2H, d, J=8.8 Hz), 7.43-7.55 (6H, m), 7.61 (1H, s).IR(KBr) ν: 3287, 2876, 1651cm⁻¹. Anal. Calcd. for C₃₁ H₃₆ N₂ O₄ : C,74.37; H, 7.25; N, 5.60. Found C, 74.33; H, 7.15; N, 5.45.

WORKING EXAMPLE 312 (Production of Compound 312)

In dichloromethane (5 ml) was suspended7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.25 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.23ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (20 ml), and the mixture wasadded dropwise to a solution of4-((N-(3-ethoxypropyl)-N-methylamino)methyl)aniline dihydrochloride (0.3g) and triethylamine (0.62 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature overnight, and the solvent was evaporated. To the residuewas added water, and the mixture was extracted with ethyl acetate. Theorganic layer washed with water and saturated brine, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate) to give crude crystals, whichwere recrystallized from ethyl acetate-hexane to giveN-(4-((N-(3-ethoxypropyl)-N-methylamino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 312) (0.3 g) as colorless crystals.

mp 119-122° C.; ¹ H-NMR(δ ppm, CDC₃) 1.19 (3H, t, J=7.1 Hz), 1.65-1.85(2H, m), 2.19 (3H, s), 2.39 (3H, s), 2.46 (2H, t, J=7.2 Hz), 3.08 (2H,t, J=4.8 Hz), 3.42-3.52 (6H, m), 4.36 (2H, t, J=4.8 Hz), 7.06 (1H, d,J=8.4 Hz), 7.24 (2H, d, J=8.0 Hz), 7.30 (2H, d, J=8.8 Hz), 7.44-7.58(7H, m). IR(KBr) ν: 2975, 2872, 1647, 1516cm⁻¹. Anal. Calcd. for C₃₁ H₃₆N₂ O₃ : C, 76.83; H, 7.49; N, 5.78. Found C, 76.73; H, 7.31; N, 5.95.

WORKING EXAMPLE 313 (Production of Compound 313)

In THF (5 ml) was dissolved7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.25 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.16ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (15 ml), and the mixture wasadded dropwise to a solution of4-((N-(1,3-dimethoxypropan-2-yl)-N-methylamino)methyl)aniline (0.23 g)and triethylamine (0.5 ml) in tetrahydrofuran (10 ml), underice-cooling. Under nitrogen atmosphere, the mixture was stirred at roomtemperature overnight, andthe solventwas evaporated. To the residue wasadded water, and the mixture was extracted with ethyl acetate. Theorganic layer washed with water and saturated brine, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/hexane) to give crude crystals, which were recrystallized fromethyl acetate-hexane to giveN-(4-((N-(1,3-dimethoxypropan-2-yl)-N-methylamino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 313) (0.25 g) as colorless crystals.

mp 128-132° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.31 (3H, s), 2.39 (3H, S),3.00-3.09 (3H, m), 3.35 (6H, s), 3.44-3.63 (4H, m), 3.71 (2H, s), 4.35(2H, t, J=4.7 Hz), 7.05 (1H, d, J=8.4 Hz), 7.24 (2H, d, J=8.0 Hz), 7.33(2H, d, J=8.8 Hz), 7.43-7.58 (7H, m). IR(KBr) ν: 3285, 2882, 1651,1516cm⁻¹. Anal. Calcd. for C₃₁ H₃₆ N₂ O₄ : C, 74.37; H, 7.25; N, 5.60.Found C, 74.17; H, 7.05; N, 5.75.

WORKING EXAMPLE 314 (Production of Compound 314)

In THF (5 ml) was dissolved7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxylic acid (0.25 g),and to the mixture were added, under ice-cooling, oxalyl chloride (0.16ml) and dimethylformamide (catalytic amount). The mixture was stirred atroom temperature for 2 hours, and the solvent was evaporated. Theresidue was dissolved in tetrahydrofuran (15 ml), and the mixture wasadded dropwise to a solution of4-((N-(2-methoxyethyl)-N-methylamino)methyl)aniline (0.21 g) andtriethylamine (0.37 ml) in tetrahydrofuran (10 ml), under ice-cooling.Under nitrogen atmosphere, the mixture was stirred at room temperatureovernight, and the solvent was evaporated. To the residue was addedwater, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and saturated brine, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column(methanol/triethylamine/ethyl acetate) to give crude crystals, whichwere recrystallized from ethyl acetate-hexane to giveN-(4-((N-(2-methoxyethyl)-N-methylamino)methyl)phenyl)-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 314) (0.24 g) as colorless crystals.

mp 121-122° C.; ¹ H-NMR(δ ppm, CDCl₃) 2.26 (3H, s), 2.39 (3H, s), 2.60(2H, t, J=5.8 Hz), 3.07 (2H, t, J=4.5 Hz), 3.35 (3H, s), 3.49-3.54 (4H,m), 4.35 (2H, t, J=4.5 Hz), 7.05 (1H, d, J=8.4 Hz), 7.24 (2H, d, J=8.8Hz), 7.31 (2H, d, J=8.8 Hz), 7.43-7.56 (6H, m), 7.62 (1H, s). IR(KBr) ν:3287, 2926, 1651, 1516cm⁻¹. Anal. Calcd. for C₂₉ H₃₂ N₂ O₃ : C, 76.29;H, 7.06; N, 6.14. Found C, 75.99; H, 7.02; N, 6.22.

WORKING EXAMPLE 315 (Production of Compound 315)

In water/ethanol/toluene(1:1:10, 18.0 ml) were dissolved4-trifluoromethoxyphenyl borate (208 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(407 mg), and to the mixture was added potassium carbonate (279 mg).Under argon atmosphere, the mixture was stirred for 30 minutes, and themixture was added tetrakistriphenylphosphine palladium (39 mg). Underargon atmosphere, the mixture was refluxed for 16 hours, and the mixturewas diluted with ethyl acetate (200 ml). The mixture was washed withwater (50 ml) and saturated brine (50 ml), and the organic layer wasdried with anhydrous magnesium sulfate. The solvent was evaporated underreduced pressure, and the residue was purified with silica gel columnchromatography (75 g, ethyl acetate→ethyl acetate/ethanol=20:1) andrecrystallized from ethanol to give1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-7-(4-trifluoromethoxyphenyl)-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 315) (148 mg, 31%).

mp 182-183° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.63-1.76 (4H, m), 2.20 (3H,s), 2.56-2.72 (1H, m), 2.96 (2H, t, J=4.6 Hz), 3.09 (3H, s), 3.30-3.43(4H, m), 3.56 (2H, s), 4.01-4.06 (2H, m), 6.89 (1H, d, J=8.6 Hz), 7.25(2H, d, J=8.2 Hz), 7.30 (2H, d, J=8.6 Hz), 7.40 (1H, s), 7.48 (1H, dd,J=8.6, 2.4 Hz), 7.51-7.58 (6H, m). IR (KBr) 2951, 2847, 1651, 1514,1501, 1260, 1221, 1163, 806, 733 cm⁻¹. Anal. Calcd. for C₃₂ H₃₄ N₃ O₃ F₃: C, 67.95; H, 6.06; N, 7.43. Found: C, 67.74; H, 5.87; N, 7.68.

WORKING EXAMPLE 316 (Production of Compound 316)

In water/ethanol/toluene (1:1:10, 18.0 ml) were dissolved4-(1-piperidinyl)phenyl borate (179 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(353 mg), and to the mixture was added potassium carbonate (242 mg).Under argon atmosphere, the mixture was stirred for 40 minutes, and tothe mixture was added tetrakistriphenylphosphine palladium (34 mg).Under argon atmosphere, the mixture was ref luxed for 15 hours, and themixture was dilute with ethyl acetate (200 ml). The mixture was washedwith water (50 ml) and saturated brine (50 ml), and the organic layerwas dried with anhydrous magnesium sulfate. The solvent was evaporatedunder reduced pressure, and the residue was purified with silica gelcolumn chromatography (75 g, ethyl acetate/ethanol=9:1) andrecrystallized from ethanol to give1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]-phenyl]-7-[4-(1-piperidinyl)phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 316) (79 mg, 19%).

mp 202-204° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.59-1.77 (10 H, m), 2.21(3H, s), 2.57-2.73 (1H, m), 2.95 (2H, t, J=4.4 Hz), 3.07 (3H, s), 3.19(4H, t, J=5.1 Hz), 3.31-3.43 (4H, m), 3.57 (2H, s), 4.01-4.06 (2H, m),6.86 (1H, d, J=8.4 Hz), 6.99 (2H, d, J=8.8 Hz), 7.30 (2H, d, J=8.6 Hz),7.39-7.50 (5H, m), 7.54 (2H, d, J=8.4 Hz), 7.57 (1H, s). IR (KBr) 2938,2849, 1645, 1607, 1505, 1314, 1235, 910, 812, 733cm⁻¹. Anal. Calcd. forC₃₆ H₄₄ N₄ O₂ : C, 76.56; H, 7.85; N, 9.92. Found: C, 76.53; H, 7.79; N,10.01.

WORKING EXAMPLE 317 (Production of Compound 317)

In water/ethanol/toluene (1:1:10, 60.0 ml) were dissolved 4-methylphenylborate (658 mg) and7-bromo-1-formyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(20 g), and to the mixture was added potassium carbonate (1.34 g). Underargon atmosphere, the mixture was stirred for 30 minutes, and to themixture was added tetrakistriphenylphosphine palladium (186 mg). Underargon atmosphere, the mixture was ref luxed for 17 hours, and themixture was dilute with ethyl acetate (750 ml). The mixture was washedwith water (200 ml) and saturated brine (100 ml), and the organic layerwas dried with anhydrous magnesium sulfate. The solvent was evaporatedunder reduced pressure, and the residue was purified with silica gelcolumn chromatography (150 g, ethyl acetate ethyl acetate/ethanol=20:1)and recrystallized from ethanol to give1-formyl-7-(4-methylphenyl)-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 317) (669 mg, 33%).

mp 229-230.5° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.69-1.79 (4H, m), 2.21(3H, s), 2.41 (3H, s), 2.57-2.72 (1H, m), 3.04 (2H, t, J=4.9 Hz), 3.37(2H, td, J=10.2, 3.1 Hz), 3.57 (2H, s), 3.93 (2H, t, J=5.5 Hz),4.01-4.07 (2H, m), 7.21 (1H, d, J=8.2 Hz), 7.29 (2H, d, J=7.6 Hz), 7.32(2H, d, J=8.4 Hz), 7.50 (2H, d, J=8.8 Hz), 7.54 (2H, d, J=8.8 Hz), 7.58(1H, s), 7.59 (1H, dd, J=8.2, 2.2 Hz), 1H was concealed under 7.55-7.58,7.71 (1H, d, J=2.2 Hz), 8.56 (1H, s). IR (KBr) 2946, 2847, 1667, 1597,1516, 1497, 1360, 1316, 814, 733 cm⁻¹. Anal. Calcd. for C₃₂ H₃₅ N₃ O₃ :C, 75.41; H, 6.92; N, 8.25. Found: C, 75.45; H, 6.95; N, 8.18.

WORKING EXAMPLE 318 (Production of Compound 318)

To1-formyl-7-(4-methylphenyl)-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(1177 mg) was added 1N hydrochloric acid (20 ml), and the mixture wasstirred at 100° C. for 1 hour. The mixture was dilute with ethyl acetate(50 ml) and made weakly basic with saturated sodium hydrogen carbonatesolution (45 ml). To the mixture were added ethyl acetate (250 ml) andwater (100 ml), and separated. The organic layer was dried withanhydrous magnesium sulfate. The solvent was evaporated under reducedpressure, and the residue was purified with silica gel columnchromatography (75 g, ethyl acetate/ethanol=9:1) to give7-(4-methylphenyl)-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyllphenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 318) (804 mg, 72%) as amorphous.

¹ H NMR (200 MHz, CDCl₃) δ 1.69-1.80 (4H, m), 2.21 (3H, s), 2.38 (3H,s), 2.58-2.72 (1H, m), 2.96 (2H, t, J=4.4 Hz), 3.37 (2H, td, J=11.4, 3.1Hz), 3.47 (2H, t, J=4.8 Hz), 3.57 (2H, s), 4.01-4.07 (2H, m), 4.53-4.70(1H, br), 6.71 (1H, d, J=8.4 Hz), 7.22 (2H, d, J=7.8 Hz), 7.28-7.32 (4H,m), 7.35 (1H, dd, J=8.4, 2.2 Hz), 7.42 (1H, s), 7.46 (1H, s), 7.48 (1H,d, J=2.0 Hz), 7.54 (2H, d, J=8.6 Hz). IR (KBr) 3330, 2949, 2847, 1651,1609, 1514, 1507, 1408, 1316, 910, 812, 735 cm⁻¹. Anal. Calcd. for C₃₁H₃₅ N₃ O₂ : C, 77.31; H. 7.32; N, 8.72. Found: C, 77.44; H. 7.12; N,8.78.

WORKING EXAMPLE 319 (Production of Compound 319)

In dimethylformamide (5 ml) was dissolved7-(4-ethoxyphenyl)-1-methyl-2,3-dihydro-1-benzazepine-4-carboxylic acidhydrochloride (0.5 g), and to the mixture was added, under ice-cooling,thionyl chloride (0.25 ml). The mixture was stirred at room temperaturefor 45 minutes, and the solvent was evaporated. The residue wasdissolved in tetrahydrofuran (15 ml), and the mixture was added dropwiseto a suspension of 4-((N-(3-ethoxypropyl)-N-methylamino)methyl)anilinedihydrochloride (0.41 g) and triethylamine (1.2 ml) in tetrahydrofuran(10 ml), under ice-cooling. Under nitrogen atmosphere, the mixture wasstirred at room temperature overnight, and the solvent was evaporated.To the residue was added water, and the mixture was extracted with ethylacetate. The organic layer was washed with water and saturated brine,and dried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (methanol/triethylamine/ethyl acetate) to give crude crystals,which were recrystallized from ethyl acetate-hexane to giveN-(4-((N-(3-ethoxypropyl)-N-methylamino)methyl)phenyl)-7-(4-ethoxyphenyl)-1-methyl-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 319) (0.39 g) as pale yellow crystals.

mp 129-131° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.19 (3H, t, J=6.9 Hz), 1.44 (3H,t, J=7.1 Hz), 1.76-1.84 (2H, m), 2.19 (3H, s), 2.46 (2H, t, J=7.4 Hz),2.97 (2H, t, J=4.6 Hz), 3.09 (3H, s), 3.35 (2H, t, J=4.8 Hz), 3.41-3.52(6H, m), 4.07 (2H,q,J=7.1 Hz), 6.88 (1H, d, J=8.4 Hz), 6.95 (2H, d,J=8.8 Hz), 7.29 (2H, d, J=8.8 Hz), 7.40-7.55 (8H, m). IR(KBr) ν: 2978,2868, 1651, 1607, 1516, 1503cm⁻¹. Anal. Calcd. for C₃₃ H₄₁ N₃ O₃ : C,75.11; H, 7.83; N, 7.96. Found C, 74.90; H, 7.98; N, 7.97.

WORKING EXAMPLE 320 (Production of Compound 320)

In water/ethanol/toluene (1:1:10, 18.0 ml) were dissolved4-ethylthiophenyl borate (264 mg) and7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(439 mg), and to the mixture was added potassium carbonate (301 mg).Under argon atmosphere, the mixture was stirred for 30 minutes, and tothe mixture was added tetrakistriphenylphosphine palladium (42 mg).Under argon atmosphere, the mixture was refluxed for 17.5 hours, and themixture was dilute with ethyl acetate (200 ml). The mixture was washedwith water (50 ml) and saturated brine (50 ml), and the organic layerwas dried with anhydrous magnesium sulfate. The solvent was evaporatedunder reduced pressure, and the residue was purified with silica gelcolumn chromatography (75 g, ethyl acetate→ethyl acetate/ethanol=9:1)and recrystallized from ethanol to give7-(4-ethylthiophenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 320) (168 mg, 34%).

mp 139-141° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.34 (3H, t, J=7.3 Hz),1.63-1.76 (4H, m), 2.21 (3H, s), 2.57-2.72 (1H, m), 2.98 (2H, q, J=7.3Hz), 2H around d 2.96 was concealed by d 2.98, 3.10 (3H, s), 3.31-3.43(4H, m), 3.57 (2H, s), 4.00-4.07 (2H, m), 6.89 (1H, d, J=8.6 Hz),7.28-7.40 (6H, m), 7.466 (1H, dd, J=8.5, 2.3 Hz), 7.473 (1H, s),7.52-7.56 (4H, m). IR (KBr) 2948, 2845, 1645, 1597, 1514, 1489, 1408,1314, 1244, 1188, 812 cm⁻¹. Anal. Calcd. for C₃₃ H₃₉ N₃ O₂ S: C, 73.16;H, 7.26; N, 7.76. Found: C, 72.96; H, 7.08; N, 7.64.

WORKING EXAMPLE 321 (Production of Compound 321)

In DMF (10.0 ml) was dissolved7-(4-methylphenyl)-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxylicacid (387 mg), and to the mixture was added thionyl chloride (0.175 ml).The mixture was stirred at room temperature for 1 hour, and excessthionyl chloride and DMF were evaporated under reduced pressure. Theresidue was dissolved in dichloromethane (10.0 ml), and the mixture wasadded dropwise to a solution of4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]anilinedihydrochloride (331 mg) and triethylamine (0.98 ml) in dichloromethane(15.0 ml) at 0° C. The mixture was stirred at room temperature for 4hours, and to the mixture was added water (50 ml). The mixture wasextracted with dichloromethane (100 ml×3), and the organic layer wasdried with anhydrous magnesium sulfate. The solvent was evaporated underreduced pressure, and the residue was purified with silica gel columnchromatography (35 g, ethyl acetate→ethyl acetate/ethanol=9:1) andrecrystallized from ethanol to give7-(4-methylphenyl)-N-[4-[[N-methyl-N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]-phenyl]-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxamide(Compound 71) (251 mg, 43%).

mp 185-187° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.70-1.77 (4H, m), 2.21 (3H,s), 2.41 (3H, s), 2.57-2.72 (1H, m), 3.11 (2H, t, J=5.9 Hz), 3.37 (2H,td, J=11.3, 2.9 Hz), 3.58 (2H, s), 4.02-4.08 (4H, m), 7.26-7.35 (4H, m),7.46-7.61 (8H, m), 7.64 (1H, s). IR (KBr) 1661, 1516, 1497, 1393, 1314,1223, 1194, 1142, 812 cm⁻¹. Anal. Calcd. for C₃₂ H₃₄ F₃ N₃ O₄ S: C,62.63; H, 5.58; N, 6.85. Found: C, 62.58; H, 5.57; N. 6.91.

WORKING EXAMPLE 322 (Production of Compound 322)

To a solution of 7-(4-methylphenyl)-2,3-dihydrobenzoxepine-4-carboxylicacid (280 mg) and 2-[(4-aminophenyl)methylamino]pyridine (199 mg) in DMF(4 ml) was added, under ice-cooling, diethyl cyanophosphate (0.18 ml)and triethylamine (0.17 ml), and the mixture was stirred at 0° C. for 30minutes and then at room temperature for 1 hour. To the mixture wasadded DMAP (1 piece), and the mixture was stirred at room temperaturefor 18 hours. Under ice-cooling, to the mixture was added sodiumbicarbonate solution, and the mixture was extracted with ethyl acetate,washed with brine, dried (anhydrous magnesium sulfate) and concentrated.The residue was purified with silica gel column chromatography (ethylacetate/hexane =1/1) and recrystallized from ethyl acetate/hexane togiveN-[4-[(pyrid-2-yl)aminomethyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide(Compound 72) (97 mg) as colorless crystals.

m.p. 189-190° C.; ¹ H-NMR (200 MHz, CDCl₃) δ: 2.39 (3H, s), 3.07 (2H, t,J=4.6), 4.36 (2H, t, J=4.6), 4.49 (2H, d, J =4.6), 4.9-5.0 (1H, brm),6.38 (1H, d, J=8.4), 6.60 (1H, dd, J=5.2, 7.2), 7.06 (1H, d, J=8.4),7.2-7.6 (12H, m), 8.05-8.15 (1H, m). IR (KBr) 1651, 1597, 1522, 1491,1439, 1316, 1254, 812, 772cm⁻¹. Anal. for C₃₀ H₂₇ N₃ O₂.0.2H₂ O; Calcd.C, 77.46; H, 5.94; N, 9.03: Found. C, 77.24; H, 5.96; N, 8.91.

REFERENCE EXAMPLE 277

A solution of p-nitrobenzyl bromide (10 g) in THF (50 ml) was addeddropwise to a solution of bis(2-methoxyethyl)amine (6.8 g) andtriethylamine (10 ml) in THF (50 ml). Under nitrogen atmosphere, themixture was stirred at room temperature overnight, and the solvent wasevaporated. To the residue was added water, and the mixture wasextracted with ethyl acetate. The organic layer was washed with waterand saturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to giveN,N-bis(2-methoxyethyl)-4-nitrobenzylamine (10.8 g) as yellow oil.

¹ H-NMR(δ ppm, CDCl₃) 2.76 (4H, t, J=5.6 Hz), 3.31 (6H, s), 3.48 (4H, t,J=5.6 Hz), 3.83 (2H, s), 7.54 (2H, d, J=8.8 Hz), 8.17 (2H, d, J=8.8 Hz).IR(neat) ν: 2878, 1599, 1520cm⁻¹.

REFERENCE EXAMPLE 278

In acetic acid (200 ml) was dissolvedN,N-bis(2-methoxyethyl)-4-nitrobenzylamine (10.5 g), and to the mixturewas added reduced iron (11 g) little by little. The mixture was stirredat room temperature overnight, and the solvent was evaporated. To theresidue was added ethyl acetate and precipitates were filtered off. Thefiltrate was washed with sodium hydroxide solution, water and saturatedbrine, and dried with anhydrous magnesium sulfate. Under reducedpressure, the solvent was evaporated, and the residue was purified withsilica gel column chromatography (ethyl acetate) to give4-((N,N-bis(2-methoxyethyl)amino)methyl)aniline (6.2 g) as red oil.

¹ H-NMR(δ ppm, CDCl₃) 2.71 (4H, t, J=6.3 Hz), 3.31 (6H, s), 3.46 (4H, t,J=6.3 Hz), 3.59 (2H, s), 6.63 (2H, d, J=8.4 Hz), 7.10 (2H, d, J=8.4 Hz).IR(neat) ν: 3353, 2874, 2818, 1615cm⁻¹.

REFERENCE EXAMPLE 279

In 1,2-dichloroethane (50 ml) were dissolved p-nitrobenzaldehyde (5 g)and 3-ethoxypropylamine (3.75 g), and to the mixture was added, underice-cooling, triacetoxy sodium boro hydride (9.8 g). Under nitrogenatmosphere, the mixture was stirred at room temperature overnight, andto the mixture were added, under ice-cooling, 37% formalin (3.5 ml) andtriacetoxy sodium boro hydride (9.8 g). Under nitrogen atmosphere, themixture was stirred at room temperature for 8 hours, and the solvent wasevaporated. The residue was neutralized with 1N sodium hydroxidesolution, and the mixture was extracted with ethyl acetate. The organiclayer was washed with water and subjected to back extraction with 1Nhydrochloric acid. The mixture was washed with ethyl acetate,neutralized with 1N sodium hydroxide and extracted with ethyl acetate.The organic layer was washed with water and saturated brine, and driedwith anhydrous magnesium sulfate. Under reduced pressure, the solventwas evaporated to give N-(3-ethoxypropyl)-N-methyl-4-nitrobenzylamine(6.6 g) as yellow oil.

¹ H-NMR(δ ppm, CDCl₃) 1.18 (3H, t, J=7.0 Hz), 1.72-1.86 (2H, m), 2.20(3H, s), 2.48 (2H, t, J=7.6 Hz) 3.41-3.52 (4H, m), 3.58 (2H, s), 7.50(2H, d, J=8.8 Hz), 8.17 (2H, d, J=8.8 Hz). IR(neat) ν: 2859, 1520,1346cm⁻¹.

REFERENCE EXAMPLE 280

In THF (60 ml) were suspendedN-(3-ethoxypropyl)-N-methyl-4-nitrobenzylamine (6.0 g), iron chloride(III) (0.06 g) and active charcoal (0.6 g), and to the suspension wasadded dropwise hydrazine monohydrate (4.1 ml) at 60-65° C. The mixturewas stirred at 65° C. for 4 hours, and to the mixture was addedhydrazine monohydrate (15 ml). The mixture was stirred at 65° C. for 4hours and filtered. The solvent of the filtrate was evaporated, and theresidue was extracted with ethyl acetate. The organic layer was washedwith saturated brine and dried with anhydrous magnesium sulfate, and thesolvent was evaporated. The residue was dissolved in 2-propanol, and tothe mixture was added hydrochloric acid (6 ml). The solvent wasevaporated, and the precipitated4-((N-(3-ethoxypropyl)-N-methylamino)methyl)aniline dihydrochloride (5.8g) was filtered with ethyl acetate and washed with ethyl acetate-hexaneto give yellow powder.

mp 173-175° C.; ¹ H-NMR(δ ppm, CDCl₃ +CD₃ OD) 1.16 (3H, t, J=7.0 Hz),2.18 (2H, br), 2.72 (3H, s), 3.05-3.29 (2H, m), 3.40-3.52 (4H, m),4.22-4.43 (2H, m), 7.58 (2H, d, J=8.2 Hz), 7.78 (2H, d, J=8.2 Hz), 11.86(1H, br). IR(KBr) ν: 1651 cm⁻¹. Anal. Calcd. for C₁₃ H₂₂ N₂ O.2HCl: C,52.88; H, 8.19; N, 9.49. Found C, 52.61; H, 8.05; N, 9.55.

REFERENCE EXAMPLE 281

In 1,2-dichloroethane (50 ml) were suspended p-nitrobenzylaminehydrochloride (3 g), 1,3-dimethoxyacetone (1.9 g) and triethylamine (2.2ml), and to the mixture was added, under ice-cooling, triacetoxy sodiumboro hydride (4.7 g). Under nitrogen atmosphere, the mixture was stirredat room temperature for 5 hours, and to the mixture were added, underice-cooling, 37% formalin (1.8 ml) and triacetoxy sodium boro hydride (5g). Under nitrogen atmosphere, the mixture was stirred at roomtemperature overnight, and the solvent was evaporated. The residue wasneutralized withlN sodium hydroxide solution and extracted with ethylacetate. The organic layer was washed with water and saturated brine,and dried with anhydrous magnesium sulfate. Under reduced pressure, thesolvent was evaporated, and the residue was purified with silica gelcolumn (ethyl acetate/hexane) to giveN-(1,3-dimethoxypropan-2-yl)-N-methyl-4-nitrobenzylamine (3.2 g) asyellow oil.

¹ H-NMR(δ ppm, CDCl₃) 2.32 (3H, s), 2.97-3.09 (1H, m), 3.36 (6H, s)3.44-3.63 (4H, m), 3.85 (2H, s), 7.53 (2H, d, J=9.0 Hz), 8.17 (2H, d,J=9.0 Hz). IR(neat) ν: 2880, 1520, 1346cm⁻¹.

REFERENCE EXAMPLE 282

In acetic acid (100 ml) was dissolvedN-(1,3-dimethoxypropan-2-yl)-N-methyl-4-nitrobenzylamine (3.1 g), and tothe mixture was added reduced iron (3.2 g) little by little. The mixturewas stirred at room temperature overnight, and the solvent wasevaporated. To the residue was added ethyl acetate, and precipitateswere filtered off. The filtrate was washed with sodium hydroxidesolution, water and saturated brine, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue dissolved in ethyl acetate. To the mixture was added 4Nhydrochloric acid-ethyl acetate, and precipitates were filtered andwashed with diethylether. The mixture was dissolved in water, and themixture was neutralized with 1N sodium hydroxide solution and extractedwith ethyl acetate. The organic layer was washed with water andsaturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give4-((N-(1,3-dimethoxypropan-2-yl)-N-methylamino)methyl)aniline (2.4 g) asred oil.

¹ H-NMR(δ ppm, CDCl₃) 2.29 (3H, s), 2.95-3.07 (1H, m), 3.34 (6H, s),3.42-3.58 (4H, m), 3.61 (2H, s), 6.64 (2H, d, J=8.4 Hz), 7.11 (2H, d,J=8.4 Hz). IR(neat) ν: 3357, 2880, 1615, 1518 cm⁻¹.

REFERENCE EXAMPLE 283

In 1,2-dichloroethane (50 ml) were dissolved p-nitrobenzaldehyde (5 g)and 2-methoxyethylamine (2.7 g), and to the mixture was added, underice-cooling, triacetoxy sodium boro hydride (9.8 g). Under nitrogenatmosphere, the mixture was stirred at room temperature for 4 hours, andto the mixture were added, under ice-cooling, 37% formalin (3.8 ml) andtriacetoxy sodium boro hydride (10 g). Under nitrogen atmosphere, themixture was stirred at room temperature overnight, and the solvent wasevaporated. The residue was neutralized with 1N sodium hydroxidesolution and extracted with ethyl acetate. The organic layer was washedwith water and saturated brine, and dried with anhydrous magnesiumsulfate. Under reduced pressure, the solvent was evaporated, and theresidue was purified with silica gel column (ethyl acetate/hexane) togive N-(2-methoxyethyl)-N-methyl-4-nitrobenzylamine (5.9 g) as yellowoil.

¹ H-NMR(δ ppm, CDCl₃) 2.28 (3H, s), 2.63 (2H, t, J=5.6 Hz), 3.35 (3H,s), 3.52 (2H, t, J=5.6 Hz), 3.65 (2H, s) 7.52 (2H, d, J=8.8 Hz), 8.18(2H, d, J=8.8 Hz). IR(neat) ν: 2814, 1605, 1520, 1346 cm⁻¹.

REFERENCE EXAMPLE 284

In acetic acid (100 ml) was dissolvedN-(2-methoxyethyl)-N-methyl-4-nitrobenzylamine (5.9 g), and to themixture was added reduced iron (7.5 g) little by little. The mixture wasstirred at room temperature overnight, and the solvent was evaporated.To the residue was added ethyl acetate, and precipitates were filteredoff. The filtrate was washed with sodium hydroxide solution, water andsaturated brine, and dried with anhydrous magnesium sulfate. Underreduced pressure, the solvent was evaporated to give4-((N-(2-methoxyethyl)-N-methylamino)methyl)aniline (3.4 g) as red oil.

¹ H-NMR(δ ppm, CDCl₃) 2.24 (3H, s), 2.57 (2H, t, J=6.0 Hz), 3.33 (3H,s), 3.44 (2H, s), 3.50 (2H, t, J=6.0 Hz), 6.64 (2H, d, J=8.4 Hz), 7.09(2H, d, J=8.4 Hz). IR(neat) ν: 3349, 2813, 1615, 1518cm⁻¹.

REFERENCE EXAMPLE 285

In THF (350 ml) was dissolved 5-bromoanthranilic acid (40.06 g), and themixture was cooled to 0° C. To the mixture was added dropwise a solutionof 10.0M borane dimethylsulfide in THF (54.5 ml), and the mixture wasstirred at room temperature for 4.5 hours. The mixture was cooled to 0°C., and to the mixture was added dropwise 3N sodium hydroxide solution.The mixture was stirred at room temperature overnight, and to themixture was added granulated sodium hydroxide to adjust the mixture topH 11. The aqueous layer was saturated with potassium carbonate, and theTHF layer was separated. The aqueous layer was extracted with ether (100ml×5). The organic layers were combined and dried with magnesiumsulfate. The solvent was evaporated under reduced pressure to give(2-amino-5-bromophenyl)methanol (36.66 g, 100%).

¹ H NMR (200 MHz, CDCl₃) δ 4.62 (2H, s), 7.20 (1H, s), 7.23-7.26 (1H,m).

REFERENCE EXAMPLE 286

To acetone (300 ml) were added (2-amino-5-bromophenyl)methanol (23.32 g)and active manganese dioxide (58.5 g), and the mixture was stirred atroom temperature for 17.5 hours and filtered. The solvent was evaporatedunder reduced pressure to give 2-amino-5-bromobenzaldehyde (16.41 g,71%).

¹ H NMR (200 MHz, CDCl₃) δ 6.10-6.20 (2H, br), 6.57 (1H, d, J=8.8 Hz),7.38 (1H, dd, J=8.8, 2.4 Hz), 7.59 (1H, d, J=2.4 Hz), 9.81 (1H, s).

REFERENCE EXAMPLE 287

To acetic acid anhydride (34.8 ml) was added formic acid (17.0 ml) at 0°C., and the mixture was stirred at 60° C. for 2 hours, cooled anddiluted with THF (200 ml). In THF (100 ml) was dissolved2-amino-5-bromobenzaldehyde (16.40 g), and the mixture was addeddropwise to the previously prepared solution of formic acid anhydride inTHF at 0° C. The mixture was stirred at 0° C. for 2 hours, and thesolvent was evaporated under reduced pressure. The residue was washedwith hexane and filtered to give 4-bromo-2-formylphenylformamide (15.24g, 82%).

¹ H NMR (200 MHz, CDCl₃) δ 7.72 (1H, dd, J=8.8, 2.6 Hz), 7.83 (1H, d,J=2.6 Hz), 8.53 (1H, s), 8.68 (1H, d, J=9.2 Hz), 9.88 (1H, s), 10.94(1H, br).

REFERENCE EXAMPLE 288

To 4-bromo-2-formylphenylformamide (18.07 g), ethyl 4-bromobutyrate(30.9 g) and potassium carbonate (21.9 g) was added DMF (160 ml), andthe mixture was stirred at 70° C. for 24 hours. The mixture was dilutewith ethyl acetate (1400 ml), washed with water (300 ml×3) and saturatedbrine (150 ml), and dried with magnesium sulfate. The solvent wasevaporated under reduced pressure, and the residue was purified withsilica gel column chromatography (300 g, hexane:ethyl acetate=4:1→1:1)to give ethyl 4-(4-bromo-2,N-diformylanilino)butyrate (21.56 g, 80%).

¹ H NMR (200 MHz, CDCl₃) (syn:anti=5:2 or 2:5) δ 1.23 (2.1H, t, J=7.2Hz), 1.25 (0.9H, t, J=7.2 Hz), 1.87 (2H, quint, J=7.5 Hz), 2.35 (1.4H,t, J=7.3 Hz), 2.36 (0.6H, t, J=6.8 Hz), 3.78 (0.6H, t, J=7.5 Hz), 3.85(1.4H, t, J=7.6 Hz), 4.10 (1.4H, q, J=6.9 Hz), 4.15 (0.6H, q, J=7.2 Hz),7.17 (0.3H, d, J=8.4 Hz), 7.24 (0.7H, d, J=8.6 Hz), 7.81 (0.3H, dd,J=8.4, 2.4 Hz), 7.82 (0.7H, dd, J=8.4, 2.4 Hz), 8.09 (0.3H, d, J=2.4Hz), 8.10 (0.7H, d, J=2.4 Hz), 8.19 (0.7H, s), 8.39 (0.3H, s), 9.92(0.3H, s), 10.04 (0.7H, s).

REFERENCE EXAMPLE 289

In t-butanol (500 ml) were dissolved ethyl4-(4-bromo-2,N-diformylanilino)butyrate (15.32 g) and potassiumt-butoxide (5.53 g), and the mixture was ref luxed for 30 minutes. Tothe mixture were added water (500 ml) and 1N hydrochloric acid (50 ml),and the mixture was extracted with ethyl acetate (1000 ml).Theorganiclayerwaswashedwithsaturatedbrine (200 ml) and dried withmagnesium sulfate. The solvent was evaporated under reduced pressure,and the residue was purified with silica gel column chromatography (300g, hexane:ethyl acetate=4:1→1:1) to give ethyl7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylate (3.13 g, 22%)and 7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylic acid (1.39g, 10%).

Ethyl 7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylate;

mp 150.5-152° C.; ¹ H NMR (200 MHz, CDCl₃) 6 1.34 (3H, t, J=7.1 Hz),2.93 (2H, t, J=4.9 Hz), 3.80 (2H, t, J=5.7 Hz), 4.28 (2H, q, J=7.2 Hz),7.00 (1H, d, J=8.4 Hz), 7.50 (1H, dd, J=8.4, 2.2 Hz), 7.57 (1H, s), 7.66(1H, d, J=2.2 Hz), 8.46 (1H, s). IR (KBr) 1707, 1678, 1491, 1358, 1265,1235, 1194, 1088 cm⁻¹. Anal. Calcd. for C₁₄ H₁₄ NO₃ Br: C, 51.87; H,4.35; N, 4.32. Found: C, 51.81; H, 4.35; N, 4.19.

7-Bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylic acid;

mp 248-249.5° C.; ¹ H NMR (200 MHz, DMSO-d₆) δ 2.73 (2H, td, J=5.1, 1.2Hz), 3.67 (2H, t, J=5.9 Hz), 7.33 (1H, d, J=8.4 Hz), 7.57 (1H, s), 7.61(1H, dd, J=8.4, 2.6 Hz), 7.91 (1H, d, J=2.4 Hz), 8.48 (1H, s). IR (KBr)1665, 1491, 1431, 1360, 1300, 1281, 1252, 1196, 999, 918, 841, 754 cm⁻¹.Anal. Calcd. for C₁₂ H₁₀ NO₃ Br: C, 48.67; H, 3.41; N, 4.73. Found: C,48.70; H, 3.56; N, 4.54.

REFERENCE EXAMPLE 290

In 1N sodium hydroxide (13.0 ml) and THF:ethanol (1:1, 50 ml) wasdissolved ethyl 7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylate(2.77 g), and the mixture was stirred at room temperature for 15 hours.To the mixture was added 1N hydrochloric acid (12.5 ml), and the mixturewas concentrated. To the residue was added water (200 ml), and themixture was adjusted to pH 2 with 1N hydrochloric acid. The mixture wasextracted with ethyl acetate(300 ml×3), and the organic layer was driedwith magnesium sulfate. The solvent was evaporated under reducedpressure to give 7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylicacid (2.52 g, 100%).

REFERENCE EXAMPLE 291

To a solution of 7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylicacid (3.28 g) in DMF (30 ml) was added dropwise thionyl chloride (2.0ml) at 0° C., and the mixture was stirred at room temperature for 30minutes. Under reduced pressure, thionyl chloride and DMF wereevaporated, and the residue was dissolved in dichloromethane (40 ml). Toa solution of4-([N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]aniline (3.90 g)and triethylamine (11.6 ml) in dichloromethane (40 ml) was addeddropwise the previously prepared chloride solution at 0° C., and themixture was stirred at room temperature for 7 hours. The mixture wasconcentrated under reduced pressure, and the residue was diluted withethyl acetate (400 ml), washed with water (100 ml×2) and saturated brine(50 ml), and dried with magnesium sulfate. The solvent was evaporatedunder reduced pressure, and the residue was purified with silica gelcolumn chromatography (200 g, ethyl acetate→ethyl acetate/ethanol=10:1)to give7-bromo-1-formyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide(2.13 g, 39%).

mp 173-175° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.66-1.77 (4H, m), 2.21 (3H,s), 2.58-2.73 (1H, m), 3.02 (2H, t, J=4.8 Hz), 3.37 (2H, td, J=10.3, 2.9Hz), 3.58 (2H, s), 3.87 (2H, t, J=5.5 Hz), 4.02-4.08 (2H, m), 7.03 (1H,d, J=8.4 Hz), 7.32 (2H, d, J=8.4 Hz), 1H was concealed under 7.27-7.34,7.50 (1H, s), 7.51 (1H, dd, J=8.5, 2.3 Hz), 7.52 (2H, d, J=8.4 Hz), 7.65(1H, d, J=2.2 Hz), 8.49 (1H, s). IR (KBr) 2953, 2845, 1669, 1599, 1520,1358, 1316, 1260, 1192, 733 cm⁻¹. Anal. Calcd. for C₂₅ H₂₈ N₃ O₃ Br: C,60.24; H, 5.66; N, 8.43. Found: C, 60.15; H, 5.69; N, 8.49.

REFERENCE EXAMPLE 292

To t-butyl 7-bromo-1-methyl-2,3-dihydro-1-benzazepine-4-carboxylate (4.0g), 4-ethoxyphenyl borate (2.35 g), 1M potassium carbonate solution (25ml) and ethanol (25 ml) was added toluene (100 ml), and the mixture wasstirred under argon atmosphere at room temperature for 30 minutes. Tothe mixture was added tetrakistriphenylphosphine palladium (0.55 g), andthe mixture was ref luxed under argon atmosphere overnight. The organiclayer was washed with water and saturated brine, and dried withanhydrous magnesium sulfate. Under reduced pressure, the solvent wasevaporated, and the residue was purified with silica gel column (ethylacetate/hexane) to give t-butyl7-(4-ethoxyphenyl)-1-methyl-2,3-dihydro-1-benzazepine-4-carboxylate (4.0g) as yellow crystals.

mp 140-142° C.; ¹ H-NMR(δ ppm, CDCl₃) 1.43 (3H, t, J=7.0 Hz), 1.54 (9H,s), 2.82 (2H, t, J=4.8 Hz), 3.05 (3H, s), 3.27 (2H, t, J=4.8 Hz), 4.07(2H,q,J=7.0 Hz), 6.83 (1H, d, J=8.4 Hz), 6.95 (2H, d, J=8.8 Hz),7.38-7.49 (4H, m), 7.66 (1H, s). IR(KBr) n: 2978, 1694cm⁻¹. Anal. Calcd.for C₂₄ H₂₉ NO₃ : C, 75.96; H, 7.70; N, 3.69. Found C, 75.91; H, 7.89;N, 3.49.

REFERENCE EXAMPLE 293

In dimethoxyethane (100 ml) was dissolved t-butyl7-(4-ethoxyphenyl)-1-methyl-2,3-dihydro-1-benzazepine-4-carboxylate (4.0g), and to the mixture was added 6N hydrochloric acid (25 ml). Themixture was refluxed for 3 hours, and the solvent was evaporated.Precipitated yellow powder was filtered and washed with ethylacetate-hexane to give7-(4-ethoxyphenyl)-1-methyl-2,3-dihydro-1-benzazepine-4-carboxylic acidhydrochloride (3.8 g).

mp 245-254° C.(dec.). ¹ H-NMR(δ ppm, DMSO-d₆) 1.35 (3H, t, J=7.0 Hz),2.77 (2H, br), 3.02 (3H, s), 3.25 (2H, br), 4.05 (2H,q,J=7.0 Hz),6.94-6.98 (3H, m), 7.49-7.68 (5H, m). IR(KBr) ν: 2976, 2880, 2475,1701cm⁻¹.

REFERENCE EXAMPLE 294

In 1N hydrochloric acid (25 ml) and ethanol (20 ml) was dissolved ethyl7-bromo-1-formyl-2,3-dihydro-1-benzazepine-4-carboxylate (1165 mg), andthe mixture was refluxed for 2 hours. The mixture was neutralized withsaturated sodium hydrogen carbonate solution, and the mixture wasextracted with ethyl acetate (300 ml). The organic layer was washed withwater (100 ml) and dried with anhydrous magnesium sulfate. The solventwas evaporated under reduced pressure, and the residue was purified withsilica gel column chromatography (150 g, hexane/ethyl acetate=9:1) togive ethyl 7-bromo-2,3-dihydro-1-benzazepine-4-carboxylate (628 mg,59%).

mp 120-121° C.; ¹ H NMR (200 MHz, CDCl₃) δ 1.34 (3H, t, J=7.1 Hz), 2.86(2H, td, J=4.8, 1.2 Hz), 3.36 (2H, t, J=4.8 Hz), 4.25 (2H, q, J=7.1 Hz),4.51-4.66 (1H, br), 6.49 (1H, d, J=8.8 Hz), 7.15 (1H, dd, J=8.7, 2.3Hz), 7.39 (1H, d, J=2.2 Hz), 7.53 (1H, s). IR (KBr) 3377, 2978, 1694,1493, 1248, 1209, 1173, 1090, 812 cm⁻¹. Anal. Calcd. for C₁₃ H₁₄ BrNO₂ :C, 52.72; H, 4.76; N, 4.73. Found: C, 52.54; H, 4.88; N, 4.60.

REFERENCE EXAMPLE 295

In dichloromethane (30 ml) were dissolved7-bromo-2,3-dihydro-1-benzazepine-4-carboxylic acid ethyl (457 mg) andtriethylamine (1.29 ml), and to the mixture was added dropwise at 0° C.trifluoromethanesulfonic acid anhydride (1.56 ml). The mixture wasstirred at 0° C. for 4 hours, and to the mixture was added water (50 ml)at 0° C. The mixture was extracted with dichloromethane (100 ml), andthe organic layer was dried with anhydrous magnesium sulfate. Thesolvent was evaporated under reduced pressure, and the residue waspurified with silica gel column chromatography (50 g, hexane/ethylacetate=9:1) to give ethyl7-bromo-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxylate(516 mg, 78%).

¹ H NMR (200 MHz, CDCl₃) δ 1.36 (3H, t, J=7.5 Hz), 3.00 (2H, t, J=6.0Hz), 3.91-4.03 (2H, m), 4.30 (2H, q, J=7.2 Hz), 7.38 (1H, d, J=8.4 Hz),7.45 (1H, dd, J=8.8, 2.2 Hz), 7.63 (1H+1H, s). IR (KBr) 2982, 1713,1487, 1397, 1252, 1227, 1194, 1142, 1100, 1090, 700, 627 cm⁻¹.

REFERENCE EXAMPLE 296

In water/ethanol/toluene (1:1:10, 36.0 ml) 4-methylphenyl borate (194mg) and ethyl7-bromo-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxylate(510 mg) were dissolved, and to the mixture was added potassiumcarbonate (395 mg). The mixture was stirred under argon atmosphere for30 minutes, and to the mixture was added tetrakistriphenylphosphinepalladium (138 mg). Under argon atmosphere, the mixture was ref luxedfor 17 hours, and the mixture was diluted with ethyl acetate (150 ml)and washed with water (50 ml) and saturated brine (50 ml). The organiclayer was dried with anhydrous magnesium sulfate. The solvent wasevaporated under reduced pressure, and the residue was purified withsilica gel column chromatography (50 g, hexane/ethyl acetate=9:1) togive ethyl7-(4-methylphenyl)-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxylate(469 mg, 90%).

¹ H NMR (200 MHz, CDCl₃) δ 1.37 (3H, t, J=7.2 Hz), 2.41 (3H, s), 3.02(2H, t, J=6.0 Hz), 3.99-4.05 (2H, m), 4.31 (2H, q, J=7.1 Hz), 7.27 (2H,d, J=8.0 Hz), 7.43-7.56 (4H, m), 7.60-7.68 (1H, m), 7.77 (1H, s). IR(KBr) 2982, 1709, 1495, 1395, 1246, 1225, 1192, 1152, 1096, 812, 642,588 cm⁻¹.

REFERENCE EXAMPLE 297

In 1N sodium hydroxide solution (3.0 ml) and THF/ethanol (1:1, 12.0 ml)was dissolved7-(4-methylphenyl)-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxylicacid ethyl (463 mg), and the mixture was stirred at room temperature for14 hours. The mixture was neutralized with 1N hydrochloric acid (3.5 ml)and concentrated. To the residue was added water (40 ml), and themixture was extracted with ethyl acetate (100 ml×3). The organic layerwas dried with anhydrous magnesium sulfate, and the solvent wasevaporated under reduced pressure to give7-(4-methylphenyl)-1-[(trifluoromethyl)sulfonyl]-2,3-dihydro-1-benzazepine-4-carboxylicacid (393 mg, 91%).

¹ H NMR (200 MHz, DMSO-d₆) δ 2.39 (3H, s), 2.94 (2H, t, J=6.2 Hz),4.00-4.08 (2H, m), 7.28 (2H, d, J=8.6 Hz), 7.41-7.49 (1H, m), 7.56 (2H,d, J=8.4 Hz), 7.61-7.66 (1H, m), 7.73-7.77 (1H, m), 8.00 (1H, s).

REFERENCE EXAMPLE 298

To a solution of 4-nitrobenzaldehyde (3.02 g) and 2-aminopyridine (1.88g) in 1,2-dichloroethane (70 ml) were added triacetoxy sodium borohydride (5.93 g) and acetic acid (1.14 ml), and the mixture was stirredunder nitrogen atmosphere at room temperature for 2 hours andconcentrated. To the residue was added sodium bicarbonate solution, andthe mixture was extracted with ethyl acetate, washed with brine, dried(anhydrous magnesium sulfate) and concentrated. The residue was purifiedwith silica gel column chromatography (ethyl acetate/hexane=1/1), and tothe purified materials were added ethyl acetate/diethylether and 1Nhydrochloric acid. The aqueous layer was extracted and washed withdiethylether, and to the mixture was added sodium carbonate. The mixturewas extracted with ethyl acetate, and the extract was dried (anhydrousmagnesium sulfate), concentrated and recrystallized from ethylacetate/hexane to give 2-[(4-nitrophenyl)methylamino]pyridine (1.63 g)as pale yellow crystals.

m.p. 131-132° C.; ¹ H-NMR (200 MHz, CDCl₃) δ: 4.67 (2H, d, J=6.0),4.9-5.1 (1H, brm), 6.37 (1H, d, J=8.4), 6.63 (1H, dd, J=5.1, 6.9),7.35-7.45 (1H, m), 7.52 (2H, d, J=8.8), 8.15-8.25 (1H, m), 8.18 (2H, d,J=8.8). IR (KBr) 1601, 1516, 1460, 1348, 1281, 1159, 999, 772cm⁻¹ Analfor C₁₂ H₁₁ N₃ O₂ Calcd. C, 62.87; H, 4.84; N, 18.33: Found. C, 62.69;H, 4.69; N, 18.20.

REFERENCE EXAMPLE 299

To a solution of nicke l bromide (44 mg) in methanol (4 ml)/THF (4 ml)was added sodium boro hydride (40 mg), and the mixture was stirred. Tothe mixture was added 2-[(4-nitrophenyl)methylamino]pyridine (0.92 g)and then sodium boro hydride (414 mg), and the mixture was stirred atroom temperature for 1 hour. To the mixture was added nickel bromide (44mg)and sodium boro hydride (454 mg), and the mixture was stirred at roomtemperature for 2 hours. Insoluble materials were filtered off withsellaite, and to the filtrate was added sodium bicarbonate solution. Themixture was extracted with ethyl acetate and washed with brine. Theextract was dried (anhydrous magnesium sulfate) and concentrated, andthe residue was purified twice with silica gel column chromatography(ethyl acetate/hexane=1/1) to give2-[(4-aminophenyl)methylamino]pyridine (369 mg) as pale red solid.

¹ H-NMR (200 MHz, CDCl₃) δ: 3.4-3.8 (2H, br), 4.36 (2H, d, J=5.2),4.7-4.85 (1H, br), 6.37 (1H, d, J=8.4), 6.58 (1H, dd, J=5.2, 8.0), 6.66(2H, d, J=8.4), 7.15 (2H, d, J=8.4), 7.35-7.45 (1H, m), 8.05-8.15 (1H,m). IR (KBr) 1603, 1578, 1514, 1443, 1335, 1294, 1159, 818, 770cm⁻¹.

INDUSTRIAL APPLICABILITY

The compound of the formula (I) or a salt thereof of the presentinvention has potent antagonistic activity on MCP-1 receptor and can beadvantageously used for the treatment or prophylaxis of variousinflammatory diseases in human and animals, cardiac inf arction,myocarditis, etc.

What is claimed is:
 1. A compound of the formula: ##STR39## wherein R¹is an optionally substituted 5- to 6-membered ring, W is a divalentgroup of the formula: ##STR40## wherein the ring A is an optionallysubstituted 5- to 6-membered aromatic ring, X is an optionallysubstituted carbon atom, an optionally substituted nitrogen atom, sulfuratom or oxygen atom, the ring B is an optionally substituted 5- to7-membered ring, Z is a chemical bond or a divalent group, R² is (1) anoptionally substituted amino group in which a nitrogen atom may form aquaternary ammonium, (2) an optionally substituted nitrogen-containingheterocyclic ring group which may contain a sulfur atom or an oxygenatom as ring constituting atoms and wherein a nitrogen atom may form aquaternary ammonium, (3) a group binding through a sulfur atom or (4) agroup of the formula: ##STR41## wherein k is 0 or 1, and when k is 0, aphosphorus atom may form a phosphonium; and R⁵ and R⁶ are independentlyan optionally substituted hydrocarbon group or an optionally substitutedamino group, and R⁵ and R⁶ may bind to each other to form a cyclic grouptogether with the adjacent phosphorus atom, or a salt thereof.
 2. Acompound according to claim 1, wherein R¹ is benzene, furan, thiophene,pyridine, cyclopentane, cyclohexane, pyrrolidine, piperidine,piperazine, morpholine, thiomorpholine or tetrahydropyran, each of whichmay be substituted.
 3. A compound according to claim 1, wherein R¹ is anoptionally substituted benzene.
 4. A compound according to claim 1,wherein the ring A is furan, thiophene, pyrrole, pyridine or benzene,each of which may be substituted.
 5. A compound according to claim 1,wherein the ring A is an optionally substituted benzene.
 6. A compoundaccording to claim 1, wherein the ring B is a 5- to 7-membered ringgroup of the formula: ##STR42## wherein Y is --Y'--(CH₂)_(m) -- (whereinY' is --S--, --O--, --NH-- or --CH₂ --, and m is an integer of 0-2),--CH═CH-- or --N═CH--), which may have a substituent at any possibleposition.
 7. A compound according to claim 6, wherein Y is --Y'--(CH₂)₂-- (wherein Y' is --S--, --O--, --NH-- or --CH₂ --).
 8. A compoundaccording to claim 6, wherein Y is --(CH₂)₂ --, --(CH₂)₃ -- or--O--(CH₂)₂ --.
 9. A compound according to claim 8, wherein the ring Ais an optionally substituted benzene.
 10. A compound according to claim1, wherein Z is an optionally substituted C₁₋₃ alkylene.
 11. A compoundaccording to claim 1, wherein Z is a divalent group of the formula:--Z'--(CH₂)_(n) -- (wherein Z' is --CH(OH)--, --C(O)-- or --CH₂ --, andn is an integer of 0-2) in which an optional methylene group may besubstituted.
 12. A compound according to claim 1, wherein Z ismethylene.
 13. A compound according to claim 1, wherein Z is substitutedat para position of the benzene ring.
 14. A compound according to claim1, wherein R² is (1) an optionally substituted amino group in which anitrogen atom may form a quaternary ammonium, (2) an optionallysubstituted nitrogen-containing heterocyclic ring group which maycontain a sulfur atom or an oxygen atom as ring constituting atoms andwherein a nitrogen atom may form a quaternary ammonium, or (3) a groupof the formula: ##STR43## wherein R⁵ and R⁶ are independently anoptionally substituted hydrocarbon group, and R⁵ and R⁶ may bind to eachother to form a cyclic group together with the adjacent phosphorus atom.15. A compound of the formula: ##STR44## wherein X⁻ is an anion.
 16. Acompound according to claim 15, wherein X is a halogen atom.
 17. Acompound selected from the group consistingofN-methyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]piperidiniumiodide,N-methyl-N-[4-[[[7-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-4-yl]carbonyl]amino]benzyl]piperidiniumiodide,N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-methylphenyl)-2,3-dihydro-1-benzoxepine-4-carboxmide,N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-7-(4-morpholinophenyl)-2,3-dihydro-1-benzoxepine-4-carboxmide,7-(4-ethoxyphenyl)-N-[4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]phenyl]-2,3-dihydro-1-benzoxepine-4-carboxmide,N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]-N-(tetrahydropyran-4-yl)ammoniumiodide andN-methyl-N-[4-[[[7-(4-methylphenyl)-3,4-dihydronaphthalen-2-yl]carbonyl]amino]benzyl]piperidiniumiodide, or a salt thereof.
 18. A method for producing a compound of theformula: ##STR45## wherein each symbol is as defined in claim 1 or asalt thereof, which comprises subjecting a compound of the formula:

    R.sup.1 --W--COOH

wherein each symbol is as defined in claim 1, a salt or a reactivederivative thereof to condensation reaction with a compound of theformula: ##STR46## wherein Z is as defined in claim 1 and R² ' is (1) anoptionally substituted amino group in which a nitrogen atom may form aquaternary ammonium, (2) an optionally substituted nitrogen-containingheterocyclic ring group which may contain a sulfur atom or an oxygenatom as ring constituting atoms and wherein a nitrogen atom may form aquaternary ammonium, (3) a group binding through a sulfur atom or (4) agroup of the formula: ##STR47## wherein k is 0 or 1, and when k is 0, aphosphorus atom may form a phosphonium; and R⁵ and R⁶ are independentlyan optionally substituted hydrocarbon group or an optionally substitutedamino group, and R⁵ and R⁶ may bind to each other to form a cyclic grouptogether with the adjacent phosphorus atom, the above groups (1)-(4)being optionally protected, or a salt thereof, and, if desired,subjecting the obtained product to deprotection, oxidation, reductionand/or ammoniumation.
 19. A pharmaceutical composition comprising acompound according to claim 1 or a salt thereof.
 20. A compositionaccording to claim 19, which is for antagonizing MCP-1 receptor.
 21. Acomposition according to claim 19, which is for the treatment orprophylaxis of cardiac infarction or myocarditis.
 22. A pharmaceuticalcomposition for antagonizing MCP-1 receptor, which comprises a compoundof the formula: ##STR48## wherein R¹ is an optionally substituted 5- to6-membered ring, W is a divalent group of the formula: ##STR49## whereinthe ring A is an optionally substituted 5- to 6-membered aromatic ring,X is an optionally substituted carbon atom, an optionally substitutednitrogen atom, sulfur atom or oxygen atom, the ring B is an optionallysubstituted 5- to 7-membered ring, Z is a chemical bond or a divalentgroup, R² is (1) an optionally substituted amino group in which anitrogen atom may form a quaternary ammonium, (2) an optionallysubstituted nitrogen-containing heterocyclic ring group which maycontain a sulfur atom or an oxygen atom as ring constituting atoms andwherein a nitrogen atom may form a quaternary ammonium, (3) a groupbinding through a sulfur atom or (4) a group of the formula: ##STR50##wherein k is 0 or 1, and when k is 0, a phosphorus atom may form aphosphonium; and R⁵ ' and R⁶ ' are independently an optionallysubstituted hydrocarbon group, an optionally substituted hydroxy groupor an optionally substituted amino group, and R⁵ ' and R⁶ ' may bind toeach other to form a cyclic group together with the adjacent phosphorusatom, or a salt thereof.
 23. A method for antagonizing MCP-1 receptorwhich comprises administering to a mammal in need thereof an effectiveamount of a compound of the formula: ##STR51## wherein R¹ is anoptionally substituted 5- to 6-membered ring; W is a divalent group ofthe formula: ##STR52## wherein the ring A is an optionally substituted5- to 6-membered aromatic ring, X is an optionally substituted carbonatom, an optionally substituted nitrogen atom, sulfur atom or oxygenatom, and the ring B is an optionally substituted 5- to 7-membered ring;Z is a chemical bond or a divalent group; R² is (1) an optionallysubstituted amino group in which a nitrogen atom may form a quaternaryammonium, (2) an optionally substituted nitrogen-containing heterocyclicring group which may contain a sulfur atom or an oxygen atom as ringconstituting atoms and wherein a nitrogen atom may form a quaternaryammonium, (3) a group binding through a sulfur atom or (4) a group ofthe formula: ##STR53## wherein k is 0 or 1, and when k is 0, aphosphorus atom may form a phosphonium; and R⁵ ' and R⁶ ' areindependently an optionally substituted hydrocarbon group, an optionallysubstituted hydroxy group or an optionally substituted amino group, andR⁵ ' and R⁶ ' may bind to each other to form a cyclic group togetherwith the adjacent phosphorus atom, or a salt thereof.
 24. A method forantagonizing MCP-1 receptor which comprises administering to a mammal inneed thereof an effective amount of a compound according to claim 1 or asalt thereof.
 25. A method of making a medicament for antagonizing MCP-1receptor comprising using a compound of the formula: ##STR54## whereinR¹ is an optionally substituted 5- to 6-membered ring; W is a divalentgroup of the formula: ##STR55## wherein the ring A is an optionallysubstituted 5- to 6-membered aromatic ring, X is an optionallysubstituted carbon atom, an optionally substituted nitrogen atom, sulfuratom or oxygen atom, and the ring B is an optionally substituted 5- to7-membered ring; Z is a chemical bond or a divalent group; R² is (1) anoptionally substituted amino group in which a nitrogen atom may form aquaternary ammonium, (2) an optionally substituted nitrogen-containingheterocyclic ring group which may contain a sulfur atom or an oxygenatom as ring constituting atoms and wherein a nitrogen atom may form aquaternary ammonium, (3) a group binding through a sulfur atom or (4) agroup of the formula: ##STR56## wherein k is 0 or 1, and when k is 0, aphosphorus atom may form a phosphonium; and R⁵ ' and R⁶ ' areindependently an optionally substituted hydrocarbon group, an optionallysubstituted hydroxy group or an optionally substituted amino group, andR⁵ ' and R⁶ ' may bind to each other to form a cyclic group togetherwith the adjacent phosphorus atom, or a salt thereof.
 26. A method formaking a medicament for antagonizing MCP-1 receptor comprising using thecompound according to claim 1 or a salt thereof.